Citrus Sinensis ID: 003576
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 810 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SW11 | 835 | U-box domain-containing p | yes | no | 0.964 | 0.935 | 0.553 | 0.0 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.948 | 0.908 | 0.505 | 0.0 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.943 | 0.959 | 0.489 | 0.0 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.934 | 0.924 | 0.485 | 0.0 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.588 | 0.595 | 0.493 | 1e-126 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.928 | 0.901 | 0.313 | 1e-101 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.520 | 0.524 | 0.376 | 3e-83 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.503 | 0.787 | 0.364 | 5e-71 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.364 | 0.335 | 0.374 | 7e-48 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.364 | 0.337 | 0.371 | 1e-46 |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 877 bits (2267), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/826 (55%), Positives = 585/826 (70%), Gaps = 45/826 (5%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIP 75
+V VA+ G+ KS+Y V WA+EKF EG FKLLH+ P ITSVPTP +GN IP
Sbjct: 21 TVVVALSGSSKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTP--------MGNAIP 72
Query: 76 IEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCN 135
I +VRDDV AY+QE W+++ +L P+ + +R+V VEV VIESD+VA AIA+EV +
Sbjct: 73 ISEVRDDVVTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDS 132
Query: 136 INKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTK 195
I+++VIG S+ F+ +K ++ S IS +P+FCTVY V KGKLS VRPSD + +
Sbjct: 133 IDRIVIGGSSRSFFS---RKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIR 189
Query: 196 DDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAV-NKTLLHLKP 254
+D S+ S+S SS S S + SA S S SLP +R+Q A+ + + ++
Sbjct: 190 EDGSERTNSSSGSSGPTSDSSDVMSSAHDS--QSRPLSLPVRRMQHFPAIAGQASVPMET 247
Query: 255 SSTEINHSRCQSFDVEEQKDASSSCLSGP--------------EVRQTVSRSSSYR---- 296
SS + +RC S D EE +D SS S E ++ +S SSS R
Sbjct: 248 SSVGSDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAMSSSSSNREYGN 307
Query: 297 ----------SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMY 345
++T + S QAS +D L S +++QV++NFE+EKLR ELRHV+ MY
Sbjct: 308 FGTRFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMY 367
Query: 346 AIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECAR 405
A+AQ E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +E ARR+AE R
Sbjct: 368 AVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMR 427
Query: 406 ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIG 465
AE+E AQR+EAE K+ + KEKE LE L +Y++ WEEI +AT SFSE L+IG
Sbjct: 428 ERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIG 487
Query: 466 MGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC 525
MG YG VYK HHT A VKVLQS N +KQF QELE+LSKIRHPHL+LLLGACP+ G
Sbjct: 488 MGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGA 547
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
LVYEYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP N
Sbjct: 548 LVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPAN 607
Query: 586 ILLDHNLVSKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 644
ILLDHN VSK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQRTG IS KSD+
Sbjct: 608 ILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDI 667
Query: 645 YAYGMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCA 703
Y++GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+ELAAL L C
Sbjct: 668 YSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCT 727
Query: 704 ELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAAD 763
ELR KDRPDLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK+VMNEPCVAAD
Sbjct: 728 ELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAAD 787
Query: 764 GYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 809
GYTYDR AIEEWL+E++ SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 788 GYTYDRHAIEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/844 (50%), Positives = 568/844 (67%), Gaps = 76/844 (9%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPI 76
VAVA+ G +KS+Y V WALEKFIPEG FKLL+VRP ++ +PTP +A+ +
Sbjct: 24 VAVAINGKKKSKYVVFWALEKFIPEGFTDFKLLYVRPPVSYIPTPMGIAVA--------V 75
Query: 77 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNI 136
++R+DV +AYKQE W + +L P++ M +R+V+VEV +++S + A AIA+E+A +
Sbjct: 76 SELREDVVSAYKQELDWSANEMLRPYKKMFERRKVQVEVLLLDSLEPAAAIAEEIAGTGV 135
Query: 137 NKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTK- 195
KLVIG +G F+ +K ++SS I+ VP FCTVY + KGKL+SVRPS+ + GS +
Sbjct: 136 TKLVIGMSLRGFFS---RKIDMSSLIATAVPRFCTVYVISKGKLASVRPSESDASGSIRF 192
Query: 196 --------------------DDSSDTGCSNSSSSSHNSSSQTDLGS-AVASYTHSSSPSL 234
D S + S S + + + +GS AVA SSS
Sbjct: 193 ERSSSTSGSTDSPRLPPEYQDFLSAVSEAQSRVSPFSPALKHSMGSNAVAQMDTSSSG-- 250
Query: 235 PTQRLQALSAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSS 294
T + + + ++H S E ++ +SF S+S G E ++S +S
Sbjct: 251 -TDQEEVSTGRGMEIVH---SGIEGKKNKDESF--------SASFPMGTEAYNSMSWTSK 298
Query: 295 YRSMETE---------------NQDW-----------SDQAS--TTDVLPYDSSSESQVD 326
+R E N DW S AS + +L S +++QV+
Sbjct: 299 WRDHEDRREMRSSSSSNNHDLVNMDWGAVVPENYSWVSHTASHMSDGLLSVHSITDNQVN 358
Query: 327 VNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIEL 386
+NFE+EKLR EL+HV+ MYA+AQ E AS+K+ +LN+ + EE +L E++ EE A +
Sbjct: 359 LNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDT 418
Query: 387 AKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNL 446
A +EK++YE A +EAE + KEA R+EAE KA+ +A+EK+ L+ +L +Y++
Sbjct: 419 ASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHY 478
Query: 447 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLS 506
TWEEI +AT F+ENL+IG+G YG+VYK HHT AVKVL + +KQF QELE+LS
Sbjct: 479 TWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILS 538
Query: 507 KIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
KIRHPHL+LLLGACP+ GCLVYEYM+NGSL+DRL N+TPPIPWFER+RIA EVASAL
Sbjct: 539 KIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALV 598
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
FLH +KP+PIIHRD+KPGNILLDHN VSK+GDVGLSTM+N D T +K T PVGTLC
Sbjct: 599 FLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLC 658
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-NLAEILDAQAG 685
YIDPEYQRTG+ISPKSDVY+ G+VILQL+TAKPAIAITH VE AI +D ILD +AG
Sbjct: 659 YIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAG 718
Query: 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNH 745
WPI +T+ELAALGL C E+RR+DRPDLK+Q++P LERL++VAD+A++ + PP+H
Sbjct: 719 SWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQNLLSRTPSGPPSH 778
Query: 746 FICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAIL 805
FICP+LK VMNEPCVAADGYTYDR+AIEEWL++ D SP+T+LPLPNKNL+ NYTL SAI+
Sbjct: 779 FICPLLKGVMNEPCVAADGYTYDREAIEEWLRQKDTSPVTNLPLPNKNLIANYTLYSAIM 838
Query: 806 DWKS 809
+WKS
Sbjct: 839 EWKS 842
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/822 (48%), Positives = 544/822 (66%), Gaps = 58/822 (7%)
Query: 14 ALSVAVAVKGNR-KSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGN 72
AL VAVA+KGN K++ V WAL++F + +FKLLHV+PR ++ + T
Sbjct: 5 ALIVAVAIKGNNSKTKGVVRWALQEFASQEHVVFKLLHVQPRDSNSVSTTR--------- 55
Query: 73 FIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVA 132
+D + YK++ KT +LLP R+M R V++++ V+ESDD+A AI+ V
Sbjct: 56 -------KDLTTSVYKKDVDRKTREMLLPSRDMFVHREVQLDIMVLESDDIADAISKAVQ 108
Query: 133 SCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIG 192
I++LVIGA S IF+WK K++NLSSRI+ P FC+V+ + KGKL +VR SD+ +
Sbjct: 109 DHGISELVIGASSSIIFSWKLKRSNLSSRIADATPRFCSVHVISKGKLLNVRKSDMDTET 168
Query: 193 STKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL--- 249
S DD S+ S SS SH+ + S+ +S+ SS+P L QR+QAL+ VN+ +
Sbjct: 169 SIADDRSE---SRFSSDSHSGTV-----SSTSSHQFSSTPLL-FQRIQALTTVNQKVGTN 219
Query: 250 ---LHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRS---SSYRSMETENQ 303
+ +P N R S DV+E K + SS+RS + E
Sbjct: 220 IGKQNNEPHHHHHN--RAGSLDVDESKLLNQKGFYRTSSSGIGYGGSDISSWRSSQME-- 275
Query: 304 DWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLN 363
+AS++ +SS SQ+ +FELEKL+IELRH++GMYA+AQ+E DAS+K+ DLN
Sbjct: 276 ----EASSSSTYSDPTSSSSQIHKDFELEKLKIELRHIKGMYAVAQSEVIDASKKMQDLN 331
Query: 364 KCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAK 423
+ + EE TRL + + EE+A E+ + E+++ E A EAE R E+E +R EAE +A+
Sbjct: 332 QRRSEEATRLKNLTIREEEADEVVEMERERQEDAENEAELVRECIERETEERLEAEARAE 391
Query: 424 HEAKEKEMLERALNG---TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT 480
KEK+ LE AL G Q+Y WEEI AT SFS+ L+IG+GGYG+VY+ HHT
Sbjct: 392 EVRKEKQRLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHT 451
Query: 481 FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRL 540
AVKVL S + KQF QELE+LSKIRHPHLLLLLGACP+ G LVYEYM NGSLE+RL
Sbjct: 452 TVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERL 511
Query: 541 YRKN------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594
++ PP+ WFER+RIAWE+ASAL FLH +P+PI+HRD+KP NILLD N VS
Sbjct: 512 MKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVS 571
Query: 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 654
KIGDVGLS M+N DPS ST + TGPVGT YIDPEYQRTG+++P+SD+YA+G+++LQL
Sbjct: 572 KIGDVGLSKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQL 631
Query: 655 LTAKPAIAITHKVETAIDEDN--LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 712
+TA+ A+ + H +E A+ + EILD AGDWP+KE KE+ +GL CAE+R++DRPD
Sbjct: 632 VTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPD 691
Query: 713 LKNQVLPVLERLKEVADRAR----DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYD 768
L ++LPVLERLKEVA AR D + H P HF CPI K+VM PCVA+DGYTY+
Sbjct: 692 LGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYE 751
Query: 769 RKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
++AI+EWLQ+N KSP+TDLP P+ +LLPN++LLSAI +W+S+
Sbjct: 752 KRAIKEWLQKNHKSPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/834 (48%), Positives = 549/834 (65%), Gaps = 77/834 (9%)
Query: 10 PNSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHP 69
P+ P ++VA+A+ G+ KS+ + WAL KF + FKL+H+ P+IT++PT +
Sbjct: 28 PSEP-MTVALAISGSIKSKNVIKWALNKFGSDKNVTFKLIHIHPKITTLPTAS------- 79
Query: 70 VGNFIPIEQVRDDVAAAYKQEEKWKTDRLLL-PFRNMCAQRR--------------VEVE 114
GN + I + ++VAAAY+Q+ +T LL PF+ MC +++ V VE
Sbjct: 80 -GNIVSISEELEEVAAAYRQKVMQETKETLLKPFKKMCERKKLKIDETRFESSLTKVAVE 138
Query: 115 VKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYG 174
++V+ES+ VA AI EV I+ L+IG SQ + + ++++ IS V + CTVY
Sbjct: 139 LQVLESNSVAVAITKEVNQHLISNLIIGRSSQAASSRNY---DITASISASVSNLCTVYV 195
Query: 175 VEKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSS------HNSSSQTDLGSAVASYTH 228
V G + D+SDT +++S S + SS + S V S
Sbjct: 196 VSNG-----------GVHILAKDTSDTERNDTSIESGFERTSSSCSSGSGANSDVMSNAL 244
Query: 229 SSSP-SLPTQRLQALSAVNKTL-LHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVR 286
S+P +L +R+Q L + + + + ++ SSTE + ++ +S D E+ +S S PE
Sbjct: 245 KSNPHTLSNKRMQNLPTIVRGVSVPMETSSTESDETKKRSSDAAEE----ASKRSSPETS 300
Query: 287 QTVSRSSSYRSMETENQDWSDQASTTD----VLPYDSSSESQVDVNFELEKLRIELRHVR 342
++VS + +R + S +S + V P D E+ KLR ELRH
Sbjct: 301 RSVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNEISKLRAELRHAH 360
Query: 343 GMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAE 402
MYA+AQ E DASRK+N+L + E+ LLE + +AK+E +K+E RRE
Sbjct: 361 EMYAVAQVETLDASRKLNEL---------KFEELTLLEHETKGIAKKETEKFEQKRRE-- 409
Query: 403 CARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQ-RYRNLTWEEIESATLSFSEN 461
E+EAAQR+EAEMKA HEAKEKE LE + + +Y+ TWEEI +AT SFSE+
Sbjct: 410 ------EREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSED 463
Query: 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
L+IGMG YG VYK HHT AAVKVL S + +KQF QELE+LSKIRHPHL+LLLGACP
Sbjct: 464 LKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACP 523
Query: 522 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM 581
DHG LVYEYMENGSLEDRL++ N++ PIPWF R RIAWEVASAL FLH +KP PIIHRD+
Sbjct: 524 DHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDL 583
Query: 582 KPGNILLDHNLVSKIGDVGLSTMLN-SDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 639
KP NILL+HN VSK+GDVGLSTM+ +DP S T YK T PVGTLCYIDPEYQRTG IS
Sbjct: 584 KPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRIS 643
Query: 640 PKSDVYAYGMVILQLLTAKPAIAITHKVETAID---EDNLAEILDAQAGDWPIKETKELA 696
PKSDVYA+GM+ILQLLT + A+A+T+ VETA++ +D L +ILD +AG+WPI+ET++LA
Sbjct: 644 PKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLA 703
Query: 697 ALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMN 756
AL L C ELR KDRPDL++Q+LPVLE LK+VAD+AR+++ + PP+HF CP+LK+VM
Sbjct: 704 ALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQPPSHFFCPLLKDVMK 763
Query: 757 EPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
EPC+AADGYTYDR+AIEEW++ + SP+T+ PL N NLLPN+TL +AI++W+++
Sbjct: 764 EPCIAADGYTYDRRAIEEWMENHRTSPVTNSPLQNVNLLPNHTLYAAIVEWRNR 817
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 236/478 (49%), Positives = 318/478 (66%), Gaps = 1/478 (0%)
Query: 333 KLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKK 392
+L+ EL+ Y A E KV L+ L E R++ EE A EK+
Sbjct: 317 RLKNELQSTVFKYKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKE 376
Query: 393 KYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIE 452
+Y A +E E A+A +E QRQ AE+ A EK+ + L GT RYR T EEI
Sbjct: 377 RYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIV 436
Query: 453 SATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH 512
+AT FS IG GGYG VY+ + T AAVKV++ + ++FL+E+EVLS++RHPH
Sbjct: 437 TATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPH 496
Query: 513 LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
++LLLGACP++GCLVYEY+ENGSLE+ ++ + N PP+PWF R+R+ +EVA LAFLH++K
Sbjct: 497 VVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSK 556
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
P+PI+HRD+KPGNILL+ N VSKI DVGL+ ++ T Y+N+ GTL YIDPEY
Sbjct: 557 PEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEY 616
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692
RTG I PKSD+YA+G++ILQLLTA+ I VE A+ + L E+LD DWP+ ET
Sbjct: 617 HRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAET 676
Query: 693 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILK 752
+ELA +GL CAE R +DRPDLK++V+PVL+RL E A+ S A P+H+ CPIL+
Sbjct: 677 EELARIGLKCAEFRCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNLRA-PSHYFCPILR 735
Query: 753 EVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
E+M EP +AADG+TY+RKAI WL++++ SP+T L + L PN+TL SAI DWKS+
Sbjct: 736 EIMEEPEIAADGFTYERKAILAWLEKHNISPVTRQKLDHFKLTPNHTLRSAIRDWKSR 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 258/822 (31%), Positives = 427/822 (51%), Gaps = 70/822 (8%)
Query: 17 VAVAV-KGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIP 75
+ VAV K KS+ ++WAL+ G L+HV +P +G P
Sbjct: 47 IFVAVDKHVAKSKSTLIWALQN---TGGKKICLIHVHQPSQMIPL---------MGAKFP 94
Query: 76 IEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCN 135
+ V+++ ++++E+ K +L + +C QR V E IE + + I ++
Sbjct: 95 VGAVKEEEVRVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQLISELG 154
Query: 136 INKLVIGAQSQGIFTWKFKKNNLSSRISICV----PSFCTVYGVEKGKLSSVRPSDLGSI 191
I KLV+GA + ++ + +L SR +I V P+ C ++ KG L R +
Sbjct: 155 IRKLVMGAAADRHYSRRM--TDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREA----- 207
Query: 192 GSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTLLH 251
T DD+ + +S S S +DL + +++ S R+Q+ +V + L+
Sbjct: 208 --TMDDTE-----SEYASPRPSISASDL---LQTFSTPESEHQHISRVQSTDSVQQ-LVS 256
Query: 252 LKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQAST 311
S+ + S + +E++ S G EV + + SS S + D D +
Sbjct: 257 NGSSTEQSGRVSDGSLNTDEEERESD----GSEVTGSATVMSSGHSSPSSFPDGVDDSFN 312
Query: 312 TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDAS-----RKVNDLNKCK 366
+ S + S F E LR + + AI + + ++++ ++ D
Sbjct: 313 VKIRKATSEAHSSKQEAFA-ETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAV 371
Query: 367 LEEETRLSEIQ-----LLEEKAIELAKQEKKKYETARREAECARASAEKEAA-------- 413
+E+ R I+ ++EE +A++ + + A+ + + + + + A
Sbjct: 372 AKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLR 431
Query: 414 -QRQEAEMKAKHEAKEKEMLE-RALNGTFQ---RYRNLTWEEIESATLSFSENLRIGMGG 468
+R+E + + +E E L A T Q + + ++ EIE AT F L+IG GG
Sbjct: 432 DEREELQTERDRALREAEELRSHAETSTLQLPQYFTDFSFSEIEEATNHFDSTLKIGEGG 491
Query: 469 YGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVY 528
YG++Y G HT A+K+L + ++ QE++VLSK+RHP+++ L+GACP+ LVY
Sbjct: 492 YGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVY 551
Query: 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588
EY+ GSLEDRL K+N+PP+ W R RIA E+ +AL FLH+ K ++H D+KP NILL
Sbjct: 552 EYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILL 611
Query: 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 648
D NLVSK+ D G ++L+ + S T GT+ Y+DPE +G ++PKSDVY++G
Sbjct: 612 DSNLVSKLSDFGTCSLLHPNGS----KSVRTDVTGTVAYLDPEASSSGELTPKSDVYSFG 667
Query: 649 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRK 708
+++L+LLT +PA+ I+++V+ A+D L ++LD AGDWP + ++LA L L C E +
Sbjct: 668 IILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSE 727
Query: 709 DRPDLKNQVLPVLE--RLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYT 766
+RPDL +V VLE R + + H P +FICPI +EVM +P VAADG+T
Sbjct: 728 NRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFT 787
Query: 767 YDRKAIEEWL-QENDKSPITDLPLPNKNLLPNYTLLSAILDW 807
Y+ +AI WL E+D SP+T++ L + +L+ N+ L SAI +W
Sbjct: 788 YEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEW 829
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (794), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 171/454 (37%), Positives = 271/454 (59%), Gaps = 32/454 (7%)
Query: 373 LSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEA-EMKAKHE--AKEK 429
+ E+Q+++ + ++L Q +K + + E + E + RQ+ E++ HE KE
Sbjct: 367 MKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 430 EMLERALNG-----TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAV 484
L R + G + + ++ EI AT F + ++G G YG+VYKG H AV
Sbjct: 427 NALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAV 486
Query: 485 KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKN 544
K+L S G++ + +F + +E+LS++RHP+L+ L+GACP+ L+Y+Y+ NGSLED +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 545 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604
N P + W R RIA E+ SAL FLH+ P IIH ++KP ILLD NLV+KI D G+S +
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQL 605
Query: 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 664
+ D + P ++DP Y + ++ +SD+YA+G+++LQLLT +P I
Sbjct: 606 IPID------GLDKSDP-----HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGIL 654
Query: 665 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
V+ A++ DN++ +LD AGDWP+ K+LA + + C + +RPDL VL ++R+
Sbjct: 655 RDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMNRPDLA-VVLRFIDRM 713
Query: 725 K-------EVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQ 777
K E + A VP PP+H++CPI +EVM +P +AADG+TY+ +AI EWL
Sbjct: 714 KAPEVPSSETSSYANQNVPR---RPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLA 770
Query: 778 E-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
+D SP+T+L + + NL+PN+ L AI DW+++
Sbjct: 771 NGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQ 804
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 163/447 (36%), Positives = 246/447 (55%), Gaps = 39/447 (8%)
Query: 366 KLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECA--RASAEKEAAQRQEAEMKAK 423
K EE R ++ +LEE+ + L K + Y + +A A + E++ A +Q E++
Sbjct: 83 KTYEEVR--KVHILEEEIVTL-KHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNELR-- 137
Query: 424 HEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAA 483
+ +L+ F R +++E AT F +G YG YKG H+
Sbjct: 138 -DQSTHIILD------FSR------KDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVL 184
Query: 484 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRK 543
+K+ S+ K F QE+ +L + RHP+++ +G C + LVYE++ NG+LEDR+
Sbjct: 185 IKLSSSQ-----KLFQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICT 239
Query: 544 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603
NN+ P+ W+ R +I E+ AL FLH+ K ++H D++P NIL+D N SKI + G+S
Sbjct: 240 NNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSN 299
Query: 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 663
+ +F L Y+DPE+ TG ++ SDVY+ G++IL+LLT P + +
Sbjct: 300 LFLQLGTFPPNL------TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTL 353
Query: 664 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723
+ KV A+ D+L ++D AGDWP E K+LA +GLSC + RK RPDL N+V V+E
Sbjct: 354 SEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEP 413
Query: 724 LKEVADRARDTVPSVHPAP-----PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE 778
L A T P + A P FICPI E+M +P VA+DG+TY+ +AI W
Sbjct: 414 LTRKPPAA--TWPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDR 471
Query: 779 N-DKSPITDLPLPNKNLLPNYTLLSAI 804
+SP+T+L LPN NL+PN L S I
Sbjct: 472 GISRSPMTNLALPNLNLVPNRVLRSFI 498
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 7e-48, Method: Compositional matrix adjust.
Identities = 119/318 (37%), Positives = 176/318 (55%), Gaps = 23/318 (7%)
Query: 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQE 501
R + EI+SAT F E L IG+GG+G+VYKG T AVK L+ N K+F E
Sbjct: 511 RRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTE 570
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRI 557
LE+LSK+RH HL+ L+G C D LVYEYM +G+L+D L+R++ PP+ W R I
Sbjct: 571 LEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEI 630
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
A L +LH IIHRD+K NILLD N V+K+ D GLS + P+ S T+
Sbjct: 631 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRV---GPTSASQTHV 687
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVE 668
+T GT Y+DPEY R +++ KSDVY++G+V+L++L +P + V+
Sbjct: 688 STVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 747
Query: 669 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE---RL 724
+ ++ + +I+D+ D ++ + + C + R +RP + N V+ LE +L
Sbjct: 748 SNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPM-NDVVWALEFALQL 806
Query: 725 KEVADRARDTVPSVHPAP 742
E A + D V S+ P
Sbjct: 807 HETAKKKNDNVESLDLMP 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 118/318 (37%), Positives = 176/318 (55%), Gaps = 23/318 (7%)
Query: 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQE 501
R + EI+SAT F + L IG+GG+G+VYKG T AVK L+ N K+F E
Sbjct: 504 RRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETE 563
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRI 557
LE+LSK+RH HL+ L+G C + LVYEYM +G+L+D L+R++ T PP+ W R I
Sbjct: 564 LEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEI 623
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
A L +LH IIHRD+K NILLD N V+K+ D GLS + P+ S T+
Sbjct: 624 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRV---GPTSASQTHV 680
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVE 668
+T GT Y+DPEY R +++ KSDVY++G+V+L++L +P + V+
Sbjct: 681 STVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 740
Query: 669 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE---RL 724
+ + +I+D+ + D ++ + + C + R +RP + N V+ LE +L
Sbjct: 741 SNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPM-NDVVWALEFALQL 799
Query: 725 KEVADRARDTVPSVHPAP 742
E A + D V S+ P
Sbjct: 800 HETAKKKNDNVESLDLMP 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 810 | ||||||
| 147858097 | 804 | hypothetical protein VITISV_021538 [Viti | 0.980 | 0.987 | 0.656 | 0.0 | |
| 359490160 | 804 | PREDICTED: U-box domain-containing prote | 0.980 | 0.987 | 0.654 | 0.0 | |
| 297745064 | 784 | unnamed protein product [Vitis vinifera] | 0.955 | 0.987 | 0.646 | 0.0 | |
| 357455815 | 809 | U-box domain-containing protein [Medicag | 0.960 | 0.961 | 0.611 | 0.0 | |
| 449451988 | 836 | PREDICTED: U-box domain-containing prote | 0.974 | 0.943 | 0.612 | 0.0 | |
| 357455813 | 797 | U-box domain-containing protein [Medicag | 0.964 | 0.979 | 0.596 | 0.0 | |
| 356508200 | 785 | PREDICTED: U-box domain-containing prote | 0.941 | 0.971 | 0.596 | 0.0 | |
| 449488729 | 1074 | PREDICTED: U-box domain-containing prote | 0.918 | 0.692 | 0.616 | 0.0 | |
| 42567138 | 835 | U-box domain-containing protein 35 [Arab | 0.964 | 0.935 | 0.553 | 0.0 | |
| 297799476 | 832 | kinase family protein [Arabidopsis lyrat | 0.960 | 0.935 | 0.547 | 0.0 |
| >gi|147858097|emb|CAN78862.1| hypothetical protein VITISV_021538 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2744), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/817 (65%), Positives = 644/817 (78%), Gaps = 23/817 (2%)
Query: 1 MEVKDIVELPNSPAL------SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR 54
ME K+I+E AL ++AVA+ G +KS+Y V WALEKF+PEG+++FK+LHVRP+
Sbjct: 1 MEAKEIIEEKQELALALPLPSTIAVAINGKKKSKYVVRWALEKFVPEGLHMFKMLHVRPK 60
Query: 55 ITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVE 114
ITSVPTP +GN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+
Sbjct: 61 ITSVPTP--------MGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKQVQVD 112
Query: 115 VKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYG 174
V VIESDDVAKAIA+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY
Sbjct: 113 VVVIESDDVAKAIAEEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYT 172
Query: 175 VEKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSL 234
V KG+LSSVRPSD GS K+DSSD +S++SS + +S GSA ASY+H SPSL
Sbjct: 173 VSKGQLSSVRPSDSDKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSL 228
Query: 235 PTQRLQALSAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSS 294
P QR QALS +N+TLLH + S E N SR QS D+ E++ S C S ++ S+ SS
Sbjct: 229 PMQRFQALSTINRTLLHTRTGSIETNSSRRQSLDIREEESFMSPCPSNSDIGYAPSQVSS 288
Query: 295 YRSMETENQDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEAN 353
RS T++Q W SDQAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E
Sbjct: 289 ARSFLTDDQSWISDQASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENI 347
Query: 354 DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAA 413
DASRK+NDL+K +LEE +L EI+L EE+A ELA++EK+KYE A+REA AR AEKEA
Sbjct: 348 DASRKLNDLSKRRLEEADKLKEIKLKEEEARELARKEKEKYEAAKREAXYARECAEKEAL 407
Query: 414 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 473
QR+EAE+KA H+ KEKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY
Sbjct: 408 QRKEAEIKALHDVKEKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVY 467
Query: 474 KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMEN 533
+ HHT AAVKVL SK + K+F QELEVLSKIRHPHLLLLLGAC DHGCLVYEYMEN
Sbjct: 468 RCNLHHTTAAVKVLHSKEGHRTKEFQQELEVLSKIRHPHLLLLLGACSDHGCLVYEYMEN 527
Query: 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593
GSLE+RL +K NT PIPWFERYRIAWEVAS L FLHN+KP+ IIHRD+KP NILLDHNLV
Sbjct: 528 GSLEERLLQKYNTAPIPWFERYRIAWEVASTLVFLHNSKPRSIIHRDLKPANILLDHNLV 587
Query: 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 653
SKIGDVGLSTMLN D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQ
Sbjct: 588 SKIGDVGLSTMLNPDSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQ 644
Query: 654 LLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDL 713
LLTAKPAIA+ H VETAI +D L EILD AG WP+KETKELA LGLSC ELRR+DRPDL
Sbjct: 645 LLTAKPAIALAHLVETAIQDDQLMEILDPMAGQWPMKETKELALLGLSCLELRRRDRPDL 704
Query: 714 KNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIE 773
K++VLP LERLK+VADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE
Sbjct: 705 KDEVLPALERLKDVADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIE 764
Query: 774 EWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
+W++END SP+T+L LPNKNL+PNYTLLSAI++WKS+
Sbjct: 765 KWVEENDNSPMTNLALPNKNLIPNYTLLSAIVEWKSQ 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490160|ref|XP_002266973.2| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1061 bits (2743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/817 (65%), Positives = 644/817 (78%), Gaps = 23/817 (2%)
Query: 1 MEVKDIVELPNSPAL------SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR 54
ME K+I+E AL ++AVA+ G +KS+Y V WALEKF+PEG+++FK+LHVRP+
Sbjct: 1 MEAKEIIEEKQELALALPLPSTIAVAINGKKKSKYVVRWALEKFVPEGLHMFKMLHVRPK 60
Query: 55 ITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVE 114
ITSVPTP +GN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+
Sbjct: 61 ITSVPTP--------MGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKKVQVD 112
Query: 115 VKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYG 174
V VIESDDVAKAIA+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY
Sbjct: 113 VVVIESDDVAKAIAEEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYT 172
Query: 175 VEKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSL 234
V KG+LSSVRPSD GS K+DSSD +S++SS + +S GSA ASY+H SPSL
Sbjct: 173 VSKGQLSSVRPSDSDKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSL 228
Query: 235 PTQRLQALSAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSS 294
P QR QALS +N+TLLH + S E N SR QS D+ E++ S C S ++ S+ SS
Sbjct: 229 PMQRFQALSTINRTLLHTRTGSIETNSSRRQSLDIREEESFMSPCPSNSDIGYAPSQVSS 288
Query: 295 YRSMETENQDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEAN 353
RS T++Q W SDQAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E
Sbjct: 289 ARSFLTDDQSWISDQASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENI 347
Query: 354 DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAA 413
DASRK+NDL+K +LEE +L EI+L EE+A ELA++EK+KYE A+REAE AR AEKEA
Sbjct: 348 DASRKLNDLSKRRLEEADKLKEIKLKEEEARELARKEKEKYEAAKREAEYARECAEKEAL 407
Query: 414 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 473
QR+EAE+KA H+ KEKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY
Sbjct: 408 QRKEAEIKALHDVKEKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVY 467
Query: 474 KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMEN 533
+ HHT AAVKVL SK + K+F QEL+VLSKIRHPHLLLLLGAC DHGCLVYEYMEN
Sbjct: 468 RCNLHHTTAAVKVLHSKEGHRTKEFQQELDVLSKIRHPHLLLLLGACSDHGCLVYEYMEN 527
Query: 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593
GSLE+RL +K NT PIPWFERYRIAWEVAS L FLHN+KPK IIHRD+KP NILLDHNLV
Sbjct: 528 GSLEERLLQKYNTAPIPWFERYRIAWEVASTLVFLHNSKPKSIIHRDLKPANILLDHNLV 587
Query: 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 653
SKIGDVGLSTMLN D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQ
Sbjct: 588 SKIGDVGLSTMLNLDSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQ 644
Query: 654 LLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDL 713
LLTAKPAIA+ H VETAI +D L +ILD AG WP+KETKELA LGLSC ELRR+DRPDL
Sbjct: 645 LLTAKPAIALAHLVETAIQDDQLMKILDPMAGQWPMKETKELALLGLSCLELRRRDRPDL 704
Query: 714 KNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIE 773
K++VLP LERLK+ ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE
Sbjct: 705 KDEVLPALERLKDAADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIE 764
Query: 774 EWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
+W++END SP+T+L LPNKNL+PNYTLLSAI++WKS+
Sbjct: 765 KWVEENDNSPMTNLALPNKNLIPNYTLLSAIMEWKSQ 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745064|emb|CBI38656.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1037 bits (2682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/817 (64%), Positives = 633/817 (77%), Gaps = 43/817 (5%)
Query: 1 MEVKDIVELPNSPAL------SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR 54
ME K+I+E AL ++AVA+ G +KS+Y V WALEKF+PEG+++FK+LHVRP+
Sbjct: 1 MEAKEIIEEKQELALALPLPSTIAVAINGKKKSKYVVRWALEKFVPEGLHMFKMLHVRPK 60
Query: 55 ITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVE 114
ITSVPTP +GN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+
Sbjct: 61 ITSVPTP--------MGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKKVQVD 112
Query: 115 VKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYG 174
V VIESDDVAKAIA+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY
Sbjct: 113 VVVIESDDVAKAIAEEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYT 172
Query: 175 VEKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSL 234
V KG+LSSVRPSD GS K+DSSD +S++SS + +S GSA ASY+H SPSL
Sbjct: 173 VSKGQLSSVRPSDSDKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSL 228
Query: 235 PTQRLQALSAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSS 294
P QR QALS +N+TLLH + S E N SR + S+ SS
Sbjct: 229 PMQRFQALSTINRTLLHTRTGSIETNSSR--------------------HIGYAPSQVSS 268
Query: 295 YRSMETENQDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEAN 353
RS T++Q W SDQAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E
Sbjct: 269 ARSFLTDDQSWISDQASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENI 327
Query: 354 DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAA 413
DASRK+NDL+K +LEE +L EI+L EE+A ELA++EK+KYE A+REAE AR AEKEA
Sbjct: 328 DASRKLNDLSKRRLEEADKLKEIKLKEEEARELARKEKEKYEAAKREAEYARECAEKEAL 387
Query: 414 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 473
QR+EAE+KA H+ KEKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY
Sbjct: 388 QRKEAEIKALHDVKEKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVY 447
Query: 474 KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMEN 533
+ HHT AAVKVL SK + K+F QEL+VLSKIRHPHLLLLLGAC DHGCLVYEYMEN
Sbjct: 448 RCNLHHTTAAVKVLHSKEGHRTKEFQQELDVLSKIRHPHLLLLLGACSDHGCLVYEYMEN 507
Query: 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593
GSLE+RL +K NT PIPWFERYRIAWEVAS L FLHN+KPK IIHRD+KP NILLDHNLV
Sbjct: 508 GSLEERLLQKYNTAPIPWFERYRIAWEVASTLVFLHNSKPKSIIHRDLKPANILLDHNLV 567
Query: 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 653
SKIGDVGLSTMLN D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQ
Sbjct: 568 SKIGDVGLSTMLNLDSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQ 624
Query: 654 LLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDL 713
LLTAKPAIA+ H VETAI +D L +ILD AG WP+KETKELA LGLSC ELRR+DRPDL
Sbjct: 625 LLTAKPAIALAHLVETAIQDDQLMKILDPMAGQWPMKETKELALLGLSCLELRRRDRPDL 684
Query: 714 KNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIE 773
K++VLP LERLK+ ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE
Sbjct: 685 KDEVLPALERLKDAADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIE 744
Query: 774 EWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
+W++END SP+T+L LPNKNL+PNYTLLSAI++WKS+
Sbjct: 745 KWVEENDNSPMTNLALPNKNLIPNYTLLSAIMEWKSQ 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455815|ref|XP_003598188.1| U-box domain-containing protein [Medicago truncatula] gi|355487236|gb|AES68439.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/800 (61%), Positives = 613/800 (76%), Gaps = 22/800 (2%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPI 76
VA+A+KGN+KS+Y V WAL KF+PEG+ +FKL+HV I VPTP +GN +PI
Sbjct: 24 VALAIKGNKKSKYVVQWALNKFVPEGMIIFKLIHVHAGIVGVPTP--------MGNMLPI 75
Query: 77 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNI 136
QVRDDVAAAYK+E + +T+++LLPF+ MC QR+V VEV VIESDDVA A+A+EV +
Sbjct: 76 SQVRDDVAAAYKKEIECETNQMLLPFKQMCEQRKVHVEVVVIESDDVASAVAEEVTKYAV 135
Query: 137 NKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKD 196
KLV+GA + G+F K K +S++IS+C P FCTVY V KGKL +RPSD+ S D
Sbjct: 136 TKLVVGASTGGLF--KSKHKGMSAKISVCTPRFCTVYAVSKGKLL-IRPSDVQIDESITD 192
Query: 197 DSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSS 256
D+S+ S+SSSS++ S++QTD GS VASY S SL TQR QALS++N+ LL PS
Sbjct: 193 DTSEISFSSSSSSNYTSTTQTDSGS-VASYAALHSSSLATQRFQALSSMNQNLLSTNPSL 251
Query: 257 TEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW-SDQASTTDVL 315
E NHSR QS D+ A+SS + + + +SR+SS+RS+ ++ W DQ S D
Sbjct: 252 NETNHSRGQSIDLGRGNVATSSARNS-DFDRGLSRASSFRSIVSDTDTWIYDQISLKDA- 309
Query: 316 PYDS---SSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETR 372
P S S Q + N ELEKLRIELRH +GM+A+AQ E DASRK+N+L+K + E +
Sbjct: 310 PLTSKLASPNRQENFNLELEKLRIELRHAQGMHAVAQTENIDASRKLNELSKRRSGESMK 369
Query: 373 LSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEML 432
+ EI EE A ELA+QE +KYE A REA + AE+EA++R+E E+KA AKEK+ L
Sbjct: 370 MKEIIAKEEVAKELARQEIEKYEAAAREASYLKECAEREASERKETELKAIRAAKEKDKL 429
Query: 433 ERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN 492
E AL+G+ +YR TW+EI SAT SFSE+LRIGMG YG VYK T HHT AVKVL S G
Sbjct: 430 EDALSGSTPQYRKFTWDEIVSATSSFSEDLRIGMGAYGMVYKCTLHHTTVAVKVLHSAGI 489
Query: 493 IQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF 552
Q+KQF QELE+LS+IRHP+LLLLLGACPDHGCLVYEYMENGSLEDRL++KN+T PI WF
Sbjct: 490 SQSKQFQQELEILSRIRHPNLLLLLGACPDHGCLVYEYMENGSLEDRLFQKNSTTPIRWF 549
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612
+R+R+AWE+ASAL+FLH++KP+PIIHRD+KP NILL NLVSKIGD+GLST+LNSD +
Sbjct: 550 DRFRVAWEIASALSFLHSSKPQPIIHRDLKPANILLGGNLVSKIGDIGLSTVLNSDE--L 607
Query: 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 672
ST YK+T PVGTL YIDPEYQR+GLIS KSDVYA+G+V+LQLLTAKPA A+TH VETAI+
Sbjct: 608 STMYKDTAPVGTLSYIDPEYQRSGLISTKSDVYAFGLVMLQLLTAKPATALTHVVETAIE 667
Query: 673 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 732
+ NL +ILD +AG WP +ET +LA L LSCAELRR+DRPDL + VLP LERLKEVADRA
Sbjct: 668 DGNLTDILDPKAGLWPFQETLDLARLALSCAELRRRDRPDLLDHVLPTLERLKEVADRAH 727
Query: 733 D--TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLP 790
++ ++ P PPNHFICPIL++VM++PCVAADGYTYDRKAIE+WL+E DKSP+T++PLP
Sbjct: 728 HSASMVAIKPKPPNHFICPILQDVMDDPCVAADGYTYDRKAIEKWLEEKDKSPMTNIPLP 787
Query: 791 NKNLLPNYTLLSAILDWKSK 810
+K L+PNYTLLSAIL+WKSK
Sbjct: 788 HKILIPNYTLLSAILEWKSK 807
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451988|ref|XP_004143742.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 945 bits (2442), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/805 (61%), Positives = 607/805 (75%), Gaps = 16/805 (1%)
Query: 9 LPNSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGH 68
LP+S VAVA+ G + S+Y + W+LEKF+PEGI F+LLH PRITSVP +
Sbjct: 15 LPSSSV--VAVAISGKKNSKYIIRWSLEKFLPEGIIDFRLLHFIPRITSVP--------N 64
Query: 69 PVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 128
VGN IPI QVR+DVAAAY++E W T LLPF+ M AQR+V ++V +E+DDVA AI
Sbjct: 65 AVGNAIPISQVREDVAAAYRKEIWWHTSEKLLPFKKMFAQRKVHLDVVTLEADDVAGAII 124
Query: 129 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDL 188
+EV C+INKLVIG SQG+F+ K + LSSRIS P +CTVY + KGKL+S+RP D+
Sbjct: 125 EEVTKCSINKLVIGVSSQGLFSRKL--SGLSSRISALAPRYCTVYAISKGKLASIRPPDM 182
Query: 189 GSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTH--SSSPSLPTQRLQALSAVN 246
+ S +DD+S+ ++S SS +SS S +SY+H S SPSLP QR QALS +N
Sbjct: 183 DTNVSIRDDASEESSASSYSSYTSSSLTDGSSSLTSSYSHFPSPSPSLPLQRFQALSTIN 242
Query: 247 KTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW- 305
+ LL KPS + +HSRCQS D+E Q D S + QT+SR+SS +S EN+ W
Sbjct: 243 QPLLTKKPSPIKADHSRCQSVDIENQVDGVHSSSYVSDCIQTLSRASSSKSSPAENKSWN 302
Query: 306 SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKC 365
SD+AS++ + SS ESQ DV+FELEKLRIELRH RGM+AIAQ E DASR++N LN
Sbjct: 303 SDEASSSGMFNDYSSCESQADVSFELEKLRIELRHARGMFAIAQRETIDASRELNHLNNQ 362
Query: 366 KLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHE 425
+ EE +L EI A E A++E+ K+E RREA+ + AE+E R+EAEMKA
Sbjct: 363 RSEEARKLEEINNKAVAAKEFAREERVKHEALRREAKYVKERAEREGIYRKEAEMKALQN 422
Query: 426 AKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVK 485
AKEK E AL G Q+Y++ WE+I SAT SFSE+L+IGMG +GTVYK + HHT AVK
Sbjct: 423 AKEKGKHENALQGPLQQYQHFQWEDIVSATSSFSEDLKIGMGAHGTVYKCSLHHTTVAVK 482
Query: 486 VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNN 545
VL S+ + + Q LQELEVLS+I HPHLLLLLGACPD CLVYEYMENGSLEDRLYR+ N
Sbjct: 483 VLHSRDSHKQMQLLQELEVLSRIHHPHLLLLLGACPDKNCLVYEYMENGSLEDRLYRRGN 542
Query: 546 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605
TP IPW+ER+RIAWE+ASAL FLH++KPK IIHRD+KP NILLD NLVSKIGDVGLST+
Sbjct: 543 TPAIPWYERFRIAWEIASALVFLHSSKPKSIIHRDLKPANILLDQNLVSKIGDVGLSTVF 602
Query: 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
NSDPS +ST + N+GPVGTLCYIDPEYQRTGLISPKSDVYA+GMVILQLLTAKPA+A+TH
Sbjct: 603 NSDPS-MSTAFMNSGPVGTLCYIDPEYQRTGLISPKSDVYAFGMVILQLLTAKPAVALTH 661
Query: 666 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725
VETAID NL +LD +AG WP++ET ELA LGL CAE++RKDRPDLK+QVLP+L LK
Sbjct: 662 VVETAIDNSNLINVLDIEAGHWPLEETYELARLGLRCAEMQRKDRPDLKDQVLPLLMTLK 721
Query: 726 EVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPIT 785
+VAD+AR+ V A PNHFICPIL++VMN+PCVAADGYTYDR+AIE+WLQ+ND SP+T
Sbjct: 722 KVADKARNLASKVPAAIPNHFICPILQDVMNDPCVAADGYTYDRQAIEKWLQKNDNSPMT 781
Query: 786 DLPLPNKNLLPNYTLLSAILDWKSK 810
LPLP+KNL+PNY+LLSAI++W SK
Sbjct: 782 KLPLPDKNLIPNYSLLSAIVEWNSK 806
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455813|ref|XP_003598187.1| U-box domain-containing protein [Medicago truncatula] gi|355487235|gb|AES68438.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2409), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 481/806 (59%), Positives = 625/806 (77%), Gaps = 25/806 (3%)
Query: 11 NSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPV 70
N+ + V +A+KGN+KS+Y V WAL+KF+ EGI++FKL+HVR IT VPTP +
Sbjct: 10 NNKSSVVGLAIKGNKKSKYVVQWALDKFVHEGISIFKLIHVRAVITGVPTP--------M 61
Query: 71 GNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADE 130
G +P+ QVR+DVA A+K+E +W+T+++LLPF+++C QR+V V+V VIESDDVA A+A+E
Sbjct: 62 GEVLPLSQVRNDVATAFKREVEWQTNQMLLPFKSLCEQRKVHVDVVVIESDDVATAVAEE 121
Query: 131 VASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGS 190
VA I KLV+GA S GIF K K +S++IS+C P FCTVY V KGKLS +RPSD
Sbjct: 122 VAREAITKLVLGASSSGIFRSKHK--GISAKISVCTPRFCTVYAVAKGKLS-IRPSDTEI 178
Query: 191 IGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTLL 250
GS D++S+T S+SSSS++ S+SQTD ++VAS S + TQR++A S++++TLL
Sbjct: 179 DGSIIDNTSETSFSSSSSSNYTSTSQTD-SASVASCNALHSYAKETQRVRAHSSMDQTLL 237
Query: 251 HLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSM-ETEN----QDW 305
PS E NH R QS D+ +K+A++S ++ +S++SS S+ +TE+ Q+
Sbjct: 238 STSPSLNETNHFRGQSLDLG-RKNAAASSSRKSDIDHALSQASSCGSISDTESFFYEQNH 296
Query: 306 SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKC 365
+ A+ + LP S Q ++N ELEKLRIELRH +GM+A+AQ+E DAS+K+N+LNK
Sbjct: 297 AKDATRVNRLP---PSNRQENINLELEKLRIELRHAQGMHAVAQSENVDASQKLNELNKR 353
Query: 366 KLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHE 425
+LEE ++ EI EE A+ELA QE++KYE A REA + AE+EAA+R+E E KA
Sbjct: 354 RLEESMKVKEIMAKEEMAMELANQEREKYEAAAREATYLKECAEREAAERKETEFKAIRA 413
Query: 426 AKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVK 485
AKEKE LE AL+G+ +YR TW+EI SAT SFSE+LR+GMG YG VYK T HHT AVK
Sbjct: 414 AKEKEKLEDALSGSTPQYRIFTWDEIVSATSSFSEDLRLGMGAYGIVYKCTLHHTTVAVK 473
Query: 486 VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNN 545
VL S GN +NKQF QELE+LS+I HP+LLLLLGACPDHGCLVYEYMENG+LEDRL +KN+
Sbjct: 474 VLHSTGNCKNKQFQQELEILSRIHHPNLLLLLGACPDHGCLVYEYMENGNLEDRLLQKNS 533
Query: 546 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605
PIPWF R++IAWEVASAL+FLH++KP+PIIHRD+KP NILLD NLVSKIGDVGLST+L
Sbjct: 534 NSPIPWFNRFQIAWEVASALSFLHSSKPQPIIHRDLKPANILLDGNLVSKIGDVGLSTIL 593
Query: 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
+SD +S YK+T PVGTL YIDPEYQR+GLIS KSDVYA+G+VILQLLTAKPAIA+TH
Sbjct: 594 DSDE--LSAMYKDTAPVGTLSYIDPEYQRSGLISTKSDVYAFGLVILQLLTAKPAIALTH 651
Query: 666 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725
VETAID NLA+ILD +AG WP++ET ++A L L CAE+RRKDRPDL + VLP+LERLK
Sbjct: 652 IVETAIDGGNLADILDPKAGSWPLQETLDIARLALGCAEMRRKDRPDLNDHVLPMLERLK 711
Query: 726 EVADRARD--TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSP 783
EVAD+A+ ++ ++ PPNHFICPIL++VM++PCVAADGYTYDR AIE+WL+ENDKSP
Sbjct: 712 EVADKAQHSASIVTIKSRPPNHFICPILQDVMDDPCVAADGYTYDRNAIEKWLEENDKSP 771
Query: 784 ITDLPLPNKNLLPNYTLLSAILDWKS 809
+T++ LP+K+L+PNYTLLSAIL+WK+
Sbjct: 772 MTNMVLPHKHLIPNYTLLSAILEWKT 797
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508200|ref|XP_003522847.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/805 (59%), Positives = 603/805 (74%), Gaps = 42/805 (5%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPI 76
VA+A+KGN+KS+Y V WAL KF+PEG+ +FKL+HV I VPTP++
Sbjct: 10 VALAIKGNKKSKYVVQWALNKFVPEGMIIFKLIHVHGGIKGVPTPST------------- 56
Query: 77 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNI 136
A+K+E +W+T+++LLPF+ MC QR+V V+V VIESDDVA AIADEVA I
Sbjct: 57 ---------AFKKEVEWQTNQMLLPFKRMCEQRKVHVDVIVIESDDVATAIADEVAKGAI 107
Query: 137 NKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKD 196
KLV+GA S+G+F K K+ +S+RIS+ P FCT+Y + KGKLS +RPSD+ G+ D
Sbjct: 108 TKLVVGASSRGLF--KSKQKGMSTRISVSTPRFCTIYAISKGKLS-IRPSDMPIDGNIID 164
Query: 197 DSSDTGCSNSSSSSHNSSSQTDLGSA-VASYTHSSSPSLPTQRLQALSAVNKTLLHLKPS 255
D+S++ S S+SSS N +S + SA V+SY S SL TQR QALS++N LL PS
Sbjct: 165 DASESETSLSTSSSSNYTSTSQTESASVSSYAALQSSSLTTQRFQALSSINSALLSTNPS 224
Query: 256 STEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWS-DQASTTDV 314
+ NHSR QS D+ + ASSS + ++ +SR SS +S ++ + W DQ S DV
Sbjct: 225 FADTNHSRGQSLDLGRENTASSSARNS-DIDHALSRVSSCKSFISDTESWMYDQNSCKDV 283
Query: 315 -----LPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEE 369
LP S Q N ELEKLRIELRH +G++A+AQ E +ASRK+NDL+K + EE
Sbjct: 284 QLATTLP---SPNRQAKYNLELEKLRIELRHAQGLHAVAQTEKIEASRKLNDLSKRRSEE 340
Query: 370 ETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEK 429
R+ EI EEKA ELAK E++KY+ A REAE + AE+EAA+++E E++A AKEK
Sbjct: 341 TMRMKEIISKEEKAKELAKLEREKYQDASREAEYLKECAEREAAEKKEMELRAIRAAKEK 400
Query: 430 EMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQS 489
E LE AL+G+ +YR TW+EI AT SFSE+L+IGMG YG VYK +HT AVKVL
Sbjct: 401 EKLEDALSGSTPQYRKFTWDEIILATSSFSEDLKIGMGAYGVVYKCNLYHTTVAVKVLTL 460
Query: 490 KGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTP 547
N+ + KQF QELE+LS+IRHP+LLLLLGACPDHGCLVYEYMENG+LEDRL RKNNT
Sbjct: 461 NTNVNSKRKQFQQELEILSRIRHPNLLLLLGACPDHGCLVYEYMENGNLEDRLLRKNNTS 520
Query: 548 PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607
PIPWFER+RIA EVAS+LAFLH++KP+PIIHRD+KP NILLD NLVSKIGD+GLST+LNS
Sbjct: 521 PIPWFERFRIALEVASSLAFLHSSKPEPIIHRDLKPANILLDRNLVSKIGDIGLSTVLNS 580
Query: 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV 667
D +S K+T PVGTLCYIDPEYQRTGLISPKSD+YA+GMVILQLLTAKPAIA+ HKV
Sbjct: 581 DN--LSIMSKDTAPVGTLCYIDPEYQRTGLISPKSDIYAFGMVILQLLTAKPAIALAHKV 638
Query: 668 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727
ETAID NL +ILD +AG WP +ET +LA LGLSCAELRR+DRPDL++ VLP LERLKEV
Sbjct: 639 ETAIDSGNLTDILDPEAGAWPYQETLDLALLGLSCAELRRRDRPDLQDHVLPTLERLKEV 698
Query: 728 ADRAR--DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPIT 785
DRA+ ++ ++ PPNHFICPIL++VM++PCVAADGYTYDRKAIE+WL+ENDKSP+T
Sbjct: 699 VDRAQCSASIVTIKSKPPNHFICPILQDVMDDPCVAADGYTYDRKAIEKWLEENDKSPMT 758
Query: 786 DLPLPNKNLLPNYTLLSAILDWKSK 810
++ LP+K+L+PNYTLLSAIL+WKS+
Sbjct: 759 NMALPHKHLIPNYTLLSAILEWKSR 783
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488729|ref|XP_004158155.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/758 (61%), Positives = 574/758 (75%), Gaps = 14/758 (1%)
Query: 56 TSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEV 115
T+VPTP +GN IPI QVR+DVAAAY++E W T LLPF+ M AQR+V ++V
Sbjct: 298 TTVPTP--------MGNAIPISQVREDVAAAYRKEIWWHTSEKLLPFKKMFAQRKVHLDV 349
Query: 116 KVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 175
+E+DDVA AI +EV C+INKLVIG SQG+F+ K + LSSRIS P +CTVY +
Sbjct: 350 VTLEADDVAGAIIEEVTKCSINKLVIGVSSQGLFSRKL--SGLSSRISALAPRYCTVYAI 407
Query: 176 EKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTH--SSSPS 233
KGKL+S+RP D+ + S +DD+S+ ++S SS +SS S +SY+H S SPS
Sbjct: 408 SKGKLASIRPPDMDTNVSIRDDASEESSASSYSSYTSSSLTDGSSSLTSSYSHFPSPSPS 467
Query: 234 LPTQRLQALSAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSS 293
LP QR QALS +N+ LL KPS + +HSRCQS D+E Q D S + QT+SR+S
Sbjct: 468 LPLQRFQALSTINQPLLTKKPSPIKADHSRCQSVDIENQVDGVHSSSYVSDCIQTLSRAS 527
Query: 294 SYRSMETENQDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEA 352
S +S EN+ W SD+AS++ + SS ESQ DV+FELEKLRIELRH RGM+AIAQ E
Sbjct: 528 SSKSSPAENKSWNSDEASSSGMFNDYSSCESQADVSFELEKLRIELRHARGMFAIAQRET 587
Query: 353 NDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEA 412
DASR++N LN + EE +L EI A E A++E+ K+E RREA+ + AE+E
Sbjct: 588 IDASRELNHLNNQRSEEARKLEEINNKAVAAKEFAREERVKHEALRREAKYVKERAEREG 647
Query: 413 AQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTV 472
R+EAEMKA AKEK E AL G Q+Y++ WE+I SAT SFSE+L+IGMG +GTV
Sbjct: 648 IYRKEAEMKALQNAKEKGKHENALQGPLQQYQHFQWEDIVSATSSFSEDLKIGMGAHGTV 707
Query: 473 YKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYME 532
YK + HHT AVKVL S+ + + Q LQELEVLS+I HPHLLLLLGACPD CLVYEYME
Sbjct: 708 YKCSLHHTTVAVKVLHSRDSHKQMQLLQELEVLSRIHHPHLLLLLGACPDKNCLVYEYME 767
Query: 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 592
NGSLEDRLYR+ NTP IPW+ER+RIAWE+ASAL FLH++KPK IIHRD+KP NILLD NL
Sbjct: 768 NGSLEDRLYRRGNTPAIPWYERFRIAWEIASALVFLHSSKPKSIIHRDLKPANILLDQNL 827
Query: 593 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 652
VSKIGDVGLST+ NSDPS +ST + N+GPVGTLCYIDPEYQRTGLISPKSDVYA+GMVIL
Sbjct: 828 VSKIGDVGLSTVFNSDPS-MSTAFMNSGPVGTLCYIDPEYQRTGLISPKSDVYAFGMVIL 886
Query: 653 QLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 712
QLLTAKPA+A+TH VETAID NL +LD +AG WP++ET ELA LGL CAE++RKDRPD
Sbjct: 887 QLLTAKPAVALTHVVETAIDNSNLINVLDIEAGHWPLEETYELARLGLRCAEMQRKDRPD 946
Query: 713 LKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAI 772
LK+QVLP+L LK+VAD+AR+ V A PNHFICPIL++VMN+PCVAADGYTYDR+AI
Sbjct: 947 LKDQVLPLLMTLKKVADKARNLASKVPAAIPNHFICPILQDVMNDPCVAADGYTYDRQAI 1006
Query: 773 EEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
E+WLQ+ND SP+T LPLP+KNL+PNY+LLSAI++W SK
Sbjct: 1007 EKWLQKNDNSPMTKLPLPDKNLIPNYSLLSAIVEWNSK 1044
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42567138|ref|NP_194246.2| U-box domain-containing protein 35 [Arabidopsis thaliana] gi|172044784|sp|Q9SW11.2|PUB35_ARATH RecName: Full=U-box domain-containing protein 35; AltName: Full=Plant U-box protein 35; Includes: RecName: Full=E3 ubiquitin ligase; Includes: RecName: Full=Serine/threonine-protein kinase gi|332659618|gb|AEE85018.1| U-box domain-containing protein 35 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2267), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/826 (55%), Positives = 585/826 (70%), Gaps = 45/826 (5%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIP 75
+V VA+ G+ KS+Y V WA+EKF EG FKLLH+ P ITSVPTP +GN IP
Sbjct: 21 TVVVALSGSSKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTP--------MGNAIP 72
Query: 76 IEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCN 135
I +VRDDV AY+QE W+++ +L P+ + +R+V VEV VIESD+VA AIA+EV +
Sbjct: 73 ISEVRDDVVTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDS 132
Query: 136 INKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTK 195
I+++VIG S+ F+ +K ++ S IS +P+FCTVY V KGKLS VRPSD + +
Sbjct: 133 IDRIVIGGSSRSFFS---RKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIR 189
Query: 196 DDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAV-NKTLLHLKP 254
+D S+ S+S SS S S + SA S S SLP +R+Q A+ + + ++
Sbjct: 190 EDGSERTNSSSGSSGPTSDSSDVMSSAHDS--QSRPLSLPVRRMQHFPAIAGQASVPMET 247
Query: 255 SSTEINHSRCQSFDVEEQKDASSSCLSGP--------------EVRQTVSRSSSYR---- 296
SS + +RC S D EE +D SS S E ++ +S SSS R
Sbjct: 248 SSVGSDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAMSSSSSNREYGN 307
Query: 297 ----------SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMY 345
++T + S QAS +D L S +++QV++NFE+EKLR ELRHV+ MY
Sbjct: 308 FGTRFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMY 367
Query: 346 AIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECAR 405
A+AQ E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +E ARR+AE R
Sbjct: 368 AVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMR 427
Query: 406 ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIG 465
AE+E AQR+EAE K+ + KEKE LE L +Y++ WEEI +AT SFSE L+IG
Sbjct: 428 ERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIG 487
Query: 466 MGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC 525
MG YG VYK HHT A VKVLQS N +KQF QELE+LSKIRHPHL+LLLGACP+ G
Sbjct: 488 MGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGA 547
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
LVYEYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP N
Sbjct: 548 LVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPAN 607
Query: 586 ILLDHNLVSKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 644
ILLDHN VSK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQRTG IS KSD+
Sbjct: 608 ILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDI 667
Query: 645 YAYGMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCA 703
Y++GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+ELAAL L C
Sbjct: 668 YSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCT 727
Query: 704 ELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAAD 763
ELR KDRPDLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK+VMNEPCVAAD
Sbjct: 728 ELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAAD 787
Query: 764 GYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 809
GYTYDR AIEEWL+E++ SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 788 GYTYDRHAIEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297799476|ref|XP_002867622.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313458|gb|EFH43881.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2254), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/826 (54%), Positives = 585/826 (70%), Gaps = 48/826 (5%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIP 75
+V VA+ G+ KS+Y V WALEKF PEG FKLLH+ P ITSVPTP +GN IP
Sbjct: 21 TVVVALSGSSKSKYVVTWALEKFAPEGNVGFKLLHIHPMITSVPTP--------MGNAIP 72
Query: 76 IEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCN 135
I +VRDDV A++QE W+++ +L PF + +++V VEV VIESD++A AIA+EV +
Sbjct: 73 ISEVRDDVVTAFRQEILWQSEEMLKPFTKLFVRKKVAVEVLVIESDNLAAAIAEEVTRDS 132
Query: 136 INKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTK 195
I+++VIG S+ F+ +K ++ S IS +P+FCTVY V KGKLS VRPSD + +
Sbjct: 133 IDRIVIGGSSRSFFS---RKADMCSAISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIR 189
Query: 196 DDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL-LHLKP 254
DD G ++SSS +S +D+ S+V + S + SLP +R+Q + + + ++
Sbjct: 190 DD----GSERTNSSSGSSGPTSDVMSSVHD-SQSRALSLPVRRMQNFPTIARQASVPMET 244
Query: 255 SSTEINHSRCQSFDVEEQKDASSSCLSG--------PEVR------QTVSRSSSYR---- 296
SS + +RC S D EE +D SS S P +R + +S SSS R
Sbjct: 245 SSVGSDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRLRDYEERKEAMSSSSSNREYGN 304
Query: 297 ----------SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMY 345
++ + S QAS +D L S ++SQV++NFE+EKLR ELRHV+ MY
Sbjct: 305 IGSRFSWTGMGVDNTHSRASQQASNMSDALSEQSYTDSQVNLNFEVEKLRAELRHVQEMY 364
Query: 346 AIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECAR 405
A+AQ E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ E ARR+AE R
Sbjct: 365 AMAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEREKQNVEKARRDAESMR 424
Query: 406 ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIG 465
AE+E AQR+E E K+ + KE+E L+ L +Y++ WEEI +AT SFSE L+IG
Sbjct: 425 ERAEREIAQRREVERKSARDTKEREKLKGTLGSPQLQYQHFAWEEIMAATSSFSEELKIG 484
Query: 466 MGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC 525
MG YG VYK HHT AAVKVL S + +KQF QELE+LSKIRHPHL+LLLGACP+ G
Sbjct: 485 MGAYGAVYKCNLHHTTAAVKVLHSAESRLSKQFQQELEILSKIRHPHLVLLLGACPEQGA 544
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
LVYEYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP N
Sbjct: 545 LVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPAN 604
Query: 586 ILLDHNLVSKIGDVGLSTMLNSD-PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 644
ILLD N VSK+GDVGLSTM+ D S T YK T PVGTLCYIDPEYQRTG+IS KSDV
Sbjct: 605 ILLDQNFVSKVGDVGLSTMVQVDLLSTKFTIYKQTSPVGTLCYIDPEYQRTGMISSKSDV 664
Query: 645 YAYGMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCA 703
Y++GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+EL AL L C
Sbjct: 665 YSFGMIVLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELTALALCCT 724
Query: 704 ELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAAD 763
ELR KDRPDLKNQ+LP LE LK+VA+ AR+++ V PP HFICP+LK+VMNEPCVAAD
Sbjct: 725 ELRGKDRPDLKNQILPALENLKKVAEMARNSLSGVSTQPPTHFICPLLKDVMNEPCVAAD 784
Query: 764 GYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 809
GYTYDR+AIEEWL+E+D SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 785 GYTYDRRAIEEWLEEHDTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 830
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 810 | ||||||
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.702 | 0.681 | 0.547 | 5.2e-210 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.456 | 0.464 | 0.583 | 2.2e-176 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.455 | 0.450 | 0.641 | 4.2e-171 | |
| TAIR|locus:2047605 | 801 | AT2G19410 [Arabidopsis thalian | 0.629 | 0.636 | 0.435 | 4.6e-120 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.361 | 0.386 | 0.547 | 1.9e-119 | |
| TAIR|locus:504954932 | 789 | AT5G57035 [Arabidopsis thalian | 0.454 | 0.466 | 0.508 | 5.2e-119 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.560 | 0.576 | 0.436 | 2.9e-116 | |
| TAIR|locus:2128131 | 764 | AT4G31230 [Arabidopsis thalian | 0.525 | 0.557 | 0.426 | 1.3e-113 | |
| TAIR|locus:2063601 | 700 | AT2G07020 [Arabidopsis thalian | 0.572 | 0.662 | 0.429 | 1.7e-113 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.769 | 0.888 | 0.358 | 1.6e-111 |
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1561 (554.6 bits), Expect = 5.2e-210, Sum P(2) = 5.2e-210
Identities = 319/583 (54%), Positives = 403/583 (69%)
Query: 233 SLPTQRLQALSAVNKTLLHLKPSSTEINHSRC--QSFDVEEQKDASSSCLSGPEVRQTVS 290
SL + + +S++N+ SST+ SR + D EE+K+A SS S E +
Sbjct: 259 SLDAEEARDVSSINR-------SSTDTT-SRWTPRRRDYEERKEAMSSSSSNREYGNFGT 310
Query: 291 RSS-SYRSMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIA 348
R S S ++T + S QAS +D L S +++QV++NFE+EKLR ELRHV+ MYA+A
Sbjct: 311 RFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHVQEMYAVA 370
Query: 349 QNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYXXXXXXXXXXXXXX 408
Q E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +
Sbjct: 371 QTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERA 430
Query: 409 XXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNLTWEEIESATLSFSENLRIGMGG 468
L +Y++ WEEI +AT SFSE L+IGMG
Sbjct: 431 EREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAATSSFSEELKIGMGA 490
Query: 469 YGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVY 528
YG VYK HHT A VKVLQS N +KQF QELE+LSKIRHPHL+LLLGACP+ G LVY
Sbjct: 491 YGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVY 550
Query: 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588
EYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPKPIIHRD+KP NILL
Sbjct: 551 EYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILL 610
Query: 589 DHNLVSKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 647
DHN VSK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQRTG IS KSD+Y++
Sbjct: 611 DHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSF 670
Query: 648 GMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKETKELAALGLSCAELR 706
GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET+ELAAL L C ELR
Sbjct: 671 GMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELR 730
Query: 707 RKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYT 766
KDRPDLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK+VMNEPCVAADGYT
Sbjct: 731 GKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLKDVMNEPCVAADGYT 790
Query: 767 YDRKAIEEWLQENDKSPITDXXXXXXXXXXXXXXXSAILDWKS 809
YDR AIEEWL+E++ SP+TD +AI++W+S
Sbjct: 791 YDRHAIEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 2.2e-176, Sum P(2) = 2.2e-176
Identities = 223/382 (58%), Positives = 279/382 (73%)
Query: 441 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQ 500
Q+Y WEEI AT SFS+ L+IG+GGYG+VY+ HHT AVKVL S + KQF Q
Sbjct: 412 QQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQ 471
Query: 501 ELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLY-RKNNT-----PPIPWFER 554
ELE+LSKIRHPHLLLLLGACP+ G LVYEYM NGSLE+RL R+ N PP+ WFER
Sbjct: 472 ELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFER 531
Query: 555 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614
+RIAWE+ASAL FLH +P+PI+HRD+KP NILLD N VSKIGDVGLS M+N DPS ST
Sbjct: 532 FRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHAST 591
Query: 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 674
+ TGPVGT YIDPEYQRTG+++P+SD+YA+G+++LQL+TA+ A+ + H +E A+ +
Sbjct: 592 VFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQ 651
Query: 675 N--LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 732
EILD AGDWP+KE KE+ +GL CAE+R++DRPDL ++LPVLERLKEVA AR
Sbjct: 652 TGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIAR 711
Query: 733 ----DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDXX 788
D + H P HF CPI K+VM PCVA+DGYTY+++AI+EWLQ+N KSP+TD
Sbjct: 712 NMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHKSPMTDLP 771
Query: 789 XXXXXXXXXXXXXSAILDWKSK 810
SAI +W+S+
Sbjct: 772 FPSDSLLPNHSLLSAIKEWRSQ 793
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1286 (457.8 bits), Expect = 4.2e-171, Sum P(2) = 4.2e-171
Identities = 240/374 (64%), Positives = 299/374 (79%)
Query: 442 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE 501
+Y+ TWEEI +AT SFSE+L+IGMG YG VYK HHT AAVKVL S + +KQF QE
Sbjct: 444 QYQEFTWEEIINATSSFSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQE 503
Query: 502 LEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 561
LE+LSKIRHPHL+LLLGACPDHG LVYEYMENGSLEDRL++ N++ PIPWF R RIAWEV
Sbjct: 504 LEILSKIRHPHLVLLLGACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEV 563
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS-DP-SFVSTTYKNT 619
ASAL FLH +KP PIIHRD+KP NILL+HN VSK+GDVGLSTM+ + DP S T YK T
Sbjct: 564 ASALVFLHKSKPTPIIHRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQT 623
Query: 620 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---EDNL 676
PVGTLCYIDPEYQRTG ISPKSDVYA+GM+ILQLLT + A+A+T+ VETA++ +D L
Sbjct: 624 SPVGTLCYIDPEYQRTGRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDEL 683
Query: 677 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVP 736
+ILD +AG+WPI+ET++LAAL L C ELR KDRPDL++Q+LPVLE LK+VAD+AR+++
Sbjct: 684 IQILDEKAGNWPIEETRQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLS 743
Query: 737 SVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDXXXXXXXXXX 796
+ PP+HF CP+LK+VM EPC+AADGYTYDR+AIEEW++ + SP+T+
Sbjct: 744 AAPSQPPSHFFCPLLKDVMKEPCIAADGYTYDRRAIEEWMENHRTSPVTNSPLQNVNLLP 803
Query: 797 XXXXXSAILDWKSK 810
+AI++W+++
Sbjct: 804 NHTLYAAIVEWRNR 817
|
|
| TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1056 (376.8 bits), Expect = 4.6e-120, Sum P(2) = 4.6e-120
Identities = 226/519 (43%), Positives = 315/519 (60%)
Query: 293 SSYRSMETENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEA 352
S+ ++ +E++D SD++ P S +V++ E+E+L+ EL+ Y A E
Sbjct: 283 SNVENIVSEHRD-SDRSP-----PETSRKSKKVEIEEEVERLKNELQSTVFKYKQACEEL 336
Query: 353 NDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYXXXXXXXXXXXXXXXXXX 412
KV L+ L E R++ EE A EK++Y
Sbjct: 337 FSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKERYMKAVKEVETAKALLAREF 396
Query: 413 XXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTV 472
L GT RYR T EEI +AT FS IG GGYG V
Sbjct: 397 CQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIVTATEGFSPEKVIGEGGYGKV 456
Query: 473 YKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYME 532
Y+ + T AAVKV++ + ++FL+E+EVLS++RHPH++LLLGACP++GCLVYEY+E
Sbjct: 457 YQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEYLE 516
Query: 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 592
NGSLE+ ++ + N PP+PWF R+R+ +EVA LAFLH++KP+PI+HRD+KPGNILL+ N
Sbjct: 517 NGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNRNY 576
Query: 593 VSKIGDVGLSTMLNS-DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
VSKI DVGL+ ++ P V T Y+N+ GTL YIDPEY RTG I PKSD+YA+G++I
Sbjct: 577 VSKIADVGLAKLVTDVAPDNV-TMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGIII 635
Query: 652 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711
LQLLTA+ I VE A+ + L E+LD DWP+ ET+ELA +GL CAE R +DRP
Sbjct: 636 LQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDRP 695
Query: 712 DLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKA 771
DLK++V+PVL+RL E A+ ++ + P+H+ CPIL+E+M EP +AADG+TY+RKA
Sbjct: 696 DLKSEVIPVLKRLVETAN-SKVKKEGSNLRAPSHYFCPILREIMEEPEIAADGFTYERKA 754
Query: 772 IEEWLQENDKSPITDXXXXXXXXXXXXXXXSAILDWKSK 810
I WL++++ SP+T SAI DWKS+
Sbjct: 755 ILAWLEKHNISPVTRQKLDHFKLTPNHTLRSAIRDWKSR 793
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 857 (306.7 bits), Expect = 1.9e-119, Sum P(4) = 1.9e-119
Identities = 161/294 (54%), Positives = 215/294 (73%)
Query: 442 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE 501
RYR + +EIE T +F+E+ ++G GGYG V++G HT AVKVL+ QF +E
Sbjct: 434 RYRKYSVQEIEEGTANFAESRKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHKE 493
Query: 502 LEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 561
+EVLS IRHP+++LLLGACP++G LVYEYM GSL+DRL+R+ NTPPI W R+RIA E+
Sbjct: 494 VEVLSCIRHPNMVLLLGACPEYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAEI 553
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
A+ L FLH TKP+PI+HRD+KPGN+LLDHN VSKI DVGL+ ++ + V T Y+ T
Sbjct: 554 ATGLLFLHQTKPEPIVHRDLKPGNVLLDHNYVSKISDVGLARLVPAVAENV-TQYRVTSA 612
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
GT CYIDPEYQ+TG++ KSDVY+ G+++LQLLTAK + + + VE AI+E L ++LD
Sbjct: 613 AGTFCYIDPEYQQTGMLGVKSDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDMLD 672
Query: 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTV 735
DWP++E LA L L CAELRRKDRPDL +V+P L RL+E+ + + D+V
Sbjct: 673 PAVPDWPLEEALSLAKLSLQCAELRRKDRPDLGKEVMPELSRLREIGEESLDSV 726
|
|
| TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 5.2e-119, Sum P(2) = 5.2e-119
Identities = 188/370 (50%), Positives = 255/370 (68%)
Query: 442 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE 501
RYR T EEI +AT +FS IG GGYG VYK + HT A+KVL+ + ++FL+E
Sbjct: 409 RYRKYTKEEIAAATDNFSSRKIIGEGGYGKVYKCSLDHTPVALKVLKPDSVEKKEEFLKE 468
Query: 502 LEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 561
+ VLS++RHPH++LLLGACP++GCLVYEYMENGSL+ + K P + WF R+RI +E
Sbjct: 469 ISVLSQLRHPHVVLLLGACPENGCLVYEYMENGSLDCHISPKKGKPSLSWFIRFRIIYET 528
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
A LAFLHN+KP+PI+HRD+KPGNILLD N VSKIGDVGL+ +++ + T Y+N+
Sbjct: 529 ACGLAFLHNSKPEPIVHRDLKPGNILLDRNFVSKIGDVGLAKLMSDEAPDSVTVYRNSII 588
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
GTL Y+DPEYQRTG I PKSD+YA+G++ILQLLTA+ + VE A+ ++LD
Sbjct: 589 AGTLYYMDPEYQRTGTIRPKSDLYAFGIIILQLLTARHPNGLLFCVEDAVKRGCFEDMLD 648
Query: 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPA 741
DWPI E KELA + + C++L+ +DRPDL QVLP L+R+ E A+ +R +
Sbjct: 649 GSVKDWPIAEAKELARIAIRCSQLKCRDRPDLSTQVLPALKRILESAN-SRLKTEQANAR 707
Query: 742 PPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN-DKSPITDXXXXXXXXXXXXXX 800
P H+ CPILKE+M +P +AADG+TY+RKAI+EW+Q++ D SP+T
Sbjct: 708 APTHYYCPILKEIMEDPQIAADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLTPNHTL 767
Query: 801 XSAILDWKSK 810
SAI +W+S+
Sbjct: 768 RSAIREWRSR 777
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 2.9e-116, Sum P(2) = 2.9e-116
Identities = 200/458 (43%), Positives = 276/458 (60%)
Query: 278 SCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIE 337
S S + ++ +SS+Y + +D S + S+S+S DV E+ +L++E
Sbjct: 304 SNFSDMDYSSSLDQSSNYGRRSVDMNSPTDFESER----FSSASQSIDDVEAEMRRLKLE 359
Query: 338 LRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYXXX 397
L+ MY+ A EA A +K +L + KLEEE +L E + EE A+ +A++EK K
Sbjct: 360 LKQTMEMYSTACKEALTAKQKATELQRWKLEEERKLEEARNAEEAALAIAEKEKAKSKAA 419
Query: 398 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNLTWEEIESATLS 457
AL + RYR + E+IE AT
Sbjct: 420 MEAAEAAQRIAELEAKKRVNAEMKALKESEEKTKALTALANSDVRYRKYSIEDIELATEF 479
Query: 458 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
F+E +IG GGYG VYK HT AVKVL+ QF QE+EVLS IRHP+++LLL
Sbjct: 480 FAEKYKIGEGGYGPVYKCYLDHTPVAVKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLL 539
Query: 518 GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
GACP+ GCLVYE+M NGSLEDRL+R N+PP+ W R+RIA E+ + L FLH KP+P++
Sbjct: 540 GACPECGCLVYEFMANGSLEDRLFRLGNSPPLSWQMRFRIAAEIGTGLLFLHQAKPEPLV 599
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637
HRD+KPGNILLD N VSKI DVGL+ ++ + T Y+ T GT CYIDPEYQ+TG+
Sbjct: 600 HRDLKPGNILLDRNFVSKISDVGLARLVPPTVADTVTQYRMTSTAGTFCYIDPEYQQTGM 659
Query: 638 ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 697
+ KSD+Y+ G++ LQL+TAKP + +TH VE A+++ L ++LD DWP+++T+E A
Sbjct: 660 LGVKSDIYSLGIMFLQLITAKPPMGLTHYVERALEKGTLVDLLDPVVSDWPMEDTEEFAK 719
Query: 698 LGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTV 735
L L CAELRRKDRPDL +LP L RL+ +AD + +V
Sbjct: 720 LALKCAELRRKDRPDLAKVILPELNRLRTLADESSHSV 757
|
|
| TAIR|locus:2128131 AT4G31230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 1.3e-113, Sum P(2) = 1.3e-113
Identities = 182/427 (42%), Positives = 254/427 (59%)
Query: 317 YDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEI 376
+ S+S+ DV E+ +L++EL+ MY+ A EA A K +L + KL EE + E
Sbjct: 327 FSSASQGGDDVEAEMRRLKLELKQTMEMYSTACKEALTAKHKATELQRWKLAEERKFEEA 386
Query: 377 QLLEEKAIELAKQEKKKYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRAL 436
+L EE A+ +A++EK K AL
Sbjct: 387 KLAEEAALAIAEKEKAKSKAAMEAAEAAQRIADIESRKRVDAETKALKESEARTKAVNAL 446
Query: 437 NGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK 496
RYR + EEIE AT F + +IG G YG VYK HT AVK L+
Sbjct: 447 AKDV-RYRKYSIEEIEDATEFFDDKYKIGEGSYGPVYKCYLDHTPVAVKALRPDAAQGRS 505
Query: 497 QFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 556
QF +E+EVL IRHP+++LLLGACP+ GCLVYE+M NGSLEDRL+R+ ++P + W R+R
Sbjct: 506 QFQKEVEVLCSIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFRQGDSPALSWQTRFR 565
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616
IA E+ + L FLH TKP+P++HRD+KP NILLD N VSK+ DVGL+ ++ + T Y
Sbjct: 566 IAAEIGTVLLFLHQTKPEPLVHRDLKPANILLDRNFVSKLADVGLARLVPPSVANTVTQY 625
Query: 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 676
T GT CYIDPEYQ+TG++ KSD+Y+ G++ LQL+T KP + +TH VE A+++ NL
Sbjct: 626 HMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITGKPPMGLTHYVERALEKGNL 685
Query: 677 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVP 736
++LD DWP+++T E A L L CAE+RRKDRPDL +LP L RL+ +A+ +
Sbjct: 686 KDLLDPAVSDWPVEDTTEFAKLALKCAEIRRKDRPDLSKVILPELNRLRVLAEESTQAAV 745
Query: 737 SVHPAPP 743
++ + P
Sbjct: 746 VINSSGP 752
|
|
| TAIR|locus:2063601 AT2G07020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 1.7e-113, Sum P(3) = 1.7e-113
Identities = 203/473 (42%), Positives = 286/473 (60%)
Query: 266 SFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQV 325
S D E ++ + S +Q++ SSY + T +Q+ S + S+ + Y SQ
Sbjct: 235 SMDWFEDNRSNYATSSSSSEKQSIDLCSSYSAFSTSSQE-SGRLSSLSM--Y-----SQD 286
Query: 326 DVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIE 385
DV E+ +L++EL++ MY A EA A + +L+K K E + +L E L +E A+
Sbjct: 287 DVESEMRRLKLELKYTMDMYNSACKEAIAAKKTTIELHKWKEERKHKLEEAILAKEAAMA 346
Query: 386 LAKQEKKKYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRN 445
+A+ EK K AL + + YR
Sbjct: 347 IAENEKAKSRAAMEALEAAHRMAETEAQKRKQIETAALREVEHENKAMHALPHSNRMYRK 406
Query: 446 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVL 505
T EEIE T FS++ +IG G YGTVYKGT +T A+KV++ QF QE+EVL
Sbjct: 407 YTIEEIEQGTTKFSDSHKIGEGSYGTVYKGTLDYTPVAIKVVRPDATQGRSQFQQEVEVL 466
Query: 506 SKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+ IRHP+++LLLGAC ++GCLVYEYM NGSL+D L R+ N+P + W R+RIA E+A++L
Sbjct: 467 TCIRHPNMVLLLGACAEYGCLVYEYMSNGSLDDCLLRRGNSPVLSWQLRFRIAAEIATSL 526
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
FLH KP+P++HRD+KP NILLD ++VSKI DVGL+ ++ ++T Y+ T GTL
Sbjct: 527 NFLHQLKPEPLVHRDLKPANILLDQHMVSKISDVGLARLVPPTIDDIATHYRMTSTAGTL 586
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685
CYIDPEYQ+TG++ KSD+Y++G+V+LQ+LTAK + +T++VE AI+E N A+ILD
Sbjct: 587 CYIDPEYQQTGMLGTKSDIYSFGIVLLQILTAKTPMGLTNQVEKAIEEGNFAKILDPLVT 646
Query: 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD-TVPS 737
DWPI+E LA +GL CAELRRKDRPDL VLP L+RL +A+ T PS
Sbjct: 647 DWPIEEALILAKIGLQCAELRRKDRPDLGTVVLPGLKRLMNLAEENMSITRPS 699
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.6e-111, Sum P(2) = 1.6e-111
Identities = 234/653 (35%), Positives = 361/653 (55%)
Query: 96 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIF--TWKF 153
++L +P+R CA++ + + +++ DV+KA+ D V + + LV+G+ S+ F + KF
Sbjct: 69 NQLFVPYRGYCARKGISMMEVILDDTDVSKAVLDYVNNNLVTNLVLGSSSKSPFARSLKF 128
Query: 154 -KKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSD---LGSIGSTKXXXXXXXXXXXXXX 209
K ++++S + P FC+VY + KGK+ S R + ++ +
Sbjct: 129 TKSHDVASSVLKSTPEFCSVYVISKGKVHSSRTAQRPITNTLVPPRVPSSTFHLPDPDHD 188
Query: 210 XXXXXXQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL---LHLKPSSTEINHSRCQS 266
+ + Y+H + P + + + N +L + + N + S
Sbjct: 189 RSPRSQRNGRNTVPERYSHENKGFKPVREMHKIPT-NGSLDFNYEFRQGKGQRNSTGRSS 247
Query: 267 FDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQVD 326
F +E D S + G ++ S+ EN D + ++D +S+S+S D
Sbjct: 248 FS-DESSDVGSMMMMG-----SIDLSA-------ENFDMVGGSGSSD----ESASQSTRD 290
Query: 327 VNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIEL 386
+ E+++L+IEL+ MY+ A EA +A +K N+LN+ K+EE R E + EE A+ +
Sbjct: 291 IEAEMKRLKIELKQTMDMYSSACKEALNAKKKANELNQWKMEEARRFEEARNAEEAALAV 350
Query: 387 AKQEKKKYXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXRALNGTFQRYRNL 446
A+ EK K AL RYR
Sbjct: 351 AEMEKAKCRAALEAAEKAQRMAELEGQRRKQAEMKARRESQEKDRALSALVQNDVRYRKY 410
Query: 447 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLS 506
+ +EIE AT F+ N +IG GGYG VY GT HT A+KVL+ KQF QE+EVLS
Sbjct: 411 SIDEIEVATERFANNRKIGEGGYGPVYHGTLDHTPVAIKVLRPDAAQGKKQFQQEVEVLS 470
Query: 507 KIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
IRHPH++LLLGACP++GCLVYE+M+NGSLEDRL+R+ N+PP+ W +R++IA E+A+AL+
Sbjct: 471 SIRHPHMVLLLGACPEYGCLVYEFMDNGSLEDRLFRRGNSPPLSWRKRFQIAAEIATALS 530
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
FLH KP+P++HRD+KP NILLD N VSKI DVGL+ ++ + + T Y T GT C
Sbjct: 531 FLHQAKPEPLVHRDLKPANILLDKNYVSKISDVGLARLVPASVANTVTQYHMTSAAGTFC 590
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686
YIDPEYQ+TG ++ KSD+++ G+++LQ++TAK + + H V AID+ ++LD D
Sbjct: 591 YIDPEYQQTGKLTTKSDIFSLGIMLLQIITAKSPMGLAHHVSRAIDKGTFKDMLDPVVPD 650
Query: 687 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 739
WP++E A L L CAELR++DRPDL +++P L RL+ + +D P H
Sbjct: 651 WPVEEALNFAKLCLRCAELRKRDRPDLGKEIVPELLRLRNLG---KDNEPGCH 700
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SW11 | PUB35_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5532 | 0.9641 | 0.9353 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00030849001 | SubName- Full=Chromosome undetermined scaffold_52, whole genome shotgun sequence; (788 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 810 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 5e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 7e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 5e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 5e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 5e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-04 | |
| pfam03763 | 112 | pfam03763, Remorin_C, Remorin, C-terminal region | 7e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 8e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.004 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 0.004 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.004 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 73/198 (36%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 520
+G GG+GTVY T A+K+++ + + + L+E+E+L K+ HP+++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
+H LV EY E GSL+D K N + E RI ++ L +LH+ IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 579 RDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 636
RD+KP NILLD N K+ D GLS +L SD S + T VGT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------VGTPAYMAPEVLLGKG 169
Query: 637 LISPKSDVYAYGMVILQL 654
S KSD+++ G+++ +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 70/163 (42%), Positives = 98/163 (60%), Gaps = 17/163 (10%)
Query: 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIP 75
SVAVAV ++KS+ A+ WAL+ +G L+HV P ITS+P+ +
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQT-IVLVHVHPPITSIPSSSG------------ 47
Query: 76 IEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCN 135
+ +VA+AYKQEE + LLLP+R C+++ V+ E V+E DDVAKAI + VA
Sbjct: 48 ----KLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHG 103
Query: 136 INKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 178
I KLV+GA S F+ KFKK++++S + P FCTVY V KG
Sbjct: 104 ITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 9e-43
Identities = 76/204 (37%), Positives = 110/204 (53%), Gaps = 19/204 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
++G G +GTVYK T AVK+L +S+ + +++ +E+ +L ++ HP+++ L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 519 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A DH LV EY E G L D L R P+ E +IA ++ L +LH+ I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 635
IHRD+KP NILLD N V KI D GL+ L S T VGT Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS------SLTTFVGTPWYMAPEVLLGG 173
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
PK DV++ G+++ +LLT KP
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 29/260 (11%)
Query: 464 IGMGGYGTVYKGT------FHHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLL 516
+G G +G VYKGT T AVK L+ + + ++ FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 517 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
LG C +V EYM G L D L + + ++A ++A + +L + K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLES---K 121
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
+HRD+ N L+ NLV KI D GLS + D + P+ ++ PE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG-GGKLPI---KWMAPESLK 177
Query: 635 TGLISPKSDVYAYGMVILQLLT--AKP-AIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
G + KSDV+++G+++ ++ T +P +V +++ P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR--------PENC 229
Query: 692 TKELAALGLSCAELRRKDRP 711
EL L L C +DRP
Sbjct: 230 PDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 78/260 (30%), Positives = 121/260 (46%), Gaps = 29/260 (11%)
Query: 464 IGMGGYGTVYKGTF------HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +G VYKGT AVK L+ Q ++FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 517 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
LG C + +V EYM G L D L RKN + + A ++A + +L + K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES---K 122
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
IHRD+ N L+ NLV KI D GLS L D YK G + ++ PE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYKVKGGKLPIRWMAPESLK 177
Query: 635 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKE 691
G + KSDV+++G+++ ++ T +P +++ V + + P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK--------PPNC 229
Query: 692 TKELAALGLSCAELRRKDRP 711
EL L L C +DRP
Sbjct: 230 PPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 5e-39
Identities = 75/260 (28%), Positives = 120/260 (46%), Gaps = 30/260 (11%)
Query: 464 IGMGGYGTVYKGT------FHHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +G VYKG AVK L+ Q ++FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 517 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
LG C + +V EYME G L L + N P + + A ++A + +L + K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES---K 121
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
IHRD+ N L+ NLV KI D GLS L D Y+ G + ++ PE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYRKRGGKLPIRWMAPESLK 176
Query: 635 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKE 691
G + KSDV+++G+++ ++ T +P ++++ V + P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ--------PPNC 228
Query: 692 TKELAALGLSCAELRRKDRP 711
EL L L C +DRP
Sbjct: 229 PPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 9e-39
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G VY T A+KV++ K ++ L+E+++L K++HP+++ L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLHNTKPKPII 577
D LV EY E G L D L ++ + R ++ SAL +LH+ K I+
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSE----DEARFYLRQILSALEYLHS---KGIV 119
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637
HRD+KP NILLD + K+ D GL+ L+ T VGT Y+ PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-------TTFVGTPEYMAPEVLLGKG 172
Query: 638 ISPKSDVYAYGMVILQLLTAKP 659
D+++ G+++ +LLT KP
Sbjct: 173 YGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 464 IGMGGYGTVYKGTF-----HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+G G +G VYKG T AVK L+ + K FL+E V+ K+ HP+++ LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 518 GACPDHG--CLVYEYMENGSLEDRL------YRKNNTPPIPWFERYRIAWEVASALAFLH 569
G C + LV EYME G L D L + + + A ++A + +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ K +HRD+ N L+ +LV KI D GLS + D + T G I
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-------GGKLPIR 172
Query: 630 ---PEYQRTGLISPKSDVYAYGMVI 651
PE + G+ + KSDV+++G+++
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 519
+G G +G+VY T AVK ++ G+ + + +E+ +LS ++HP+++ G+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 520 C----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ + EY+ GSL L +K P P +Y ++ LA+LH+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKY--TRQILEGLAYLHS---NG 121
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
I+HRD+K NIL+D + V K+ D G + L + T GT ++ PE R
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGD----IETGEGTGSVRGTPYWMAPEVIRG 177
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+D+++ G ++++ T KP
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 91/359 (25%), Positives = 144/359 (40%), Gaps = 28/359 (7%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHL---LLLL 517
+G G +G VY A+KVL K ++K +FL+E+++L+ + HP L
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 518 GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
LV EY++ GSLED L + P+ E I ++ SAL +LH K II
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGII 123
Query: 578 HRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY---Q 633
HRD+KP NILLD + V K+ D GL+ +L S S + VGT Y+ PE
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDAQAGDW 687
S SD+++ G+ + +LLT P + T + I E + +
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243
Query: 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFI 747
P +K + L K+R + + L ++ + + + P
Sbjct: 244 PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLS 303
Query: 748 CPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILD 806
P + A + + AI + D S + PN + S +L
Sbjct: 304 --------LPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLS 354
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLGAC 520
+G G G VYK T A+K + G+ + KQ L+EL+ L P+++ GA
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 521 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 576
G +V EYM+ GSL D L + IP E IA ++ L +LH + I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKK---VGKIP--EPVLAYIARQILKGLDYLHTKRH--I 121
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+KP N+L++ KI D G+S +L + + NT VGT+ Y+ PE +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTF-VGTVTYMSPERIQGE 175
Query: 637 LISPKSDVYAYGMVILQLLTAK 658
S +D+++ G+ +L+ K
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 463 RIGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG GG+G VYK H A+KV++ + + ++ + E+++L K +HP+++ G
Sbjct: 7 KIGKGGFGEVYKA--RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 519 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKP 573
+ D +V E+ GSL+D L + N +IA+ E+ L +LH+
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKD-LLKSTNQT----LTESQIAYVCKELLKGLEYLHSNG- 118
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
IIHRD+K NILL + K+ D GLS +S T VGT ++ PE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSA-------QLSDTKARNTMVGTPYWMAPEVI 169
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKP 659
K+D+++ G+ ++L KP
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 44/218 (20%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF-LQELEVLSKIRHPHLLLLLGA 519
IG G +G VY + ++ S + + ++ L E+++L K+ HP+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII----K 63
Query: 520 C------PDHGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRI-AW--EVASALAFL 568
C+V EY + G L ++ +K P F +I W ++ AL +L
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP----FPEEQILDWFVQLCLALKYL 119
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H+ K I+HRD+KP NI L N + K+GD G+S +L+S T VGT Y+
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYL 170
Query: 629 DPE------YQRTGLISPKSDVYAYGMVILQLLTAKPA 660
PE Y + KSD+++ G V+ +L T K
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 72/219 (32%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNI--QNKQ--FLQELEVLSKI-RHPHLLLL 516
IG G + TV T A+K+L K + + K E EVL+++ HP ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 517 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
D L V EY NG L + RK + R+ A E+ AL +LH+ K
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCT-RFYAA-EILLALEYLHS---K 121
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP------------- 621
IIHRD+KP NILLD ++ KI D G + +L+ + S S T
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 622 -VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
VGT Y+ PE SD++A G +I Q+LT KP
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G G V K T AVK ++ + N KQ L+EL++L K P+++ GA
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 521 PDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
++G C+ EYM+ GSL+ K IP +IA V L +LH I
Sbjct: 69 YNNGDISICM--EYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
IHRD+KP NIL++ K+ D G+S L NS ++ T+ VGT Y+ PE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTF-----VGTSSYMAPERIQG 173
Query: 636 GLISPKSDVYAYGMVILQLLTAK 658
S KSD+++ G+ +++L T +
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
IG G +G VYKG T F A+K L+ K +QE+++L ++HP+++ +G+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 520 CPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPKPI 576
L + EY ENGSL + K P P Y + +V LA+LH +
Sbjct: 68 IETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVY-VY-QVLQGLAYLHEQG---V 120
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+K NIL + V K+ D G++T LN + VGT ++ PE
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSK------DDASVVGTPYWMAPEVIEMS 174
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
S SD+++ G +++LLT P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-23
Identities = 29/63 (46%), Positives = 41/63 (65%)
Query: 745 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAI 804
F+CPI EVM +P + G TY+R AIE+WL + P+T PL +++L+PN L SAI
Sbjct: 1 EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLSHGTDPVTGQPLTHEDLIPNLALKSAI 60
Query: 805 LDW 807
+W
Sbjct: 61 QEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 28/259 (10%)
Query: 463 RIGMGGYGTVYKGTFH---HTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G +G V+K +A ++ L + ++ + E VL+K+ +++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 519 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+ D G +V EY ENG L L + P+P + +R ++ LA LH+ K I
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
+HRD+K N+ LD KIGD+G++ +L+ + +F +T VGT Y+ PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI------VGTPYYLSPELCEDK 176
Query: 637 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETK 693
+ KSDV+A G+V+ + T K H + + A IL G +P ++
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK------HPFDA---NNQGALILKIIRGVFPPVSQMYSQ 227
Query: 694 ELAALGLSCAELRRKDRPD 712
+LA L C + RPD
Sbjct: 228 QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLL 516
+G G +G V K T +A +KVL+ K I+ K+ E +LS+I HP ++ L
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYA-MKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
A + LV EY G L L K Y A E+ AL +LH+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY-AA-EIVLALEYLHS---L 112
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-Q 633
II+RD+KP NILLD + K+ D GL+ L+S+ S +T GT Y+ PE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT------FCGTPEYLAPEVLL 166
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKP 659
G D ++ G+++ ++LT KP
Sbjct: 167 GKG-YGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 45/272 (16%)
Query: 463 RIGMGGYGTVYK------GTFHHTFAAVKVLQSK----GNIQNK---QFLQELEVLSKIR 509
IG G +GTV K G K+L K GN+ K Q + E+ +L +++
Sbjct: 7 TIGKGSFGTVRKVRRKSDG---------KILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 510 HPHLLLLLGACPDHGC----LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVAS 563
HP+++ D +V EY E G L + +K I +RI ++
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLL 116
Query: 564 ALAFLHN-TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
AL HN + P ++HRD+KP NI LD N K+GD GL+ +L D SF + TY
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTY----- 170
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-IL 680
VGT Y+ PE KSD+++ G +I +L P TA ++ LA I
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-------TARNQLQLASKIK 223
Query: 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPD 712
+ + P + + EL + S + RP
Sbjct: 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 457 SFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
S ++G G +G V+ GT++ T AVK L+ G + + FLQE +++ K+RH L+
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 516 LLGACPDHG--CLVYEYMENGSLEDRLY----RKNNTPPIPWFERYRIAWEVASALAFLH 569
L C + +V EYM GSL D L +K P + +A ++A +A+L
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLE 120
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ IHRD+ NIL+ NLV KI D GL+ ++ D K P+ +
Sbjct: 121 SRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIK---WTA 172
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLT 656
PE G + KSDV+++G+++ +++T
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 464 IGMGGYGTVYKGTFHHTF--------AAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLL 514
+G G +G V + AVK L S F +E+E+L + H +++
Sbjct: 12 LGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 515 LLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
G C G L+ EY+ +GSL D L R + + + + ++ + +L +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLGS 127
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+ IHRD+ NIL++ + KI D GL+ +L D + P+ + P
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWYAP 181
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLT 656
E RT S SDV+++G+ + +L T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 509
I S L IG G +G V G + AVK L+ + FL E V++ +R
Sbjct: 2 AINSKELKLGA--TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLR 58
Query: 510 HPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
HP+L+ LLG L V EYM GSL D L R I ++ A +V + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
L K +HRD+ N+L+ +LV+K+ D GL+ + + +
Sbjct: 118 LEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKW 165
Query: 628 IDPEYQRTGLISPKSDVYAYGMVI 651
PE R S KSDV+++G+++
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 69/229 (30%), Positives = 117/229 (51%), Gaps = 30/229 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSK 507
E+E ++ L G G YG VY+G + + AVK L+ ++ ++FL+E V+ +
Sbjct: 2 EMERTDITMKHKL--GGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKE 58
Query: 508 IRHPHLLLLLGAC----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 563
I+HP+L+ LLG C P + ++ E+M G+L D L R+ N + +A +++S
Sbjct: 59 IKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 115
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623
A+ +L + K IHRD+ N L+ N + K+ D GLS ++ D TY T G
Sbjct: 116 AMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TY--TAHAG 164
Query: 624 T---LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT----AKPAIAITH 665
+ + PE S KSDV+A+G+++ ++ T P I ++
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-AVKVLQSKGNIQNKQFLQELEVLS 506
WE I+ ++ ++G G +G V++G +++T AVK L+ G + K FL E +++
Sbjct: 1 WE-IDRTSIQLLR--KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMK 56
Query: 507 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
K+RHP L+ L C +V E M+ GSL + L + + + +A +VAS
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASG 115
Query: 565 LAFL--HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGP 621
+A+L N IHRD+ N+L+ N + K+ D GL+ ++ D Y+ G
Sbjct: 116 MAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGA 164
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ + PE S KSDV+++G+++ +++T
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 464 IGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +GTVYKG + A+KVL + NK+ L E V++ + HPH++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 517 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 573
LG C L+ + M G L D Y +N+ I +Y + W ++A +++L
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLD--YVRNHKDNIG--SQYLLNWCVQIAKGMSYLEE--- 127
Query: 574 KPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
K ++HRD+ N+L+ V KI D GL+ +L+ D Y G + ++ E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHV-KITDFGLAKLLDVD----EKEYHAEGGKVPIKWMALES 182
Query: 633 QRTGLISPKSDVYAYGMVILQLLT--AKP 659
+ + KSDV++YG+ + +L+T AKP
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 41/271 (15%)
Query: 464 IGMGGYGTVYKGTFH-----HTF--AAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLL 515
+G G +G VY+G A+K + ++ + +FL E V+ + H++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 516 LLGACPD--HGCLVYEYMENGSLEDRLY------RKNNTPPIPWFER-YRIAWEVASALA 566
LLG +V E M G L+ L N P ++ ++A E+A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG----PV 622
+L K +HRD+ N ++ +L KIGD G++ + + Y+ G PV
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-----TDYYRKGGKGLLPV 185
Query: 623 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEIL 680
++ PE + G+ + KSDV+++G+V+ ++ T +P +++ E+ L ++
Sbjct: 186 R---WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVI 235
Query: 681 DAQAGDWPIKETKELAALGLSCAELRRKDRP 711
D D P +L L C + K RP
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 464 IGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 519
IG G +G VY AVK ++ + N K+ E++VL ++HP+L+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 520 --CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
+ + EY G+LE+ L Y + ++ LA+LH+ I+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEH-VIRVYTL--QLLEGLAYLHSHG---IV 121
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637
HRD+KP NI LDHN V K+GD G + L ++ + + ++ GT Y+ PE G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--AGTPAYMAPEVITGGK 179
Query: 638 ISPK---SDVYAYGMVILQLLTAKP 659
+D+++ G V+L++ T K
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 519
IG G YG VYK T A+K++ + + ++ +E +L K HP++ GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 520 -------CPDHGCLVYEYMENGSLED---RLYRKNNTPPIPWFERYRIAW---EVASALA 566
D LV E GS+ D L +K W IA+ E LA
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLA 127
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTL 625
+LH K +IHRD+K NILL N K+ D G+S L+ ST + NT +GT
Sbjct: 128 YLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTF-IGTP 177
Query: 626 CYIDPE-----YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 669
++ PE Q +SDV++ G+ ++L KP + H +
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 70/203 (34%), Positives = 114/203 (56%), Gaps = 24/203 (11%)
Query: 464 IGMGGYGTVYKGTFH---HTFAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+G G G+V K H T A KV + +K +++ KQ L+EL+++ + R P+++ G
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR-KQILRELQIMHECRSPYIVSFYG 70
Query: 519 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A ++ C+ E+M+ GSL DR+Y+K PIP +IA V L +L+N I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+HRD+KP NIL++ K+ D G+S ++NS ++ T+ VGT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTF-----VGTSTYMSPERIQG 176
Query: 636 GLISPKSDVYAYGMVILQLLTAK 658
G + KSDV++ G+ I++L K
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 463 RIGMGGYGTVYKGT-----FHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLL 515
++G G +G V +G AVK L+S + + FL+E ++ + H +L+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 516 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
L G H +V E GSL DRL RK+ A ++A+ + +L + K
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLES---K 116
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
IHRD+ NILL + KIGD GL L ++ +V + + PE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESL 172
Query: 634 RTGLISPKSDVYAYGMVILQLLT 656
RT S SDV+ +G+ + ++ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 499 LQELEVLSKIRHPHLLLLLGACPDHGCLV--YEYMENGSLEDRLYRKNNTPPIPWFERYR 556
L E+ +LS ++HP+++ D L+ EY G+L D++ R+ FE
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ----LFEEEM 102
Query: 557 IAW---EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613
+ W ++ SA++++H I+HRD+K NI L + K+GD G+S +L S+ S
Sbjct: 103 VLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159
Query: 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 673
T VGT Y+ PE + + KSD++A G V+ +LLT K D
Sbjct: 160 TV------VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK----------RTFDA 203
Query: 674 DNLAEILDA-QAGDW-PIKE--TKELAALGLSCAELRRKDRP 711
N ++ G++ P+ + EL +L S + + RP
Sbjct: 204 TNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 40/232 (17%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQNKQ-FLQE 501
EI + + F E L G G +G VYKG T A+K L+ + +Q F QE
Sbjct: 1 EIPLSAVRFLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTP------------ 547
E++S ++HP+++ LLG C C+++EY+ +G L + L R N+P
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR--NSPHSDVGAESGDET 116
Query: 548 ---PIPWFERYRIAWEVASALAFL--HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
+ + IA ++A+ + +L H+ +HRD+ N L+ L KI D GLS
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 654
+ S + K+ PV ++ PE G + +SD++++G+V+ ++
Sbjct: 172 RDIYSA-DYYRVQSKSLLPVR---WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 463 RIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
++G G +G V++G + + A+K+L+S ++ + F +E++ L ++RH HL+ L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 522 DHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
G VY E ME GSL L R +P +A +VA +A+L IH
Sbjct: 73 V-GEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIH 127
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 638
RD+ NIL+ +LV K+ D GL+ ++ D V + P + PE G
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKED---VYLSSDKKIPYK---WTAPEAASHGTF 181
Query: 639 SPKSDVYAYGMVILQLLT 656
S KSDV+++G+++ ++ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPHLLLLLGA 519
+G G +G V+ + +K + + ++++ E +VL + HP+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 520 CPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
+ L V EY G+L + + ++ N+ + I L LH+ K I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 578 HRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
HRD+K NILLD H +V KIGD G+S +L S+ K VGT CYI PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVVGTPCYISPELCEGK 176
Query: 637 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL-AEILDAQAGDW-PIKE--T 692
+ KSD++A G V+ +L + ++ A + NL A +L +G + PI + +
Sbjct: 177 PYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAPISDRYS 226
Query: 693 KELAALGLSCAELRRKDRPDLKNQVL 718
+L L LS L RP L +Q++
Sbjct: 227 PDLRQLILSMLNLDPSKRPQL-SQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF--------LQELEVLSKI-RHP 511
++G G +G+VY T A+K + K+F L+E++ L K+ HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 512 HLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
+++ L ++ L V+EYME G+L L + P I +++ LA +H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
HRD+KP N+L+ V KI D GL+ + S P + T Y V T Y
Sbjct: 117 KHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDY-----VSTRWYRA 166
Query: 630 PE-YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE R+ S D++A G ++ +L T +P
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-19
Identities = 73/259 (28%), Positives = 121/259 (46%), Gaps = 32/259 (12%)
Query: 483 AVKVLQS---KGNIQNKQFLQELEVLSKIRHPHLLLLL--GACPDHGCL--VYEYMENGS 535
A+K+L++ + Q +F +E + +++ HP+++ LL G P G L V+EY+ +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRT 65
Query: 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNL 592
L + L P E R+ +V ALA HN + I+HRD+KP NI++
Sbjct: 66 LREVLAADGALPAG---ETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 593 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+K+ D G+ T+L T T V GT Y PE R ++P SD+YA+G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 652 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711
L+ LT + V+ A ++AEIL Q + +A L LR+
Sbjct: 180 LECLTGQRV------VQGA----SVAEILYQQLSPVDVSLPPWIAGHPLG-QVLRKALNK 228
Query: 712 DLKNQVLP---VLERLKEV 727
D + + + ER + +
Sbjct: 229 DPRQRAASAPALAERFRAL 247
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 464 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLL 516
I G YG V+ K + +A +KV+ K ++ K Q L E ++LS+ + P+++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYA-IKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+ + LV EY+ G L L + R IA E+ AL +LH+
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDV-ARIYIA-EIVLALEYLHSNG-- 113
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTM-LNSDPSFVS-TTYKNTGPVGTLCYIDPEY 632
IIHRD+KP NIL+D N K+ D GLS + L ++ ++ VGT YI PE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
S D ++ G ++ + L P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLG 518
+G G YG V K T V + + K K L+E++VL ++RH +++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 519 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A G LV+EY+E LE PP W++ A+A+ H+ I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSHN---I 121
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+KP NIL+ + V K+ D G + L + P+ T Y V T Y PE
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY-----VATRWYRAPEL---- 172
Query: 637 LISPKS-----DVYAYGMVILQLLTAKP 659
L+ + DV+A G ++ +LL +P
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLLGACP 521
+IG G G VYK T T V + + + QNK+ + E+ ++ +HP+++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 522 DHGCL--VYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
L V EYM+ GSL D + + N P I + EV L +LH+ + +
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-----YVCREVLQGLEYLHS---QNV 137
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+K NILL + K+ D G + L + S K VGT ++ PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------KRNSVVGTPYWMAPEVIKRK 191
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
PK D+++ G++ +++ +P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 36/287 (12%)
Query: 445 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH---HTFA----AVKVLQSKGNIQNKQ 497
+L WE LSF + L G G +G V + T + + A AVK+L+ + ++
Sbjct: 27 DLKWE-FPRNNLSFGKTL--GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 498 FL-QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFE 553
L EL+++S + H +++ LLGAC G ++ EY G L + L RK + F
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-----FL 138
Query: 554 RYR----IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609
+++VA +AFL + K IHRD+ N+LL H + KI D GL+ + +D
Sbjct: 139 TLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 610 SFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 668
++V N PV ++ PE + + +SDV++YG+++ ++ + +
Sbjct: 196 NYVVK--GNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPG 246
Query: 669 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715
+D I + P E+ + +C + RP K
Sbjct: 247 MPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLL 517
RIG G +G V+K T A+K + + G I N Q L+E++ L +HP+++ LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN-QALREIKALQACQHPYVVKLL 65
Query: 518 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
P LV EYM L + L + P + Y + +A++H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMR--MLLKGVAYMHANG--- 119
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY--- 632
I+HRD+KP N+L+ + V KI D GL+ + + + + + V T Y PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-----QVATRWYRAPELLYG 174
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
R P D++A G + +LL P
Sbjct: 175 ARK--YDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 40/220 (18%)
Query: 464 IGMGGYGTVYKGTFHH-------TFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLL 515
+G G +G V+ G +H AVK L+ + N K F +E E+L+ +H +++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 516 LLGACPDHGCL--VYEYMENGSLEDRLYRKNN-------TPPIPWFERYR-----IAWEV 561
G C + V+EYME+G L ++ R + +P P E IA ++
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG- 620
AS + +L + +HRD+ N L+ ++LV KIGD G+S +T Y G
Sbjct: 132 ASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRVGG 182
Query: 621 ----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
P+ ++ PE + +SDV+++G+V+ ++ T
Sbjct: 183 HTMLPIR---WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
R+G G G+V K +T FA + KQ L+ELE+ + P+++ GA
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 520 CPD-HGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKP 573
D + EY E GSL D +Y+K E+ +IA V L++LH+ K
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NS-DPSFVSTTYKNTGPVGTLCYIDPE 631
IIHRD+KP NILL K+ D G+S L NS +F T++ Y+ PE
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF----------YMAPE 173
Query: 632 YQRTGLISPKSDVYAYGMVILQL 654
+ S SDV++ G+ +L++
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 72/224 (32%), Positives = 106/224 (47%), Gaps = 49/224 (21%)
Query: 453 SATLSFSENLR---IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEV 504
SA S SE R IG G GTVYK T A+KV+ GN ++ +Q +E+E+
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEI 125
Query: 505 LSKIRHPHLLLLLGACPD---HGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERY--R 556
L + HP+++ C D H ++ E+M+ GSLE E++
Sbjct: 126 LRDVNHPNVV----KCHDMFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLAD 172
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS--DPSFVST 614
+A ++ S +A+LH I+HRD+KP N+L++ KI D G+S +L DP S
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYA-----YGMVILQ 653
VGT+ Y+ PE T L D YA G+ IL+
Sbjct: 229 -------VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 66/230 (28%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 464 IGMGGYGTVYKGTFHHT---FA-----AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
IG G +G V T FA K + KG+++N L E +L ++ HP L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRN--VLNERRILQELNHPFLVN 64
Query: 516 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 570
L + D LV + + G L L +K F E+ + E+ AL +LH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK------FSEEQVKFWICEIVLALEYLHS 118
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
K IIHRD+KP NILLD I D ++T V+ T GT Y+ P
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATK-------VTPDTLTTSTSGTPGYMAP 168
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAK---------PAIAITHKVETAI 671
E S D ++ G+ + L K I K ETA
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 451 IESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 509
I + L+ + IG G +G V+ G + A+K ++ +G + + F++E +V+ K+
Sbjct: 1 IHPSELTLVQ--EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLS 57
Query: 510 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER---YRIAWEVASA 564
HP L+ L G C + CLV+E+ME+G L D L + F + + +V
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-----FSQETLLGMCLDVCEG 112
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+A+L ++ +IHRD+ N L+ N V K+ D G++ + D ST K PV
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVK- 166
Query: 625 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ PE S KSDV+++G+++ ++ +
Sbjct: 167 --WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 5e-18
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 516
++G G YG VYK T A+K + + + + + L+E+ +L +++HP+++ L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALK--KIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 517 LGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L LV+EY + D + Y P+ I +++ LA+ H+ +
Sbjct: 64 LDVIHTERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 631
I+HRD+KP NIL++ + V K+ D GL+ +F T V TL Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 632 -----YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y S D+++ G + +++T KP
Sbjct: 171 LGSKHY------STAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 30/273 (10%)
Query: 464 IGMGGYGTVYKGTF-----HHTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLL 517
IG G +G V G A+K L++ Q + FL E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 518 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G +V EYMENGSL D RK++ + + +AS + +L +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMG--- 126
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+HRD+ NIL++ NLV K+ D GLS +L DP TT P+ + PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR---WTAPEAIAY 183
Query: 636 GLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDED-NLAEILDAQAGDWPIKE 691
+ SDV++YG+V+ ++++ +P ++++ V AI+E L +D A
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA------ 237
Query: 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
L L L C + R +RP Q++ +L++L
Sbjct: 238 ---LHQLMLDCWQKDRNERPKF-EQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 464 IGMGGYGTVYKG---TFHHTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G YG+VYK + + +A +V L S + + + E+ +L+ + HP+++ A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 520 CPDHG--CLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
D C+V EY G L + RK IP E +RI ++ L LH K I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
+HRD+K NILL N + KIGD+G+S +L T +GT Y+ PE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKK-------NMAKT-QIGTPHYMAPEVWKGR 176
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
S KSD+++ G ++ ++ T P
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 7e-18
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 46/215 (21%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHPHLLL 515
+G G +G V +KG+ + A+K+L SK I Q + L E +L IRHP L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGK--YYALKIL-SKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 516 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L G+ D L V EY+ G L L RK+ P P Y A +V AL +LH+
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALEYLHS--- 119
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 629
I++RD+KP N+LLD + KI D G + + TY TLC Y+
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TY-------TLCGTPEYLA 166
Query: 630 PEYQRTGLISPK-----SDVYAYGMVILQLLTAKP 659
PE +I K D +A G++I ++L P
Sbjct: 167 PE-----IILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
S +++G G +G V+ GT++ T A+K L+ G + + FLQE +V+ K+RH L+
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 516 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKP 573
L + +V EYM GSL D L + +P + +A ++AS +A++
Sbjct: 66 LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN- 122
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
+HRD++ NIL+ NLV K+ D GL+ ++ D + + G + + PE
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAA 175
Query: 634 RTGLISPKSDVYAYGMVILQLLT 656
G + KSDV+++G+++ +L T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYK T A K+ + K L+E+++L ++ HP+++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 519 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
G LV+E+M+ + L + + +++ LAF H+ I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKS-YLYQLLQGLAFCHSHG---I 119
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 635
+HRD+KP N+L++ V K+ D GL+ S T Y V T Y PE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THY-----VVTRWYRAPELLLGD 173
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
S D+++ G + +LL+ +P
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 59/202 (29%), Positives = 109/202 (53%), Gaps = 12/202 (5%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
S ++++G G +G V+ GT++ T A+K L+ G + + FLQE +++ K+RH L+
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 516 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
L + +V E+M GSL D L ++ + + + +A ++A +A++
Sbjct: 66 LYAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN-- 122
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
IHRD++ NIL+ NLV KI D GL+ ++ D + + G + + PE
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAAL 176
Query: 635 TGLISPKSDVYAYGMVILQLLT 656
G + KSDV+++G+++ +L+T
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
RIG G YG VYK T A+KV L+ + + Q QE+ +L + RHP+++ G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISMLKECRHPNIVAYFG 67
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKP 573
+ L V EY GSL+D +Y+ P +IA+ E LA+LH T
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP----LSELQIAYVCRETLKGLAYLHETG- 121
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY- 632
IHRD+K NILL + K+ D G+S L +T K +GT ++ PE
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVSAQLT------ATIAKRKSFIGTPYWMAPEVA 173
Query: 633 --QRTGLISPKSDVYAYGMVILQLLTAKP 659
+R G K D++A G+ ++L +P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 14/209 (6%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
E+ TL + ++G G +G V+ G ++ HT A+K L+ G++ + FL E ++ ++
Sbjct: 2 EVPRETLKLVK--KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQL 58
Query: 509 RHPHLLLLLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
+HP L+ L ++ EYMENGSL D L + + + +A ++A +AF
Sbjct: 59 QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+ K IHRD++ NIL+ L KI D GL+ ++ + K P+ +
Sbjct: 118 IER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIK---W 169
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PE G + KSDV+++G+++ +++T
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 27/260 (10%)
Query: 463 RIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLL 516
+G G +G+V KG + AVK L+ + K+ FL+E V++++ HP ++ L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 517 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+G C LV E G L L ++ P E +A +VA +A+L +
Sbjct: 62 IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH--- 115
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCYIDPEYQR 634
+HRD+ N+LL + +KI D G+S L + S Y+ T L + PE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWYAPECIN 171
Query: 635 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692
G S KSDV++YG+ + + + AKP + A+ E E L P +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ERLPR-----PEECP 224
Query: 693 KELAALGLSCAELRRKDRPD 712
+E+ ++ LSC + R +DRP
Sbjct: 225 QEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 464 IGMGGYGTVYKGTFHH-----TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLL 517
IG G +G V +G F A+K L+S Q + FL E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 518 G----ACPDHGCLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRIAWEVASALAFLHNT 571
G + P ++ E+MENG+L D R+N+ I R +A+ + +L
Sbjct: 72 GVVTKSRPV--MIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG---TLCYI 628
+HRD+ NIL++ NLV K+ D GLS L D S TY T +G + +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTY--TSSLGGKIPIRWT 178
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDED-NLAEILDAQA 684
PE + SDV++YG+V+ ++++ +P ++++ V AI++D L +D
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238
Query: 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
L L L C + R RP Q++ L+++
Sbjct: 239 A---------LHQLMLDCWQKDRNARPKFG-QIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 46/219 (21%)
Query: 463 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNIQNK------QFLQELEVLSKIRHPHLL 514
+IG G YG VYK A+K K ++N+ ++E+++L K+RHP+++
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 515 LLLGACPDHGC----LVYEYME---NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
L G +V+EYM+ G L+ + T + ++ L +
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKF--TES----QIKCYMKQLLEGLQY 115
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH+ I+HRD+K NIL++++ V K+ D GL+ S T + V TL Y
Sbjct: 116 LHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNR----VITLWY 167
Query: 628 IDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE Y P+ D+++ G ++ +L KP
Sbjct: 168 RPPELLLGATRY------GPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN------KQFLQELEVLSKIRHPHLLLLL 517
+G G YG V H + + K N++N K QE ++LS+++HP+++
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 518 GACPDHGCLVYEYM---ENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTK 572
+ L+Y M E G L +L ++ +P E + W ++A AL +LH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLP--ENQVVEWFVQIAMALQYLHE-- 120
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
K I+HRD+K N+ L + K+GD+G++ +L + ST +GT Y+ PE
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL------IGTPYYMSPEL 173
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA-EILDAQAGDWPIKE 691
+ KSDV+A G + ++ T K A A D ++L I++ + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAF-------NAKDMNSLVYRIIEGKLPPMPKDY 226
Query: 692 TKELAALGLSCAELRRKDRPDLKN 715
+ EL L + R + RP +K+
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 522
IG G +G V +G + AVK + K ++ + FL+E V++K+ H +L+ LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 523 HGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM 581
+G +V E M G+L + L R + + + + +VA + +L + K ++HRD+
Sbjct: 71 NGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126
Query: 582 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPK 641
NIL+ + V+K+ D GL+ + V + PV + PE + S K
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL---PVK---WTAPEALKHKKFSSK 177
Query: 642 SDVYAYGMVILQLLT 656
SDV++YG+++ ++ +
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 49/273 (17%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ------FLQELEVLSKIRHPHLLL 515
+G G + + Y + T AVK + N ++Q +E+ +++++ HPH++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 516 LLGA-CPD-HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNT 571
+LGA C D H L E+M GS+ L + + E I + ++ L++LH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 572 KPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCY 627
+ IIHRD+K N+L+D L +I D G + L + + + G +GT+ +
Sbjct: 123 Q---IIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAK---GTGAGEFQGQLLGTIAF 174
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVETAIDEDNLAE 678
+ PE R DV++ G VI+++ TAKP +A+ K+ +A ++ E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 679 ILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711
L D + L C EL+ +DRP
Sbjct: 235 HLSPGLRD-----------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 464 IGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL 517
IG G +G V++G A+K L+ + +Q FL E ++ + H +++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 518 GACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G ++ EYMENG+L D+ R ++ ++ + +A+ + +L +
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSS-YQLVGMLRGIAAGMKYLSDMN--- 127
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+HRD+ NIL++ NL K+ D GLS +L DP TY +G + + PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---EGTYTTSGGKIPIRWTAPEAIAY 184
Query: 636 GLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDEDNLAEILDAQAGDWPIKET 692
+ SDV+++G+V+ ++++ +P ++ H+V AI++ L A P+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPA-----PMDCP 236
Query: 693 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
+ L L C + R RP + ++ +L++L
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVD-IVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
+G G YG+VYK T A+KV+ + ++Q ++E+ +L + P+++ G+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVKYYGSYF 68
Query: 522 DHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA---LAFLHNTKPKPI 576
+ L V EY GS+ D + N T IA + L +LH+ K
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-QRT 635
IHRD+K GNILL+ +K+ D G+S L + +NT +GT ++ PE Q
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
G + K+D+++ G+ +++ KP
Sbjct: 175 GYNN-KADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 53/187 (28%), Positives = 95/187 (50%), Gaps = 21/187 (11%)
Query: 483 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSL--- 536
AVK+L++ + FL+E++++S++++P+++ LLG C D C++ EYMENG L
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 537 ------EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 590
E NN P + +A ++AS + +L + +HRD+ N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGN 164
Query: 591 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGM 649
+ KI D G+S L S Y+ G V + ++ E G + SDV+A+G+
Sbjct: 165 HYTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 650 VILQLLT 656
+ ++ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 463 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
++G G +G V+ GT++ +T AVK L+ G + + FL+E +++ K+RH L+ L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 522 DHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 580
+ +V EYM GSL D L + + +A +VA+ +A++ IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 581 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 640
++ NIL+ LV KI D GL+ ++ D + + G + + PE G +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAALYGRFTI 182
Query: 641 KSDVYAYGMVILQLLT 656
KSDV+++G+++ +L+T
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 464 IGMGGYGTVYKGTFHHTFA--------AVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLL 514
+G G +G VY+GT AVK L+ Q K +FL+E ++S HP+++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 515 LLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPP--IPWFERYRIAWEVASALAFL 568
LLG C + ++ E ME G L R R P + E I +VA +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 569 HNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--- 620
IHRD+ N L+ D + V KIGD GL+ + + S Y+ G
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-----YKSDYYRKEGEGL 174
Query: 621 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV ++ PE G + +SDV+++G+++ ++LT
Sbjct: 175 LPVR---WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 39/263 (14%)
Query: 464 IGMGGYGTVYKG--TFHHTFAAVKVL-------QSKGNIQNKQFLQELEVLSKIRHPHLL 514
+G G +G+VY+G F AVK + + + KQ QE+ +LSK++HP+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV--KQLEQEIALLSKLQHPNIV 65
Query: 515 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
LG + + E + GSL +L +K + P P Y ++ L +LH+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLY--TRQILLGLEYLHDRN 122
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS---TMLNSDPSFVSTTYKNTGPVGTLCYID 629
+HRD+K NIL+D N V K+ D G++ + SF + Y ++
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY----------WMA 169
Query: 630 PEY-QRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDA 682
PE + G +D+++ G +L++ T KP +A K+ + + + + L
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 683 QAGDWPIKETKELAALGLSCAEL 705
+A D+ +K + +L + AEL
Sbjct: 230 EAKDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 35/275 (12%)
Query: 464 IGMGGYGTVYKGTFHHTF-----AAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLL 515
IG G +G V +G A+K L K +KQ FL E ++ + HP+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 516 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L G ++ EYMENGSL D+ R+N+ + + +AS + +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
+HRD+ NIL++ NLV K+ D GLS L TY G + + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLED----SEATYTTKGGKIPIRWTAPEAI 180
Query: 634 RTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDED-NLAEILDAQAGDWPI 689
+ SDV+++G+V+ ++++ +P ++ V A+++ L +D +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSA---- 236
Query: 690 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
L L L C + R +RP Q++ L+++
Sbjct: 237 -----LYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 451 IESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 509
I+ + L+F + L G G +G V+ G + A+K+++ +G + F++E +V+ K+
Sbjct: 1 IDPSELTFLKEL--GSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLS 57
Query: 510 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW------EV 561
HP+L+ L G C +V EYM NG L + L + + W +V
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK--------GKLGTEWLLDMCSDV 109
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
A+ +L + IHRD+ N L+ + V K+ D GL+ + D S K P
Sbjct: 110 CEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--P 164
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
V + PE S KSDV+++G+++ ++ +
Sbjct: 165 VK---WAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 500 QELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI 557
+E+ VLS ++HP+++ + ++G L V +Y E G L ++ N + + E +
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQIL 104
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
W V LA H + I+HRD+K NI L + K+GD G++ +LNS T
Sbjct: 105 DWFVQICLALKH-VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-- 161
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 660
+GT Y+ PE + KSD++A G V+ ++ T K A
Sbjct: 162 ----IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGA 519
+G G GTVYK +H AVKV+ ++ KQ + ELE+L K P+++ GA
Sbjct: 9 LGHGNGGTVYK-AYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 520 --CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
+ + E+M+ GSL+ +YRK IP RIA V L +L + K I+
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRK-----IPEHVLGRIAVAVVKGLTYLWSLK---IL 117
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
HRD+KP N+L++ K+ D G+ST L NS ++ TY VGT Y+ PE
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTY-----VGTNAYMAPERISGE 168
Query: 637 LISPKSDVYAYGMVILQL 654
SDV++ G+ ++L
Sbjct: 169 QYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-16
Identities = 26/69 (37%), Positives = 35/69 (50%), Gaps = 1/69 (1%)
Query: 743 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPNYTLL 801
P+ F+ PI E+M +P + G TYDR IE L D + P T PL + L+PN L
Sbjct: 2 PDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLELK 61
Query: 802 SAILDWKSK 810
I W +
Sbjct: 62 EKIDAWLEE 70
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 53/283 (18%)
Query: 464 IGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLL 515
IG G +G V++ T AVK+L+ + + F +E ++++ HP+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 516 LLGACPDHG--CLVYEYMENGSLEDRLYRKN-------------------NTPPIPWFER 554
LLG C CL++EYM G L + L ++ N P+ E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 555 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614
IA +VA+ +A+L K +HRD+ N L+ N+V KI D GLS + S +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS-----AD 184
Query: 615 TYK-NTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVE 668
YK + + ++ PE Y R + +SDV+AYG+V+ ++ + +P + H
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238
Query: 669 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711
E+ + + D P EL L C DRP
Sbjct: 239 ----EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 464 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLL 515
+G G +G V K T T AVK+L+ + + + L E +L ++ HPH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 516 LLGACPDHG--CLVYEYMENGSLED--RLYRK-------------------NNTPPIPWF 552
L GAC G L+ EY + GSL R RK + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612
+ AW+++ + +L K ++HRD+ N+L+ KI D GLS + + S+V
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ K PV ++ E + + +SDV+++G+++ +++T
Sbjct: 185 KRS-KGRIPVK---WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 463 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 520
+IG G +G VYKG +T AVK +S K+ FLQE E+L + HP+++ L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 521 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
+ V E + GSL L +K N + + +++ + A+ + +L + K IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLES---KNCIH 116
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 638
RD+ N L+ N V KI D G+S VS K P+ + PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIK---WTAPEALNYGRY 172
Query: 639 SPKSDVYAYGMVILQLLT 656
+ +SDV++YG+++ + +
Sbjct: 173 TSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 464 IGMGGYGTVYKGTF--HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
IG+G VY ++ A+K + K + +E++ +S+ HP+++ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 521 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
L V Y+ GSL D + + + EV L +LH+ IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIH 125
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTG 636
RD+K GNILL + KI D G+S L +D + + T VGT C++ PE Q G
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKT-FVGTPCWMAPEVMEQVHG 183
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
K+D++++G+ ++L T
Sbjct: 184 YDF-KADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQ-SKGNIQNKQFLQ-ELEVLSKIRHPHLLLLLGA 519
IG G +G +Y K +K + +K ++ K+ + E+ +L+K++HP+++ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 520 CPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPI 576
++G L V EY + G L R+ R+ F +I +W V +L H + I
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKH-IHDRKI 122
Query: 577 IHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+HRD+K NI L N +V+K+GD G++ LN T VGT Y+ PE +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC------VGTPYYLSPEICQN 176
Query: 636 GLISPKSDVYAYGMVILQLLTAK 658
+ K+D+++ G V+ +L T K
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 464 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G YG+VYK H T A ++ + Q + EL++L K P+++ GA
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 520 CPDHGCLVY--EYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFL---HNTKP 573
G + EYM+ GSL D+LY T IP RI + V L FL HN
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
IIHRD+KP N+L++ N K+ D G+S L V++ K +G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTN--IGCQSYMAPERI 173
Query: 634 RTG------LISPKSDVYAYGMVILQL 654
++G + +SDV++ G+ IL++
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
+G G +G VYK T FAA K++Q + + + F+ E+++LS+ +HP+++ L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 522 DHGCL--VYEYMENGSLE---DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
L + E+ + G+L+ L R P I RY + ++ AL FLH+ K +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQI----RY-VCRQMLEALNFLHSHK---V 124
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLC--YIDP 630
IHRD+K GNILL + K+ D G+S S +F+ T Y P C + D
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW-MAPEVVACETFKDN 183
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y K+D+++ G+ +++L +P
Sbjct: 184 PYDY------KADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 58/210 (27%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
EI +L + ++G G +G V+ T++ HT AVK ++ G++ + FL E V+ +
Sbjct: 2 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 509 RHPHLLLLLGACPDHGC-LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALA 566
+H L+ L ++ E+M GSL D L + + P+P + + ++A +A
Sbjct: 59 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMA 116
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
F+ + IHRD++ NIL+ +LV KI D GL+ ++ D + + G +
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTA----REGAKFPIK 168
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ PE G + KSDV+++G+++++++T
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 464 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +G V+ H+ AVK L+ + F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 517 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTP-------------PIPWFERYRIAWEV 561
G C + L V+EYM +G L +R R + + + IA ++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
AS + +L + +HRD+ N L+ LV KIGD G+S ST Y G
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGG 182
Query: 622 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
L ++ PE + +SD++++G+V+ ++ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 464 IGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL 517
IG G +G VY GT AVK L +++ +QFL+E ++ HP++L LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 518 GAC-PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
G C P G +V YM++G L + + + + P + + +VA + +L + K
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASKK-- 118
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--PVGTLCYIDPEY 632
+HRD+ N +LD + K+ D GL+ + D + S PV ++ E
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVK---WMALES 173
Query: 633 QRTGLISPKSDVYAYGMVILQLLT 656
+T + KSDV+++G+++ +L+T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTF----HHTFAAVKVLQSKGNIQN-KQFLQEL 502
WE+I+ + IG G +G V + AA+K+L+ + + + F EL
Sbjct: 1 WEDIKFEDV-------IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGEL 53
Query: 503 EVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER----- 554
EVL K+ HP+++ LLGAC + G L EY G+L D L + P F +
Sbjct: 54 EVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 555 --------YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606
+ A +VA+ + +L K IHRD+ N+L+ NL SKI D GLS
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS---R 167
Query: 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ +V T PV + Y + + KSDV+++G+++ ++++
Sbjct: 168 GEEVYVKKTMGRL-PVRWMAIESLNYS---VYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 51/284 (17%)
Query: 455 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHL 513
TL F N+R G AVK+L+ N + FL+E+++LS+++ P++
Sbjct: 34 TLQFPFNVRKG------------RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81
Query: 514 LLLLGAC--PDHGCLVYEYMENGS---------LEDRLYRKNNT-------PPIPWFERY 555
+ LLG C D C++ EYMENG L+D+ N+ P I +
Sbjct: 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141
Query: 556 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615
+A ++AS + +L + +HRD+ N L+ NL KI D G+S L +
Sbjct: 142 HVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL-----YAGDY 193
Query: 616 YKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV---ILQLLTAKPAIAITHKVETAI 671
Y+ G V + ++ E G + SDV+A+G+ IL L +P +T E I
Sbjct: 194 YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD--EQVI 251
Query: 672 DEDNLAEILDAQAGD----WPIKETKELAALGLSCAELRRKDRP 711
+N E Q P + L L L C ++RP
Sbjct: 252 --ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVK-VLQSKGNIQNKQ--------FLQELEVLSKIRHPH 512
IG G +G+VY G + AVK V + +K +E+ +L +++H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 513 LLLLLGACPD--HGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAFL 568
++ LG+ D H + EY+ GS+ L Y + F R ++ L +L
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-----QILKGLNYL 122
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
HN + IIHRD+K NIL+D+ KI D G+S L ++ T G++ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
PE + + K+D+++ G +++++LT K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-CPD 522
IG G +G V G + AVK +++ Q FL E V++++RH +L+ LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 523 HGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 580
G L V EYM GSL D L R + + + +V A+ +L +HRD
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 581 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 640
+ N+L+ + V+K+ D GL+ +S K T PE R S
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALREKKFST 178
Query: 641 KSDVYAYGMVILQL 654
KSDV+++G+++ ++
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLL 516
+G G Y VYK T A+K L + + N L+E+++L +++HP+++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 517 LGACPDHG--CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTK 572
L LV+E+ME LE + K+ TP + L +LH+
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA----DIKSYMLMTLRGLEYLHS-- 120
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 631
I+HRD+KP N+L+ + V K+ D GL+ SF S K T V T Y PE
Sbjct: 121 -NWILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQVVTRWYRAPEL 173
Query: 632 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y D+++ G + +LL P
Sbjct: 174 LFGARHY------GVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLL 517
+G GG+G V T A K L K ++ ++ L E ++L K+ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKK-RLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTK 572
A D CLV M G L+ +Y P F R A ++ L LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
I++RD+KP N+LLD + +I D+GL+ L K G GT Y+ PE
Sbjct: 116 ---IVYRDLKPENVLLDDHGNVRISDLGLAVEL-------KGGKKIKGRAGTPGYMAPEV 165
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692
+ + D +A G + +++ + K ++++ L A ++P K +
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFR-QRK--EKVEKEELKRRTLEMAVEYPDKFS 222
Query: 693 KELAALGLSCAELRRKD 709
E L C L +KD
Sbjct: 223 PEAKDL---CEALLQKD 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 451 IESATLSFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIR 509
I+ L+F + L G G +G V G + + A+K+++ +G++ +F++E +V+ K+
Sbjct: 1 IDPKDLTFLKEL--GTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLS 57
Query: 510 HPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASAL 565
H L+ L G C +V EYM NG L + R + K P + + +V +
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGM 113
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT- 624
A+L + K IHRD+ N L+D K+ D GLS + D + T VG+
Sbjct: 114 AYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--------EYTSSVGSK 162
Query: 625 --LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ + PE S KSDV+A+G+++ ++ +
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
+G G +G VYK T AA KV+++K + + ++ E+E+L+ HP+++ LLGA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 522 DHGCL--VYEYMENGSLED---RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
G L + E+ G+++ L R P I I ++ AL +LH+ K I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSMK---I 131
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLST----MLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
IHRD+K GN+LL + K+ D G+S L SF+ T Y P +C E
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW-MAPEVVMC----ET 186
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
+ K+D+++ G+ ++++ +P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 36/265 (13%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK-------QFLQELEVLSKIRHPHLLLL 516
+G G +G VY T + V Q + + E+++L ++H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 517 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
G + + EYM GS++D+L K R + ++ + +LH+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLHSNM-- 124
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 631
I+HRD+K NIL D K+GD G S L + S S T + GT ++ PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS--SGTGMKS-VTGTPYWMSPEVIS 180
Query: 632 ---YQRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDA 682
Y R K+DV++ G ++++LT KP A+A K+ T L +
Sbjct: 181 GEGYGR------KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
Query: 683 QAGDWPIKETKELAALGLSCAELRR 707
A ++ + E A S EL R
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 464 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +G V+ ++ AVK L+ + K F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 517 LGAC--PDHGCLVYEYMENGSLE--------DRLYRKNNTPP--IPWFERYRIAWEVASA 564
G C D +V+EYM++G L D + P + + IA ++A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+ +L + + +HRD+ N L+ NL+ KIGD G+S ST Y G
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR------DVYSTDYYRVGGHTM 183
Query: 625 LC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
L ++ PE + +SDV++ G+V+ ++ T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-14
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 451 IESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH 510
I S E I G G YKG ++ + + N N E+ + K++H
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKN--GMQFVVKEINDVNSIPSSEIADMGKLQH 742
Query: 511 PHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 568
P+++ L+G C L++EY+E +L + L N + W R +IA +A AL FL
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---RN---LSWERRRKIAIGIAKALRFL 796
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS-FVSTTYKNTGPVGTLCY 627
H ++ ++ P I++D + + L +L +D F+S+ Y
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSAY----------- 844
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
+ PE + T I+ KSD+Y +G+++++LLT K
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 457 SFSENLRIGMGGYGTVYKG-------TFHHTFAAVKVLQS-KGNIQNKQFLQELEVLSKI 508
+ E +G G +G V+ T VK LQ K +F +EL++ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 509 RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL------YRKNNTPPIPWFERYRIAWE 560
H +++ LLG C + ++ EY + G L+ L K PP+ ++ + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 620
+A + L N + +HRD+ N L+ K+ + LS + + + +N
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY---KLRNA- 178
Query: 621 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680
+ L ++ PE + S KSDV+++G+++ ++ T + + DE+ L
Sbjct: 179 -LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG---ELPFYGLS--DEEVLN--- 229
Query: 681 DAQAGD--WPIKET--KELAALGLSCAELRRKDRP 711
QAG P+ E L L C + KDRP
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 52/224 (23%)
Query: 460 ENL-RIGMGGYGTVYKGTFHHT--FAAVKV-LQSKGN-IQNKQFLQELEVLSKIRHPHLL 514
ENL +G G YG V K T A+K L+S+ + + K ++E+ +L ++RH +L+
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 515 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY----------RIAWEVA 562
L+ LV+E++++ L+D E+Y + +++
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD-------------LEKYPNGLDESRVRKYLFQIL 110
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622
+ F H+ IIHRD+KP NIL+ + V K+ D G + L + P V T Y V
Sbjct: 111 RGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDY-----V 161
Query: 623 GTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
T Y PE Y R D++A G ++ ++LT +P
Sbjct: 162 ATRWYRAPELLVGDTKYGRA------VDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 58/222 (26%)
Query: 464 IGMGGYGTVYKGTFHH---TFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHP----- 511
+G+GG+G V TFA V K +I Q + E E+L + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV--KKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 512 --------HLLLLLGACPDHGCLVYEYM-ENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 562
++ +L+ C G ++ + + G ++ + R+ IA V
Sbjct: 59 YRTFKDKKYIYMLMEYCL--GGELWTILRDRGLFDE------------YTARFYIA-CVV 103
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622
A +LHN + II+RD+KP N+LLD N K+ D G + L T+
Sbjct: 104 LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTF---C 153
Query: 623 GTLCYIDPEYQRTGLISPK-----SDVYAYGMVILQLLTAKP 659
GT Y+ PE +I K D ++ G+++ +LLT +P
Sbjct: 154 GTPEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 464 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLL 517
IG G +G V K AA+K ++ + + + F ELEVL K+ HP+++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER-------------YRIAWEVA 562
GAC G L EY +G+L D L + P F A +VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622
+ +L K IHRD+ NIL+ N V+KI D GLS +V T PV
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRL-PV 175
Query: 623 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ Y + + SDV++YG+++ ++++
Sbjct: 176 RWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 512
F++ RIG G +G VYKG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 513 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFL 568
+ G+ L + EY+ GS D L P P E Y I E+ L +L
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYL 117
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H+ + IHRD+K N+LL K+ D G++ L T K VGT ++
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT------DTQIKRNTFVGTPFWM 168
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
PE + K+D+++ G+ ++L +P + H
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 483 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLE 537
AVK L+ + QN + +E+ +L + H +++ G C + G L+ EY+ GSL
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 538 DRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596
D L + N + F A ++ +A+LH+ + IHRD+ N+LLD++ + KI
Sbjct: 97 DYLPKHKLNLAQLLLF-----AQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148
Query: 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
GD GL+ + + PV + E + S SDV+++G+ + +LLT
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPV---FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 483 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDR 539
AVK+L+ N + FL+E++++S+++ P+++ LL C D C++ EYMENG L
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 540 LYR--------KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 591
L R K + I + +A ++AS + +L + +HRD+ N L+ N
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN 166
Query: 592 LVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
KI D G+S L S Y+ G V + ++ E G + SDV+A+G+
Sbjct: 167 YTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 651 ILQLLT 656
+ ++LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 483 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMENGSLEDR 539
AVKVL+ + ++ FL+E+++LS++ P++ LLG C C++ EYMENG L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 540 LYR--------KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 591
L + N+ + + +A ++AS + +L + +HRD+ N L+ N
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN 166
Query: 592 LVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
KI D G+S L + S Y+ G + ++ E G + KSDV+A+G+
Sbjct: 167 YTIKIADFGMSRNL-----YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 651 ILQLLT 656
+ ++LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 463 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLL 517
+IG G + VYK A+K +Q + K L+E+++L ++ HP+++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
+ ++ L V E + G L R+ + K IP ++ ++ SAL +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--- 124
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
K I+HRD+KP N+ + V K+GD+GL F S T VGT Y+ PE
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYMSPERI 178
Query: 634 RTGLISPKSDVY-----AYGMVILQ 653
+ KSD++ Y M LQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 464 IGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLL 515
+G G +G VY+G T AVK + +++ + +FL E V+ H++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 516 LLGACP--DHGCLVYEYMENGSLEDRLY-----RKNNT--PPIPWFERYRIAWEVASALA 566
LLG +V E M +G L+ L +NN PP E ++A E+A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL- 625
+L+ K +HRD+ N ++ H+ KIGD G++ T Y G G L
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 626 -CYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDNLAEILDA 682
++ PE + G+ + SD++++G+V+ ++ L +P ++ +E L ++D
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDG 237
Query: 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
D P + + L C + K RP L ++ LK+
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTF----LEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
RIG G YG VYK +T AA+KV++ + QE+ ++ +H +++ G+
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
D + E+ GSL+D +Y + T P+ + ++ E L +LH+ K +H
Sbjct: 76 LRRDKLWICMEFCGGGSLQD-IY--HVTGPLSESQIAYVSRETLQGLYYLHS---KGKMH 129
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRT 635
RD+K NILL N K+ D G+S + +T K +GT ++ PE +R
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQIT------ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITH 665
G + D++A G+ ++L +P + H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
IG G +G VYK T A+KV+ +++ I++ Q QE++ LS+ R P++
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRSPYITKYY 65
Query: 518 GACPDHGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTK 572
G G ++ EY GS D L P E Y I EV L +LH
Sbjct: 66 G-SFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
IHRD+K NILL K+ D G+S L ST K VGT ++ PE
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT------STMSKRNTFVGTPFWMAPEV 169
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
+ K+D+++ G+ ++L +P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V KGT AVKVL+ +Q+ + E VL+ L
Sbjct: 3 LGKGSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 572
L +C D V EY+ G L + R R R A E+ L FLH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHE-- 114
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLST--MLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+ II+RD+K N+LLD KI D G+ +L ++T+ GT YI P
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTF-----CGTPDYIAP 165
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP 659
E P D +A G+++ ++L +
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 512
F++ IG G +G VY T A+K + G N+++ ++E+ L ++RHP+
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 513 LLLLLGAC--PDHGC-LVYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAF 567
+ G C +H LV EY GS D L ++K P+ E I LA+
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAY 130
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH+ + IHRD+K GNILL K+ D G +++++ SFV T Y V +
Sbjct: 131 LHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEV--ILA 185
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
+D E Q G K DV++ G+ ++L KP
Sbjct: 186 MD-EGQYDG----KVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 464 IGMGGYGTVYKG-------TFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +G V+ T AVK L+ K F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 517 LGACPDHGCL--VYEYMENGSLE--------DRLYRKNNTP-----PIPWFERYRIAWEV 561
G C D L V+EYM++G L D + + P + + IA ++
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
AS + +L + + +HRD+ N L+ NL+ KIGD G+S ST Y G
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDYYRVGG 183
Query: 622 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
L ++ PE + +SDV+++G+++ ++ T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF-LQELEVLSKIRHPHLLLLLG 518
+IG G YG V+K T V K ++S+ + K+ L+E+ +L +++HP+L+ L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 519 ACPD----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
H LV+EY ++ ++ + L + N +P +I W+ A+ F H
Sbjct: 68 VFRRKRKLH--LVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
IHRD+KP NIL+ K+ D G + +L P T Y V T Y PE
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDY-----VATRWYRAPE--- 170
Query: 635 TGLI------SPKSDVYAYGMVILQLLTAKP 659
L+ P DV+A G V +LLT +P
Sbjct: 171 --LLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGNIQN-KQFLQEL 502
E+ + + F E L G +G +YKG H A+K L+ N Q +F QE
Sbjct: 1 ELPLSAVRFMEEL--GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 503 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN--------------T 546
+++++ HP+++ LLG C+++EY+ G L + L ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 547 PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606
+ + IA ++A+ + +L + +H+D+ NIL+ L KI D+GLS +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
S + K+ P+ ++ PE G S SD++++G+V+ ++ +
Sbjct: 176 S-ADYYRVQPKSLLPIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 42/191 (21%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ------FLQELEVLSKIR---HP 511
IG G YGTVYK +T F A+K K + + L+E+ +L ++ HP
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALK----KVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 512 HLLLLLGACPDHGC---------LVYEYMENGSLED-RLYRKNNTPP-IPWFERYRIAWE 560
+++ LL C HG LV+E+++ +D Y P +P + +
Sbjct: 62 NIVRLLDVC--HGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 620
+ + FLH+ + I+HRD+KP NIL+ + KI D GL+ + + + + S
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV------ 166
Query: 621 PVGTLCYIDPE 631
V TL Y PE
Sbjct: 167 -VVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQ----SKGNIQNKQ------FLQELEVLSKIRHP 511
IG G YG VY T AVK ++ G ++Q E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 512 HLLLLLG--ACPDHGCLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASALAF 567
+++ LG ++ + EY+ GS+ R Y + + +F +V LA+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLAY 123
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH+ K I+HRD+K N+L+D + + KI D G+S SD + + +N G++ +
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDN--DQNMSMQGSVFW 176
Query: 628 IDPEY---QRTGLISPKSDVYAYGMVILQLLTAK 658
+ PE G S K D+++ G V+L++ +
Sbjct: 177 MAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 45/290 (15%)
Query: 463 RIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHL 513
+G G +G V K + AVK+L+ ++ + E+E++ I +H ++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 514 LLLLGACPDHGCL--VYEYMENGSLEDRLYRK----------NNTPPIPWFERYRI---A 558
+ LLG C G L V EY +G+L D L + + PP + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618
++VA + FL + K IHRD+ N+L+ + V KI D GL+ ++ Y+
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHH-----IDYYRK 190
Query: 619 TG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 674
T PV ++ PE + + +SDV+++G+++ ++ T + VE
Sbjct: 191 TTNGRLPVK---WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--K 245
Query: 675 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
L E + P T+EL L C RP K Q++ L+R+
Sbjct: 246 LLKE---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 50/197 (25%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 463 RIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
++G G +G V+ G +++ T AVK L+ G + + FL+E ++ ++H L+ L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 522 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
++ EYM GSL D L + + + + + ++A +A++ K IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 639
D++ N+L+ +L+ KI D GL+ ++ + G + + PE G +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDN-----EYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 640 PKSDVYAYGMVILQLLT 656
KSDV+++G+++ +++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 456 LSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRH- 510
L E L G G YG V K H T AVK +++ N Q K+ L +L++ +
Sbjct: 3 LEVIEEL--GRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 511 PHLLLLLGACPDHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALA 566
P+ + GA G V+ ME + SL D+ Y+K + E +IA + AL
Sbjct: 60 PYTVTFYGALFREGD-VWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
+LH +K +IHRD+KP N+L++ N K+ D G+S L S T P
Sbjct: 118 YLH-SKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPE 173
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
I+PE + G KSDV++ G+ +++L T +
Sbjct: 174 RINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 68/205 (33%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSK-IRHPHLLLLL 517
IG G +G V K F AVKVLQ K + + K + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 574
+ D V +Y+ G L L R+ + P R R A E+ASAL +LH+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLHSLN-- 116
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
II+RD+KP NILLD + D GL + S ++T+ GT Y+ PE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTF-----CGTPEYLAPEVLR 169
Query: 635 TGLISPKSDVYAYGMVILQLLTAKP 659
D + G V+ ++L P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 464 IGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLL 516
+G G +GTVYKG + A+KVL+ + + NK+ L E V++ + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 517 LGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 573
LG C LV + M G L D Y + N I + + W ++A +++L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLD--YVRENKDRIG--SQDLLNWCVQIAKGMSYLEEVR- 129
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
++HRD+ N+L+ KI D GL+ +L+ D T Y G + ++ E
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMALESI 183
Query: 634 RTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIK 690
+ +SDV++YG+ + +L+T AKP I + + ++L+ + P
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLPQPPI 235
Query: 691 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 733
T ++ + + C + + RP + E + E + ARD
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFR-------ELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 458 FSENLRIGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 512
FS+ IG G +G VY + + A+K + G N+++ ++E+ L K+RHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 513 LLLLLGA-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+ G +H LV EY GS D L + + P+ E + LA+LH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+IHRD+K GNILL + K+GD G ++++ FV T Y ++ P
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY----------WMAP 180
Query: 631 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAI 661
E G K DV++ G+ ++L KP +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 464 IGMGGYGTVYKG-TFHHTFAAVKVL------QSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G YGTVY G T AVK + + ++ +E+++L ++H +++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 517 LGACPDHGCLVYEYME---NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
LG C D + +ME GS+ L R P P F +Y ++ +A+LHN
Sbjct: 68 LGTCLDD-NTISIFMEFVPGGSISSILNRFGPLPE-PVFCKY--TKQILDGVAYLHNNC- 122
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
++HRD+K N++L N + K+ D G + L + + GT ++ PE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIA 662
KSD+++ G + ++ T KP +A
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 464 IGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLL 516
+G G +GTVYKG + A+K L+ + + NK+ L E V++ + +PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 517 LGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 573
LG C L+ + M G L D Y + + I +Y + W ++A + +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLD--YVREHKDNIG--SQYLLNWCVQIAKGMNYLEE--- 127
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
+ ++HRD+ N+L+ KI D GL+ +L +D Y G + ++ E
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD----EKEYHAEGGKVPIKWMALESI 183
Query: 634 RTGLISPKSDVYAYGMVILQLLT--AKP 659
+ + +SDV++YG+ + +L+T +KP
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 512
F++ RIG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 513 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+ G+ L + EY+ GS D L P F+ + E+ L +LH+
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
K IHRD+K N+LL K+ D G++ L T K VGT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAP 170
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
E + K+D+++ G+ ++L +P + H
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 24/176 (13%)
Query: 487 LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN 544
L+ K I+N Q ++EL+VL + P+++ GA G + E+M+ GSL+ L +
Sbjct: 36 LEIKPAIRN-QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 94
Query: 545 NTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
P E +I+ V L +L I+HRD+KP NIL++ K+ D G+S
Sbjct: 95 RIP-----ENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 147
Query: 603 TML-NS-DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
L +S SF VGT Y+ PE + + +SD+++ G+ ++++
Sbjct: 148 GQLIDSMANSF----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 62/209 (29%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 463 RIGMGGYGTVYKG---TFHHTFAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
RIG G YG VY+ T A KV + I L+E+ +L +RHP+++ L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHPNIVELK 72
Query: 518 ----GACPDHGCLVYEYMEN--GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
G D LV EY E SL D N P + + ++ L +LH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQYLHE- 126
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
IIHRD+K N+LL KI D GL+ ++ V TL Y PE
Sbjct: 127 --NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK------VVTLWYRAPE 178
Query: 632 YQRTGLISPKS-DVYAYGMVILQLLTAKP 659
+ D++A G ++ +LL KP
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 60/204 (29%), Positives = 81/204 (39%), Gaps = 46/204 (22%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLL 516
+G G G V+ KGT A+KVL K I+ K+ L E E+L+ + HP L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGK--LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 517 LG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLHN 570
+ CLV +Y G L +R P R+ A EV AL +LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHL 121
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP--------- 621
I++RD+KP NILL + + D LS + +P VS +
Sbjct: 122 ---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 622 --------------VGTLCYIDPE 631
VGT YI PE
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA- 519
R+G G YG VYK HT AAVK+++ + QE+ ++ + +H +++ G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 520 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
+ + EY GSL+D +Y + T P+ + + E LA+LH +K K +H
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IY--HVTGPLSELQIAYVCRETLQGLAYLH-SKGK--MH 129
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRT 635
RD+K NILL N K+ D G++ + +T K +GT ++ PE ++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKIT------ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITH 665
G + D++A G+ ++L +P + H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 485 KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRK 543
KVL S + F + ++S++ H HL+ L G C D +V EY++ G L+ L+R+
Sbjct: 36 KVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHRE 94
Query: 544 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603
N + W +A ++ASAL +L + K ++H GN+ + LV++ G
Sbjct: 95 KNNVSLHWK--LDVAKQLASALHYLEDKK---LVH-----GNVCGKNILVARYGLNEGYV 144
Query: 604 MLN--SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS--DVYAYGMVILQL 654
SDP T V + +I PE R G S D +++G +L++
Sbjct: 145 PFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 463 RIGMGGYGTVY--KGTFHHTFAAVKVLQ--SKGNIQNKQFLQ---ELEVLSKIRHPHLLL 515
R+G G +GTVY K +KVL+ G + + +Q E ++LSK+ HP ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 516 LLGAC--PDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ D C++ EY E L+ +L K+ + E W + L +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS--ENQVCEWFIQLLLG-VHYMH 123
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
+ I+HRD+K NI L +NL+ KIGD G+S +L +T GT Y+ PE
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF------TGTPYYMSPEA 176
Query: 633 QRTGLISPKSDVYAYGMVILQL 654
+ KSD+++ G ++ ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 464 IGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +GTVYKG + A+K+L ++ G N +F+ E +++ + HPHL+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 517 LGACPDHGC-LVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAW--EVASALAFLHNTK 572
LG C LV + M +G L D ++ K+N + + W ++A + +L +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIG-----SQLLLNWCVQIAKGMMYLEERR 129
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
++HRD+ N+L+ KI D GL+ +L D Y G + ++ E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD----EKEYNADGGKMPIKWMALEC 182
Query: 633 QRTGLISPKSDVYAYGMVILQLLT 656
+ +SDV++YG+ I +L+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 464 IGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLL 515
+G G +G VY+G T A+K + +++ + +FL E V+ + H++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 516 LLGACPDH--GCLVYEYMENGSLEDRLY----RKNNTP---PIPWFERYRIAWEVASALA 566
LLG ++ E M G L+ L N P P + ++A E+A +A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
+L+ K +HRD+ N ++ + KIGD G++ T Y G G L
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 627 --YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
++ PE + G+ + SDV+++G+V+ ++ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 464 IGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLGACP 521
+G G +G V+KGT T AVK + + K +FL E +L + HP+++ L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 522 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
+V E + G L +K + ++ A + A+ +A+L + K IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLES---KNCIHR 117
Query: 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 639
D+ N L+ N V KI D G+S D S++ P+ + PE G S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIK---WTAPEALNYGRYS 172
Query: 640 PKSDVYAYGMVILQLLT 656
+SDV++YG+++ + +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSK 507
E E E + +G G YG VY T A+K + + + + +E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 508 IRHPHLLLLLGACPDHGCLVYEYMEN---GSLEDRLYRK-----NNTPPIPWFERYRIAW 559
++H +++ LG+ ++G +ME GSL L K +N I ++ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKI-FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK----- 115
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNS-DPSFVSTTYK 617
++ L +LH+ + I+HRD+K N+L++ ++ V KI D G S L +P + T+
Sbjct: 116 QILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFT 170
Query: 618 NTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKP 659
GTL Y+ PE G +D+++ G I+++ T KP
Sbjct: 171 -----GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 464 IGMGGYGTVYKGTFHHTF-----AAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL 517
IG G +G VY+G + AVK ++ + ++ FLQE ++ + HPH++ L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 518 GACPDHGCLVYEYMENGSL-EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
G ++ V+ ME L E R Y + N + ++++++ALA+L + +
Sbjct: 74 GVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC--YIDPE--- 631
+HRD+ N+L+ K+GD GLS L + + YK + G L ++ PE
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-----SYYKAS--KGKLPIKWMAPESIN 181
Query: 632 YQRTGLISPKSDVYAYGMVILQLL 655
++R + SDV+ +G+ + ++L
Sbjct: 182 FRR---FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
IG G +G VY T HT AVK + G N+++ ++E++ L +++HP+ + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 519 A-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+H LV EY GS D L + + P+ E I LA+LH+ +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS---HNM 142
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY---Q 633
IHRD+K GNILL K+ D G ++ + SFV T Y ++ PE
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY----------WMAPEVILAM 192
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAI 661
G K DV++ G+ ++L KP +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 50/219 (22%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQ------SKGNIQNKQFLQELEVLSKIRHPHLLL 515
IG G YG VY+G T A+K++ +IQ +E+ +LS++R
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-----REVALLSQLRQ----- 58
Query: 516 LLGACPD----HGCL--------VYEYMENGSLEDRLYRKNNTPPIPWFERYR--IAWEV 561
P+ +G + EY E GS+ + P E+Y I EV
Sbjct: 59 --SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM------KAGPIAEKYISVIIREV 110
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
AL ++H +IHRD+K NIL+ + K+ D G++ +LN + K +
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN------QNSSKRSTF 161
Query: 622 VGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKP 659
VGT ++ PE G K+D+++ G+ I ++ T P
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 483 AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLED 538
AVK LQ + F +E+E+L ++H +++ G C G LV EY+ GSL D
Sbjct: 37 AVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD 96
Query: 539 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598
Y + + + + A ++ + +L + K +HRD+ NIL++ KIGD
Sbjct: 97 --YLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGD 151
Query: 599 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
GL+ +L D + P+ + PE S SDV+++G+V+ +L T
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 464 IGMGGYGTVYKG--TFHHTFAAVKVLQ----SKGNIQNKQF----------LQELEVLSK 507
+G G YG V K T A+K ++ S +++Q L+EL+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 508 IRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR--IAWEVAS 563
I+H +++ L+ + LV + M L+ + RK I E I ++ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILN 130
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY------- 616
L LH +HRD+ P NI ++ + KI D GL+ P + +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 617 -KNTGPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ T V TL Y PE Y D+++ G + +LLT KP
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKY------HFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 51/227 (22%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF--------------LQELEVLSKIR 509
IG G YG VYK A K + K+F +E+ +L +++
Sbjct: 8 IGRGTYGRVYK-------AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 510 HPHLLLLLGACPDHGC----LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASA 564
H +++ L+ +H L+++Y E+ + + +R+ IP + W++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 565 LAFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
+ +LH+ ++HRD+KP NIL+ + +V KIGD+GL+ + N+
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVV-KIGDLGLARLFNAPL---KPLADLD 173
Query: 620 GPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
V T+ Y PE Y + D++A G + +LLT +P
Sbjct: 174 PVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 512
F++ +IG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 513 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+ G+ L + EY+ GS D L P+ + I E+ L +LH+
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 119
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
K IHRD+K N+LL + K+ D G++ L T K VGT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAP 170
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 668
E + K+D+++ G+ ++L +P + H ++
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 64/263 (24%), Positives = 117/263 (44%), Gaps = 25/263 (9%)
Query: 462 LRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLL 515
+ +G G +G V KG + A+KVL++ N ++ + ++E E++ ++ +P+++
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN-ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 516 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
++G C LV E G L L K + I + +V+ + +L K
Sbjct: 60 MIGVCEAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEG---K 114
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
+HRD+ N+LL + +KI D GLS L +D S+ P L + PE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP---LKWYAPECIN 171
Query: 635 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692
S +SDV++YG+ + + + KP + + ++ I + D P +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-------GPEVMSFIEQGKRLDCPAECP 224
Query: 693 KELAALGLSCAELRRKDRPDLKN 715
E+ AL C + +DRP+
Sbjct: 225 PEMYALMKDCWIYKWEDRPNFAK 247
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLL 517
I G +G+VY K + A+KVL+ I Q + ++ + P++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ D+ LV EY+ G L + P W ++Y EV + LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ---RG 117
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
IIHRD+KP N+L+D K+ D GLS + F VGT Y+ PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----------VGTPDYLAPETILG 167
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
SD ++ G VI + L P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 519
+G G YG VYKG T AA+KV+ G+ + ++ QE+ +L K H ++ GA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 520 -------CPDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNT 571
D LV E+ GS+ D + K NT W I E+ L+ LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLCY 627
K +IHRD+K N+LL N K+ D G+S L+ +F+ T Y P C
Sbjct: 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW-MAPEVIACD 186
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
+P+ KSD+++ G+ +++ P + H
Sbjct: 187 ENPD----ATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 464 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 518
IG G +G V G H VK L++ + FLQE++ ++ HP++L LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 519 ACPDHG--CLVYEYMENGSLEDRLYRKNNT----PPIPWFERYRIAWEVASALAFLHNTK 572
C + LV E+ G L++ L R N + R+A EVAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQ-RMACEVASGLLWLHQAD 120
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
IH D+ N L +L KIGD GL+ + +++ L ++ PE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH----AVPLRWLAPEL 173
Query: 633 Q-------RTGLISPKSDVYAYGMVILQLLTA 657
+ KS++++ G+ + +L TA
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQEL-------EVLSKIRHPHLL 514
+G G +G V + T A+K L+ KG+I + ++ L E + RHP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 515 LLLGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
L AC DH C V EY G L ++ + P F Y A V L +LH
Sbjct: 66 NLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF--Y--AACVVLGLQYLHEN 120
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
K I++RD+K N+LLD KI D GL F T T C PE
Sbjct: 121 K---IVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRT-------STFCGT-PE 166
Query: 632 YQRTGLISPKS-----DVYAYGMVILQLL 655
+ +++ S D + G++I ++L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-11
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 463 RIGMGGYGTVYKGT---FHHTFAAVKVLQSKGNIQNKQ-------FLQELEVLSKIRHPH 512
++G G YG V+K A K+ + N + Q FLQEL HP+
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPN 68
Query: 513 LLLLLG---ACPDHGC-LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASALA 566
++ LL A D LV+EYME D + R N + +RY I +++ AL
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMET----DLHAVIRANILEDV--HKRY-IMYQLLKALK 121
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL----STMLNSDPSFVSTTYKNTGPV 622
++H+ +IHRD+KP NILL+ + K+ D GL S + + + V T Y V
Sbjct: 122 YIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY-----V 173
Query: 623 GTLCYIDPEYQRTGLISPKS-----DVYAYGMVILQLLTAKP 659
T Y PE L+ D+++ G ++ ++L KP
Sbjct: 174 ATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 66/205 (32%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLLL 517
IG G +G V K +F AVKVLQ K ++ K+ + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPK 574
+ + V +Y+ G L L R+ P F A EVASA+ +LH+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF----YAAEVASAIGYLHSLN-- 116
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
II+RD+KP NILLD + D GL +P ++T+ GT Y+ PE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTF-----CGTPEYLAPEVLR 169
Query: 635 TGLISPKSDVYAYGMVILQLLTAKP 659
D + G V+ ++L P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 520
+G G +G VYK T AA KV+ +K + + ++ E+++L+ HP+++ LL A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 521 -PDHGCLVYEYMENGSLED---RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
++ ++ E+ G+++ L R P I + + AL +LH K I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIR-----VVCKQTLEALNYLHENK---I 124
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLST----MLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
IHRD+K GNIL + K+ D G+S + SF+ T Y P +C E
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW-MAPEVVMC----ET 179
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
+ K+DV++ G+ ++++ +P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 48/218 (22%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI-QNKQFLQELEVLSKIRH--PHLLLLLG 518
IG G G VYK F T AVK ++ GN +NK+ L +L+V+ K H P+++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIV---- 77
Query: 519 ACPDHGCLVYEY-----ME-NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL---H 569
C +G + + ME + D+L ++ P IP ++ + AL +L H
Sbjct: 78 KC--YGYFITDSDVFICMELMSTCLDKLLKRIQGP-IPEDILGKMTVAIVKALHYLKEKH 134
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+IHRD+KP NILLD + K+ D G+S L + T G Y+
Sbjct: 135 G-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-------KTRSAGCAAYMA 182
Query: 630 PEYQRTGLISPK---------SDVYAYGMVILQLLTAK 658
PE I P +DV++ G+ +++L T +
Sbjct: 183 PER-----IDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFL--QELEVLSKIRHPHLLLLLGA- 519
+IG G GTVY T V + Q Q K+ L E+ V+ + +HP+++ L +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 520 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 575
D +V EY+ GSL D + + +IA E AL FLH+ +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSNQ--- 135
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+K NILL + K+ D G + + S K + VGT ++ PE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTR 189
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
PK D+++ G++ ++++ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 20/141 (14%)
Query: 460 ENLRIGMGGYGTVYKGT---------FHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH 510
E+L G G + ++KG H T +KVL ++ F + ++S++ H
Sbjct: 1 ESL--GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58
Query: 511 PHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF- 567
HL+L G C D +V EY++ GSL+ L + N I W EVA LA+
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW------KLEVAKQLAWA 112
Query: 568 LHNTKPKPIIHRDMKPGNILL 588
LH + K + H ++ N+LL
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 38/235 (16%)
Query: 443 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQN-KQ 497
Y L W +I+ + IG G +G V K AA+K ++ + + +
Sbjct: 1 YPVLEWNDIKFQDV-------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 53
Query: 498 FLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWF-- 552
F ELEVL K+ HP+++ LLGAC G L EY +G+L D L + P F
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 553 -----------ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
+ A +VA + +L K IHRD+ NIL+ N V+KI D GL
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 170
Query: 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
S +V T PV + Y + + SDV++YG+++ ++++
Sbjct: 171 S---RGQEVYVKKTMGRL-PVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 9e-11
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLL---- 514
RI G YG VY+ T V + + K + + F L+E+ +L K++HP+++
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 515 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+++G+ D +V EY+E+ L+ + + P E + ++ S +A LH+
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD---N 125
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 631
I+HRD+K N+LL++ + KI D GL+ + S T V TL Y PE
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAR------EYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 632 ----YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y S D+++ G + +LLT KP
Sbjct: 180 GAKEY------STAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 451 IESATLSFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIR 509
I + L+F + L G G +G V+ G + A+K + +G + + F++E +V+ K+
Sbjct: 1 INPSELTFMKEL--GSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLS 57
Query: 510 HPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER---YRIAWEVASA 564
HP L+ L G C L V E+MENG L + L ++ + + +V
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEG 112
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+ +L IHRD+ N L+ V K+ D G++ + D S+ K PV
Sbjct: 113 MEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVK- 166
Query: 625 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ PE S KSDV+++G+++ ++ T
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 457 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 511
+F +IG G + VY+ T A+K +Q + K ++E+++L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 512 HLLLLLGACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFL 568
+++ + + L V E + G L + + K IP ++ ++ SAL +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H+ + ++HRD+KP N+ + V K+GD+GL F S T VGT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYM 173
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQL 654
PE + KSD+++ G ++ ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 518
+G G +G V+ + + A+KV+ I+ KQ E VL ++ HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 519 ACPDHGCL--VYEYMENGSLEDRLY---RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
D L + EY+ G L L R +N+ + + A E+ AL +LH+
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVCALEYLHS--- 119
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 629
K I++RD+KP NILLD K+ D G + L T+ TLC Y+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTW-------TLCGTPEYLA 166
Query: 630 PE-YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE Q G + D +A G++I ++L P
Sbjct: 167 PEVIQSKGH-NKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 484 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLY 541
+++ +S +++ + +E +L+K++HP+++ + G L V EY + G L ++
Sbjct: 33 IRLPKSSSAVEDSR--KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK 90
Query: 542 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
+ + E + W V L H + K ++HRD+K NI L N K+GD G
Sbjct: 91 LQRGKL---FPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
+ +L + P + TY VGT Y+ PE + KSD+++ G ++ +L T K
Sbjct: 147 ARLL-TSPGAYACTY-----VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 51/255 (20%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR------IAWEVASALAF 567
L +C D V EY+ G L +Y I +++ A E+A L F
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYH------IQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH+ K II+RD+K N++LD KI D G+ N + T+ GT Y
Sbjct: 117 LHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTF-----CGTPDY 167
Query: 628 IDPE---YQRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683
I PE YQ G KS D +A+G+++ ++L +P DED L + +
Sbjct: 168 IAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPF-------DGEDEDELFQSIMEH 216
Query: 684 AGDWPIKETKELAAL 698
+P +KE ++
Sbjct: 217 NVSYPKSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 511
+F + +G GG+G V T A K L+ K + K L E ++L K+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 512 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
++ L A D CLV M G L+ +Y N P FE R + A L L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLE 116
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ + ++RD+KP NILLD +I D+GL+ + S G VGT+ Y+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI-------RGRVGTVGYMA 169
Query: 630 PEY---QRTGLISPKSDVYAYGMVILQLLTAK 658
PE QR L SP D + G +I +++ +
Sbjct: 170 PEVLNNQRYTL-SP--DYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLGA 519
RIG G +G V+ G +T AVK + K +FLQE +L + HP+++ L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 520 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
C +V E ++ G L + P + E ++ A+ + +L + K I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637
HRD+ N L+ V KI D G+S D + ST PV + PE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVK---WTAPEALNYGR 172
Query: 638 ISPKSDVYAYGMVILQL--LTAKPAIAITHK 666
S +SDV+++G+++ + L A P ++++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 464 IGMGGYGTVYKGTFHH---TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRH-PHLLLLLG 518
IG G +GTV K H T AVK ++S + K+ L +L+V+ + P+++ G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 519 ACPDHG-CLV-YEYMENGSLEDRLYR-----KNNTPPIPWFERY--RIAWEVASALAFLH 569
A G C + E M+ SL D+ Y+ + P E +IA AL +L
Sbjct: 71 ALFREGDCWICMELMDI-SL-DKFYKYVYEVLKSVIP----EEILGKIAVATVKALNYLK 124
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
IIHRD+KP NILLD N K+ D G+S L V + K T G Y+
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL------VDSIAK-TRDAGCRPYMA 175
Query: 630 PEYQRTGLISP---KSDVYAYGMVILQLLTAK 658
PE +SDV++ G+ + ++ T K
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 464 IGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLL 517
+G G +GTV KG + AVK+L++ N + L+E V+ ++ +P+++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 518 GACP-DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
G C + LV E E G L L + + E + +V+ + +L T
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETN---F 116
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
+HRD+ N+LL +KI D GLS L +D ++ PV + PE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK---WYAPECMNYY 173
Query: 637 LISPKSDVYAYGMVI 651
S KSDV+++G+++
Sbjct: 174 KFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 463 RIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+IG G + VY+ T V++ + + ++E+++L ++ HP+++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 518 GACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+ + L V E + G L + Y K IP ++ ++ SA+ +H+ +
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-- 126
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
++HRD+KP N+ + V K+GD+GL F S T VGT Y+ PE
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYMSPERIH 179
Query: 635 TGLISPKSDVYAYGMVILQL 654
+ KSD+++ G ++ ++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 67/226 (29%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
+G G +G V + AVKVL+ +Q+ + E +LS R+ L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 519 AC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTK 572
C PD V E++ G L + + F+ R A E+ SAL FLH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEITSALMFLHD-- 114
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
K II+RD+K N+LLDH K+ D G+ + ST GT YI PE
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------CGTPDYIAPEI 167
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 678
+ L P D +A G+++ ++L H A +ED+L E
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG-------HAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLLG 518
+IG G G V T T V V K +++ +Q E+ ++ +HP+++ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAV--KKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 519 A--CPDHGCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ D +V E++E G+L D + N I V AL+FLH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-----VLKALSFLHAQG--- 135
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+K +ILL + K+ D G ++ + + VGT ++ PE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPEVISR 189
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+ D+++ G+++++++ +P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSK---GNIQNKQFLQELEVLSK-IRHPHLLLLL 517
IG G +G V K AVKVLQ K + K + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ + V +++ G L L ++ + P P Y A E+ASAL +LH+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFY--AAEIASALGYLHSIN--- 116
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
I++RD+KP NILLD + D GL ++ + T GT Y+ PE R
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
D + G V+ ++L P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 512
F++ IG G +G VY T A+K + G N+++ ++E++ L +I+HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 513 LLLLLGA-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+ G +H LV EY GS D L + + P+ E I LA+LH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+IHRD+K GNILL K+ D G +++ + SFV T Y ++ P
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY----------WMAP 190
Query: 631 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAI 661
E G K DV++ G+ ++L KP +
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 464 IGMGGYGTVYKGTFHH---TF--AAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLL 516
+G G +G+V +G + AVK ++ + + ++FL E + HP+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 517 LGAC--------PDHGCLVYEYMENGSLEDRLYR---KNNTPPIPWFERYRIAWEVASAL 565
+G C ++ +M++G L L +P + ++A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
+L N + IHRD+ N +L ++ + D GLS + S + PV
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVK-- 180
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+I E + + KSDV+A+G+ + ++ T
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 7e-10
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 463 RIGMGGYGTVYK------GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+IG G + V K G ++ K +S + N + +Q L LS HP++L L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP--HPNILRL 63
Query: 517 LGACPD--HGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ D G LV+E M+ +L + K P+P +++ +L +H
Sbjct: 64 IEVLFDRKTGRLALVFELMD-MNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
I HRD+KP NIL+ +++ K+ D G + S P + T Y + T Y PE
Sbjct: 119 -NGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY--TEY-----ISTRWYRAPEC 169
Query: 633 QRT-GLISPKSDVYAYGMVILQLLTAKP 659
T G PK D++A G V ++L+ P
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLLL 517
IG G +G V + F AVKVLQ K ++ K+ + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE-RYRI-AWEVASALAFLHNTKP 573
+ D V +Y+ G L L R+ + E R R A E+ASAL +LH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLN- 116
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
I++RD+KP NILLD + D GL N + + ++T+ GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTF-----CGTPEYLAPEVL 168
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKP 659
D + G V+ ++L P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGA 519
IG G YG VYK T V + + + + + + F ++E+++L ++ H +++ L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 520 CPDHGC------------LVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
D LV+EYM++ G LE L + + + ++
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK------QLLEG 128
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
L + H K +HRD+K NILL++ K+ D GL+ + NS+ S Y N V T
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE---SRPYTNK--VIT 180
Query: 625 LCYIDPEY----QRTGLISPKSDVYAYGMVILQLLTAKP 659
L Y PE +R G P DV++ G ++ +L T KP
Sbjct: 181 LWYRPPELLLGEERYG---PAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 519
+IG G GTVY T V + Q Q K+ + E+ V+ + ++P+++ L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 520 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
D +V EY+ GSL D + + + + E AL FLH+ + +IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 638
RD+K NILL + K+ D G + + S K + VGT ++ PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTRKAY 193
Query: 639 SPKSDVYAYGMVILQLLTAKP 659
PK D+++ G++ ++++ +P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 519
+IG G GTVY T V + Q Q K+ + E+ V+ + ++P+++ L +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 520 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
D +V EY+ GSL D + + + + E AL FLH+ + +IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ---VIH 138
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 638
RD+K NILL + K+ D G + + S ST VGT ++ PE
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTRKAY 192
Query: 639 SPKSDVYAYGMVILQLLTAKP 659
PK D+++ G++ ++++ +P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 519
+IG G GTV+ T V + Q Q K+ + E+ V+ ++++P+++ L +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 520 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 575
D +V EY+ GSL D + + +IA E AL FLH +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHANQ--- 135
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+K N+LL + K+ D G + + S ST VGT ++ PE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTR 189
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
PK D+++ G++ ++++ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGA 519
+G G YG V K T V + + K + +N++ L+EL++L ++ +++ L A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 520 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLHNTKPKPI 576
G LV+EY+E LE N PP E+ R +++ A+ + H I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----EKVRSYIYQLIKAIHWCHKND---I 121
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
+HRD+KP N+L+ HN V K+ D G + L+ + T Y V T Y PE
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRSPELLLGA 176
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
D+++ G ++ +L +P
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 54/235 (22%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQ---SKGNIQNKQFLQELEVLSKIRHP 511
+F + ++G G Y TVYKG T A+K + +G ++E+ ++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHE 58
Query: 512 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
+++ L + LV+EYM+ L+ + + +++ +AF H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ ++HRD+KP N+L++ K+ D GL+ +F + V TL Y
Sbjct: 118 ENR---VLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRA 168
Query: 630 PEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
P+ RT S D+++ G ++ +++T +P T+ +ED L +I
Sbjct: 169 PDVLLGSRT--YSTSIDIWSVGCIMAEMITGRPLFPGTN------NEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 38/248 (15%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLL 516
IG+G YGTVYK H+ F A+K ++ + N + + + L+ L HP+++ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 517 LGACPD-------HGCLVYEYMENGSLEDRLYRKNNTPP-IPWFERYRIAWEVASALAFL 568
+ C LV+E+++ + R Y PP +P + + L FL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H I+HRD+KP NIL+ K+ D GL+ + + + T V TL Y
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------TPVVVTLWYR 174
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD----AQA 684
PE + D+++ G + ++ KP + D L +I D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS------EADQLGKIFDLIGLPPE 228
Query: 685 GDWPIKET 692
DWP T
Sbjct: 229 DDWPRDVT 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 483 AVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLED 538
AVK+L+ ++ + E+E++ I +H +++ LLGAC G L + EY G+L +
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 539 RL-----------YRKNNTP--PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
L Y P + + + ++VA + +L + K IHRD+ N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167
Query: 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVY 645
+L+ N V KI D GL+ +N+ + TT PV ++ PE + + +SDV+
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL-PVK---WMAPEALFDRVYTHQSDVW 223
Query: 646 AYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLS 701
++G+++ ++ T P I + E+ + + D P T EL +
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPV---------EELFKLLKEGHRMDKPANCTNELYMMMRD 274
Query: 702 CAELRRKDRPDLKNQVLPVLERL 724
C RP K Q++ L+R+
Sbjct: 275 CWHAIPSHRPTFK-QLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 464 IGMGGYGTV--YKGTFHHTFAAVKVLQS--KGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+GMG +G V + A+K + + K+ +EL++L +RH +++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 520 CPDHGCLVYEYMENGSLEDRLYRKNNTPPI-PWFERYRIAWEVASALAFLHNTKPKPIIH 578
+Y E L L+R + P+ F +Y +++ L ++H+ ++H
Sbjct: 78 FISPLEDIYFVTE--LLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVHSAG---VVH 131
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----YQR 634
RD+KP NIL++ N KI D GL+ + DP TG V T Y PE +Q+
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARI--QDPQM-------TGYVSTRYYRAPEIMLTWQK 182
Query: 635 TGLISPKSDVYAYGMVILQLLTAKP 659
+ + D+++ G + ++L KP
Sbjct: 183 YDV---EVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 31/203 (15%)
Query: 501 ELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRL--YRKNNTPPIPWFER 554
E+++L ++H ++ G D + EYM GS++D+L Y + R
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 555 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG----LSTMLNSDPS 610
++ +++LH+ I+HRD+K NIL D K+GD G L T+ S
Sbjct: 114 -----QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AIAIT 664
S T GT ++ PE K+DV++ G ++++LT KP A+A
Sbjct: 166 IRSVT-------GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218
Query: 665 HKVETAIDEDNLAEILDAQAGDW 687
K+ T L + A D+
Sbjct: 219 FKIATQPTNPQLPSHISEHARDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 519
+G G YG VYKG T AA+KV+ + + ++ E+ +L K H ++ GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 520 ---CP----DHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNT 571
P D LV E+ GS+ D + K N W I E+ LA LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLCY 627
K +IHRD+K N+LL N K+ D G+S L+ +F+ T Y P C
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW-MAPEVIACD 196
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
+P+ +SD+++ G+ +++ P + H
Sbjct: 197 ENPD----ATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 483 AVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC----LVYEYMENGSL 536
AVK L +S GN +E+E+L + H +++ G C + G L+ E++ +GSL
Sbjct: 37 AVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596
++ L R N + +Y A ++ + +L + + +HRD+ N+L++ KI
Sbjct: 96 KEYLPRNKNKINLKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKI 150
Query: 597 GDVGLSTMLNSDPSFVSTTYKNTGPV---GTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 653
GD GL+ + +D + + PV C I ++ SDV+++G+ + +
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA------SDVWSFGVTLYE 204
Query: 654 LLT 656
LLT
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 50/214 (23%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---QFLQELE----VLSKIRHPHLLLL 516
+G G +GTV+KG + ++K+ + IQ++ Q QE+ + + H +++ L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 517 LGACPDHGC-LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAW--EVASALAFLHNTK 572
LG CP LV + GSL D + +++ P + + W ++A + +L +
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDP-----QRLLNWCVQIAKGMYYLEEHR 129
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPE 631
++HR++ NILL + + +I D G++ +L D + + +K + ++ E
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT-----PIKWMALE 181
Query: 632 YQRTGLISPKSDVYAYGMVILQLLT--AKPAIAI 663
G + +SDV++YG+ + ++++ A+P +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 46/237 (19%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----------AVKVLQSKGNIQ-NKQF 498
EI +T+ F E L G +G VYKG H F A+K L+ K ++F
Sbjct: 1 EINLSTVRFMEEL--GEDRFGKVYKG---HLFGTAPGEQTQAVAIKTLKDKAEGPLREEF 55
Query: 499 LQELEVLSKIRHPHLLLLLGA-------------CPD---HGCLVYE--YMENGSLEDRL 540
E + S+++HP+++ LLG C H LV + + GS +D
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 541 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600
K+ P + I ++A+ + FL + ++H+D+ N+L+ L KI D+G
Sbjct: 116 TVKSTLEPADFVH---IVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLG 169
Query: 601 LSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
L + + + YK G + + ++ PE G S SD+++YG+V+ ++ +
Sbjct: 170 LFREV-----YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLL 517
+G GG+G V T A K L+ K I+ ++ L E ++L K+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
A D CLV M G L+ +Y N P F+ R + A L + +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRER 122
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
I++RD+KP NILLD +I D+GL+ + + G VGT+ Y+ PE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-------RGRVGTVGYMAPEVVKN 175
Query: 636 GLISPKSDVYAYGMVILQLLTAK 658
+ D + G +I +++ K
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 487 LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN 544
L+ K I+N Q ++EL+VL + P+++ GA G + E+M+ GSL D++ ++
Sbjct: 40 LEIKPAIRN-QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEA 97
Query: 545 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604
P + IA V LA+L + I+HRD+KP NIL++ K+ D G+S
Sbjct: 98 KRIPEEILGKVSIA--VLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153
Query: 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 661
L ++ ++ VGT Y+ PE + S +SD+++ G+ +++L + I
Sbjct: 154 LIDS---MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 46/229 (20%)
Query: 483 AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----------------CL 526
AVK + K L+E++++ ++ H +++ + G +
Sbjct: 34 AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI 93
Query: 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 586
V EYME L P+ +++ L ++H+ ++HRD+KP N+
Sbjct: 94 VQEYMETD-----LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANV 145
Query: 587 LLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS--- 642
++ +LV KIGD GL+ ++ DP + Y + G V T Y P L+SP +
Sbjct: 146 FINTEDLVLKIGDFGLARIV--DPHYSHKGYLSEGLV-TKWYRSPRL----LLSPNNYTK 198
Query: 643 --DVYAYGMVILQLLTAKPAIAITHKVE---------TAIDEDNLAEIL 680
D++A G + ++LT KP A H++E + E++ E+L
Sbjct: 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHL 513
F + +G G G V+K + + A K+ L+ K I+N Q ++EL+VL + P++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYI 65
Query: 514 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
+ GA G + E+M+ GSL D++ +K P + IA V L +L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIA--VIKGLTYLR-- 120
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
+ I+HRD+KP NIL++ K+ D G+S L ++ ++ VGT Y+ PE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF-----VGTRSYMSPE 172
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAI 661
+ S +SD+++ G+ ++++ + I
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 5e-09
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
IG G YG V T A+K V I K+ L+E+++L +RH +++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL--IDAKRILREIKLLRHLRHENIIGLL 65
Query: 518 GACPDHGC-------LVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFL 568
+V E ME D L++ K+ P +Y +++ L +L
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
H+ +IHRD+KP NIL++ N KI D GL+ ++ D
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G GG+G V +T +A K+ L+ K K L E E+L K+ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNT 571
A H CLV M G L+ +Y E R+ ++ + LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSM 114
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I++RDMKP N+LLD ++ D+GL+ L + T + GT Y+ PE
Sbjct: 115 D---IVYRDMKPENVLLDDQGNCRLSDLGLAVEL---KDGKTITQR----AGTNGYMAPE 164
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAK 658
+ S D +A G I +++ +
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 34/264 (12%)
Query: 483 AVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLED 538
AVK+L+ ++ + E+E++ I +H +++ LLGAC G L + EY G+L +
Sbjct: 48 AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 539 RLYRKNNTPPIPW-FERYRI-------------AWEVASALAFLHNTKPKPIIHRDMKPG 584
L R P + + F+ ++ A++VA + +L + K IHRD+
Sbjct: 108 YL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163
Query: 585 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 644
N+L+ + V KI D GL+ +++ + TT PV ++ PE + + +SDV
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL-PVK---WMAPEALFDRVYTHQSDV 219
Query: 645 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCA 703
+++G+++ ++ T + I + L ++L + D P T EL + C
Sbjct: 220 WSFGVLLWEIFTLGGS------PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECW 273
Query: 704 ELRRKDRPDLKNQVLPVLERLKEV 727
RP K Q++ L+R+ V
Sbjct: 274 HAVPSQRPTFK-QLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 511
+F + +G GG+G V T A K L+ K + K L E ++L K+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 512 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
++ L A D CLV M G L+ +Y FE R + A L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLE 116
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ + I++RD+KP NILLD + +I D+GL+ + + G VGT+ Y+
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-------KGRVGTVGYMA 169
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLTAK 658
PE + + D +A G ++ +++ +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIR-HPHLLL 515
+G G +G V KGT A+KVL+ +Q+ + E +L+ HP L
Sbjct: 3 LGKGSFGKVMLAELKGT--DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR---IAWEVASALAFLHN 570
L D V EY+ G L ++ R F+ R A EV AL FLH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK------FDEPRSRFYAAEVTLALMFLHR 114
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+I+RD+K NILLD K+ D G+ +TT+ GT YI P
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTF-----CGTPDYIAP 165
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 678
E + P D +A G+++ +++ +P A +ED+L E
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPF-------EADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 464 IGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 515
+G G +G VY+G + AVK L + Q++ FL E ++SK H +++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 516 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR----IAWEVASALAFLH 569
L+G + ++ E M G L+ L P P + A +VA +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 570 NTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTG----PV 622
IHRD+ N LL V+KI D G++ + + ++ Y+ G P+
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-----YRASYYRKGGRAMLPI 185
Query: 623 GTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
++ PE G+ + K+DV+++G+++
Sbjct: 186 K---WMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 67/244 (27%), Positives = 102/244 (41%), Gaps = 46/244 (18%)
Query: 447 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEV 504
TWE IE+ IG G YG VYK T + AAVK+L ++ +++ E +
Sbjct: 23 TWEIIET----------IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNI 71
Query: 505 LSKI-RHPHLLLLLGAC--PDHGC-----LVYEYMENGSLED------RLYRKNNTPPIP 550
L + HP+++ G D LV E GS+ + ++ + I
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 551 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
+ I + L LHN + IIHRD+K NILL K+ D G+S L
Sbjct: 132 Y-----ILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---- 179
Query: 611 FVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
ST + VGT ++ PE Q + DV++ G+ ++L P + H
Sbjct: 180 --STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 666 KVET 669
V+T
Sbjct: 238 PVKT 241
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV--GTL 625
+H+ K +IHRD+K NILL N + K+GD G S M + +T + G GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM------YAATVSDDVGRTFCGTP 209
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
Y+ PE R S K+D+++ G+++ +LLT K
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 464 IGMGGYGTVY---KGTFHH--TFAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRH-PHL 513
+G G YG V+ K H A+KVL+ +Q + + E +VL +R P L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 514 LLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAF 567
+ L A L + +Y+ G L LY++ + F R IA E+ AL
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH------FTESEVRVYIA-EIVLALDH 120
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH II+RD+K NILLD + D GLS ++ + GT+ Y
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-----EEERAYSFCGTIEY 172
Query: 628 IDPEYQRTGLISPKS--DVYAYGMVILQLLT-AKP 659
+ PE R G D ++ G++ +LLT A P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 36/190 (18%)
Query: 463 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLL 515
+IG G +G V+K T A KVL + + F L+E+++L ++H +++
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVN 75
Query: 516 LLGAC-----PDHGC-----LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
L+ C P + LV+E+ E+ L L KN + E ++ + + L
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNGL 132
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL----STMLNSDPSFVSTTYKNTGP 621
++H K I+HRDMK NIL+ + + K+ D GL S NS P+ + T
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN------RYTNR 183
Query: 622 VGTLCYIDPE 631
V TL Y PE
Sbjct: 184 VVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 518
+G GG+G V T A K L+ K + K L E +L K+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 519 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A D CLV M G L+ +Y N P F+ R + A L + + + I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
++RD+KP NILLD +I D+GL+ + + G VGT+ Y+ PE
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV-------RGRVGTVGYMAPEVINNE 176
Query: 637 LISPKSDVYAYGMVILQLL 655
+ D + G +I +++
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 42/268 (15%)
Query: 480 TFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGS 535
T AVK+L+S ++ + E+E++ I +H +++ LLGAC G L + EY G+
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 536 LEDRLYRKNNTPP---------------IPWFERYRIAWEVASALAFLHNTKPKPIIHRD 580
L R Y + PP + + + A++VA + +L + K IHRD
Sbjct: 111 L--REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRD 165
Query: 581 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 640
+ N+L+ + V KI D GL+ ++ + TT PV ++ PE + +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL-PVK---WMAPEALFDRIYTH 221
Query: 641 KSDVYAYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 696
+SDV+++G+++ ++ T P + + E+ + + D P T EL
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVPV---------EELFKLLKEGHRMDKPSNCTNELY 272
Query: 697 ALGLSCAELRRKDRPDLKNQVLPVLERL 724
+ C RP K Q++ L+R+
Sbjct: 273 MMMRDCWHAVPSQRPTFK-QLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623
AL +LH K K I+HRD+ P NI+L + I D GL+ + K T VG
Sbjct: 125 ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVVG 175
Query: 624 TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683
T+ Y PE + K+DV+A+G ++ Q+ T +P T+ + A +I++A
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIVEAV 229
Query: 684 AGDWPIKE---TKELAALGLSCAELRRKDRPDL 713
P+ E ++++ + SC + RPD+
Sbjct: 230 YE--PLPEGMYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 43/272 (15%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNI------QNKQFLQELEVLSKIRHPHLLLLL 517
+G G +G+V +G + + +KV I + + FL E + + HP+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 518 GACPDHG--------CLVYEYMENGSLEDRLY--RKNNTPP-IPWFERYRIAWEVASALA 566
G C ++ +M++G L L R + P +P + ++AS +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTL 625
+L + K IHRD+ N +L+ N+ + D GLS + N D Y G + +
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-------YYRQGRIAKM 176
Query: 626 C--YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683
+I E + + KSDV+++G+ + ++ T + +T +EI D
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT---------RGQTPYPGVENSEIYDYL 227
Query: 684 AGDWPIKETKE----LAALGLSCAELRRKDRP 711
+K+ + L +L SC L KDRP
Sbjct: 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
+V EYM G L + + N P W R+ A EV AL +H+ IHRD+KP N
Sbjct: 120 MVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDN 172
Query: 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT----GLISPK 641
+LLD + K+ D G ++++ T VGT YI PE ++ G +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDT-----AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 642 SDVYAYGMVILQLLTAKP---AIAITHKVETAIDEDNLAEILDAQAGDWPI-KETKELAA 697
D ++ G+ + ++L A ++ +D N D D I K+ K+L
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD----DIEISKQAKDLIC 283
Query: 698 LGLSCAELR--RKDRPDLKNQVLPVLERLKEVADRARDTVPSVHP 740
L+ E+R R ++K+ P + + D R+TV V P
Sbjct: 284 AFLTDREVRLGRNGVDEIKSH--PFFKNDQWTFDNIRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 66/248 (26%), Positives = 104/248 (41%), Gaps = 31/248 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQE---LEVLSKIRHPHLL 514
IG GG+G VY T A+K L K I+ KQ L E L ++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 515 LLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ A PD + + M G L Y + E A E+ L +HN
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEAEMRFYAAEIILGLEHMHN-- 115
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
+ +++RD+KP NILLD + +I D+GL+ + S VGT Y+ PE
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEV 166
Query: 633 QRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
+ G+ S D ++ G ++ +LL HK + + D + + + P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVE---LPDSF 222
Query: 692 TKELAALG 699
+ EL +L
Sbjct: 223 SPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYKG T A+K L+S+ ++E+ +L +++HP+++ L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 519 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA---WEVASALAFLHNTKP 573
L++E++ S++ + Y ++ P + + + +++ + F H+ +
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY- 632
++HRD+KP N+L+D+ V K+ D GL+ +F T V TL Y PE
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 633 ---QRTGLISPKSDVYAYGMVILQLLTAKP 659
R S D+++ G + ++ T KP
Sbjct: 174 LGSPR---YSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 28/244 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRH---PHLL 514
IG GG+G VY T A+K L K I+ KQ L E +LS + P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 515 LLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ A PD C + + M G L Y + E A E+ L +HN
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
+ +++RD+KP NILLD + +I D+GL+ + S VGT Y+ PE
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEV 166
Query: 633 QRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
+ G S D ++ G ++ +LL HK + + D + ++ + D E
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPDSFSPE 225
Query: 692 TKEL 695
K L
Sbjct: 226 LKSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
+G GG+G V T A K L K + K + + E +L+K+ ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 519 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A CLV M G L +Y + P F R + A ++ L + + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
I+RD+KP N+LLD++ +I D+GL+ L S K G GT ++ PE +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS------KTKGYAGTPGFMAPELLQGE 172
Query: 637 LISPKSDVYAYGMVILQLLTAK-PAIAITHKVE 668
D +A G+ + +++ A+ P A KVE
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSK------GN-IQNKQFLQELEVLSKIRHPHLLLL 516
IG GG G VY + + +V K N + K+FL+E ++ + + HP ++ +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 517 LGACPDHGCLVY---EYMENGSLEDRL---YRKNNTP-------PIPWFERYRIAWEVAS 563
C D G VY Y+E +L+ L ++K + + F I ++ +
Sbjct: 68 YSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--LSIFHKICA 124
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK--IGDVGLSTMLN---SDPSFVSTTYKN 618
+ ++H+ K ++HRD+KP NILL L + I D G + D + +N
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 619 ------TGP---VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
T P VGT Y+ PE S +D+YA G+++ Q+LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 42/280 (15%)
Query: 468 GYGTVYKGTFHHTFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGC 525
YG AVK+L+ ++ + E+E++ I +H +++ LLG C G
Sbjct: 33 AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92
Query: 526 L--VYEYMENGSLEDRLYRKNNTPPIP--WFERYRI-------------AWEVASALAFL 568
L + EY G+L R + + PP P F+ ++ A++VA + +L
Sbjct: 93 LYVIVEYAAKGNL--REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
+ + IHRD+ N+L+ + V KI D GL+ ++ D + T PV ++
Sbjct: 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSNGRLPVK---WM 203
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQA 684
PE + + +SDV+++G+++ ++ T P I + E+ + +
Sbjct: 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---------EELFKLLREGHR 254
Query: 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
D P T EL L C RP K Q++ L+++
Sbjct: 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 67/240 (27%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 447 TWEEIESATLSFSENLRIGMGGYGTVYK--GTFHHTFAAVKVLQSKGNIQNKQFLQELEV 504
TWE IE+ IG G YG V+K + + AAVK+L +I +++ E +
Sbjct: 19 TWEIIET----------IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNI 67
Query: 505 LSKIR-HPHLLLLLG-------ACPDHGCLVYEYMENGSLED------RLYRKNNTPPIP 550
L + HP+++ G D LV E GS+ D + + P I
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 551 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
+ I E L LH K IHRD+K NILL K+ D G+S L
Sbjct: 128 Y-----ILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---- 175
Query: 611 FVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
ST + VGT ++ PE Q + DV++ G+ ++L P +A H
Sbjct: 176 --STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 31/131 (23%), Positives = 49/131 (37%), Gaps = 27/131 (20%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPI 76
+ VAV G+ +S A+ WA G L LLHV
Sbjct: 2 ILVAVDGSEESERALRWAARLARRLGAELV-LLHVVDP---------------------- 38
Query: 77 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNI 136
AA + + + LL R A+ V+VE V+E D A+AI +
Sbjct: 39 ---PPSSAAELAELLEEEARALLEALREALAEAGVKVETVVLE-GDPAEAILEAAEELGA 94
Query: 137 NKLVIGAQSQG 147
+ +V+G++ +
Sbjct: 95 DLIVMGSRGRS 105
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 69/250 (27%), Positives = 106/250 (42%), Gaps = 41/250 (16%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT 571
L +C D V EY+ G L + + K P ++ A E++ L FLH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLFFLHR- 119
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
+ II+RD+K N++LD KI D G+ D + T+ GT YI PE
Sbjct: 120 --RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTF-----CGTPDYIAPE 171
Query: 632 ---YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688
YQ G D +AYG+++ ++L +P DED L + + +P
Sbjct: 172 IIAYQPYGK---SVDWWAYGVLLYEMLAGQPPF-------DGEDEDELFQSIMEHNVSYP 221
Query: 689 IKETKELAAL 698
+KE ++
Sbjct: 222 KSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 516
+G G +G V +KGT + A+K L+ + ++ KQ QE +L ++ HP ++ +
Sbjct: 26 LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 517 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+ + D + + E++ G L L RK P + Y E+ A +LH+ K
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHA--ELVLAFEYLHS---K 137
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
II+RD+KP N+LLD+ K+ D G + + D +F TLC PEY
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF------------TLCGT-PEYLA 183
Query: 635 TGLISPKS-----DVYAYGMVILQLLTAKP 659
+I K D + G+++ + + P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 483 AVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLE 537
A+KV++ F +E ++LS P + L A D + LV EY G L
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 538 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 597
L R + F+ + +A + +H+ +HRD+KP N+L+D K+
Sbjct: 90 SLLNRYEDQ-----FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA 144
Query: 598 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
D G + L ++ S PVGT YI PE
Sbjct: 145 DFGSAARLTANKMVNSKL-----PVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 47/270 (17%)
Query: 467 GGYGTVYKGTFHHTF------AAVK-VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
G +G ++ G VK V IQ LQE +L + H ++L +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 520 C---PDHGCLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
C + ++Y YM G+L+ RL NN + + +A ++A +++LH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-----PVGTLC 626
+ +IH+D+ N ++D L KI D LS L F Y G PV
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDL-----FPM-DYHCLGDNENRPVK--- 184
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD----- 681
++ E S SDV+++G+++ +L+T + T VE ID +A L
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT----LGQTPYVE--IDPFEMAAYLKDGYRL 238
Query: 682 AQAGDWPIKETKELAALGLSCAELRRKDRP 711
AQ PI EL A+ C L ++RP
Sbjct: 239 AQ----PINCPDELFAVMACCWALDPEERP 264
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 46/203 (22%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 462 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
++IG G G V T + AVK + + + + E+ ++ +H +++ + +
Sbjct: 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 520 --CPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
D +V E++E G+L D + + + N I + V AL+ LH + +
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGV 137
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+K +ILL H+ K+ D G ++ + + VGT ++ PE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPELISRL 191
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
P+ D+++ G+++++++ +P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 464 IGMGGYGTVYKGT----FHHTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 518
IG G +G V G + VK L+ ++Q + +FL+E + ++H +LL LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 519 ACPDHG--CLVYEYMENGSLEDRLYR----KNNTPPIPWFERYRIAWEVASALAFLHNTK 572
C + LV E+ G L+ L + TP +R +A E+A L LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHKNN 120
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
IH D+ N LL +L KIGD GLS
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 484 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLEDRLY 541
+KVL + F + ++ ++ H H++LL G C +V E++E G L+ ++
Sbjct: 37 LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH 96
Query: 542 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
RK++ PW ++++A ++ASAL++L + K ++H ++ NILL + G+ G
Sbjct: 97 RKSDVLTTPW--KFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGID--GECGP 149
Query: 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVILQLLTAKPA 660
L SDP T V + +I PE + + +S +D +++G + +
Sbjct: 150 FIKL-SDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE------- 201
Query: 661 IAITHKVETAIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRP 711
I + E + + LAE G + KELA L C RP
Sbjct: 202 --ICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 464 IGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLL 514
+G GGYG V++ G A+KVL+ ++N++ E +L ++HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 515 LLLGACPDHG--CLVYEYMENGSLEDRLYRK----NNTPPIPWFERYRIAWEVASALAFL 568
L+ A G L+ EY+ G L L R+ +T + ++ E++ AL L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA------CFYLS-EISLALEHL 116
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H + II+RD+KP NILLD K+ D GL + + V+ T+ GT+ Y+
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTF-----CGTIEYM 167
Query: 629 DPE-YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE R+G D ++ G ++ +LT P
Sbjct: 168 APEILMRSGH-GKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 464 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
+G G +G V + + A+K+L+ + I + L E VL RHP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 519 A--CPDHGCLVYEYMENGSL-----EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
+ D C V EY+ G L +R++ ++ T R+ A E+ SAL +LH+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-------RFYGA-EIVSALDYLHSG 114
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
K I++RD+K N++LD + KI D GL +D + + T GT Y+ PE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF------CGTPEYLAPE 165
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAK 658
D + G+V+ +++ +
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 59/200 (29%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 463 RIGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 516
IG G +G V+ +A +KVL+ I+ Q E ++L+ P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYA-MKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 517 LGACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+ D H LV EYM G L + L RK+ P R+ IA E+ AL +H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE--TARFYIA-ELVLALDSVHKLG-- 121
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS--DPSFVSTTYKNTG------------ 620
IHRD+KP NIL+D + K+ D GL +N D + N
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 621 ---------PVGTLCYIDPE 631
VGT YI PE
Sbjct: 181 KQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 50/239 (20%)
Query: 453 SATLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQELEVL 505
S + ++G G +G VYK T V K+L + F L+E+++L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKIL 61
Query: 506 SKIRHPHLLLLL--------GACPDHGC--LVYEYME---NGSLEDRLYRKNNTPPIPWF 552
K++HP+++ L+ + G +V YM+ +G LE+ T
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTES---- 115
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL-------STML 605
+ ++ + +LH I+HRD+K NIL+D+ + KI D GL
Sbjct: 116 QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 606 NSDPSFVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKP 659
+ Y T V T Y PE + T + D++ G V ++ T +P
Sbjct: 173 KGGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V +
Sbjct: 179 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----R 231
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDN 675
L ++ PE + + +SDV+++G+++ ++ + A P + IDE+
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------IDEEF 285
Query: 676 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711
+ + P T E+ ++ L C +DRP
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHPHLLL 515
I G YG VY K T FA K+ +K N+ Q +Q E ++L+ +P ++
Sbjct: 9 ISNGAYGAVYLVRHKET-RQRFAMKKI--NKQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW-EVASALAFLHNTK 572
+ + H C+V EY+E G L N +P + R+ + E AL +LHN
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALP-VDMARMYFAETVLALEYLHNYG 121
Query: 573 PKPIIHRDMKPGNILL---------DHNLVSKIGDVGLSTMLNSDPSFVST-TYKNTGPV 622
I+HRD+KP N+L+ D L SKIG + L+T L T + +
Sbjct: 122 ---IVHRDLKPDNLLITSMGHIKLTDFGL-SKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 623 GTLCYIDPEY-QRTGLISPKSDVYAYGMVILQLL 655
GT YI PE R G P D +A G+++ + L
Sbjct: 178 GTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V K
Sbjct: 180 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---K 233
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDN 675
+ + L ++ PE + + +SDV+++G+++ ++ L A P + I+E+
Sbjct: 234 GSARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------INEEF 286
Query: 676 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711
+ D P T E+ + L+C + K+RP
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 37/236 (15%)
Query: 464 IGMGGYGTVY-----KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLL 515
+G G +G V+ G A+KVL+ K ++ + ++ E ++L+++ HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 516 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFE---RYRIAWEVASALAFLHN 570
L A G L+ +++ G L RL ++ + + E ++ +A E+A AL LH+
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLA-ELALALDHLHS 116
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
II+RD+KP NILLD K+ D GLS + K GT+ Y+ P
Sbjct: 117 LG---IIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEYMAP 167
Query: 631 E-YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685
E R G + +D +++G+++ ++LT + ET + IL A+ G
Sbjct: 168 EVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILKAKLG 216
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 464 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 518
IG G +G V + A+K+L I+ F +E ++++ P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A D L V EYM G L + + N P W R+ A EV AL +H+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMG---F 163
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT- 635
IHRD+KP N+LLD + K+ D G +N + T VGT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQ 218
Query: 636 ---GLISPKSDVYAYGMVILQLLTA 657
G + D ++ G+ + ++L
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 37/188 (19%)
Query: 501 ELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRL-----YRKNNTPPIPW 551
E+++L +RH ++ G D + EYM GS++D+L +N T
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT----- 108
Query: 552 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS----TMLNS 607
R ++ +++LH+ I+HRD+K NIL D K+GD G S T+ S
Sbjct: 109 ---RRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AI 661
S T GT ++ PE K+DV++ ++++LT KP A+
Sbjct: 163 GTGIKSVT-------GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
Query: 662 AITHKVET 669
A K+ T
Sbjct: 216 AAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 498 FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY 555
F + ++S++ H HL + G C +V E++E+G L+ L ++ P+ W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 556 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615
+A ++ASAL++L + K ++H ++ NILL + + + SDP T
Sbjct: 121 TVAQQLASALSYLED---KNLVHGNVCAKNILLAR---LGLAEGTSPFIKLSDPGVSFTA 174
Query: 616 YKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQL 654
V + +I PE G +S +D +++G +L++
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 464 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 518
IG G +G V + VK L++ + + + +FLQ+ + ++HP++L LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 519 ACPDH--GCLVYEYMENGSL------EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
C + LV+EY E G L E R + R+A E+A+ + +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL-----LLLQRMACEIAAGVTHMHK 117
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+H D+ N L +L K+GD G+ ++ T P L ++ P
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVP---LRWLAP 170
Query: 631 EY---QRTGLISPK----SDVYAYGMVILQLL 655
E GLI+ + S+V+A G+ + +L
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 66/245 (26%), Positives = 100/245 (40%), Gaps = 31/245 (12%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L +C D V EY+ G L +Y+ A E+A L FLH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS--- 119
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
K II+RD+K N++LD KI D G+ N + T+ GT YI PE
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTF-----CGTPDYIAPEII 173
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693
D +A+G+++ ++L + DED L + + +P +K
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPF-------EGEDEDELFQSIMEHNVAYPKSMSK 226
Query: 694 ELAAL 698
E A+
Sbjct: 227 EAVAI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 42/181 (23%)
Query: 557 IAWEVASALAFLHNTKPKP----IIHRDMKPGNILLD-------------HNL----VSK 595
I ++ ALA+ HN K P ++HRD+KP NI L +NL ++K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 596 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQ 653
IGD GLS + + S VGT Y PE T KSD++A G +I +
Sbjct: 183 IGDFGLSKNIGIESMAHSC-------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 654 LLTAKPAIAITHKVETAIDEDNLAEILD--AQAGDWPIK-ETKELAALGLSCAELRRKDR 710
L + K HK +N ++++ + D PIK ++KEL L + L K+R
Sbjct: 236 LCSGKTPF---HKA------NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286
Query: 711 P 711
P
Sbjct: 287 P 287
|
Length = 1021 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYK T + + L+ + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFER-YRIA----WEVASALAFLHNT 571
LV+EY++ L K + P F + R+ +++ +A+ H+
Sbjct: 69 VVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 572 KPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+ ++HRD+KP N+L+D + K+ D GL+ +F T V TL Y P
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTFTHEVVTLWYRAP 172
Query: 631 EY---QRTGLISPKSDVYAYGMVILQLLTAKP 659
E R S D+++ G + +++ KP
Sbjct: 173 EILLGSRH--YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 44/199 (22%), Positives = 86/199 (43%), Gaps = 27/199 (13%)
Query: 472 VYKGTFHHTFAAVKVLQ--SKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 522
+YKG F++ ++ + KG + E++ L +I ++L + G D
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 523 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 582
L+ EY G L + L ++ + + + + +A + L L+ KP ++++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 583 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP-- 640
+ L+ N KI GL +L+S P +KN V + Y + + S
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPP------FKN---VNFMVYFSYKML-NDIFSEYT 200
Query: 641 -KSDVYAYGMVILQLLTAK 658
K D+Y+ G+V+ ++ T K
Sbjct: 201 IKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 462 LRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
++IG G G V T HT AVK + + + + E+ ++ H +++ + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 520 --CPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
D +V E++E G+L D + + + N I + V AL++LHN + +
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGV 139
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+K +ILL + K+ D G ++ + K VGT ++ PE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSLVGTPYWMAPEVISRL 193
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
+ D+++ G+++++++ +P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 464 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 518
IG G +G V + A+K+L I+ F +E ++++ P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 519 ACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
A D + +V EYM G L + + N P W + Y EV AL +H+ +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTA--EVVLALDAIHSMG---L 163
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT- 635
IHRD+KP N+LLD + K+ D G ++ T VGT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-----AVGTPDYISPEVLKSQ 218
Query: 636 ---GLISPKSDVYAYGMVILQLLTA 657
G + D ++ G+ + ++L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 27/159 (16%)
Query: 483 AVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL- 536
A+K+L+ + I + L E VL RHP L L + H C V EY G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 537 ----EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 592
+R++ ++ R+ A E+ SAL +LH+ +++RD+K N++LD +
Sbjct: 84 FHLSRERVFSEDRA-------RFYGA-EIVSALGYLHSCD---VVYRDLKLENLMLDKDG 132
Query: 593 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
KI D GL SD + + T GT Y+ PE
Sbjct: 133 HIKITDFGLCKEGISDGATMKTF------CGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 34/210 (16%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V K T + A+K+L+ + + + L E VL RHP L L
Sbjct: 3 LGKGTFGKVILVKEKATGR--YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 517 LGACPDHG--CLVYEYMENGSL-----EDRLYRKNNTPPIPWFERYRI-AWEVASALAFL 568
+ H C V EY G L +R++ + +R R E+ SAL +L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---------DRARFYGAEIVSALDYL 111
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H+ K +++RD+K N++LD + KI D GL D + + T GT Y+
Sbjct: 112 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGTPEYL 163
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
PE D + G+V+ +++ +
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 464 IGMGGYGTVYK-------GTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLL 514
+G G +G+V + G+F AVK+L++ + ++FL+E + + HP+++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKV--AVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 515 LLLGACPDHGC--------LVYEYMENGSLE-----DRLYRKNNTPPIPWFERYRIAWEV 561
L+G ++ +M++G L R+ + T P+ R+ I ++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DI 122
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
AS + +L + K IHRD+ N +L+ N+ + D GLS + S Y G
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKI------YSGDYYRQGC 173
Query: 622 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
L ++ E + + SDV+A+G+ + +++T
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 481 FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535
+ A+K+L+ + I + + E VL RHP L L A H C V EY G
Sbjct: 22 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81
Query: 536 LEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594
L L R+ + ER R E+ SAL +LH+ + +++RD+K N++LD +
Sbjct: 82 LFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHI 134
Query: 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 654
KI D GL SD + + T GT Y+ PE D + G+V+ ++
Sbjct: 135 KITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 655 LTAK 658
+ +
Sbjct: 189 MCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF-----LQELEVLSKIRHPHLLLLLG 518
IG G YG V T T VKV K + Q L+E+++L + +H +++ +L
Sbjct: 13 IGEGAYGMVCSATHKPT--GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 519 A-CPDHGC------LVYEYMENGSLEDRLYRKNNTPP-----IPWFERYRIAWEVASALA 566
P +V E ME LY+ T I +F +++ L
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF-----LYQILRGLK 120
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGT 624
++H+ ++HRD+KP N+LL+ N KI D GL D + T Y V T
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY-----VAT 172
Query: 625 LCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 659
Y PE K+ D+++ G ++ ++L+ +P
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-06
Identities = 17/41 (41%), Positives = 23/41 (56%), Gaps = 4/41 (9%)
Query: 745 HFICPILKEVM----NEPCVAADGYTYDRKAIEEWLQENDK 781
F+CPI KEVM N P + G+ Y RKA+E+ + K
Sbjct: 10 IFVCPISKEVMTDEENPPVMLPCGHVYSRKALEKLAKNGGK 50
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 464 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL-- 517
IG G YG V + V K+ + K+ L+EL++L +H +++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 518 ----GACPDHGCLVYEYME---------NGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
GA +V + ME + L + R + Y++
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR---------YFLYQLL----RG 119
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP---SFVSTTYKNTGP 621
L ++H+ +IHRD+KP N+L++ + +IGD G++ L+S P + T Y
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY----- 171
Query: 622 VGTLCYIDPE 631
V T Y PE
Sbjct: 172 VATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 35/243 (14%)
Query: 463 RIGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLL 514
++G GGYG V+ K T A+K + K + + L E ++L+ + L+
Sbjct: 8 QVGQGGYGQVFLAKKKDT--GEIVALKRM-KKSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 515 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE-RYRIAWEVASALAFLHNT 571
LL A ++ L EY+ G L NN + R+ +A E+ A+ LH
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMA-EMFEAVDALHEL 120
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
IHRD+KP N L+D + K+ D GLS V TY N+ VG+ Y+ PE
Sbjct: 121 G---YIHRDLKPENFLIDASGHIKLTDFGLSK------GIV--TYANS-VVGSPDYMAPE 168
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
R D ++ G ++ + L P + + ET + E L P+ +
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----QRPVYD 223
Query: 692 TKE 694
Sbjct: 224 DPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 37/244 (15%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF--LQELEVLSKIR---HPHLLL 515
IG G YG V+K F A+K ++ + + ++E+ VL + HP+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 516 LLGACP-------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 568
L C LV+E+++ L L K P +P + +++ L FL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H+ + ++HRD+KP NIL+ + K+ D GL+ + SF T V TL Y
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMAL---TSVVVTLWYR 176
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA----QA 684
PE + D+++ G + ++ KP + D D L +ILD
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF------RGSSDVDQLGKILDVIGLPGE 230
Query: 685 GDWP 688
DWP
Sbjct: 231 EDWP 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 463 RIGMGGYGTVYKG---TFHHTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYK A K+ L+++ ++E+ +L ++ HP+++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 519 ACPDHGCL--VYEY--MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
L V+E+ ++ D PP+ + Y +++ +A+ H+ +
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSY--LYQLLQGIAYCHSHR-- 119
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGL 601
++HRD+KP N+L+D K+ D GL
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 349 QNEANDASRKVNDLNKCKLEEETRLSEI--QLLEEKAIELAKQEKKKYETARREAECARA 406
Q ++ + K + E+ R E+ + EKA + A+Q K+ E +++AE A+A
Sbjct: 67 QERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAEEKQKQAEEAKA 126
Query: 407 SAEKEAAQRQEA--EMKAKHEAKEKEMLERA 435
EA + EA E KAK EAK++ E
Sbjct: 127 KQAAEAKAKAEAEAEKKAKEEAKKQAEEEAK 157
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHP------HL 513
IG G YG V HT V + + ++ + L+E+++L +RHP H+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 514 LLLLGACPDHG-----CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRI-AWEVASAL 565
+L P +V+E ME S ++ + N+ TP E ++ +++ AL
Sbjct: 68 ML----PPSRREFKDIYVVFELME--SDLHQVIKANDDLTP-----EHHQFFLYQLLRAL 116
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVS-TTYKNTGPVG 623
++H + HRD+KP NIL + + KI D GL+ N P+ + T Y V
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-----VA 168
Query: 624 TLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKP 659
T Y PE + +P D+++ G + ++LT KP
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 46/228 (20%)
Query: 460 ENLRIGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 514
E ++G G YG VYK G +A + Q +G + +E+ +L +++HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYA---LKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 515 LLLGACPDHG----CLVYEYMENGSLE----DRLYRKNNTP-PIPWFERYRIAWEVASAL 565
L H L+++Y E+ R + N P +P + +++ +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 566 AFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNS--------DPSFV 612
+LH ++HRD+KP NIL+ + V KI D+G + + NS DP V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV 177
Query: 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 659
T Y PE K+ D++A G + +LLT++P
Sbjct: 178 -----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK-----IRHPHLLLLLG 518
IG G +G V AV ++ I + L + E+L + R +L+ G
Sbjct: 9 IGRGAFGEV----------AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG 58
Query: 519 AC------------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
C ++ LV +Y G L L + + P Y +A +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVL 113
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
+H+ +HRD+KP N+LLD N ++ D G +N D T +++ VGT
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-----GTVQSSVAVGTPD 168
Query: 627 YIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 669
YI PE + G P+ D ++ G+ + ++L + VET
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 15/148 (10%)
Query: 464 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLLL 517
IG+G +G V K + +A +K L+ + Q E ++L++ + ++ L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYA-MKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ D L V +Y+ G + L R R+ IA E+ A+ +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--LARFYIA-ELTCAIESVHKMG--- 121
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLST 603
IHRD+KP NIL+D + K+ D GL T
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVK----VLQSKGNIQNKQFLQELEVLSKIR-HPHLL 514
+G G YG V T A+K V K I K+ L+EL++L R H ++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNIT 65
Query: 515 LLLG---ACPDHGCLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLH 569
L P + +Y Y E +E L++ ++ P + I +++ L ++H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ ++HRD+KPGN+L++ + KI D GL+ + + T V T Y
Sbjct: 123 SAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS--ENPGENAGFMTEYVATRWYRA 177
Query: 630 PE----YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE +Q + DV++ G ++ +LL KP
Sbjct: 178 PEIMLSFQS---YTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 501 ELEVLSKIRHPHLLLLLGA-------C---PDHGCLVYEYMENGSLEDRLYRKNNTPPIP 550
E+++L I H ++ L+ A C P + C ++ Y++ P+P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------------PLP 183
Query: 551 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
+ I + ALA+LH + IIHRD+K NI LD + +GD G + L++ P
Sbjct: 184 LEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
T + G GTL PE K+D+++ G+V+ ++
Sbjct: 241 ----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 463 RIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPHLLLLLG 518
++G G Y TVYKG + A+KV+ K + F ++E +L ++H +++LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
L V+EYM + Y + + + +++ LA++H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---I 124
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
+HRD+KP N+L+ + K+ D GL+ S S TY + V TL Y P+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLA----RAKSIPSQTY--SSEVVTLWYRPPDVLLGA 178
Query: 637 L-ISPKSDVYAYGMVILQLLTAKPAIA 662
S D++ G + +++L +PA
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPH 512
+F + +IG G YG VYK T V + + + + + + ++E+ +L ++ HP+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 513 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTP----PIPWFERYRIAWEVASALA 566
++ LL LV+E++ +D + +P P+P + Y +++ LA
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSY--LFQLLQGLA 114
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
F H+ + ++HRD+KP N+L++ K+ D GL+ +F T V TL
Sbjct: 115 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLW 165
Query: 627 YIDPE-YQRTGLISPKSDVYAYGMVILQLLTAK 658
Y PE S D+++ G + +++T +
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPG 584
LV EY+ G L + R+ P E R A E+ AL FLH + II+RD+K
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPE----EHARFYAAEICIALNFLHE---RGIIYRDLKLD 125
Query: 585 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 644
N+LLD + K+ D G+ P ++T+ GT YI PE R D
Sbjct: 126 NVLLDADGHIKLTDYGMCKE-GLGPGDTTSTF-----CGTPNYIAPEILRGEEYGFSVDW 179
Query: 645 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680
+A G+++ +++ + I ED L +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
+++VA ++FL + K IHRD+ NILL H ++KI D GL+ + +D ++V
Sbjct: 220 SYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV ++ PE + + +SDV++YG+++ ++ +
Sbjct: 277 RL-PVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 28/180 (15%)
Query: 522 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTKPKPIIH 578
+H V E++ G L + K F+ YR A E+ L FLH+ K II+
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHS---KGIIY 119
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 638
RD+K N++LD + KI D G+ V + + GT YI PE +
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCK------ENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 639 SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETKEL 695
+ D +++G+++ ++L + DED L E + +P KE+K++
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFH-------GDDEDELFESIRVDTPHYPRWITKESKDI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 46/228 (20%)
Query: 460 ENLRIGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 514
E ++G G YG VYK G +A + Q +G + +E+ +L +++HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYA---LKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 515 LLLGACPDHG----CLVYEYMENGSLE----DRLYRKNNTP-PIPWFERYRIAWEVASAL 565
L H L+++Y E+ R + N P +P + +++ +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 566 AFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNS--------DPSFV 612
+LH ++HRD+KP NIL+ + V KI D+G + + NS DP V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV 177
Query: 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 659
T Y PE K+ D++A G + +LLT++P
Sbjct: 178 -----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRH-PHLLLLL 517
+IG G YG VYK +T V + +++ + + L+E+ +L + +++ LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 518 GACPDHG---------CLVYEYMENG--SLEDRLYRKNNTP-PIPWFERYRIAWEVASAL 565
+H LV+EY+++ D R P P + + +++ +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF--MYQLLKGV 123
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
A H ++HRD+KP N+L+D + KI D+GL +F T + T
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIVT 174
Query: 625 LCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKP 659
L Y PE S D+++ G + ++ +P
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE-------LEVLSKIRHPHLLLL 516
+G G +G VY T + V Q + + ++ + +E +++L + H ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 517 LGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
G D + E+M GS++D+L K+ R + ++ +++LH+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHSNM 126
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVG----LSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
I+HRD+K NIL D K+GD G L T+ S S T GT ++
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-------GTPYWM 176
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVET 669
PE K+D+++ G ++++LT KP A+A K+ T
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 526 LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 584
L+ EY G L ++ R P +E + +++ AL +H+ K ++HRD+K
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA 198
Query: 585 NILLDHNLVSKIGDVGLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSD 643
NI L + K+GD G S + S V++++ GT Y+ PE S K+D
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF-----CGTPYYLAPELWERKRYSKKAD 253
Query: 644 VYAYGMVILQLLT 656
+++ G+++ +LLT
Sbjct: 254 MWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 348 AQNEANDASRKVNDLNKCKLE---EETRLSEIQLLEEKAIELAKQEKKKYETARREAECA 404
+ A A+++ K E + Q E KA A+ EKK E A+++AE
Sbjct: 96 QRAAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEE 155
Query: 405 RASAEKEAAQRQEAEMKAKHEAKEKE 430
+ A+++ AE K K EA+ K
Sbjct: 156 AKAKAAAEAKKKAAEAKKKAEAEAKA 181
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 464 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRH-PHL 513
+G G YG V+ K T H T A+KVLQ +Q + ++ E VL +R P L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 514 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHN 570
+ L A L+ +Y+ G + LY+++N + R + E+ AL LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHLHK 123
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCYID 629
I++RD+K NILLD + D GLS F+S + T GT+ Y+
Sbjct: 124 LG---IVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYMA 174
Query: 630 PEYQRTGLISPKS-DVYAYGMVILQLLT-AKP 659
PE R K+ D ++ G++I +LLT A P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 60/252 (23%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
+G G +G V T F A+K L+ L++ +V + +L L P
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEHP 56
Query: 522 ------------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALA 566
+H V EY+ G L + F+ R A E+ L
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
FLH K II+RD+K N+LLD + KI D G+ N + ++T+ GT
Sbjct: 111 FLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTF-----CGTPD 161
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686
YI PE + + D +++G+++ ++L + DED L + +
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-------HGEDEDELFDSILNDRPH 214
Query: 687 WPIKETKELAAL 698
+P +KE
Sbjct: 215 FPRWISKEAKDC 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLLGA 519
IG G +G V+ T V + + QN K+ +EL++L +H ++L L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 520 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPI 576
P Y+ ++ L++ +P + ++ +++ L +LH+ I
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---I 124
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
+HRD+KPGN+L++ N V KI D GL+ + D S
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 57/271 (21%), Positives = 112/271 (41%), Gaps = 28/271 (10%)
Query: 464 IGMGGYGTVYKGTF-----HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+G G +G + +G A+ L+ + Q + FL E L + H +++ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G + V EYM NG+L+ L + + + + +AS + +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSEMG--- 127
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+H+ + +L++ +LV KI G + + TT PV + PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQY 182
Query: 636 GLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693
S SDV+++G+V+ ++++ +P ++ +D + + D P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGFRLPAPRNCPN 235
Query: 694 ELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
L L L C + R +RP +Q+ +L ++
Sbjct: 236 LLHQLMLDCWQKERGERPRF-SQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
L ++H+ ++HRD+KP N+LL+ N KI D GL+ + F+ T Y V T
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEY-----VVT 171
Query: 625 LCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKP 659
Y PE + T I DV++ G + +LL KP
Sbjct: 172 RWYRAPELLLNCSEYTTAI----DVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHL 513
+ + ++G G YGTV T A V + + Q++ F +EL +L ++H ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 514 LLLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+ LL PD LV +M G+ +L + RI + V L
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK------LSEDRIQFLVYQML 128
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
L IIHRD+KPGN+ ++ + KI D GL+ +S+ TG V T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYVVTR 179
Query: 626 CYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y PE Y +T D+++ G ++ ++LT KP
Sbjct: 180 WYRAPEVILNWMHYTQT------VDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 47/222 (21%)
Query: 460 ENLR-IGMGGYGTVYKGTFHHT--FAAVKVL----QSKGNIQNKQFLQELEVLSKIRHPH 512
+NL +G G YG V T A+K L QS I K+ +EL +L + H +
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHEN 75
Query: 513 LLLLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
++ LL P LV M L + + + + F Y+I
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL----RG 130
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
L ++H+ IIHRD+KP NI ++ + KI D GL+ + + TG V T
Sbjct: 131 LKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD---------EMTGYVAT 178
Query: 625 LCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y PE Y +T D+++ G ++ +LLT K
Sbjct: 179 RWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V +
Sbjct: 185 SFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----R 237
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDN 675
L ++ PE + + +SDV+++G+++ ++ L A P + IDE+
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEF 291
Query: 676 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717
+ + P T E+ L C RP V
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 15/130 (11%)
Query: 543 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
++ P+ + R + +VA + FL K IHRD+ N+LL V+KI D GL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 603 TMLNSDPSFVSTTYKNTG--PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL----LT 656
+ +D ++V K PV ++ PE + + +SDV++YG+++ ++ +
Sbjct: 260 RDIMNDSNYV---VKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
Query: 657 AKPAIAITHK 666
P I + K
Sbjct: 314 PYPGILVNSK 323
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLLL 517
++G G Y TV+KG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 574
CL V+EY+++ D +N + +I +++ L++ H K
Sbjct: 70 DIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--Y 632
I+HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 124 -ILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNE--VVTLWYRPPDVLL 176
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
T +P D++ G ++ ++ T +P
Sbjct: 177 GSTEYSTP-IDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 29/204 (14%)
Query: 467 GGYGTVYKGTFHHTFAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG 524
+ K +T AVK L S K QE+ +++HP++L + +
Sbjct: 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72
Query: 525 CL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKPIIHR 579
L V M GS ED L K + P IA+ +V +AL ++H+ K IHR
Sbjct: 73 ELYVVSPLMAYGSCEDLL--KTHFPE--GLPELAIAFILKDVLNALDYIHS---KGFIHR 125
Query: 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG-------TLCYIDPE- 631
+K +ILL + + GL + S + + L ++ PE
Sbjct: 126 SVKASHILLSGDGKVVLS--GLRYSV----SMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 632 -YQRTGLISPKSDVYAYGMVILQL 654
Q + KSD+Y+ G+ +L
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 464 IGMGGYGTVYKGTF---HHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLL 517
+G G +G V T+ A+K + I+ KQ E ++L+ I HP + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPK 574
G+ D L V E++ G L R P + F A ++ +L +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----YAAQIVLIFEYLQSLN-- 151
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YIDP 630
I++RD+KP N+LLD + K+ D G + +++ + TY TLC YI P
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTY-------TLCGTPEYIAP 197
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP 659
E +D + G+ I ++L P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 42/311 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLS-KIRHPHL--LL 515
+G G +G V+ T F A+K L+ + + + E VLS HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 516 LLGACPDHGCLVYEYMENGSLEDRLY--RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
++ V EY+ G L + K + P ++ A E+ L FLH+
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----AAEIICGLQFLHS--- 114
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
K I++RD+K NILLD + KI D G+ ML K GT YI PE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------KTCTFCGTPDYIAPE 166
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL---DAQAGDWP 688
+ D +++G+++ ++L + DE+ L + + + W
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH-------GHDEEELFQSIRMDNPCYPRWL 219
Query: 689 IKETKE-LAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFI 747
+E K+ L L + E R + D++ P + A R+ P P +
Sbjct: 220 TREAKDILVKLFVREPERRLGVKGDIRQH--PFFREIDWSALEEREIEPPFKPKVKSAND 277
Query: 748 CPIL-KEVMNE 757
C KE +NE
Sbjct: 278 CSNFDKEFLNE 288
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)
Query: 510 HPHLLLLLGACPDHGC--------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWE 560
HP L+ L H C V E++ G L + R+ P E R + E
Sbjct: 55 HPFLVGL------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPE----EHARFYSAE 104
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 620
++ AL FLH + II+RD+K N+LLD K+ D G+ P ++T+
Sbjct: 105 ISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTF---- 156
Query: 621 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
GT YI PE R D +A G+++ +++ +
Sbjct: 157 -CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
LV +Y G L L + + P R+ +A E+ A+ +H +HRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLA-EMVLAIDSVHQLG---YVHRDIKPDN 132
Query: 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISP 640
+LLD N ++ D G L +D + S VGT YI PE + G P
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNV-----AVGTPDYISPEILQAMEDGKGRYGP 187
Query: 641 KSDVYAYGMVILQLL 655
+ D ++ G+ + ++L
Sbjct: 188 ECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 464 IGMGGYGTVYKGTFH---HTFA----AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 515
+G G +G V + T H H+ + AVK+L+S KQ + EL+++S + PHL +
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHL-GPHLNI 103
Query: 516 --LLGACPDHG--CLVYEYMENGSLEDRLYRKNNT 546
LLGAC G ++ EY G L D L+R +T
Sbjct: 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHT 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/93 (33%), Positives = 40/93 (43%), Gaps = 7/93 (7%)
Query: 346 AIAQNEAN-DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECA 404
A+ +A +A K K K E + +E E KA AK K K E A+ +AE A
Sbjct: 146 EEAKKQAEEEAKAKAAAEAKKKAAEAKKKAEA---EAKAKAEAK-AKAKAEEAKAKAEAA 201
Query: 405 RASAEKEAAQ--RQEAEMKAKHEAKEKEMLERA 435
+A A EAA EA A EA+ K
Sbjct: 202 KAKAAAEAAAKAEAEAAAAAAAEAERKADEAEL 234
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/115 (26%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 541 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600
Y + P+P + I ++ L +LH + IIHRD+K NI ++ IGD+G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLG 202
Query: 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLL 655
+ P+F+ G GT+ PE + K+D+++ G+V+ ++L
Sbjct: 203 AAQFPVVAPAFL-------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YGTV+K T V + L L+E+ +L +++H +++ L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 519 ACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
H LV+EY + L+ N + + +++ LAF H+
Sbjct: 67 VL--HSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF--MFQLLKGLAFCHSHN-- 119
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLS 602
++HRD+KP N+L++ N K+ D GL+
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 59/258 (22%), Positives = 102/258 (39%), Gaps = 29/258 (11%)
Query: 454 ATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNI-----QNKQFLQELE 503
A+L+ R G+ G TF FA + ++ ++ Q E
Sbjct: 77 ASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQRGGTATEAH 135
Query: 504 VLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 561
+L I HP ++ L G + CL+ + L L K N I + I V
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRN---IAICDILAIERSV 191
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
A+ +LH + IIHRD+K NI ++H +GD G + P + K G
Sbjct: 192 LRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF----PVDI-NANKYYGW 243
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
GT+ PE P D+++ G+V+ ++ T ++ ++ D D +++
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303
Query: 682 AQAG----DWPIKETKEL 695
++G ++PI L
Sbjct: 304 RRSGTHPNEFPIDAQANL 321
|
Length = 391 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 43/203 (21%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 462 LRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
++IG G G V H+ AVK++ + + + E+ ++ +H +++ + +
Sbjct: 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 520 --CPDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+ ++ E+++ G+L D + + + N I + V AL +LH+ + +
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS---QGV 138
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
IHRD+K +ILL + K+ D G ++ D K VGT ++ PE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSLVGTPYWMAPEVISRT 192
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
+ D+++ G+++++++ +P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 348 AQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYET--ARREAECAR 405
Q +A +A K K K E E + +E+A + A++E K A+++A A+
Sbjct: 117 KQKQAEEAKAKQAAEAKAKAEAE----AEKKAKEEAKKQAEEEAKAKAAAEAKKKAAEAK 172
Query: 406 ASAEKEAAQRQEAEMKAKHE-AKEK 429
AE EA + EA+ KAK E AK K
Sbjct: 173 KKAEAEAKAKAEAKAKAKAEEAKAK 197
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 48/178 (26%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
IG G +G VY+ T A+KVL K + K+ + E +L + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 519 -----ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
LV +YM G L L ++ F R + +A + L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR------FSEDRAKFYIAELVLALEHLHK 114
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I++RD+KP NILLD + D GLS + NT GT Y+ PE
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTF-CGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 464 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLL 514
+G G YG V+ K + H + A+KVL+ +Q + + E +VL IR L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 515 LLLGACPDHGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFL 568
+ L L+ +Y+ G L L ++ F+ + + E+ AL L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRER------FKEQEVQIYSGEIVLALEHL 121
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H II+RD+K NILLD N + D GLS + D + ++ GT+ Y+
Sbjct: 122 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-----CGTIEYM 173
Query: 629 DPEYQRTGLISPKS--DVYAYGMVILQLLTA 657
P+ R G D ++ G+++ +LLT
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLLL 517
++G G Y TVYKG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 518 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
LV+EY++ + + Y + I +++ L + H K
Sbjct: 71 DIIHTEKSLTLVFEYLDK---DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--- 124
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
++HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNE--VVTLWYRPPDILLG 178
Query: 636 GL-ISPKSDVYAYGMVILQLLTAKP 659
S + D++ G + ++ T +P
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585
LV +Y G L L + + P R+ +A E+ A+ +H +HRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA-EMVIAIDSVHQLH---YVHRDIKPDN 132
Query: 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISP 640
IL+D N ++ D G L D T +++ VGT YI PE + G P
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMED-----GTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 641 KSDVYAYGMVILQLLTAKPAIAITHKVET 669
+ D ++ G+ + ++L + VET
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLL- 516
++G G Y TV+KG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 517 -LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 574
+ LV+EY++ +D ++ I +I +++ LA+ H K
Sbjct: 71 DIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK-- 124
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
++HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNE--VVTLWYRPPDVLL 177
Query: 635 -TGLISPKSDVYAYGMVILQLLTAKP 659
+ S + D++ G + ++ + +P
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLLL 517
IG G +G V + T A+K ++ K +I ++ L E VL+++ P ++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ P+ LV ++ G L L R+ F+ R + A L L N
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR------FDLSRARFYTAELLCALENLHKFN 113
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+I+RD+KP NILLD+ + D GL LN + T+ GT Y+ PE
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTF-----CGTPEYLAPELLLG 167
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+ D + G+++ ++LT P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS--TTY 616
++VA + FL + K +HRD+ N+LL + KI D GL+ + D ++VS +T+
Sbjct: 244 YQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV ++ PE L + SDV++YG+++ ++ +
Sbjct: 301 L---PVK---WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 52/221 (23%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 515
++G G Y TVYKG T A+K ++ +++++ ++E +L ++H +++
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR----LEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 516 LLGACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALA 566
L H LV+EY++ D ++ R+ +++ LA
Sbjct: 68 L------HDIIHTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
+ H + ++HRD+KP N+L+ K+ D GL+ S S TY N V TL
Sbjct: 118 YCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNE--VVTLW 168
Query: 627 YIDP-------EYQRTGLISPKSDVYAYGMVILQLLTAKPA 660
Y P EY S D++ G + ++ T +P
Sbjct: 169 YRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 29/115 (25%), Positives = 62/115 (53%), Gaps = 11/115 (9%)
Query: 544 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603
N +P + + + +++VA+ + FL + K +HRD+ N+L+ + KI D GL+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 604 MLNSDPSFVS--TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
+ D +++S +T+ L ++ PE L + SDV+++G+++ ++ T
Sbjct: 288 DIMRDSNYISKGSTFL------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 496 KQFLQELEVLSKIRHPHLLL--LLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPW 551
+E+ +L + L + +L + G L+ E++E +L++
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SE 85
Query: 552 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 589
E+ IA ++A LA LH + H D+ PGNIL+D
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 31/132 (23%), Positives = 50/132 (37%), Gaps = 24/132 (18%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPI 76
+ VAV G+ +S A+ WALE G L LLHV I
Sbjct: 5 ILVAVDGSEESERALEWALELAKRRGAELI-LLHV----------------------IDP 41
Query: 77 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVK-VIESDDVAKAIADEVASCN 135
E A ++EE+ + A V V+ V+ D A+AI + +
Sbjct: 42 EPSGAASEALEEEEEEELEEEEAEAEALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEED 101
Query: 136 INKLVIGAQSQG 147
+ +V+G++ +
Sbjct: 102 ADLIVMGSRGRS 113
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 5e-04
Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 1/74 (1%)
Query: 357 RKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQ 416
+K ++ K K EE + E + E+A + A KKK E A++ AE A+A AE A + +
Sbjct: 1302 KKADEAKK-KAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAE 1360
Query: 417 EAEMKAKHEAKEKE 430
AE KA+ K+KE
Sbjct: 1361 AAEEKAEAAEKKKE 1374
|
Length = 2084 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 364 KCKLEEETRLSEIQL---LEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 420
+ K E+ RL+ + EE A + A ++K+ E A + A A+A AE EA + A
Sbjct: 102 RLKQLEKERLAAQEQKKQAEEAAKQAALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAK 161
Query: 421 KAKHEAKEKEMLERA 435
KA EAK+K E A
Sbjct: 162 KAAAEAKKKAEAEAA 176
|
Length = 387 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 457 SFSENLRIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPH 512
S+ + ++G G Y TVYKG + A+KV++ + + F ++E +L ++H +
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHAN 64
Query: 513 LLLL--LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
++LL + + LV+EY+ + Y + + +++ L+++H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+ I+HRD+KP N+L+ K+ D GL+ S S TY N V TL Y P
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLARA----KSVPSHTYSNE--VVTLWYRPP 172
Query: 631 E 631
+
Sbjct: 173 D 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|190741 pfam03763, Remorin_C, Remorin, C-terminal region | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 361 DLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 420
+ K K E E + E +L ++KA K K K A ++AE RA+AE A+R E E
Sbjct: 37 NKKKAKAEAELKKIERKLEKKKAEAAEKL-KNKLAAAHKKAEEKRATAE---AKRGEEEA 92
Query: 421 KAKHEAK 427
KA+ +A
Sbjct: 93 KAEEKAA 99
|
Remorins are plant-specific plasma membrane-associated proteins. In tobacco remorin co-purifies with lipid rafts. Most remorins have a variable, proline-rich C-half and a more conserved N-half that is predicted to form coiled coils. Consistent with this, circular dichroism studies have demonstrated that much of the protein is alpha-helical. Remorins exist in plasma membrane preparations as oligomeric structures and form filaments in vitro. The proteins can bind polyanions including the extracellular matrix component oligogalacturonic acid (OGA). In vitro, remorin in plasma membrane preparations is phosphorylated (principally on threonine residues) in the presence of OGA and thus co-purifies with a protein kinases(s). The biological functions of remorins are unknown but roles as components of the membrane/cytoskeleton are possible. Length = 112 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 346 AIAQNEANDASRKVNDLNKCKLEEETRLSEI---QLLEE-KAIELAKQEKKKYETARREA 401
A+ Q +A +A+ K K K E E + + + E K A+ KK A+++A
Sbjct: 128 ALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKKKAEAEAAKKAAAEAKKKA 187
Query: 402 EC---------ARASAEKEAAQRQEAEMKAKHEAKEKEMLERA 435
E A+ AE EA ++ AE K K A+ K +A
Sbjct: 188 EAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEAKAAAAKA 230
|
Length = 387 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 14/87 (16%)
Query: 526 LVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLHNTKPKPIIHRDM 581
L+ EY+ G + L +K+ F R+ IA E A+ +H IHRD+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDT------FTEEETRFYIA-ETILAIDSIHKLG---YIHRDI 127
Query: 582 KPGNILLDHNLVSKIGDVGLSTMLNSD 608
KP N+LLD K+ D GL T L
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKS 154
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 28/163 (17%)
Query: 510 HPHLLLLLGACPDHGCL--------VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWE 560
HP L+ L H C V EY+ G L + R+ P E R + E
Sbjct: 55 HPFLVGL------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAE 104
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 620
++ AL +LH + II+RD+K N+LLD K+ D G+ P ++T+
Sbjct: 105 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTF---- 156
Query: 621 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 663
GT YI PE R D +A G+++ +++ + I
Sbjct: 157 -CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 27/153 (17%)
Query: 464 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNK----QFLQELEVLSKIRHP---HL 513
I G +G VY K +A VKV++ K ++ NK Q E + L+ + P HL
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYA-VKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 514 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLH 569
L + ++ LV EY+ G ++ L+ +F+ I+ EVA AL +LH
Sbjct: 70 YYSLQSA-NNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYIS-EVALALDYLH 121
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
IIHRD+KP N+L+ + K+ D GLS
Sbjct: 122 R---HGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (98), Expect = 0.002
Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 1/84 (1%)
Query: 351 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEK 410
+A + +KV L K + EE+ + E++ EE+ A +E KK E +++AE A+ AE+
Sbjct: 1627 KAEEEKKKVEQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEAK-KAEE 1685
Query: 411 EAAQRQEAEMKAKHEAKEKEMLER 434
+ + EA K EAK+ E L++
Sbjct: 1686 DEKKAAEALKKEAEEAKKAEELKK 1709
|
Length = 2084 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 30/113 (26%), Positives = 49/113 (43%), Gaps = 26/113 (23%)
Query: 331 LEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQE 390
LE+L E + +A +A + + K K E LEEK +L ++E
Sbjct: 525 LEELERE----------LEQKAEEAEALLKEAEKLKEE----------LEEKKEKLQEEE 564
Query: 391 KKKYETARREAECARASAEKEAAQ----RQEAEMKAKHEAKEKEMLE--RALN 437
K E A +EA+ A A+KEA + ++ + K E++E + LN
Sbjct: 565 DKLLEEAEKEAQQAIKEAKKEADEIIKELRQLQKGGYASVKAHELIEARKRLN 617
|
Length = 782 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 36/264 (13%)
Query: 460 ENLR-IGMGGYGTV---YKGTFHHTFAAVKVLQS-KGNIQNKQFLQELEVLSKIRHPHLL 514
+NL+ IG G G V Y A K+ + + K+ +EL ++ + H +++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 515 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPW-FERYRIAWEVASALAFLHNTKP 573
LL L E ++ L L N I + R+++ + L + +
Sbjct: 80 SLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
IIHRD+KP NI++ + KI D GL+ + SF+ T Y V T Y PE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPY-----VVTRYYRAPEVI 190
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693
D+++ G ++ +++ K I ID+ N K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWN-----------------K 229
Query: 694 ELAALGLSCAELRRKDRPDLKNQV 717
+ LG C E +K +P ++N V
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYV 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 349 QNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASA 408
Q + A++K + K ++ + + E+ + +Q + A++ + A+ +
Sbjct: 56 QQQKKPAAKKEQERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAE 115
Query: 409 EK-----EAAQRQEAEMKAKHEAKEK 429
EK EA +Q AE KAK EA+ +
Sbjct: 116 EKQKQAEEAKAKQAAEAKAKAEAEAE 141
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 31/132 (23%), Positives = 61/132 (46%), Gaps = 19/132 (14%)
Query: 527 VYEYMENGSLE--DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 584
+Y +M + + + DR P+ R I ++ A+ ++H+ K +IHRD+K
Sbjct: 249 LYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLE 296
Query: 585 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 644
NI L+ + +GD G + + + G VGT+ PE +D+
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKE-----REAFDYGWVGTVATNSPEILAGDGYCEITDI 351
Query: 645 YAYGMVILQLLT 656
++ G+++L +L+
Sbjct: 352 WSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 24/63 (38%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 369 EETRLSEIQLLEEKAIELAKQEKKKYETARRE--AECARASAEKEAAQRQEAEMKAKHEA 426
E+ E + EE+A + A ++KKK E A+ + AE A+ A EA ++ E KA EA
Sbjct: 124 EKQAQLEQKQQEEQARKAAAEQKKKAEAAKAKAAAEAAKLKAAAEAKKKAEEAAKAAEEA 183
Query: 427 KEK 429
K K
Sbjct: 184 KAK 186
|
Length = 387 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 464 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLLLG 518
+G+G +G V H A+K L+ K + Q E ++L++ + ++ L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+ D L V +Y+ G + L R P + R+ IA E+ A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV--LARFYIA-ELTLAIESVHKMG---F 122
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLST 603
IHRD+KP NIL+D + K+ D GL T
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.004
Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 348 AQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE--KAIELAK-QEKKKYETARREAECA 404
A+ +A +A +K ++ K E + + E + EE KA E K +E KK + A++ E
Sbjct: 1488 AKKKAEEAKKKADEAKK-AAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEKK 1546
Query: 405 RASAEKEAAQRQEAEMKAKHEAKEKE 430
+A K+A + ++AE K K E +K
Sbjct: 1547 KADELKKAEELKKAEEKKKAEEAKKA 1572
|
Length = 2084 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 29/110 (26%), Positives = 40/110 (36%), Gaps = 9/110 (8%)
Query: 330 ELEKLRIELRHVRGMYAIAQNE---ANDASRKVNDLNKCKLEEETRL-----SEIQLLEE 381
L+ +L VR A Q E R LEE + SE+ ++
Sbjct: 165 ALKATLKQLAAVRAEIAAEQAELTTLLSEQRAQQAKLAQLLEERKKTLAQLNSELSADQK 224
Query: 382 KAIELAKQEKK-KYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKE 430
K EL E + K E A EA A+A AA+ A +A + E
Sbjct: 225 KLEELRANESRLKNEIASAEAAAAKAREAAAAAEAAAARARAAEAKRTGE 274
|
Length = 420 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 28/126 (22%), Positives = 44/126 (34%), Gaps = 10/126 (7%)
Query: 330 ELEKLRIELRHVRGMYAIAQNEANDASRKVN----DLNKCKLEEETRLSEIQLLE----- 380
L +LR EL + + E + SR+++ DL + + E E I L
Sbjct: 699 ALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTE 758
Query: 381 -EKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGT 439
E IE ++ ++ E EAE E + Q +E + E LN
Sbjct: 759 LEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEELKALREALDELRAELTLLNEE 818
Query: 440 FQRYRN 445
R
Sbjct: 819 AANLRE 824
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 10/64 (15%)
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH+ IIHRD+KP NI++ + KI D GL+ + SF+ T Y V T Y
Sbjct: 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPY-----VVTRYY 183
Query: 628 IDPE 631
PE
Sbjct: 184 RAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 810 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.74 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.66 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.65 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.61 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.53 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.26 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.54 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.34 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.23 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=427.56 Aligned_cols=276 Identities=43% Similarity=0.745 Sum_probs=235.0
Q ss_pred ccccCCHHHHHHhhcCcccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeecee
Q 003576 442 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520 (810)
Q Consensus 442 ~~~~~~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~ 520 (810)
..+.|++.++..+|++|+..+.||+||||.||+|...+ +.||||.+.........+|.+|+.+|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999987 79999988765543145599999999999999999999999
Q ss_pred cCC---CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEe
Q 003576 521 PDH---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 597 (810)
Q Consensus 521 ~~~---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~ 597 (810)
.+. .+||||||++|+|.++|+..... +++|..|++|+.++|.||+|||...+++||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 644 48999999999999999876654 79999999999999999999999887789999999999999999999999
Q ss_pred eeccccccCC-CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc---------chh
Q 003576 598 DVGLSTMLNS-DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT---------HKV 667 (810)
Q Consensus 598 DFGla~~~~~-~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~---------~~~ 667 (810)
|||+|+..+. .... .+...||.+|+||||+..+..+.|+|||||||+|+||+||++|.+.. .+.
T Consensus 220 DFGLa~~~~~~~~~~------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CccCcccCCccccce------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999976553 2111 01117999999999999999999999999999999999999888732 233
Q ss_pred hhhhccchhHHHhhhhCC--CCCh-hHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 668 ETAIDEDNLAEILDAQAG--DWPI-KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 668 ~~~~~~~~l~~~ld~~~~--~~p~-~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
...+..+.+.+++|+... .++. .....+..++.+|++.+|.+||+|.+ |..+|+.+.
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~-Vv~~L~~~~ 353 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ-VVKELEGIL 353 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH-HHHHHHhhc
Confidence 345556688889998853 4553 57788999999999999999999995 566665443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=394.81 Aligned_cols=253 Identities=34% Similarity=0.516 Sum_probs=212.7
Q ss_pred ceeeccCCcEEEEEEEECCeE-EEEEEEcccCccc--hHHHHHHHHHHHhcCCCceeeeeceecCC---CeEEEEeccCC
Q 003576 461 NLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYMENG 534 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~~~~-vavK~l~~~~~~~--~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---~~lV~Ey~~~g 534 (810)
...||.|+||+||+|.+.++. ||||++....... .+.|.+|+.+|.+++|||||+|+|+|.+. .++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 345999999999999999998 9999998654322 45899999999999999999999999776 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-ceEEeeeccccccCCCCCccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-~~kL~DFGla~~~~~~~~~~~ 613 (810)
+|.++|+.. ....+++..+++|+.||+.||.|||+.++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---- 198 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---- 198 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence 999999875 33469999999999999999999999985 99999999999999997 99999999998766432
Q ss_pred ccccccCCccCccccCccccc--cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQR--TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.......... .-.........|..+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~-----~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS-----AVVVGGLRPPIPKEC 271 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH-----HHHhcCCCCCCCccC
Confidence 1234468999999999999 5689999999999999999999999997554422211 111233345667778
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHhh
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 728 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~~ 728 (810)
++.+..|+.+||..||..||++. ++...|+.+....
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~-ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFL-EIVSRLESIMSHI 307 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHH-HHHHHHHHHHHhh
Confidence 99999999999999999999999 6777887776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=375.03 Aligned_cols=239 Identities=32% Similarity=0.430 Sum_probs=201.7
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeeeceecCC---CeEEEEeccCC
Q 003576 461 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYMENG 534 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---~~lV~Ey~~~g 534 (810)
...||+|..|+||++.++ +..+|+|++... .....+++.+|+++|+.++||+||.+||+|... .+|+||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 346999999999999997 569999999544 334567899999999999999999999998544 37999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
||++++...+ .+++...-+|+.++++||.|||. .+ ||||||||+|||++..|.+||||||.++.+...
T Consensus 164 SLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----- 232 (364)
T KOG0581|consen 164 SLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----- 232 (364)
T ss_pred CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-----
Confidence 9999987653 48999999999999999999996 77 999999999999999999999999999887654
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-cchhHHHhhhhCCCCChh-H
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-EDNLAEILDAQAGDWPIK-E 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~-~~~l~~~ld~~~~~~p~~-~ 691 (810)
....++||..|||||.+.+..|+.++||||||++++|+.+|+.||..... .... -..+..+++...+..|.. .
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll~~Iv~~ppP~lP~~~f 307 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELLCAIVDEPPPRLPEGEF 307 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHHHHHhcCCCCCCCcccC
Confidence 22456999999999999999999999999999999999999999965411 0011 122334444444556665 8
Q ss_pred HHHHHHHHHHHhhhcCCCCCcccc
Q 003576 692 TKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
++++..|+..||++||.+||++.+
T Consensus 308 S~ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 308 SPEFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHH
Confidence 999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=388.75 Aligned_cols=245 Identities=27% Similarity=0.407 Sum_probs=209.5
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc---CccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
..|...+.||+|||+.||.+++. +..||+|++.+. .....+.+.+||+|.+.|+|||||+++++|+|.. |||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45888899999999999999983 669999999864 3445677899999999999999999999998877 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
|+|..++|..++.+. .++++.++..++.||+.||.|||+++ |||||||..||||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988743 45999999999999999999999999 999999999999999999999999999988754
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.. +....+|||.|+|||++....++..+||||+|||||.||+|+|||..... .. ....+.......|
T Consensus 172 ~E------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-ke------ty~~Ik~~~Y~~P 238 (592)
T KOG0575|consen 172 GE------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KE------TYNKIKLNEYSMP 238 (592)
T ss_pred cc------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HH------HHHHHHhcCcccc
Confidence 32 23456999999999999999999999999999999999999999953321 11 1122223334567
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
...+.+.++||.++|+.||.+||++.+++..
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 7889999999999999999999999965533
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=371.80 Aligned_cols=241 Identities=30% Similarity=0.479 Sum_probs=200.0
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
..+|....+||+|+||+||+|+++ ++.||||.+... .....+.+..|+.+|+.++|||||.|++++.+.. ||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999986 569999998776 3334566789999999999999999999997655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC------CceEEeeeccc
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN------LVSKIGDVGLS 602 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~------~~~kL~DFGla 602 (810)
|||.||+|.++|.+++. +++..+..++.||+.||++||+++ ||||||||+||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999988763 899999999999999999999999 9999999999999764 56899999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
+.+.... .....+|++.|||||++..++|+.|+|+||+|+|||+|++|++||......+... .+..
T Consensus 163 R~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-------~~~k 228 (429)
T KOG0595|consen 163 RFLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-------YIKK 228 (429)
T ss_pred hhCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHhc
Confidence 9987433 2345699999999999999999999999999999999999999997544333221 1111
Q ss_pred h---CCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 683 Q---AGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 683 ~---~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
. ....+...+..+.+|+...+..+|.+|-++.+
T Consensus 229 ~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 229 GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred cccccCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 1 12334455666778888888888888877664
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.48 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=204.8
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeec-eecCCC---eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLG-ACPDHG---CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g-~~~~~~---~lV 527 (810)
.+|.+.++||+|+||.||++.. ++..+|.|.++... ....+....|+.+|++|+|||||++++ .|.+.. +||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3577888999999999999976 46789999887543 234466889999999999999999999 444333 799
Q ss_pred EEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 528 YEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKP-KPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~-~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
||||.+|+|...+... .....+++..+++++.|++.||.++|+.-+ ..|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998763 334569999999999999999999999432 23999999999999999999999999999998
Q ss_pred CCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh-C
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-A 684 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~-~ 684 (810)
.....+ ....+|||.||+||.+....|+++|||||+||++|||+.-++||...+... +...+... .
T Consensus 179 ~s~~tf------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~ 245 (375)
T KOG0591|consen 179 SSKTTF------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDY 245 (375)
T ss_pred cchhHH------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCC
Confidence 765432 345699999999999999999999999999999999999999997553221 22222221 1
Q ss_pred CCCC-hhHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 685 GDWP-IKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 685 ~~~p-~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
+..| ..++..+..||..|+..||..||+....|.+
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 2234 6789999999999999999999997543333
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=364.19 Aligned_cols=240 Identities=27% Similarity=0.318 Sum_probs=203.5
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
..+|...+.||+|+||.||.++.. ++.+|+|++++..... ......|..||..++||+||.|+..|++.. |||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999876 4599999998764433 456789999999999999999999998766 999
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
++|+.||.|...|.+.+. +++..+.-++.+|+.||.|||+.+ ||||||||+|||||..|+++|+|||+|+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987664 889999999999999999999999 99999999999999999999999999986443
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... ....++||+.|||||++.+..|+..+|+|||||++|+|+||.+||...+.... ...++.......
T Consensus 178 ~~~------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 178 DGD------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILKGKLPLP 245 (357)
T ss_pred CCC------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhcCcCCCC
Confidence 322 12346999999999999999999999999999999999999999975543221 122222223444
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
|.-.+.+..+|+.++|..||++|-.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcC
Confidence 5557899999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=364.73 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=195.4
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc-------hHHHHHHHHHHHhcCCCceeeeeceecCCC-
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGACPDHG- 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 524 (810)
.+.|...+.||+|+||.|-+|..+ +..||||++++..... ...+.+|++||++|+|||||+++++|.+..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 446778899999999999999876 4599999998653222 233579999999999999999999996544
Q ss_pred -eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC---CceEEeeec
Q 003576 525 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVG 600 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~---~~~kL~DFG 600 (810)
|+||||++||.|.+.+..++. +.+.....++.|++.||.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 899999999999999977654 667777889999999999999999 9999999999999765 889999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCccccccCCC---CCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhH
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI---SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 677 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~ 677 (810)
+|+..... . .+...+||+.|.|||++.++.+ ..+.||||+||+||-+|+|.+||....... ....
T Consensus 325 lAK~~g~~-s------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----sl~e 392 (475)
T KOG0615|consen 325 LAKVSGEG-S------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----SLKE 392 (475)
T ss_pred hhhccccc-e------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----cHHH
Confidence 99987632 2 2345699999999999876653 347899999999999999999996332111 0111
Q ss_pred HHhhhhCCCCC---hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 678 EILDAQAGDWP---IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 678 ~~ld~~~~~~p---~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
++........| ...+.+..+||.+||..||++||++.+.+
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 22222211122 35688999999999999999999998643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=371.15 Aligned_cols=247 Identities=28% Similarity=0.355 Sum_probs=209.3
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc---hHHHHHHHHHHHhc-CCCceeeeeceecCCC--eE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~l 526 (810)
.++|...+.||.|+|++||+|+.. ++.||||++.+..... .+-+..|-++|.+| .||.|++||..|.|.. |+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 346788889999999999999986 4599999998764332 23467899999999 7999999999998876 99
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
|+||+++|+|.++|.+.+. |++.....++.+|+.||+|||++| ||||||||+|||||.+|++||+|||.|+.++
T Consensus 152 vLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999987754 888899999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCc-------ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHH
Q 003576 607 SDPSF-------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 607 ~~~~~-------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
..... .........++||..|.+||++..+..++.+|||+||||||+|+.|.|||...+... .+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iFqk- 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IFQK- 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HHHH-
Confidence 54322 112222366899999999999999999999999999999999999999996554322 2222
Q ss_pred hhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 680 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 680 ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
+......+|...++.+.+|+.+.|..||.+|++..
T Consensus 299 I~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 299 IQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred HHHhcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 33344678888889999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.58 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=207.2
Q ss_pred ccceeeccCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 459 SENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 459 ~~~~~LG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
...+.||+|-||.||.|.++++ .||+|.++.. ....+.|.+|+.+|++|+|+|||+|+|+|.... |||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3456799999999999999876 9999999875 345678999999999999999999999997755 99999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|.++|... ....+...+.+.++.|||+|++||++++ +|||||-..||||+++..+||+|||+|+.+.++...
T Consensus 288 Ll~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~---- 359 (468)
T KOG0197|consen 288 LLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT---- 359 (468)
T ss_pred HHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee----
Confidence 99999873 2345888899999999999999999999 999999999999999999999999999955443211
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......-...|.|||.+..+.++.+||||||||+||||+| |+.||......+ .+..+-...+...|..++..
T Consensus 360 -~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 360 -ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred -ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhccCcCCCCCCCCHH
Confidence 1223344667999999999999999999999999999999 888886443322 12222223356678899999
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
+.+|+..||+.+|++|||+. .+...|+.+
T Consensus 433 vY~lM~~CW~~~P~~RPtF~-~L~~~l~~~ 461 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFE-TLREVLEDF 461 (468)
T ss_pred HHHHHHHHhhCCcccCCCHH-HHHHHHHHh
Confidence 99999999999999999998 455555544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=356.27 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=203.4
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
..++|.....||+|+||.||+|+-+ +..+|+|++++..... ...+..|-.+|...++|+||+||..|++.. ||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4567888899999999999999876 4599999998865443 355788999999999999999999998766 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||++||++..+|.+.+ .|++..+..++.+++.|+..||+.| ||||||||+|+|||..|++||+|||||.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998765 4999999999999999999999999 9999999999999999999999999996543
Q ss_pred CCC---------------------Cccc--cc------------------ccccCCccCccccCccccccCCCCCcchhh
Q 003576 607 SDP---------------------SFVS--TT------------------YKNTGPVGTLCYIDPEYQRTGLISPKSDVY 645 (810)
Q Consensus 607 ~~~---------------------~~~~--~~------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVw 645 (810)
... .... +. ......+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 210 0000 00 001135899999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCc
Q 003576 646 AYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 646 SlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
|||||+||||.|.|||......++.-..-.+...+... .....+.+..+||.+||. ||.+|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP---~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP---EEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC---CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999998776665544433333333221 122456899999999999 9999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=335.00 Aligned_cols=233 Identities=26% Similarity=0.367 Sum_probs=203.0
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
.+|+....||.|+||.|.+++.+ +..+|+|++.+..... .+...+|..+|+.+.||++++|++.|.+.. |+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888889999999999999886 4599999998765433 345678999999999999999999998776 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||++||.|..+|.+.+. +++..+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999977553 899999999999999999999999 999999999999999999999999999987753
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
....+|||.|+|||++....++.++|+|||||++|||+.|.+||...+.... ...++. ....+|
T Consensus 198 ---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~~-~~v~fP 261 (355)
T KOG0616|consen 198 ---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKILE-GKVKFP 261 (355)
T ss_pred ---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHHh-CcccCC
Confidence 2345999999999999999999999999999999999999999986654322 223332 334678
Q ss_pred hhHHHHHHHHHHHHhhhcCCCC
Q 003576 689 IKETKELAALGLSCAELRRKDR 710 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~R 710 (810)
...+..+.+|+.+.|+.|-..|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 8889999999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=353.94 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=203.3
Q ss_pred hcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeece--ecCC--CeEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA--CPDH--GCLVY 528 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~--~~lV~ 528 (810)
..+|...+.||+|+||.||++.... ...|||..........+.+.+|+.+|++++|||||+++|. ..+. .++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457778889999999999999874 7999998876543335668999999999999999999996 3443 47999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-CCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-~~~~kL~DFGla~~~~~ 607 (810)
||+++|+|.+++.+.+. .+++..+.++..||+.||.|||++| ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987765 5999999999999999999999999 999999999999999 79999999999987764
Q ss_pred CCCcccccccccCCccCccccCccccccCC-CCCcchhhhHHHHHHHHHhCCCCcccc-chhhhhhccchhHHHhhhhCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAIT-HKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDVwSlGvil~eLltg~~Pf~~~-~~~~~~~~~~~l~~~ld~~~~ 685 (810)
.. ..........||+.|||||++..+. ..+++|||||||+++||+||++||... ..... .+........+
T Consensus 171 ~~---~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~-----~~~ig~~~~~P 242 (313)
T KOG0198|consen 171 KG---TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA-----LLLIGREDSLP 242 (313)
T ss_pred cc---ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH-----HHHHhccCCCC
Confidence 11 1111233568999999999988543 346999999999999999999999642 11111 11111122245
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchh
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~ 718 (810)
.+|...+.+..+++.+|+..+|..|||+.+.+.
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 778889999999999999999999999996443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.88 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=208.6
Q ss_pred cCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|-....||+|+||+||||+.+.+ .||+|.+.+.... ..+.+.+|++|++.++|||||.++++|.... ++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 3566667899999999999998765 8999998765433 3456899999999999999999999997665 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+.| +|..+|...+. +++..+..|+.+++.||.|||+++ |+|||+||.||||+.+|.+|+||||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 99999977654 999999999999999999999999 9999999999999999999999999999876532
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
...+...|||.|||||+..+++|+..+|+||+|||+|||++|+|||..... ..+.+.+-.....||.
T Consensus 155 ------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 ------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILKDPVKPPS 221 (808)
T ss_pred ------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhcCCCCCcc
Confidence 244567999999999999999999999999999999999999999963321 2233444444567889
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+..+..|+...|..||..|.++.+.+
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 9999999999999999999999998644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.64 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=197.7
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
.|+...++|+|+||.||+++++. ..||||++..... .-.+-.++|+.+|++|+|||+|.|+.+|.... +||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46677789999999999999874 5999999875432 33455789999999999999999999997655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
|+..-| +.|.+..+ .++...+.++++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 83 ~dhTvL-~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVL-HELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHH-HHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 986544 44655443 3888999999999999999999999 99999999999999999999999999999874322
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc-h-------hHHHhh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-N-------LAEILD 681 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~-~-------l~~~ld 681 (810)
. .+..+.|.+|.|||.+.+ ..|++..||||+||++.||+||.+-|....+++..+... . ...++.
T Consensus 157 -~-----YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 -N-----YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred -h-----hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 1 244588999999998877 689999999999999999999999998777666543211 1 111111
Q ss_pred hhC-------CCC---------ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 682 AQA-------GDW---------PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 682 ~~~-------~~~---------p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
... +.. -+..+.-+.+|+..||++||.+|++-.+.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 110 000 013456789999999999999999988544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.34 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=205.1
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceec--CCCeEEEEecc
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYME 532 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~ 532 (810)
.|....+||+|+.|.||.+... +..||||.+........+-+.+|+.+|+..+|+|||.++..|. +..++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3555668999999999999875 4589999998877777778899999999999999999999874 44589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
||+|.|.+.... +++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999886543 889999999999999999999999 99999999999999999999999999988775543
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC--CCCChh
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIK 690 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~ 690 (810)
++...+||++|||||+.....|+++.||||||++++||+-|.|||........ +..+.+... ...+..
T Consensus 425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPKLKNPEK 494 (550)
T ss_pred ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcCCCCcCCccc
Confidence 44567999999999999999999999999999999999999999964332221 111112111 234567
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.++.|.+|+.+||+.|+.+||++.+++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL 521 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELL 521 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHh
Confidence 899999999999999999999999643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=353.78 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=202.5
Q ss_pred hcCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCC--
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH-- 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~-- 523 (810)
.++|...++||+|+||.||+|.+. +..||||++..... .....+.+|+.+|..+ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457888999999999999999752 24799999875432 2345689999999999 899999999988643
Q ss_pred -CeEEEEeccCCCHHHHHhhcCC---------------------------------------------------------
Q 003576 524 -GCLVYEYMENGSLEDRLYRKNN--------------------------------------------------------- 545 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 545 (810)
.++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 3789999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCcc
Q 003576 546 --TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623 (810)
Q Consensus 546 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~g 623 (810)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....... ......+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~----~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchh----cccCCCC
Confidence 134788899999999999999999998 9999999999999999999999999998654332111 1122356
Q ss_pred CccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHH
Q 003576 624 TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 702 (810)
Q Consensus 624 t~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~c 702 (810)
+..|+|||++.+..++.++|||||||+||||++ |.+||........ ....+.+......|...++.+.+|+.+|
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~c 313 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMRAPENATPEIYRIMLAC 313 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 788999999988899999999999999999997 9999964322111 1111112222233456678899999999
Q ss_pred hhhcCCCCCccccchhhHHHHHH
Q 003576 703 AELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 703 l~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
|+.||.+||++. +++..|+.+.
T Consensus 314 l~~dp~~RPs~~-el~~~l~~~~ 335 (338)
T cd05102 314 WQGDPKERPTFS-ALVEILGDLL 335 (338)
T ss_pred ccCChhhCcCHH-HHHHHHHHHH
Confidence 999999999998 5777777653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.84 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=204.4
Q ss_pred ccCCHHHHHHhhcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeeecee
Q 003576 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGAC 520 (810)
Q Consensus 444 ~~~~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~ 520 (810)
+.++.++| +......||+|++|.||+|.+++..||||.+....... .+.|.+|+.+|.+++||||++++|+|
T Consensus 13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred eecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 34455554 33334679999999999999999999999987653332 36678999999999999999999998
Q ss_pred cC------CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCceEecCCCc
Q 003576 521 PD------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 521 ~~------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLkp~NILld~~~~ 593 (810)
.+ ..++||||+++|+|.+++.... .+++.....++.+++.||.|||+. + ++||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYK 161 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCc
Confidence 65 2379999999999999987543 488999999999999999999985 6 889999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 671 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~ 671 (810)
+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|+|+||+.||.......
T Consensus 162 ~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--- 229 (283)
T PHA02988 162 LKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--- 229 (283)
T ss_pred EEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---
Confidence 9999999998654321 12368899999999876 678999999999999999999999996432211
Q ss_pred ccchhHHHhhh-hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 672 DEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 672 ~~~~l~~~ld~-~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
....++.. .....|...+..+.+|+.+||+.||.+||++. +++..|+.+.
T Consensus 230 ---~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~~l~~~~ 280 (283)
T PHA02988 230 ---IYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK-EILYNLSLYK 280 (283)
T ss_pred ---HHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHH
Confidence 11111111 12234446788999999999999999999999 5777777664
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=351.18 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=203.3
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc----Cc-cchHHHHHHHHHHHhcC-CCceeeeeceecCCC
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK----GN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG 524 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~----~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~ 524 (810)
.....|...+.||+|+||.||.|.+. +..||+|++... .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568899999999999999999875 569999977654 22 23456778999999999 999999999985544
Q ss_pred --eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeecc
Q 003576 525 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGL 601 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGl 601 (810)
++||||+.||+|.+++...+ ++.+..+..++.|++.|+.|||++| |+||||||+|||+|.+ +.+||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 89999999999999998733 4888999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCC-CC-CcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHH
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-IS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
+........ .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....... +...
T Consensus 168 s~~~~~~~~------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~k 234 (370)
T KOG0583|consen 168 SAISPGEDG------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRK 234 (370)
T ss_pred ccccCCCCC------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHH
Confidence 998742111 223469999999999998866 64 88999999999999999999997532221 1222
Q ss_pred hhhhCCCCChhH-HHHHHHHHHHHhhhcCCCCCccccch
Q 003576 680 LDAQAGDWPIKE-TKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 680 ld~~~~~~p~~~-~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+......+|... ++++..|+.+||..||..|+++.+++
T Consensus 235 i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 333344566666 99999999999999999999998533
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.85 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=197.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC----CeEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV 527 (810)
..|+...+||+|.||.||+|++. +..||+|.+..+. .....-..+||.||++|+||||++|.+...+. .|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 35666778999999999999986 4579999988765 23334567999999999999999999998655 2899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+|||+. +|..++....- .|++.++..++.||+.||+|||..| |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999985 88887765432 4899999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchh--------HH
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--------AE 678 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l--------~~ 678 (810)
.... ..+..+-|.+|.|||++.+ ..|+++.|+||.||||.||++|++.|.....+++.-....+ +.
T Consensus 271 ~~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 271 SGSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 5432 2456689999999997765 46999999999999999999999999876655543211100 00
Q ss_pred Hhhhh-----C--CCCC-------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 679 ILDAQ-----A--GDWP-------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 679 ~ld~~-----~--~~~p-------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+-. . ..+. ...+....+|+..+|.+||.+|.|+.+.+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 00000 0 0000 12356778999999999999999998543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.47 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=203.4
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcC-CCceeeeeceecCCC---eEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIR-HPHLLLLLGACPDHG---CLV 527 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~---~lV 527 (810)
.+.|...++||.|.||.||+|+.. +..||||.++..... ..-.-++|+..|++|+ |||||+|..++.|.. ++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 356888889999999999999875 558999988765432 2223478999999999 999999999997665 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||||+ .+|..++..+ ...+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+|+.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99996 7999988766 456999999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCcccccccccCCccCccccCccc-cccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc-------------
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEY-QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------------- 673 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~-~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~------------- 673 (810)
... .+..+.|.+|.|||+ ++.+.|+.+.|||++|||++|+.+-+|-|.+.+.++..+..
T Consensus 163 kpP-------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPP-------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCC-------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 543 245688999999995 46788999999999999999999999999877665544321
Q ss_pred --chhHHHhhhhCCCC--------ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 --DNLAEILDAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 --~~l~~~ld~~~~~~--------p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+...+....+.. -...+.++.+|+.+||..||.+||++.+.+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 12222222221111 123678999999999999999999999633
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.20 Aligned_cols=240 Identities=23% Similarity=0.299 Sum_probs=202.5
Q ss_pred hhcCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCccc---hHHHHHHHHHHHhcC-CCceeeeeceecCCC--e
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ---NKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 525 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~---~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~ 525 (810)
...+|.....||+|+||+|+++..+++ .+|||++++..... .+..+.|..|+.... ||.++.|+++|+... |
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 456899999999999999999998754 99999999875443 455678999988875 999999999996554 9
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||||+.||++..+.+ ...+++..+.-++..|+.||.|||++| |||||||.+|||||.+|++||+|||+|+..
T Consensus 446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999544332 234899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
-.... ....++|||.|||||++.+..|+.++|+|||||+|||||.|.+||...+. +.+.+.+-....
T Consensus 519 m~~g~------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------ee~FdsI~~d~~ 585 (694)
T KOG0694|consen 519 MGQGD------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------EEVFDSIVNDEV 585 (694)
T ss_pred CCCCC------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCC
Confidence 42222 23467999999999999999999999999999999999999999965432 223333333445
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCcc
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
.+|...+.+...|+.++|..+|.+|-..
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 6888999999999999999999999887
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=314.85 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=207.5
Q ss_pred hcCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
.++|+..+.||+|.||.||.|+.+.+ .||+|++.+.. .....++.+|++|-+.|+||||+++|++|.|.. ||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45789999999999999999998754 89999987643 223467899999999999999999999998876 999
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+||..+|+|...|..... ..+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||.+..-+.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999975433 34888889999999999999999999 99999999999999999999999999976542
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
+ ++...+||..|.+||...+..++...|+|++|++.||++.|.+||..... +....-+......+
T Consensus 177 ~--------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------~etYkrI~k~~~~~ 241 (281)
T KOG0580|consen 177 N--------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------SETYKRIRKVDLKF 241 (281)
T ss_pred C--------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------HHHHHHHHHccccC
Confidence 2 34567999999999999999999999999999999999999999964331 22233333444566
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
|...+...++||.+|+..+|.+|..+.++
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHH
Confidence 78889999999999999999999998853
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=350.51 Aligned_cols=248 Identities=32% Similarity=0.477 Sum_probs=196.9
Q ss_pred hcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEec
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYM 531 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~ 531 (810)
...+.....||+|.||+||+|.|.| .||||+++.... ...+.|.+|+.+|++-+|.||+-++|+|.... .||..+|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwC 469 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWC 469 (678)
T ss_pred HHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhc
Confidence 3445566789999999999999987 599999987643 34577999999999999999999999997655 7899999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
+|.+|..+|+-.. ..|.....+.|+.||++|+.|||.++ |||||||..||||.+++.|||+|||++.....-
T Consensus 470 eGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w--- 541 (678)
T KOG0193|consen 470 EGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW--- 541 (678)
T ss_pred cCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee---
Confidence 9999999997654 34888899999999999999999999 999999999999999999999999998654321
Q ss_pred ccccccccCCccCccccCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-ccchhHHHhhhhCCCC
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-DEDNLAEILDAQAGDW 687 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~-~~~~l~~~ld~~~~~~ 687 (810)
..........|...|||||+++. .+|++.+|||||||++|||+||..||.+. ..+..+ ..+.- .+.+.....
T Consensus 542 -~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGrG--~l~pd~s~~ 617 (678)
T KOG0193|consen 542 -SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGRG--YLMPDLSKI 617 (678)
T ss_pred -ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEeccc--ccCccchhh
Confidence 11112234578999999997753 46899999999999999999999999733 222211 11110 011111122
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...++.++.+|+..||..++++||.+.+
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~ 645 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQ 645 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHH
Confidence 3356779999999999999999999995
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.94 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=195.1
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--------------chHHHHHHHHHHHhcCCCceeeee
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--------------QNKQFLQELEVLSKIRHPHLLLLL 517 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--------------~~~~~~~Ei~iL~~l~HpnIv~l~ 517 (810)
..++|.....||+|.||.|-+|... ++.||||++.+.... ..+...+||.||++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3567888899999999999999874 679999998754211 125788999999999999999999
Q ss_pred ceecCC----CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 518 GACPDH----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 518 g~~~~~----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
.+..+. .|||+|||..|.+... ....+.+++.++++|+.+++.||+|||.+| ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 997543 3999999998877542 233334899999999999999999999999 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCccccccCC----CCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVET 669 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~ 669 (810)
+||+|||.+............ ......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d-~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSD-DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred EEeeccceeeecccCCccccH-HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 999999999877543221111 1122369999999999776633 35788999999999999999999964433222
Q ss_pred hhccchhHHHhhhhCCCCCh--hHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 670 AIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 670 ~~~~~~l~~~ld~~~~~~p~--~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+..++.. ...+|. +..+.+.+||.++|++||..|.++.++
T Consensus 328 ------~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 328 ------FDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred ------HHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 1222222 122332 468899999999999999999998853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.26 Aligned_cols=239 Identities=25% Similarity=0.354 Sum_probs=205.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
.-|...+.||.|+.|.|-+|++. |..+|||++.+.. ......+.+|+-||+.+.|||+++||+++.++. |||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34777888999999999999985 5699999997653 223456889999999999999999999997765 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||++||-|.++|..++. +++.++.++++||+.|+.|+|..+ |+||||||+|+|||..+.+||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999988764 899999999999999999999999 999999999999999999999999999875544
Q ss_pred CCcccccccccCCccCccccCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh---hhC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD---AQA 684 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld---~~~ 684 (810)
.- ....||.+.|.+||++.+.+| +.++||||.|||||.||||+.||+. +++..++. ...
T Consensus 166 kl-------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----------dNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 166 KL-------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----------DNIRVLLLKVQRGV 228 (786)
T ss_pred cc-------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----------ccHHHHHHHHHcCc
Confidence 32 233489999999999999887 5899999999999999999999962 23333333 334
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...|...+.++++|+.+|+..||..|.++.+++
T Consensus 229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred ccCCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 567888999999999999999999999999644
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=329.97 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=203.8
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
....|.....||.|..++||+|+.. +..||||++....... .+.+.+|+..|+.++||||++++..|.... ++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 4567888999999999999999874 6799999998664433 477899999999999999999999985544 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
.||.+||+.+++...-.. .+++..+..|+++++.||.|||.+| .||||||+.||||+.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999875443 3999999999999999999999999 999999999999999999999999998766654
Q ss_pred CCcccccccccCCccCccccCccccc--cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC--
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQR--TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 684 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~-- 684 (810)
... ..+....+.||++|||||++. ...|+.|+|||||||+..||.+|..||......+..+ ..+....
T Consensus 180 G~R--~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tLqn~pp~ 251 (516)
T KOG0582|consen 180 GDR--QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTLQNDPPT 251 (516)
T ss_pred Cce--eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHhcCCCCC
Confidence 422 222226679999999999743 3568999999999999999999999997554433221 1111100
Q ss_pred -------CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 685 -------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 685 -------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+.....+..+.+++..||..||.+||++.+.+
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 011124567899999999999999999998644
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=335.35 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+|...+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+|.+++|+||++++++|.+.. ++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4677889999999999999874 66999998865432 22345788999999999999999999986554 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988765432 35899999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||........ ...+...+......++.
T Consensus 157 ~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 157 T-------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQEEYSE 226 (285)
T ss_pred e-------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccccCCc
Confidence 1 1234789999999999999999999999999999999999999974332110 01111111122234555
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+..+.+|+.+||..||.+||+..
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 6788999999999999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=337.66 Aligned_cols=234 Identities=24% Similarity=0.308 Sum_probs=196.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+|.....||+|+||.||+|... +..||+|++.... ......+.+|+.+|+.++||||+++++++.+.. ++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888899999999999999986 6689999986532 123456889999999999999999999987665 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999999987543 4888999999999999999999999 9999999999999999999999999998654321
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... +...+......+|.
T Consensus 156 ---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~~~~ 219 (291)
T cd05612 156 ---------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKLEFPR 219 (291)
T ss_pred ---------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcCCCc
Confidence 23478999999999998889999999999999999999999996443211 11112222344566
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCc
Q 003576 690 KETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
..+..+.+|+.+||+.||.+||+
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccC
Confidence 67889999999999999999997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=342.43 Aligned_cols=236 Identities=22% Similarity=0.312 Sum_probs=196.9
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
.+|...+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|++++||||+++++++.+.. |+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 4689999987542 223456889999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987643 4788899999999999999999999 999999999999999999999999999876432
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
. ....||+.|+|||++.+..++.++|||||||++|+|+||++||........ ...+. .....+|
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~-~~~~~~p 235 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YEKIL-AGRLKFP 235 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HHHHh-cCCcCCC
Confidence 1 124799999999999988899999999999999999999999964432211 11111 2223445
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCcc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
...+..+.+|+.+||+.||.+||+.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 5577889999999999999999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.16 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=196.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC------------------CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeee
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH------------------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLL 516 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~------------------~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l 516 (810)
+.|...++||+|+||.||+|.+. +..||+|++..... .....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46788889999999999999753 23699999876532 234578999999999999999999
Q ss_pred eceecCCC--eEEEEeccCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEe
Q 003576 517 LGACPDHG--CLVYEYMENGSLEDRLYRKN----------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578 (810)
Q Consensus 517 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH 578 (810)
+++|.+.. ++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99986544 89999999999999886532 1134788899999999999999999998 999
Q ss_pred cCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh--
Q 003576 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-- 656 (810)
Q Consensus 579 rDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-- 656 (810)
|||||+|||++.++.+||+|||+++.+...... .......++..|+|||++..+.++.++|||||||++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999865433211 11123356788999999988889999999999999999987
Q ss_pred CCCCccccchhhhhhccchhHHHhhh----hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 657 AKPAIAITHKVETAIDEDNLAEILDA----QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 657 g~~Pf~~~~~~~~~~~~~~l~~~ld~----~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
+..||.......... .....+.. .....+..++..+.+|+.+||..+|.+||++.+ |...|+
T Consensus 238 ~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~-i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIE---NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD-IHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHH---HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH-HHHHHh
Confidence 556775432211110 01111111 011224456788999999999999999999984 555543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=341.82 Aligned_cols=231 Identities=26% Similarity=0.312 Sum_probs=190.6
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||++... +..||+|++.... ......+.+|+.+|.+++||||++++++|.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999875 5689999987542 223356788999999999999999999986655 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 82 LFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-----
Confidence 999886543 4889999999999999999999999 99999999999999999999999999875332211
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 695 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+......+|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-------HHHHHHHcCCCCCCCCCCHHH
Confidence 123457999999999999889999999999999999999999999643221 112222222344566778999
Q ss_pred HHHHHHHhhhcCCCCCc
Q 003576 696 AALGLSCAELRRKDRPD 712 (810)
Q Consensus 696 ~~Li~~cl~~dP~~RPs 712 (810)
.+|+.+||..||.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 223 KSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHccCCHHHcCC
Confidence 99999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.65 Aligned_cols=235 Identities=26% Similarity=0.431 Sum_probs=195.9
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHHHH
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDR 539 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~ 539 (810)
..||.|+.|.||+|++++..||||+++.-. ..+|.-|++|+||||+.|.|+|.... |||||||..|.|..+
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 459999999999999999999999765321 24677899999999999999998766 799999999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccccccc
Q 003576 540 LYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619 (810)
Q Consensus 540 l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 619 (810)
|.... ++.......|..+||.|+.|||.++ |||||||.-||||..+..+||+|||.++...... .+-
T Consensus 203 Lka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------TkM 269 (904)
T KOG4721|consen 203 LKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------TKM 269 (904)
T ss_pred HhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------hhh
Confidence 97544 3666788899999999999999999 9999999999999999999999999998776432 234
Q ss_pred CCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHH
Q 003576 620 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 699 (810)
Q Consensus 620 ~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li 699 (810)
.++||..|||||++...+.+.|+|||||||+|||||||..||.........+.-+. .. .....|..++..|.-|+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--Ns---L~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NS---LHLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--Cc---ccccCcccCchHHHHHH
Confidence 67999999999999999999999999999999999999999964433222211111 00 11345778889999999
Q ss_pred HHHhhhcCCCCCccccchhhHHH
Q 003576 700 LSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 700 ~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
..||.-.|..||++++ ++.-|+
T Consensus 345 Kqcw~sKpRNRPSFrq-il~Hld 366 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQ-ILLHLD 366 (904)
T ss_pred HHHHhcCCCCCccHHH-HHHHHh
Confidence 9999999999999995 444443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=357.48 Aligned_cols=257 Identities=27% Similarity=0.480 Sum_probs=211.9
Q ss_pred CcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
+......||+|.||.||+|... .+.||||.++..... ...+|++|+++|..|+|||||+|+|+|.++. |+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3444567999999999999864 348999999987665 7789999999999999999999999997665 99
Q ss_pred EEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceE
Q 003576 527 VYEYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 595 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~k 595 (810)
|+|||..|+|..+|..... .++++..+.+.|+.|||.|+.||-++. +|||||-..|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999975321 234888999999999999999999999 99999999999999999999
Q ss_pred EeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccc
Q 003576 596 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDED 674 (810)
Q Consensus 596 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~ 674 (810)
|+|||+++.+-..+.+. ......-...|||||.+..++||.+||||||||+|||+++ |+.||.....- +
T Consensus 644 IsDfGLsRdiYssDYYk----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------E 713 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYK----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------E 713 (774)
T ss_pred ecccccchhhhhhhhhc----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------H
Confidence 99999998765433211 1112345678999999999999999999999999999998 88898644322 2
Q ss_pred hhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHh
Q 003576 675 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 675 ~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~ 727 (810)
-+..+-.......|..++.++.+|+..||+.+|++||+++ +|...|+.+...
T Consensus 714 VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~-eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFK-EIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHHHHHhc
Confidence 2233333444667889999999999999999999999999 577777766443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.90 Aligned_cols=232 Identities=24% Similarity=0.293 Sum_probs=190.6
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|.+++||||++++++|.+.. ++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999986 4589999986532 233456788999999999999999999986654 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------
Confidence 99987643 4889999999999999999999998 99999999999999999999999999976432211
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 696 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 696 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..++ .....+|...+..+.
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~-~~~~~~~~~~~~~~~ 221 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKIL-QEPLRFPDGFDRDAK 221 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHH-cCCCCCCCcCCHHHH
Confidence 1234579999999999998899999999999999999999999996432211 111111 222345666788999
Q ss_pred HHHHHHhhhcCCCCCccc
Q 003576 697 ALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 697 ~Li~~cl~~dP~~RPs~~ 714 (810)
+|+.+||..||.+||++.
T Consensus 222 ~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHcCCCHHHcCCCC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=336.54 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=202.8
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
..|....+||+|+||.||+|.+.. ..||+|++..... ...+++++|+.+|.+++++||.++||.+..+. +++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356667789999999999999874 4899999986643 34578999999999999999999999986555 789999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
|.||++.+.|.... .+.+..+.-|+.+++.||.|||..+ .+|||||+.||||..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999886543 3477788889999999999999999 9999999999999999999999999998776543
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh-CCCCCh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 689 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 689 (810)
.+...++||+.|||||++....|+.++||||||++.+||++|.||+...+.+...+ ++... .+....
T Consensus 166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIPKSAPPRLDG 233 (467)
T ss_pred -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------eccCCCCCcccc
Confidence 23356799999999999998899999999999999999999999997655532211 11111 122333
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..++.+++|+..||..||+.||++.+.+
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 6688999999999999999999999644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=306.58 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=196.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
.|...++||+|.||.||+|++. ++.||||.++..... -.....+|+..|+.++||||+.|+++|.... .||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4666778999999999999986 559999998765322 2345789999999999999999999997655 789999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
|+ .+|+..+.... ..++..++..++.+++.||+|||.+. |+||||||.|+|++.+|.+||+|||+++.+.....
T Consensus 83 m~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 97 69999886554 35888899999999999999999999 99999999999999999999999999999875442
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc---------------
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------------- 674 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--------------- 674 (810)
.. +..+-|..|.|||.+.+ ..|+...|+||.|||+.||+-|.|-|.+.+++++....-
T Consensus 157 ~~------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 IQ------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cc------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 21 22378999999997655 569999999999999999999999887666555431110
Q ss_pred hhHHHhhhhC------CCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 675 NLAEILDAQA------GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 675 ~l~~~ld~~~------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.+.+...... ...-...+.++.+|+.+++.+||.+|+++.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 0000011000 0011234677899999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=342.80 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=199.9
Q ss_pred hcCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC-
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 524 (810)
.++|...++||+|+||.||+|++. +..||||+++... ....+.+.+|+.+|..+ +||||++++++|.+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 447888999999999999999742 3489999987543 23345688999999999 8999999999997655
Q ss_pred -eEEEEeccCCCHHHHHhhcCC----------------------------------------------------------
Q 003576 525 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 545 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 545 (810)
++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 899999999999998865321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 546 --------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 546 --------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CCCCCh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 689 (810)
. ......++..|+|||++.+..++.++|||||||++|+|++ |.+||....... .+...+... ....|.
T Consensus 271 ~----~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 271 V----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRMLSPE 340 (375)
T ss_pred c----ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCCCCC
Confidence 1 1122345678999999999999999999999999999998 889986432111 111222211 122334
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
..+.++.+|+.+||..||.+||++. .|+..|+.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~-eil~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFK-QIVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHh
Confidence 4567899999999999999999999 46666654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=337.50 Aligned_cols=231 Identities=26% Similarity=0.309 Sum_probs=189.4
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||++... +..||+|++.... ......+.+|+.+|+.++||||++++++|.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5999999999999875 5689999987542 223345778999999999999999999986555 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 82 LFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 998886543 4889999999999999999999998 99999999999999999999999999875332211
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 695 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......+|...++.+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCCCCCCCHHH
Confidence 122357999999999999899999999999999999999999999643221 111112222234566778999
Q ss_pred HHHHHHHhhhcCCCCCc
Q 003576 696 AALGLSCAELRRKDRPD 712 (810)
Q Consensus 696 ~~Li~~cl~~dP~~RPs 712 (810)
.+|+.+||..||.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 223 KSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHccCCHHHhCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=325.40 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=199.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC-----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||.||+|.+. +..||+|.++.... .....|.+|+.+|.+++||||++++|++.... ++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999764 35899999876533 23456889999999999999999999986544 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 35899999999999999999999998 99999999999999999999999998765432
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
... +......++..|+|||.+.+..++.++|||||||++|+|++ |.+||....... .+..+.+.....
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 228 (266)
T cd05064 160 EAI-----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAVEDGFRLP 228 (266)
T ss_pred cch-----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCC
Confidence 111 11122345678999999998999999999999999999775 999996432211 111111111223
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.|..++..+.+++.+||+.+|.+||++. .+...|.++
T Consensus 229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~-~i~~~l~~~ 265 (266)
T cd05064 229 APRNCPNLLHQLMLDCWQKERGERPRFS-QIHSILSKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCCCHH-HHHHHHHhh
Confidence 4556778899999999999999999998 566666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.52 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=210.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCCC---eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG---CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~---~lV~ 528 (810)
.+|...+.+|+|+||.++.++++ ...+++|.+...... .+....+|+.++++++|||||.+++.|.+.. ||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46788889999999999988765 568999988765433 3345789999999999999999999997665 7899
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
+||+||+|.+.|.+.. ..-+++..++.|+.|++.|+.|||++. |+|||||+.|||++.++.+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 345899999999999999999999888 999999999999999999999999999998865
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
... .....||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+... -..++........|
T Consensus 160 ~~~------a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 160 DSL------ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGLYSPLP 227 (426)
T ss_pred hhh------hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhccCCCCC
Confidence 432 234599999999999999999999999999999999999999996544322 12233333345677
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
..++.++..|+..|+..+|..||++.+++..
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 8899999999999999999999999975544
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.57 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=197.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|....+||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|..++||||+++++++.+.. |+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999985 5689999987542 223456889999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999986543 4888999999999999999999999 99999999999999999999999999976543
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC-CCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~~ 687 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||......+...........+.... ...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcc
Confidence 12245799999999999988999999999999999999999999975432221110000000011000 000
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
....+..+.+|+.+||..+|.+||++.+++
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 124578899999999999999999988533
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.79 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=200.9
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccch---HHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
...|++.+.||+|.||.|-++..+ ++.||||.++++...+. -.+.+|++||+.|+||||+.+|.+|.+.. .||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 346788889999999999999864 67999999987654443 35789999999999999999999997665 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||..+|.|.|++...+. |++.++.++++||.+|+.|+|.++ ++|||||.+|||||.|+.+||+|||++.++..
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999987664 999999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCcccccccccCCccCccccCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
.. ..+.++|++.|.+||++.+.+| ++..|-|||||+||.|+.|.-||+..+. ..+..-+.....
T Consensus 206 ~k-------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaY- 270 (668)
T KOG0611|consen 206 KK-------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAY- 270 (668)
T ss_pred cc-------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccc-
Confidence 43 1245699999999999999887 5899999999999999999999975432 112222221111
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
..+..+....-||.+||-.||..|.++.+
T Consensus 271 rEP~~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 271 REPETPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred cCCCCCchHHHHHHHHHhcCcccchhHHH
Confidence 12234567788999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=342.37 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=201.5
Q ss_pred hcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC-
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~- 524 (810)
.++|...+.||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+|+.+ +||||++++++|.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4578889999999999999988532 379999997543 22345688999999999 8999999999997655
Q ss_pred -eEEEEeccCCCHHHHHhhcCC----------------------------------------------------------
Q 003576 525 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 545 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 545 (810)
++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 899999999999998864211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 546 ---------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 546 ---------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
..++++..+.+|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~---- 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---- 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee----
Confidence 124788889999999999999999998 9999999999999999999999999998654332111
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CCCCChhHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKE 694 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~ 694 (810)
......++..|+|||++....++.++|||||||++|+|++ |+.||...... ..+...+... ....|...++.
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------SKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc------HHHHHHHHcccCccCCCCCCHH
Confidence 1122345678999999988899999999999999999997 99999643211 1111222211 12234445789
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
+.+++.+||+.||.+||++. .|++.|+.+
T Consensus 344 l~~li~~cl~~dp~~RPs~~-~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFS-QISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 99999999999999999999 577777665
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=336.76 Aligned_cols=231 Identities=25% Similarity=0.300 Sum_probs=189.8
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||++... +..||+|++.... ......+.+|+.+|+.++||||+++++++.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999875 5699999987542 223456788999999999999999999986554 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 82 LFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----
Confidence 998886543 4889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 695 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... +...+......+|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~~~p~~~~~~~ 222 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEDIKFPRTLSADA 222 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-------HHHHhccCCccCCCCCCHHH
Confidence 1223579999999999998899999999999999999999999996432211 11122222234566778899
Q ss_pred HHHHHHHhhhcCCCCCc
Q 003576 696 AALGLSCAELRRKDRPD 712 (810)
Q Consensus 696 ~~Li~~cl~~dP~~RPs 712 (810)
.+|+.+||..||.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 223 KSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHHHHHcCCCHHHcCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.90 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=201.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--Ce----EEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~----~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 527 (810)
.+|+..+.||+|+||.||+|.+. +. .||+|++.... ......+.+|+.+++.++||||++++|+|.... ++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46888899999999999999863 22 48999987543 334567889999999999999999999986554 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
++|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999987643 24888899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~ 685 (810)
.... .......++..|++||++.+..++.++|||||||++|+|+| |++||....... +..++.. ...
T Consensus 162 ~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~ 230 (316)
T cd05108 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL 230 (316)
T ss_pred CCcc----eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC
Confidence 3221 11122345778999999998999999999999999999998 999996432211 1122221 112
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
..+..++..+.+++.+||..+|.+||++.+ ++..|..+.
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-l~~~l~~~~ 269 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMA 269 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHH
Confidence 334456788999999999999999999994 555565554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=351.14 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=202.7
Q ss_pred CcccceeeccCCcEEEEEEEEC---CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.|.....||+|+||.||+|... +..|++|.+..........+.+|+.+|+.++||||++++++|.+.. ||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999864 4578888776555545566788999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 532 ENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 532 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+||+|.++|... ....++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23346889999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ..+..++.......|..
T Consensus 225 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~ 294 (478)
T PTZ00267 225 L----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYDPFPCP 294 (478)
T ss_pred c----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCcc
Confidence 1 1123457999999999999899999999999999999999999999643221 11222222222334556
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccchh
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v~ 718 (810)
.+..+.+|+.+||..||..||++.+++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 7789999999999999999999987553
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.24 Aligned_cols=234 Identities=26% Similarity=0.327 Sum_probs=190.3
Q ss_pred eeeccCCcEEEEEEEE-----CCeEEEEEEEcccC----ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 462 LRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~-----~~~~vavK~l~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
++||+|+||.||++.. .+..||+|++.... ......+.+|+.+|+.++||||++++++|.+.. |+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999975 35689999987532 223345788999999999999999999986655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999886543 3788888999999999999999998 99999999999999999999999999875432221
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|++||....... .+..++. .....|..
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~-~~~~~~~~ 222 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILK-GKLNLPPY 222 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHc-CCCCCCCC
Confidence 1223479999999999988889999999999999999999999996543221 1122222 22345666
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
.+..+.+|+.+||+.+|.+||+..
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCC
Confidence 788999999999999999999543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=338.81 Aligned_cols=235 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred cCcccceeeccCCcEEEEEEEECC---eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH---TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~---~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.+|..++||||+++++++.+.. |+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998643 479999886432 223456889999999999999999999997665 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999987643 4889999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.. ....||+.|+|||++.+..++.++|||||||++|+|+||.+||........ ...+. .....+
T Consensus 184 ~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~-~~~~~~ 247 (340)
T PTZ00426 184 RT---------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKIL-EGIIYF 247 (340)
T ss_pred Cc---------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHh-cCCCCC
Confidence 21 234799999999999888899999999999999999999999975432211 11111 222345
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
|...+..+.+++.+||+.||.+|++
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCC
Confidence 6667788999999999999999974
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.11 Aligned_cols=242 Identities=23% Similarity=0.262 Sum_probs=195.0
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCC-ceeeeeceecCCC--eEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHP-HLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~~~--~lV~ 528 (810)
+|...+.||+|+||.||+|...+ ..||+|++.... ......+..|+.++..+.|+ +|+.+++++.+.. |+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999864 489999987542 22345678899999999765 5788888876544 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886543 3888999999999999999999998 999999999999999999999999998753221
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... +...+......+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~~~~~ 221 (324)
T cd05587 155 GK------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHNVSYP 221 (324)
T ss_pred CC------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 11 1223479999999999999999999999999999999999999996443211 1112222234456
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+..+.+|+.+||..||.+||+.....
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 250 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTG 250 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 67788999999999999999999975433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.87 Aligned_cols=247 Identities=26% Similarity=0.321 Sum_probs=202.4
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccc---hHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.|...++||.|.-|+||++.+.+ ..+|+|++.+..... ..+.+.|-+||+.++||.++.||..|.... |||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45566789999999999999987 589999998765433 345678999999999999999999997655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
||+||+|..+++++.. ..+++..+.-++.+++.||+|||-.| ||+|||||+||||.++|++.|+||.++..+.-..
T Consensus 158 yCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999997776544 56999999999999999999999999 9999999999999999999999999987653211
Q ss_pred Ccc--------------------------------------------------cccccccCCccCccccCccccccCCCC
Q 003576 610 SFV--------------------------------------------------STTYKNTGPVGTLCYIDPEYQRTGLIS 639 (810)
Q Consensus 610 ~~~--------------------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 639 (810)
... ....+...++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011223356899999999999999999
Q ss_pred CcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC--CCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 640 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 640 ~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
.++|+|+|||+|||||.|..||.....- ..+..++.... ...| ..+..+.+||.+.|.+||.+|....
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~------~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK------ETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch------hhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccc
Confidence 9999999999999999999999766543 33444444332 2222 5678999999999999999998844
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=333.08 Aligned_cols=236 Identities=24% Similarity=0.304 Sum_probs=190.1
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+.+ ..||+|++.... ......+..|..++..+ +||||+++++++.... ++||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 59999999999999864 479999987542 22334456677777654 7999999999986554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---- 151 (316)
T cd05592 82 DLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----
Confidence 9999886543 4889999999999999999999998 99999999999999999999999999976432221
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILNDRPHFPRWISKE 222 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCCCCCCHH
Confidence 1234579999999999998889999999999999999999999996443211 1112222234456667889
Q ss_pred HHHHHHHHhhhcCCCCCccccch
Q 003576 695 LAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+.+|+.+||..||.+||++.+.+
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHH
Confidence 99999999999999999986434
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.74 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=197.2
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.++|.....||+|+||.||++.+. +..+|+|++..... .....+.+|+.+|++++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357889999999999999999986 45899999876432 23467899999999999999999999986554 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999986543 4889999999999999999999853 29999999999999999999999999987654321
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhcc--------------
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDE-------------- 673 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~--~~~~-------------- 673 (810)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||......+. .+..
T Consensus 159 --------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred --------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 1234789999999999988999999999999999999999999964322110 0000
Q ss_pred --------------------chhHHHhhh----hCCCC-ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 --------------------DNLAEILDA----QAGDW-PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 --------------------~~l~~~ld~----~~~~~-p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
......++. ..... ....+.++.+|+.+||..||++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000011111 01111 123578899999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=333.90 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=193.5
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHH---HhcCCCceeeeeceecCCC--eEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVL---SKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL---~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.++ ..++||||+++++++.+.. |+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999885 5689999987542 22234566676665 4667999999999986655 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887753 24899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+.......
T Consensus 154 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~~~~ 220 (324)
T cd05589 154 FGD------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-------VFDSIVNDEVRY 220 (324)
T ss_pred CCC------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC
Confidence 211 1234579999999999998899999999999999999999999996443211 111111222345
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
|...+..+.+++.+||..||.+||+..+..+..
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ 253 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAED 253 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 566788999999999999999999876544333
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.40 Aligned_cols=240 Identities=23% Similarity=0.265 Sum_probs=194.9
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCc---cchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~ 528 (810)
+|.....||+|+||.||+|...+ ..||+|++..... .....+..|..++..+ +||+|+.+++++.+.. ++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999998864 4899999875432 2234567788888877 5899999999886554 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 3888999999999999999999998 999999999999999999999999998754322
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... +...+......+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-------~~~~i~~~~~~~p 221 (323)
T cd05616 155 GV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVAYP 221 (323)
T ss_pred CC------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCC
Confidence 11 1234579999999999999999999999999999999999999996443211 1122222234456
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+..+.+|+.+||+.+|.+|++...
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~ 248 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGP 248 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCC
Confidence 677899999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.09 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=193.3
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||+|+||.||++.+. +..+|+|++...... ....+..|+.+|+.++||||+++++++.... ++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 568999998654222 2345778999999999999999999886554 899999999999
Q ss_pred HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 537 EDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 537 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 2345899999999999999999999998 99999999999999999999999999976653321
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 695 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......++ .....++...+..+
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~ 228 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-NDSVTYPDKFSPAS 228 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-ccCCCCcccCCHHH
Confidence 12234789999999999999999999999999999999999999964321110 000011111 11223455678899
Q ss_pred HHHHHHHhhhcCCCCCccccchhhH
Q 003576 696 AALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 696 ~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
.+++.+||+.||.+||++.+.....
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~ 253 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDG 253 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHH
Confidence 9999999999999999876543333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=327.18 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=193.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|.....||+|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||++++++|.+.. ++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999986 4589999987542 223456889999999999999999999986655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|++++.|..+... . ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~-~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM-P--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc-C--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998777654432 2 34889999999999999999999998 9999999999999999999999999998765322
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch---------hHHHh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---------LAEIL 680 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~---------l~~~l 680 (810)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||.............. +....
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 11 11234789999999999888899999999999999999999999975432221110000 00000
Q ss_pred -hhh--CCC-------------CChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 681 -DAQ--AGD-------------WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 681 -d~~--~~~-------------~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
+.. ... +....+..+.+|+.+||+.||.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 000 000 11124678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=324.70 Aligned_cols=246 Identities=32% Similarity=0.558 Sum_probs=192.4
Q ss_pred cceeeccCCcEEEEEEEEC------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 460 ENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
....||.|.||.||+|.+. +..|+||++...... ..+.|.+|+.+|++++||||++++|+|.+.. ++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999998 568999999654332 4678999999999999999999999997433 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++|+|.++|.... ...+++..+..|+.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 234899999999999999999999998 99999999999999999999999999987632221
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. .......+...|+|||.+....++.++||||||+++|||+| |+.||...... .....+.+......+.
T Consensus 159 ~----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~ 228 (259)
T PF07714_consen 159 Y----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKLKQGQRLPIPD 228 (259)
T ss_dssp E----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHHHTTEETTSBT
T ss_pred c----ccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccceecc
Confidence 1 12233467788999999998889999999999999999999 77888533211 1122233333344556
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
.++..+.+++..||..+|.+||++.+ +++.
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~-i~~~ 258 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQE-ILQE 258 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHH-HHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHH-HHhc
Confidence 67889999999999999999999994 4443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=347.80 Aligned_cols=259 Identities=23% Similarity=0.281 Sum_probs=205.7
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceec-----CC--
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACP-----DH-- 523 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~-----~~-- 523 (810)
...++.+.+.|.+|||+.||+|.+.+ ..||+|++-..+....+.+.+||++|++|. |||||.+++.+. +.
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 45567788899999999999999853 699999988777777888999999999997 999999999431 11
Q ss_pred --CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.+|.||||.||+|-|++..+.... |++.++++|+.+++.|+.+||... .||||||||-+||||+.+|..||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 168999999999999998765544 999999999999999999999998 6899999999999999999999999999
Q ss_pred ccccCCCCCcc---cccccccCCccCccccCccc---cccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch
Q 003576 602 STMLNSDPSFV---STTYKNTGPVGTLCYIDPEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 602 a~~~~~~~~~~---~~~~~~~~~~gt~~Y~aPE~---~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~ 675 (810)
+.......... ..........-|+.|.+||+ +.+..++.|+|||+|||+||-|+....||.....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------- 263 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------- 263 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence 97544332100 00000112256899999995 4577899999999999999999999999963321
Q ss_pred hHHHhhhhCC-CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 676 LAEILDAQAG-DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 676 l~~~ld~~~~-~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
..++...-. .....++..|.+||..||+.||.+||++.+ |+..+-+|.
T Consensus 264 -laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q-v~~~~~~l~ 312 (738)
T KOG1989|consen 264 -LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ-VLEEIFELA 312 (738)
T ss_pred -eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH-HHHHHHHHh
Confidence 122332211 112478999999999999999999999994 555555554
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.32 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=193.6
Q ss_pred CcccceeeccCCcEEEEEEEE-----CCeEEEEEEEcccC----ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--
Q 003576 457 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~-----~~~~vavK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-- 524 (810)
+|...++||+|+||.||++.. .+..||+|++.... ......+..|+.+|..+ +||||+++++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999876 35689999986532 22345678899999999 4999999999886655
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 89999999999999987543 3889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||........ ...+...+...
T Consensus 155 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~ 226 (332)
T cd05614 155 FLSEEKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC 226 (332)
T ss_pred ccccCCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC
Confidence 5432211 12235799999999988764 478899999999999999999999964321110 01111111122
Q ss_pred CCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 684 AGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 684 ~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
....+...+..+.+|+.+||..||.+||++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 2345556788999999999999999999655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=339.44 Aligned_cols=258 Identities=23% Similarity=0.401 Sum_probs=202.8
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeeeceecCCC
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~ 524 (810)
....|.+.++||+|+||.||+|++.+ ..||||++..... ...+.+.+|+.+|+++. ||||++++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678888999999999999998632 2699999875433 23457899999999996 999999999997655
Q ss_pred --eEEEEeccCCCHHHHHhhcCC---------------------------------------------------------
Q 003576 525 --CLVYEYMENGSLEDRLYRKNN--------------------------------------------------------- 545 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 545 (810)
||||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 899999999999998865311
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec
Q 003576 546 ------------------------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 589 (810)
Q Consensus 546 ------------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld 589 (810)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788889999999999999999998 99999999999999
Q ss_pred CCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 003576 590 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 668 (810)
Q Consensus 590 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~ 668 (810)
.++.+||+|||+++.+....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYV----SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCCEEEEEeCCcceecccccccc----ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99999999999998764332111 1123357788999999988889999999999999999997 999986322111
Q ss_pred hhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 669 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 669 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
. ....+........+...+..+.+++.+||..+|.+||++. .|.+.|+++
T Consensus 348 ~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~l~~l 397 (400)
T cd05105 348 T-----FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL-HLSDIVESL 397 (400)
T ss_pred H-----HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH-HHHHHHHHH
Confidence 1 0111111112233455678899999999999999999998 577777765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.86 Aligned_cols=252 Identities=25% Similarity=0.453 Sum_probs=201.0
Q ss_pred CcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
+|...+.||+|+||.||+|.+.+ ..+++|.+..... .....|.+|+.++..++||||+++++++.+.. ++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998743 3689998875432 23456899999999999999999999986554 89
Q ss_pred EEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 527 VYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
+|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999876422 134788899999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 672 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~ 672 (810)
+||+|||++......... .......+++.|+|||++..+.++.++|||||||++|+|++ |..||......+
T Consensus 163 ~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---- 234 (283)
T cd05048 163 VKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---- 234 (283)
T ss_pred EEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999865432211 11223467889999999988889999999999999999998 999986432211
Q ss_pred cchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 673 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 673 ~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
....+........|..++..+.+|+.+||..||.+||++. +|+..|+
T Consensus 235 --~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05048 235 --VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFK-DIHTRLR 281 (283)
T ss_pred --HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHh
Confidence 1111222222344567789999999999999999999999 4655554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=335.70 Aligned_cols=240 Identities=25% Similarity=0.288 Sum_probs=194.8
Q ss_pred eeeccCCcEEEEEEEE-----CCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 462 LRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~-----~~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
+.||+|+||.||++.. .+..+|+|++..... .....+.+|+.+|.+++||||+++++++.+.. |+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 356899999875432 23345778999999999999999999987655 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999886543 4899999999999999999999999 99999999999999999999999999876543211
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ +..+ .......|...+
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i-~~~~~~~p~~~~ 222 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMI-LKAKLGMPQFLS 222 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHH-HcCCCCCCCCCC
Confidence 11235799999999999888899999999999999999999999964432111 1111 122234556678
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
..+.+|+.+||+.||.+||++.++++..
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 8999999999999999999987654433
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=323.62 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=205.0
Q ss_pred cCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
.+|...+.||+|+||.||++... +..+|+|.+..........+.+|+.+|.+++||||++++++|.+.. ++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888889999999999999752 2468999887665555677999999999999999999999986554 89
Q ss_pred EEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEE
Q 003576 527 VYEYMENGSLEDRLYRKN----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL 596 (810)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999987543 1234899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccch
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~ 675 (810)
+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|+|+| |.+||....... .
T Consensus 162 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~ 231 (288)
T cd05093 162 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------V 231 (288)
T ss_pred ccCCccccccCCcee----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence 999999865432211 11223356788999999988889999999999999999998 999986433211 1
Q ss_pred hHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 676 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 676 l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
+..+........+...+..+.+|+.+||+.||.+||++. .+...|+.+..
T Consensus 232 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~v~~~l~~~~~ 281 (288)
T cd05093 232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK-EIHSLLQNLAK 281 (288)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 111222112233445678899999999999999999999 57777777653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.83 Aligned_cols=240 Identities=23% Similarity=0.282 Sum_probs=191.8
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||++.+. +..||+|+++... ......+..|..++..+ +||||++++++|.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999985 4589999997642 22335578899999998 6999999999986655 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---- 151 (329)
T cd05588 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---- 151 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC----
Confidence 9998886543 4899999999999999999999999 99999999999999999999999999874321111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--hccchhHHHhhhhCCCCChhHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--IDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~--~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||......... .....+...+.......|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 229 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC
Confidence 122357999999999999999999999999999999999999999632211100 0111122222233334566678
Q ss_pred HHHHHHHHHHhhhcCCCCCccc
Q 003576 693 KELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+.+|+.+||..||.+||+..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~ 251 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCH 251 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCC
Confidence 8999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.14 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=197.3
Q ss_pred cCcccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
++|...+.||+|+||.||++.+.. ..+|+|.+... ......+.+|+.+|++++||||++++++|.+.. ++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357778899999999999998865 48999987643 334567899999999999999999999986654 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886543 24889999999999999999999998 999999999999999999999999998865432211
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......++..|+|||++.+..++.++||||||+++|+|++ |++||........ +..+........|...
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGFRLYRPKLA 226 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCCCCCCCCC
Confidence 1122345678999999988889999999999999999999 8999964332111 1112211122234456
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
+..+.+|+.+||..+|.+||++.+ ++..
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~-l~~~ 254 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAE-LLRA 254 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHH-HHHh
Confidence 778999999999999999999994 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.01 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=202.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC-----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||.||+|.+. ...||+|++..... .....|.+|+.++.+++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999874 23789998875432 33457889999999999999999999986554 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999876433 5899999999999999999999988 99999999999999999999999999988752
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.......
T Consensus 159 ~~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~ 228 (266)
T cd05033 159 SEATY----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKAVEDGYRLP 228 (266)
T ss_pred cccce----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence 22111 1122345678999999998889999999999999999998 999985322111 111111111223
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.+..++..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~-ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 4456678999999999999999999999 576666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.65 Aligned_cols=254 Identities=23% Similarity=0.394 Sum_probs=199.4
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 524 (810)
.+++|+....||+|+||.||+|.+.+ ..||+|++..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998643 4799998865332 23456889999999999999999999987654
Q ss_pred -eEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEE
Q 003576 525 -CLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL 596 (810)
++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 899999999999999865321 234678889999999999999999988 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccch
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~ 675 (810)
+|||++..+....... ......+++.|+|||++.++.++.++|||||||++|+|++ |.+||....... .
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYR----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------V 230 (277)
T ss_pred CCCCCccccCCcceee----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence 9999987654322111 1122355788999999988889999999999999999999 788885432211 1
Q ss_pred hHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 676 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 676 l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+..+........+...+..+.+++.+||+.+|.+||++.+ ++..|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-~l~~l 275 (277)
T cd05062 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSI 275 (277)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHh
Confidence 1111222223345556788999999999999999999984 44444
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.95 Aligned_cols=249 Identities=23% Similarity=0.261 Sum_probs=192.0
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...++||.|+||.||++... +..||||++.... ......+.+|+.+|..++||||++++++|.+.. |+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999875 5689999986532 223456788999999999999999999997655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999986543 4888899999999999999999999 999999999999999999999999999643211
Q ss_pred CCcc----------cc-------------------------------cccccCCccCccccCccccccCCCCCcchhhhH
Q 003576 609 PSFV----------ST-------------------------------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 647 (810)
Q Consensus 609 ~~~~----------~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSl 647 (810)
.... .. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00 000112479999999999988889999999999
Q ss_pred HHHHHHHHhCCCCccccchhhhhhccchhHHHhhh-hCCCCCh--hHHHHHHHHHHHHhhhcCCCC---Cccccch
Q 003576 648 GMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWPI--KETKELAALGLSCAELRRKDR---PDLKNQV 717 (810)
Q Consensus 648 Gvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~--~~~~~l~~Li~~cl~~dP~~R---Ps~~~~v 717 (810)
||++|+|+||.+||........ +..++.. ....+|. ..+..+.+|+.+|+. +|.+| +++.+.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET------YRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH------HHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 9999999999999964432211 1111111 0112222 357889999999998 77765 4766433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.91 Aligned_cols=236 Identities=23% Similarity=0.299 Sum_probs=190.9
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. +..||+|++.... ......+..|..++..+ +||||+++++++.+.. |+||||+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 6999999999999986 4589999987542 22344567788888764 8999999999987655 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05620 82 DLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC----
Confidence 9999886543 4888999999999999999999998 99999999999999999999999999874322111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 222 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDTPHYPRWITKE 222 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCCCCCHH
Confidence 123457999999999999999999999999999999999999999643321 11222222233445567889
Q ss_pred HHHHHHHHhhhcCCCCCccccch
Q 003576 695 LAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+.+|+.+||+.||.+||++.+.+
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHH
Confidence 99999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.17 Aligned_cols=231 Identities=25% Similarity=0.304 Sum_probs=188.8
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+++++++.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999874 5689999987542 223356778999999999999999999886655 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 82 LFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence 998886543 48999999999999999999997 67 99999999999999999999999999875432211
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~~~~~i~~~~~~~p~~~~~~ 222 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEIRFPRTLSPE 222 (325)
T ss_pred --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-------HHHHHHhcCCCCCCCCCCHH
Confidence 112347999999999999889999999999999999999999999643221 12222222233456667889
Q ss_pred HHHHHHHHhhhcCCCCCc
Q 003576 695 LAALGLSCAELRRKDRPD 712 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs 712 (810)
+.+|+.+||+.||.+|++
T Consensus 223 ~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHHHHHhhcCHHHhCC
Confidence 999999999999999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.45 Aligned_cols=236 Identities=24% Similarity=0.305 Sum_probs=189.9
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+.+ ..||+|++.... ......+..|..++..+ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 59999999999999864 589999987642 22334567788888764 8999999999986655 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 82 DLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence 9999886542 4888999999999999999999998 99999999999999999999999999875332111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNPCYPRWLTRE 222 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCccCCHH
Confidence 112347899999999999889999999999999999999999999643321 11112222223345557788
Q ss_pred HHHHHHHHhhhcCCCCCccccch
Q 003576 695 LAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+.+|+.+||+.||.+||++.+.+
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHH
Confidence 99999999999999999997433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.89 Aligned_cols=243 Identities=24% Similarity=0.422 Sum_probs=195.4
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~----~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~gs 535 (810)
.||+|+||.||+|.+. +..+|+|++..... ...+.+.+|+.++..++||||+++++++.+.. ++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999763 46899999865432 23467899999999999999999999986544 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||.|||++.++.+||+|||++..+........
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 153 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-- 153 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence 999986543 4889999999999999999999998 99999999999999999999999999987654332111
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKETK 693 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~ 693 (810)
......++..|+|||.+....++.++|||||||++|+|+| |.+||...... .+...+.. .....|...+.
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 225 (257)
T cd05116 154 -AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGERMECPQRCPP 225 (257)
T ss_pred -ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCCCCCCCCH
Confidence 1122345678999999988889999999999999999998 99999643221 11222222 22345666789
Q ss_pred HHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 694 ELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 694 ~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
.+.+|+.+||+.||.+||++. .|...|+
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~-~i~~~l~ 253 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFA-VVELRLR 253 (257)
T ss_pred HHHHHHHHHhccCchhCcCHH-HHHHHHh
Confidence 999999999999999999998 4555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.05 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=191.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecC-------CCe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HGC 525 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~~ 525 (810)
.|....+||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3778889999999999999875 5689999987432 2234568899999999999999999998732 138
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 78988886543 4899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-------------
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------------- 670 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~------------- 670 (810)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........
T Consensus 154 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCcc---ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 4322111 11234579999999998765 67899999999999999999999999643321110
Q ss_pred ----hccchhHHHhhhhCCCCC-------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 671 ----IDEDNLAEILDAQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 671 ----~~~~~l~~~ld~~~~~~p-------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+........+.......+ ...++.+.+|+.+||..||.+||++.+++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 000001111111100001 12456789999999999999999998644
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=310.59 Aligned_cols=248 Identities=25% Similarity=0.287 Sum_probs=193.6
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeecee----cCCCeEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGAC----PDHGCLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~----~~~~~lV 527 (810)
.+|...++|++|.||.||+|+++. ..||+|.++..... -.-.-++||.+|.+++|||||.+-.+. .+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 467778899999999999999874 58999998754321 112347999999999999999986665 4555999
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||||+. +|..++..-. .++...++..++.|++.||+|||.+. |+||||||+|+|++..|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999974 8998887654 45888999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc------------
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED------------ 674 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~------------ 674 (810)
.. ...+..+-|..|.|||++.+ ..|+...|+||+|||+.||++++|-|......++....-
T Consensus 230 p~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 230 PL------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred Cc------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 43 23456689999999997765 459999999999999999999999997554433221100
Q ss_pred -----hhHHHhhhh-------CCCCChh-HHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 675 -----NLAEILDAQ-------AGDWPIK-ETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 675 -----~l~~~ld~~-------~~~~p~~-~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.....+... ...++.. .+..-.+|+..+|.+||.+|.|+.+
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 000000000 0011111 3477789999999999999999986
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=337.61 Aligned_cols=248 Identities=27% Similarity=0.324 Sum_probs=198.9
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+|..++||||+++++++.+.. |+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999987 6799999987542 233456889999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998765 34889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCc-----------------------ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccc
Q 003576 609 PSF-----------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665 (810)
Q Consensus 609 ~~~-----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~ 665 (810)
... ...........||+.|+|||++.+..++.++|||||||+||+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000112234579999999999999999999999999999999999999997544
Q ss_pred hhhhhhccchhHHHhhh-hCCCCCh--hHHHHHHHHHHHHhhhcCCCCCc-cccc
Q 003576 666 KVETAIDEDNLAEILDA-QAGDWPI--KETKELAALGLSCAELRRKDRPD-LKNQ 716 (810)
Q Consensus 666 ~~~~~~~~~~l~~~ld~-~~~~~p~--~~~~~l~~Li~~cl~~dP~~RPs-~~~~ 716 (810)
.... ...+... .....|. ..++.+.+|+.+|+. ||.+||+ +.++
T Consensus 235 ~~~~------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 235 LQET------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred HHHH------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 2221 1112210 0111222 258899999999998 9999999 7743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=336.28 Aligned_cols=241 Identities=26% Similarity=0.404 Sum_probs=187.1
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
|...++||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+.++|+||+++++++.+.. ++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 344567999999999999985 56999999865432 23467899999999999999999999997655 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.+.. ...+..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 99986532 2456778899999999999999998 99999999999999999999999999987653221
Q ss_pred cccccccCCccCccccCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
......||..|+|||++.. ...+.++|||||||++|+|++|+.||......... .....+........
T Consensus 224 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 296 (353)
T PLN00034 224 ----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA---SLMCAICMSQPPEA 296 (353)
T ss_pred ----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHHhccCCCCC
Confidence 1123479999999998743 23456899999999999999999999632211100 00111111112233
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+...+..+.+|+.+||..||.+||++.+++
T Consensus 297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 297 PATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 456778999999999999999999998533
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.13 Aligned_cols=240 Identities=28% Similarity=0.355 Sum_probs=189.6
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHH-HHHhcCCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999985 56899999875421 22234555555 467799999999999886554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC----
Confidence 9999886543 4888999999999999999999998 99999999999999999999999999875332211
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|++||....... ....++. .....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~~~~~~~~~~~ 222 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-KPLRLKPNISVS 222 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CCCCCCCCCCHH
Confidence 1234579999999999999999999999999999999999999996432211 1111221 122344456889
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+.+|+.+||+.||.+||++.+.+.+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~il 249 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDFLEIK 249 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence 999999999999999999975443333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.06 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=204.4
Q ss_pred hhcCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecC-------CC
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HG 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------~~ 524 (810)
..+.|.+.++||+|||+-||++.. .+..||+|++......+.+..++|++..++++|||++++++++.. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 346799999999999999999875 355899999988777788889999999999999999999998721 13
Q ss_pred eEEEEeccCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
||+++|...|+|.+.+...... ..+++.++++|+.+|++||.+||...| |++||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 8999999999999998864433 368999999999999999999999984 89999999999999999999999999998
Q ss_pred ccCCCC---CcccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhH
Q 003576 604 MLNSDP---SFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 677 (810)
Q Consensus 604 ~~~~~~---~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~ 677 (810)
...-.- ..............|..|.|||.+. +...+.++|||||||+||.|+.|..||...-. ..+.+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSla 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSLA 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeEE
Confidence 654211 1111111223346799999999875 34578899999999999999999999952110 111111
Q ss_pred HHhhhhCCCCC--hhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 678 EILDAQAGDWP--IKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 678 ~~ld~~~~~~p--~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
-.+......+| ..++..+.+|+..|++.||.+||++.+ ++..++.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~-ll~~~d~ 299 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE-LLSKLDD 299 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH-HHHHHHh
Confidence 11111111122 237899999999999999999999994 5444443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=322.38 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=196.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+|+..++||+|+||.||++.+. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+.. ++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778889999999999999875 56999999865422 22345778999999999999999999986544 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886543 245899999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+...+.......+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (285)
T cd05605 157 T-------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQEEYSE 226 (285)
T ss_pred c-------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcccccCc
Confidence 1 1234789999999999888899999999999999999999999964322110 01112222222334555
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+..+.+|+.+||..||.+||+..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCC
Confidence 6788999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.82 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=191.0
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||++.+. +..||+|++.... ......+..|+.++.++ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6999999999999885 4589999987542 22334577899998877 7999999999986554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---- 151 (329)
T cd05618 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---- 151 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----
Confidence 9998876543 4899999999999999999999998 99999999999999999999999999875332111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhccchhHHHhhhhCCCCChhHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~--~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ......+...+.......|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~ 229 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC
Confidence 11235799999999999999999999999999999999999999953211110 00111122222233344666778
Q ss_pred HHHHHHHHHHhhhcCCCCCccc
Q 003576 693 KELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+.+|+.+||..||.+||+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~ 251 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCH 251 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCC
Confidence 8999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.27 Aligned_cols=253 Identities=26% Similarity=0.465 Sum_probs=206.9
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
...+|...++||.|+||.||+|.+. +..+++|++..........+..|+.+++.++||||+++++++.+.. ++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3457888899999999999999886 4689999988766556678999999999999999999999986555 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999976432 35889999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
......++..|++||.+....++.++||||||+++|+|++ |+.||...... ..+..+........+.
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 227 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQITAGYRMPCPA 227 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHHhCCcCCCCC
Confidence 1123356778999999988889999999999999999998 89999643311 1112222222233455
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
..+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~-~l~~~L~~ 260 (261)
T cd05148 228 KCPQEIYKIMLECWAAEPEDRPSFK-ALREELDN 260 (261)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHhc
Confidence 6788999999999999999999999 56666654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.24 Aligned_cols=233 Identities=24% Similarity=0.307 Sum_probs=190.3
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. ++.||+|++.... ......+..|..++..+ +||||+++++++.+.. |+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999985 5689999987542 22345677888998876 6999999999986655 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---- 151 (320)
T cd05590 82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---- 151 (320)
T ss_pred hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC----
Confidence 9999886543 4889999999999999999999998 99999999999999999999999999875432211
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVYPTWLSQD 222 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCCCCCCCCCHH
Confidence 1233579999999999998899999999999999999999999996443211 1122222223445567889
Q ss_pred HHHHHHHHhhhcCCCCCccc
Q 003576 695 LAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~ 714 (810)
+.+|+.+||+.||.+||++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHcccCHHHCCCCC
Confidence 99999999999999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.49 Aligned_cols=251 Identities=23% Similarity=0.398 Sum_probs=200.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
++|...++||+|+||.||+|.+. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.. +++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56888899999999999999875 4579999876543 24567899999999999999999999886555 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999987543 234888899999999999999999988 999999999999999999999999999876542211
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......++..|+|||++..+.++.++|||||||++|+|+| |..||........ ...+........+...
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 229 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV------MSALQRGYRMPRMENC 229 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH------HHHHHcCCCCCCCCCC
Confidence 1123356778999999988889999999999999999998 9999963321111 1111111111222345
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
+..+.+++.+||..+|++||++. ++...|+.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFD-YLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 67899999999999999999998 57777664
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.80 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=191.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
.+|....+||.|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 35888899999999999999875 56899999875432 23456789999999999999999999987665 799999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 58988886543 24788899999999999999999998 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-----------------
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------------- 672 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~----------------- 672 (810)
......|++.|+|||++.+ ..++.++|||||||++|+|+||++||......+....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1123478999999998765 5689999999999999999999999964332111000
Q ss_pred -cchhHHHhhhhCC-----CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 673 -EDNLAEILDAQAG-----DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 673 -~~~l~~~ld~~~~-----~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...+...+.+... ......+.++.+|+.+||..||.+|||+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 0000000000000 0011346788999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=316.65 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=201.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.+|...++||+|+||.||+|.+. ++.+++|++... ......+.+|+.+|..++||||++++++|.... ++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999885 568999998754 334567899999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999886543 235889999999999999999999998 999999999999999999999999999876542211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhh-hhCCCCCh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~ 689 (810)
......++..|+|||++.+..++.++|||||||++|+|++ |..||......+ +...+. ......+.
T Consensus 161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 228 (263)
T cd05052 161 -----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYRMERPE 228 (263)
T ss_pred -----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCCCCCCC
Confidence 1112234678999999988899999999999999999998 999986432211 111111 11234455
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+..+.+++.+||..+|.+||++. .+++.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFA-EIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHhh
Confidence 6778999999999999999999999 466666643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.02 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=190.4
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.++|...++||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999985 56899999875432 23345788999999999999999999986555 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 68888776543 34888899999999999999999999 9999999999999999999999999987543221
Q ss_pred CcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch----------hHH
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN----------LAE 678 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~----------l~~ 678 (810)
. ......||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.........+..-. +..
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 H------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred c------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 1 1223478999999998764 4578899999999999999999999975433221111000 000
Q ss_pred H-----hhhhC--CCCC---------hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 679 I-----LDAQA--GDWP---------IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 679 ~-----ld~~~--~~~p---------~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
. ..+.. ...+ ...+..+.+|+.+||+.||.+|||+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~ 284 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence 0 00000 0000 012467889999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.46 Aligned_cols=240 Identities=24% Similarity=0.271 Sum_probs=191.6
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|... +..||+|++..... .....+.+|+.++.++ +||||+.+++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999875 45899999976432 2335578899999888 6999999999986554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 151 (327)
T cd05617 82 DLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---- 151 (327)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC----
Confidence 9998886543 4899999999999999999999998 99999999999999999999999999875322111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||..............+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 112357999999999999999999999999999999999999999632211111111112222222233456667889
Q ss_pred HHHHHHHHhhhcCCCCCccc
Q 003576 695 LAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~ 714 (810)
+.+++.+||..||.+||++.
T Consensus 230 ~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=321.99 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=204.4
Q ss_pred CcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
+|.....||+|+||.||+|.+. ...+++|.+..........+.+|+.++++++||||+++++++.+.. ++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 5677788999999999999753 2368888887665555677999999999999999999999997655 899
Q ss_pred EEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 528 YEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 999999999999975431 234889999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhcc
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 673 (810)
Q Consensus 595 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~ 673 (810)
+|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|+| |++||.......
T Consensus 163 ~l~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 233 (291)
T cd05094 163 KIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----- 233 (291)
T ss_pred EECCCCcccccCCCcee----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999765432211 11223457889999999988889999999999999999999 999986433211
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
.+..+........+...+..+.+++.+||+.+|.+||++. .|+..|+.+..
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~v~~~l~~~~~ 284 (291)
T cd05094 234 -VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK-EIYKILHALGK 284 (291)
T ss_pred -HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHh
Confidence 1111111222233445678899999999999999999999 57777777643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.07 Aligned_cols=253 Identities=24% Similarity=0.408 Sum_probs=200.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--e
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 525 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 525 (810)
.+|.....||+|+||.||+|.+. +..||+|++...... ....+.+|+.+|..++||||+++++++.+.. +
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777788999999999999863 247999998765443 4567999999999999999999999986654 8
Q ss_pred EEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 526 LVYEYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
+||||+++++|.+++...+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975431 234788899999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhcc
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 673 (810)
Q Consensus 595 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~ 673 (810)
||+|||++..+....... ......+++.|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 162 kl~d~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----- 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----- 232 (280)
T ss_pred EECCcccceecccCccee----cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence 999999997654322110 1123356788999999999999999999999999999999 999986432211
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
....+........+...+..+.+++.+||..||.+||++. +|+..|+
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-eil~~l~ 279 (280)
T cd05049 233 -VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIK-DIHERLQ 279 (280)
T ss_pred -HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHhh
Confidence 1111111222233445678999999999999999999998 4555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.50 Aligned_cols=244 Identities=24% Similarity=0.294 Sum_probs=193.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||+|.+. ++.||||++.... ......+.+|+.+|..++||||++++++|.+.. |+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999985 5699999987542 223355788999999999999999999987665 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987643 4899999999999999999999999 999999999999999999999999998765422
Q ss_pred CCccc--------------------------------ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh
Q 003576 609 PSFVS--------------------------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656 (810)
Q Consensus 609 ~~~~~--------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt 656 (810)
..... ........+||+.|+|||++....++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 0001113469999999999998899999999999999999999
Q ss_pred CCCCccccchhhhhhccchhHHHhhhh-CCCCC--hhHHHHHHHHHHHHhhhcCCCCCc
Q 003576 657 AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 657 g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
|.+||........ ...++... ....| ...++.+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 9999975443221 11111111 01111 2357889999999997 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.34 Aligned_cols=233 Identities=25% Similarity=0.316 Sum_probs=189.0
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+.+ ..||+|++.... ......+..|..++..+ +||||+++++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 59999999999999864 589999987542 22335577899999876 7999999999987655 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 9999886543 4888999999999999999999999 99999999999999999999999999875432211
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..+. ......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~-~~~~~~p~~~~~~ 222 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESIL-HDDVLYPVWLSKE 222 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCCCCCCCCCHH
Confidence 1234579999999999998899999999999999999999999996443211 111111 1222345556789
Q ss_pred HHHHHHHHhhhcCCCCCccc
Q 003576 695 LAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~ 714 (810)
+.+|+.+||..||.+||+..
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=356.08 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=208.1
Q ss_pred CcccceeeccCCcEEEEEEEECCe-------EEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~~-------~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
+......||+|.||.||.|...+. .||||.+.... .....+|.+|..+|+.++|||||+++|+|.+.. +|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 445567899999999999987432 48999887653 445678999999999999999999999997755 89
Q ss_pred EEEeccCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 527 VYEYMENGSLEDRLYRKN----NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
++|||+||+|..+|.... ....+...+.+.++.|||+|+.||++++ +|||||...|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998651 1345889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCC-ccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh
Q 003576 603 TMLNSDPSFVSTTYKNTGP-VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
+.+-.... |+.... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+. +..++
T Consensus 850 rDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~ 918 (1025)
T KOG1095|consen 850 RDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVL 918 (1025)
T ss_pred Hhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHH
Confidence 94433221 111222 34467999999999999999999999999999999 8899975544332 22234
Q ss_pred hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 681 d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
...+.+.|..++..+.+++..||+.+|.+||++. .++..+..+..
T Consensus 919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~-~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFR-TIVEQDPAISN 963 (1025)
T ss_pred hCCccCCCCCCChHHHHHHHHHccCChhhCccHH-HHHhhhhhhhh
Confidence 4445677889999999999999999999999999 45555555443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=322.48 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=189.6
Q ss_pred CcccceeeccCCcEEEEEEEEC---CeEEEEEEEcccCc--cchHHHHHHHHHHHhc---CCCceeeeeceecC------
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACPD------ 522 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~---~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~------ 522 (810)
+|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788899999999999999873 46899998875432 2234566788887766 69999999998741
Q ss_pred -CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 523 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 523 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 2389999996 689998865432 34889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld 681 (810)
+....... ......||+.|+|||++....++.++|||||||++|+|++|++||......... ..+++
T Consensus 157 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~------~~i~~ 223 (290)
T cd07862 157 ARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL------GKILD 223 (290)
T ss_pred eEeccCCc-------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH------HHHHH
Confidence 98654321 123457899999999998888999999999999999999999999754432211 11111
Q ss_pred hh----------------------CC----CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 682 AQ----------------------AG----DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 682 ~~----------------------~~----~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.. .. ......+..+.+|+.+||+.||++||++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 00 00 0012346778999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.81 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=187.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.+|...++||+|+||.||++.+. +..||+|... ...+.+|+.+|++++||||++++++|.... ++||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46888999999999999999885 4589999643 335788999999999999999999886544 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
. ++|..++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 5 78888876543 4889999999999999999999998 99999999999999999999999999975432211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-------------------
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID------------------- 672 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~------------------- 672 (810)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||...........
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 112345799999999999988999999999999999999999988753221100000
Q ss_pred ----cchhHHHh----hhh-C--CCCC-----hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 673 ----EDNLAEIL----DAQ-A--GDWP-----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 673 ----~~~l~~~l----d~~-~--~~~p-----~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+.... ... . ...+ ...+.++.+|+.+||+.||.+||++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 00001110 000 0 0001 124568999999999999999999985
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.34 Aligned_cols=245 Identities=23% Similarity=0.274 Sum_probs=196.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~ 528 (810)
+|.....||+|+||.||+|... +..||+|++.... ......+..|..++..+. |++|+++++++.+.. |+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999885 5689999987542 223355778999998886 577888888876544 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886543 4899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... ....++ .....+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~-~~~~~~p 221 (323)
T cd05615 155 GV------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIM-EHNVSYP 221 (323)
T ss_pred Cc------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCCCCC
Confidence 11 1223469999999999998889999999999999999999999996443211 112222 2233456
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
...+..+.+++.+||..+|.+|++..+.....
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ 253 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPEGERD 253 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHH
Confidence 66788999999999999999999976544333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.61 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=193.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+|..++||||+++++++.+.. |+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999885 45899999875432 23456889999999999999999999997655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|++||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 4888899999999999999999998 9999999999999999999999999986442110
Q ss_pred Ccc-----------------------------------------cccccccCCccCccccCccccccCCCCCcchhhhHH
Q 003576 610 SFV-----------------------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 648 (810)
Q Consensus 610 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlG 648 (810)
... ..........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 000011235799999999999888899999999999
Q ss_pred HHHHHHHhCCCCccccchhhhhhccchhHHHhhhh-CCCCC--hhHHHHHHHHHHHH--hhhcCCCCCccccch
Q 003576 649 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSC--AELRRKDRPDLKNQV 717 (810)
Q Consensus 649 vil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~Li~~c--l~~dP~~RPs~~~~v 717 (810)
|++|+|+||++||......... ..++... ....| ...++++.+|+.+| +..+|..||++.+++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999999754322211 1121111 11122 24678899999884 455666799988543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=346.21 Aligned_cols=256 Identities=23% Similarity=0.274 Sum_probs=205.7
Q ss_pred HHHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-
Q 003576 449 EEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH- 523 (810)
Q Consensus 449 ~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~- 523 (810)
.++.....+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|..++|+||+++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344556689999999999999999999874 6799999987543 23345678999999999999999998776321
Q ss_pred ---------CeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 524 ---------GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 524 ---------~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
.++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 268999999999999987532 2346899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 673 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~ 673 (810)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 182 vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~----- 252 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----- 252 (496)
T ss_pred EEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----
Confidence 999999999876532211 11234579999999999999999999999999999999999999996432211
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+...+.......|...++.+.+|+.+||..||.+||++.+++
T Consensus 253 -~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 253 -VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 1122222222345566788999999999999999999998644
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=318.34 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=189.4
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||+|+||.||++... +..||+|.+..... .....+..|+++|++++||||+++++++.+.. ++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 56899998864321 12344567999999999999999999986554 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 988865432 34888999999999999999999998 99999999999999999999999999977653221
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 696 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 696 (810)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ........+...........+.++.
T Consensus 151 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05607 151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDEVKFEHQNFTEESK 227 (277)
T ss_pred -eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccccccccccCCHHHH
Confidence 1234689999999999888899999999999999999999999964321100 0011111111111111124678899
Q ss_pred HHHHHHhhhcCCCCCccccch
Q 003576 697 ALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 697 ~Li~~cl~~dP~~RPs~~~~v 717 (810)
+|+.+||+.||.+||++.+.+
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHhccCHhhCCCCccch
Confidence 999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.83 Aligned_cols=233 Identities=25% Similarity=0.294 Sum_probs=190.2
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. +..||+|++.... ......+..|..++..+ +||||+++++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999986 4589999987542 22345577899999888 6999999999986555 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 82 DLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence 9998886543 4899999999999999999999998 99999999999999999999999999875322111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... +...+.......|...+..
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEVRYPRWLSKE 222 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCCCcCCHH
Confidence 1123468999999999999999999999999999999999999996433211 1112222223445567889
Q ss_pred HHHHHHHHhhhcCCCCCccc
Q 003576 695 LAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~ 714 (810)
+.+|+.+||..||.+||++.
T Consensus 223 ~~~li~~~l~~dP~~R~s~~ 242 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCL 242 (318)
T ss_pred HHHHHHHHccCCHHHcCCCC
Confidence 99999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=328.32 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=195.3
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.++|+..++||.|+||.||++.+. +..+|+|++.... ......+.+|+.+|+.++||||++++++|.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999986 4588999887542 223466899999999999999999999986655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
|+++|+|.+++.... .+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999986543 488889999999999999999975 5 999999999999999999999999998765432
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--hc---c----------
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--ID---E---------- 673 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~--~~---~---------- 673 (810)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||......... +. .
T Consensus 158 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred c--------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 1 12347899999999999888999999999999999999999999643211100 00 0
Q ss_pred -------------------chhHHHhhhh----CCCCC-hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 -------------------DNLAEILDAQ----AGDWP-IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 -------------------~~l~~~ld~~----~~~~p-~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.....+.+.. ....+ ...+.++.+|+.+||+.||.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 0000011110 01111 12457899999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.00 Aligned_cols=239 Identities=27% Similarity=0.323 Sum_probs=189.2
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHH-HHHhcCCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++.+.. |+||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999985 56899999875421 22334555554 578899999999999886554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 82 ELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----
Confidence 9998886543 4788889999999999999999998 99999999999999999999999999875322111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|++||...+... +...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKPLQLPGGKTVA 222 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCCCCCCCCCCHH
Confidence 1234578999999999998889999999999999999999999996443211 1111112223455567888
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
+.+++.+||+.||.+||+....+.+.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~~ 248 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLEI 248 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHHH
Confidence 99999999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.51 Aligned_cols=245 Identities=24% Similarity=0.438 Sum_probs=194.5
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccCCCH
Q 003576 463 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSL 536 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~gsL 536 (810)
.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.++++++||||++++++|.... ++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999764 34689999876533 23456899999999999999999999986554 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence 99886533 34899999999999999999999998 99999999999999999999999999986554322111
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh-hhhCCCCChhHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETKE 694 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~~~p~~~~~~ 694 (810)
......++..|+|||++.+..++.++|||||||++|+|++ |.+||....... +...+ .......|...+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLDCPAECPPE 226 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCCCCCCCCHH
Confidence 1122344678999999988889999999999999999996 999996432211 11111 11223455667899
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
+.+++.+||..+|++||++. .|.+.|+.
T Consensus 227 l~~li~~c~~~~~~~Rp~~~-~i~~~l~~ 254 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFA-KVEERMRT 254 (257)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHhh
Confidence 99999999999999999999 45555543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.21 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=202.4
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEc--ccCccchHHHHHHHHHHHhcCCCceeeeeceecC------
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQ--SKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 522 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~--~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------ 522 (810)
.....|.....||+|+||.|+.+.+. +..||||.+. .......++..+|+.+|+.++|+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34455666788999999999999886 5699999987 4556667888999999999999999999998744
Q ss_pred -CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 523 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 523 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
..|+|+|+| +.+|...+.... .++...+..++.||+.||.|+|+.+ |+||||||+|+|++.+..+||||||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 128999999 578988886543 3888899999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh----------
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA---------- 670 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~---------- 670 (810)
|+..... ......+..+.|.+|.|||++ ....|+...||||.||||.||++|++-|.+.+.+.+.
T Consensus 172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9988654 222345677899999999965 5567999999999999999999999999865544332
Q ss_pred -------hccchhHHHhhhhC--CCCC-----hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 671 -------IDEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 671 -------~~~~~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+........+.... ...| +...+...+|+.+||..||.+|+|+.+.+
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 11112222222111 1111 24578899999999999999999998644
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.37 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=200.3
Q ss_pred hcCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
..+|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+.+|+.++++++||||+++++++.... ++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999875 4579999987543 34567899999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986544 235899999999999999999999998 999999999999999999999999999876532111
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CCCCCh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 689 (810)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||....... +...+... ....+.
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 227 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYRMPCPP 227 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCCCC
Confidence 1112233568999999988889999999999999999999 999996432211 11111111 122344
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
..+..+.+++.+||..+|.+||++. .+...|+
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~-~l~~~l~ 259 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFE-TLQWKLE 259 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHh
Confidence 5678999999999999999999999 4555554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.14 Aligned_cols=240 Identities=27% Similarity=0.342 Sum_probs=188.9
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHH-HHHhcCCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++.+.. |+||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5999999999999985 45899999875321 12233444444 567889999999999986554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----
Confidence 9999886543 3778888899999999999999999 99999999999999999999999999875432211
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|++||........ +..+.. .....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~-~~~~~~~~~~~~ 222 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILN-KPLQLKPNITNS 222 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHHh-CCcCCCCCCCHH
Confidence 12345799999999999999999999999999999999999999964332211 111111 122334467889
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+.+++.+||+.||.+||++.+.+...+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 999999999999999999986544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=334.28 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=201.1
Q ss_pred eeeccCCcEEEEEEEECCe--EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCCe--EEEEeccCCCHH
Q 003576 462 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC--LVYEYMENGSLE 537 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~--lV~Ey~~~gsL~ 537 (810)
..||+|.||+||-|++..+ ..|||-+........+-+..|+.+-+.|+|.|||+++|.|.++++ +.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3699999999999999876 568888877766666778899999999999999999999988885 689999999999
Q ss_pred HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec-CCCceEEeeeccccccCCCCCcccc
Q 003576 538 DRLYRKNNTPPI--PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 538 ~~l~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld-~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
++|..+- .|+ ++.++-.+..||+.||.|||.+. |||||||-+|||++ -.|.+||+|||.++.+..-.+.
T Consensus 661 sLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--- 732 (1226)
T KOG4279|consen 661 SLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--- 732 (1226)
T ss_pred HHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc---
Confidence 9997643 345 77888889999999999999999 99999999999995 5799999999999987654322
Q ss_pred cccccCCccCccccCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
...+.||..|||||++..|+ |++++|||||||++.||.||+|||........++-.-.+. ..-+..|...+
T Consensus 733 ---TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy----KvHP~iPeels 805 (1226)
T KOG4279|consen 733 ---TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY----KVHPPIPEELS 805 (1226)
T ss_pred ---ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce----ecCCCCcHHHH
Confidence 23468999999999987764 8999999999999999999999996433322222111111 12356788999
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchh
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~ 718 (810)
.+...+|++|+.+||.+||++.+.+.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999997553
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.93 Aligned_cols=253 Identities=21% Similarity=0.354 Sum_probs=198.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC--Ce----EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~----~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 527 (810)
.+|.....||+|+||.||+|.+. +. .+++|.+..... .....+..|+.++..++||||+++++++.+.. +++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35677788999999999999883 33 477787754322 22356778888999999999999999986554 789
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999997543 34899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 685 (810)
.... .......++..|++||++.++.++.++|||||||++|||+| |..||....... +..++... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~ 230 (279)
T cd05111 162 DDKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERL 230 (279)
T ss_pred CCcc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC
Confidence 3211 11223457788999999988899999999999999999998 999996432211 12222221 12
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
..+..++..+.+++.+||..+|.+||++.+ ++..|..+.
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~e-l~~~l~~~~ 269 (279)
T cd05111 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKE-LANEFTRMA 269 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHH
Confidence 223345678899999999999999999984 666666543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.56 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=207.7
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC-----eE-EEEEEEccc---CccchHHHHHHHHHHHhcCCCceeeeeceecCCC
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH-----TF-AAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~-vavK~l~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~ 524 (810)
...+-...++||+|.||.||+|.+.- .. ||||..+.. ......+|.+|.++|++++|||||+|||++.+..
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 33444455899999999999998742 13 899988753 2445678999999999999999999999985544
Q ss_pred --eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 525 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
+||||+|.||+|.++|..... .++..+++.++.+.+.||+|||+.+ +|||||-..|+|++.++.+||+|||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999987664 4899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHH-h
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI-L 680 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~-l 680 (810)
+...... . ......-...|+|||.+..+.|+.++|||||||++||+++ |..||......+. ...+ .
T Consensus 310 ~~~~~~~---~---~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~~kI~~ 377 (474)
T KOG0194|consen 310 RAGSQYV---M---KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------KAKIVK 377 (474)
T ss_pred cCCccee---e---ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------HHHHHh
Confidence 7644111 0 0111134678999999999999999999999999999999 8889975543321 1222 2
Q ss_pred hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHhhh
Q 003576 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 729 (810)
Q Consensus 681 d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~~~ 729 (810)
.......|...+..+..++.+||..+|.+||+|. .+.+.|+.+.....
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~-~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMS-TIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHH-HHHHHHHHHHhccc
Confidence 2333455667789999999999999999999999 67788877765433
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=314.41 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=197.4
Q ss_pred CcccceeeccCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
+|.....||+|+||.||+|.+.+. .+|+|.+.... .....|.+|+.++.+++||||++++++|.+.. ++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 567778899999999999988654 69999887543 34567899999999999999999999986554 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-- 156 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee--
Confidence 999998865432 5899999999999999999999998 999999999999999999999999998866432211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......++..|++||++.+..++.++|||||||++|+|+| |..||....... ....+........+...+
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05113 157 ---SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRLYRPHLAS 227 (256)
T ss_pred ---ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCCCCCCCCC
Confidence 1122346678999999988889999999999999999999 999986433211 111122222223344567
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
..+.+++.+||..+|.+||++.+ ++..
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~-ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQ-LLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHH-HHHh
Confidence 89999999999999999999984 4433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.20 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=198.0
Q ss_pred cCcccceeeccCCcEEEEEEEE------CCeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
.+|+....||+|+||.||+|.+ .+..+++|.+..... .....+.+|+.+++.++||||+++++++.... |+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577778999999999999985 235889998875432 23367889999999999999999999986544 89
Q ss_pred EEEeccCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC
Q 003576 527 VYEYMENGSLEDRLYRKNN--------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 592 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~ 592 (810)
||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 224788899999999999999999998 99999999999999999
Q ss_pred ceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhh
Q 003576 593 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAI 671 (810)
Q Consensus 593 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~ 671 (810)
.+||+|||+++......... ......++..|+|||++.++.++.++|||||||++|+|++ |.+||......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---- 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYR----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---- 233 (283)
T ss_pred cEEeccccccccccCCccee----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 99999999998764322111 1123356778999999988889999999999999999998 99998643211
Q ss_pred ccchhHHHhhh-hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 672 DEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 672 ~~~~l~~~ld~-~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
.+.+.+.. .....+...+..+.+++.+||..||.+||++.+ +.+.|.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l~ 281 (283)
T cd05090 234 ---EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKD-IHTRLR 281 (283)
T ss_pred ---HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH-HHHHhh
Confidence 11112211 122344566789999999999999999999984 555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=328.95 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=200.5
Q ss_pred cCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCC---
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--- 523 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--- 523 (810)
..|.+.+.||+|+||.||+|...+ +.||+|++..... .....+..|+.++.++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 468888999999999999997532 4799999875432 2335678899999999 799999999988543
Q ss_pred CeEEEEeccCCCHHHHHhhcCC----------------------------------------------------------
Q 003576 524 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 545 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 545 (810)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 2789999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCc
Q 003576 546 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625 (810)
Q Consensus 546 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 625 (810)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....... ......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~----~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----hccCCCCCc
Confidence 125889999999999999999999998 9999999999999999999999999998764332111 122345677
Q ss_pred cccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhHHHHHHHHHHHHh
Q 003576 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKETKELAALGLSCA 703 (810)
Q Consensus 626 ~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~~l~~Li~~cl 703 (810)
.|+|||++.+..++.++|||||||+||+|++ |..||......+ .+...+.. .....+...+..+.+++.+||
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence 8999999999999999999999999999998 999996422111 11111111 112234456788999999999
Q ss_pred hhcCCCCCccccchhhHHHHHH
Q 003576 704 ELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 704 ~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
+.+|.+||++. +++..|+.+.
T Consensus 314 ~~~p~~RPs~~-ell~~l~~~~ 334 (337)
T cd05054 314 HNNPEDRPTFS-ELVEILGDLL 334 (337)
T ss_pred cCChhhCcCHH-HHHHHHHHHH
Confidence 99999999999 5777777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.50 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=198.5
Q ss_pred cccceeeccCCcEEEEEEEE------CCeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCC----CeE
Q 003576 458 FSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 526 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~l 526 (810)
|.....||+|+||.||++.+ .+..||+|++..... .....+.+|+.+|+.++||||++++++|... .++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37778899999999988764 245899999876532 3456788999999999999999999987542 379
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999988653 3899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch-hhhhh-------ccchhHH
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK-VETAI-------DEDNLAE 678 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~-~~~~~-------~~~~l~~ 678 (810)
....... ......++..|+|||++....++.++||||||+++|+|+||..||..... +.... ....+..
T Consensus 159 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYR---VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred Ccchhhc---cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 4321100 11223456779999999888899999999999999999999999864321 11111 0111111
Q ss_pred Hhhhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 679 ILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 679 ~ld~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
.++.. ....+...+..+.+++.+||+.+|.+||++. .++..|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR-SLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHH-HHHHHHHHhh
Confidence 22111 1223445678999999999999999999999 5767776653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=329.24 Aligned_cols=239 Identities=28% Similarity=0.330 Sum_probs=188.8
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHH-HHHhcCCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~-iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|... +..+|+|++.... ......+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5999999999999875 5689999987542 122344555655 467789999999999886554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----
Confidence 9998886543 4889999999999999999999998 99999999999999999999999999875332211
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 694 (810)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||........ +..++.. ....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~~-~~~~~~~~~~~ 222 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILHK-PLVLRPGASLT 222 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHcC-CccCCCCCCHH
Confidence 12345799999999999999999999999999999999999999964432111 1112211 12233456788
Q ss_pred HHHHHHHHhhhcCCCCCccccchhhH
Q 003576 695 LAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
+.+++.+||..+|.+||++.+.+...
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 99999999999999999998544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.40 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=200.2
Q ss_pred cCcccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 533 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 533 (810)
++|...++||+|+||.||+|.+.+ ..+|+|.+..... ....+.+|+.++++++|||++++++++.+.. +++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 467788899999999999998754 5789998876433 4567999999999999999999999886544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc--
Confidence 99999886543 234889999999999999999999998 999999999999999999999999999876532211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......++..|+|||++.+..++.++||||||+++|+|++ |.+||......+ .+..+........+...+
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYRMPCPQDCP 229 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCCCcCC
Confidence 1122345678999999988889999999999999999999 899996432211 111121112233455667
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
..+.+|+.+||..+|.+||++. .+...|+
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 258 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFE-YLQSFLE 258 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHH-HHHHHHh
Confidence 8999999999999999999998 4555554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.33 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=200.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecC----CCe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGC 525 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 525 (810)
.+|.....||+|+||.||++... +..||+|.+..........+.+|+.+|++++||||+++++++.. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999752 45899999877655556788999999999999999999998642 238
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 24889999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchh-hhhhcc--------chh
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV-ETAIDE--------DNL 676 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~-~~~~~~--------~~l 676 (810)
........ ......++..|+|||++.+..++.++|||||||++|+|++|..|+...... ...... ..+
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYK---VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCccee---ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 54332111 111223455699999998888999999999999999999998776432211 000000 011
Q ss_pred HHHhhhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 677 AEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 677 ~~~ld~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.+.+... ....+...+..+.+|+.+||..+|.+||++. .|+..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS-ELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHhc
Confidence 1122111 1122345678899999999999999999999 566666643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.67 Aligned_cols=244 Identities=28% Similarity=0.416 Sum_probs=200.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|...+.||+|+||.||+|.+. +..|++|.+... .......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999885 568999988643 2334567889999999999999999999987665 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++.... ...+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987642 245889999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
. .....|++.|+|||++.+..++.++|||||||++|+|+||+.||....... ....+........+..
T Consensus 157 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (256)
T cd08529 157 F------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKIIRGVFPPVSQM 224 (256)
T ss_pred h------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCCccc
Confidence 1 123468899999999998889999999999999999999999997443211 1122222222334446
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+..+.+++.+||+.+|++||++.++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~l 250 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQL 250 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHH
Confidence 67899999999999999999999853
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.81 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=200.5
Q ss_pred cCcccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 533 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 533 (810)
.+|...++||+|+||.||+|.+.+ ..||+|++..... ....+.+|+.+++.++||||+++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 468889999999999999998864 4799999875332 4567899999999999999999999875544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc--
Confidence 99999997543 234789999999999999999999998 999999999999999999999999999876543211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......++..|++||+..+..++.++|||||||++|+|+| |.+||....... ....+........+...+
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPCPPECP 229 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhcCCCCCCccccC
Confidence 1123356778999999988889999999999999999999 888886432111 111111111122344567
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
..+.+|+.+||+.+|.+||++. .++..|+.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~-~~~~~l~~ 259 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFE-YLQAFLED 259 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHH-HHHHHHHH
Confidence 8899999999999999999998 56666654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.47 Aligned_cols=246 Identities=28% Similarity=0.473 Sum_probs=196.8
Q ss_pred eeeccCCcEEEEEEEECC-----eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccCC
Q 003576 462 LRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 534 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~g 534 (810)
++||+|+||.||+|.+.. ..+|+|.+..... .....+.+|+.+++.+.||||+++++++.... ++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 369999999999998642 4799999876544 24567899999999999999999999986544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~- 153 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR- 153 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence 9999997654 4889999999999999999999998 99999999999999999999999999987654332111
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKET 692 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~ 692 (810)
......++..|+|||.+.+..++.++|||||||++|+|++ |.+||....... +...+.. .....+...+
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05060 154 --ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGERLPRPEECP 224 (257)
T ss_pred --cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCcCCCCCCCC
Confidence 1112234568999999988889999999999999999998 999996432211 1111111 1223455667
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+.+++.+||..+|.+||++. .|+..|+.+
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 255 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFS-ELESTFRRD 255 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHH-HHHHHHHhc
Confidence 8999999999999999999999 576666654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.05 Aligned_cols=246 Identities=23% Similarity=0.287 Sum_probs=191.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+|...++||+|+||.||++... +..||||++.... ......+.+|+.+|..++||||+++++.|.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 5689999986532 223456789999999999999999999987655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999986643 4788889999999999999999998 9999999999999999999999999985332100
Q ss_pred Cc-------------------------------------ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHH
Q 003576 610 SF-------------------------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 652 (810)
Q Consensus 610 ~~-------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~ 652 (810)
.. ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00 00000112357999999999999889999999999999999
Q ss_pred HHHhCCCCccccchhhhhhccchhHHHhhhh---CCCCChhHHHHHHHHHHHHhhhcCCCCC---cccc
Q 003576 653 QLLTAKPAIAITHKVETAIDEDNLAEILDAQ---AGDWPIKETKELAALGLSCAELRRKDRP---DLKN 715 (810)
Q Consensus 653 eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~---~~~~p~~~~~~l~~Li~~cl~~dP~~RP---s~~~ 715 (810)
+|+||++||.......... .+.... ........+..+.+++.+|+ .+|.+|+ ++.+
T Consensus 236 ell~G~~Pf~~~~~~~~~~------~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLADTPAETQL------KVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCCCHHHHHH------HHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 9999999997554322211 111100 01112246788899999977 5999999 5554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=315.27 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=194.7
Q ss_pred ccceeeccCCcEEEEEEEECCe----EEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecC--------CC
Q 003576 459 SENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------HG 524 (810)
Q Consensus 459 ~~~~~LG~G~~g~Vy~~~~~~~----~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--------~~ 524 (810)
....+||+|+||.||+|.+... .+|+|.+.... ......+.+|+.+++.++||||++++++|.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987543 58999876542 3345678899999999999999999998632 23
Q ss_pred eEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 525 CLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
+++|||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 79999999999998875321 2234889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
++.+....... ......+++.|++||++....++.++|||||||++|+|++ |++||....... ....+.
T Consensus 159 ~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~ 228 (272)
T cd05075 159 SKKIYNGDYYR----QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYLR 228 (272)
T ss_pred ccccCccccee----cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHH
Confidence 98765432110 1122346778999999998899999999999999999999 889986432211 111111
Q ss_pred hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 681 d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
.......+...+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l~~ 270 (272)
T cd05075 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFE-TLRCELEK 270 (272)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHh
Confidence 1112233445678899999999999999999998 46555554
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.78 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=198.7
Q ss_pred cccceeeccCCcEEEEEEEECC-----eEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCC-------
Q 003576 458 FSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 523 (810)
|...+.||+|+||.||+|.+.. ..||+|.+..... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567789999999999998742 4799999875432 2345789999999999999999999987331
Q ss_pred -CeEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeee
Q 003576 524 -GCLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DF 599 (810)
.+++|||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 379999999999999886532 2235899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHH
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 678 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~ 678 (810)
|+++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |.+||......+ .+..
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------~~~~ 227 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDY 227 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence 9998765432211 1112345678999999988889999999999999999999 889986433211 1122
Q ss_pred HhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 679 ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 679 ~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
+........|...+..+.+++.+||..||.+||++. +++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFT-KLREVLENI 272 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 222222334556788999999999999999999998 466666543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.53 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=198.0
Q ss_pred cCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceec-C--CCeEEEEecc
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP-D--HGCLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~-~--~~~lV~Ey~~ 532 (810)
.+|.....||+|+||.||++...+..+++|.+.... ..+.+.+|+.++++++|+|++++++++. + ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 367788899999999999999999999999986543 3457899999999999999999999763 2 2389999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999875432 34889999999999999999999998 9999999999999999999999999987654321
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhh-hhCCCCChh
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIK 690 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~ 690 (810)
....++..|+|||++....++.++|||||||++|+|++ |+.||....... +...+. ......+..
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~ 223 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDG 223 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCCCCCC
Confidence 12245678999999988889999999999999999998 999986332111 111111 112233455
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
.++.+.+++.+||..+|.+||++. .++..|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFL-QLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHH-HHHHHHhc
Confidence 678999999999999999999999 45555543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=331.80 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=190.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|+..+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+++++.+.+.. |+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888999999999999999875 5689999987542 223356788999999999999999999997665 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999987643 4899999999999999999999998 999999999999999999999999999765421
Q ss_pred CCcc-----------------------------cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 003576 609 PSFV-----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659 (810)
Q Consensus 609 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~ 659 (810)
.... .........+||+.|+|||++.+..++.++|||||||++|+|++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 00000124579999999999998899999999999999999999999
Q ss_pred CccccchhhhhhccchhHHHhhhh-CCCCC--hhHHHHHHHHHHHHhhhcCC---CCCcccc
Q 003576 660 AIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSCAELRRK---DRPDLKN 715 (810)
Q Consensus 660 Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~Li~~cl~~dP~---~RPs~~~ 715 (810)
||........ +..+.... ...+| ...+..+.+|+.+++. +|. .||++.+
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 235 PFCSETPQET------YKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCHHHH------HHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 9964432221 11111110 01112 2356788899888654 344 4577774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.44 Aligned_cols=253 Identities=25% Similarity=0.461 Sum_probs=199.8
Q ss_pred CcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
+|.....||+|+||.||+|.... ..+++|.+..... .....+.+|+.+|+.++||||+++++.|.... ++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46777889999999999998642 4688888765432 23457889999999999999999999986554 89
Q ss_pred EEEeccCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003576 527 VYEYMENGSLEDRLYRKN---------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~N 585 (810)
||||+.+|+|.+++.... ...++++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1134789999999999999999999998 9999999999
Q ss_pred eEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCcccc
Q 003576 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAIT 664 (810)
Q Consensus 586 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~ 664 (810)
||+++++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYV----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchh----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999998654332211 1122356778999999888889999999999999999999 99999543
Q ss_pred chhhhhhccchhHHHhhhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 665 HKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 665 ~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.. ..+...+... ....+...+..+.+++.+||+.+|.+||++. +++..|+.+
T Consensus 234 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~-~i~~~l~~~ 286 (290)
T cd05045 234 AP-------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA-DISKELEKM 286 (290)
T ss_pred CH-------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHH
Confidence 21 1122222211 2233455678999999999999999999999 566666655
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.24 Aligned_cols=253 Identities=24% Similarity=0.414 Sum_probs=200.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
.+|....+||+|+||.||++... +..+++|.+..........+.+|+.+++.++||||+++++++.+.. ++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666788999999999999642 3478999887665556678999999999999999999999987554 89
Q ss_pred EEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 527 VYEYMENGSLEDRLYRKNN------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
+|||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875432 134789999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhcc
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 673 (810)
Q Consensus 595 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~ 673 (810)
||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.......
T Consensus 162 kL~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 232 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYR----VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----- 232 (280)
T ss_pred EECCCCceeEcCCCceee----cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----
Confidence 999999997654322110 1122345788999999988889999999999999999998 999985332211
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
.+...........+..++..+.+|+.+||+.||.+||++.+ |+..|+
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~-l~~~l~ 279 (280)
T cd05092 233 -AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKD-IHSRLQ 279 (280)
T ss_pred -HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHHh
Confidence 11112222222334456788999999999999999999994 555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.69 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=203.2
Q ss_pred HhhcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCC
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 523 (810)
...++|.....||+|+||.||++.+.+ ..+|+|.+..... .....+.+|+.++.++ +||||++++++|.+.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345578888999999999999998642 4789998875432 2345688999999999 799999999998765
Q ss_pred C--eEEEEeccCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe
Q 003576 524 G--CLVYEYMENGSLEDRLYRK-------------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl 588 (810)
. +++|||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 4 8999999999999998653 22345889999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 003576 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 667 (810)
Q Consensus 589 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~ 667 (810)
+.++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYR----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred cCCCeEEeCcccccccccccccee----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999999999999998765432111 1122345678999999888889999999999999999998 99998533211
Q ss_pred hhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 668 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 668 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
. ....+........+...+..+.+|+.+||..+|.+||++. .++..|+.+
T Consensus 242 ~------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-eil~~l~~~ 291 (293)
T cd05053 242 E------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291 (293)
T ss_pred H------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHHHHh
Confidence 1 0111111222344556678999999999999999999999 466666654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.47 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=192.3
Q ss_pred eeccCCcEEEEEEEE--CCeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHH
Q 003576 463 RIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLE 537 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~ 537 (810)
.||+|+||.||+|.+ .++.+|+|.+.... ......+.+|+.+|+.++||||++++++|.+.. ++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999987 46789999876443 233467899999999999999999999986655 8999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccccc
Q 003576 538 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617 (810)
Q Consensus 538 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 617 (810)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA----ST 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc----cc
Confidence 9986543 34889999999999999999999998 999999999999999999999999998765432110 00
Q ss_pred ccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhHHHHH
Q 003576 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKETKEL 695 (810)
Q Consensus 618 ~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~~l 695 (810)
.....++..|+|||++.++.++.++|||||||++|+|++ |.+||...... .....+.. .....+...+..+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRLPCPELCPDAV 225 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCCCCcccCCHHH
Confidence 111133567999999998889999999999999999998 88888533221 11111111 1233455667899
Q ss_pred HHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 696 AALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 696 ~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
.+|+.+||..+|.+||++. .++..|+
T Consensus 226 ~~li~~~l~~~p~~Rps~~-~~~~~l~ 251 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFS-TVHQELQ 251 (252)
T ss_pred HHHHHHHcCCChhhCcCHH-HHHHHHh
Confidence 9999999999999999999 4555553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.42 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=201.0
Q ss_pred hcCcccceeeccCCcEEEEEEEECC-----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
.++|...+.||+|+||.||+|.... ..+++|.+.... ......+.+|+.++.+++||||+++++++.+.. ++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999998742 268999886543 334567899999999999999999999986554 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999986543 34889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCC
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
...... ........+..|+|||++....++.++|||||||++|+|+| |+.||...... .....+......
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~~~ 229 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGFRL 229 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCCCC
Confidence 432111 11112234567999999988889999999999999999998 99999533221 111111111122
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+...+..+.+++.+||..+|.+||++. .|+..|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 33445678899999999999999999999 566666553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=316.08 Aligned_cols=241 Identities=21% Similarity=0.349 Sum_probs=204.9
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC--CeEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~E 529 (810)
.-|...+.||+|.|+.|-++++ .+..||||++.+.. ......+.+|+..|+.++|||||+||.+.... .|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3467777899999999999875 57899999998754 33456788999999999999999999998544 499999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe-cCCCceEEeeeccccccCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl-d~~~~~kL~DFGla~~~~~~ 608 (810)
+-++|+|.|+|.++.. .+.+....+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999987764 3899999999999999999999999 9999999999976 55699999999999877655
Q ss_pred CCcccccccccCCccCccccCccccccCCCC-CcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.. .+..+|...|.|||++.+..|+ ++.||||||||||-|++|++||...++. +.+..++|- ....
T Consensus 173 ~k-------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------ETLTmImDC-KYtv 238 (864)
T KOG4717|consen 173 KK-------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------ETLTMIMDC-KYTV 238 (864)
T ss_pred ch-------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch------hhhhhhhcc-cccC
Confidence 42 3456999999999999988886 7899999999999999999999755443 334445543 3557
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
|...+.++.+||..||..||++|.++.+
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 8889999999999999999999999774
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.30 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=202.5
Q ss_pred cCcccceeeccCCcEEEEEEEECC-----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~ 528 (810)
.+|....+||+|+||.||+|.+.. ..|++|...... ....+.+.+|+.++++++||||++++++|.+.. ++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457788899999999999998743 268999887654 344567899999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... ..+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999996543 24899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.. +......++..|+|||.+....++.++||||||+++|+|++ |.+||......+. +..+........
T Consensus 161 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~ 229 (270)
T cd05056 161 SY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERLPM 229 (270)
T ss_pred cc-----eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcCCC
Confidence 21 11122345678999999888889999999999999999996 9999964432211 111111112233
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
+...+..+.+++.+||..+|.+||++. .++..|+.+.
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~-~~~~~l~~~~ 266 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRFT-ELKAQLSDIL 266 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 456678999999999999999999998 4666666654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.27 Aligned_cols=246 Identities=26% Similarity=0.432 Sum_probs=202.3
Q ss_pred cCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
.+|.....||.|+||.||+|...+..||+|.+..... ..+++.+|+.++..++|+||+++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4678888999999999999999999999999976654 5677899999999999999999999986543 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999876542 24899999999999999999999999 99999999999999999999999999987643211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKE 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~ 691 (810)
...++..|+|||++.++.++.++||||||+++|+|++ |..||....... +...+.. .....+...
T Consensus 158 ------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 158 ------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRMEAPEGC 224 (256)
T ss_pred ------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCCCccCC
Confidence 2245678999999988889999999999999999997 999986432211 1111111 122334456
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFK-QLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHH-HHHHHHhc
Confidence 78999999999999999999998 56666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.47 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=197.1
Q ss_pred cCcccceeeccCCcEEEEEEEECCe----EEEEEEEccc-CccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSK-GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~----~vavK~l~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||.||+|..... .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.. ++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4688888999999999999987532 4688877643 223446788999999999 7999999999987655 899
Q ss_pred EEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 528 YEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1134889999999999999999999988 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhcc
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 673 (810)
Q Consensus 595 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~ 673 (810)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----- 226 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----- 226 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999986432111 0111233567999999988889999999999999999997 999995432211
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
.+..+........+...+..+.+|+.+||..+|.+||++.+ ++..|+.+.
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~~~ 276 (297)
T cd05089 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ-ISVQLSRML 276 (297)
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHH
Confidence 11112211122344557789999999999999999999994 555555554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.44 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=197.8
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
|...+.||.|+||.||+|.+. +..+|+|++..... .....+.+|+.+|+.++|+||+.+++++.+.. |+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999885 56899999865432 22345788999999999999999998886554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 999999988865432 35899999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
.....|+..|+|||++.+..++.++|||||||++|+|+||..||......... ..+...+......++..
T Consensus 158 -------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 158 -------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEEVYSAK 227 (285)
T ss_pred -------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhccccccCcc
Confidence 12347899999999998888999999999999999999999999643321110 11111111112234455
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
.+..+.+|+.+||..||.+||+..+.....|
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEV 258 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHH
Confidence 6788999999999999999999765443333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=350.85 Aligned_cols=264 Identities=21% Similarity=0.250 Sum_probs=203.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...++||+|+||.||+|.+. +..||+|++..... ....++.+|+.++++++||||+++++++.+.. ++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999885 56899999875422 23457899999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 529 EYMENGSLEDRLYRKNN--------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
||++||+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123567788999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcc------------cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 003576 601 LSTMLNSDPSFV------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 668 (810)
Q Consensus 601 la~~~~~~~~~~------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~ 668 (810)
+++......... ..........||+.|+|||++.+..++.++|||||||++|+|+||++||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998763211100 00111223579999999999999999999999999999999999999996422111
Q ss_pred hhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 669 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 669 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
.... ..+..+.........++.+.+++.+||..||++||+..+++...|+....
T Consensus 239 i~~~----~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR----DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1000 00011100011124567899999999999999999988888887776644
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.61 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=200.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--Ce----EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~----~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 527 (810)
.+|...++||.|+||.||+|.+. +. .||+|++..... .....+.+|+.++..++||||++++++|.... +++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 46788889999999999999864 22 489999875433 33567889999999999999999999986544 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|+|+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999886543 34899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 685 (810)
.... .......+++.|++||...+..++.++|||||||++|||+| |.+||..... ..+...+... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 230 (279)
T cd05109 162 DETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLLEKGERL 230 (279)
T ss_pred ccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcC
Confidence 3221 11122345678999999988889999999999999999998 8999853321 1112222221 12
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+...+..+.+++.+||..||.+||++.+ ++..|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~-l~~~l~~~ 268 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRE-LVDEFSRM 268 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHh
Confidence 234456788999999999999999999995 55665554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=335.27 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=190.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.|...++||+|+||.||+|... +..||+|++..... .....+.+|+.+|++++||||++++++|.+.. |+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999885 45899999875422 23456889999999999999999999997665 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999886643 4788899999999999999999998 9999999999999999999999999985432100
Q ss_pred Cc-----------------------------------------ccccccccCCccCccccCccccccCCCCCcchhhhHH
Q 003576 610 SF-----------------------------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 648 (810)
Q Consensus 610 ~~-----------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlG 648 (810)
.. ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 0000011234799999999999988999999999999
Q ss_pred HHHHHHHhCCCCccccchhhhhhccchhHHHhhhh-CCCC--ChhHHHHHHHHHHHHhhhcCCCCCc
Q 003576 649 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDW--PIKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 649 vil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~--p~~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
|++|+|+||++||......... ..++... .... ....++.+.+++.+|+ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ------MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH------HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 9999999999999754332211 1111110 1111 2345788999998876 49999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.25 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=198.9
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 524 (810)
.+++|...+.||+|+||.||+|.+.. ..|++|.+..... .....|.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999998854 4788888765432 23456899999999999999999999886554
Q ss_pred -eEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC---ceEE
Q 003576 525 -CLVYEYMENGSLEDRLYRKNN----TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKI 596 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~---~~kL 596 (810)
++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 899999999999999876432 124899999999999999999999998 99999999999998654 6899
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccch
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~ 675 (810)
+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~ 229 (277)
T cd05036 161 ADFGMARDIYRASYYR----KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------E 229 (277)
T ss_pred ccCccccccCCcccee----cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 9999998764322110 1112234578999999988899999999999999999997 99999643221 1
Q ss_pred hHHHhh-hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 676 LAEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 676 l~~~ld-~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+...+. ......|...+..+.+++.+||+.+|.+||++.+ |+..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~-vl~~l 275 (277)
T cd05036 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT-ILERI 275 (277)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHh
Confidence 112222 1223455667889999999999999999999995 54443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.09 Aligned_cols=285 Identities=23% Similarity=0.364 Sum_probs=211.9
Q ss_pred cCcccceeeccCCcEEEEEEEEC--Ce----EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~----~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 527 (810)
.+|...+.||+|+||.||+|.+. +. .+|+|.+..... .....+.+|+.+++.++||||++++|+|.... +++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45677788999999999999873 22 578888865433 22346889999999999999999999986544 799
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999987543 24888999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 685 (810)
.... .......++..|++||++.+..++.++|||||||++|+|++ |..||..... ..+..++... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 230 (303)
T cd05110 162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERL 230 (303)
T ss_pred cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC
Confidence 3211 11223356788999999988889999999999999999997 8899853321 1111222211 11
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHhhhccccCCCCCCCCCCCCccCccccccccC
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 757 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~~~~~~~~~~~~~~~~p~~f~cPi~~evM~d 757 (810)
..+...+..+.+++.+||..+|.+||++.+ ++..|+.+..-..+.....+......|.....|.+++.|.+
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKE-LAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDE 301 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhchhhheeeccCCcCCCCCCchhhHHhccccc
Confidence 223345678999999999999999999984 66677766443322221111123334555555666665554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.14 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=198.9
Q ss_pred CcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
.|...++||.|+||.||+|.+. +..||+|++...... ....+.+|+.++..++||||+++++++.+.. ++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566678999999999999864 257999998754332 2456889999999999999999999986554 88
Q ss_pred EEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 527 VYEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1234788889999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 672 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~ 672 (810)
+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||+| |.+||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 232 (283)
T cd05091 163 VKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 232 (283)
T ss_pred eEecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999998865432211 11123356789999999988889999999999999999998 8888854321
Q ss_pred cchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 673 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 673 ~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
...+..+........+...+..+.+|+.+||+.+|.+||++. +|+..|+
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~-~i~~~l~ 281 (283)
T cd05091 233 QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFK-DIHSRLR 281 (283)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHhh
Confidence 112222333333445667788999999999999999999998 4555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.55 Aligned_cols=246 Identities=24% Similarity=0.408 Sum_probs=196.2
Q ss_pred CcccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
+|...+.||+|+||.||+|.+.. ..+|+|++.... .....+.+|+.+++.++||||+++++++.+.. ++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46777889999999999998864 479999886433 23457889999999999999999999986655 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 999999875433 4899999999999999999999999 999999999999999999999999999765432111
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||........ ...+........+...+
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 227 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAGYRLYRPKLAP 227 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHHHHcCCcCCCCCCCC
Confidence 1112234567999999988889999999999999999999 8999964332211 11111111233455678
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
..+.+++.+||..+|.+||++.+ ++..
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~-~l~~ 254 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKK-LLSQ 254 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHH-HHHH
Confidence 89999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.77 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=201.0
Q ss_pred hcCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEecc
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 532 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~ 532 (810)
.++|...++||+|+||.||+|... +..+|+|.+..... ....+.+|+.++++++||||+++++++.+.. +++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 356888899999999999999875 46899999875443 4567899999999999999999999885544 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 9999998865443 35889999999999999999999998 999999999999999999999999999876532211
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......++..|+|||++....++.++||||||+++|+|++ |++||........ ...+........+...
T Consensus 159 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 228 (260)
T cd05067 159 ----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV------IQNLERGYRMPRPDNC 228 (260)
T ss_pred ----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHHcCCCCCCCCCC
Confidence 1123356778999999988889999999999999999999 9999964332111 1111111112334455
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
+..+.+++.+||..+|++||++. .+...|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~ 258 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFE-YLRSVLE 258 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHH-HHHHHhh
Confidence 67899999999999999999998 4655554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.20 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=198.7
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecC---C--C--
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---H--G-- 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~--~-- 524 (810)
.+..|...+.+|.|+||.||+|.... ..||||..-.+.... .+|+.+|+.++|||||+|+.+|.. . .
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 34568888999999999999999864 489999876554322 369999999999999999988732 2 2
Q ss_pred eEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeeccc
Q 003576 525 CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLS 602 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGla 602 (810)
.||||||+ .+|..++... .....++...+.-+.+||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 58999998 5898888742 12234777888999999999999999988 9999999999999976 99999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch------
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN------ 675 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~------ 675 (810)
+.+..+... .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+...+....-.
T Consensus 174 K~L~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 174 KVLVKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eeeccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 988765432 23478899999997655 5699999999999999999999999986554433221100
Q ss_pred hHHH--hhh--------h--CCC----CChhHHHHHHHHHHHHhhhcCCCCCccccchh-hHHHHHHHh
Q 003576 676 LAEI--LDA--------Q--AGD----WPIKETKELAALGLSCAELRRKDRPDLKNQVL-PVLERLKEV 727 (810)
Q Consensus 676 l~~~--ld~--------~--~~~----~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~-~~L~~l~~~ 727 (810)
..++ +.+ . ... +....++++.+|+.++|.++|..|.+..+.+. +..+.|++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0000 000 0 011 23356789999999999999999999886553 356666554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.65 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=195.4
Q ss_pred cCcccceeeccCCcEEEEEEEECC--e--EEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--T--FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~--~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||.||+|.+.. . .+++|.+.... ......+.+|+.++.++ +||||+++++++.+.. ++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999998753 2 45777665432 23445788999999999 8999999999987655 899
Q ss_pred EEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 528 YEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235889999999999999999999998 9999999999999999999
Q ss_pred EEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhcc
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 673 (810)
Q Consensus 595 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~ 673 (810)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|+| |.+||......+.
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---- 232 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---- 232 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH----
Confidence 999999986432111 0111234678999999988889999999999999999998 9999953322111
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
...+........+...+..+.+|+.+||..+|.+||++.+ ++..|..+
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-il~~l~~~ 280 (303)
T cd05088 233 --YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRM 280 (303)
T ss_pred --HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHH
Confidence 1111111112234446788999999999999999999995 55555554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.35 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=200.8
Q ss_pred hcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 524 (810)
.++|.....||+|+||.||+|.+.+ ..||+|.+..... .....+.+|+.+|..++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998753 4799999865432 33456889999999999999999999986555
Q ss_pred eEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEe
Q 003576 525 CLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 597 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~ 597 (810)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999875332 224788899999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchh
Q 003576 598 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNL 676 (810)
Q Consensus 598 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l 676 (810)
|||+++.+....... ......++..|+|||.+.++.++.++|||||||++|+|+| |.+||....... ..
T Consensus 162 dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 231 (277)
T cd05032 162 DFGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VL 231 (277)
T ss_pred CcccchhhccCcccc----cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HH
Confidence 999998665432111 1123356789999999988889999999999999999998 999985332211 11
Q ss_pred HHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 677 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 677 ~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
..+........|...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l 275 (277)
T cd05032 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLE-IVSSL 275 (277)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHH-HHHHh
Confidence 111222223445566889999999999999999999984 54444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.83 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=199.9
Q ss_pred cCcccceeeccCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 533 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 533 (810)
..|....+||+|+||.||+|.+.+. .+++|.+.... .....+.+|+.++++++|||++++++++.+.. ++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 4577888999999999999988653 78999876543 34567889999999999999999999886544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--
Confidence 99999987543 234889999999999999999999998 999999999999999999999999999876432211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......++..|+|||+..+..++.++||||||+++|+|+| |..||....... ....+........+...+
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERGYRMPCPQGCP 229 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCcccC
Confidence 1122356778999999988889999999999999999999 899996432211 111111111223344567
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
..+.+++.+||..+|.+||++. .|.+.|+
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 258 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFE-YIQSFLE 258 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHH-HHHHHHh
Confidence 8899999999999999999998 5666654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.88 Aligned_cols=255 Identities=22% Similarity=0.365 Sum_probs=201.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
.+|.....||+|+||.||+|+.. +..||||.+.... ......+.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999874 6799999876432 223456889999999999999999999886544 8999
Q ss_pred EeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886422 2345788999999999999999999998 99999999999999999999999999887653
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh-hCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~ 686 (810)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+...+.. ....
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 227 (267)
T cd08228 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FSLCQKIEQCDYPP 227 (267)
T ss_pred hhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HHHHHHHhcCCCCC
Confidence 221 1123468899999999988889999999999999999999999985332110 111111111 1111
Q ss_pred -CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 687 -WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 687 -~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
.+...+..+.+++.+||..+|.+||++. +++..|+.|+
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIG-YVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHH-HHHHHHHHhc
Confidence 1234567899999999999999999999 5777777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=332.23 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=195.6
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
...+|....+||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. |+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467899999999999999999885 5589999986432 223345788999999999999999999987665 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||++||+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988643 3788888999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccCccccCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||....... .+..++..
T Consensus 194 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~ 262 (370)
T cd05596 194 ANGMV-----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDH 262 (370)
T ss_pred CCCcc-----cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC
Confidence 32211 11235799999999987643 47899999999999999999999997543221 12222221
Q ss_pred h-CCCCCh--hHHHHHHHHHHHHhhhcCCC--CCccccc
Q 003576 683 Q-AGDWPI--KETKELAALGLSCAELRRKD--RPDLKNQ 716 (810)
Q Consensus 683 ~-~~~~p~--~~~~~l~~Li~~cl~~dP~~--RPs~~~~ 716 (810)
. ...+|. ..+..+.+|+.+||..+|.+ ||++.+.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 1 122332 46889999999999999987 9998853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.69 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=202.6
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||+|... +..|++|.++... ......+.+|+.++++++|+||+++++++.+.. ++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999985 6789999886432 223567889999999999999999999986654 8999
Q ss_pred EeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||+++|+|.+++... .....+++..++.++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 22345889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHh-hhhCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~~ 686 (810)
.... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+...+ ......
T Consensus 159 ~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 227 (267)
T cd08224 159 KTTA------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEKCDYPP 227 (267)
T ss_pred CCcc------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HHHHhhhhcCCCCC
Confidence 2211 123468899999999988889999999999999999999999995332110 0011111 111122
Q ss_pred CCh-hHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 687 WPI-KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 687 ~p~-~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.|. ..+..+.+++.+||..+|.+||++. .|+..|+.+
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~il~~~~~~ 265 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDIS-YVLQVAKEM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHH-HHHHHHHHh
Confidence 233 5667899999999999999999998 477777655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=329.25 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=202.4
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC-------eEEEEEEEcccCcc-chHHHHHHHHHHHhcC-CCceeeeeceecCCC
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIR-HPHLLLLLGACPDHG 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~ 524 (810)
...+|...++||+|+||.||+|++.+ ..||+|++...... ....+.+|+.+|.++. ||||++++++|....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 34567788899999999999998643 47999999764322 2346889999999997 999999999997654
Q ss_pred --eEEEEeccCCCHHHHHhhcCC---------------------------------------------------------
Q 003576 525 --CLVYEYMENGSLEDRLYRKNN--------------------------------------------------------- 545 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 545 (810)
++||||+++|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 899999999999999975321
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceE
Q 003576 546 --------------------------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587 (810)
Q Consensus 546 --------------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NIL 587 (810)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 124677888999999999999999988 999999999999
Q ss_pred ecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccch
Q 003576 588 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 666 (810)
Q Consensus 588 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~ 666 (810)
++.++.+||+|||+++.+....... ......++..|+|||++....++.++|||||||++|||++ |..||.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYI----SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EeCCCEEEEEecCcceecccccccc----cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999998654322111 1122357888999999988889999999999999999998 8899864322
Q ss_pred hhhhhccchhHHHhhhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 667 VETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 667 ~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.+. +...+... ....|...+..+.+|+.+||..+|..||++. .|+..|+.+
T Consensus 348 ~~~------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L~~~ 399 (401)
T cd05107 348 NEQ------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLVGDL 399 (401)
T ss_pred hHH------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 111 11111111 2234555678999999999999999999999 576777665
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.10 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=200.4
Q ss_pred HHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--e
Q 003576 450 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 525 (810)
Q Consensus 450 ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 525 (810)
|++.+++++.....||+|+||.||+|.+. +..|++|.+..........+.+|+.++++++||||+++++++.+.. +
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34566778888889999999999999875 4579999887766556678999999999999999999999987655 8
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-CCceEEeeeccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTM 604 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-~~~~kL~DFGla~~ 604 (810)
+|+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999875432211277888899999999999999988 999999999999976 67999999999976
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
...... ......|++.|+|||++.... ++.++||||||+++|+|++|++||.......... .......
T Consensus 159 ~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~~~ 228 (268)
T cd06624 159 LAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGMFK 228 (268)
T ss_pred cccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhhhc
Confidence 543221 112236889999999886543 7889999999999999999999996432211111 0001111
Q ss_pred hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 683 ~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.....|......+.+|+.+||..+|.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 2234555677889999999999999999999853
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=329.12 Aligned_cols=245 Identities=24% Similarity=0.289 Sum_probs=196.6
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|.....||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999875 56899999875422 23456789999999999999999999986654 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999987653 24899999999999999999999999 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCccccCccccc------cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQR------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ +..++..
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~ 224 (330)
T cd05601 156 KMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNF 224 (330)
T ss_pred Cce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcC
Confidence 221 122347899999999876 45678999999999999999999999964433221 1222211
Q ss_pred h-CCCCC--hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 683 Q-AGDWP--IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 683 ~-~~~~p--~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
. ...+| ...+..+.+|+.+||. +|.+||++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 1 11122 2467889999999998 999999998533
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.59 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=203.4
Q ss_pred hcCcccceeeccCCcEEEEEEEECC---------eEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCC
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~---------~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 523 (810)
..+|...+.||+|+||.||++.+.+ ..+|+|++.... ......+.+|+.++..+ +||||++++++|.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578899999999999999997632 369999987643 23345688899999999 799999999998665
Q ss_pred C--eEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe
Q 003576 524 G--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl 588 (810)
. ++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 5 899999999999999976431 124889999999999999999999998 9999999999999
Q ss_pred cCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 003576 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 667 (810)
Q Consensus 589 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~ 667 (810)
+.++.+||+|||++..+....... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhh----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence 999999999999987654322111 1112234578999999988889999999999999999998 8888853321
Q ss_pred hhhhccchhHHHhhhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHh
Q 003576 668 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 668 ~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~ 727 (810)
. .+...+... ....+...+..+.+|+.+||..+|.+||++. .++..|+.+...
T Consensus 249 ~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~~l~~~~~~ 302 (307)
T cd05098 249 E------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILAL 302 (307)
T ss_pred H------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHHH
Confidence 1 111112111 2234556678999999999999999999999 577777776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.66 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=193.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCc-eeeeeceecCC-------
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPH-LLLLLGACPDH------- 523 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~------- 523 (810)
..|....+||+|.||+||+|+.. +..||+|++.-.... ......+|+.+|+.|+|+| |+.|++++...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666778999999999999885 568999998765432 3445689999999999999 99999998542
Q ss_pred -CeEEEEeccCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 -GCLVYEYMENGSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.++|+||++ .+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 278999996 6999999765532 34777889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
|+.+.-... ..+..++|..|.|||++.+. .|++..||||+|||++||+++++-|............. .++
T Consensus 167 Ara~~ip~~------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If---~~l 237 (323)
T KOG0594|consen 167 ARAFSIPMR------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF---RLL 237 (323)
T ss_pred HHHhcCCcc------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH---HHc
Confidence 996653221 13455899999999987766 69999999999999999999999998665543322111 111
Q ss_pred hh-hCCCCC------------------h-------hHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 681 DA-QAGDWP------------------I-------KETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 681 d~-~~~~~p------------------~-------~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.. ....|| . ...+...+++.+||+.+|.+|.++..
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 10 001111 1 11247899999999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=323.16 Aligned_cols=250 Identities=24% Similarity=0.450 Sum_probs=207.6
Q ss_pred cccceeeccCCcEEEEEEEECC------eEEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYE 529 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~------~~vavK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~E 529 (810)
....++||.|-||.||+|.+.. -.||||..+.+ .....+.|+.|..+|+.++|||||+|+|+|.+.. +||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 3445679999999999998742 26889988764 3445678999999999999999999999998877 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
.++.|.|..+|..+... ++......++.||+.||.|||+.. +|||||-..|||+..+-.+||+|||+++.+.+..
T Consensus 471 L~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999876654 888899999999999999999999 9999999999999999999999999999988654
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.+ +.+...-..-|||||-+.-..++.+||||.|||++||++. |..||......+. +..+-...+...|
T Consensus 546 yY-----kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------I~~iEnGeRlP~P 614 (974)
T KOG4257|consen 546 YY-----KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------IGHIENGERLPCP 614 (974)
T ss_pred hh-----hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce------EEEecCCCCCCCC
Confidence 32 2333345677999999999999999999999999999886 9999975433221 1112223356778
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+++.|..|+.+||.++|.+||.+.+ +...|..+
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrfte-i~~~lsdv 649 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTE-IKAILSDV 649 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHH-HHHHHHHH
Confidence 899999999999999999999999984 54444443
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.28 Aligned_cols=245 Identities=32% Similarity=0.537 Sum_probs=200.2
Q ss_pred eeccCCcEEEEEEEEC-----CeEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+. +..+++|++....... ...+.+|+.++..++|+||+++++++.+.. ++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6899999999999886 5689999988764433 677899999999999999999999987654 8999999999
Q ss_pred CHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 535 SLEDRLYRKNN------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 535 sL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999876521 245899999999999999999999988 999999999999999999999999999877654
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... .......+++.|+|||.+....++.++|||||||++|+|++ |..||....... ....+........
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 228 (262)
T cd00192 159 DYY----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEYLRKGYRLPK 228 (262)
T ss_pred ccc----ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCC
Confidence 321 11234467889999999988889999999999999999999 699996542211 1122222223345
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~l 261 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSE-LVERL 261 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHH-HHHhh
Confidence 5667899999999999999999999984 44433
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.13 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=199.6
Q ss_pred cCcccceeeccCCcEEEEEEEEC-----CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
.+|...+.||+|+||.||+|.+. ...+|+|.+.... ......+.+|+.+|.+++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778889999999999999873 2378999886543 223467899999999999999999999986544 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999987643 34889999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
..... .......++..|++||++.+..++.++|||||||++|++++ |..||....... ....+.+.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 229 (267)
T cd05066 159 DPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLP 229 (267)
T ss_pred cccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCcCC
Confidence 32211 11122334678999999998889999999999999999886 999986432211 111112211223
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
.+...+..+.+++.+||+.+|.+||++. .++..|+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 265 (267)
T cd05066 230 APMDCPAALHQLMLDCWQKDRNERPKFE-QIVSILDK 265 (267)
T ss_pred CCCCCCHHHHHHHHHHcccCchhCCCHH-HHHHHHHh
Confidence 3445678899999999999999999999 56666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.13 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=203.2
Q ss_pred hcCcccceeeccCCcEEEEEEEECC------eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecC---CC
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HG 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~------~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~~ 524 (810)
.++|.....||+|+||.||+|.+.. ..|++|.+.... ......+.+|+.+|++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999754 588999876543 2335668899999999999999999998754 23
Q ss_pred eEEEEeccCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeee
Q 003576 525 CLVYEYMENGSLEDRLYRKNNT-----PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DF 599 (810)
+++++|+++|+|.+++...... ..+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998764322 45899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHH
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 678 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~ 678 (810)
|+++.+....... ......++..|+|||++.+..++.++|||||||++|++++ |++||....... +..
T Consensus 162 g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~ 230 (280)
T cd05043 162 ALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAA 230 (280)
T ss_pred CCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHH
Confidence 9998664332111 1122356778999999988889999999999999999999 999996432211 111
Q ss_pred Hh-hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 679 IL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 679 ~l-d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
.+ +......+...+..+.+++.+||..+|++||++. +++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~~~~l~~~~ 277 (280)
T cd05043 231 YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFS-QLVQCLTDFH 277 (280)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 11 1111223445678899999999999999999999 5777776654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.44 Aligned_cols=244 Identities=25% Similarity=0.286 Sum_probs=189.0
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||++++++|.+.. |+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36888899999999999999885 5689999987532 223455888999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986533 24889999999999999999999999 999999999999999999999999998765433
Q ss_pred CCcccccccccCCccCccccCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
... ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||......+. +..++...
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~ 224 (331)
T cd05597 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (331)
T ss_pred CCc-----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence 211 1122469999999998763 4578899999999999999999999964432221 11111110
Q ss_pred ----CCCCChhHHHHHHHHHHHHhhhcCC--CCCcccc
Q 003576 684 ----AGDWPIKETKELAALGLSCAELRRK--DRPDLKN 715 (810)
Q Consensus 684 ----~~~~p~~~~~~l~~Li~~cl~~dP~--~RPs~~~ 715 (810)
........+..+.+|+.+|+..++. .||++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~ 262 (331)
T cd05597 225 EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD 262 (331)
T ss_pred CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 0111123578899999998865333 3667764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.61 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=204.3
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC---------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecC
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPD 522 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~---------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~ 522 (810)
...+|.....||+|+||.||+|.+. ...+|+|++.... ......+.+|+.++..+ +||||+++++++.+
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3457888899999999999999752 2368999887543 23446788999999999 79999999999866
Q ss_pred CC--eEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceE
Q 003576 523 HG--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587 (810)
Q Consensus 523 ~~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NIL 587 (810)
.. ++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 54 899999999999999876421 234788899999999999999999998 999999999999
Q ss_pred ecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccch
Q 003576 588 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 666 (810)
Q Consensus 588 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~ 666 (810)
++.++.+||+|||+++.+....... ......++..|+|||++.+..++.++||||||+++|+|+| |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccc----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999998765432211 1122356778999999988889999999999999999998 7888853321
Q ss_pred hhhhhccchhHHHh-hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHh
Q 003576 667 VETAIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 667 ~~~~~~~~~l~~~l-d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~ 727 (810)
.+ +...+ .......+...+..+.+|+.+||..+|.+||++. +++..|+++...
T Consensus 246 ~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~l~~l~~~~~~ 299 (304)
T cd05101 246 EE-------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK-QLVEDLDRILTL 299 (304)
T ss_pred HH-------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHHHHh
Confidence 11 11111 1112233456678999999999999999999998 577777777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.10 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=194.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.+|...++||+|+||.||+|... +..||+|++..........+.+|+.++.+++||||+++++++.+.. ++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888899999999999999974 5689999987655445567889999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999886543 4889999999999999999999998 99999999999999999999999999987643211
Q ss_pred ccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
......|++.|+|||.+. ...++.++|||||||++|+|++|++||.............. ..+.......+
T Consensus 162 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (267)
T cd06646 162 -----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKLKDK 234 (267)
T ss_pred -----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCCccc
Confidence 122346889999999874 34578899999999999999999999853322211110000 00000001112
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+..+.+|+.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 235678999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.50 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=193.7
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
|+..+.||+|+||.||++.+. +..||+|.+...... ....+.+|+.++.+++|+||+.+++.+.+.. |+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999986 458999988654322 2345778999999999999999999986554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 34889999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
.....|+..|+|||++.+..++.++|||||||++|+|++|++||....... ........+.......+..
T Consensus 158 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05630 158 -------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEVQEEYSEK 227 (285)
T ss_pred -------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhhhhhhcCcc
Confidence 123478999999999998899999999999999999999999996432110 0111112222212233445
Q ss_pred HHHHHHHHHHHHhhhcCCCCCcc
Q 003576 691 ETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
.+..+.+|+.+||+.||.+||++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCC
Confidence 67889999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=317.15 Aligned_cols=259 Identities=23% Similarity=0.396 Sum_probs=196.0
Q ss_pred cCcccceeeccCCcEEEEEEEECC----------------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH----------------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLG 518 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~----------------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g 518 (810)
+.|...++||+|+||.||++...+ ..||+|.+..... .....|.+|+++|.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888899999999999987643 2589999876432 23456899999999999999999999
Q ss_pred eecCCC--eEEEEeccCCCHHHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceE
Q 003576 519 ACPDHG--CLVYEYMENGSLEDRLYRKN---------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587 (810)
Q Consensus 519 ~~~~~~--~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NIL 587 (810)
++.... ++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 986544 89999999999999886532 1134788899999999999999999998 999999999999
Q ss_pred ecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh--CCCCccccc
Q 003576 588 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITH 665 (810)
Q Consensus 588 ld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt--g~~Pf~~~~ 665 (810)
++.++.+||+|||++..+...... .......++..|+|||++..+.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999765432211 11123355778999999988889999999999999999998 567775432
Q ss_pred hhhhhhccchhHHH-hhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 666 KVETAIDEDNLAEI-LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 666 ~~~~~~~~~~l~~~-ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
.............. ........+...+..+.+|+.+||..+|.+||++. .|++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN-KIHHFLR 294 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHh
Confidence 21110000000000 00001122334578999999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=309.78 Aligned_cols=246 Identities=23% Similarity=0.373 Sum_probs=197.3
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc---------hHHHHHHHHHHHhcCCCceeeeeceecCCC--
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---------NKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~---------~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 524 (810)
|.....||.|+||.||+|.+. +..+|+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566788999999999999874 5689999886543221 245788999999999999999999986554
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 89999999999999996543 4888899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
+.................|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 229 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKIGENAS 229 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHHhccCC
Confidence 75322111111112234688999999999888899999999999999999999999964432221 112222222
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+...+..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 3445567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.34 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=199.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 524 (810)
...+|....+||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999754 23799998764432 23346788999999999999999999986554
Q ss_pred -eEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEE
Q 003576 525 -CLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL 596 (810)
++||||+++|+|.+++..... .+.+.+..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 899999999999999975321 234577788999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccch
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~ 675 (810)
+|||+++.+....... ......++..|+|||++.++.++.++|||||||++|+|++ |.+||......+ .
T Consensus 161 ~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------V 230 (288)
T ss_pred CcCCcccccccccccc----ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence 9999998654322111 1122345778999999988889999999999999999998 788885432211 1
Q ss_pred hHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 676 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 676 l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
...+.+......+...+..+.+++.+||+.+|.+||++.+ ++..|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~~ 277 (288)
T cd05061 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE-IVNLLKD 277 (288)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHHh
Confidence 1122222223344456789999999999999999999984 5444443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=321.84 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=189.6
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|....+||+|+||.||++.+.+ ..+|+|++.... ......+.+|+.++..++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368888999999999999999864 589999986432 222345788999999999999999999986655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 4889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCcccccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......+. +..+....
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~ 224 (332)
T cd05623 156 GTV-----QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (332)
T ss_pred Ccc-----eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCC
Confidence 211 112347999999999875 34688999999999999999999999964432221 11121111
Q ss_pred -CCCCC---hhHHHHHHHHHHHHhhhcCCC--CCcccc
Q 003576 684 -AGDWP---IKETKELAALGLSCAELRRKD--RPDLKN 715 (810)
Q Consensus 684 -~~~~p---~~~~~~l~~Li~~cl~~dP~~--RPs~~~ 715 (810)
...+| ...+..+.+|+.+|+..++.. |+++.+
T Consensus 225 ~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~ 262 (332)
T cd05623 225 ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIED 262 (332)
T ss_pred ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHH
Confidence 11122 345788999999988654443 567664
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=307.56 Aligned_cols=247 Identities=22% Similarity=0.297 Sum_probs=198.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
++|...+.||+|+||.||++... +..+++|.+..... .....+.+|+.++++++||||+++++++.+.. ++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47888999999999999999874 56999998865422 12346888999999999999999999987655 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886543 4888899999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... ..........
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSG---TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-----KIATQPTNPQ 227 (263)
T ss_pred cccccc---ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-----HHhccCCCCC
Confidence 321110 01123468889999999998889999999999999999999999996433222111 0011111233
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.|...+..+.+++.+||..+|.+||++.++
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 257 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEEL 257 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 455678899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.78 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=198.8
Q ss_pred hcCcccceeeccCCcEEEEEEEECC------------------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceee
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH------------------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLL 515 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~------------------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~ 515 (810)
...|.....||+|+||.||++.+.. ..||+|++..... .....+.+|+.+|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3468888999999999999988643 3589999876543 34567889999999999999999
Q ss_pred eeceecCCC--eEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003576 516 LLGACPDHG--CLVYEYMENGSLEDRLYRKNN--------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585 (810)
Q Consensus 516 l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~N 585 (810)
++++|.+.. ++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999986644 899999999999999876431 225899999999999999999999998 9999999999
Q ss_pred eEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh--CCCCccc
Q 003576 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAI 663 (810)
Q Consensus 586 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt--g~~Pf~~ 663 (810)
||++.++.++|+|||+++........ .......+++.|+|||++.++.++.++|||||||++|+|++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999765432211 11223456788999999988889999999999999999998 6778754
Q ss_pred cchhhhhhccchhHHHh----hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 664 THKVETAIDEDNLAEIL----DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 664 ~~~~~~~~~~~~l~~~l----d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
....... . ...... .......+...+.++.+|+.+||+.||.+||++.+ |+..|+
T Consensus 237 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e-l~~~L~ 295 (296)
T cd05051 237 LTDQQVI-E--NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE-IHLFLQ 295 (296)
T ss_pred cChHHHH-H--HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHH-HHHHhc
Confidence 3221110 0 000000 00011223445688999999999999999999994 555543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=297.82 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=197.2
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--------chHHHHHHHHHHHhc-CCCceeeeeceecCC
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--------QNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--------~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 523 (810)
-++|.....||+|+.+.|.++..+ +..+|+|++...... -.+.-.+|++||+++ .||||+++.++|...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 345677778999999999998876 447888887643221 123456899999998 599999999999877
Q ss_pred C--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
. ++|+|.|+.|.|.|+|...- .+++....+|+.|+..|+.|||..+ ||||||||+|||+|+|..+||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 6 78999999999999997643 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCcccccc------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~ 675 (810)
++.+..+.. ....+|||+|+|||.+.. ..|+...|+|++|||+|.||.|.+||..-..+ .
T Consensus 170 a~~l~~Gek-------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------l 235 (411)
T KOG0599|consen 170 ACQLEPGEK-------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------L 235 (411)
T ss_pred eeccCCchh-------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------H
Confidence 998876542 345699999999997653 34788999999999999999999999633221 1
Q ss_pred hHHHhhhh-----CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 676 LAEILDAQ-----AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 676 l~~~ld~~-----~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
+..++... .++| .+.+....+||.+||+.||.+|.|..+.+..
T Consensus 236 MLR~ImeGkyqF~speW-adis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 MLRMIMEGKYQFRSPEW-ADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHhcccccCCcch-hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11222211 2233 3568889999999999999999999976543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.99 Aligned_cols=256 Identities=29% Similarity=0.405 Sum_probs=203.6
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc-------hHHHHHHHHHHHhcCCCceeeeeceec---C
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGACP---D 522 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~-------~~~~~~Ei~iL~~l~HpnIv~l~g~~~---~ 522 (810)
...|-...+||+|||+.||++.+- ++.||||+-..+.... .+...+|..|-+.|+||.||++|++|. +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 345777788999999999999873 6799999876543221 234678999999999999999999983 4
Q ss_pred CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC---CCceEEeee
Q 003576 523 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDV 599 (810)
Q Consensus 523 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~---~~~~kL~DF 599 (810)
..|-|+|||+|.+|+-+|..+. .+++.++..|+.||+.||.||.... .||||-||||.||||-. -|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 4589999999999999987654 3899999999999999999999988 68999999999999944 488999999
Q ss_pred ccccccCCCCCc-ccccccccCCccCccccCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc
Q 003576 600 GLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 674 (810)
Q Consensus 600 Gla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~ 674 (810)
|++++++++... ...........||.+|++||++.-+ .++.++||||.|||+|+.+.|+.||+........+..+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999998865432 2222234556899999999977544 47889999999999999999999998766555555554
Q ss_pred hhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 675 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 675 ~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.+.....-..+.. +..+.+...+|.+||.+.-++|.+..+
T Consensus 698 TIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 698 TILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred chhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 4433222222222 356789999999999999999998764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=308.98 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=196.4
Q ss_pred eeccCCcEEEEEEEECC---e--EEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFHH---T--FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~---~--~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~gs 535 (810)
.||+|+||.||+|.+.. + .+|+|.+..... ...+.+.+|+.++++++||||+++++.+.+.. ++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 58999999999998743 2 689999887655 55678999999999999999999999987733 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-- 155 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-- 155 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee--
Confidence 9999876543 45899999999999999999999998 99999999999999999999999999988754322111
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh-hhhCCCCChhHHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETK 693 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~~~p~~~~~ 693 (810)
......++..|+|||++.+..++.++|||||||++|+|+| |+.||......+.. ..+. .......+...+.
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 228 (257)
T cd05040 156 -MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL------KKIDKEGERLERPEACPQ 228 (257)
T ss_pred -cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCCcCCCCccCCH
Confidence 1123467889999999988889999999999999999999 99999533222110 1111 1111223445678
Q ss_pred HHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 694 ELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 694 ~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
.+.+++.+||..+|.+||++.+ ++..|
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~-~~~~l 255 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAA-LREFL 255 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHH-HHHHh
Confidence 8999999999999999999995 44433
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.92 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=201.8
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCC
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 523 (810)
...++|...+.||+|+||.||++.+. ...+|+|++.... ......+.+|+.+++++ +||||++++++|...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467899999999999999999752 2378999887543 23345689999999999 799999999998655
Q ss_pred C--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
. ++||||+++|+|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 4 899999999999999875432 33899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
+..+....... ......++..|+|||++..+.++.++|||||||++|+|+| |.+||....... .+...+
T Consensus 188 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~ 257 (302)
T cd05055 188 ARDIMNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLI 257 (302)
T ss_pred cccccCCCcee----ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHH
Confidence 98665432111 1122356788999999988889999999999999999998 999986432211 111222
Q ss_pred hhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 681 DAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 681 d~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
... ....+...+..+.+|+.+||..+|.+||++. +++..|+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ell~~l~~ 300 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFK-QIVQLIGK 300 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHh
Confidence 211 1222334578899999999999999999999 46666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=299.24 Aligned_cols=242 Identities=23% Similarity=0.369 Sum_probs=196.4
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
+++|+.-..||+|.|+.||++... +..+|+|++... ...+.+.+.+|+.|-+.|+||||++|...+.+.. |||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 346677778999999999998775 457888876533 3336678899999999999999999999987665 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec---CCCceEEeeecccccc
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTML 605 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld---~~~~~kL~DFGla~~~ 605 (810)
|+|.|++|..-|..+. .+++..+-.++.||+.+|.|+|.++ |||||+||+|+||. ..--+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999976665442 3778888999999999999999999 99999999999994 3457899999999988
Q ss_pred CCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC-
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 684 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~- 684 (810)
.... ...+.+|||.|||||++...+|+..+|||+.|||||-||.|.+||...+. ..+.+-+....
T Consensus 164 ~~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------~rlye~I~~g~y 229 (355)
T KOG0033|consen 164 NDGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYEQIKAGAY 229 (355)
T ss_pred CCcc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhcccc
Confidence 7322 23467999999999999999999999999999999999999999975221 11222222221
Q ss_pred ----CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 685 ----GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 685 ----~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..| ...+++..+|+.+||..||.+|.|+.+.+
T Consensus 230 d~~~~~w-~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 230 DYPSPEW-DTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCCCccc-CcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 233 35689999999999999999999998644
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.95 Aligned_cols=241 Identities=29% Similarity=0.360 Sum_probs=190.6
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|.....||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|.+++||||++++++|.... ++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677789999999999999874 5689999986542 233456889999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 3678889999999999999999998 9999999999999999999999999997654321
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch-hHHHhhhhCCCC-Ch
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN-LAEILDAQAGDW-PI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~-l~~~ld~~~~~~-p~ 689 (810)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.............. ...+.+...... ..
T Consensus 150 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 150 ------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 1234789999999999888899999999999999999999999964221111111111 111111111111 12
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
..+..+.+++.+||+.+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 35678999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.59 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=192.8
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
...+|.....||+|+||.||++.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.. |+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467899999999999999999986 4589999986432 223445789999999999999999999987655 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988543 3788899999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccCccccCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
.... .......||+.|+|||++.+. .++.++|||||||++|+|+||++||....... .+..+++.
T Consensus 194 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~ 262 (370)
T cd05621 194 ETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH 262 (370)
T ss_pred cCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence 3221 112345799999999988653 37889999999999999999999996443221 22233322
Q ss_pred h-CCCCCh--hHHHHHHHHHHHHhhhcCC--CCCcccc
Q 003576 683 Q-AGDWPI--KETKELAALGLSCAELRRK--DRPDLKN 715 (810)
Q Consensus 683 ~-~~~~p~--~~~~~l~~Li~~cl~~dP~--~RPs~~~ 715 (810)
. ...+|. ..+..+.+++.+|+..++. .||++.+
T Consensus 263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 1 122333 4578899999999985543 3778774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.68 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=198.2
Q ss_pred CcccceeeccCCcEEEEEEEECC-----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
.|...+.||+|+||.||+|.+.. ..||||++.... ......|..|+.+++.++||||+++++++.+.. ++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999998753 369999987542 334567999999999999999999999986655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999886543 34889999999999999999999998 999999999999999999999999998876543
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
...... ........+..|+|||++.+..++.++|||||||++|||++ |..||........ ...+........
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~------~~~i~~~~~~~~ 232 (269)
T cd05065 160 TSDPTY-TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------INAIEQDYRLPP 232 (269)
T ss_pred cccccc-ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH------HHHHHcCCcCCC
Confidence 221110 00111123457999999998899999999999999999887 9999964332111 111111111233
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
+...+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 267 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFG-QIVSTLDK 267 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHh
Confidence 445678899999999999999999998 46666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=309.39 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=196.7
Q ss_pred CcccceeeccCCcEEEEEEEE-CCeEEEEEEEcccCc------cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
+|.....||.|+||.||+|.. .+..+|+|.+..... .....+.+|+++|+.++|+||++++++|.+.. ++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367778899999999999987 456899998765421 12345889999999999999999999997665 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999986543 3788999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
...............|+..|+|||++.+..++.++|||||||++|+|++|..||.............. ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA----HRGLMPRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----ccCCCCCC
Confidence 22111111112334689999999999988899999999999999999999999964332221110000 00111234
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
+..++..+.+++.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 4567889999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=315.40 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=198.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
..|.....||+|+||.||+|... +..+++|.+..........+.+|+.+++.++||||+++++.|.+.. |+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888889999999999999874 5689999988766556677899999999999999999999886544 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999988542 3788899999999999999999998 999999999999999999999999998765432211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh-CCCCChh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIK 690 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~ 690 (810)
.....|++.|+|||++.+..++.++|||||||++|+|++|++||.......... ....... ....+..
T Consensus 173 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~ 241 (296)
T cd06654 173 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGTPELQNPEK 241 (296)
T ss_pred ------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-----HHhcCCCCCCCCccc
Confidence 123468899999999988889999999999999999999999996443221111 0000110 1122345
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+..+.+|+.+||..+|.+||++.+++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil 268 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELL 268 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHh
Confidence 678899999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.74 Aligned_cols=248 Identities=19% Similarity=0.282 Sum_probs=187.2
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCC---------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--------- 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--------- 523 (810)
..+|...++||+|+||.||+|... +..||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 346888999999999999999885 5689999885432 2345799999999999999998876321
Q ss_pred -CeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeec
Q 003576 524 -GCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 600 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFG 600 (810)
.++||||++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 258999997 4777766532 22345899999999999999999999999 9999999999999866 479999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch----
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---- 675 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~---- 675 (810)
+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||.+||..............
T Consensus 217 la~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 217 SAKNLLAGQR-------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred cchhccCCCC-------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9987653221 123478999999998765 4689999999999999999999999975433221110000
Q ss_pred --hHH--Hhhhh--------------CCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 676 --LAE--ILDAQ--------------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 676 --l~~--~ld~~--------------~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
... .+.+. ...+|...+.++.+|+.+||..||.+||++.+.+
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 00000 0012233567899999999999999999999654
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=313.66 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=199.6
Q ss_pred hcCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 524 (810)
.++|.....||+|+||.||++.+. +..+|+|++..... .....+.+|+.+++.++||||++++++|.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999863 45899999875432 23466889999999999999999999987654
Q ss_pred eEEEEeccCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003576 525 CLVYEYMENGSLEDRLYRKN-------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 585 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~N 585 (810)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 89999999999999986432 1234788899999999999999999998 9999999999
Q ss_pred eEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCcccc
Q 003576 586 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAIT 664 (810)
Q Consensus 586 ILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~ 664 (810)
||++.++.++|+|||++..+....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYK----ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcccc----ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999987654322110 0112245677999999888889999999999999999998 88888533
Q ss_pred chhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 665 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 665 ~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
...+ ....+.+......+...+..+.+|+.+||..+|.+||++.+ ++..|+
T Consensus 237 ~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e-l~~~l~ 287 (288)
T cd05050 237 AHEE------VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS-INRILQ 287 (288)
T ss_pred CHHH------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHH-HHHHhh
Confidence 2211 11112222222334456788999999999999999999994 666654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=349.93 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=196.6
Q ss_pred HHhhcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC----
Q 003576 452 ESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---- 523 (810)
Q Consensus 452 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---- 523 (810)
+....+|.+..+||.|+||.||++.+.. ..+|+|++.... ......|..|+.+|.+|+|||||+++++|.+.
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445689999999999999999999864 588999887542 22346688999999999999999999987432
Q ss_pred CeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCEEecCCCCCceEecC--------
Q 003576 524 GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKP----KPIIHRDMKPGNILLDH-------- 590 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~~ivHrDLkp~NILld~-------- 590 (810)
.||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 389999999999999987532 22459999999999999999999998542 34999999999999964
Q ss_pred ---------CCceEEeeeccccccCCCCCcccccccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCC
Q 003576 591 ---------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKP 659 (810)
Q Consensus 591 ---------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~ 659 (810)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|+||+.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc-------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 34589999999987643221 123479999999998754 458899999999999999999999
Q ss_pred CccccchhhhhhccchhHHHhhhhCCCCC-hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 660 AIAITHKVETAIDEDNLAEILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 660 Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p-~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
||......... ...+... ...+ ...+..+.+||..||..+|.+||++.+.+
T Consensus 242 PF~~~~~~~ql------i~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 242 PFHKANNFSQL------ISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCcCCcHHHH------HHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99644332221 1111111 1122 23578899999999999999999998644
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.64 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=215.6
Q ss_pred cccceeeccCCcEEEEEEEEC-----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
..+.+.||.|.||.||+|+++ ...||||.++.... ..+.+|+.|..||.+++||||++|.|+..... .||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 345678999999999999985 23899999987654 45678999999999999999999999986655 78999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
||++|+|+.+|..+.+. +.+.+...+++.|+.|+.||-+.+ +|||||-..|||++.|..+|++|||+++.+.++.
T Consensus 711 yMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999877643 888899999999999999999999 9999999999999999999999999999887655
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.. .|...+..-...|.|||.+...++|.+||||||||+|||.++ |..||.... +.+-+..+-+......|
T Consensus 786 ~~---~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS------NQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 786 EA---AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS------NQDVIKAIEQGYRLPPP 856 (996)
T ss_pred Cc---cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc------hHHHHHHHHhccCCCCC
Confidence 22 222233344678999999999999999999999999999876 888885322 23334444455567788
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHhhh
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 729 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~~~ 729 (810)
.+++..|.+|++.||++|..+||.+. +|+..|++|..-..
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~-qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFA-QIVSTLDKLIRNPN 896 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHH-HHHHHHHHHhcCch
Confidence 99999999999999999999999999 57788888765444
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=322.13 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=204.4
Q ss_pred hhcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCcc---chHHHHHHHHHHHhcC-CCceeeeeceecCCC--e
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI---QNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 525 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~ 525 (810)
....|.....||+|.||.||+++... ..+|+|++.+.... ....+.+|+.||+++. |||||.++++|.+.. +
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888899999999999999864 58999999876543 3357899999999998 999999999998766 8
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC----CCceEEeeecc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDVGL 601 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~----~~~~kL~DFGl 601 (810)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|||+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2899999999999999999999999 999999999999953 35899999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld 681 (810)
+...... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .....-++
T Consensus 186 a~~~~~~-------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~i~~~~~~ 256 (382)
T KOG0032|consen 186 AKFIKPG-------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--AILRGDFD 256 (382)
T ss_pred ceEccCC-------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--HHHcCCCC
Confidence 9987752 13345699999999999999999999999999999999999999997655433322 00111112
Q ss_pred hhCCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 682 ~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.....|+ .++..+.+++.+|+..||..|+++.+
T Consensus 257 f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 257 FTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred CCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHH
Confidence 2233443 45899999999999999999999995
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=307.65 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=190.0
Q ss_pred eeccCCcEEEEEEEEC-----CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecC-C--CeEEEEeccC
Q 003576 463 RIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-H--GCLVYEYMEN 533 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~--~~lV~Ey~~~ 533 (810)
.||+|+||.||+|.+. ...+|+|.+.... ......+.+|+.+++.++||||++++++|.. . .++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 2479999875432 2345678899999999999999999997742 2 3899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+........
T Consensus 82 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999875432 3677788899999999999999988 99999999999999999999999999976543221110
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg-~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
.......++..|+|||++.+..++.++|||||||++|+|++| .+||....... ....+........+...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 228 (262)
T cd05058 157 --HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD------ITVYLLQGRRLLQPEYCP 228 (262)
T ss_pred --cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhcCCCCCCCCcCC
Confidence 111233567789999999888899999999999999999995 56664322111 111111111222334456
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+.+++.+||..+|++||++. .++..|+.+
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~-~il~~l~~~ 259 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFS-ELVSRIEQI 259 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHH-HHHHHHHHH
Confidence 7899999999999999999998 566666655
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=322.24 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=198.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCC---
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--- 523 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~--- 523 (810)
.+|...+.||+|+||.||+|.+. ++.||||++..... .....+.+|+.+|.++ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 46888899999999999999742 45899999875432 2345688999999999 689999999988543
Q ss_pred CeEEEEeccCCCHHHHHhhcCC----------------------------------------------------------
Q 003576 524 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 545 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 545 (810)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 2789999999999999865321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccccccc
Q 003576 546 ------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619 (810)
Q Consensus 546 ------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 619 (810)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchh----hcC
Confidence 123678888999999999999999998 9999999999999999999999999998754322111 112
Q ss_pred CCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHH
Q 003576 620 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAAL 698 (810)
Q Consensus 620 ~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~L 698 (810)
...++..|+|||++.+..++.++||||||+++|+|++ |..||........ ....+........|...++.+.++
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCCCCCCCCCCHHHHHH
Confidence 2345678999999988889999999999999999997 9999864321111 011111111222334456789999
Q ss_pred HHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 699 GLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 699 i~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
+.+||+.+|.+||++. +|+..|+.+.
T Consensus 315 ~~~cl~~~p~~Rps~~-eil~~l~~~~ 340 (343)
T cd05103 315 MLDCWHGEPSQRPTFS-ELVEHLGNLL 340 (343)
T ss_pred HHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 9999999999999999 4666666653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=311.96 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=192.9
Q ss_pred cccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 458 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
|+....||.|+||.||+|.+.. ..+++|.+..........+.+|+.+++.++||||++++++|.+.. ++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4566789999999999999864 578888887655555677899999999999999999999886555 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence 99998876532 35899999999999999999999998 99999999999999999999999999876543211
Q ss_pred ccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh--CCC
Q 003576 614 TTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGD 686 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~ 686 (810)
......|++.|+|||++. +..++.++|||||||++|+|++|++||......... ....... ...
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~~ 229 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSEPPTLA 229 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHHhhcCCCCCC
Confidence 122346899999999873 445778999999999999999999999644322211 1111111 112
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.|...+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 23456788999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=312.05 Aligned_cols=259 Identities=21% Similarity=0.362 Sum_probs=198.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC------CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCC----C
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 524 (810)
..|...+.||+|+||.||++.+. +..||+|.+.... ......+.+|+.+|+.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678889999999999999753 4589999987543 23346789999999999999999999998654 3
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||++|++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 79999999999999986543 24899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--------hccchh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--------IDEDNL 676 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~--------~~~~~l 676 (810)
+....... .......++..|+|||++.+..++.++|||||||++|+|+|++.|+......... ......
T Consensus 159 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYY---TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccce---eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 65432211 0112345778899999988888999999999999999999988765422111000 000011
Q ss_pred HHHhh-hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 677 AEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 677 ~~~ld-~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
...+. ......+...+..+.+|+.+||+.+|.+||++.+ ++..|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~l~~ 282 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN-LIEGFEA 282 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHH-HHHHHHh
Confidence 11111 1112223456789999999999999999999984 5555554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=324.15 Aligned_cols=248 Identities=21% Similarity=0.226 Sum_probs=190.7
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 523 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 523 (810)
..++|...+.||+|+||.||++.+. +..||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3568999999999999999999875 5689999986532 23345678999999999999999999987432
Q ss_pred --CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 3899999975 56665532 3778889999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc------c--
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID------E-- 673 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~------~-- 673 (810)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........... .
T Consensus 170 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 97643221 12335789999999999988999999999999999999999999974432211000 0
Q ss_pred --------chhHHHhhhh-----------CCC--------CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 --------DNLAEILDAQ-----------AGD--------WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 --------~~l~~~ld~~-----------~~~--------~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.......... ... .+...+..+.+|+.+||..||.+||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0000000000 000 0112356789999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.23 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=201.5
Q ss_pred cCcccceeeccCCcEEEEEEEEC---------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~---------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 524 (810)
.+|...++||+|+||.||++... ...+|+|++.... ......+.+|+.++..+ +||||++++++|.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999752 2368999887543 23345688999999999 6999999999987655
Q ss_pred --eEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec
Q 003576 525 --CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 589 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld 589 (810)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 899999999999999975321 234889999999999999999999998 99999999999999
Q ss_pred CCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 003576 590 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 668 (810)
Q Consensus 590 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~ 668 (810)
.++.+||+|||+++.......... .....++..|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKK----TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CCCcEEEccccccccccccccccc----cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999987653221110 111234568999999988889999999999999999999 888885332111
Q ss_pred hhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHHh
Q 003576 669 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 669 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~~ 727 (810)
.+..+........+...+..+.+|+.+||..+|.+||++. .++..|+.+...
T Consensus 245 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~~l~~~~~~ 296 (314)
T cd05099 245 ------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKVLAA 296 (314)
T ss_pred ------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHHH
Confidence 1111111112233455678899999999999999999998 577777776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.99 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=200.9
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
.+|...+.||.|+||.||++.. .+..++||.+..... .....+.+|+.+++.++||||++++++|.+.. +++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677788899999999999986 466999998764322 23457889999999999999999999986544 8999
Q ss_pred EeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 2345899999999999999999999998 99999999999999999999999999876653
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh-hCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~ 686 (810)
.... .....|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..+...+.. ....
T Consensus 159 ~~~~------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 227 (267)
T cd08229 159 KTTA------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDYPP 227 (267)
T ss_pred CCcc------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhhhhcCCCCC
Confidence 3211 123468899999999988889999999999999999999999985322110 011111111 1111
Q ss_pred -CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 687 -WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 687 -~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.+...+..+.+++.+||..+|.+||++. .|+..++++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~i~~~~~~~ 265 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDIT-YVYDVAKRM 265 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHH-HHHHHHhhh
Confidence 1234678899999999999999999999 577777665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=307.10 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=199.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
++|.....||.|+||.||+|... +..+++|++..........+.+|+.++++++||||+++++++.+.. +++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 4689999988765556678999999999999999999999986555 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999886542 34889999999999999999999998 99999999999999999999999999976553211
Q ss_pred ccccccccCCccCccccCccccccC---CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
......++..|+|||.+.+. .++.++|||||||++|+|+||++||............. ...+.......+
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (262)
T cd06613 157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNFPPPKLKDK 229 (262)
T ss_pred -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCCCccccch
Confidence 12234788899999998776 78899999999999999999999996543322211000 000001111123
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...+..+.+++.+||..+|.+||++.++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 4557889999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.15 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=197.5
Q ss_pred cCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccCC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 534 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~g 534 (810)
.+|.....||+|+||.||+|...+..+|+|.+.... ....+.+|+.++.+++|||++++++++.... ++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 357888899999999999999988999999986543 3467899999999999999999999986544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999876432 34889999999999999999999988 9999999999999999999999999987643221
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhHH
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKET 692 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~ 692 (810)
.....+..|+|||++.++.++.++|+|||||++|+|++ |++||....... +...+.. .....+...+
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 223 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGCP 223 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCCCCCcCC
Confidence 11234578999999988899999999999999999998 999996433211 1111111 1122344567
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
..+.+++.+||..+|..||++.+ ++..|
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~-l~~~l 251 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHK-LREKL 251 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHH-HHHHH
Confidence 88999999999999999999984 44444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.11 Aligned_cols=245 Identities=28% Similarity=0.439 Sum_probs=190.4
Q ss_pred eeccCCcEEEEEEEECCe----EEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMGGYGTVYKGTFHHT----FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~~----~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+|+||.||+|.+.++ .+++|.+.... ......+.+|+.++.++ +||||++++++|.... ++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999988542 46888776432 23446788999999999 7999999999987655 8999999999
Q ss_pred CHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 535 SLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 535 sL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999987532 1234789999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
+....... .......+..|+|||++....++.++|||||||++|+|++ |..||....... .+..+.
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~ 225 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLP 225 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHh
Confidence 86322111 0111234667999999988889999999999999999997 999995432111 111111
Q ss_pred hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 681 d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
.......+...+..+.+|+.+||..+|.+||++. .++..|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l~~~ 268 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 268 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHh
Confidence 1112223445667899999999999999999999 466666554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.75 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=192.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+++++.+.+.. |+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999885 5689999987532 223456788999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999986543 4889999999999999999999999 999999999999999999999999998755321
Q ss_pred CCcc-----------------------------cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 003576 609 PSFV-----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659 (810)
Q Consensus 609 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~ 659 (810)
.... ..........||+.|+|||++.+..++.++|||||||++|+|+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00001123579999999999999999999999999999999999999
Q ss_pred CccccchhhhhhccchhHHHhhhh-CCCCCh--hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 660 AIAITHKVETAIDEDNLAEILDAQ-AGDWPI--KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 660 Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~--~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
||........ +..++... ...+|. ..+..+.+|+.+|+. ||.+|++..
T Consensus 235 Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 235 PFCSETPQET------YRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCHHHH------HHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 9964433221 11111110 111222 357789999999874 999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.11 Aligned_cols=244 Identities=21% Similarity=0.319 Sum_probs=197.8
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|...++||.|+||.||++.+. +..+++|.+... .....+.+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777889999999999999875 558999988643 2334567889999999999999999999987655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999886533 234788999999999999999999998 999999999999999999999999999766532211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
.....|++.|+|||++.+..++.++|+||||+++|+|++|.+||........ ...+........+...
T Consensus 157 ------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (255)
T cd08219 157 ------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQGSYKPLPSHY 224 (255)
T ss_pred ------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhcCCCCCCCccc
Confidence 1234689999999999888899999999999999999999999964332111 1111112222344556
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccc
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+..+.+|+.+||..||.+||++.++
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHH
Confidence 7889999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=312.04 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=191.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|...+.||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999885 56899998865422 23456889999999999999999999986554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689888866544456899999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc---------------
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------------- 674 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--------------- 674 (810)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||.............
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 1123367899999998765 447889999999999999999999997443222111000
Q ss_pred ---hhHHHhhh----hCCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 675 ---NLAEILDA----QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 675 ---~l~~~ld~----~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
........ .........+.++.+|+.+||..||.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 00000000 000011235678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.32 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=193.6
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
++|....+||+|+||.||+|.+. +..||+|+++.........+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777888999999999999874 5689999987665545566889999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++...+ .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 9999999886543 4889999999999999999999998 99999999999999999999999999876543211
Q ss_pred ccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
......|+..|+|||++. .+.++.++|||||||++|+|++|.+||............ . ............
T Consensus 162 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~ 234 (267)
T cd06645 162 -----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-T-KSNFQPPKLKDK 234 (267)
T ss_pred -----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-h-ccCCCCCccccc
Confidence 123447899999999874 456889999999999999999999998533221110000 0 000000000011
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 234578999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.92 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=192.9
Q ss_pred HHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC-
Q 003576 451 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 524 (810)
Q Consensus 451 i~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~- 524 (810)
+....++|...+.||+|+||.||++.+. +..+|+|++.... ......+.+|+.++..++||||+++++++.+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445678999999999999999999986 4589999986432 223345788999999999999999999987655
Q ss_pred -eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 525 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 8999999999999988543 3788888999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCccccCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHH
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
.+...... ......||+.|+|||++... .++.++|||||||++|+|++|++||....... .+..+
T Consensus 191 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i 259 (371)
T cd05622 191 KMNKEGMV-----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKI 259 (371)
T ss_pred EcCcCCcc-----cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 76532211 12345799999999987643 37899999999999999999999997543321 12222
Q ss_pred hhhh-CCCCC--hhHHHHHHHHHHHHhhhcCCC---CCcccc
Q 003576 680 LDAQ-AGDWP--IKETKELAALGLSCAELRRKD---RPDLKN 715 (810)
Q Consensus 680 ld~~-~~~~p--~~~~~~l~~Li~~cl~~dP~~---RPs~~~ 715 (810)
+... ...+| ...+..+.+|+.+||. +|.. ||++.+
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~e 300 (371)
T cd05622 260 MNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEE 300 (371)
T ss_pred HcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHH
Confidence 2211 11222 2568889999999998 5554 566653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.42 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=195.3
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceecC-------
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------- 522 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------- 522 (810)
.+++.|.....||+|+||.||+|... +..+|+|++.... .....+.+|+.++.++ +||||++++++|.+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45667888889999999999999885 5689999986543 3446788999999998 69999999999853
Q ss_pred -CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 523 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 523 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
..++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 2379999999999999887533 235889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 676 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l 676 (810)
+........ ......|+..|+|||++. ...++.++|||||||++|+|++|+.||..........
T Consensus 158 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----- 226 (272)
T cd06637 158 SAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 226 (272)
T ss_pred ceecccccc------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence 986543221 123457899999999875 3457889999999999999999999996433221111
Q ss_pred HHHhh-hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 677 AEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 677 ~~~ld-~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.... ......+...+..+.+|+.+||..+|.+||++.++
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 227 -LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred -HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0111 11111223456789999999999999999999853
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.14 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=205.3
Q ss_pred ceeeccCCcEEEEEEEECC-----eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccC
Q 003576 461 NLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 533 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 533 (810)
.++||+|.||.|++|.|+. -.||||++...... ...+|++|+.+|.+|+|||+++|||+..+.. .+|||+++.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 3569999999999999963 28999999877554 5678999999999999999999999998765 789999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+.|.. .....|.....+.++.|||.|+.||..++ +|||||-..||||-....+||||||+.+-+..+.+...
T Consensus 195 GSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 195 GSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred chHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 999999987 44566888899999999999999999998 99999999999999999999999999999887665432
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhh-hhCCCCChhH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKE 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~ 691 (810)
. .....-.+.|+|||.++...++.+||||+|||+||||+| |..||...... .+.+.+| ......|..+
T Consensus 271 m---~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------qIL~~iD~~erLpRPk~c 340 (1039)
T KOG0199|consen 271 M---APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------QILKNIDAGERLPRPKYC 340 (1039)
T ss_pred e---cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------HHHHhccccccCCCCCCC
Confidence 1 112244678999999999999999999999999999998 67888644322 2233333 2345668889
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccch
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+..+.+++..||..+|.+||++..+.
T Consensus 341 sedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHH
Confidence 99999999999999999999999644
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=308.16 Aligned_cols=234 Identities=22% Similarity=0.373 Sum_probs=182.8
Q ss_pred eeccCCcEEEEEEEECC--------------eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 463 RIGMGGYGTVYKGTFHH--------------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~--------------~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
.||+|+||.||+|++.. ..+++|++..........|.+|+.++..++||||+++++++.+.. ++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 258889887655545567889999999999999999999986544 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc-------eEEeee
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-------SKIGDV 599 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~-------~kL~DF 599 (810)
||||+++|+|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998876543 34889999999999999999999998 999999999999987654 899999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCccccc-cCCCCCcchhhhHHHHHHHHH-hCCCCccccchhhhhhccchhH
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLL-TAKPAIAITHKVETAIDEDNLA 677 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDVwSlGvil~eLl-tg~~Pf~~~~~~~~~~~~~~l~ 677 (810)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||......+. .
T Consensus 157 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~ 219 (262)
T cd05077 157 GIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------E 219 (262)
T ss_pred CCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------H
Confidence 998654321 1236788999999876 466899999999999999998 58888753321110 0
Q ss_pred HHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 678 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 678 ~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
..... ...........+.+|+.+||+.||.+||++.+ ++..
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~-il~~ 260 (262)
T cd05077 220 RFYEG-QCMLVTPSCKELADLMTHCMNYDPNQRPFFRA-IMRD 260 (262)
T ss_pred HHHhc-CccCCCCChHHHHHHHHHHcCCChhhCcCHHH-HHHh
Confidence 11111 11112223578999999999999999999984 4433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.35 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=196.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|+..+.||+|+||.||++.+. +..||+|.+.... ......+.+|+.++.+++||||+++++++.... ++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677788999999999999986 6699999886542 233467889999999999999999999886554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
++++|..++........+++..+..++.+++.||.|||. .+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999888664333468999999999999999999996 46 9999999999999999999999999987654321
Q ss_pred cccccccccCCccCccccCccccccCC------CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ...+..+.....
T Consensus 158 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 227 (286)
T cd06622 158 -------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIVDGDP 227 (286)
T ss_pred -------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHhhcCC
Confidence 12236888999999875443 47899999999999999999999964321110 112222333333
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+...+..+.+|+.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 4455667899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.82 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=195.5
Q ss_pred cCcccceeeccCCcEEEEEEEECC------------------eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeee
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH------------------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLL 516 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~------------------~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l 516 (810)
++|+..++||+|+||.||++.+.+ ..+|+|++.... ......+.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468888999999999999985432 368999987543 2334678999999999999999999
Q ss_pred eceecCCC--eEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCce
Q 003576 517 LGACPDHG--CLVYEYMENGSLEDRLYRKNN--------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 586 (810)
Q Consensus 517 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NI 586 (810)
++++.+.. ++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99986544 899999999999999876431 123778899999999999999999998 99999999999
Q ss_pred EecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh--CCCCcccc
Q 003576 587 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT 664 (810)
Q Consensus 587 Lld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt--g~~Pf~~~ 664 (810)
|++.++.++|+|||++..+....... ......+++.|++||....+.++.++|||||||++|+|+| |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR----IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee----ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999998654322110 1122345678999998888889999999999999999998 67888543
Q ss_pred chhhhhhccchhHH-HhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 665 HKVETAIDEDNLAE-ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 665 ~~~~~~~~~~~l~~-~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
...+.......... .........+..++..+.+|+.+||+.||.+||++.+ |...|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l 294 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE-IHATL 294 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHH
Confidence 22211110000000 0000011223445689999999999999999999994 55544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.53 Aligned_cols=243 Identities=22% Similarity=0.362 Sum_probs=200.0
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.+|.....||.|+||.||+|.. .+..|++|.+..........+.+|+.+++.++||||+++++++.+.. ++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999986 45689999987665555677899999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|..++... .+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999988542 3889999999999999999999998 999999999999999999999999998865533211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh--CCCCCh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~p~ 689 (810)
.....|+..|+|||.+.+..++.++|||||||++|+|++|++||.......... .+.... ....+.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~~~~~~~~~~~~~ 239 (296)
T cd06655 172 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPELQNPE 239 (296)
T ss_pred ------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCCcccCCcc
Confidence 123468899999999988889999999999999999999999997544322211 111111 112344
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+..+.+|+.+||..||.+||++.+++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 5678899999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.54 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=200.8
Q ss_pred hcCcccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.++|....+||.|+||.||+|.+.+ ..++||.+.... .....+.+|+.++++++||||+++++++.+.. ++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4578889999999999999998764 478999887543 34567999999999999999999999986543 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999987643 234899999999999999999999998 99999999999999999999999999987653211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
.......++..|+|||.+.+..++.++||||||+++|+|+| |+.||...... ..+..+........+..
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 228 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERGYRMPRPPN 228 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCCCCC
Confidence 11112245678999999988889999999999999999999 99999533211 11112221112233445
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
.+..+.+++.+||..+|.+||++. .+...|+
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~l~ 259 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFE-YLQSFLE 259 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHH-HHHHHHh
Confidence 578899999999999999999998 4666554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=334.46 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=187.9
Q ss_pred HHHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCC------Cceeeeecee
Q 003576 449 EEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH------PHLLLLLGAC 520 (810)
Q Consensus 449 ~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~g~~ 520 (810)
+++...+++|.+..+||+|+||.||+|.+. +..||||++..... ....+..|+.++..++| ++++.++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999999999999875 56899999864322 23446678888877754 4588888888
Q ss_pred cCC---CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCC----
Q 003576 521 PDH---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL---- 592 (810)
Q Consensus 521 ~~~---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~---- 592 (810)
... .|+||+++ +++|.+++.... .+++..+..|+.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 543 38899988 778988886543 48999999999999999999997 47 99999999999998765
Q ss_pred ------------ceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCC
Q 003576 593 ------------VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 660 (810)
Q Consensus 593 ------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~P 660 (810)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||+||++|
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 499999998764321 12345899999999999999999999999999999999999999
Q ss_pred ccccchhhhhhcc-----------------chhHHHhhhhC---CC---------------CChhHHHHHHHHHHHHhhh
Q 003576 661 IAITHKVETAIDE-----------------DNLAEILDAQA---GD---------------WPIKETKELAALGLSCAEL 705 (810)
Q Consensus 661 f~~~~~~~~~~~~-----------------~~l~~~ld~~~---~~---------------~p~~~~~~l~~Li~~cl~~ 705 (810)
|......+..... .....+.+... .. ........+.+||.+||..
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9744322111000 00000000000 00 0001245678999999999
Q ss_pred cCCCCCccccch
Q 003576 706 RRKDRPDLKNQV 717 (810)
Q Consensus 706 dP~~RPs~~~~v 717 (810)
||.+||++.+++
T Consensus 425 dP~~R~ta~e~L 436 (467)
T PTZ00284 425 DRQKRLNARQMT 436 (467)
T ss_pred ChhhCCCHHHHh
Confidence 999999999633
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.47 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=157.2
Q ss_pred ceeeccCCcEEEEEEEEC----CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCC----CeEEEEecc
Q 003576 461 NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYME 532 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~----~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~Ey~~ 532 (810)
..+||+|+||.||+|... +..+|+|.+.... ....+.+|+.+|++++||||+++++++.+. .++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999864 3589999886543 234578899999999999999999988432 279999985
Q ss_pred CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe----cCCCceEEeeeccc
Q 003576 533 NGSLEDRLYRKN------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLS 602 (810)
Q Consensus 533 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl----d~~~~~kL~DFGla 602 (810)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 1224889999999999999999999999 9999999999999 45689999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccc
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 663 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~ 663 (810)
+.+...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876543211 111234578999999998876 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.65 Aligned_cols=238 Identities=25% Similarity=0.326 Sum_probs=187.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++|+||+.+++++.+.. |+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999885 4589999986532 223345788999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||++||+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997643 24888999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCccccCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
... ......||+.|+|||++.+ +.++.++|||||||+||+|++|+.||........ +..+....
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~ 224 (331)
T cd05624 156 GTV-----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHE 224 (331)
T ss_pred Cce-----eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCC
Confidence 211 1123479999999998865 5678999999999999999999999964432211 11111111
Q ss_pred -CCCCC---hhHHHHHHHHHHHHhhhcCCC
Q 003576 684 -AGDWP---IKETKELAALGLSCAELRRKD 709 (810)
Q Consensus 684 -~~~~p---~~~~~~l~~Li~~cl~~dP~~ 709 (810)
...+| ...+..+.+|+.+|+..++++
T Consensus 225 ~~~~~p~~~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 225 ERFQFPSHITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred CcccCCCccccCCHHHHHHHHHHccCchhh
Confidence 11122 235788999999999865543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.90 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=201.8
Q ss_pred CcccceeeccCCcEEEEEEEEC------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecC----CCe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD----HGC 525 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~----~~~ 525 (810)
.|.....||+|+||.||+|.+. +..+|||++...... ....|.+|+.+++.+.||||+++++++.+ ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566688999999999999864 458999998866543 46679999999999999999999998865 348
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999975442 4899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--------hccchhH
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--------IDEDNLA 677 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~--------~~~~~l~ 677 (810)
........ ......++..|++||++.+..++.++||||||+++|+|+||..|+......... .....+.
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYY---VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCccee---ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 63322111 111234566799999998888999999999999999999999998633211100 0011122
Q ss_pred HHhhhh-CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 678 EILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 678 ~~ld~~-~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..+... ....+..++..+.+|+.+||..+|.+||++. .|+.+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA-DLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH-HHHHHHhhc
Confidence 222211 1222344567899999999999999999999 577776654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.16 Aligned_cols=248 Identities=24% Similarity=0.351 Sum_probs=188.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhc---CCCceeeeeceecCC------
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKI---RHPHLLLLLGACPDH------ 523 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~------ 523 (810)
+|...+.||+|+||.||+|.+. +..||+|.+...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778889999999999999886 458999988754221 234566788877766 699999999987532
Q ss_pred -CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 524 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
.++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 289999997 58888876543 234899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc---------
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------- 673 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~--------- 673 (810)
........ .....||..|+|||++.+..++.++|||||||++|+|++|++||............
T Consensus 156 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQMA-------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCccc-------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 87653221 12346899999999998888999999999999999999999999643222111000
Q ss_pred chhHHHhh-------hhC----CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 674 DNLAEILD-------AQA----GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 674 ~~l~~~ld-------~~~----~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
..+..... ... .......+..+.+|+.+||+.||.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 00000000 000 00112346778999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.69 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=198.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
++|....+||.|+||.||+|.+. +..+++|.+..... ...+.+|+.++++++||||+++++++.+.. |+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888899999999999999986 46899999875533 678999999999999999999999986655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999986543 35899999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......|+..|+|||++.+..++.++||||||+++|+|+||++||.............. ........+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN----KPPPTLSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----CCCCCCCchhhc
Confidence 11234588999999999888899999999999999999999999964332221110000 000011123345
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccc
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+..+.+++.+||+.+|.+||++.++
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~i 250 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQL 250 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHH
Confidence 6789999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.36 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=191.3
Q ss_pred eeccCCcEEEEEEEEC-CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHHH
Q 003576 463 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED 538 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~ 538 (810)
.||+|+||.||+|... +..+|+|++...... ....+.+|+.+++.++||||++++++|.+.. ++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5899999999999875 458999988755332 2346889999999999999999999986554 89999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccc
Q 003576 539 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618 (810)
Q Consensus 539 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 618 (810)
++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 886543 34789999999999999999999998 999999999999999999999999998764432111 11
Q ss_pred cCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHH
Q 003576 619 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 697 (810)
Q Consensus 619 ~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~ 697 (810)
....++..|+|||++.++.++.++||||||+++|+|++ |..||........ ...+........+...+..+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------REQVEKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHHcCCCCCCCCCCCHHHHH
Confidence 12244677999999998889999999999999999998 9999964322111 1111111122334456789999
Q ss_pred HHHHHhhhcCCCCCccccchhhHH
Q 003576 698 LGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 698 Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
++.+||..+|.+||++.+ +++.|
T Consensus 226 li~~~l~~~p~~Rp~~~~-l~~~l 248 (250)
T cd05085 226 VMQRCWDYKPENRPKFSE-LQKEL 248 (250)
T ss_pred HHHHHcccCcccCCCHHH-HHHHh
Confidence 999999999999999984 54444
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.41 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=199.4
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
..+|...+.||.|+||.||+|... +..||+|.+........+.+.+|+.+++.++||||++++++|.+.. ++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 357888899999999999999874 6799999987765556677889999999999999999999986554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++... .+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999988542 3788899999999999999999998 99999999999999999999999999876543321
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
. .....+++.|+|||.+.+..++.++|||||||++|+|++|++||.............. ........+..
T Consensus 171 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~ 240 (297)
T cd06656 171 K------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----NGTPELQNPER 240 (297)
T ss_pred C------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----CCCCCCCCccc
Confidence 1 1234688999999999888899999999999999999999999964432221110000 00001123445
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+..+.+|+.+||..+|.+||++.+++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il 267 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELL 267 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 677899999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.97 Aligned_cols=239 Identities=22% Similarity=0.260 Sum_probs=184.8
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhc---CCCceeeeeceecCCC--eEEEEeccC
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKI---RHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
||+|+||.||+|.+. +..||+|++...... ....+..|..++..+ +||||+.+++++.+.. |+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999885 569999998653221 223455677777765 6999999999986554 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 151 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--- 151 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---
Confidence 99999886543 4889999999999999999999999 99999999999999999999999999875432221
Q ss_pred ccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC-hhH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP-IKE 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p-~~~ 691 (810)
......||+.|+|||++.+. .++.++|||||||++|+|+||+.||........ +..+. .....+| ...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i~-~~~~~~~~~~~ 221 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNIA-FGKVRFPKNVL 221 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHHH-cCCCCCCCccC
Confidence 12234799999999988654 478999999999999999999999964332111 11111 1111222 235
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+..+.+|+.+||..||.+||+..+.+.+.+
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll 251 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELK 251 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHh
Confidence 788999999999999999998765443333
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.66 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=195.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
..|....+||.|+||.||+|... +..+++|++..........+.+|+.+++.++||||+++++++.... ++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888889999999999999885 4689999988766556677899999999999999999999875544 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988776543 24889999999999999999999998 9999999999999999999999999987543221
Q ss_pred ccccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC--
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 684 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~-- 684 (810)
.......+++.|+|||++. ...++.++|||||||++|+|++|.+||........ ...+.....
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 234 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEPPT 234 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCCCcc
Confidence 1122346889999999874 34568899999999999999999999964432211 111111111
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...+...+..+.+++.+||..+|.+||++.++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11234556789999999999999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.93 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=192.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
++|...++||+|+||.||++.+. +..+|+|.+..... ....++.+|++++.+++||||++++++|.+.. ++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999886 45788888765422 23456889999999999999999999986655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998754 348899999999999999999997 46 9999999999999999999999999987653221
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--hcc--------------
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--IDE-------------- 673 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~--~~~-------------- 673 (810)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||......... +..
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 12347899999999988888999999999999999999999998532211100 000
Q ss_pred ----------chhHHHhhhh----CCCCC-hhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 674 ----------DNLAEILDAQ----AGDWP-IKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 674 ----------~~l~~~ld~~----~~~~p-~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.......+.. ....| ...+..+.+|+.+||..+|.+||++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 284 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0000111110 01111 1246789999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=316.56 Aligned_cols=250 Identities=19% Similarity=0.308 Sum_probs=190.5
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
.+|...++||+|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 45899999875432 23346788999999999999999999986544 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 97 48888776543 24788899999999999999999998 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------cchhHHH-
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAEI- 679 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~---------~~~l~~~- 679 (810)
......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||......+.... ...+..+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1123467899999998754 4688999999999999999999999964432111000 0000000
Q ss_pred -----hhhhCCC--------CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 680 -----LDAQAGD--------WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 680 -----ld~~~~~--------~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+..... .....+..+.+|+.+||..||.+||++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 0000000 0113467889999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=310.62 Aligned_cols=234 Identities=24% Similarity=0.399 Sum_probs=182.2
Q ss_pred eeccCCcEEEEEEEEC--------------------------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeee
Q 003576 463 RIGMGGYGTVYKGTFH--------------------------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--------------------------~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 516 (810)
+||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999742 12588998876544445678899999999999999999
Q ss_pred eceecCCC--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC--
Q 003576 517 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-- 592 (810)
Q Consensus 517 ~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-- 592 (810)
+++|.+.. ++||||+++|+|..++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99996654 89999999999999886533 34889999999999999999999988 99999999999997643
Q ss_pred -----ceEEeeeccccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHH-hCCCCccccc
Q 003576 593 -----VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLL-TAKPAIAITH 665 (810)
Q Consensus 593 -----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLl-tg~~Pf~~~~ 665 (810)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|+|+ +|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4799999987643321 12357888999998765 56899999999999999984 7999986432
Q ss_pred hhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 666 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 666 ~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
.... ...+.. ....|......+.+++.+||+.+|.+||++.+ ++..
T Consensus 227 ~~~~-------~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-il~~ 272 (274)
T cd05076 227 PSEK-------ERFYEK-KHRLPEPSCKELATLISQCLTYEPTQRPSFRT-ILRD 272 (274)
T ss_pred hHHH-------HHHHHh-ccCCCCCCChHHHHHHHHHcccChhhCcCHHH-HHHh
Confidence 2111 111111 11223334568999999999999999999984 4433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.10 Aligned_cols=241 Identities=27% Similarity=0.357 Sum_probs=197.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|.....||.|+||.||+|.+. +..+++|++.... ......+.+|+.+++.++||||+++++++.+.. ++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777788999999999999875 5689999987553 334456889999999999999999999986655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++... ++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 999999988653 5899999999999999999999998 99999999999999999999999999987764321
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh-
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK- 690 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~- 690 (810)
......|++.|+|||++.+..++.++|||||||++|+|+||++||...+.... ...+........+..
T Consensus 154 -----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 222 (274)
T cd06609 154 -----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIPKNNPPSLEGNK 222 (274)
T ss_pred -----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhhhcCCCCCcccc
Confidence 12334788999999999888899999999999999999999999964432111 111111111222222
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+..+.+++.+||..+|.+||++.++
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~i 248 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKEL 248 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 67789999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=325.61 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=191.2
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-------Ce
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 525 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~~ 525 (810)
+|+..++||+|+||.||++.+. +..||||++.... ......+.+|+.+|+.++||||+++++++... .|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 6799999886532 22345788999999999999999999998543 38
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 6788877543 34899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh------ccc----
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------DED---- 674 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~------~~~---- 674 (810)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.......... ...
T Consensus 154 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDESK-----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCccc-----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 432211 12334689999999988764 47899999999999999999999996443221110 000
Q ss_pred ------hhHHHhhhhCC---------CCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 675 ------NLAEILDAQAG---------DWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 675 ------~l~~~ld~~~~---------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.....+..... ......+..+.+|+.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 00000100000 11123467889999999999999999998644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.68 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=197.6
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC---CeEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---~~lV~E 529 (810)
+|...+.||.|+||.||++... +..+++|.+.... ......+.+|+.++++++|||++++++.+... .++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 4589999986543 23345688999999999999999999887532 279999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999887543 235899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+........+.
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~ 224 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIEGKLPPMPK 224 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCCCCcc
Confidence 1 1223468999999999998889999999999999999999999996432211 111122222233455
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
..+..+.+++.+||..+|.+||++.++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~ 251 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSI 251 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHH
Confidence 677899999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.99 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=201.2
Q ss_pred cCcccceeeccCCcEEEEEEEECC------eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~------~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV 527 (810)
..|...+.||+|+||.||+|.+.. ..+|+|++..... .....+.+|+.++++++||||++++++|.... ++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 457777899999999999998742 2689998876543 33467889999999999999999999986644 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999876433 3899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhh-hhCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~ 685 (810)
.... .......++..|++||.+....++.++||||||+++|+|+| |++||...... .+...+. ....
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~ 230 (279)
T cd05057 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIPDLLEKGERL 230 (279)
T ss_pred cccc----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhCCCCC
Confidence 3221 11122334678999999988889999999999999999999 99999643221 1111221 1122
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
..|...+..+.+++.+||..+|..||++. .++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~-~l~~~l~~~~ 269 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFK-ELINEFSKMA 269 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 33445678899999999999999999999 4666666653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.84 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=211.4
Q ss_pred ccccCCHHHHHHhh-cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceee
Q 003576 442 RYRNLTWEEIESAT-LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLL 515 (810)
Q Consensus 442 ~~~~~~~~ei~~~~-~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~ 515 (810)
+|-.+.|-|....+ +.|+.-+.||+||||.||-+... +..||.|.+.+... ......++|-.||.+++.+.||.
T Consensus 170 rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 170 RFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVS 249 (591)
T ss_pred HHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence 44445555655555 56888999999999999988765 55788888765432 23345688999999999999999
Q ss_pred eeceecC--CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 516 LLGACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 516 l~g~~~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
|-.+|.. ..||||..|.||+|.-+|.+.++ +.+++..+.-++.+|+.||.+||+.. ||+|||||+|||||+.|+
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGH 325 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCC
Confidence 9888854 45999999999999998887765 67999999999999999999999999 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 673 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~ 673 (810)
++|+|+|+|..+..... .+..+||.+|||||++.++.|+...|+|||||+||+|+.|+.||-... .....
T Consensus 326 vRISDLGLAvei~~g~~-------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---eKvk~ 395 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKP-------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---EKVKR 395 (591)
T ss_pred eEeeccceEEecCCCCc-------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---hhhhH
Confidence 99999999998876543 234589999999999999999999999999999999999999995221 11122
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
+.+...+......++...++++.+|....|..||.+|-.-..
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg 437 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRG 437 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCC
Confidence 222233333334567788999999999999999999977653
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=307.19 Aligned_cols=246 Identities=30% Similarity=0.484 Sum_probs=192.9
Q ss_pred cccceeeccCCcEEEEEEEECCe--EEEEEEEcccCccchH--HHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK--QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~--~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
|+..+.||+|+||.||++...++ .+|+|++......... ...+|+.++.+++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56778999999999999999754 7999999876544332 2356999999999999999999986544 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
.+++|.+++.... .+++..++.++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~- 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE- 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 9999999997333 4899999999999999999999998 99999999999999999999999999976421111
Q ss_pred ccccccccCCccCccccCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-hccchhHHHhhhhCCCCCh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~-~~~~~l~~~ld~~~~~~p~ 689 (810)
......++..|+|||++. +..++.++||||||+++|+|++|..||......... .-.......+... .....
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 227 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-SQQSR 227 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-TTSHT
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-ccccc
Confidence 223457899999999988 888999999999999999999999999754111110 0000111011111 11111
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.....+.+++.+||+.||.+||++.++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 124899999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.64 Aligned_cols=248 Identities=18% Similarity=0.219 Sum_probs=191.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 523 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 523 (810)
..++|.....||+|+||.||++.+. +..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4568999999999999999999875 5689999987542 23345678999999999999999999987432
Q ss_pred --CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 289999996 477776642 3778889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc--------
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 673 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~-------- 673 (810)
++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654321 123347899999999999999999999999999999999999999754322211000
Q ss_pred chh--------HHHhhhh-------------------CCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 DNL--------AEILDAQ-------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ~~l--------~~~ld~~-------------------~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+ ....... ....+......+.+|+.+||..||.+||++.+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 000 0000000 0001111245789999999999999999998633
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=326.44 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=188.8
Q ss_pred cCcccceeeccCCcEEEEEEEECC----eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
..|....+||.|+||.||++...+ ..|++|.+... ..+.+|+.+|++++||||+++++++.... |+|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 468889999999999999997643 47888887543 23568999999999999999999886544 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+. ++|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 167 ~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 6888888432 35899999999999999999999998 9999999999999999999999999998665432
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh------hh----------cc
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET------AI----------DE 673 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~------~~----------~~ 673 (810)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+ ..
T Consensus 240 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 240 DT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 11 112245799999999999989999999999999999999999999964321100 00 00
Q ss_pred ---chhHHHhhh----hCCCCC-------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 ---DNLAEILDA----QAGDWP-------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ---~~l~~~ld~----~~~~~p-------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+...+.. ....++ ...+..+.++|.+||..||.+||++.+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 000000000 001111 12356788999999999999999999633
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=322.34 Aligned_cols=248 Identities=19% Similarity=0.221 Sum_probs=191.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 523 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 523 (810)
..++|...+.||+|+||.||++.+. +..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999875 5689999987542 22345678899999999999999999987432
Q ss_pred --CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 3899999974 67666642 3788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------- 672 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~--------- 672 (810)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 166 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 166 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred cccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98654321 12334789999999999888899999999999999999999999974432211100
Q ss_pred -------cchhHHHhhhh-------------------CCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 673 -------EDNLAEILDAQ-------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 673 -------~~~l~~~ld~~-------------------~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.......+... ....+...+..+.+|+.+||..||.+|||+.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 00000010000 0011122356789999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.58 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=184.8
Q ss_pred eeccCCcEEEEEEEECC----eEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~----~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||+|.+.+ ..+++|.+..... .....+.+|+.++++++||||++++++|.+.. ++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 3689998865543 23356889999999999999999999986654 89999999999
Q ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 536 LEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 536 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 9999875332 234567788899999999999999998 999999999999999999999999998754432211
Q ss_pred ccccccCCccCccccCccccccC-------CCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCC
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTG-------LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
.......++..|+|||++... .++.++||||||+++|+|++ |+.||......+... .............
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YTVREQQLKLPKP 233 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHhhcccCCCCCC
Confidence 111234678889999987532 35789999999999999996 999996433221110 0000000000011
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
......+..+.+++.+|| .+|.+||++.+ |+..|
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~-l~~~l 267 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEE-VHLLL 267 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHH-HHHHh
Confidence 122245677899999999 68999999995 54444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.71 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=197.9
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
++|.+..+||.|+||.||+|.+. +..+|+|++..........+..|+.++++++||||+++++++.+.. ++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888889999999999999885 5689999987665556677899999999999999999999986655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999886543 24899999999999999999999999 99999999999999999999999999876543221
Q ss_pred ccccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh--C
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--A 684 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~--~ 684 (810)
......|++.|++||++. ...++.++|||||||++|+|++|++||........ +..+.... .
T Consensus 159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~ 227 (280)
T cd06611 159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKILKSEPPT 227 (280)
T ss_pred -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHhcCCCCC
Confidence 122346899999999864 34567899999999999999999999964432211 11111111 1
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+...+..+.+++.+||..+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 122345678899999999999999999998543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.78 Aligned_cols=233 Identities=25% Similarity=0.447 Sum_probs=185.0
Q ss_pred eeccCCcEEEEEEEECCe------------EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecC-CCeEEEE
Q 003576 463 RIGMGGYGTVYKGTFHHT------------FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-HGCLVYE 529 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~~------------~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-~~~lV~E 529 (810)
.||+|+||.||+|.+..+ .+++|++...... ...|.+|+.+|+.++||||++++++|.. ..++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 589999999999998644 3788877654433 6778999999999999999999998864 3389999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-------ceEEeeeccc
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-------VSKIGDVGLS 602 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-------~~kL~DFGla 602 (810)
|+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999876543 4889999999999999999999988 99999999999999887 7999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccC--CCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHH
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
...... ....++..|+|||++... .++.++|||||||++|+|++ |..||........ ...
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~ 218 (259)
T cd05037 156 ITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERF 218 (259)
T ss_pred cccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHH
Confidence 865431 123567789999998776 78999999999999999999 5777754321111 000
Q ss_pred hhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 680 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 680 ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
.. .....+......+.+++.+||..+|.+||++.+ ++..
T Consensus 219 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~ 257 (259)
T cd05037 219 YQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRA-ILRD 257 (259)
T ss_pred Hh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHH-HHHh
Confidence 10 111222333488999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.56 Aligned_cols=194 Identities=25% Similarity=0.415 Sum_probs=156.5
Q ss_pred ceeeccCCcEEEEEEEECC----eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCC----CeEEEEecc
Q 003576 461 NLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYME 532 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~~----~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~Ey~~ 532 (810)
..+||+|+||.||+|.... ..||+|.+.... ....+.+|+.+|+.++||||+++++++... .++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999998643 579999886543 234578999999999999999999988432 289999986
Q ss_pred CCCHHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe----cCCCceEEeeeccc
Q 003576 533 NGSLEDRLYRK------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLS 602 (810)
Q Consensus 533 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl----d~~~~~kL~DFGla 602 (810)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777776432 11234888999999999999999999998 9999999999999 56689999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccc
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 663 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~ 663 (810)
+.+...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543211 111234578999999998866 4578999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.62 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=202.1
Q ss_pred hcCcccceeeccCCcEEEEEEEEC---------CeEEEEEEEcccC-ccchHHHHHHHHHHHhc-CCCceeeeeceecCC
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~---------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~ 523 (810)
...|...+.||+|+||.||++.+. ...||+|++.... ......+.+|+.++.++ +||||++++++|.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346888899999999999999752 1268999887543 22346788999999999 799999999998765
Q ss_pred C--eEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe
Q 003576 524 G--CLVYEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl 588 (810)
. +++|||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 5 89999999999999987532 1234788899999999999999999998 9999999999999
Q ss_pred cCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 003576 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 667 (810)
Q Consensus 589 d~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~ 667 (810)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred cCCCcEEECCcccceecccccccc----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999998665322111 1122344678999999988889999999999999999998 88888543221
Q ss_pred hhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 668 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 668 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
. ....+........+...+..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 244 ~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-ell~~l~~~~~ 295 (334)
T cd05100 244 E------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK-QLVEDLDRVLT 295 (334)
T ss_pred H------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHhh
Confidence 1 1111112222334556678999999999999999999998 56677776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.75 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=183.4
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||+|... ...+++|.+..... .....|.+|+.+++.++||||+++++.|.+.. ++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 23678887654432 23456889999999999999999999987654 89999999999
Q ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 536 LEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 536 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999876432 223467788899999999999999998 99999999999999999999999999875433221111
Q ss_pred ccccccCCccCccccCccccc-------cCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh--
Q 003576 614 TTYKNTGPVGTLCYIDPEYQR-------TGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-- 683 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-- 683 (810)
.....++..|+|||++. ...++.++|||||||++|+|++ |..||......+ .+...+...
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~ 228 (269)
T cd05042 159 ----KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQDI 228 (269)
T ss_pred ----cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccCc
Confidence 12335677899999764 2356789999999999999999 788886432211 111111111
Q ss_pred ---CCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 684 ---AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 684 ---~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
....+...+..+.+++..|| .||.+||++.+ |+..|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~-v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE-VHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHH-HHHHh
Confidence 12233456788888999998 59999999984 54443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.67 Aligned_cols=246 Identities=26% Similarity=0.459 Sum_probs=192.9
Q ss_pred eeccCCcEEEEEEEECC--------eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 463 RIGMGGYGTVYKGTFHH--------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~--------~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.||+|+||.||+|.+.. ..+++|.+.... ......+.+|+.+|+.++||||++++++|.+.. ++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998753 468999876543 234567889999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-----ceEEeeeccc
Q 003576 532 ENGSLEDRLYRKN----NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-----VSKIGDVGLS 602 (810)
Q Consensus 532 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-----~~kL~DFGla 602 (810)
++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999987532 2234788999999999999999999988 99999999999999877 8999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhh
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD 681 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld 681 (810)
..+....... ......++..|+|||++.++.++.++|||||||++|+|+| |..||........ ...+..
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~ 228 (269)
T cd05044 159 RDIYKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV------LQHVTA 228 (269)
T ss_pred cccccccccc----cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH------HHHHhc
Confidence 7654322111 1122356788999999999999999999999999999998 9999863322111 111111
Q ss_pred hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 682 ~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
......+...+..+.+|+.+||..+|.+||++. .++..|+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 268 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFD-RIQEILQ 268 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 112234456678999999999999999999999 4555543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.60 Aligned_cols=246 Identities=29% Similarity=0.420 Sum_probs=195.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
++|...++||+|+||.||++.+. +..+|+|++.... ......+.+|++++..++||||+++++++.+.. ++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777788999999999999986 6789999876543 334567899999999999999999999987655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++...+ .+++..+..++.+++.||.|||+ .+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999886533 48899999999999999999997 46 9999999999999999999999999986543221
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-hcc----chhHHHhhhhC
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDE----DNLAEILDAQA 684 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~-~~~----~~l~~~ld~~~ 684 (810)
.....|+..|+|||++.++.++.++|||||||++|+|+||+.||......... ... ..+..++....
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 12347899999999988888999999999999999999999999743321000 000 11112222112
Q ss_pred CCCCh-hHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 685 GDWPI-KETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 685 ~~~p~-~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+. ..+..+.+|+.+||..||.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 22222 25678999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.75 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=208.8
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
+..-.++||.|-||.||.|.|+. -.||||.++.+. ...++|+.|..+|+.++|||+|+|+|+|..+. |||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44556789999999999999975 489999997654 46788999999999999999999999996554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.++|.+.+. ..++.-..+.++.||..|+.||...+ +|||||-..|.|+..+..+||+|||+++++..+...
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT- 421 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT- 421 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence 9999999987554 34677788899999999999999999 999999999999999999999999999998754311
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CCCCChh
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIK 690 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~ 690 (810)
...+..-..-|.|||-+....++.|+|||+|||+|||+.| |..||...+. .....++... .-+-|..
T Consensus 422 ----AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 422 ----AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred ----cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhccccccCCCC
Confidence 1122344677999999999999999999999999999998 8888864332 2333444432 3456788
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
+++.+.+|++.||+.+|.+||++. ++.+.++.|.
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFa-eiHqafEtmf 524 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFA-EIHQAFETMF 524 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHH-HHHHHHHHHh
Confidence 999999999999999999999999 5777777653
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.35 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=199.1
Q ss_pred CHHHHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceec--
Q 003576 447 TWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACP-- 521 (810)
Q Consensus 447 ~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~-- 521 (810)
.++.+..+.++|.....||+|+||.||++... ++.+|+|++..... ....+.+|+.++..+ +||||++++++|.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556678889999999999999999999885 56899998765322 345688899999999 6999999999873
Q ss_pred ---C--CCeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceE
Q 003576 522 ---D--HGCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 595 (810)
Q Consensus 522 ---~--~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~k 595 (810)
+ ..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 1 238999999999999987642 22345888999999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCCCcccccccccCCccCccccCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh
Q 003576 596 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA 670 (810)
Q Consensus 596 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~ 670 (810)
|+|||++..+..... ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||.........
T Consensus 165 l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 165 LVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred EccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 999999987643221 1223468999999998753 44788999999999999999999999644332211
Q ss_pred hccchhHHHhhhh--CCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 671 IDEDNLAEILDAQ--AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 671 ~~~~~l~~~ld~~--~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.. ..... ....+...+..+.+|+.+||+.||.+||++.+++
T Consensus 239 ~~------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 239 FK------IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred hh------ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11 00000 0112233467899999999999999999998533
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=303.34 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=193.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeeeceecCC----C
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 524 (810)
.+|.....||+|+||.||+|... +..|++|++..... .....+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57889999999999999999874 56899998764321 1234688899999999999999999988542 2
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999986543 3788899999999999999999988 99999999999999999999999999976
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHh-hhh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQ 683 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~l-d~~ 683 (810)
+....... .......++..|+|||++.+..++.++|||||||++|+|++|++||......... .... ...
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~~ 226 (266)
T cd06651 156 LQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQPT 226 (266)
T ss_pred cccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCCC
Confidence 54321110 0112346889999999998888999999999999999999999999643222111 1111 111
Q ss_pred CCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 684 ~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
....|......+.+++ +||..+|.+||++.++
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ei 258 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEEL 258 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHH
Confidence 2344555677888888 7888999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=307.93 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=185.0
Q ss_pred eeccCCcEEEEEEEECC---------eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecC--CCeEEEEec
Q 003576 463 RIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYM 531 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~---------~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~ 531 (810)
.||.|+||.||+|.... ..+++|.+........+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999998742 2488888765544455678899999999999999999999865 348999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc--------eEEeeecccc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--------SKIGDVGLST 603 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~--------~kL~DFGla~ 603 (810)
++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999876443 4889999999999999999999998 999999999999987664 6999999886
Q ss_pred ccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhccchhHHHhh
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILD 681 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~-~Pf~~~~~~~~~~~~~~l~~~ld 681 (810)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|. +||........ .....
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~ 219 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFYE 219 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHHH
Confidence 54321 12467889999998876 45789999999999999999995 66643222111 11111
Q ss_pred hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 682 ~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
.....|......+.+|+.+||+.+|.+||++.+ ++..|
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~l 257 (258)
T cd05078 220 -DRHQLPAPKWTELANLINQCMDYEPDFRPSFRA-IIRDL 257 (258)
T ss_pred -ccccCCCCCcHHHHHHHHHHhccChhhCCCHHH-HHHhc
Confidence 123344455678999999999999999999995 44443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.72 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=195.6
Q ss_pred cCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
.+|.....||.|+||.||++.+. +..+|+|.+.... .....|.+|+.++++++|||++++++++.+.. ++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777789999999999999876 6689999886543 24567899999999999999999999986554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999886543 24789999999999999999999998 999999999999999999999999998765432110
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......++..|+|||++.++.++.++||||||+++|+|++ |..||....... .+..+........|...
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFRLYKPRLA 226 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCCCCCCCCCCC
Confidence 1122345678999999988889999999999999999998 999986332111 11111111111223345
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
+..+.+|+.+||..+|.+||++.+ ++..
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~-~l~~ 254 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSL-LLHQ 254 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHH-HHHh
Confidence 788999999999999999999984 4444
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=301.29 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=199.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEeccC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 533 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey~~~ 533 (810)
..|...++||+|+||.||++.+. +..+++|.+.... .....+.+|+.++++++|+||+++++++.+.. +++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 46888899999999999999865 4579999876542 24567889999999999999999999987644 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 158 (260)
T cd05073 85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--
Confidence 99999987643 235788899999999999999999988 999999999999999999999999999766532211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCChhH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKE 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~ 691 (810)
......++..|+|||++..+.++.++|||||||++|+|+| |..||....... +...+.. .....+...
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 228 (260)
T cd05073 159 ---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPRPENC 228 (260)
T ss_pred ---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCCCcccC
Confidence 1122345678999999988889999999999999999999 999996432211 1111111 112233456
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
+..+.+++.+||..+|.+||++. .+...|+.
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~L~~ 259 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFE-YIQSVLDD 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 78899999999999999999998 56666653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=304.56 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=197.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC-------CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--e
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 525 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~ 525 (810)
.+|.....||.|+||.||+|+.. ...+++|.+...... ....+.+|+.+|++++||||++++++|.+.. +
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888889999999999999864 347899988654433 3567899999999999999999999997644 8
Q ss_pred EEEEeccCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeee
Q 003576 526 LVYEYMENGSLEDRLYRKNNT------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DF 599 (810)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998765422 25899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHH
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 678 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~ 678 (810)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+..
T Consensus 162 ~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~~~~ 229 (275)
T cd05046 162 SLSKDVYNSEY-----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------EVLN 229 (275)
T ss_pred ccccccCcccc-----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------HHHH
Confidence 99875432211 11223366788999999888888999999999999999999 78888532211 1111
Q ss_pred HhhhhC--CCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 679 ILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 679 ~ld~~~--~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
...... ...+...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~-~l~~l 273 (275)
T cd05046 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE-LVSAL 273 (275)
T ss_pred HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHh
Confidence 111111 1123356789999999999999999999984 54444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.01 Aligned_cols=240 Identities=25% Similarity=0.281 Sum_probs=205.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHH---HHHHHHHHHhcCCCceeeeeceecCC--CeEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~---~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~ 528 (810)
++|...+.||+|.||.|.+++-+ ++.+|+|++++.......+ -..|-.+|+..+||.+..|-..|+.+ .|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56788889999999999999876 5699999999876555544 46789999999999999998777554 49999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||..||.|.-+|.+.. .+++.....+-.+|+.||.|||+.+ ||+||||.+|+|||.+|++||+|||+|+.--..
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988886644 3788888889999999999999998 999999999999999999999999999853322
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
. .....++|||.|+|||++....|+...|+|.+||++|||++|+.||... +.+.+.+++-.....+|
T Consensus 322 g------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-------dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 322 G------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-------DHEKLFELILMEDLKFP 388 (516)
T ss_pred c------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-------chhHHHHHHHhhhccCC
Confidence 2 1345679999999999999999999999999999999999999999633 34556666666667788
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
...+++...|+...|..||.+|..-.
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgG 414 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGG 414 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCC
Confidence 99999999999999999999996544
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=300.70 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=194.5
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeeeceecCC----C
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 524 (810)
.+|.....||+|+||.||+|.+. +..|++|.+..... .....+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999875 46899998764321 1235678899999999999999999988653 2
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 68999999999999887543 3788889999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......... .........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~ 227 (265)
T cd06652 156 LQTICLSG---TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-----FKIATQPTN 227 (265)
T ss_pred cccccccc---cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-----HHHhcCCCC
Confidence 54321110 0112346889999999988888999999999999999999999999643222211 011111122
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...|...+..+.+++.+|+. +|.+||++.++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~i 258 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADEL 258 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHH
Confidence 34556677889999999995 99999998853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=299.18 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=198.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|+..+.||.|+||.||.+... +..+++|.+.... ......+.+|+.+|++++|+||+++++++.+.. +++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778889999999988887764 5689999876542 334567889999999999999999999997665 789999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987653 245889999999999999999999998 99999999999999999999999999987654331
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+........+..
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQGNYTPVVSV 224 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCCCccc
Confidence 1223468999999999988888999999999999999999999996433211 1112222222223345
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+..+.+++.+||..+|.+||++.+.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~l 250 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEV 250 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHH
Confidence 67889999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.43 Aligned_cols=246 Identities=20% Similarity=0.288 Sum_probs=189.1
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCC------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 523 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 523 (810)
..+.|.....||.|+||.||+|.+. +..||||++..... .....+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467888899999999999999875 45899999875322 2345677899999999999999999987422
Q ss_pred --CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 27899988 7899887743 24899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-------- 672 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~-------- 672 (810)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 165 ~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 165 ARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred ceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9865432 123478999999998866 5688999999999999999999999964332211100
Q ss_pred ---------cchhHHHhhhhCCCCC--------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 673 ---------EDNLAEILDAQAGDWP--------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 673 ---------~~~l~~~ld~~~~~~p--------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.......+.. ....+ ....+.+.+|+.+||..||.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 236 SPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000 01111 12345678999999999999999998644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.82 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=191.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
..|....+||.|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999875 5689999986543 223456788999999999999999999986555 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 68988886543 34888999999999999999999998 99999999999999999999999999976543221
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh---------ccchhHHHh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------DEDNLAEIL 680 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~---------~~~~l~~~l 680 (810)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||......+... ....+..++
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 1123367899999998765 457889999999999999999999997443211100 000001110
Q ss_pred hhh------CCC--------CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 681 DAQ------AGD--------WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 681 d~~------~~~--------~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
... ... .....+..+.+|+.+||..||.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000 000 1123467889999999999999999998533
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.51 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=195.0
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
|.....||.|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||++++++|.+.. ++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555667999999999999874 5689999987543 233457889999999999999999999986654 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 9999998753 24888999999999999999999988 99999999999999999999999999976653221
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
......|+..|+|||++.+..++.++|||||||++|+|+||+.||........ ...+........+...+
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (277)
T cd06642 157 ----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIPKNSPPTLEGQYS 226 (277)
T ss_pred ----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------HhhhhcCCCCCCCcccC
Confidence 12234688999999999988899999999999999999999999863322111 11111111222334567
Q ss_pred HHHHHHHHHHhhhcCCCCCccccchh
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v~ 718 (810)
..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 88999999999999999999996553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.91 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=199.4
Q ss_pred cccceeeccCCcEEEEEEEECCe--EEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceec--CCCeEEEEeccC
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMEN 533 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey~~~ 533 (810)
|.+...||.|+||.||++..+.+ ..|.|++........++|+-||+||..++||+||+|+++|. ...++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44555799999999999998765 56788888777778889999999999999999999998753 344889999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|-.+.++..-+. +|.+.++.-+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+.... .
T Consensus 114 GAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~------~ 182 (1187)
T KOG0579|consen 114 GAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------S 182 (1187)
T ss_pred chHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch------h
Confidence 999888766543 5899999999999999999999999 9999999999999999999999999986533 2
Q ss_pred ccccccCCccCccccCcccc-----ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 614 TTYKNTGPVGTLCYIDPEYQ-----RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~-----~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
+..+...+.|||+|||||+. ...+|+.++|||||||+|.||..+.||....+.+...+.... -++...-.|
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK----SePPTLlqP 258 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----SEPPTLLQP 258 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh----cCCCcccCc
Confidence 33455678999999999964 456799999999999999999999999864443332211100 011111245
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+..+.+|+.+||..||..||++.+.+
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 67789999999999999999999998543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=326.36 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=187.5
Q ss_pred hcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
..+|.+...||+|+||.||++.+.. ..||||... ...+.+|+.+|++|+|||||++++++.... ++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578899999999999999999864 578998532 234678999999999999999999886544 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 78888876543 25899999999999999999999998 99999999999999999999999999987653321
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchh-hhhhccchhHHHhhhh------
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV-ETAIDEDNLAEILDAQ------ 683 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~-~~~~~~~~l~~~ld~~------ 683 (810)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+...... ........+..++...
T Consensus 316 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 T----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 1112457999999999999999999999999999999999988655321100 0000000011111100
Q ss_pred ---------------------C-----CCCCh--hHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 684 ---------------------A-----GDWPI--KETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 684 ---------------------~-----~~~p~--~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
. ..|.. .....+.+|+.+||+.||.+||++.++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el 452 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL 452 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence 0 01110 234578899999999999999999853
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=298.30 Aligned_cols=242 Identities=27% Similarity=0.424 Sum_probs=192.8
Q ss_pred eeccCCcEEEEEEEEC-CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHHH
Q 003576 463 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED 538 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~ 538 (810)
+||.|+||.||++.+. +..|++|.+...... ....+.+|+.++++++||||+++++++.+.. ++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999886 679999988765443 4567899999999999999999999986654 89999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccc
Q 003576 539 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618 (810)
Q Consensus 539 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 618 (810)
++..... .+++..+..++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++.......... ..
T Consensus 82 ~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----~~ 152 (251)
T cd05041 82 FLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SD 152 (251)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee----cc
Confidence 9865432 4788899999999999999999998 9999999999999999999999999998654221110 00
Q ss_pred cCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhh-CCCCChhHHHHHH
Q 003576 619 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELA 696 (810)
Q Consensus 619 ~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~ 696 (810)
....++..|+|||++.++.++.++|||||||++|+|+| |..||...... .....+... ....+...+..+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESGYRMPAPQLCPEEIY 225 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcCCCCCCCccCCHHHH
Confidence 11234667999999988889999999999999999999 88888543221 111112111 1223445678999
Q ss_pred HHHHHHhhhcCCCCCccccchhhHH
Q 003576 697 ALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 697 ~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
+++.+||..+|.+||++.+ ++..|
T Consensus 226 ~li~~~l~~~p~~Rp~~~e-ll~~l 249 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSE-IYNEL 249 (251)
T ss_pred HHHHHHhccChhhCcCHHH-HHHHh
Confidence 9999999999999999984 55444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.81 Aligned_cols=242 Identities=25% Similarity=0.380 Sum_probs=196.5
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.|+...+||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666778999999999999875 5689999987543 334567889999999999999999999987655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++|+|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 999999988542 4788899999999999999999998 99999999999999999999999999977653221
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......++..|+|||++.+..++.++|+|||||++|+|+||.+||......... ..+........+...
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~ 225 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FLIPKNNPPTLTGEF 225 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hhhhcCCCCCCchhh
Confidence 112346888999999998888999999999999999999999999643322111 111111122334467
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccch
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+..+.+++.+||+.+|.+||++.+++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELL 251 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHH
Confidence 78899999999999999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.61 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=198.3
Q ss_pred CHHHHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceecC-
Q 003576 447 TWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD- 522 (810)
Q Consensus 447 ~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~- 522 (810)
+..++......|+....||.|+||.||+|.+. +..+|+|++..... ....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667788999999999999999999984 46899998865432 345688899999998 69999999999842
Q ss_pred -------CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceE
Q 003576 523 -------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 595 (810)
Q Consensus 523 -------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~k 595 (810)
..|++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 23899999999999998865432 34788889999999999999999998 99999999999999999999
Q ss_pred EeeeccccccCCCCCcccccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh
Q 003576 596 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA 670 (810)
Q Consensus 596 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~ 670 (810)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|++|.+||.........
T Consensus 162 l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EeeCcchhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999876543211 122347899999999875 345788999999999999999999999643322211
Q ss_pred hccchhHHHhhhhC-CCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 671 IDEDNLAEILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 671 ~~~~~l~~~ld~~~-~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
. ....... ...+..++..+.+|+.+||..||.+||++.+
T Consensus 236 ~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 236 F------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred h------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 1 1111111 1112245788999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=300.02 Aligned_cols=242 Identities=30% Similarity=0.508 Sum_probs=195.7
Q ss_pred ccceeeccCCcEEEEEEEECC------eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 459 SENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 459 ~~~~~LG~G~~g~Vy~~~~~~------~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.....||.|+||.||++.+.. ..+|+|++...... ....+..|+.+|..++||||+++++++.+.. +++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999875 67999999765443 5668899999999999999999999987644 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999875432 12899999999999999999999998 9999999999999999999999999998766442
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
... .....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||....... .+..+........+
T Consensus 158 ~~~-----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~ 226 (258)
T smart00219 158 YYK-----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEYLKKGYRLPKP 226 (258)
T ss_pred ccc-----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCCCCCC
Confidence 211 112347889999999988889999999999999999998 888886422111 11111112222334
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 456889999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=300.25 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=202.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
++|...+.||.|+||.||++... +..+++|++..... .....+.+|+.++.+++||||+++++++.... ++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999986 56899999876544 34577999999999999999999999987654 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998764 348999999999999999999999 88 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
.. .....++..|+|||.+.+..++.++||||||+++|+|+||++||....... .......+........+.
T Consensus 155 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06623 155 DQ------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDGPPPSLPA 225 (264)
T ss_pred Cc------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcCCCCCCCc
Confidence 21 123468899999999998889999999999999999999999996543200 011122222222333444
Q ss_pred h-HHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 690 K-ETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 690 ~-~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
. .+..+.+++.+||..+|.+||++.+.+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 4 678999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=300.32 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=197.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC----CeEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~ 528 (810)
+|.....||.|+||.||++.+. +..+++|++.... ......+..|+.+++.++||||+++++++... .+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999874 4689999886543 23345688999999999999999999977432 28999
Q ss_pred EeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 529 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLH-----NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH-----~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
||+++++|.+++... ....++++..++.++.+|+.||.||| +.+ |+|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998753 22346899999999999999999999 666 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
......... .....|++.|++||++....++.++||||||+++|+|++|+.||....... ....+...
T Consensus 158 ~~~~~~~~~------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~ 225 (265)
T cd08217 158 KILGHDSSF------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LASKIKEG 225 (265)
T ss_pred ccccCCccc------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH------HHHHHhcC
Confidence 876643321 123468999999999988889999999999999999999999997443111 11112222
Q ss_pred hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 683 ~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.....+...+..+.+++.+||..+|.+||++.++
T Consensus 226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i 259 (265)
T cd08217 226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259 (265)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 2234556678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=309.20 Aligned_cols=248 Identities=27% Similarity=0.342 Sum_probs=198.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+|...+.||+|+||.||+|... +..+|+|.+...... ....+..|+.+|..++||||+++++.+.+.. |+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6788899999999999999885 469999998765432 3456889999999999999999999986655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999886543 245899999999999999999999998 9999999999999999999999999987654322
Q ss_pred Cccc-----------------------ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch
Q 003576 610 SFVS-----------------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK 666 (810)
Q Consensus 610 ~~~~-----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~ 666 (810)
.... .........||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1110 00111234789999999999888899999999999999999999999964432
Q ss_pred hhhhhccchhHHHhhhhCCCCChh--HHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 667 VETAIDEDNLAEILDAQAGDWPIK--ETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 667 ~~~~~~~~~l~~~ld~~~~~~p~~--~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.. .+..+.... ..++.. .+..+.+++.+||..+|.+||+...
T Consensus 238 ~~------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 238 DE------TFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred HH------HHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 21 122222211 122222 5789999999999999999999553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.99 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=200.3
Q ss_pred cccceeeccCCcEEEEEEEECC-eEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeeeceecC--CCeEEEEeccC
Q 003576 458 FSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMEN 533 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~ 533 (810)
..+.++||+|-||.|.++...+ ..||||.++...... +..|..|+.+|.+|+||||+.|+|+|.. ..|+|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 4556789999999999999887 899999999876554 4789999999999999999999999943 34999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|..+|..+... .+......+|+.||+.|++||.+.+ ||||||.+.|+|+|.++++||+|||+++.+-..+.+..
T Consensus 620 GDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 620 GDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred CcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999876432 1344556789999999999999999 99999999999999999999999999986654432211
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh--CCCCccccchhhhhhccchhHHHhhhh----CCCC
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQ----AGDW 687 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt--g~~Pf~~~~~~~~~~~~~~l~~~ld~~----~~~~ 687 (810)
....+-...|||||.+..++++.+||||+||+++||+++ ...||...++-.. .++...+++.. ....
T Consensus 696 ----qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 696 ----QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred ----ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceeccC
Confidence 123456788999999999999999999999999999865 6788864432211 11222333322 1335
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
|.-++..+.+|+++||..+-.+||++.++.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 667888999999999999999999999543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=305.57 Aligned_cols=237 Identities=27% Similarity=0.349 Sum_probs=195.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|.....||+|+||.||++.+. +..+|+|++.... ......+.+|+.+|++++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999885 5689999986532 223456889999999999999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 4889999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||....... ....+. ......|
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~ 218 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKIL-EGKVRFP 218 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCccCC
Confidence 123468999999999988888999999999999999999999996443211 111111 1223345
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
...+..+.+++.+||..+|.+||+..
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcc
Confidence 55688999999999999999999543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=299.49 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=199.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
.|+..++||+|+||.||++... +..+++|.+.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999874 5689999886432 223457899999999999999999999987655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998865432 34788999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
......|++.|+|||++.+..++.++|+|||||++|+|+||+.||...... .....++.......+..
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 224 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGSYPPVSSH 224 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCCCCCCccc
Confidence 112346888999999998888999999999999999999999999643221 11222222223334556
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+..+.+++.+||+.+|.+||++.+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 688999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.38 Aligned_cols=256 Identities=26% Similarity=0.339 Sum_probs=201.4
Q ss_pred cCCHHHHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceec
Q 003576 445 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACP 521 (810)
Q Consensus 445 ~~~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~ 521 (810)
.++..++..++++|.....||+|+||.||++... +..+|+|++..... ....+.+|+.++.++ +|||+++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556677788999999999999999999999885 56899999865422 345678899999999 7999999999884
Q ss_pred C-------CCeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 522 D-------HGCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 522 ~-------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
. ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 2 238999999999999988642 22345899999999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCCCcccccccccCCccCccccCccccccCC-----CCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 003576 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-----ISPKSDVYAYGMVILQLLTAKPAIAITHKVE 668 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~ 668 (810)
+||+|||++........ ......|+..|+|||++.... ++.++|||||||++|+|++|++||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999886553221 112346889999999875433 6889999999999999999999996443222
Q ss_pred hhhccchhHHHhhhhCC--CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 669 TAIDEDNLAEILDAQAG--DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 669 ~~~~~~~l~~~ld~~~~--~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.. ..+...... ..+......+.+|+.+||+.+|.+||++.+.
T Consensus 241 ~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 284 (291)
T cd06639 241 TL------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284 (291)
T ss_pred HH------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 11 111111111 1133456789999999999999999999853
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.38 Aligned_cols=238 Identities=19% Similarity=0.307 Sum_probs=192.4
Q ss_pred cceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 460 ENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
...+||+|+||.||++... +..||+|++..........+.+|+.++..++||||++++++|.... ++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3446999999999999874 6799999987655555667889999999999999999999886544 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 9987744 23889999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC---CCCChhHH
Q 003576 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---GDWPIKET 692 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~---~~~p~~~~ 692 (810)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......... . .+.... ...+...+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~ 244 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------K-RLRDSPPPKLKNAHKIS 244 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-HHhccCCCCccccCCCC
Confidence 112347899999999998888999999999999999999999999644322211 1 111110 11122456
Q ss_pred HHHHHHHHHHhhhcCCCCCccccch
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+.+++.+||..+|.+||++.+++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHh
Confidence 7899999999999999999998533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.48 Aligned_cols=246 Identities=29% Similarity=0.393 Sum_probs=197.5
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|...+.||.|+||.||++.+. +..+++|.+..... .....+.+|++++++++||||+++++++.... ++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999986 56899998876533 34567899999999999999999999986655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999987643 458899999999999999999999 88 99999999999999999999999999876542211
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...+..++.......+..
T Consensus 157 --------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06605 157 --------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQYIVNEPPPRLPSG 227 (265)
T ss_pred --------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHHHHhcCCCCCCChh
Confidence 11578899999999988899999999999999999999999996442110000 011122222222223333
Q ss_pred -HHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 691 -ETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 691 -~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+..+.++|.+||..+|.+||++.+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~l 254 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKEL 254 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 67889999999999999999998853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=317.53 Aligned_cols=187 Identities=25% Similarity=0.382 Sum_probs=158.3
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.+|...+.||+|+||.||+|...+ ..||+|+.... ....|+.+|++++||||++++++|.+.. ++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 368888999999999999999864 48999975432 2356999999999999999999986555 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
. ++|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 140 S-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred C-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 5 68888876543 35899999999999999999999998 9999999999999999999999999997533221
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCc
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 661 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf 661 (810)
......||+.|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 212 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 112347999999999999889999999999999999999865544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.86 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=196.7
Q ss_pred CcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCc------cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eE
Q 003576 457 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~l 526 (810)
+|+....||+|+||.||+|.. .+..+|+|++..... .....+.+|+.+|++++||||+++++++.+.. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999987 356899999875431 12356889999999999999999999997655 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-ceEEeeecccccc
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 605 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-~~kL~DFGla~~~ 605 (810)
||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999986543 4889999999999999999999998 99999999999998775 6999999999876
Q ss_pred CCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHh-hhhC
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQA 684 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~l-d~~~ 684 (810)
........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||......... ....... ....
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATTA 229 (268)
T ss_pred ccccccCC--ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCCC
Confidence 54321111 1122346889999999998888999999999999999999999999633211110 0111111 1112
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...+...+..+.+++.+||..+|.+||++.++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 34555678899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.70 Aligned_cols=237 Identities=27% Similarity=0.409 Sum_probs=194.1
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
-|...+.||.|+||.||-+++.. ..||||.+...... ...++..|+..|.+++|||+|.+-|||.... +||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36777789999999999998854 48999998765433 3467899999999999999999999985443 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
||- ||-.|+|.-.. +++-+-++..|+.+.+.||.|||+++ .||||||..||||+++|.|||+|||.|....+.
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 995 78888775443 45888899999999999999999999 999999999999999999999999999877643
Q ss_pred CcccccccccCCccCccccCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
..++|||+|||||++ ..|.|+-++|||||||+..||.-.+||+...+.+...+. +-....+.
T Consensus 180 ---------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH------IAQNesPt 244 (948)
T KOG0577|consen 180 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNESPT 244 (948)
T ss_pred ---------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH------HHhcCCCC
Confidence 346999999999975 467899999999999999999999999875544332211 11111111
Q ss_pred -CChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 687 -WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 687 -~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.....+..+..|+..||+.-|.+|||..+
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 12356889999999999999999999874
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.98 Aligned_cols=246 Identities=23% Similarity=0.289 Sum_probs=193.2
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|...+.||+|+||.||++.... ..|++|.+..... .....+.+|+.+++.++||||+++++.+.+.. ++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999998864 5899998875432 23456789999999999999999999987665 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||++|++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999986543 4889999999999999999999998 999999999999999999999999998742211
Q ss_pred CCc---------ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHH
Q 003576 609 PSF---------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 609 ~~~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
... ...........|+..|+|||++....++.++|||||||++|+|++|..||......+ .+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 000 000111123467889999999988889999999999999999999999996332211 11111
Q ss_pred hhhhCCCCC---hhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 680 LDAQAGDWP---IKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 680 ld~~~~~~p---~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
... ...+| ...+..+.+++.+||+.+|.+||+..
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 229 ISD-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred Hhc-ccCCCCccccCCHHHHHHHHHHhccChhhccCcc
Confidence 111 11111 24578899999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=298.35 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=195.5
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-----cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
|.....||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566778999999999999885 67999998865432 23456889999999999999999999987654 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999986543 4889999999999999999999998 999999999999999999999999998875433
Q ss_pred CCcccccccccCCccCccccCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh-hhCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGD 686 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~ 686 (810)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|++||.......... .... .....
T Consensus 156 ~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~ 222 (258)
T cd06632 156 S-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF------KIGRSKELPP 222 (258)
T ss_pred c-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH------HHHhcccCCC
Confidence 2 112346889999999887666 8999999999999999999999996543222111 1111 11233
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+...+..+.+++.+||..+|.+||++.+.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 445567899999999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.22 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=195.8
Q ss_pred cccceeeccCCcEEEEEEEEC-----CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-------
Q 003576 458 FSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~-----~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 523 (810)
|...+.||+|+||.||+|.+. +..+|||++.... ....+++.+|+.+|+.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999863 3589999987543 23456788999999999999999999987432
Q ss_pred -CeEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeee
Q 003576 524 -GCLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DF 599 (810)
.+++++|+.+|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 168899999999998875422 1224788899999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHH
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 678 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~ 678 (810)
|+++......... ......+++.|++||.+....++.++|||||||++|+|++ |++||....... ....
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~~~~ 227 (273)
T cd05074 158 GLSKKIYSGDYYR----QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNY 227 (273)
T ss_pred cccccccCCccee----cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------HHHH
Confidence 9998764322111 1122345678999999988889999999999999999999 889986432211 1111
Q ss_pred HhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 679 ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 679 ~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
+........+...+..+.+++.+||..+|.+||++. .++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~-~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQ-HLRDQLELI 272 (273)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 111112223445678999999999999999999999 566666543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.66 Aligned_cols=244 Identities=26% Similarity=0.390 Sum_probs=197.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|.....||+|+||.||++... +..+++|.+.... ......+.+|+.+|++++||||+++++.+.+.. ++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999998874 5689999886542 234567889999999999999999999886554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++.... ...+++..+..++.+++.||.|||+++ |+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 234889999999999999999999998 9999999999999854 568999999998765432
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ............+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 223 (256)
T cd08220 157 K-------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIMSGTFAPISD 223 (256)
T ss_pred c-------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHHhcCCCCCCC
Confidence 1 1224688999999999888899999999999999999999999964332111 11122222233444
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+..+.+++.+||..+|.+||++.+++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 5678999999999999999999999644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.46 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=199.0
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
++|+..+.||.|+||.||+|... +..+++|++.... ......+.+|+.+|+.++||||+++++.+.+.. ++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999874 4589999987543 234567899999999999999999999886554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876543345899999999999999999999998 99999999999999999999999999987664432
Q ss_pred cccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC-
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP- 688 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p- 688 (810)
... .......|+..|++||++... .++.++|+|||||++|+|++|+.||........ +...+......++
T Consensus 158 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 229 (267)
T cd06610 158 RTR--KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQNDPPSLET 229 (267)
T ss_pred ccc--cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCCCCCcCC
Confidence 110 112334689999999988776 789999999999999999999999964432211 1111111111111
Q ss_pred ----hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 689 ----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 689 ----~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+..+.+++.+||..||.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 245688999999999999999999885
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.67 Aligned_cols=243 Identities=19% Similarity=0.296 Sum_probs=193.0
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
|.....||+|+||.||++... +..||||.+........+.+.+|+.+++.++||||+++++.+.... ++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333456999999999999874 5689999987655555667899999999999999999999886544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--- 173 (292)
T cd06658 104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--- 173 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---
Confidence 9999987432 3788999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 693 (810)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .+...+.. ........+.
T Consensus 174 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~ 246 (292)
T cd06658 174 ---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR---RIRDNLPP-RVKDSHKVSS 246 (292)
T ss_pred ---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcCCC-ccccccccCH
Confidence 1123468999999999988889999999999999999999999996433221100 01111111 1111224567
Q ss_pred HHHHHHHHHhhhcCCCCCccccch
Q 003576 694 ELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 694 ~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+.+++.+||..||.+||++.+++
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il 270 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELL 270 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHh
Confidence 899999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.09 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=182.4
Q ss_pred eeccCCcEEEEEEEECC----eEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 463 RIGMGGYGTVYKGTFHH----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~----~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
.||+|+||.||+|.... ..+++|.+.... ......+.+|+.+++.++||||+++++.|.+.. |+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 59999999999997532 245677665443 234567899999999999999999999987554 89999999999
Q ss_pred HHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 536 LEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 536 L~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 9999876432 234677778899999999999999988 99999999999999999999999999864322110
Q ss_pred cccccCCccCccccCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh----
Q 003576 615 TYKNTGPVGTLCYIDPEYQRT-------GLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA---- 682 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~---- 682 (810)
........++..|+|||++.. ..++.++|||||||++|+|++ |.+||......+. +..++..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~~~~~ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIKDQQVK 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhhcccc
Confidence 011123468899999998743 235789999999999999997 5678853322111 1111111
Q ss_pred -hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 683 -QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 683 -~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
.....+...+..+.+++..|| .+|.+||++.+ |++.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~-i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE-VHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH-HHHHh
Confidence 112233446788999999999 68999999995 55544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=300.59 Aligned_cols=241 Identities=24% Similarity=0.275 Sum_probs=198.7
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+|.....||.|+||.||+|.+. +..+|+|++..... ...+.+.+|+.++++++||||+++++++.+.. ++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999986 56999999875432 23567899999999999999999999986555 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+.+++|.+++... .++++..+..++.||+.||.|||+++ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998654 35889999999999999999999998 9999999999999999999999999988765432
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. .....|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ...+...........|.
T Consensus 155 ~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 223 (258)
T cd05578 155 L-------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETADVLYPA 223 (258)
T ss_pred c-------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccccccCcc
Confidence 1 123468889999999988889999999999999999999999997443210 11112222212344555
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+..+.+++.+||..||.+||++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCcc
Confidence 6778999999999999999999993
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.04 Aligned_cols=250 Identities=29% Similarity=0.339 Sum_probs=195.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCC----CeEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~ 528 (810)
++|...++||.|++|.||++.+. +..+|+|.+..... .....+.+|++++++++||||++++++|.+. .++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999984 56899999875433 3456789999999999999999999988542 38999
Q ss_pred EeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 22345888999999999999999999998 99999999999999999999999999876542
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh---C
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ---A 684 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~---~ 684 (810)
.. .....++..|++||.+.+..++.++|||||||++|+|++|+.||...... ..........+.... .
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCCchhh
Confidence 21 11336788999999998889999999999999999999999999744220 000001111111101 0
Q ss_pred CCCC---hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 685 GDWP---IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 685 ~~~p---~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+ ...+..+.+++.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 1111 23467899999999999999999998533
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=303.37 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=191.5
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|+....||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788889999999999999985 5689999876432 223456789999999999999999999986654 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887664332 4899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch-h-------HHHh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN-L-------AEIL 680 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~-l-------~~~l 680 (810)
. ......++..|+|||++.+ ..++.++||||||+++|+|+||++||......+....... + ....
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1123367889999998765 5578999999999999999999999974433221111000 0 0000
Q ss_pred hhh-------CC----CC-----ChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 681 DAQ-------AG----DW-----PIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 681 d~~-------~~----~~-----p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
+.. .. .. -...+..+.+|+.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 000 00 00 0124678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=301.91 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=197.0
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceecCC------
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH------ 523 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~------ 523 (810)
..+++|.....||.|+||.||+|.+. +..+++|++..... ....+.+|+.+++++ +||||++++++|.+.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999985 45899999876543 346789999999999 699999999998432
Q ss_pred --CeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 524 --GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 289999999999999886532 2345889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~ 675 (810)
++........ ......|+..|+|||++.. ..++.++|||||||++|+|+||++||........
T Consensus 159 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------ 226 (275)
T cd06608 159 VSAQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------ 226 (275)
T ss_pred cceecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------
Confidence 9876543221 1223468999999998653 3467899999999999999999999964322211
Q ss_pred hHHHhhhhC--CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 676 LAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 676 l~~~ld~~~--~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+..+..... ...+...+..+.+|+.+||..||.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 227 LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 111111111 112233567899999999999999999998533
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=310.29 Aligned_cols=253 Identities=16% Similarity=0.205 Sum_probs=186.4
Q ss_pred ceeeccC--CcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 461 NLRIGMG--GYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 461 ~~~LG~G--~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
..+||+| +||+||++... +..||+|.+..... .....+.+|+.+++.++||||++++++|.+.. ++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 78999999885 46899999875432 23356778999999999999999999986554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999865432 34889999999999999999999998 9999999999999999999999998765433211100
Q ss_pred -cccccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--cchhHHHhhh-----
Q 003576 613 -STTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--EDNLAEILDA----- 682 (810)
Q Consensus 613 -~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~--~~~l~~~ld~----- 682 (810)
..........++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... .+.....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 00001122357788999998875 4588999999999999999999999963221111000 0000000000
Q ss_pred ------------------------h--------CCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 683 ------------------------Q--------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 683 ------------------------~--------~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
. ........++.+.+|+.+||+.||.+||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 0 0011123467899999999999999999998543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.80 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=192.2
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|+..++||+|+||.||+|.+. +..+|+|++...... ..+.+.+|+.+|+.++||||++++++|.+.. ++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999985 568999987654322 3456889999999999999999999997655 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+++++|..+..... .+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999998887664432 3889999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc--------hhHHHh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NLAEIL 680 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--------~l~~~l 680 (810)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|++||......+...... ......
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1123468899999998765 457889999999999999999999996443221110000 000000
Q ss_pred h------hh-CC---------CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 681 D------AQ-AG---------DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 681 d------~~-~~---------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+ .. .. ......+..+.+|+.+||..+|.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 0 00 00 0012346789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.83 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=196.3
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
.|...+.||+|+||.||+|... +..+++|++...... ....+.+|+.+++.++|+||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3677889999999999999874 568999998766443 5567899999999999999999999986554 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++.... .+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999886542 3788899999999999999999998 99999999999999999999999999987654432
Q ss_pred cccccccccCCccCccccCccccccCC---CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGL---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.... ......++..|++||++.... ++.++||||||+++|+|++|+.||........ ....+........
T Consensus 155 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~ 227 (264)
T cd06626 155 TMGE--EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVGAGHKPPI 227 (264)
T ss_pred cccc--cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHhcCCCCCC
Confidence 1111 012346889999999988766 88999999999999999999999964321110 0001111111223
Q ss_pred Chh--HHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 688 PIK--ETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 688 p~~--~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
|.. .+..+.+++.+||+.+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 333 37889999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=303.70 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=190.4
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|+....||.|+||.||+|.+. +..|+||.+..... .....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788899999999999999885 56899998865432 23356889999999999999999999986655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. ++|..++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 689888765432 35899999999999999999999998 99999999999999999999999999876543221
Q ss_pred cccccccccCCccCccccCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch--------h----H
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN--------L----A 677 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~--------l----~ 677 (810)
. .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||.............. . .
T Consensus 156 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 T------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 1 12235788999999876544 68899999999999999999999964432221110000 0 0
Q ss_pred HHhh--hhCC--------CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 678 EILD--AQAG--------DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 678 ~~ld--~~~~--------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.... .... ......+..+.+++.+||+.||.+||++.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 0000 0000 0112345778899999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.34 Aligned_cols=238 Identities=24% Similarity=0.372 Sum_probs=190.6
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||+|+||.||++... +..+|+|++.... ......+..|+.+|++++||||+++++.+.... |+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999875 5689999986532 223445678999999999999999999886544 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 999876543 35899999999999999999999998 99999999999999999999999999876543211
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 696 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 696 (810)
.....++..|++||++.++.++.++|||||||++|+|++|+.||....... ....+...........+...++.+.
T Consensus 151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05577 151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLEMAVEYPDKFSPEAK 226 (277)
T ss_pred -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc---cHHHHHhccccccccCCccCCHHHH
Confidence 123467889999999888889999999999999999999999996433210 0111111111122334455688999
Q ss_pred HHHHHHhhhcCCCCCcccc
Q 003576 697 ALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 697 ~Li~~cl~~dP~~RPs~~~ 715 (810)
+++.+||+.+|.+||++.+
T Consensus 227 ~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHccCChhHccCCCc
Confidence 9999999999999998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.25 Aligned_cols=243 Identities=25% Similarity=0.310 Sum_probs=202.2
Q ss_pred HHhhcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--
Q 003576 452 ESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 452 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-- 524 (810)
.....+|.+.+.||+|+||.|..+++++ ..||+|++.+.. .....-|..|-+||..-+.+.|+.|..+|.|..
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 3345678888999999999999999875 489999998743 234456899999999999999999999998876
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
|+|||||+||+|-.++.+.. .+|+..+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||.|-.
T Consensus 151 YlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred EEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHh
Confidence 89999999999999997665 4899999999999999999999999 99999999999999999999999999988
Q ss_pred cCCCCCcccccccccCCccCccccCccccc----c-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHH
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQR----T-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
+..++.. .....+|||.|++||++. + +.|++.+|+||+||++||||.|..||.....+++. ..+
T Consensus 225 m~~dG~V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------~KI 293 (1317)
T KOG0612|consen 225 MDADGTV-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------GKI 293 (1317)
T ss_pred cCCCCcE-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------HHH
Confidence 8765532 234569999999999874 2 67999999999999999999999999876666554 223
Q ss_pred hhhh-CCCCC--hhHHHHHHHHHHHHhhhcCCCCCc
Q 003576 680 LDAQ-AGDWP--IKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 680 ld~~-~~~~p--~~~~~~l~~Li~~cl~~dP~~RPs 712 (810)
++.. ...+| ...+.+..+||.+.+. +|..|-.
T Consensus 294 m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 294 MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred hchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 3321 23344 5689999999998876 6667765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.85 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=197.1
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
.+|...+.||+|+||.||++.. .+..+++|.+..........+.+|+.+++.++||||++++++|.+.. ++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999986 35689999987655555677899999999999999999999986543 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999988643 3788899999999999999999998 99999999999999999999999999876553321
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC--CCCh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--DWPI 689 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~--~~p~ 689 (810)
......|++.|++||++..+.++.++|||||||++|+|++|++||........... +...... ..+.
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~~~~~~~ 239 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTPELQNPE 239 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCCCCCCcc
Confidence 11234688999999999888899999999999999999999999964432211110 0000011 1223
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+..+.+++.+||..+|.+||++.+.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 4567899999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.53 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=189.5
Q ss_pred hcCcccceeeccCCcEEEEEEEEC-CeEEEEEEEccc--CccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~ 528 (810)
...|++.++||+||.+.||++... .+.||+|..... +......|.+|+..|.+|+ |.+||+||+|-.... |+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 345888899999999999999875 457777765433 3345567999999999996 999999999964444 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||-+ .+|..+|..+... ++...+..+..|++.++.++|++| |||.||||.|+|+- .|.+||+|||+|.-+..+
T Consensus 440 E~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9864 7999999876543 332367789999999999999999 99999999999994 579999999999987754
Q ss_pred CCcccccccccCCccCccccCccccccC-----------CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhH
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-----------LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 677 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~ 677 (810)
. +.......+||+.||+||.+... +.+++|||||||||||+|+.|++||+...... ..+.
T Consensus 513 T----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-----aKl~ 583 (677)
T KOG0596|consen 513 T----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-----AKLH 583 (677)
T ss_pred c----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----HHHH
Confidence 3 22334566999999999976432 25679999999999999999999997433222 2344
Q ss_pred HHhhhhC-CCCChhH-HHHHHHHHHHHhhhcCCCCCcccc
Q 003576 678 EILDAQA-GDWPIKE-TKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 678 ~~ld~~~-~~~p~~~-~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.+.++.. -.+|..- ..++.+++..||..||++||++.+
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence 5555532 1222211 223999999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.75 Aligned_cols=247 Identities=24% Similarity=0.418 Sum_probs=193.4
Q ss_pred CcccceeeccCCcEEEEEEEECC---eEEEEEEEcccC----------ccchHHHHHHHHHHHh-cCCCceeeeeceecC
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH---TFAAVKVLQSKG----------NIQNKQFLQELEVLSK-IRHPHLLLLLGACPD 522 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~---~~vavK~l~~~~----------~~~~~~~~~Ei~iL~~-l~HpnIv~l~g~~~~ 522 (810)
+|.....||+|+||.||+|.+.. ..+|+|.+.... .....++.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778889999999999999864 589999875432 1223457788888875 799999999999866
Q ss_pred CC--eEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEee
Q 003576 523 HG--CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGD 598 (810)
Q Consensus 523 ~~--~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~D 598 (810)
.. ++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ |+|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 55 8999999999999987542 223458999999999999999999996 56 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHH
Q 003576 599 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 678 (810)
Q Consensus 599 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~ 678 (810)
||++....... ......|+..|++||++.++.++.++||||||+++|+|++|++||......... ..
T Consensus 158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~------~~ 224 (269)
T cd08528 158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------TK 224 (269)
T ss_pred ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH------HH
Confidence 99998765432 123447899999999999888999999999999999999999999644322111 11
Q ss_pred HhhhhCCCCC-hhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 679 ILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 679 ~ld~~~~~~p-~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
+........+ ...+..+.+++.+||+.||.+||++.+ +..+
T Consensus 225 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e-~~~~ 266 (269)
T cd08528 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ-VSAM 266 (269)
T ss_pred HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHH-HHHH
Confidence 1111111111 145688999999999999999999984 4433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=298.89 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=194.7
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
-|....+||.|+||.||+|.+. +..+|+|++.... ......+.+|+.++.+++||||+++++++.+.. ++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3666778999999999999874 5689999876433 233456889999999999999999999986555 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999998853 24889999999999999999999998 99999999999999999999999999876643221
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......++..|++||++.+..++.++|+|||||++|+|++|..||........ ...+........+...
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 225 (277)
T cd06641 157 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPKNNPPTLEGNY 225 (277)
T ss_pred -----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHhcCCCCCCCccc
Confidence 11234688899999999888889999999999999999999999964322111 1111111122334456
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccch
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+..+.+++.+||..+|.+||++.+.+
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l 251 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELL 251 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 78899999999999999999998633
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.00 Aligned_cols=239 Identities=22% Similarity=0.361 Sum_probs=188.9
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEE--Ec----ccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC----eEEEEec
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKV--LQ----SKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYM 531 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~--l~----~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~----~lV~Ey~ 531 (810)
..||+|+|-+||+|.+..+.+.|.. ++ .......++|..|+.+|+.|+||||+++|.+|.+.. .+|.|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 3699999999999998766443321 11 112334578999999999999999999999986543 5799999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeeccccccCCCCC
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGla~~~~~~~~ 610 (810)
..|+|..|+.+.+. ++...+..|++||+.||.|||++. +||||||||.+||+|+.+ |.|||+|+|||.......
T Consensus 126 TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 99999999987664 778899999999999999999998 589999999999999876 999999999999876543
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC-CCCh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-DWPI 689 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~-~~p~ 689 (810)
.....|||.|||||++. ..|+...||||||++++||+|+..||.-.......+. .++....+ .+..
T Consensus 201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK-----KV~SGiKP~sl~k 267 (632)
T KOG0584|consen 201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK-----KVTSGIKPAALSK 267 (632)
T ss_pred -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH-----HHHcCCCHHHhhc
Confidence 23468999999999887 7799999999999999999999999974443322221 11111100 0111
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
-..+++.+||.+|+.. ..+||++.+.+..
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2257899999999999 9999999975543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.51 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=188.1
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|...+.||.|+||.||+|.+. +..+++|.+..... .....+.+|+.++++++||||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999985 56899998865422 22356788999999999999999999986655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 57888776533 34899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc----------chh---
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE----------DNL--- 676 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~----------~~l--- 676 (810)
......+++.|+|||++.+. .++.++|||||||++|+|+||..||.........+.. ..+
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 11234678999999987664 4789999999999999999999886433222111100 000
Q ss_pred HHHhhhh-CC---------CCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 677 AEILDAQ-AG---------DWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 677 ~~~ld~~-~~---------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
....+.. .. ......+..+.+|+.+||..||.+|||+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 0000000 00 001234678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.04 Aligned_cols=241 Identities=27% Similarity=0.431 Sum_probs=197.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
.|.....||+|++|.||++.+. +..+++|++..........+.+|+.++++++|||++++++++.... ++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999986 6689999998765545678999999999999999999999986544 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+++|.+++.... ..+++..+..++.+++.||.|||..+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999886643 35899999999999999999999988 99999999999999999999999999987664321
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC--CChh
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD--WPIK 690 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~--~p~~ 690 (810)
.....++..|++||++....++.++||||||+++|+|++|+.||.......... ......... .+..
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~ 222 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIATNGPPGLRNPEK 222 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhcCCCCcCcccc
Confidence 123478899999999988889999999999999999999999996442221111 011111111 2222
Q ss_pred HHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.+..+.+++.+||..||.+||++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHH
Confidence 3788999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.73 Aligned_cols=242 Identities=26% Similarity=0.409 Sum_probs=193.5
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC---CCceeeeeceecCCC--eEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~--~lV~ 528 (810)
.|+....||.|+||.||+|.+. +..+++|.+.... ......+.+|+.+++.++ |||+++++++|.+.. ++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677788999999999999974 5689999987543 334567889999999997 999999999986654 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++++|.+++... .+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988542 4889999999999999999999998 999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.. ......|+..|+|||++.++ .++.++|||||||++|+|++|.+||.......... .+........
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~~~~~~~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIPKSKPPRL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccccCCCCCC
Confidence 21 12234689999999987654 46889999999999999999999996443222110 0000011122
Q ss_pred Ch-hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 688 PI-KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 688 p~-~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+. ..+..+.+++.+||..||.+||++.+++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il 253 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELL 253 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 22 2567899999999999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.56 Aligned_cols=237 Identities=25% Similarity=0.316 Sum_probs=193.1
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||.|+||.||++.+. +..+++|++..... ...+.+.+|+.+++.++||||+++++++.+.. ++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999997 67999999875432 23467899999999999999999999986554 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99986543 3888999999999999999999988 9999999999999999999999999998765432
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh-hhCCCCChhHHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKETKEL 695 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~~~~l 695 (810)
......|++.|++||.+....++.++|+||||+++|+|++|..||....... ......+.. ......|...+..+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGKLEFPNYIDKAA 223 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCCCCCCcccCHHH
Confidence 1123468899999999888889999999999999999999999997543100 011122221 22334555567899
Q ss_pred HHHHHHHhhhcCCCCCccccch
Q 003576 696 AALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 696 ~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+++.+||..+|.+||++.+..
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred HHHHHHHccCChhhCcCCcccC
Confidence 9999999999999999965433
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.26 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=200.0
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
..+++|.....||.|+||.||+|.+. +..+++|++..... ....+.+|++++..++|+|++++++++.... ++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567888889999999999999986 67899999876544 5667889999999999999999999986544 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997654 35899999999999999999999988 999999999999999999999999998765533
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC--
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD-- 686 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~-- 686 (810)
.. ......++..|++||++.+..++.++|||||||++|+|++|+.||......... ..+.......
T Consensus 170 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~ 237 (286)
T cd06614 170 KS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLITTKGIPPLK 237 (286)
T ss_pred hh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCCCCc
Confidence 21 112335788999999988888999999999999999999999999643332111 1111111111
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+...+..+.+++.+||+.+|..||++.++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 267 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 122356789999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.22 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=192.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|.....||.|+||.||+|.+. ++.|++|++.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999974 5699999987654 223467899999999999999999999987655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+ +++|.+++.... .++++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 45899999999999999999999998 99999999999999999999999999987654321
Q ss_pred cccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc------c---hh----
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------D---NL---- 676 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~------~---~l---- 676 (810)
. ......|+..|+|||++.+. .++.++|||||||++|+|+||.+||............ . .+
T Consensus 155 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 R-----LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-----ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 0 11234789999999987654 4689999999999999999998888643321110000 0 00
Q ss_pred -----HHHhhhhCC-----CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 677 -----AEILDAQAG-----DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 677 -----~~~ld~~~~-----~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
..+...... ......+..+.+|+.+||..+|.+||++.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 279 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence 000000000 0112345889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=300.27 Aligned_cols=241 Identities=20% Similarity=0.308 Sum_probs=193.4
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
|....+||.|++|.||++... +..+++|.+........+.+.+|+.+++.++||||+++++++.... ++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999874 5689999887655555667889999999999999999999875443 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999998865 23888999999999999999999998 99999999999999999999999998876543221
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh--CCCCChhH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPIKE 691 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~p~~~ 691 (810)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ..+.... ....+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRIRDNLPPKLKNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHhcCCCCCcccccC
Confidence 112346899999999998888999999999999999999999999643322111 1111110 11112235
Q ss_pred HHHHHHHHHHHhhhcCCCCCccccch
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+..+.+++.+||..+|.+||++.+.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHc
Confidence 68899999999999999999998533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.46 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=193.8
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|+...+||+|+||.||+|.+. +..|++|++.... ......+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999986 4589999886542 233467899999999999999999999986554 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|++++.|..++... ..+++..+..++.+|+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776655332 23889999999999999999999998 9999999999999999999999999998766433
Q ss_pred CcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchh--------HHHh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--------AEIL 680 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l--------~~~l 680 (810)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|++||............... ....
T Consensus 155 ~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 AS-----PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred cc-----cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 21 11234678999999998887 7899999999999999999999999644322211100000 0000
Q ss_pred ------------hhh-----CCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 681 ------------DAQ-----AGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 681 ------------d~~-----~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
... ...++...+..+.+|+.+||..+|.+||++.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 282 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL 282 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence 000 001222347889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=297.88 Aligned_cols=242 Identities=22% Similarity=0.358 Sum_probs=201.9
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCC--CeEEEEecc
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 532 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~~ 532 (810)
-|.+..+||+|+||.||++.++ +..+|||..... .+.+++..|+.||++++.|++|++||.+..+ .++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3777889999999999999886 558899987654 3567899999999999999999999987544 389999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
.|++.|++..+. +++++.++..++...+.||.|||... -||||||..||||+.+|.+||+|||.+..+.+..
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--- 183 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--- 183 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH---
Confidence 999999886554 46999999999999999999999988 8999999999999999999999999998766432
Q ss_pred cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
..+....||+.|||||++..-.|+.++||||||++..||.-|+|||...+.....+-... -.+..-..|...+
T Consensus 184 ---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 184 ---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----KPPPTFKKPEEWS 256 (502)
T ss_pred ---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----CCCCCCCChHhhh
Confidence 234456899999999999988999999999999999999999999986665443221100 0000112356778
Q ss_pred HHHHHHHHHHhhhcCCCCCcccc
Q 003576 693 KELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.++.+++.+||-.+|++|-++.+
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHH
Confidence 99999999999999999988764
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.53 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=191.4
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc-----chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-----~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV 527 (810)
+|.....||.|+||.||+|.+. +..|++|.+...... ....+..|+.++++++||||+++++++.+.. ++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677788999999999999975 569999998765432 2345678999999999999999999997654 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986543 35899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc---------hhH
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLA 677 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~---------~l~ 677 (810)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||............. .+.
T Consensus 155 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNRK------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCcc------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 3211 122356888999998754 457899999999999999999988886433221110000 000
Q ss_pred ------HHhhhh-CCC-----CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 678 ------EILDAQ-AGD-----WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 678 ------~~ld~~-~~~-----~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...... ... .....+..+.+++.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000000 000 1123467899999999999999999998533
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.82 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=193.0
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|+..++||.|++|.||+|++. +..||||++..... .....+.+|+.++++++||||++++++|.+.. ++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999985 56899999876533 23456788999999999999999999987654 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
+ ++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 8 488888876554456899999999999999999999998 99999999999999999999999999976543211
Q ss_pred ccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc---------chhHHHhh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEILD 681 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~---------~~l~~~ld 681 (810)
......++..|++||++.+ ..++.++|||||||++|+|++|++||......+..... ..+..+..
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1122357889999998765 45688999999999999999999999754332211100 00000000
Q ss_pred h--hC-----------CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 682 A--QA-----------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 682 ~--~~-----------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
. .. .......+..+.+++.+||+.||.+||++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 0 00 00112346778999999999999999998853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=298.44 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=189.5
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHH-HHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEV-LSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~i-L~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|.....||+|+||.||++.+. +..||+|.+..... .....+..|+.+ ++.++||||+++++++.+.. ++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999985 56999999875432 233456667765 55668999999999986544 89999
Q ss_pred eccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 530 YMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 530 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|++ |+|.+++... .....+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877642 2334689999999999999999999987 7 99999999999999999999999999986543
Q ss_pred CCCcccccccccCCccCccccCcccccc----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRT----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
.. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... ..+...+...
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~ 224 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVVEEP 224 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHHhcC
Confidence 21 1123468899999998754 446889999999999999999999995321110 1122222221
Q ss_pred CCCCC-hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 684 AGDWP-IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 684 ~~~~p-~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
....+ ...+..+.+++.+||..+|.+||++.+++
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 22222 23578899999999999999999998533
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.64 Aligned_cols=244 Identities=23% Similarity=0.396 Sum_probs=196.6
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|...+.||.|+||.||+|... +..+|+|.+.... ......+.+|+.+++.++||||+++++.+.+.. ++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999985 4689999886542 223456889999999999999999999987655 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-ceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998875432 34789999999999999999999998 99999999999998875 56999999998765432
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ............+.
T Consensus 157 ~~------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 224 (257)
T cd08225 157 EL------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKICQGYFAPISP 224 (257)
T ss_pred cc------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhcccCCCCCC
Confidence 11 1224689999999999888899999999999999999999999964332111 11222222223334
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
..+..+.+++.+||..+|.+||++.++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 557789999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.44 Aligned_cols=249 Identities=20% Similarity=0.333 Sum_probs=188.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
++|.....||.|+||.||+|... +..||+|.+...... ....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999875 568999998754322 2345778999999999999999999987654 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. ++|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 97 589998865433 5889999999999999999999998 99999999999999999999999999875432111
Q ss_pred cccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc----------cchhHHH
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------EDNLAEI 679 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~----------~~~l~~~ 679 (810)
......++..|+|||++.+ ..++.++|||||||++|+|++|++||.........+. ...+...
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 1112356889999998765 4578999999999999999999999964431111100 0000000
Q ss_pred hhh------hCC---------CC-ChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 680 LDA------QAG---------DW-PIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 680 ld~------~~~---------~~-p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
... ... .. .......+.+++.+||+.+|.+||++.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~ 285 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA 285 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence 000 000 00 01112778899999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.18 Aligned_cols=248 Identities=20% Similarity=0.302 Sum_probs=190.3
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
|+..++||.|++|.||+|.+. +..|++|++..... .....+.+|+.+++.++|||++++++++.+.. +++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999874 67999999875432 23356889999999999999999999987655 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
+ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689998865442 34899999999999999999999988 99999999999999999999999999976543211
Q ss_pred ccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch---------------
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN--------------- 675 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~--------------- 675 (810)
......+++.|+|||++.+. .++.++||||||+++|+|+||++||..............
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11223568899999987654 578899999999999999999999964433221111000
Q ss_pred hHHHhh-------hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 676 LAEILD-------AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 676 l~~~ld-------~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+..... ..........+..+.+++.+||+.+|.+||++.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 000000 00011122345789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.66 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=191.1
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc----------chHHHHHHHHHHHhcCCCceeeeeceecCCC
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI----------QNKQFLQELEVLSKIRHPHLLLLLGACPDHG 524 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~----------~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~ 524 (810)
+|.....||.|+||.||+|... +..+|+|.+...... ..+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667788999999999999864 568999987532110 1245788999999999999999999986554
Q ss_pred --eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 525 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 8999999999999998765 34888999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHh
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
......... .......|+..|+|||.+.... ++.++|+||||+++|+|++|..||............. .
T Consensus 156 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~ 226 (272)
T cd06629 156 KKSDDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG-----N 226 (272)
T ss_pred ccccccccc----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh-----c
Confidence 765432111 1123346889999999877654 7899999999999999999999996433322111100 0
Q ss_pred hhhCCC----CChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 681 DAQAGD----WPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 681 d~~~~~----~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...... .....+..+.+++.+||..+|.+||++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (272)
T cd06629 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266 (272)
T ss_pred cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 000111 112357899999999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=291.18 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=201.7
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCC--C--eEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--G--CLVY 528 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~--~lV~ 528 (810)
+|...+.||+|++|.||+|... +..+++|++..... .....+.+|+.++++++||||+++++.+.+. . ++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999986 67899999876543 3456789999999999999999999998765 3 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 5899999999999999999999988 999999999999999999999999999877654
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh-hhCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~ 687 (810)
... .......++..|++||.+.+...+.++||||||+++|+|++|..||........ ....+.. ......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGSSGEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhccccCCCcCC
Confidence 321 012234788999999999888899999999999999999999999965431111 1111111 122344
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
|...+..+.+++.+|+..+|.+||++.+.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 556688999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=300.79 Aligned_cols=240 Identities=26% Similarity=0.395 Sum_probs=190.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
..|.....||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||++++++|.+.. ++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778889999999999999874 66899998864332 23356889999999999999999999986544 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 67777765433 24899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCcccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
....++..|+|||++. .+.++.++||||||+++|+|+||++||.......... .+......
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~~~ 232 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNDSP 232 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhcCCCC
Confidence 1236788999999874 4568899999999999999999999996443222111 11111111
Q ss_pred C-CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 686 D-WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 686 ~-~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
. .+...+..+.+++.+||..+|.+||++.+++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 1 1234567899999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=302.60 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=190.6
Q ss_pred CcccceeeccCCcEEEEEEEEC----CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCC----Ce
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GC 525 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~----~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~ 525 (810)
.|....+||+|+||.||+|... +..||+|.+.... ......+.+|+.++..++||||++++++|.+. .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999984 4699999988743 33346678899999999999999999999766 38
Q ss_pred EEEEeccCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC----CCceEEeee
Q 003576 526 LVYEYMENGSLEDRLYRKN--NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDV 599 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~----~~~~kL~DF 599 (810)
+||||+++ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999974 6777664322 1235889999999999999999999998 999999999999999 999999999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhh---hhhccch
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE---TAIDEDN 675 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~---~~~~~~~ 675 (810)
|++..+...... ........+++.|+|||++.+ ..++.++|||||||++|+|++|++||....... .......
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999876543221 112234578899999997765 457899999999999999999999996432211 0000000
Q ss_pred hHHHhh------------------------h-hCCCCC-----------hhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 676 LAEILD------------------------A-QAGDWP-----------IKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 676 l~~~ld------------------------~-~~~~~p-----------~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+..++. . ....++ ...+..+.+++.+||+.||.+||++.++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000000 0 000111 0345678999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=297.92 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=189.5
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++.+|...+.||+|+||.||+|... +..|++|++...... ....+.+|+.+|+.++|+||+++++++.+.. |+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3568999999999999999999874 669999998754322 2346788999999999999999999986654 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777665433 34778888999999999999999998 999999999999999999999999998764332
Q ss_pred CCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc---------h---
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------N--- 675 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~---------~--- 675 (810)
.. ......+++.|+|||++.+. .++.++|||||||++|+|+||.+||.........+... .
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 11 11233578999999988653 47889999999999999999999996433221111000 0
Q ss_pred -hHH-------HhhhhCC-C----C-ChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 676 -LAE-------ILDAQAG-D----W-PIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 676 -l~~-------~ld~~~~-~----~-p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+.. ....... . + ....+..+.+++.+|+..||.+||++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 000 0000000 0 0 01125688999999999999999999853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.92 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=191.1
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCC----CeEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV 527 (810)
++|.....||.|+||.||+|.+. ++.+++|.+...... ....+.+|+.++.+++||||+++++++.+. .|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888889999999999999986 568999988754322 233567899999999999999999987543 4899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+. ++|.+++..... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 599998865432 5899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc---------chhH
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLA 677 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~---------~~l~ 677 (810)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||............ ..+.
T Consensus 159 ~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PLKP------YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Cccc------cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 3211 1234678899999987654 4689999999999999999999999643322110000 0000
Q ss_pred ---HHh------------hhhCCCCChh-HHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 678 ---EIL------------DAQAGDWPIK-ETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 678 ---~~l------------d~~~~~~p~~-~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+. ......++.. .+..+.+|+.+||+.+|++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 000 0000112222 477899999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.34 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=195.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-----ccchHHHHHHHHHHHhcCCCceeeeeceecCC----C
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~ 524 (810)
.+|...+.||+|+||.||+|.+. +..+++|.+.... ......+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999875 5689999875421 22335688999999999999999999998543 2
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999886543 3788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhh-hh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQ 683 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld-~~ 683 (810)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|++||........ ...... +.
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 226 (264)
T cd06653 156 IQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQPT 226 (264)
T ss_pred ccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCCC
Confidence 5432110 0111234689999999999888889999999999999999999999964432211 111111 11
Q ss_pred CCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 684 ~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
....|...+..+.+++.+||. +|..||+..+
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 234566778999999999999 5799999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.77 Aligned_cols=255 Identities=17% Similarity=0.200 Sum_probs=181.5
Q ss_pred cCcccceeeccCCcEEEEEEEECCe-----EEEEEEEcccCccch-----------HHHHHHHHHHHhcCCCceeeeece
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN-----------KQFLQELEVLSKIRHPHLLLLLGA 519 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~-----~vavK~l~~~~~~~~-----------~~~~~Ei~iL~~l~HpnIv~l~g~ 519 (810)
+.|...++||+|+||.||+|.+.++ .+++|+......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999987644 567776443322111 111233344556789999999987
Q ss_pred ecCCC------eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc
Q 003576 520 CPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 520 ~~~~~------~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
+.... +++++++. .++.+.+.... ..++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 64332 56777764 46666654332 2567888999999999999999998 999999999999999999
Q ss_pred eEEeeeccccccCCCCCccc-ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc
Q 003576 594 SKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 672 (810)
Q Consensus 594 ~kL~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~ 672 (810)
++|+|||+++.+........ .........||+.|+|||++.+..++.++|||||||++|+|++|++||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987653221111 11112334799999999999999999999999999999999999999974422111111
Q ss_pred ---cchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhH
Q 003576 673 ---EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 720 (810)
Q Consensus 673 ---~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~ 720 (810)
.+.+..+.... ..+...+..+.+++..|+..+|.+||++.+ +.+.
T Consensus 245 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~-l~~~ 292 (294)
T PHA02882 245 AAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDA-LIKI 292 (294)
T ss_pred HhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHH-HHHh
Confidence 11111111111 112334688999999999999999999984 4443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=296.81 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=192.4
Q ss_pred CcccceeeccCCcEEEEEEEE-----CCeEEEEEEEcccCc----cchHHHHHHHHHHHhc-CCCceeeeeceecCCC--
Q 003576 457 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN----IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~-----~~~~vavK~l~~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-- 524 (810)
+|+....||.|+||.||++.. .+..||+|++..... ...+.+.+|+.+|.++ +||||+.+++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999986 457899999875322 2345678899999999 5999999999886655
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 79999999999999987543 4888899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccCccccCccccccC--CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
....... ......|+..|+|||++... .++.++||||||+++|+|+||..||........ ...+...+..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~~~ 226 (290)
T cd05613 155 FHEDEVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEISRRILK 226 (290)
T ss_pred ccccccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHHHHHhhc
Confidence 6432211 11234689999999987653 467899999999999999999999963221110 0111122222
Q ss_pred hCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 683 ~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
....+|...+..+.+++.+||..+|.+||+..
T Consensus 227 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~ 258 (290)
T cd05613 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCG 258 (290)
T ss_pred cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 23345666788999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.39 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=199.7
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|.....||+|++|.||++... +..|++|.+..... .....+.+|++++.+++|||++++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 45899999876643 34567899999999999999999999986654 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988655 34899999999999999999999998 99999999999999999999999999987764332
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
. .....++..|+|||+..+..++.++||||||+++|+|++|..||........ ............+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQDDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhccCCCCCCCC
Confidence 1 1234688999999998888889999999999999999999999964332211 111112222344556
Q ss_pred HHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+..+.+++.+||..+|++||++.+.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 67899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.17 Aligned_cols=247 Identities=22% Similarity=0.283 Sum_probs=204.6
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCC--CeE
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCL 526 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~l 526 (810)
....+|.+..+||+|.|+.|.+|++. ++.||||++.+.... ....+.+|+.+|+.|+|||||+++.+.... .|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44678999999999999999999875 669999999876432 334588999999999999999999997644 499
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||+.+|.+.++|..++. +.+..+..++.|+.+|++|||+.+ |||||||++||||+.+..+||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999988765 555788899999999999999999 9999999999999999999999999999887
Q ss_pred CCCCcccccccccCCccCccccCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
... ....++|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+....+. ..-.-....
T Consensus 207 ~~~-------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------r~rvl~gk~ 272 (596)
T KOG0586|consen 207 YGL-------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------RPRVLRGKY 272 (596)
T ss_pred ccc-------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------cchheeeee
Confidence 433 2245699999999999988765 6899999999999999999999964332110 000011123
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
..|...+.++.+|+.++|-++|.+|+++.+....
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 4566778999999999999999999999865543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.45 Aligned_cols=237 Identities=22% Similarity=0.238 Sum_probs=183.2
Q ss_pred HhhcCcccceee--ccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--e
Q 003576 453 SATLSFSENLRI--GMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--C 525 (810)
Q Consensus 453 ~~~~~f~~~~~L--G~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~ 525 (810)
...++|...+.+ |.|+||.||++... +..+|+|++....... .|+.+...+ +||||+++++.|.... +
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334455665555 99999999999875 4589999886542211 123333323 6999999999985544 8
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-ceEEeeeccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTM 604 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-~~kL~DFGla~~ 604 (810)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+|||++..
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999986543 5899999999999999999999998 99999999999999988 999999999876
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
..... ...|+..|+|||++.+..++.++||||||+++|+|++|+.||....... +....+.... ...
T Consensus 160 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~~~ 226 (267)
T PHA03390 160 IGTPS----------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-QKK 226 (267)
T ss_pred cCCCc----------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-ccc
Confidence 54321 2368899999999998889999999999999999999999996332211 1111122222 111
Q ss_pred CCCChhHHHHHHHHHHHHhhhcCCCCCcc
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 685 ~~~p~~~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
...+...+..+.+++.+||+.+|.+||+.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCch
Confidence 23334578899999999999999999964
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.90 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=201.3
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|...+.||.|+||.||++.+. +..+++|++..... .....+.+|+++++.++|||++++++.+.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999987 67999999876543 45567889999999999999999999886554 899999
Q ss_pred ccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 1245899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
. ......|++.|+|||.+....++.++|+||||+++|+|++|..||...... ..............+.
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 225 (258)
T cd08215 158 D------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQYPPIPS 225 (258)
T ss_pred c------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCCCCCCCC
Confidence 1 122347889999999988888999999999999999999999999643311 1111222222334455
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
..+..+.+++.+||..+|.+||++.++
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l 252 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQI 252 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.14 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=195.7
Q ss_pred CcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCccch---HHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
-|...+.||-|+||.|.++.-..+ .||+|.+.+.+...+ .....|-+||...+.+.||+||..|.|.. |+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477778899999999999876544 899999887654443 34678999999999999999999998766 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC--
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS-- 607 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~-- 607 (810)
|++||++..+|.+.+- |++..+..++.++.+|+++.|..| +|||||||+|||||.+|++||+|||||.-+.-
T Consensus 710 YIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999987664 888888899999999999999999 99999999999999999999999999975421
Q ss_pred CCCc------c----------------------------cccccccCCccCccccCccccccCCCCCcchhhhHHHHHHH
Q 003576 608 DPSF------V----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 653 (810)
Q Consensus 608 ~~~~------~----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~e 653 (810)
+..+ . .........+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 0 00011124589999999999999999999999999999999
Q ss_pred HHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCC
Q 003576 654 LLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 711 (810)
Q Consensus 654 Lltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RP 711 (810)
|+.|++||......++.+...++...++.. +-...++++.+||.++|. +++.|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~---~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIP---YQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccc---cccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999998777777766666676666542 223456777777766443 344553
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.83 Aligned_cols=238 Identities=27% Similarity=0.319 Sum_probs=191.0
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||.|+||.||++.+. +..+++|++..... .....+.+|+.++++++||||+++++.+.+.. |+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 66999999876543 34567889999999999999999999886555 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc--ccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF--VST 614 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~--~~~ 614 (810)
.+++.... .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987644 4899999999999999999999998 999999999999999999999999998765432110 000
Q ss_pred cccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH--H
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE--T 692 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~--~ 692 (810)
........++..|++||.......+.++||||||+++|+|++|..||....... .... +......++... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQN-ILNGKIEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhcCCcCCCccccCC
Confidence 111233467889999999888889999999999999999999999996443211 1111 111223344444 7
Q ss_pred HHHHHHHHHHhhhcCCCCCccc
Q 003576 693 KELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 693 ~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+.+++.+||+.+|.+||++.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~ 249 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAK 249 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCc
Confidence 8999999999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.82 Aligned_cols=241 Identities=23% Similarity=0.314 Sum_probs=193.8
Q ss_pred cCcccc-eeeccCCcEEEEEEEECCe--EEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceecCCC------e
Q 003576 456 LSFSEN-LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG------C 525 (810)
Q Consensus 456 ~~f~~~-~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~------~ 525 (810)
.+|.+. .+||-|-.|.|..+..+.+ .+|+|++.. .....+|+++--.. .|||||.++++|.+.. .
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 344433 4699999999999988644 899998853 34466788876655 5999999999985432 4
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC---CCceEEeeeccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLS 602 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~---~~~~kL~DFGla 602 (810)
+|||.|+||.|...+..++. ..+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||+|
T Consensus 136 iVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 79999999999999987765 45999999999999999999999999 999999999999954 568899999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
+...... ....++.|+.|.|||++...+|+..+|+||+||++|-||+|.|||...+. .++..+--..+...
T Consensus 212 K~t~~~~-------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g 282 (400)
T KOG0604|consen 212 KETQEPG-------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG 282 (400)
T ss_pred cccCCCc-------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc
Confidence 8755322 23456889999999999999999999999999999999999999986654 33344433333222
Q ss_pred hCCCCC----hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 683 QAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 683 ~~~~~p----~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+| ...+...+++|+.+|..+|.+|.++.+
T Consensus 283 -qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 283 -QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred -CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 22333 256888999999999999999999985
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.82 Aligned_cols=239 Identities=26% Similarity=0.314 Sum_probs=198.5
Q ss_pred cCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCccchHH---HHHHHHHHHhc-CCCceeeeeceec--CCCeEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKI-RHPHLLLLLGACP--DHGCLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~~~~~---~~~Ei~iL~~l-~HpnIv~l~g~~~--~~~~lV 527 (810)
.+|.....||+|+||.|.++..+++ .+|||+++++-..+..+ -+.|-.+|... +-|.+++|..+|+ +..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 3677888999999999999998876 89999999875444333 35677777766 4778889988885 556999
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+.||+|.-.+++.+. +.+..+.-++.+|+-||-|||+.| ||+||||.+|||||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999988887654 666788889999999999999999 99999999999999999999999999975322
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.. .....++|||.|+|||++...+|+.+.|+|||||+|||||.|++||...+. ..+...+......+
T Consensus 503 ~~------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-------~elF~aI~ehnvsy 569 (683)
T KOG0696|consen 503 DG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQAIMEHNVSY 569 (683)
T ss_pred CC------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHHccCcC
Confidence 11 123467999999999999999999999999999999999999999975532 33344444445578
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCcc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
|...+.+..++....|...|.+|...
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred cccccHHHHHHHHHHhhcCCccccCC
Confidence 89999999999999999999999543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.65 Aligned_cols=195 Identities=29% Similarity=0.500 Sum_probs=169.6
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcCCCceeeeeceecCC--------CeE
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--------GCL 526 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--------~~l 526 (810)
|.....||+||||.||+|+++ |..||||.++.... ...+...+|+++|++|+|||||+++++-.+. ..+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445567999999999999976 56999999887543 3456678999999999999999999885332 379
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec--CCC--ceEEeeeccc
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNL--VSKIGDVGLS 602 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld--~~~--~~kL~DFGla 602 (810)
|||||.||||..+|.+-.+...|++.+.+.++.+++.||.|||++| |+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888888999999999999999999999999 99999999999983 223 4599999999
Q ss_pred cccCCCCCcccccccccCCccCccccCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
+.++++. ..+..+||..|++||++. .+.|+..+|.|||||++|+++||..||-
T Consensus 172 rel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9988765 235679999999999888 4889999999999999999999999995
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=307.71 Aligned_cols=193 Identities=24% Similarity=0.340 Sum_probs=165.6
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC------CCceeeeeceec--CCCeE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR------HPHLLLLLGACP--DHGCL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~g~~~--~~~~l 526 (810)
.|.+...||+|.||.|.+|.+.+ ..||||+++.... -..+-..|+.+|..|+ .-|+|+++++|. ++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 68889999999999999999875 4999999987644 3445678999999996 358999999974 55699
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC--CceEEeeeccccc
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--LVSKIGDVGLSTM 604 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~--~~~kL~DFGla~~ 604 (810)
|+|.+. .+|.++|..+.- .+++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.++.
T Consensus 266 VfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 799999976554 45999999999999999999999999 9999999999999543 4789999999998
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 664 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~ 664 (810)
...... ....+..|.|||++.+.+|+.+.||||||||+.||+||.|.|.+.
T Consensus 341 ~~q~vy---------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY---------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce---------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 664321 346788999999999999999999999999999999999888643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=297.69 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=189.4
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcC-CCceeeeeceecC--C-----
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIR-HPHLLLLLGACPD--H----- 523 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~----- 523 (810)
++|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999985 56899998765432 23356888999999995 6999999998743 2
Q ss_pred CeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-CCceEEeeec
Q 003576 524 GCLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVG 600 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-~~~~kL~DFG 600 (810)
.|+||||+++ +|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 3899999985 88888765432 245899999999999999999999998 999999999999998 8999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchh---
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--- 676 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l--- 676 (810)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||...............
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9876543211 1122357889999998754 45789999999999999999999999754333221110000
Q ss_pred ------HHH------hhh------hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 677 ------AEI------LDA------QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 677 ------~~~------ld~------~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
... ... .........+..+.+||.+||..||.+||++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 000 000 0000012356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=299.42 Aligned_cols=254 Identities=19% Similarity=0.195 Sum_probs=190.8
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 460 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
..+.+|.|+++.||++...+..||||++... .......+.+|+.+|+.++||||+++++++.+.. +++|||+++|+
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 3445677778888888878889999998765 2334567899999999999999999999986554 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc-ccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF-VST 614 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~-~~~ 614 (810)
|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+...... ...
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999876432 34888899999999999999999998 999999999999999999999999998765432211 011
Q ss_pred cccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc--hhHHHhh---------
Q 003576 615 TYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--NLAEILD--------- 681 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--~l~~~ld--------- 681 (810)
........++..|+|||++.. ..++.++|||||||++|+|++|+.||............. .....++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111233467889999998865 357899999999999999999999997443222111100 0000000
Q ss_pred ----------------hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 682 ----------------AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 682 ----------------~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
......+...+..+.+|+.+||..||.+||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 000111234467899999999999999999998544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=281.09 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=201.3
Q ss_pred eeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 462 LRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
..||+|+|+.|-.+.. .+..||||++.+.....+.++.+|++++..++ |+||++|+.+|.+.. |||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 4699999999998765 46689999999988888899999999999995 999999999998765 999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC---CceEEeeeccccccCCCCCc-c
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLNSDPSF-V 612 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~---~~~kL~DFGla~~~~~~~~~-~ 612 (810)
...|.++.. +++.++.++..+|+.||.|||..| |.||||||+|||-... .-+|||||.+..-+....+. .
T Consensus 164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999987654 899999999999999999999999 9999999999999654 35799999887654422211 1
Q ss_pred cccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc--------hhHHH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NLAEI 679 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--------~l~~~ 679 (810)
..+-....++|+..|||||+.. ...|+.++|.||||||||-||.|.+||...-...-.++.+ .+.+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 2222345679999999999542 3458899999999999999999999997554444444433 34444
Q ss_pred hhhhCCCCCh----hHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 680 LDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 680 ld~~~~~~p~----~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+......+|. ..+.+..+|+...+..++.+|-++.+.+
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 4444445554 4578889999999999999999988544
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=297.08 Aligned_cols=245 Identities=28% Similarity=0.348 Sum_probs=186.8
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|.....||+|+||.||++.+. +..+|+|.+.... ......+.+|+.++.++. ||||+++++++.+.. +++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445567999999999999885 4689999887543 234456889999999996 999999999886544 889999
Q ss_pred ccCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 531 MENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 531 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+. ++|.++... ......+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 466554321 11224589999999999999999999975 6 99999999999999999999999999976543
Q ss_pred CCCcccccccccCCccCccccCccccccC---CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||....... ..+........
T Consensus 161 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~ 228 (288)
T cd06616 161 SIA-------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-----DQLTQVVKGDP 228 (288)
T ss_pred CCc-------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-----HHHhhhcCCCC
Confidence 221 1233688999999988766 68899999999999999999999996432111 11111111111
Q ss_pred ----CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 685 ----GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 685 ----~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+...+..+.+|+.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 111234678899999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.04 Aligned_cols=232 Identities=24% Similarity=0.320 Sum_probs=179.4
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHh---cCCCceeeeeceecCCC--eEEEEecc
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSK---IRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~---l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
.||+|+||.||++... +..+|+|++...... ....+.+|..++.. .+||||+.+++++.... ++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999875 568999988654321 12234455544443 47999999999886543 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999886543 4899999999999999999999999 9999999999999999999999999987554321
Q ss_pred cccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
.....||..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ..+...........|...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 222 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTVNVELPDSF 222 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhcCCcCCcccc
Confidence 122468999999998764 5578999999999999999999999964321110 111111111122345567
Q ss_pred HHHHHHHHHHHhhhcCCCCCc
Q 003576 692 TKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs 712 (810)
+..+.+++.+||..||.+||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 889999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=321.61 Aligned_cols=254 Identities=17% Similarity=0.247 Sum_probs=179.2
Q ss_pred hcCcccceeeccCCcEEEEEEEECCe---EEEEEE--------------Ecc---cCccchHHHHHHHHHHHhcCCCcee
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHHT---FAAVKV--------------LQS---KGNIQNKQFLQELEVLSKIRHPHLL 514 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~vavK~--------------l~~---~~~~~~~~~~~Ei~iL~~l~HpnIv 514 (810)
..+|....+||+|+||.||++.++.. .+++|. +.+ ........+.+|+.+|.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 35788999999999999999876421 111110 100 1112335678999999999999999
Q ss_pred eeeceecCCC--eEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC
Q 003576 515 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 590 (810)
Q Consensus 515 ~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~ 590 (810)
++++++.+.. |+|++++. ++|.+++..... ........+..|+.||+.||.|||+++ ||||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999986544 88999985 577777654321 112345567789999999999999998 999999999999999
Q ss_pred CCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCC-Cccccch--h
Q 003576 591 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP-AIAITHK--V 667 (810)
Q Consensus 591 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~-Pf~~~~~--~ 667 (810)
++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|.. ||..... .
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCEEEEeCCCceecCccccc-----ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999876543211 1224579999999999999999999999999999999999875 4432110 0
Q ss_pred hhhhc---------------cchhHHHhhhhC-C----CCC-----hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 668 ETAID---------------EDNLAEILDAQA-G----DWP-----IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 668 ~~~~~---------------~~~l~~~ld~~~-~----~~p-----~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..... ...+...++... . ..+ ...+..+.+++.+||..||.+||++.+.+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 00000 001111111100 0 000 11245678889999999999999999644
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=297.29 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=189.1
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.|.....||+|+||.||+|.+. +..+|+|++..... .....+.+|+.++++++|||+++++++|.+.. ++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677788999999999999874 56899999865422 22346889999999999999999999986554 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 57877775433 34899999999999999999999998 999999999999999999999999998754422
Q ss_pred CcccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC-
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG- 685 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~- 685 (810)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||........ +..+......
T Consensus 179 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 243 (317)
T cd06635 179 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPT 243 (317)
T ss_pred ---------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhccCCC
Confidence 2336888999999873 45688999999999999999999999864322111 1112221111
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+...+..+.+|+.+||+.+|.+||++.+++
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 11234567899999999999999999998533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=331.99 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=199.8
Q ss_pred HHhhcCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeecee--cCCCe
Q 003576 452 ESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHGC 525 (810)
Q Consensus 452 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~--~~~~~ 525 (810)
...+.+|....+||.|.||.||.|...++ ..|+|-+..... .....+.+|+.+|..|+|||+|++||+- .+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34566788889999999999999987644 678887665433 2335578899999999999999999985 45559
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
|.||||++|+|.+++..... .++.....+..|++.||.|||++| ||||||||.||||+.+|.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999998865443 566667788899999999999999 999999999999999999999999999988
Q ss_pred CCCCCcccccccccCCccCccccCccccccC---CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
...... .........||+.|||||.+.+. ...-+.|||||||+++||+||+.||...+.-+. .+..+-..
T Consensus 1385 ~~~~~~--~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-----IMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQT--MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-----IMYHVAAG 1457 (1509)
T ss_pred cCchhc--CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-----HHhHHhcc
Confidence 765311 11223456999999999988653 356789999999999999999999964332211 12222233
Q ss_pred hCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 683 ~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+..|...+.+-.+++.+||+.||+.|.++.
T Consensus 1458 h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1458 HKPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred CCCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 34677888999999999999999999997765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=296.18 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=188.5
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCC-------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 523 (810)
.++|....+||+|+||.||+|... +..||||.+..... .....+.+|+.++++++||||++++++|...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 347889999999999999999985 56899998864422 2234567899999999999999999987432
Q ss_pred ---CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 524 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 524 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
.++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 289999996 58888775543 24899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchh---
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--- 676 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l--- 676 (810)
++..+....... ........++..|+|||++.+. .++.++||||||+++|+|+||++||..............+
T Consensus 165 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CcccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 998765432211 1112334678899999987654 4688999999999999999999999643321110000000
Q ss_pred -----------HHHhhhhC-C----------CCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 677 -----------AEILDAQA-G----------DWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 677 -----------~~~ld~~~-~----------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
....+... . .++...+..+.+|+.+||..||.+||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 00000000 0 001123466789999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.67 Aligned_cols=246 Identities=30% Similarity=0.376 Sum_probs=199.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV 527 (810)
++|.....||.|+||.||+|... +..+++|++.... ......+.+|+.++.+++ ||||+++++++.+.. ++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999884 5699999987532 223456788999999998 999999999986654 899
Q ss_pred EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
|||+++++|.+++.... .+++..++.|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999987643 4899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCccc--------------ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc
Q 003576 608 DPSFVS--------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 673 (810)
Q Consensus 608 ~~~~~~--------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~ 673 (810)
...... .........|+..|++||.+....++.++||||||+++|+|++|+.||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---- 230 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---- 230 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----
Confidence 331100 01122345688999999998888899999999999999999999999975432111
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
+.... .....+|...+..+.+|+.+||..+|.+||++.
T Consensus 231 --~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 231 --FQKIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred --HHHHH-hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 11111 222345566688999999999999999999995
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.69 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=191.4
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCC------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 523 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------ 523 (810)
..+.|.....||+|+||.||+|... +..||+|++... .......+.+|+.++++++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999874 568999998643 222345677899999999999999999987422
Q ss_pred --CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 524 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
.|+||||+. ++|.+.+... +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 389999996 5888877432 788889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------c
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------E 673 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~--------~ 673 (810)
++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+....... .
T Consensus 165 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSFM-------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCCC-------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 987643221 2234688999999999988999999999999999999999999964432111000 0
Q ss_pred chhHHH--------hhhhC--------------------CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 DNLAEI--------LDAQA--------------------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ~~l~~~--------ld~~~--------------------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+... .+... ...+...+..+.+|+.+||..||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000000 00000 000113466789999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=291.41 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=185.8
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcC-CCceeeeeceecCC--C--eEEEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH--G--CLVYE 529 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~--~--~lV~E 529 (810)
|....+||+|+||.||+|... +..+|+|++.... ........+|+.++.++. |||++++++++.+. . ++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999874 5689999987542 222234557999999885 99999999998655 3 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++. +.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888776533 35899999999999999999999998 999999999999999 999999999998765332
Q ss_pred CcccccccccCCccCccccCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc--------chhHHHh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------DNLAEIL 680 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~--------~~l~~~l 680 (810)
.. ....++..|+|||++. .+.++.++|||||||++|+|++|.+||...+..+..... ..+...+
T Consensus 154 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 PY-------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred Cc-------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 11 2236789999999754 456789999999999999999999999654332211000 0000000
Q ss_pred hhh---CCCC-----------ChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 681 DAQ---AGDW-----------PIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 681 d~~---~~~~-----------p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
... ...+ ....+..+.+|+.+||..+|.+||++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 000 0011 12346889999999999999999999853
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=303.70 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=190.3
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCC-------C
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------G 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~ 524 (810)
.++|...++||+|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999875 5689999986432 22345678899999999999999999886432 3
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 79999996 588777643 24889999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh------hc---cc
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------ID---ED 674 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~------~~---~~ 674 (810)
......... ......||..|+|||.+.+ ..++.++|||||||++|+|++|++||...+..... +. ..
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTG---FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccC---CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 654321111 1233578999999997654 56889999999999999999999999643321110 00 00
Q ss_pred hhHHHhhhh----------CCCC-----ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 675 NLAEILDAQ----------AGDW-----PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 675 ~l~~~ld~~----------~~~~-----p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.+..+.... .... ....+..+.+++.+||+.+|.+||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l 290 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh
Confidence 111111000 0000 112357789999999999999999998533
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.83 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=189.8
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC----CeEEEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYE 529 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~E 529 (810)
|....+||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999986 4789999998653 33345688999999999999999999998765 389999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 48888876543 35899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc---------chhH--
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLA-- 677 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~---------~~l~-- 677 (810)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||++||............ ..+.
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SA-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cc-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 11 1123367889999997654 45789999999999999999999999643321110000 0000
Q ss_pred -HH-----hhhhC-------CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 678 -EI-----LDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 678 -~~-----ld~~~-------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.+ ..... ......++..+.+++.+||..+|.+||++.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00 00000 00001136789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.41 Aligned_cols=236 Identities=19% Similarity=0.330 Sum_probs=189.9
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHH
Q 003576 462 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLE 537 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~ 537 (810)
.+||+|+||.||++... +..||+|.+..........+.+|+.+++.++||||+++++++.+.. ++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999884 5689999886555445667899999999999999999999886544 8999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccccc
Q 003576 538 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617 (810)
Q Consensus 538 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~ 617 (810)
+++... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------~ 172 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------R 172 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc------c
Confidence 977432 3788999999999999999999998 99999999999999999999999999876543221 1
Q ss_pred ccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC-CC--CChhHHHH
Q 003576 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GD--WPIKETKE 694 (810)
Q Consensus 618 ~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~--~p~~~~~~ 694 (810)
.....|++.|++||++.+..++.++|+||||+++|+|++|.+||........ ...+.... .. .....+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPPKLKNLHKVSPS 245 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhCCcccCCcccCCHH
Confidence 1234688999999998888889999999999999999999999964332211 11111111 11 11235678
Q ss_pred HHHHHHHHhhhcCCCCCccccch
Q 003576 695 LAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 695 l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+.+++.+||..+|.+||++.+++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHh
Confidence 99999999999999999998533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.81 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=193.0
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecC------CCe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGC 525 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------~~~ 525 (810)
.+|.....||.|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||++++++|.. ..+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999875 5689999987542 2334567889999999999999999998742 238
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||||+. |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68988875433 3899999999999999999999998 999999999999999999999999999776
Q ss_pred CCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--------------
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-------------- 670 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~-------------- 670 (810)
...... .........|+..|+|||.+.. ..++.++|||||||++|+|++|++||.........
T Consensus 158 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred cccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 533211 1111234578999999998755 45889999999999999999999999643221110
Q ss_pred ---hccchhHHHhhhhC--CCCC-----hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 671 ---IDEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 671 ---~~~~~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.....+...++... ...+ ...+..+.+++.+||+.+|.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 00011111111110 1111 23468899999999999999999998544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=293.57 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=192.3
Q ss_pred CcccceeeccCCcEEEEEEEE-----CCeEEEEEEEcccC----ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--
Q 003576 457 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~-----~~~~vavK~l~~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~-- 524 (810)
+|.....||+|+||.||++.. .+..+|||++.... ......+.+|+.++.++ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999875 34689999987532 22335678999999999 5999999999886554
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|.||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 89999999999999886532 4888999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
+...... ......|+..|++||.+.+.. .+.++||||||+++|+|+||..||......... ..+...+..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~ 226 (288)
T cd05583 155 FLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISRRILK 226 (288)
T ss_pred ccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHHHHHc
Confidence 5433211 112346889999999887655 788999999999999999999999633211110 111111112
Q ss_pred hCCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 683 ~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.....|...+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~ 259 (288)
T cd05583 227 SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259 (288)
T ss_pred cCCCCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence 223445556788999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=294.40 Aligned_cols=245 Identities=27% Similarity=0.385 Sum_probs=190.6
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~ 528 (810)
.++|.....||.|+||.||+|.+. +..||||.+..... .....+..|+.++.++. ||||++++++|.+.. |+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356888899999999999999997 67999999875432 23455677888777775 999999999987655 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||+. ++|.+++..... .+++..+..++.+++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 577777655332 58999999999999999999997 46 99999999999999999999999999876543
Q ss_pred CCCcccccccccCCccCccccCccccccCC----CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhh
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ..+...+...
T Consensus 168 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~ 235 (296)
T cd06618 168 SKA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEE 235 (296)
T ss_pred CCc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCC
Confidence 221 12235788999999886553 7889999999999999999999996422111 1122222222
Q ss_pred CCCCC--hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 684 AGDWP--IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 684 ~~~~p--~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
....+ ..++..+.+|+.+||..||.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 271 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 22222 23578899999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=294.86 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=188.6
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
++|.....||.|++|.||+|.+. +..|++|.+..... .....+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 56899998865432 23356889999999999999999999987654 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-CCceEEeeeccccccCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-~~~~kL~DFGla~~~~~~ 608 (810)
|++ ++|.+.+..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578877754332 23678888899999999999999998 999999999999985 567999999999765432
Q ss_pred CCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch-----hHHHh--
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN-----LAEIL-- 680 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~-----l~~~l-- 680 (810)
... .....+++.|+|||++.+ ..++.++|||||||++|+|+||++||.............. .....
T Consensus 157 ~~~------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VRT------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred ccc------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 111 123367899999998765 4578999999999999999999999964432211110000 00000
Q ss_pred -----h--hhCCCC--------ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 681 -----D--AQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 681 -----d--~~~~~~--------p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+ .....+ ....+..+.+++.+||..+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 0 000000 123467789999999999999999998644
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=276.31 Aligned_cols=237 Identities=27% Similarity=0.406 Sum_probs=188.8
Q ss_pred eeeccCCcEEEEEEEECC--eEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEeccCCC
Q 003576 462 LRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
..||.|..|.|+++++.. ...|||.+..... ...++++..+.++.+.+ .|+||+.+|+|..+. ++.||.|. ..
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 349999999999999976 6899999877654 34567888888887765 999999999996544 77888884 45
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~ 615 (810)
++.+|.+-. .++++..+-++...++.||.||.... +|+|||+||+|||+|..|.+||||||++..+.+....
T Consensus 177 ~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---- 248 (391)
T KOG0983|consen 177 AEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---- 248 (391)
T ss_pred HHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc----
Confidence 666665543 35999999999999999999999765 4999999999999999999999999999877655432
Q ss_pred ccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC--hh
Q 003576 616 YKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP--IK 690 (810)
Q Consensus 616 ~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p--~~ 690 (810)
+...|-+.|||||.+. ...|+.++|||||||.|+||.||+.||..... +-+.+..+++...+..| ..
T Consensus 249 ---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-----dFe~ltkvln~ePP~L~~~~g 320 (391)
T KOG0983|consen 249 ---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-----DFEVLTKVLNEEPPLLPGHMG 320 (391)
T ss_pred ---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-----cHHHHHHHHhcCCCCCCcccC
Confidence 3448999999999775 34688899999999999999999999975321 12234444443322222 23
Q ss_pred HHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.++.+.+|+..||..|+.+||...+
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~ 345 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNK 345 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHH
Confidence 6899999999999999999999884
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=294.94 Aligned_cols=251 Identities=25% Similarity=0.276 Sum_probs=190.8
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCC----CeE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 526 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~l 526 (810)
..+|...+.||.|+||.||+|.+. +..||+|++...... ....+.+|+.++++++||||+++++++.+. .++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457899999999999999999985 568999998654322 223467899999999999999999998543 389
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 58888876543 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc--------hhH
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NLA 677 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--------~l~ 677 (810)
.... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||............. ...
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 4321 1122356788999998765 457899999999999999999999997443322110000 000
Q ss_pred HHhhh-------hCCCCC--------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 678 EILDA-------QAGDWP--------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 678 ~~ld~-------~~~~~p--------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..++. .....+ ...++.+.+|+.+||..||.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00000 000000 11367889999999999999999998533
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=285.87 Aligned_cols=230 Identities=24% Similarity=0.235 Sum_probs=181.6
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHH-HhcCCCceeeeeceecCCC--eEEEEeccC
Q 003576 462 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVL-SKIRHPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL-~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
+.||.|+||.||+|... +..||+|++...... ....+..|..++ ...+|||++++++++.+.. ++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999884 569999998654321 122344555544 4458999999999986554 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++......
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 99999886543 4888999999999999999999998 999999999999999999999999998754321
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC----CCh
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD----WPI 689 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~----~p~ 689 (810)
....|+..|++||.+.+..++.++||||||+++|+|+||.+||........ ...+...... .+.
T Consensus 151 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 218 (260)
T cd05611 151 -----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRINWPEEVKE 218 (260)
T ss_pred -----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcccCCCCcccc
Confidence 234688899999998888889999999999999999999999964332111 1111111111 122
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
.++..+.+++.+||..+|.+||++.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCC
Confidence 4578999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=290.70 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=192.1
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
|.....||.|++|.||+|... +..+++|.+...... ....+.+|+.+|++++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999874 568999988654322 3467889999999999999999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++ +|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 74 8888776543 35899999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc---------chhHHHhh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEILD 681 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~---------~~l~~~ld 681 (810)
......++..|+|||.+.+. .++.++||||||+++|+|+||++||...+..+..... ..+.....
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 11234678899999988766 7899999999999999999999999654433221100 00000000
Q ss_pred ---hh------C-----CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 682 ---AQ------A-----GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 682 ---~~------~-----~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.. . .......+..+.+++.+||..||.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 00 0 001123567899999999999999999998543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.00 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=192.7
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhc-CCCceeeeeceecCC----C
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH----G 524 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~----~ 524 (810)
..++|.....||+|+||.||+|.+. +..+|+|.+... .......+.+|+.++.++ +||||++++++|... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457888889999999999999875 568999987543 223345677899999999 999999999987532 3
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
++||||+. ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 5898887543 4788899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-----------
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------- 672 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~----------- 672 (810)
+....... .........||..|+|||++.+ ..++.++||||||+++|+|+||++||...........
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65432211 0112233468999999997654 5578899999999999999999999964332211000
Q ss_pred ------cchhHHHhhhhC-------CCCChhHHHHHHHHHHHHhhhcCCCCCccccchh
Q 003576 673 ------EDNLAEILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 673 ------~~~l~~~ld~~~-------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~ 718 (810)
......+++... .......+..+.+++.+||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000001111000 0111125678999999999999999999996553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=293.75 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=191.8
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecC------
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 522 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~------ 522 (810)
...++|.....||.|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35568899999999999999999985 56899999875432 233567789999999999999999998854
Q ss_pred ------CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEE
Q 003576 523 ------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596 (810)
Q Consensus 523 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL 596 (810)
..++|+||+++ +|.+.+... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 23799999975 777776543 235899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~ 675 (810)
+|||++..+...... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........-..
T Consensus 158 ~dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999876543211 1122356788999997754 4578999999999999999999999975433221100000
Q ss_pred h---------HHH--------hhhhC------CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 676 L---------AEI--------LDAQA------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 676 l---------~~~--------ld~~~------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
. ..+ .+... .......+..+.+++.+||..+|.+||++.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 0 000 00000 00011246789999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=285.08 Aligned_cols=242 Identities=28% Similarity=0.444 Sum_probs=197.1
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|....+||.|+||.||++... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999875 4589999887543 233456788999999999999999999886555 899999
Q ss_pred ccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 531 MENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 531 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886632 2245889999999999999999999998 9999999999999999999999999998765431
Q ss_pred CcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCCh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 689 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 689 (810)
.....+++.|++||.+.+..++.++|+||||+++|+|++|+.||........ ...+........+.
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 223 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL------RYKVQRGKYPPIPP 223 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCCCCCch
Confidence 1123678899999999888899999999999999999999999964432111 11111122233445
Q ss_pred hHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 690 KETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 690 ~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
..+.++.+++.+||..+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 67788999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=289.29 Aligned_cols=232 Identities=24% Similarity=0.316 Sum_probs=180.0
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHH---HHhcCCCceeeeeceecCCC--eEEEEecc
Q 003576 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEV---LSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~i---L~~l~HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
.||+|+||.||++... +..||+|++...... ....+..|..+ +....||||+.+++++.+.. ++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999874 568999998754321 12224444443 44457999999999886554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
||+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999888643 34899999999999999999999998 9999999999999999999999999987654321
Q ss_pred cccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||........ .............+|...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 222 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTMAVELPDSF 222 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHhhccCCCCCCcC
Confidence 1234689999999988754 588999999999999999999999964422111 111111122223455566
Q ss_pred HHHHHHHHHHHhhhcCCCCCc
Q 003576 692 TKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs 712 (810)
+..+.+++.+||..+|.+||.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccC
Confidence 889999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=281.73 Aligned_cols=200 Identities=26% Similarity=0.430 Sum_probs=164.6
Q ss_pred cCcccceeeccCCcEEEEEEEECC------eEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC---
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--- 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~------~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--- 524 (810)
..|+...+||+|.||.||+|...+ ..+|||.++... ........+|+.+++.++|||++.|..+|....
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 467778889999999999996532 268999887542 223355789999999999999999999886532
Q ss_pred eEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC----CceEEee
Q 003576 525 CLVYEYMENGSLEDRLYRK--NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN----LVSKIGD 598 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~----~~~kL~D 598 (810)
+|++||.+. +|..+|+-+ .....++...+..|++||+.|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 799999975 888877643 23346889999999999999999999999 9999999999999877 9999999
Q ss_pred eccccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCcc
Q 003576 599 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 599 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
||+++.+...-. ..+.....+-|..|.|||++.+ ..||++.|||+.|||+.||||-.|-|.
T Consensus 180 lGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999875432 2223345678999999998766 468999999999999999999988875
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=300.20 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=191.9
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCC-------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 523 (810)
.+.|.....||+|+||.||+|... +..||||.+... .......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999875 569999988653 222345677899999999999999999987432
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 389999995 7898887643 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh------------
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------------ 670 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~------------ 670 (810)
....... ......++..|+|||.+.. ..++.++|||||||++|+|++|++||.........
T Consensus 157 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCcc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 7653321 1123467889999997754 46889999999999999999999999643221100
Q ss_pred -----hccchhHHHhhhhC-------CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 671 -----IDEDNLAEILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 671 -----~~~~~l~~~ld~~~-------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.........+.... .......+..+.+|+.+||..+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell 289 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH
Confidence 00011111111000 011124567899999999999999999998644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=323.03 Aligned_cols=254 Identities=29% Similarity=0.377 Sum_probs=187.8
Q ss_pred hhcCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecC--------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 522 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~-------- 522 (810)
-..+|++...||+||||.||+++. +++.||||++.... ......+.+|+.+|.+|+|||||++|.++.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456788889999999999999986 58999999987664 2234568899999999999999999853200
Q ss_pred --------------------------------------------------------------------------------
Q 003576 523 -------------------------------------------------------------------------------- 522 (810)
Q Consensus 523 -------------------------------------------------------------------------------- 522 (810)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C----------CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003576 523 -----------------------H----------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569 (810)
Q Consensus 523 -----------------------~----------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH 569 (810)
. .||-||||+..+|.+++.++.... .....++++++|+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 0 056789998877777776543211 24578899999999999999
Q ss_pred hcCCCCEEecCCCCCceEecCCCceEEeeeccccccC----C--------CCCcccccccccCCccCccccCccccccCC
Q 003576 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN----S--------DPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637 (810)
Q Consensus 570 ~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~----~--------~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 637 (810)
+.| ||||||||.||+||.+..|||+|||+|+... . ...........++.+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998722 0 000111222456789999999999887654
Q ss_pred ---CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 638 ---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 638 ---~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
|+.|+|+|||||||+||+. ||+ ..++.+..-..+....-+...++.....+.-+.+|.++++.||.+|||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 9999999999999999996 564 22222211111111000001122334556778999999999999999998
Q ss_pred cch
Q 003576 715 NQV 717 (810)
Q Consensus 715 ~~v 717 (810)
+++
T Consensus 867 eLL 869 (1351)
T KOG1035|consen 867 ELL 869 (1351)
T ss_pred HHh
Confidence 644
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=290.60 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=189.0
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEec
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
|.....||.|+||.||+|... +..|+||.+..... .......+|+..+.+++ ||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999985 46899998865433 22334567999999999 999999999986654 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
+|+|.+++.... ...+++..+..++.|++.+|.|||+++ |+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 789998887654 235899999999999999999999998 999999999999999999999999999866543211
Q ss_pred ccccccccCCccCccccCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccch---------h-----
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---------L----- 676 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~---------l----- 676 (810)
....++..|+|||++. ...++.++|+||||+++|+|++|++||.............. +
T Consensus 156 -------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 156 -------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 2236788999999774 45578999999999999999999999965433222110000 0
Q ss_pred -HHHhhhhC--------CCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 677 -AEILDAQA--------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 677 -~~~ld~~~--------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
...+.... .......+..+.+++.+||..+|.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 277 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence 00000000 00011225789999999999999999999853
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=296.67 Aligned_cols=260 Identities=17% Similarity=0.229 Sum_probs=189.0
Q ss_pred eeccC--CcEEEEEEEE--CCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCC
Q 003576 463 RIGMG--GYGTVYKGTF--HHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 534 (810)
Q Consensus 463 ~LG~G--~~g~Vy~~~~--~~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~g 534 (810)
.||+| +||.||++.+ .++.||+|++..... ...+.+.+|+.+++.++||||++++++|.... ++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 467999999875432 23466889999999999999999999996655 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+............
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998876432 34889999999999999999999998 999999999999999999999999876543322111100
Q ss_pred cc-cccCCccCccccCccccccC--CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc---------------hh
Q 003576 615 TY-KNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------------NL 676 (810)
Q Consensus 615 ~~-~~~~~~gt~~Y~aPE~~~~~--~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~---------------~l 676 (810)
.+ ......++..|++||++.+. .++.++|||||||++|+|++|++||............- ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00 01112456779999998763 47899999999999999999999996432211110000 00
Q ss_pred H------------------------HHhhh-hCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchh-hHHHHHHH
Q 003576 677 A------------------------EILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL-PVLERLKE 726 (810)
Q Consensus 677 ~------------------------~~ld~-~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~-~~L~~l~~ 726 (810)
. .+... .....+...+..+.+|+.+||..||.+||++.+++. +.+..+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0 00000 001112345778999999999999999999996552 34444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=286.01 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=190.9
Q ss_pred cccceeeccCCcEEEEEEEECCe--EEEEEEEcccC-----ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
|...++||+|+||.||++.+... .+++|+++... ......+..|+.++..++||||+++++++.+.. ++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 67778999999999999987643 45666654321 123345778999999999999999999986554 8999
Q ss_pred EeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 529 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988652 22346899999999999999999999998 999999999999975 5699999999977643
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ............
T Consensus 158 ~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 225 (260)
T cd08222 158 SCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV------VLRIVEGPTPSL 225 (260)
T ss_pred Ccc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHcCCCCCC
Confidence 321 11234678899999998888889999999999999999999999963322111 112222223334
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+..++..+.+++.+||..+|.+||++.++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEI 254 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 55678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=293.65 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=189.2
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhcCCCceeeeeceecCC-------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 523 (810)
.++|....+||.|+||.||+|.+. +..+++|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 568999999999999999999985 568999988654322 234578899999999999999999886321
Q ss_pred ---CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 524 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 524 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
.++||||+. ++|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 278999996 46777665432 35899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCccc-----ccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc-
Q 003576 601 LSTMLNSDPSFVS-----TTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE- 673 (810)
Q Consensus 601 la~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~- 673 (810)
++........... .....+...+++.|+|||++.+ ..++.++|||||||++|+|++|++||............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9987654322111 1111234467889999997754 45789999999999999999999999644332111000
Q ss_pred --------chh---HHHhh----hhCCCCC-------hhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 674 --------DNL---AEILD----AQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 674 --------~~l---~~~ld----~~~~~~p-------~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
..+ ..+.. ......+ ......+.+++.+||..||.+||++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 000 00000 0000001 1233678899999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=299.98 Aligned_cols=238 Identities=24% Similarity=0.301 Sum_probs=202.8
Q ss_pred cccceeeccCCcEEEEEEEECCeE--EEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~~--vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+.....||-||||.|-++..++.. +|+|++++... .+.+.+..|-.||..++.|.||+||..|.+.. |+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344456999999999999887664 89998877643 34566788999999999999999999998877 788999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
|-||.|+..|..++. +.......++..++.|++|||+++ ||+|||||+|.|||.+|.+||.|||+|+.+..+.
T Consensus 502 ClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 999999999977654 777888899999999999999999 9999999999999999999999999999887654
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 690 (810)
+...++|||.|.|||++....++.++|.|||||++||||||.|||...+.+... ..+..-+| .-.||..
T Consensus 575 ------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY---n~ILkGid--~i~~Pr~ 643 (732)
T KOG0614|consen 575 ------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY---NLILKGID--KIEFPRR 643 (732)
T ss_pred ------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHhhhh--hhhcccc
Confidence 334679999999999999999999999999999999999999999877765542 11111122 2467888
Q ss_pred HHHHHHHHHHHHhhhcCCCCCcc
Q 003576 691 ETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 691 ~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
.+....+|+.+.|..+|.+|...
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhcc
Confidence 89999999999999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=299.35 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=191.2
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-----
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----- 523 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----- 523 (810)
...++|.....||+|+||.||++... +..||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34667999999999999999999875 5689999886432 22345688999999999999999999988532
Q ss_pred ---CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 524 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 524 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 27999999 7899887753 24889999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc------
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------ 673 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~------ 673 (810)
++....... ....+++.|++||.+.+ ..++.++|||||||++|+|++|++||............
T Consensus 164 ~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 164 LARQTDSEM---------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred cccccccCc---------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 997654321 23467899999998765 45789999999999999999999999744322111000
Q ss_pred --chhH---------HHhhhhC-------CCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 --DNLA---------EILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 --~~l~---------~~ld~~~-------~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+. ..+.... .......+..+.+++.+|+..||.+||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000 0000000 001123466789999999999999999998644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=299.20 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=195.5
Q ss_pred cccCCHHHHHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeec
Q 003576 443 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLG 518 (810)
Q Consensus 443 ~~~~~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g 518 (810)
|+.....++...+++|.....||+|+||.||+|... +..||+|++.... ......+.+|+.++.+++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 344455667778899999999999999999999864 5689999987532 223456788999999999999999999
Q ss_pred eecCC--------CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC
Q 003576 519 ACPDH--------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 590 (810)
Q Consensus 519 ~~~~~--------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~ 590 (810)
++... .|++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 87421 26777776 78998877532 3889999999999999999999998 999999999999999
Q ss_pred CCceEEeeeccccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 003576 591 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 669 (810)
Q Consensus 591 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~ 669 (810)
++.+||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|++||........
T Consensus 156 ~~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 156 DCELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred CCCEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999998764321 123468899999998765 5688999999999999999999999964322111
Q ss_pred hh-----------------ccchhHHHhhh--hCC-----CCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 670 AI-----------------DEDNLAEILDA--QAG-----DWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 670 ~~-----------------~~~~l~~~ld~--~~~-----~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.. ........+.. ... ......++.+.+|+.+||+.||.+||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 00 00000000000 000 00112467789999999999999999988533
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=336.99 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=191.9
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
..|.....||+|+||.||+|.+ .+..||||.+...... ...|+.++++++|||||+++|+|.+.. ++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577778899999999999986 4679999988643321 235688999999999999999996554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
++|+|.+++. .++|..+.+|+.|++.||.|||.....+|+||||||+|||++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999984 28899999999999999999996544559999999999999999888875 6655433211
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch--------hhhhhccchhHHHhhhh
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK--------VETAIDEDNLAEILDAQ 683 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~--------~~~~~~~~~l~~~ld~~ 683 (810)
....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .............+++.
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 123688999999999999999999999999999999999999853211 11111111222233332
Q ss_pred C---CCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 684 A---GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 684 ~---~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
. ...+.....++.+++.+||+.||.+||++. ++++.|+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN-DVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH-HHHHHHHHhhc
Confidence 2 122345566788999999999999999999 56677766543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=290.88 Aligned_cols=238 Identities=26% Similarity=0.394 Sum_probs=186.7
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
|....+||+|+||.||+|... +..+++|++..... .....+.+|+.+++.++|||++++++++.+.. ++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555677999999999999874 56899999865432 22346788999999999999999999987654 899999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+. |+|.+++.... .++++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 67877775543 34899999999999999999999998 99999999999999999999999999864321
Q ss_pred cccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC-
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 686 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~- 686 (810)
.....|+..|+|||++. .+.++.++|||||||++|+|++|.+||.......... .+.......
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~ 240 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNDSPTL 240 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCCC
Confidence 12346889999999874 4568889999999999999999999986443222111 111111111
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
.....+..+.+|+.+||+.+|.+||++.+++
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1123456799999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=280.81 Aligned_cols=233 Identities=29% Similarity=0.354 Sum_probs=192.1
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
||.|+||.||++... +..+++|++...... ....+..|+.++++++||||+++++.+.+.. |+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999985 569999998765332 3457889999999999999999999986655 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99987553 4889999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHH
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 696 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 696 (810)
......++..|++||.+.+...+.++|+||||+++|+|++|..||...... .....+. ......|...+..+.
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~~~~~l~ 221 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKIL-KDPLRFPEFLSPEAR 221 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh-cCCCCCCCCCCHHHH
Confidence 122346889999999998888899999999999999999999999644321 1111111 122345556688999
Q ss_pred HHHHHHhhhcCCCCCcccc
Q 003576 697 ALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 697 ~Li~~cl~~dP~~RPs~~~ 715 (810)
+++.+||..||.+||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999963
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=297.40 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=194.5
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-------Ce
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 525 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~~ 525 (810)
+|.....||.|+||.||+|... +..+++|++.... ....+.+.+|+.+++.++||||+++++++.+. .|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999975 4689999987643 33456789999999999999999999998554 38
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
+||+|+. ++|.+++.... .+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888876533 5899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-------------
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------------- 671 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~------------- 671 (810)
...... ........++..|+|||++.+. .++.++||||||+++|+|++|++||......+...
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 643211 0112334688999999998877 78999999999999999999999996443221100
Q ss_pred ----ccchhHHHhhhhCC-------CCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 672 ----DEDNLAEILDAQAG-------DWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 672 ----~~~~l~~~ld~~~~-------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
........+..... ......+..+.+++.+||+.+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 00000001110000 00122467889999999999999999998544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=291.23 Aligned_cols=237 Identities=28% Similarity=0.423 Sum_probs=186.6
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC---ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
.|...+.||.|+||.||+|... +..+++|.+.... .....++.+|+.+++.++|||++++++++.+.. ++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666678999999999999884 5589999876432 223356788999999999999999999986554 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
|+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ ++||||+|+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 68887775433 34889999999999999999999998 999999999999999999999999998765432
Q ss_pred CcccccccccCCccCccccCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||........ ...+.......
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 233 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPA 233 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcCCCC
Confidence 1236888999999864 35678899999999999999999999854322111 11111111111
Q ss_pred -CChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 687 -WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 687 -~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.+...+..+.+|+.+||..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred cCcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 12346788999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=297.76 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=186.8
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------- 523 (810)
.++|.....||+|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888999999999999999874 5689999986532 22235678999999999999999999988532
Q ss_pred -CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 524 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
.++|+||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 279999996 47766541 24889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------c
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------E 673 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~--------~ 673 (810)
+..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... .
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 764321 123467889999998765 4688999999999999999999999974332111100 0
Q ss_pred chhHHHhhh--------hCCCC--------ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 DNLAEILDA--------QAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ~~l~~~ld~--------~~~~~--------p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+...+.. ..... ....+..+.+|+.+||+.||.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000000000 00000 012456789999999999999999998644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=293.84 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=190.7
Q ss_pred HHHhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecC---C
Q 003576 451 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---H 523 (810)
Q Consensus 451 i~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~---~ 523 (810)
+...+++|...+.||.|+||.||++... +..||+|++.... ......+.+|+.++..++||||++++++|.. .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457789999999999999999999875 5589999876432 2234668899999999999999999998843 2
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.++||||+ +++|..++... ++++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 38999998 57898877532 3788888899999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-----------
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI----------- 671 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~----------- 671 (810)
..... .....++..|+|||++.+ ..++.++|||||||++|+|+||++||..........
T Consensus 157 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 157 IQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 54321 123467889999998765 568999999999999999999999996433211100
Q ss_pred ------ccchhHHHhhhhC--CCCC-----hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 672 ------DEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 672 ------~~~~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
........+.... ...| ...+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 0000011111110 1111 124678999999999999999999885
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=288.53 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=195.0
Q ss_pred ccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhc--CCCceeeeeceecC------CCeEEEEe
Q 003576 459 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI--RHPHLLLLLGACPD------HGCLVYEY 530 (810)
Q Consensus 459 ~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~g~~~~------~~~lV~Ey 530 (810)
.....||+|.||.||+|.++++.||||++... ..+.|++|-+|.+.. +|+||++++++-.. +..||++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 33456999999999999999999999999753 566788998888764 79999999998532 22799999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC------CCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP------KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
.+.|+|.++|..+. ++|....+|+..+++||+|||..-| ++|+|||||..||||..++++.|+|||+|..
T Consensus 290 h~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 290 HPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred ccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999997654 8999999999999999999997543 5799999999999999999999999999998
Q ss_pred cCCCCCcccccccccCCccCccccCccccccCC-CC-----CcchhhhHHHHHHHHHhCCCCcc--ccchhhhhhc----
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-IS-----PKSDVYAYGMVILQLLTAKPAIA--ITHKVETAID---- 672 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-----~~sDVwSlGvil~eLltg~~Pf~--~~~~~~~~~~---- 672 (810)
+........ ..+.+||..|||||++.+.. +. .+.||||+|.+||||++.-..+. ........+.
T Consensus 366 ~~p~~~~~d----~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 366 LEPGKPQGD----THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred ecCCCCCcc----hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 875443222 23469999999999887543 22 36899999999999999654331 1111111111
Q ss_pred ----cchhHHHh--hhhCCCCCh-----hHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 673 ----EDNLAEIL--DAQAGDWPI-----KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 673 ----~~~l~~~l--d~~~~~~p~-----~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
-+.+..++ +..++.+|. .....|.+.+..||..||..|.|+. -+.+.+..|..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~-Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG-CVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH-HHHHHHHHHhc
Confidence 11222222 222344544 2356789999999999999999998 56555555543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=284.83 Aligned_cols=241 Identities=26% Similarity=0.372 Sum_probs=187.8
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCcc--chHHHHHHHHHHHhc---CCCceeeeeceecCC-------
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKI---RHPHLLLLLGACPDH------- 523 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~--~~~~~~~Ei~iL~~l---~HpnIv~l~g~~~~~------- 523 (810)
|.....||.|+||.||+|.+. +..+|+|++...... ....+.+|+.++.++ +||||+++++++.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567788999999999999986 579999998754322 234566788887766 599999999998532
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 478999997 589888865432 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh-
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA- 682 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~- 682 (810)
.+..... .....++..|+|||++.+..++.++|||||||++|+|+||.+||......+.. ..+++.
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~------~~~~~~~ 222 (287)
T cd07838 156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL------DKIFDVI 222 (287)
T ss_pred eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH------HHHHHHc
Confidence 7653321 11235788999999998888999999999999999999999999744322211 111110
Q ss_pred ---------------------hCC----CCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 683 ---------------------QAG----DWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 683 ---------------------~~~----~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
... ......+..+.+++.+||..||.+||++.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i 281 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence 000 0011345778999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=298.19 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=189.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCC----------
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---------- 523 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~---------- 523 (810)
.+|...+.||.|+||.||+|... +..||+|.+........+.+.+|+.+|++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999885 568999998766555667788999999999999999999876432
Q ss_pred ------CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec-CCCceEE
Q 003576 524 ------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKI 596 (810)
Q Consensus 524 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld-~~~~~kL 596 (810)
.|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 379999997 5888877432 3889999999999999999999998 99999999999997 4568899
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--- 672 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~--- 672 (810)
+|||++..+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........
T Consensus 157 ~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999998654321110 01122367889999997644 5678899999999999999999999964432221100
Q ss_pred ---------cchhH----HHhh--hhCCCC-----ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 673 ---------EDNLA----EILD--AQAGDW-----PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 673 ---------~~~l~----~~ld--~~~~~~-----p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+. .... ...... ....+..+.+|+.+||..||.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 00000 0000 000011 113457889999999999999999998533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=287.08 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=191.3
Q ss_pred cccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 458 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
|+....||+|+||.||+|... +..+++|++.... ......+..|+.++++++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999986 5699999988653 233466788999999999999999999986654 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~ 611 (810)
. ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999987653 34899999999999999999999998 999999999999999999999999999876543211
Q ss_pred ccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc---------chhHHHh-
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEIL- 680 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~---------~~l~~~l- 680 (810)
.....++..|+|||++.+. .++.++|||||||++|+|++|++||............ ..+....
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 155 ------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred ------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 1223567889999988766 7899999999999999999999999654432211100 0000000
Q ss_pred ----hhhCCCC--------ChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 681 ----DAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 681 ----d~~~~~~--------p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
+.....+ ....+..+.+++.+||..+|.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 0000000 01235789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=291.30 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=187.5
Q ss_pred CcccceeeccCCcEEEEEEEECC----eEEEEEEEcccC--ccchHHHHHHHHHHHhc-CCCceeeeeceecC------C
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKG--NIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------H 523 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~----~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~------~ 523 (810)
+|...+.||+|+||.||++.+.+ ..||+|.+.... ......+.+|+.++.++ +||||+++++.+.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999999864 489999886432 22345678899999999 59999999987421 1
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.+++++|+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 277888885 6898888543 34889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh---------cc
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------DE 673 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~---------~~ 673 (810)
.+....... ........||..|+|||++.+ ..++.++|||||||++|+|++|++||.......... ..
T Consensus 154 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGEN--AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccc--cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 765432211 111234578999999997755 468899999999999999999999996433211000 00
Q ss_pred chhHHHhhh-------hC---C-----CCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 DNLAEILDA-------QA---G-----DWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ~~l~~~ld~-------~~---~-----~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+..+... .. . ......+..+.+|+.+||+.||.+||++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000 00 0 00112367899999999999999999998644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=292.61 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=186.7
Q ss_pred Cccc-ceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc--------------hHHHHHHHHHHHhcCCCceeeeece
Q 003576 457 SFSE-NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ--------------NKQFLQELEVLSKIRHPHLLLLLGA 519 (810)
Q Consensus 457 ~f~~-~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~--------------~~~~~~Ei~iL~~l~HpnIv~l~g~ 519 (810)
.|.. ...||.|+||.||+|.+. +..||||++....... ...+.+|+.+++.++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 4443 456999999999999875 5689999886543221 1247789999999999999999999
Q ss_pred ecCCC--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEe
Q 003576 520 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 597 (810)
Q Consensus 520 ~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~ 597 (810)
+.... ++||||+. |+|.+++.... .+++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 86554 89999996 68998886433 4888999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCCcc--------cccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 003576 598 DVGLSTMLNSDPSFV--------STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVE 668 (810)
Q Consensus 598 DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~ 668 (810)
|||++.......... ..........+++.|+|||++.+. .++.++|||||||++|+|+||.+||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998765211000 001111233578899999988654 46899999999999999999999997544322
Q ss_pred hhhccchhHHHhh-hhCC-----------------------CCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 669 TAIDEDNLAEILD-AQAG-----------------------DWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 669 ~~~~~~~l~~~ld-~~~~-----------------------~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
... .+...+. +... ......+..+.+++.+||..+|.+||++.+++
T Consensus 242 ~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 242 QLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 110 0000000 0000 00112367789999999999999999998533
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=302.18 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=204.4
Q ss_pred ccceeeccCCcEEEEEEEEC------CeEEEEEEEcccC-ccchHHHHHHHHHHHhcCCCceeeeeceecCCC-eEEEEe
Q 003576 459 SENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEY 530 (810)
Q Consensus 459 ~~~~~LG~G~~g~Vy~~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~-~lV~Ey 530 (810)
...++||+|+||+||+|.|- +-+||||++.... .....+++.|+-+|.+++|||+++|+|+|.... .||++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 34567999999999999883 2389999987653 345678999999999999999999999997665 789999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
+++|+|.|+++.+.. .+..+..+.|..||++|+.|||.+. +|||||-..|||+.....+||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999987543 4888899999999999999999988 99999999999999999999999999999886653
Q ss_pred cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh-hCCCCC
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWP 688 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p 688 (810)
. |......-.+.|||-|.+....|+.++|||||||++|||+| |..|+..... ..+.+++.. .+...|
T Consensus 854 e----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 854 E----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EEIPDLLEKGERLSQP 922 (1177)
T ss_pred c----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HHhhHHHhccccCCCC
Confidence 3 23334455678999999999999999999999999999999 8888853221 122222222 235567
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
..++.++..++.+||..|+..||.+++ +...+.++
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fke-l~~~fs~~ 957 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKE-LAEEFSRM 957 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHH-HHHHHHHH
Confidence 889999999999999999999999995 44444433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=282.13 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=196.9
Q ss_pred hhcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHh--cCCCceeeeeceecCC------Ce
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK--IRHPHLLLLLGACPDH------GC 525 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~g~~~~~------~~ 525 (810)
........+.||+|.||.||+|.|+|..||||++... +...+.+|.+|.+. |+|+||+.++++-... .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hhheeEEEEEecCccccceeeccccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 3345666788999999999999999999999999764 34557788888875 5999999999885322 28
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-----TKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
||.+|.++|||.|+|.+. .++....++++..+|+||++||. +|.+.|.|||||..|||+..|+.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999774 38888999999999999999995 455679999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCccccccCC----C--CCcchhhhHHHHHHHHHhC----------CCCcccc
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----I--SPKSDVYAYGMVILQLLTA----------KPAIAIT 664 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~--~~~sDVwSlGvil~eLltg----------~~Pf~~~ 664 (810)
+|.......+... ......+||..|||||++.... + -..+||||||.++||+... ++||...
T Consensus 362 LAv~h~~~t~~id--i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 362 LAVRHDSDTDTID--IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred eeEEecccCCccc--CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9987765532221 1234459999999999876432 1 2358999999999999863 4677533
Q ss_pred chhhhhhccchhHHHh--hhhCCCCC-----hhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 665 HKVETAIDEDNLAEIL--DAQAGDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 665 ~~~~~~~~~~~l~~~l--d~~~~~~p-----~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
...+..+ +.+.+++ +...+..| ......+.+|+..||..+|.-|-++- .+.+.|.++.+
T Consensus 440 Vp~DPs~--eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSF--EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKLSN 505 (513)
T ss_pred CCCCCCH--HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHHhc
Confidence 2222211 1122211 12222222 24567889999999999999999976 46666665543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=274.28 Aligned_cols=219 Identities=20% Similarity=0.164 Sum_probs=176.4
Q ss_pred CCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHHHHHhh
Q 003576 467 GGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYR 542 (810)
Q Consensus 467 G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~ 542 (810)
|.||.||++.+. +..+|+|.+.... .+.+|...+....||||+++++++.+.. ++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999885 5689999987643 2344555566667999999999986554 899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCc
Q 003576 543 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622 (810)
Q Consensus 543 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 622 (810)
.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+..+.... ....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------DGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---------ccCC
Confidence 43 3899999999999999999999998 9999999999999999999999999886654321 1235
Q ss_pred cCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHH
Q 003576 623 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 702 (810)
Q Consensus 623 gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~c 702 (810)
++..|+|||++.+..++.++||||||+++|+|++|+.|+....... ........|...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------ccccccCCcccCCHHHHHHHHHH
Confidence 6778999999988889999999999999999999998875321100 00011224455678899999999
Q ss_pred hhhcCCCCCccccc
Q 003576 703 AELRRKDRPDLKNQ 716 (810)
Q Consensus 703 l~~dP~~RPs~~~~ 716 (810)
|+.||.+||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=271.14 Aligned_cols=247 Identities=23% Similarity=0.264 Sum_probs=202.1
Q ss_pred hcCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccC---ccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~l 526 (810)
.++|.....||+|+|+.|..+++..+ .+|+|++++.. ..+....+.|-.+..+. +||.+|-|..+|.... ++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 35788889999999999999998754 89999987642 33445567888888776 6999999999997665 89
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
|.||++||+|.-.+++.. .+|+..+..+..+|+.||.|||+.| ||+||||.+|+|||..|++||+|||+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999977666544 3999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh-hhhccchhHHHhhhhCC
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE-TAIDEDNLAEILDAQAG 685 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~-~~~~~~~l~~~ld~~~~ 685 (810)
...+ ....++|||.|+|||++.+..|+...|+|+|||+++||+.|+.||++...-. ..-.++.+.+++-...-
T Consensus 403 ~~gd------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 403 GPGD------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CCCc------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 3222 2245699999999999999999999999999999999999999998543111 11123345555555555
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCcc
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
..|...+-....++..-|..||.+|..-
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCC
Confidence 6777788888899999999999999653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.54 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=189.8
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecCC-----
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----- 523 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----- 523 (810)
...++|.....||+|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999985 5689999886532 22345678899999999999999999876422
Q ss_pred ---CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeec
Q 003576 524 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 524 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFG 600 (810)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 47999998 6799998864 24899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-------
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID------- 672 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~------- 672 (810)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||...........
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99865432 123467889999998754 3678999999999999999999999964332211000
Q ss_pred ----------cchhHHHhhhhC----C---CCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 673 ----------EDNLAEILDAQA----G---DWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 673 ----------~~~l~~~ld~~~----~---~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.......+.... . ......+..+.+|+.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 000000000000 0 001124678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=298.22 Aligned_cols=254 Identities=26% Similarity=0.366 Sum_probs=207.5
Q ss_pred HHHHHhhcCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeecee-----
Q 003576 449 EEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC----- 520 (810)
Q Consensus 449 ~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~----- 520 (810)
+.+..-+.-|.+...||.|.||.||+++. .++.+|+|++..... ..+++..|.+||+.+ +|||++.+||+|
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33444567799999999999999999876 467999999987654 345678899999987 599999999997
Q ss_pred --cCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEee
Q 003576 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598 (810)
Q Consensus 521 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~D 598 (810)
.|..+||||||.|||..|++.... ...+.|..+..|+..++.||.+||.+. ++|||||-.||||+.++.|||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 344499999999999999987765 556999999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCCcccccccccCCccCccccCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhcc
Q 003576 599 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 673 (810)
Q Consensus 599 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~ 673 (810)
||.+..++... .++....|||+|||||++... .|+..+|+||||++..||.-|.||+...+.+...+..
T Consensus 167 FGvSaQldsT~------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 167 FGVSAQLDSTV------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred eeeeeeeeccc------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 99998776443 344566999999999987543 4778999999999999999999999877766543211
Q ss_pred chhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..- .+.....|...+.++.++|..||..|...||++.+.+
T Consensus 241 pRN----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 241 PRN----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCC----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 100 0000123557789999999999999999999988533
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=311.22 Aligned_cols=143 Identities=30% Similarity=0.375 Sum_probs=125.9
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCc---cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~ 528 (810)
++|.+..+||+|+||.||+|.+. +..||||++..... .....+..|+.++..++||||+++++++.+.. ||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999987 67999999875432 22356889999999999999999998886544 8999
Q ss_pred EeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
||+.+++|.+++.... .+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999986543 3788899999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.24 Aligned_cols=235 Identities=23% Similarity=0.294 Sum_probs=190.4
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+..|.....+|.|+|+.|-.+.+. +...++|++.... .+..+|+.++... +||||+++.+.|.+.. ++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556777778999999999999875 4588999987652 2345678777766 6999999999998876 89999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe-cCCCceEEeeeccccccCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl-d~~~~~kL~DFGla~~~~~~ 608 (810)
++.|+-|.+.+..... + ...+..|+.+|+.|+.|||.+| +|||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---F-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---h-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988887765432 2 2577789999999999999988 9999999999999 68899999999999987754
Q ss_pred CCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCC
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
....+-|..|.|||++....|+.++||||||++||+||+|+.||.....- ..+...+ ..+.+.
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i--~~~~~s 532 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRI--QMPKFS 532 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhh--cCCccc
Confidence 12346789999999999999999999999999999999999999643221 1111111 123334
Q ss_pred hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 689 ~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+...++|+.+||+.||.+||++.+..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 67789999999999999999999999643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=306.86 Aligned_cols=255 Identities=25% Similarity=0.460 Sum_probs=204.3
Q ss_pred cCcccceeeccCCcEEEEEEEEC---------CeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCCC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 524 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~---------~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 524 (810)
.+......||+|.||.|++|... ...||||.++.... ...+.+..|+.+|+.+ +||||+.++|+|....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34445558999999999999753 34799999886543 3557799999999999 5999999999997744
Q ss_pred --eEEEEeccCCCHHHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec
Q 003576 525 --CLVYEYMENGSLEDRLYRKN-----NT--------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 589 (810)
Q Consensus 525 --~lV~Ey~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld 589 (810)
++|+||+..|+|.++|.... .. ..++..+.+.++.|||.|++||++.. +|||||-..|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 89999999999999998765 00 23888999999999999999999988 99999999999999
Q ss_pred CCCceEEeeeccccccCCCCCcccccccccCCcc--CccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccch
Q 003576 590 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG--TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 666 (810)
Q Consensus 590 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~ 666 (810)
.+..+||+|||+|+.......+. .....| ...|||||.+....|+.+||||||||+||||+| |..||.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~-----~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYR-----TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCCEEEEccccceeccCCCCceE-----ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999999765543322 122233 334999999999999999999999999999999 7888864211
Q ss_pred hhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 667 VETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 667 ~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
. .+.+..+.+..+...|..++.++.+++..||+.+|.+||++. ++...++.+
T Consensus 528 ~-----~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~-~~~~~~~~~ 579 (609)
T KOG0200|consen 528 T-----EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS-ECVEFFEKH 579 (609)
T ss_pred H-----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHHHHH
Confidence 1 111222333445677888899999999999999999999999 466666663
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=284.20 Aligned_cols=238 Identities=23% Similarity=0.343 Sum_probs=191.5
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEcccC--ccchHHHHHHHHHHHhcCCCceeeeeceecC--CCeEEEEeccCC
Q 003576 461 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENG 534 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~g 534 (810)
.+.||.|-||+||-|+++ ++.||||++.+.. ..+..++.+|+.||+.++||.||.|-..|.. ..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 357999999999999886 5699999987643 3345778999999999999999999988854 448999999655
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC---CceEEeeeccccccCCCCCc
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~---~~~kL~DFGla~~~~~~~~~ 611 (810)
-|+-+|.... ..+++.....++.||+.||.|||-.+ |+|+||||+||||... -.+||||||+|+.++...
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 5555554433 34899888999999999999999999 9999999999999543 578999999999987532
Q ss_pred ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhH
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
-+...+||+.|+|||++....|+..-|+||.|||+|--|+|..||....++...+....+. .....| .+.
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM----yPp~PW-~ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM----YPPNPW-SEI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc----cCCCch-hhc
Confidence 2345699999999999999999999999999999999999999997655544433322211 001122 356
Q ss_pred HHHHHHHHHHHhhhcCCCCCcccc
Q 003576 692 TKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 692 ~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
+....+||...|+..-++|.+...
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHh
Confidence 788999999999999999998764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=271.93 Aligned_cols=239 Identities=26% Similarity=0.339 Sum_probs=182.2
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEEeccCCC
Q 003576 462 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGS 535 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~Ey~~~gs 535 (810)
..||.|.||+|++-.++ +...|||.++.... ....+++.|.+...+- +.||||++||++..++ ++.||.|+ .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 45999999999998886 56889999987654 4556788898876655 6999999999975444 68999995 67
Q ss_pred HHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 536 LEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 536 L~~~l~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|..+... .-....+++...-.|....+.||.||...-. |||||+||+|||||..|.+||||||++..+.++-
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---- 222 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---- 222 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHHH----
Confidence 7664432 1112348898888999999999999987642 9999999999999999999999999997765432
Q ss_pred ccccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC--CCCC-
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWP- 688 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p- 688 (810)
..+.-+|-..|||||.+.. ..|+.+|||||||++|||+.||+.|+..-..+- +.+..+..... ...+
T Consensus 223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-----eql~~Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-----EQLCQVVIGDPPILLFDK 294 (361)
T ss_pred ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-----HHHHHHHcCCCCeecCcc
Confidence 2344578899999997643 348899999999999999999999985222111 11111111111 1111
Q ss_pred --hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 689 --IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 689 --~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
...+..+..+|..|+.+|..+||...+
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhh
Confidence 246889999999999999999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=262.24 Aligned_cols=231 Identities=29% Similarity=0.417 Sum_probs=188.8
Q ss_pred CcEEEEEEEECC--eEEEEEEEcccCccc-hHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHHHHHhh
Q 003576 468 GYGTVYKGTFHH--TFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYR 542 (810)
Q Consensus 468 ~~g~Vy~~~~~~--~~vavK~l~~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~ 542 (810)
+||.||+|.+.+ ..+++|++....... ...+.+|+..+++++|+||+++++++.... +++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 689999999864 789999998765544 678999999999999999999999987543 899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCc
Q 003576 543 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622 (810)
Q Consensus 543 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 622 (810)
... +++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 432 788999999999999999999998 9999999999999999999999999998776432 122346
Q ss_pred cCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChh---HHHHHHHHH
Q 003576 623 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK---ETKELAALG 699 (810)
Q Consensus 623 gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~---~~~~l~~Li 699 (810)
++..|++||.+....++.++||||||+++|+|++|..||...... ..+...+.......... .+..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFPPPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCccccccCCHHHHHHH
Confidence 888999999998888899999999999999999999999642211 11222222222221111 678899999
Q ss_pred HHHhhhcCCCCCccccch
Q 003576 700 LSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 700 ~~cl~~dP~~RPs~~~~v 717 (810)
.+||..+|.+||++.+++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 222 RKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred HHHccCCchhccCHHHHh
Confidence 999999999999998533
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-31 Score=261.09 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=188.7
Q ss_pred CcccceeeccCCcEEEEEEEECC--eEEEEEEEcc--cCccchHHHHHHHHHHHhcCCCceeeeeceecCC---------
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQS--KGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--------- 523 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--------- 523 (810)
.|....+||+|.||.||+|+.++ ..||+|+.-. ....-.....+|+.+|..|+|+|++.++..|...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 46666789999999999998764 4677775432 1222234567899999999999999999988321
Q ss_pred -CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 524 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
.||||.+|+ -+|..+|.... ..++..++.+++.++..||.|+|... |+|||+||.|+||+.+|.+||+|||++
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 289999997 47888775443 34888899999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhh-------------
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE------------- 668 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~------------- 668 (810)
+.+......... +.+..+-|..|.+||.+.+ ..|+++.|||..|||+.+|+||.+-|.......
T Consensus 172 r~fs~~~n~~kp--rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKP--RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCCC--CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 877654433222 2355678999999997654 569999999999999999999999886433221
Q ss_pred ----hhhccchhHHHhhhh-CC--C--------CChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 669 ----TAIDEDNLAEILDAQ-AG--D--------WPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 669 ----~~~~~~~l~~~ld~~-~~--~--------~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
...+.-.+.+.+... .+ . .|..-..+..+|+.+++.+||.+|+++.+.+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 111111222222100 00 0 0112234788999999999999999998633
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=239.51 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=183.4
Q ss_pred CcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCc--cchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEe
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
+|...++||+|.||+||+|+..++ .||+|..+.+.. .......+|+-+|+.++|.|||++++...... .||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455667899999999999988654 899998876533 33466789999999999999999999875443 799999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
|. .+|..+...-++ .++...+..++.|++.||.|+|+++ +.||||||.|+|++.||.+||+|||+++-++-...
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 96 578887765443 4888899999999999999999999 99999999999999999999999999997764321
Q ss_pred cccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhh-hhCCCC
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDW 687 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~ 687 (810)
.....+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |+|.|...+ +...+.. +...+. +....|
T Consensus 157 ------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkr--if~~lg~p~ed~w 227 (292)
T KOG0662|consen 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKR--IFRLLGTPTEDQW 227 (292)
T ss_pred ------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHH--HHHHhCCCccccC
Confidence 12234679999999987765 48899999999999999987 555554433 2222111 111110 111122
Q ss_pred Ch------------------------hHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 688 PI------------------------KETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 688 p~------------------------~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
|. .....-.+|+.+.+.-+|.+|.++..
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea 279 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA 279 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence 21 11223367888888889999988873
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=267.10 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=190.2
Q ss_pred hcCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC--CCc----eeeeeceecCCC--
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR--HPH----LLLLLGACPDHG-- 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~--Hpn----Iv~l~g~~~~~~-- 524 (810)
++.|.+..++|+|.||.|-.+.+.. ..||||+++.-.. -.+..+-|+++|.++. -|+ +|++.++|.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6788889999999999999998864 4899999876433 3445677999999994 232 678888875444
Q ss_pred eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC--------------
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------------- 590 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-------------- 590 (810)
|+|+|.+ |.|+.++|..++ ..+++...+..|++|++.+++|||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 569999997654 456899999999999999999999999 999999999999921
Q ss_pred ------CCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc
Q 003576 591 ------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 664 (810)
Q Consensus 591 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~ 664 (810)
+..+||+|||.|....... ...+.|..|.|||++.+-.++..+||||+||||+||.||...|...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3457999999998755432 3457899999999999999999999999999999999999988744
Q ss_pred chhhhh------hc--------cchhHHHhhhhCCCCC-------------------------hhHHHHHHHHHHHHhhh
Q 003576 665 HKVETA------ID--------EDNLAEILDAQAGDWP-------------------------IKETKELAALGLSCAEL 705 (810)
Q Consensus 665 ~~~~~~------~~--------~~~l~~~ld~~~~~~p-------------------------~~~~~~l~~Li~~cl~~ 705 (810)
...+.. +. .....+.+.....+|| .....+|.+|+.+||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 422211 00 0000111111112222 13356799999999999
Q ss_pred cCCCCCccccch
Q 003576 706 RRKDRPDLKNQV 717 (810)
Q Consensus 706 dP~~RPs~~~~v 717 (810)
||.+|+|+.+.+
T Consensus 393 DP~~RiTl~EAL 404 (415)
T KOG0671|consen 393 DPARRITLREAL 404 (415)
T ss_pred CccccccHHHHh
Confidence 999999999744
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=292.41 Aligned_cols=259 Identities=27% Similarity=0.337 Sum_probs=195.7
Q ss_pred CcccceeeccCCcEE-EEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEecc
Q 003576 457 SFSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~-Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~ 532 (810)
-|...+.+|.|+-|+ ||+|.+.++.||||.+-... ..-.++|+..|+.-+ |||||++|+.-.+.. ||..|.|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 455666789998875 89999999999999875432 234578999999884 999999998876665 88999995
Q ss_pred CCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-----CCceEEeeeccccccC
Q 003576 533 NGSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTMLN 606 (810)
Q Consensus 533 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-----~~~~kL~DFGla~~~~ 606 (810)
.+|.+++...... ........+.++.|++.||++||+.+ ||||||||.||||+. ...++|+|||+|+.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7999999764111 11111345778999999999999999 999999999999965 2678999999999998
Q ss_pred CCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhhhhhccchhHHHhhhhCC
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg-~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
.+..... +..+..||-+|+|||++....-+.++|||||||++|+.++| .+||+..-..+..+-.+...- .. ..
T Consensus 663 ~~~sS~~---r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L--~~-L~ 736 (903)
T KOG1027|consen 663 GGKSSFS---RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL--VH-LE 736 (903)
T ss_pred CCcchhh---cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce--ee-ec
Confidence 7654332 35677999999999999988888899999999999999996 899985433332222111110 00 00
Q ss_pred CCChhHHHHHHHHHHHHhhhcCCCCCccccchh--------hHHHHHHHhhhcc
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVL--------PVLERLKEVADRA 731 (810)
Q Consensus 686 ~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~--------~~L~~l~~~~~~~ 731 (810)
+.. ..+..+||.+|+.++|..||++.+++. +.|+-|++..++.
T Consensus 737 --~~~-d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRv 787 (903)
T KOG1027|consen 737 --PLP-DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRV 787 (903)
T ss_pred --cCc-hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhh
Confidence 111 118899999999999999999997653 3566666665554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=281.63 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=178.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEE------------------CCeEEEEEEEcccCccchHHH--------------HHH
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTF------------------HHTFAAVKVLQSKGNIQNKQF--------------LQE 501 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~------------------~~~~vavK~l~~~~~~~~~~~--------------~~E 501 (810)
..++|...++||+|+||.||+|.+ .++.||||.+........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 234799999875443333333 346
Q ss_pred HHHHHhcCCCce-----eeeeceecC----------CCeEEEEeccCCCHHHHHhhcCC---------------------
Q 003576 502 LEVLSKIRHPHL-----LLLLGACPD----------HGCLVYEYMENGSLEDRLYRKNN--------------------- 545 (810)
Q Consensus 502 i~iL~~l~HpnI-----v~l~g~~~~----------~~~lV~Ey~~~gsL~~~l~~~~~--------------------- 545 (810)
+.++.+++|.++ +.++++|.. ..+|||||+++++|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777632 23899999999999999874321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCc
Q 003576 546 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625 (810)
Q Consensus 546 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 625 (810)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 112467788899999999999999998 999999999999999999999999999765432211 111234588
Q ss_pred cccCccccccCC--------------------C--CCcchhhhHHHHHHHHHhCCC-Cccccchhhhhhcc--chh--HH
Q 003576 626 CYIDPEYQRTGL--------------------I--SPKSDVYAYGMVILQLLTAKP-AIAITHKVETAIDE--DNL--AE 678 (810)
Q Consensus 626 ~Y~aPE~~~~~~--------------------~--~~~sDVwSlGvil~eLltg~~-Pf~~~~~~~~~~~~--~~l--~~ 678 (810)
.|+|||.+.... + ..+.||||+||++|+|++|.. ||.....+...+.. ..+ ..
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999765322 1 134799999999999999975 77533222221111 000 11
Q ss_pred HhhhhCCCCC--hhHHHHHHHHHHHHhhhcC---CCCCcccc
Q 003576 679 ILDAQAGDWP--IKETKELAALGLSCAELRR---KDRPDLKN 715 (810)
Q Consensus 679 ~ld~~~~~~p--~~~~~~l~~Li~~cl~~dP---~~RPs~~~ 715 (810)
.......+++ ...+....+|+.+||..+| .+|+|+.+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 1111111121 2357889999999999876 68999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=287.43 Aligned_cols=252 Identities=20% Similarity=0.211 Sum_probs=162.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC------CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeece--------
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-------- 519 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~-------- 519 (810)
..++|...++||+|+||.||+|.+. +..||+|.+..... .+.+..+ .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3568999999999999999999985 45899998764322 1111111 1222222333322222
Q ss_pred ecCCCeEEEEeccCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCC
Q 003576 520 CPDHGCLVYEYMENGSLEDRLYRKNNT-----------------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 582 (810)
Q Consensus 520 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLk 582 (810)
..+..+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 122348999999999999988653210 00122345679999999999999998 9999999
Q ss_pred CCceEecC-CCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccC----------------------CCC
Q 003576 583 PGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----------------------LIS 639 (810)
Q Consensus 583 p~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~~ 639 (810)
|+|||++. ++.+||+|||+++.+..... +......+|+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999985 68999999999986543322 122345789999999954322 234
Q ss_pred CcchhhhHHHHHHHHHhCCCCccccch-hhhhhcc-----chhHHHhhhhCC-C------CChhHHHHHHHHHHHHhhhc
Q 003576 640 PKSDVYAYGMVILQLLTAKPAIAITHK-VETAIDE-----DNLAEILDAQAG-D------WPIKETKELAALGLSCAELR 706 (810)
Q Consensus 640 ~~sDVwSlGvil~eLltg~~Pf~~~~~-~~~~~~~-----~~l~~~ld~~~~-~------~p~~~~~~l~~Li~~cl~~d 706 (810)
.++|||||||+||||+++..|+..... ....+.. ..+...+..... + ..........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 467999999999999997766542110 0000000 011111111100 0 00011234558999999999
Q ss_pred CCCCCccccch
Q 003576 707 RKDRPDLKNQV 717 (810)
Q Consensus 707 P~~RPs~~~~v 717 (810)
|.+||++.+.+
T Consensus 438 P~kR~ta~e~L 448 (566)
T PLN03225 438 GRQRISAKAAL 448 (566)
T ss_pred cccCCCHHHHh
Confidence 99999998533
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=239.00 Aligned_cols=197 Identities=29% Similarity=0.395 Sum_probs=158.8
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCc-cchHHHHHHHHHHHhc-CCCceeeeeceecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~g~~~~~~--~lV~E 529 (810)
+.......||+|+||.|-+-++ .++..|+|.+...-. ...++.++|+++..+. ..|.+|.+||...+.. ++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444456699999999877665 577999999876543 3446678899987765 6999999999875554 78999
Q ss_pred eccCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCC
Q 003576 530 YMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 530 y~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~ 608 (810)
.|. .||..+... ......+++..+-+|+..++.||.|||++- .+||||+||+|||++.+|++||||||++..+.++
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 995 688776543 122345899999999999999999999975 3999999999999999999999999999887654
Q ss_pred CCcccccccccCCccCccccCccccc----cCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQR----TGLISPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
-. .+...|-..|||||.+. ...|+.++||||||+++.||.+++.||.
T Consensus 203 iA-------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 203 IA-------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hH-------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 32 22346888999999764 3468999999999999999999999995
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=239.48 Aligned_cols=245 Identities=21% Similarity=0.386 Sum_probs=190.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceecCCC----eE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG----CL 526 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~----~l 526 (810)
...+|++.+++|+|.|+.||.|.. ++..++||++++- ..+.+.+|+.||..|. ||||++|++...+.. .|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 356799999999999999999984 5668999999763 4567899999999997 999999999987654 79
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeecccccc
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTML 605 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGla~~~ 605 (810)
|+||+.+.+...+. +.++..++..++.+++.||.|+|+.| |+|||+||.|+++|.. ..++|+|+|+|.++
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998877654 23667788999999999999999999 9999999999999864 67899999999988
Q ss_pred CCCCCcccccccccCCccCccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-------hccchhH
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-------IDEDNLA 677 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~-------~~~~~l~ 677 (810)
....... ..+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||...+..... +....+.
T Consensus 184 Hp~~eYn-------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 184 HPGKEYN-------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred CCCceee-------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 7654322 2255677889997654 56888999999999999999999999743321111 1111122
Q ss_pred HHhhhh----------------CCCCC--------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 678 EILDAQ----------------AGDWP--------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 678 ~~ld~~----------------~~~~p--------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..+... ...|. .-.+++..+|+.+.|..|-.+|||+.+.+
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 221111 11121 12358899999999999999999998644
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=245.45 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=183.3
Q ss_pred CcccceeeccCCcEEEEEEEEC--CeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCC-------Ce
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 525 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------~~ 525 (810)
+.+..+.||-|+||.||.+++. ++.||+|.+..- .-...+++.+|+.+|.-++|.|++..++..... .|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556788999999999999874 678999987643 223456789999999999999999998876332 26
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
++.|.|. .+|..+|..- ..++...+.-+++||+.||.|||+.+ |.||||||.|+|++.|..+||||||+++..
T Consensus 134 V~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 7888884 5787777543 24777788889999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcccccccccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhh------hc------
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------ID------ 672 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~------~~------ 672 (810)
..+... .++..+-|-.|.|||++.+. .|+.+.||||.|||+.||+..+..|.....++.. +.
T Consensus 207 e~d~~~-----hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 207 DQRDRL-----NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred chhhhh-----hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 654322 34455778999999988764 5899999999999999999988877643332221 00
Q ss_pred -----cchhHHHhhhhC--CCCC--------hhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 673 -----EDNLAEILDAQA--GDWP--------IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 673 -----~~~l~~~ld~~~--~~~p--------~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
++.-.-++.... +..+ .....+...+...++..||..|.+..+
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~ 339 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE 339 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh
Confidence 011111111110 1111 122345667788888999999988764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=258.06 Aligned_cols=197 Identities=23% Similarity=0.291 Sum_probs=167.3
Q ss_pred HhhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcC------CCceeeeeceec--C
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR------HPHLLLLLGACP--D 522 (810)
Q Consensus 453 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~g~~~--~ 522 (810)
.....|.+....|+|-|++|.+|.+. +..||||++..+.. ..+.=+.|++||++|+ --|+++|+..|. .
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34556777788899999999999885 55999999987543 3344578999999995 457888888774 4
Q ss_pred CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeecc
Q 003576 523 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGL 601 (810)
Q Consensus 523 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGl 601 (810)
+.|||+|-+. .+|.++|...+..-.|....+..++.|+..||..|..++ |+|.||||+|||++.+ ..+||||||.
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 5599999984 799999999888888999999999999999999999999 9999999999999875 6789999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
|.....+.- +.+.-+..|.|||++.+-+|+...|+||.||+||||.||+..|.
T Consensus 584 A~~~~enei--------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 584 ASFASENEI--------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ccccccccc--------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 988765431 22355677999999999999999999999999999999998886
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=245.43 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=199.1
Q ss_pred cccceeeccCCcEEEEEEEECCe-------EEEEEEEccc-CccchHHHHHHHHHHHhcCCCceeeeeceecCCC---eE
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG---CL 526 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~-------~vavK~l~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~---~l 526 (810)
++....+-+|.||.||.|.|... .|-+|.++.. +..+...++.|--.|..+.|||+..+.|++.+.. ++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 44455688999999999977532 3455555433 3345567888999999999999999999985543 88
Q ss_pred EEEeccCCCHHHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecc
Q 003576 527 VYEYMENGSLEDRLY-----RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGl 601 (810)
+|.++.-|+|..+|. .......+...+...++.|++.|+.|||+++ |||.||-..|.+||+..++||+|=.+
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchh
Confidence 999999999999998 2233345777788899999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHh
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
++.+-..+.. ....+......||+||.+....|+.++|||||||+||||+| |+.|+...+.++. ..-+.
T Consensus 443 SRDLFP~DYh----cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------~~ylk 512 (563)
T KOG1024|consen 443 SRDLFPGDYH----CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------EHYLK 512 (563)
T ss_pred ccccCccccc----ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------HHHHh
Confidence 9876543321 11223345678999999999999999999999999999998 8899875544332 12344
Q ss_pred hhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHH
Q 003576 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723 (810)
Q Consensus 681 d~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~ 723 (810)
|..+...|.+++.+|..++..||...|++||++.+ +..-|..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q-lv~cLse 554 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ-LVICLSE 554 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH-HHHHHHH
Confidence 55566778899999999999999999999999994 4444443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=230.95 Aligned_cols=203 Identities=37% Similarity=0.569 Sum_probs=176.2
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecC--CCeEEEEeccCCCHHH
Q 003576 464 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLED 538 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~ 538 (810)
||.|++|.||++... +..+++|++...... ....+.+|+.+++.+.|++++++++++.. ..+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 779999998865432 34678999999999999999999999876 4489999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-CCceEEeeeccccccCCCCCccccccc
Q 003576 539 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYK 617 (810)
Q Consensus 539 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 617 (810)
++.... ..+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 987543 34888999999999999999999998 999999999999999 89999999999987654321 1
Q ss_pred ccCCccCccccCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHH
Q 003576 618 NTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 696 (810)
Q Consensus 618 ~~~~~gt~~Y~aPE~~~~~-~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 696 (810)
.....+...|++||.+... ..+.++|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2234678899999988877 788999999999999998 5688
Q ss_pred HHHHHHhhhcCCCCCcccc
Q 003576 697 ALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 697 ~Li~~cl~~dP~~RPs~~~ 715 (810)
+++..|+..+|.+||++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHhhCCcccCcCHHH
Confidence 9999999999999999975
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=245.90 Aligned_cols=129 Identities=27% Similarity=0.445 Sum_probs=107.6
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcC-----C---CceeeeeceecCCC
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----H---PHLLLLLGACPDHG 524 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-----H---pnIv~l~g~~~~~~ 524 (810)
...|-..++||.|.|++||++.+. .+.||+|+.+... .-.+....||.+|++++ | .+||+|++.|.-.+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 357889999999999999999875 5699999987642 23455678999999984 2 46999999984322
Q ss_pred ------eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe
Q 003576 525 ------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 525 ------~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl 588 (810)
|+|+|++ |.+|..+|.... ...++...+..|+.||+.||.|||... +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999999 678888887644 345999999999999999999999876 49999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-28 Score=264.73 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=202.3
Q ss_pred hcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceec--CCCeEEEEe
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEY 530 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~--~~~~lV~Ey 530 (810)
..+|....++|.|.||.||++++. +...|+|+++........-+++|+-+++.++|||||.++|.+. +..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 356888889999999999999986 4589999999887777888899999999999999999999984 556999999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~ 610 (810)
|.||+|.+..+- ..++++.++...+++.+.||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 999999997643 346889899999999999999999999 899999999999999999999999998766532
Q ss_pred cccccccccCCccCccccCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
..+...+.||+.|||||+- +.+.|...+|||++|+...||---++|....+.....+--. ....++....-
T Consensus 166 ----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~qpp~lkD 239 (829)
T KOG0576|consen 166 ----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQPPTLKD 239 (829)
T ss_pred ----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCCCCcccC
Confidence 2345678999999999953 56779999999999999999998888876554433211000 00011111112
Q ss_pred ChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+...++.+.+|+..|+..+|++||+....+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 335678999999999999999999988544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=254.71 Aligned_cols=193 Identities=24% Similarity=0.308 Sum_probs=163.6
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccc--------hHHHHHHHHHHHhcC---CCceeeeeceecC
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQ--------NKQFLQELEVLSKIR---HPHLLLLLGACPD 522 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~--------~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~ 522 (810)
.+|.....+|.|+||.|++++++. ..|+||.+.+..... ...+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999999974 488999887643211 122456999999997 9999999999988
Q ss_pred CC--eEEEEec-cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeee
Q 003576 523 HG--CLVYEYM-ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 523 ~~--~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DF 599 (810)
.. ||+||-- +|-+|.++|..+. .+++.++..|+.|++.|+++||+.+ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 77 6777753 5668899886554 4999999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCccccCccccccCCC-CCcchhhhHHHHHHHHHhCCCCcc
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
|.+.+..... ...++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998776543 234689999999999998776 577899999999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.29 Aligned_cols=245 Identities=20% Similarity=0.235 Sum_probs=185.6
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEccc--CccchHHHHHHHHHHHhcCCCceeeeeceecCC--------
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------- 523 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~-------- 523 (810)
..|.....+|.|.- .|..+.+ .+.+||+|.+... .....++..+|+.++..++|+||+.++.+|.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888888 5655544 3678999986543 223346678999999999999999999998432
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.|+|||||. ++|...+... ++-..+..|+.|+++|+.|||+.+ |+||||||+||++..++.+||+|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 289999995 6898888633 556688899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccc--------h
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------N 675 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~--------~ 675 (810)
.-... +..+..+.|..|.|||++.+..+...+||||+||++.||++|+--|.+........... .
T Consensus 167 ~e~~~-------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc-------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 64422 35667789999999999888889999999999999999999998886443322221100 0
Q ss_pred hH-HH----------hh--------hhCC--CCC------hhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 676 LA-EI----------LD--------AQAG--DWP------IKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 676 l~-~~----------ld--------~~~~--~~p------~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
+. ++ .. ...+ .|+ ......+.+|+.+||-.||++|.++.+.+
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 00 00 00 0001 111 12356688999999999999999998633
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=229.79 Aligned_cols=196 Identities=31% Similarity=0.488 Sum_probs=167.4
Q ss_pred cccceeeccCCcEEEEEEEECC--eEEEEEEEcccCcc-chHHHHHHHHHHHhcCCCceeeeeceecCC--CeEEEEecc
Q 003576 458 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 532 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~--~~lV~Ey~~ 532 (810)
|.....||.|++|.||++...+ ..+++|.+...... ....+.+|+..+.+++|+|++++++++... .++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999864 68999999876554 567889999999999999999999998643 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
+++|.+++...... +++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 99999988754321 788899999999999999999998 999999999999999999999999999877643200
Q ss_pred cccccccCCccCccccCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCccc
Q 003576 613 STTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAI 663 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~sDVwSlGvil~eLltg~~Pf~~ 663 (810)
......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11234678889999988 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=228.55 Aligned_cols=242 Identities=19% Similarity=0.262 Sum_probs=178.5
Q ss_pred cCcccceeeccCCcEEEEEEEECC--eEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeece-ecCCC--eEEEE
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA-CPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~-~~~~~--~lV~E 529 (810)
+.|.+.+.||+|.||.+-++.+++ +.+++|.+..... ...+|.+|...--.|. |.||+.-|.. |+... ++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 468888999999999999999974 5889998766533 5678999988766664 9999988875 44333 67999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe-c-CCCceEEeeeccccccCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-D-HNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl-d-~~~~~kL~DFGla~~~~~ 607 (810)
|++.|+|..-+... .+.+....+++.|+++||.|+|+.+ +||||||.+|||| + +..++||||||+.+..+.
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998877543 3778888999999999999999999 9999999999999 2 346899999999987654
Q ss_pred CCCcccccccccCCccCccccCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-hccchhHHHhh
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDEDNLAEILD 681 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~-~~~~~l~~~ld 681 (810)
... ...-+..|.+||..... ...+.+|||.|||++|.+|||.+||......... .+-..+..-..
T Consensus 176 tV~---------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TVK---------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred eeh---------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 322 12346779999965432 2467899999999999999999999622111111 11111111111
Q ss_pred hhCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 682 ~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
...+..-...++.+..+..+-|..+|++|--+.
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhH
Confidence 112222234577888899999999999994444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=237.17 Aligned_cols=200 Identities=24% Similarity=0.357 Sum_probs=161.5
Q ss_pred HHhhcCcccceeeccCCcEEEEEEEECC-----eEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceecC--C
Q 003576 452 ESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--H 523 (810)
Q Consensus 452 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~ 523 (810)
....+.|....+||.|.|++||++++.. ..||+|.+.... ...++.+|++.|..+. +.||+++.+++.. .
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678888999999999999997643 489999886543 4566899999999995 9999999999854 4
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeeccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLS 602 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGla 602 (810)
.++|+||++.....+++.. ++...+..+++.++.||.++|.+| ||||||||+|+|.+.. +.-.|+|||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 4899999999999887743 667789999999999999999999 9999999999999754 67799999999
Q ss_pred cccCCCC------C-------c-------------------------ccccccccCCccCccccCccccc-cCCCCCcch
Q 003576 603 TMLNSDP------S-------F-------------------------VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSD 643 (810)
Q Consensus 603 ~~~~~~~------~-------~-------------------------~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~sD 643 (810)
....... . . ...........||++|.|||++. ....++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8322110 0 0 00011123458999999999764 556789999
Q ss_pred hhhHHHHHHHHHhCCCCcc
Q 003576 644 VYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 644 VwSlGvil~eLltg~~Pf~ 662 (810)
|||.|||++-+++++.||.
T Consensus 261 iws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eeeccceeehhhccccccc
Confidence 9999999999999999996
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-25 Score=266.86 Aligned_cols=197 Identities=16% Similarity=0.169 Sum_probs=136.5
Q ss_pred hcCC-Cceeeeecee-------cC--CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCE
Q 003576 507 KIRH-PHLLLLLGAC-------PD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576 (810)
Q Consensus 507 ~l~H-pnIv~l~g~~-------~~--~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 576 (810)
.++| +||+.++++| .+ ..++++||+ +++|.++|... ...+++..++.|+.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 5788888877 11 125677887 57999999643 245899999999999999999999999 9
Q ss_pred EecCCCCCceEecCCC-------------------ceEEeeeccccccCCCCCc----------ccccccccCCccCccc
Q 003576 577 IHRDMKPGNILLDHNL-------------------VSKIGDVGLSTMLNSDPSF----------VSTTYKNTGPVGTLCY 627 (810)
Q Consensus 577 vHrDLkp~NILld~~~-------------------~~kL~DFGla~~~~~~~~~----------~~~~~~~~~~~gt~~Y 627 (810)
+||||||+||||+..+ .+||+|||+++........ ...........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 4555666665432210000 0000011224689999
Q ss_pred cCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcC
Q 003576 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRR 707 (810)
Q Consensus 628 ~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP 707 (810)
+|||++.+..++.++|||||||+||||++|.+|+........ .+.............+....++.+||+.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS--------SLRHRVLPPQILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH--------HHHHhhcChhhhhcCHHHHHHHHHhCCCCh
Confidence 999999999999999999999999999999998752211110 110011111111224556788999999999
Q ss_pred CCCCccccch
Q 003576 708 KDRPDLKNQV 717 (810)
Q Consensus 708 ~~RPs~~~~v 717 (810)
.+||++.+++
T Consensus 254 ~~Rps~~eil 263 (793)
T PLN00181 254 SCRPSMSELL 263 (793)
T ss_pred hhCcChHHHh
Confidence 9999999654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=208.41 Aligned_cols=159 Identities=20% Similarity=0.246 Sum_probs=122.8
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|+|.+++...+ .++++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 78999987543 35999999999999999999999976 999999999999999 99998765321
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC------CC
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG------DW 687 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~------~~ 687 (810)
..||+.|+|||++.+..++.++|||||||++|+|+||++||......... +..++..... ..
T Consensus 64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 131 (176)
T smart00750 64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-----LEILLNGMPADDPRDRSN 131 (176)
T ss_pred -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-----HHHHHHHhccCCcccccc
Confidence 26899999999999999999999999999999999999999643322111 1111111111 11
Q ss_pred ChhHHH--HHHHHHHHHhhhcCCCCCccccchhhHHH
Q 003576 688 PIKETK--ELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 688 p~~~~~--~l~~Li~~cl~~dP~~RPs~~~~v~~~L~ 722 (810)
+..... .+.+++.+||..+|.+||++.+ ++..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~-ll~~~~ 167 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANH-YLAHCR 167 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHH-HHHHHH
Confidence 222333 6999999999999999999985 444443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=221.80 Aligned_cols=259 Identities=22% Similarity=0.237 Sum_probs=192.6
Q ss_pred CcccceeeccCCcEEEEEEEECCe---EEEEEEEcccCccchHHHHHHHHHHHhcCC----Cceeeeeceec-CC--CeE
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLGACP-DH--GCL 526 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~~---~vavK~l~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~g~~~-~~--~~l 526 (810)
.|....+||+|+||.||.+..... .+|+|+...........+..|+.+|..+.. +++..+++... .. .++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999998654 689998776544333368889999999873 58888887773 33 389
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-----CceEEeeecc
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-----LVSKIGDVGL 601 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-----~~~kL~DFGl 601 (810)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789999775555 456999999999999999999999999 9999999999999765 4689999999
Q ss_pred cc--ccCCCCCc--ccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhH
Q 003576 602 ST--MLNSDPSF--VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 677 (810)
Q Consensus 602 a~--~~~~~~~~--~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~ 677 (810)
++ .+...... .........+.||..|+++..+.+...+.+.|+||++.++.+|+.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 43222211 1111112356799999999999999999999999999999999999999954332111 11111
Q ss_pred HHhhhhCCC-CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHH
Q 003576 678 EILDAQAGD-WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 678 ~~ld~~~~~-~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l 724 (810)
......... .....+..+..+...+-..+..++|+.. .+...|..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~-~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYE-KLAELLKDV 297 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHH-HHHHHHHHH
Confidence 111111111 2223456777888778889999999998 455554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=222.75 Aligned_cols=171 Identities=20% Similarity=0.175 Sum_probs=130.4
Q ss_pred HHHhhcCcccceeeccCCcEEEEEEEEC---CeEEEEEEEcccC-----ccchHHHHHHHHHHHhcCCCceee-eeceec
Q 003576 451 IESATLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLL-LLGACP 521 (810)
Q Consensus 451 i~~~~~~f~~~~~LG~G~~g~Vy~~~~~---~~~vavK~l~~~~-----~~~~~~~~~Ei~iL~~l~HpnIv~-l~g~~~ 521 (810)
+.....+|.....||+|+||.||+|.+. +..+|||++.... ......|.+|+.+|++++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 4455678999999999999999999874 4578999875331 123456899999999999999985 5442
Q ss_pred CCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCC-CCCceEecCCCceEEeeec
Q 003576 522 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM-KPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 522 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL-kp~NILld~~~~~kL~DFG 600 (810)
+..||||||++|++|.. +. . .. ...++.+++.+|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~--~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR--P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC--c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45699999999999963 21 1 11 1467889999999999998 999999 9999999999999999999
Q ss_pred cccccCCCCCcccc-c-ccccCCccCccccCccccccC
Q 003576 601 LSTMLNSDPSFVST-T-YKNTGPVGTLCYIDPEYQRTG 636 (810)
Q Consensus 601 la~~~~~~~~~~~~-~-~~~~~~~gt~~Y~aPE~~~~~ 636 (810)
+|+.+......... . ..-+...+++.|++||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99987653311110 0 011356789999999987543
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=190.69 Aligned_cols=142 Identities=46% Similarity=0.691 Sum_probs=117.5
Q ss_pred eEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHHHH
Q 003576 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKT 95 (810)
Q Consensus 16 ~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 95 (810)
+||||||+|+.|.+||+||++++...+. .++||||.++....... .+ .......+.+..++.+
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~-~l~ll~v~~~~~~~~~~--------~~--------~~~~~~~~~~~~~~~~ 63 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQ-TIVLVHVHPPITSIPSS--------SG--------KLEVASAYKQEEDKEA 63 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCC-cEEEEEeccCcccCCCC--------cc--------chHHHHHHHHHHHHHH
Confidence 5999999999999999999998776655 59999998764332111 00 0112334555666778
Q ss_pred hhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCc-cccccccC-Cc--ce
Q 003576 96 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLS-SRISICVP-SF--CT 171 (810)
Q Consensus 96 ~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lg-Sv~~~v~~-~~--cp 171 (810)
+++|..+...|...|++++..++++|+|+++|+++|+++++|+||||+||++ ++.++++| ||+.++++ ++ ||
T Consensus 64 ~~~l~~~~~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~----~l~~~~~gssva~~Vi~~a~~~c~ 139 (146)
T cd01989 64 KELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDN----HFSMKFKKSDVASSVLKEAPDFCT 139 (146)
T ss_pred HHHHHHHHHHHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCC----ceeecccCCchhHHHHhcCCCCce
Confidence 8999999999988899999999996699999999999999999999999999 77778887 69999999 99 99
Q ss_pred EEEEecC
Q 003576 172 VYGVEKG 178 (810)
Q Consensus 172 V~vV~~~ 178 (810)
|+||++|
T Consensus 140 Vlvv~~~ 146 (146)
T cd01989 140 VYVVSKG 146 (146)
T ss_pred EEEEeCc
Confidence 9999987
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-23 Score=204.10 Aligned_cols=262 Identities=21% Similarity=0.397 Sum_probs=206.3
Q ss_pred HhcccccccccCCHHHHHHhhcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCc--cchHHHHHHHHHHHhcCCCc
Q 003576 435 ALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPH 512 (810)
Q Consensus 435 ~~~~~~~~~~~~~~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~iL~~l~Hpn 512 (810)
....+..+|..++..++...| +|.+...|..|+|+|.+..+++|++..... ....+|..|.-.|+.+.|||
T Consensus 176 ~rdatlsr~~gid~~~lnl~t-------kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpn 248 (448)
T KOG0195|consen 176 TRDATLSRYTGIDVSSLNLIT-------KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPN 248 (448)
T ss_pred ccccccccccCcchhhhhhhh-------hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCc
Confidence 345566777777777666655 488999999999999999999998875432 23467999999999999999
Q ss_pred eeeeeceecCCC--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEe-cCCCCCceEec
Q 003576 513 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH-RDMKPGNILLD 589 (810)
Q Consensus 513 Iv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH-rDLkp~NILld 589 (810)
|+.++|+|.... .++..||+.|+|...|+...+ -.++..++.+++.+++.|+.|||+..| ++- --|....+++|
T Consensus 249 ilpvlgacnsppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmid 325 (448)
T KOG0195|consen 249 ILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMID 325 (448)
T ss_pred hhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEec
Confidence 999999996654 788999999999999987543 235667889999999999999999874 444 46899999999
Q ss_pred CCCceEEe--eeccccccCCCCCcccccccccCCccCccccCccccccCCC---CCcchhhhHHHHHHHHHhCCCCcccc
Q 003576 590 HNLVSKIG--DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI---SPKSDVYAYGMVILQLLTAKPAIAIT 664 (810)
Q Consensus 590 ~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---~~~sDVwSlGvil~eLltg~~Pf~~~ 664 (810)
++.+++|+ |--++. ...+..-.|.|++||.++..+- -.++|+|||.++||||.|...||..-
T Consensus 326 edltarismad~kfsf-------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 326 EDLTARISMADTKFSF-------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred chhhhheecccceeee-------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 99888774 322221 1123355789999998876653 35789999999999999999999765
Q ss_pred chhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHH
Q 003576 665 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 665 ~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~ 725 (810)
...+... .-.+.......|+..+..+.+|+.-|+..||.+||.+. .+.+.|+++.
T Consensus 393 spmecgm-----kialeglrv~ippgis~hm~klm~icmnedpgkrpkfd-mivpilekm~ 447 (448)
T KOG0195|consen 393 SPMECGM-----KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD-MIVPILEKMI 447 (448)
T ss_pred Cchhhhh-----hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc-eehhhHHHhc
Confidence 5554432 22344445677889999999999999999999999998 7889998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-21 Score=205.44 Aligned_cols=255 Identities=30% Similarity=0.419 Sum_probs=194.1
Q ss_pred cccceeeccCCcEEEEEEEECCeEEEEEEEcccCcc---chHHHHHHHHHHHhcCCC-ceeeeeceecCCC--eEEEEec
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHP-HLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~~~--~lV~Ey~ 531 (810)
|.....||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +++++++++.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999988 78899988766443 366789999999999988 7999999986554 8999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC-ceEEeeeccccccCCCCC
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~-~~kL~DFGla~~~~~~~~ 610 (810)
.+++|.+++........+.......++.|++.+|.|+|..+ ++||||||+|||++..+ .++++|||++..+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966654321124888899999999999999999999 99999999999999988 799999999986554332
Q ss_pred cccccccccCCccCccccCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC--
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-- 685 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~-- 685 (810)
............||..|++||.+.. ..++...|+||+|++++++++|..||...... .........+.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPS 234 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCcc
Confidence 1110012345689999999998887 57889999999999999999999997644321 000111111111111
Q ss_pred ---CCCh----hHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 686 ---DWPI----KETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 686 ---~~p~----~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
.... .....+.+++..|+..+|..|.+....+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111 113578999999999999999998865544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=197.55 Aligned_cols=259 Identities=18% Similarity=0.215 Sum_probs=197.3
Q ss_pred cCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEe
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey 530 (810)
-+|.+.++||+|+||.++.|+. ++.+||||.-...+. .-++..|....+.|. .++|...|.+-+++. .||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 4799999999999999999975 578999998654432 345777888888885 788888877766655 799999
Q ss_pred ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-----CceEEeeecccccc
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-----LVSKIGDVGLSTML 605 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-----~~~kL~DFGla~~~ 605 (810)
+ |-||+|++.-.+. .++..++..|+.|++.-++|+|.+. +|+|||||+|+||... ..+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7899998765554 3899999999999999999999999 9999999999999643 46899999999988
Q ss_pred CCCCCccccccc-ccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhC
Q 003576 606 NSDPSFVSTTYK-NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 606 ~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
.+........|+ .....||..||+-..+.+...+.+.|+-|||-++.+.|-|..||........ +.....+=+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKIGe~Kr 256 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKIGETKR 256 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHhccccc
Confidence 776654444443 3567899999999999999999999999999999999999999974322111 112222222111
Q ss_pred CC----CChhHHHHHHHHHHHHhhhcCCCCCccccchhhHHHHHHH
Q 003576 685 GD----WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 685 ~~----~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L~~l~~ 726 (810)
.. .-...+.++...+.-.-.++-.+-|+.. -+...+..+.+
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd-ylr~Lf~dvld 301 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD-YLRKLFDDVLD 301 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH-HHHHHHHHHHH
Confidence 11 0112456788888888888888999986 44444444433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=188.04 Aligned_cols=249 Identities=20% Similarity=0.216 Sum_probs=190.3
Q ss_pred hcCcccceeeccCCcEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCC-CceeeeeceecCCC--eEEEE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~g~~~~~~--~lV~E 529 (810)
..+|...++||.|+||.+|.|.. .+..||||+-..... ..++..|..+...|++ ..|..+..+..+.. .+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45789999999999999999986 466999999766543 3457789999998874 55666655554444 79999
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC---CceEEeeeccccccC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLN 606 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~---~~~kL~DFGla~~~~ 606 (810)
.+ |.||++++.-... .++..+++-++-|++.-++|+|..+ +|||||||+|+|..-+ ..+.|+|||+|+.+-
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 98 7899998764433 3888999999999999999999999 9999999999999654 467899999999877
Q ss_pred CCCCccccccc-ccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCC
Q 003576 607 SDPSFVSTTYK-NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685 (810)
Q Consensus 607 ~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 685 (810)
+........++ .....||..|.+-..+.+...+.+.|+-|+|.+|.++.-|..||......... .....+......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---QKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---HHHHHHHHhhcC
Confidence 65543333333 45678999999998888888889999999999999999999999754332221 222222222211
Q ss_pred CC----ChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 686 DW----PIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 686 ~~----p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
.. -...+.++.-.+.-|-.+.-.+-|+..
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 11 112357788889999999999999976
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=191.10 Aligned_cols=170 Identities=14% Similarity=0.074 Sum_probs=132.9
Q ss_pred hhcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHH---------HHHHHHHHHhcCCCceeeeeceecC--
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ---------FLQELEVLSKIRHPHLLLLLGACPD-- 522 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~---------~~~Ei~iL~~l~HpnIv~l~g~~~~-- 522 (810)
..++|...+.||.|+||.||+....+..+|||++.......... +.+|+..+.++.||+|..+..++.+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46789999999999999999987777799999998654433322 5789999999999999988776431
Q ss_pred --------CCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 523 --------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 523 --------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
..+|||||++|.+|.++.. ++. ....+++.+|..||..| ++||||||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 2489999999999988631 222 34569999999999999 99999999999999988 9
Q ss_pred EEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656 (810)
Q Consensus 595 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt 656 (810)
+|+|||........... ..+.....+..++|+|+||+++..+..
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988755322110 013344456679999999999876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-21 Score=219.53 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=179.6
Q ss_pred CcccceeeccCCcEEEEEEEECCeEEEEEEEcccC-ccchHHHHHHHHH--HHhcCCCceeeeeceecCCC--eEEEEec
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG-NIQNKQFLQELEV--LSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~-~~~~~~~~~Ei~i--L~~l~HpnIv~l~g~~~~~~--~lV~Ey~ 531 (810)
+|...+-||.+.|=.|.+|.++...|+||++-+.. ......|.+++.- ...++|||.+++.-+-.... |||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 56667789999999999999998889999987665 3444445444333 44458999999877643333 8888998
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc--CCCC
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML--NSDP 609 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~--~~~~ 609 (810)
. -+|.|+|..+ +-+...+...|+.|++.||..+|..| |+|||||.+||||+.-.-+.|+||..-+.. +.+.
T Consensus 104 k-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 K-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 6 4899988543 34677788899999999999999999 999999999999999889999999876532 2222
Q ss_pred CcccccccccCCccCccccCccccccC----------C-CCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc-cchh
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTG----------L-ISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID-EDNL 676 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------~-~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~-~~~l 676 (810)
+. ...|-......-.+|+|||.+... . ++++.||||+||++.||++ |+|||.+.+.....-. ....
T Consensus 177 Pa-df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 PA-DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred cc-cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 21 112222223455789999965431 2 6889999999999999998 7999986655443222 1111
Q ss_pred HHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 677 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 677 ~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
..++.. -....+..|+..|++.||..|-++.+.+
T Consensus 256 e~~Le~-------Ied~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 256 EQLLEK-------IEDVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred HHHHHh-------CcCccHHHHHHHHHccCchhccCHHHHH
Confidence 222221 1134789999999999999999998643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=184.47 Aligned_cols=138 Identities=17% Similarity=0.181 Sum_probs=106.9
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEcccCcc--c-------hHH-----------------HHHHHHHHHhcCCCcee
Q 003576 462 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI--Q-------NKQ-----------------FLQELEVLSKIRHPHLL 514 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~iL~~l~HpnIv 514 (810)
..||+|+||.||+|... +..||||+++..... . ... ...|+.+|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46999999999999874 779999998764221 1 112 23599999999877664
Q ss_pred eeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCEEecCCCCCceEecCCCc
Q 003576 515 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL-HNTKPKPIIHRDMKPGNILLDHNLV 593 (810)
Q Consensus 515 ~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivHrDLkp~NILld~~~~ 593 (810)
..........+|||||++|++|...+... .+++...+..++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 33322333458999999988776543322 2488889999999999999999 6888 99999999999998 478
Q ss_pred eEEeeeccccccC
Q 003576 594 SKIGDVGLSTMLN 606 (810)
Q Consensus 594 ~kL~DFGla~~~~ 606 (810)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-20 Score=181.66 Aligned_cols=189 Identities=15% Similarity=0.084 Sum_probs=140.3
Q ss_pred ccceeeccCCcEEEEEEEECCeEEEEEEEcccCccc----hHHHHHHHHHHHhcC-CCceeeeeceecCCCeEEEEeccC
Q 003576 459 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ----NKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYMEN 533 (810)
Q Consensus 459 ~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~----~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~~lV~Ey~~~ 533 (810)
.....|++|+||+||.+...+..++.+.+....... ...|.+|+++|++|. |+++++++++ +..+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 345679999999999988888888877766543311 225789999999995 5889999886 445999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCC-CCCceEecCCCceEEeeeccccccCCCCCcc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM-KPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL-kp~NILld~~~~~kL~DFGla~~~~~~~~~~ 612 (810)
.+|...+.. ....++.+++.+|.+||..| |+|||| ||+|||++.++.++|+|||++..........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 998654311 11357789999999999999 999999 7999999999999999999998655432110
Q ss_pred ---c----ccccccCCccCccccCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCcc
Q 003576 613 ---S----TTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 613 ---~----~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
. ..........++.|++|+...- ..--...++++.|+.+|.++|+..++.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0000011246788888884322 222257799999999999999998764
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=172.50 Aligned_cols=138 Identities=16% Similarity=0.118 Sum_probs=107.9
Q ss_pred CceEEEEecCCc--chHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHH
Q 003576 14 ALSVAVAVKGNR--KSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEE 91 (810)
Q Consensus 14 ~~~VlVaVDgs~--~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 91 (810)
+++||||||||+ .|.+|++||+..+.. .+ .|+||||+++...... .. .. ...+.+.+..
T Consensus 2 ~~~ILv~vD~S~~~~s~~al~~A~~la~~-~~-~l~llhv~~~~~~~~~----------~~-~~------~~~~~~~~~~ 62 (142)
T PRK15456 2 YKTIIMPVDVFEMELSDKAVRHAEFLAQD-DG-VIHLLHVLPGSASLSL----------HR-FA------ADVRRFEEHL 62 (142)
T ss_pred CccEEEeccCCchhHHHHHHHHHHHHHhc-CC-eEEEEEEecCcccccc----------cc-cc------cchhhHHHHH
Confidence 689999999994 899999999986544 44 6999999976432110 00 00 0112344556
Q ss_pred HHHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-Ccc
Q 003576 92 KWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFC 170 (810)
Q Consensus 92 ~~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~c 170 (810)
++.+++.|..+.+.+...+++++..+.. |+|++.|+++|+++++|+||||+||++ +.+.++||++.++++ ++|
T Consensus 63 ~~~~~~~l~~~~~~~~~~~~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~-----~~~~llGS~a~~v~~~a~~ 136 (142)
T PRK15456 63 QHEAEERLQTMVSHFTIDPSRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPS-----ISTHLLGSNASSVIRHANL 136 (142)
T ss_pred HHHHHHHHHHHHHHhCCCCcceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCC-----ccceecCccHHHHHHcCCC
Confidence 6677778888887776667888888887 999999999999999999999999965 345789999999999 999
Q ss_pred eEEEEe
Q 003576 171 TVYGVE 176 (810)
Q Consensus 171 pV~vV~ 176 (810)
||+||+
T Consensus 137 pVLvV~ 142 (142)
T PRK15456 137 PVLVVR 142 (142)
T ss_pred CEEEeC
Confidence 999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=179.21 Aligned_cols=140 Identities=19% Similarity=0.142 Sum_probs=110.2
Q ss_pred ceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccc--------------------------hHHHHHHHHHHHhcCCCce
Q 003576 461 NLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQ--------------------------NKQFLQELEVLSKIRHPHL 513 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~--------------------------~~~~~~Ei~iL~~l~HpnI 513 (810)
...||+|+||.||+|.+. ++.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999875 7899999988653210 1123578999999999987
Q ss_pred eeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCCC
Q 003576 514 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL 592 (810)
Q Consensus 514 v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~~ 592 (810)
.....+.....+|||||++|+++....... ..++......++.+++.+|.+||. .| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 544333334569999999988654432222 236778899999999999999999 88 99999999999999 88
Q ss_pred ceEEeeeccccccCC
Q 003576 593 VSKIGDVGLSTMLNS 607 (810)
Q Consensus 593 ~~kL~DFGla~~~~~ 607 (810)
.++|+|||++...+.
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=207.60 Aligned_cols=222 Identities=24% Similarity=0.252 Sum_probs=180.6
Q ss_pred eccCCcEEEEEE-----EECCeEEEEEEEcccCccc--hHHHHHHHHHHHhcC-CCceeeeeceecCCC--eEEEEeccC
Q 003576 464 IGMGGYGTVYKG-----TFHHTFAAVKVLQSKGNIQ--NKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMEN 533 (810)
Q Consensus 464 LG~G~~g~Vy~~-----~~~~~~vavK~l~~~~~~~--~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~lV~Ey~~~ 533 (810)
+|.|.||.|+++ .+.+..+|+|++++..... ......|..++..++ ||.+|++..++.... +++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999974 3446688999887653221 124566888888887 999999998886554 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccc
Q 003576 534 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 613 (810)
Q Consensus 534 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~ 613 (810)
|.|...+..... +.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999887755433 666777788899999999999999 9999999999999999999999999998765432
Q ss_pred ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHH
Q 003576 614 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693 (810)
Q Consensus 614 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 693 (810)
..+||..|||||++. ......|+||||+++++|+||..||.. .....+-......|...+.
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccCCchhhhH
Confidence 118999999999988 567899999999999999999999964 1222333334567888899
Q ss_pred HHHHHHHHHhhhcCCCCCccc
Q 003576 694 ELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 694 ~l~~Li~~cl~~dP~~RPs~~ 714 (810)
.+.+++..++..+|..|-...
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 999999999999999997764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=217.58 Aligned_cols=248 Identities=18% Similarity=0.250 Sum_probs=176.2
Q ss_pred cceeeccCCcEEEEEEEEC--CeEEEEEEEccc--Cccch----HHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEE
Q 003576 460 ENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQN----KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~--~~~~~----~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~E 529 (810)
....+|.|.+|.|+..... ...++.|..... ..... ..+..|+-+-..+.|||++..+..+.+.. .-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567999999977766542 223333332210 11111 12556777778889999988877765443 34599
Q ss_pred eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCC
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~ 609 (810)
||++ +|..++.... .+...++..++.|++.|+.|||..| |.||||||+|+|++.+|.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9998 9999887652 2667788899999999999999999 9999999999999999999999999997655332
Q ss_pred CcccccccccCCccCccccCccccccCCCCC-cchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCC--
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISP-KSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD-- 686 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~-- 686 (810)
. .......+.+|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......+..........-.....+.
T Consensus 475 e--~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 475 E--KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred c--hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 1 1123445779999999999999888876 5799999999999999999997554433221000000000000011
Q ss_pred CChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 687 ~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
.-...+.....++.++|+++|.+|.++.++
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 112346677899999999999999999853
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=167.54 Aligned_cols=140 Identities=14% Similarity=0.115 Sum_probs=105.1
Q ss_pred CceEEEEecCCcc--hHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHH
Q 003576 14 ALSVAVAVKGNRK--SRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEE 91 (810)
Q Consensus 14 ~~~VlVaVDgs~~--S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 91 (810)
+++||||||||+. +.+|++||++.+...+. .|+|+||+++.+.... .+.. ..... . .....
T Consensus 2 ~~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~-~l~ll~v~~~~~~~~~---------~~~~-~~~~~--~----~~~~~ 64 (144)
T PRK15005 2 NRTILVPIDISDSELTQRVISHVEAEAKIDDA-EVHFLTVIPSLPYYAS---------LGLA-YSAEL--P----AMDDL 64 (144)
T ss_pred CccEEEecCCCchhHHHHHHHHHHHHHhccCC-eEEEEEEEccCccccc---------cccc-ccccc--h----HHHHH
Confidence 6899999999988 57999999997766555 5999999976432111 0000 00000 0 11233
Q ss_pred HHHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-Ccc
Q 003576 92 KWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFC 170 (810)
Q Consensus 92 ~~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~c 170 (810)
++.+++.|..+...+...+++++..+.. |+|++.|+++|+++++|+||||+| ++ ++.+.++||++.++++ ++|
T Consensus 65 ~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~-~~----~~~~~llGS~a~~vl~~a~c 138 (144)
T PRK15005 65 KAEAKSQLEEIIKKFKLPTDRVHVHVEE-GSPKDRILELAKKIPADMIIIASH-RP----DITTYLLGSNAAAVVRHAEC 138 (144)
T ss_pred HHHHHHHHHHHHHHhCCCCCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCC-CC----CchheeecchHHHHHHhCCC
Confidence 4455566677766666677888888887 999999999999999999999999 45 5677899999999999 999
Q ss_pred eEEEEe
Q 003576 171 TVYGVE 176 (810)
Q Consensus 171 pV~vV~ 176 (810)
||+||+
T Consensus 139 pVlvVr 144 (144)
T PRK15005 139 SVLVVR 144 (144)
T ss_pred CEEEeC
Confidence 999985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-18 Score=178.93 Aligned_cols=229 Identities=19% Similarity=0.249 Sum_probs=145.6
Q ss_pred cccceeeccCCcEEEEEEEECC--eEEEEEEEcccCc---cchHHHHHHHHHHHhcCC----------Cc------eeee
Q 003576 458 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRH----------PH------LLLL 516 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~--~~vavK~l~~~~~---~~~~~~~~Ei~iL~~l~H----------pn------Iv~l 516 (810)
+.....||.|+|+.||.+++.. ..+|+|+...... ...+++.+|.-....+.+ -. ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556789999999999999975 6999998765432 233556666544444322 11 1111
Q ss_pred ece---e---c-------CCCeEEEEeccCCCHHHHHh---hcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEec
Q 003576 517 LGA---C---P-------DHGCLVYEYMENGSLEDRLY---RKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579 (810)
Q Consensus 517 ~g~---~---~-------~~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHr 579 (810)
-+- + . -+.+++|+-+ .++|.+++. ..... ..+....+..+..|++..+++||..| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 110 0 1 0125677777 478888754 22221 22344455677799999999999999 9999
Q ss_pred CCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCcccccc--------CCCCCcchhhhHHHHH
Q 003576 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--------GLISPKSDVYAYGMVI 651 (810)
Q Consensus 580 DLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~sDVwSlGvil 651 (810)
||+|+|+|++.+|.++|+||+.....+.... ....+..|.+||.... -.++.+.|.|+||+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee---------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999999999998776543111 0244577999996533 2478899999999999
Q ss_pred HHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCC
Q 003576 652 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDR 710 (810)
Q Consensus 652 ~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~R 710 (810)
|.|++|..||+.......... ....+. ..+..++.||..+|+.||.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~~~----------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADPEW----------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTSGG----------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccccc----------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999985533221100 112334 678899999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=172.51 Aligned_cols=135 Identities=16% Similarity=0.224 Sum_probs=105.1
Q ss_pred cccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhc-----CCCceeeeeceecCCC---e---E
Q 003576 458 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-----RHPHLLLLLGACPDHG---C---L 526 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~g~~~~~~---~---l 526 (810)
......||+|+||.||.-... ...+||++........+.+.+|+.++..+ .||||++++|++.+.. + +
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCC-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 345568999999999962222 23478988765444567799999999999 5799999999997652 3 6
Q ss_pred EEEe--ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCEEecCCCCCceEecC----CCceEEeee
Q 003576 527 VYEY--MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL-AFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDV 599 (810)
Q Consensus 527 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~ivHrDLkp~NILld~----~~~~kL~DF 599 (810)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ .|||+++ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999553 14444 35678888888 8999999 999999999999974 348999995
Q ss_pred ccc
Q 003576 600 GLS 602 (810)
Q Consensus 600 Gla 602 (810)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.9e-18 Score=188.83 Aligned_cols=205 Identities=24% Similarity=0.425 Sum_probs=152.4
Q ss_pred HHhcCCCceeeeeceecCCC--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCE-EecCC
Q 003576 505 LSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI-IHRDM 581 (810)
Q Consensus 505 L~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i-vHrDL 581 (810)
|+.+.|.|+.+++|.+.+.. ++|.+||..|+|.|.+.... ..+++.-...++.+|+.||.|||... | .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 45688999999999997665 78999999999999997643 34889999999999999999999976 4 99999
Q ss_pred CCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccC-------CCCCcchhhhHHHHHHHH
Q 003576 582 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-------LISPKSDVYAYGMVILQL 654 (810)
Q Consensus 582 kp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~sDVwSlGvil~eL 654 (810)
++.|.++|..+.+||+|||+........... ......-...|.|||.+... ..+.+.||||||++++|+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~----~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPE----AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccccccc----ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999988765311000 01112345679999987653 146789999999999999
Q ss_pred HhCCCCccccchhhhhhccchhHHHhh-hh---CCCCC-h-hHHHHHHHHHHHHhhhcCCCCCccccchhhHH
Q 003576 655 LTAKPAIAITHKVETAIDEDNLAEILD-AQ---AGDWP-I-KETKELAALGLSCAELRRKDRPDLKNQVLPVL 721 (810)
Q Consensus 655 ltg~~Pf~~~~~~~~~~~~~~l~~~ld-~~---~~~~p-~-~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~~L 721 (810)
++...||......... .+.+..+.+ .. .+... . ...+.+..++..||..+|.+||++.+ +-..+
T Consensus 152 ~~r~~~~~~~~~~~~~--~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~-i~~~~ 221 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDP--DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ-IRSKL 221 (484)
T ss_pred HhccCccccccccCCh--HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH-HHhhh
Confidence 9999999854433322 111122222 11 11111 1 33447999999999999999999983 43333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=174.22 Aligned_cols=200 Identities=19% Similarity=0.219 Sum_probs=144.1
Q ss_pred CCCceeeeeceecCC-----------------------------CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q 003576 509 RHPHLLLLLGACPDH-----------------------------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559 (810)
Q Consensus 509 ~HpnIv~l~g~~~~~-----------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 559 (810)
+|||||.++++|.+. .|+||..++ .+|..++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999987321 178888775 68999886544 45567778999
Q ss_pred HHHHHHHHHhhcCCCCEEecCCCCCceEe--cCCC--ceEEeeeccccccCCCCCcccccccccCCccCccccCcccccc
Q 003576 560 EVASALAFLHNTKPKPIIHRDMKPGNILL--DHNL--VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635 (810)
Q Consensus 560 qia~aL~~LH~~~~~~ivHrDLkp~NILl--d~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 635 (810)
|++.|+.|||.+| |.|||||.+|||| |+++ .+.|+|||+|--.....-........-..-|.-..||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999998 4443 5688999987543321111111112223467888999998764
Q ss_pred CC------CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCC
Q 003576 636 GL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKD 709 (810)
Q Consensus 636 ~~------~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~ 709 (810)
.+ .-.++|.|+.|.+.||+++...||....... ++.. ..-....+..|..+++.+.+|+...|+.||++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r---~Yqe~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTR---TYQESQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echh---hhhhhhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 33 1248999999999999999999997422111 1111 12223345667788999999999999999999
Q ss_pred CCccccchhhHHH
Q 003576 710 RPDLKNQVLPVLE 722 (810)
Q Consensus 710 RPs~~~~v~~~L~ 722 (810)
|++.. +...+|+
T Consensus 501 Rvsp~-iAANvl~ 512 (598)
T KOG4158|consen 501 RVSPN-IAANVLN 512 (598)
T ss_pred cCCcc-HHHhHHH
Confidence 99987 4554443
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=161.98 Aligned_cols=136 Identities=15% Similarity=0.163 Sum_probs=100.7
Q ss_pred CceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHH
Q 003576 14 ALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKW 93 (810)
Q Consensus 14 ~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 93 (810)
+++||||||||+.|.+|+++|+..+...++ +|+|+||.++.+.... +..++. .+...+..++
T Consensus 3 ~k~ILvavD~S~~s~~al~~A~~lA~~~~a-~l~llhV~~~~~~~~~----------~~~~~~-------~~~~~~~~~~ 64 (142)
T PRK09982 3 YKHIGVAISGNEEDALLVNKALELARHNDA-HLTLIHIDDGLSELYP----------GIYFPA-------TEDILQLLKN 64 (142)
T ss_pred ceEEEEEecCCcchHHHHHHHHHHHHHhCC-eEEEEEEccCcchhch----------hhhccc-------hHHHHHHHHH
Confidence 689999999999999999999997765544 6999999876432100 000010 1123344455
Q ss_pred HHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-CcceE
Q 003576 94 KTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTV 172 (810)
Q Consensus 94 ~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cpV 172 (810)
.+++.+.++...+.. ..++..+.. |+|++.|+++|++.++|+||||+| ++ ++.+++ | ++.++++ +.|||
T Consensus 65 ~~~~~l~~~~~~~~~--~~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~----~~~~~~-~-va~~V~~~s~~pV 134 (142)
T PRK09982 65 KSDNKLYKLTKNIQW--PKTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HS----FINRLM-P-AYRGMINKMSADL 134 (142)
T ss_pred HHHHHHHHHHHhcCC--CcceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hh----HHHHHH-H-HHHHHHhcCCCCE
Confidence 566677777665543 345666666 999999999999999999999986 77 566655 5 9999999 99999
Q ss_pred EEEec
Q 003576 173 YGVEK 177 (810)
Q Consensus 173 ~vV~~ 177 (810)
+||+.
T Consensus 135 Lvv~~ 139 (142)
T PRK09982 135 LIVPF 139 (142)
T ss_pred EEecC
Confidence 99975
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.2e-18 Score=161.09 Aligned_cols=137 Identities=15% Similarity=0.155 Sum_probs=95.6
Q ss_pred CCceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHH
Q 003576 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEK 92 (810)
Q Consensus 13 ~~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 92 (810)
.+++||||+|+|+.|..||+||+..+...++ .|+|+||..+.... .. ...+ .....+.+...
T Consensus 2 ~~~~ILvavD~S~~s~~al~~a~~la~~~~a-~l~ll~v~~~~~~~-~~----------~~~~------~~~~~~~~~~~ 63 (144)
T PRK15118 2 AYKHILIAVDLSPESKVLVEKAVSMARPYNA-KVSLIHVDVNYSDL-YT----------GLID------VNLGDMQKRIS 63 (144)
T ss_pred CceEEEEEccCChhHHHHHHHHHHHHHhhCC-EEEEEEEccChhhh-hh----------hhhh------cchHHHHHHHH
Confidence 4789999999999999999999997665544 69999994332110 00 0000 00112223333
Q ss_pred HHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-Ccce
Q 003576 93 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCT 171 (810)
Q Consensus 93 ~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cp 171 (810)
+...+.+.. ++...|+.+...++..|+|+++|+++|+++++|+||||+|| + .+.. +||++.++++ ++||
T Consensus 64 ~~~~~~l~~---~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~----~~~~--lgSva~~v~~~a~~p 133 (144)
T PRK15118 64 EETHHALTE---LSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-D----FWSK--LMSSARQLINTVHVD 133 (144)
T ss_pred HHHHHHHHH---HHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-c----HHHH--HHHHHHHHHhhCCCC
Confidence 334444443 34456777655555459999999999999999999999996 3 2332 5799999999 9999
Q ss_pred EEEEec
Q 003576 172 VYGVEK 177 (810)
Q Consensus 172 V~vV~~ 177 (810)
|+||+.
T Consensus 134 VLvv~~ 139 (144)
T PRK15118 134 MLIVPL 139 (144)
T ss_pred EEEecC
Confidence 999985
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=196.39 Aligned_cols=197 Identities=24% Similarity=0.283 Sum_probs=153.6
Q ss_pred HHHHhhcCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccchHHHHHHHHHHHhcC---CCceeeeece--ecCC
Q 003576 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR---HPHLLLLLGA--CPDH 523 (810)
Q Consensus 450 ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~--~~~~ 523 (810)
+++.....|.+...||+|+||.||+|... +..||+|+-++..... |.-=.+++.+|+ -+.|..+..+ |.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 44455567888999999999999999874 6799999987665432 222234455555 1223333332 4667
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec-------CCCceEE
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-------HNLVSKI 596 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld-------~~~~~kL 596 (810)
.+||+||.+.|+|.+++. ....++|..+..++.|++..++.||..+ ||||||||+|+||. ++.-++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 799999999999999987 3445999999999999999999999999 99999999999993 2456899
Q ss_pred eeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 003576 597 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659 (810)
Q Consensus 597 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~ 659 (810)
+|||.+.-+.--... .+....++|-.+-.+|+..+..++...|.|.|+-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDG----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCC----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999998654422211 23345688999999999999999999999999999999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.5e-18 Score=194.67 Aligned_cols=213 Identities=23% Similarity=0.301 Sum_probs=148.8
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCCeEEEEec
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYM 531 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~~lV~Ey~ 531 (810)
...+|...+.|..|+||.||.++++ .+.+|+|+-+. ... +.+ ||.....|. .|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~li----lRn---ilt~a~npf-------------vv---- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLI----LRN---ILTFAGNPF-------------VV---- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccccc-chh----hhc---cccccCCcc-------------ee----
Confidence 4568999999999999999999887 45788854322 111 111 222223333 33
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCC-
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS- 610 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~- 610 (810)
|+-...+..- ++++. +++.+++|||+.+ |+|||+||+|+||+.-|++|++|||+++.......
T Consensus 136 --gDc~tllk~~---g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKNI---GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcccC---CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3444434322 23433 2388999999999 99999999999999999999999999875432111
Q ss_pred --------cccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhh
Q 003576 611 --------FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 611 --------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
.....+.....+||+.|+|||++....|+..+|+|++|+|+|+.+.|..||+....-+. +..++ .
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~vi-s 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVI-S 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhh-h
Confidence 11223334566999999999999989999999999999999999999999975432111 11111 1
Q ss_pred hCCCCCh---hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 683 QAGDWPI---KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 683 ~~~~~p~---~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
....||. ...+++++++.+.|+.+|..|--..
T Consensus 273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 1223332 4578999999999999999995543
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=151.00 Aligned_cols=131 Identities=15% Similarity=0.140 Sum_probs=108.4
Q ss_pred eEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHHHH
Q 003576 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKT 95 (810)
Q Consensus 16 ~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 95 (810)
+|+||||+++.+..||+||...+... +..|+++||++++.... + . ......+..
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~-~~~v~ll~v~~~~~~~~---------------~----~------~~~~~~~~~ 54 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQ-NGEIIPLNVIEVPNHSS---------------P----S------QLEVNVQRA 54 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcC-CCeEEEEEEEecCCCCC---------------c----c------hhHHHHHHH
Confidence 59999999999999999999977654 44699999998643210 0 0 011223456
Q ss_pred hhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-CcceEEE
Q 003576 96 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYG 174 (810)
Q Consensus 96 ~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cpV~v 174 (810)
++.+..+...+...|++++..+..+|+|+++|+++++++++|+||||+++++ .+.+.++||++.++++ ++|||+|
T Consensus 55 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~----~~~~~~lGs~~~~v~~~~~~pvlv 130 (132)
T cd01988 55 RKLLRQAERIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGST----SLRDRLFGGVIDQVLESAPCDVAV 130 (132)
T ss_pred HHHHHHHHHHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCC----CccceecCchHHHHHhcCCCCEEE
Confidence 7788888888888999999888877899999999999999999999999999 6677889999999999 9999999
Q ss_pred Ee
Q 003576 175 VE 176 (810)
Q Consensus 175 V~ 176 (810)
|+
T Consensus 131 v~ 132 (132)
T cd01988 131 VK 132 (132)
T ss_pred eC
Confidence 85
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=163.79 Aligned_cols=132 Identities=23% Similarity=0.319 Sum_probs=109.5
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCcc--------chHHHHHHHHHHHhcCCCceeeeece--ecCCCeEEEEec
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--------QNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYM 531 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~--------~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~~~lV~Ey~ 531 (810)
..||+|++|.||+|.+.+..+++|+....... ....+.+|+.++..+.|+++.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46999999999999998889999987653321 12457889999999999887654444 455568999999
Q ss_pred cCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
+|++|.+++.... . .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885421 2 77899999999999999998 99999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.1e-17 Score=162.91 Aligned_cols=128 Identities=25% Similarity=0.362 Sum_probs=105.5
Q ss_pred eeccCCcEEEEEEEECCeEEEEEEEcccCcc--------chHHHHHHHHHHHhcCCCce--eeeeceecCCCeEEEEecc
Q 003576 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--------QNKQFLQELEVLSKIRHPHL--LLLLGACPDHGCLVYEYME 532 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~--------~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~~~lV~Ey~~ 532 (810)
.||+|+||.||+|.+.+..+++|+....... ...++.+|+.++..+.|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999999999999986543211 12557789999999987754 4555555666699999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
|++|.+++.... ..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998774321 078999999999999998 99999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=164.94 Aligned_cols=142 Identities=18% Similarity=0.150 Sum_probs=109.6
Q ss_pred CcccceeeccCCcEEEEEEE-E--CCeEEEEEEEcccCcc------------------------chHHHHHHHHHHHhcC
Q 003576 457 SFSENLRIGMGGYGTVYKGT-F--HHTFAAVKVLQSKGNI------------------------QNKQFLQELEVLSKIR 509 (810)
Q Consensus 457 ~f~~~~~LG~G~~g~Vy~~~-~--~~~~vavK~l~~~~~~------------------------~~~~~~~Ei~iL~~l~ 509 (810)
.|.....||+|+||.||+|. . .+..||+|++...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37778899999999999998 3 4679999998754210 0123568999999997
Q ss_pred CC--ceeeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceE
Q 003576 510 HP--HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587 (810)
Q Consensus 510 Hp--nIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NIL 587 (810)
+. .+.+++++ ...+|||||++|++|...+... ..+.......++.||+.+|.+||..+ .|+||||||+|||
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 53 34455543 2458999999998887654222 23555667899999999999999976 3999999999999
Q ss_pred ecCCCceEEeeeccccccC
Q 003576 588 LDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 588 ld~~~~~kL~DFGla~~~~ 606 (810)
++ ++.++|+|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=182.42 Aligned_cols=173 Identities=29% Similarity=0.391 Sum_probs=135.9
Q ss_pred CeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.|+.|++|.-.+|.++|.+.......++.....++.|++.|+.| .+ .+|+|+||.||++..+..+||+|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhee
Confidence 47899999999999999876666668888999999999999999 66 9999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhccchhHHHhhh
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA 682 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLlt-g~~Pf~~~~~~~~~~~~~~l~~~ld~ 682 (810)
...............+...||..||+||.+.+..|+.++||||||+||+||++ -..+|. ....+. +.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~---d~ 472 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLT---DI 472 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhh---hh
Confidence 77665533333344567799999999999999999999999999999999998 222221 111111 22
Q ss_pred hCCCCCh---hHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 683 QAGDWPI---KETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 683 ~~~~~p~---~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
..+.+|+ ..-+.-..|+.+++.+.|.+||++.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 2244442 2234556899999999999999543
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=147.02 Aligned_cols=121 Identities=17% Similarity=0.140 Sum_probs=97.8
Q ss_pred eEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHHHH
Q 003576 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKT 95 (810)
Q Consensus 16 ~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 95 (810)
+|+||||+|+.+..|++||+..+...+. .|++|||.++... . ..+++
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~-~l~ll~v~~~~~~-----------------~---------------~~~~~ 47 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKA-PWYVVYVETPRLN-----------------R---------------LSEAE 47 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCC-CEEEEEEecCccc-----------------c---------------CCHHH
Confidence 5999999999999999999997766555 5999999865211 0 00123
Q ss_pred hhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-C-cceEE
Q 003576 96 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-S-FCTVY 173 (810)
Q Consensus 96 ~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~-~cpV~ 173 (810)
++.++.+.+.++..+++ ..++.+|+++++|+++++++++|+||||+++++ .+.++++||++.++++ + +|||+
T Consensus 48 ~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~----~~~~~~~Gs~~~~v~~~a~~~~v~ 121 (124)
T cd01987 48 RRRLAEALRLAEELGAE--VVTLPGDDVAEAIVEFAREHNVTQIVVGKSRRS----RWRELFRGSLVDRLLRRAGNIDVH 121 (124)
T ss_pred HHHHHHHHHHHHHcCCE--EEEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCc----hHHHHhcccHHHHHHHhCCCCeEE
Confidence 45566677777666654 445556899999999999999999999999999 8888999999999999 8 99999
Q ss_pred EE
Q 003576 174 GV 175 (810)
Q Consensus 174 vV 175 (810)
|+
T Consensus 122 v~ 123 (124)
T cd01987 122 IV 123 (124)
T ss_pred Ee
Confidence 97
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=183.93 Aligned_cols=142 Identities=23% Similarity=0.314 Sum_probs=113.1
Q ss_pred HHHHHHhhcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccC-c-------cchHHHHHHHHHHHhcCCCceeeeece
Q 003576 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG-N-------IQNKQFLQELEVLSKIRHPHLLLLLGA 519 (810)
Q Consensus 448 ~~ei~~~~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~-~-------~~~~~~~~Ei~iL~~l~HpnIv~l~g~ 519 (810)
|.........|...+.||+|+||.||+|.+.+..+++|+..... . .....+.+|+.++..++|++++..+.+
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 33334445556678899999999999999887766666543221 1 123568899999999999998776555
Q ss_pred e--cCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEe
Q 003576 520 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 597 (810)
Q Consensus 520 ~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~ 597 (810)
+ .+..++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 4 345699999999999999874 34678999999999999999 9999999999999 67799999
Q ss_pred eeccccc
Q 003576 598 DVGLSTM 604 (810)
Q Consensus 598 DFGla~~ 604 (810)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.4e-16 Score=157.90 Aligned_cols=140 Identities=18% Similarity=0.097 Sum_probs=109.1
Q ss_pred hhcCcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCcc----------------------chHHHHHHHHHHHhcCC
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI----------------------QNKQFLQELEVLSKIRH 510 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~----------------------~~~~~~~Ei~iL~~l~H 510 (810)
....|.....||.|+||.||++... +..||||++...... ....+..|+.++..+.|
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 3334777788999999999999884 779999987643210 11235778999999987
Q ss_pred C--ceeeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEe
Q 003576 511 P--HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 511 p--nIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILl 588 (810)
+ +++..++. ...++||||++|++|...... .....++.+++.++.++|..+ |+||||||+||++
T Consensus 93 ~~i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 93 EGFPVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred cCCCCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 7 44455543 344899999999999775421 234678899999999999988 9999999999999
Q ss_pred cCCCceEEeeeccccccCC
Q 003576 589 DHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 589 d~~~~~kL~DFGla~~~~~ 607 (810)
+.++.++|+|||++..+..
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999976553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.3e-16 Score=148.38 Aligned_cols=137 Identities=12% Similarity=0.098 Sum_probs=101.5
Q ss_pred CCceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHH
Q 003576 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEK 92 (810)
Q Consensus 13 ~~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 92 (810)
++++|+||+|+|+.+..||++|+..+...+. .++++||++++.... . ......+.+.+..+
T Consensus 2 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a-~l~ll~v~~~~~~~~-~-----------------~~~~~~~~~~~~~~ 62 (142)
T PRK10116 2 SYSNILVAVAVTPESQQLLAKAVSIARPVNG-KISLITLASDPEMYN-Q-----------------FAAPMLEDLRSVMQ 62 (142)
T ss_pred CCceEEEEccCCcchHHHHHHHHHHHHHhCC-EEEEEEEccCcccch-h-----------------hhHHHHHHHHHHHH
Confidence 4789999999999999999999997765554 699999986632210 0 11112233444444
Q ss_pred HHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-Ccce
Q 003576 93 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCT 171 (810)
Q Consensus 93 ~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cp 171 (810)
+++++.|..+ +.+.|+..+..++..|++.+.|+++|++.++|+||||+|+++ .+.+++ |++.+++. ++||
T Consensus 63 ~~~~~~l~~~---~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~----~~~~~~--s~a~~v~~~~~~p 133 (142)
T PRK10116 63 EETQSFLDKL---IQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHS----FFSRAS--CSAKRVIASSEVD 133 (142)
T ss_pred HHHHHHHHHH---HHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcch----HHHHHH--HHHHHHHhcCCCC
Confidence 4555555544 345677666555555999999999999999999999999998 555543 78999999 9999
Q ss_pred EEEEec
Q 003576 172 VYGVEK 177 (810)
Q Consensus 172 V~vV~~ 177 (810)
|+||+-
T Consensus 134 VLvv~~ 139 (142)
T PRK10116 134 VLLVPL 139 (142)
T ss_pred EEEEeC
Confidence 999973
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=146.41 Aligned_cols=138 Identities=25% Similarity=0.264 Sum_probs=98.4
Q ss_pred CceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHH
Q 003576 14 ALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKW 93 (810)
Q Consensus 14 ~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 93 (810)
+++|+||+|+++.+..|++||+.++...++ .|+++||.+........ ..............
T Consensus 2 ~~~Ilv~~d~~~~~~~al~~a~~la~~~~~-~i~~l~v~~~~~~~~~~----------------~~~~~~~~~~~~~~-- 62 (140)
T PF00582_consen 2 YKRILVAIDGSEESRRALRFALELAKRSGA-EITLLHVIPPPPQYSFS----------------AAEDEESEEEAEEE-- 62 (140)
T ss_dssp TSEEEEEESSSHHHHHHHHHHHHHHHHHTC-EEEEEEEEESCHCHHHH----------------HHHHHHHHHHHHHH--
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHhhCC-eEEEEEeeccccccccc----------------cccccccccccchh--
Confidence 689999999999999999999997776555 69999999874321100 00000000010000
Q ss_pred HHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-CcceE
Q 003576 94 KTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTV 172 (810)
Q Consensus 94 ~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cpV 172 (810)
..........+...+.......+..|+++++|++++++.++|+||||+++++ ++.++++||++.+++. ++|||
T Consensus 63 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~----~~~~~~~gs~~~~l~~~~~~pV 136 (140)
T PF00582_consen 63 --EQARQAEAEEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRS----GLERLLFGSVAEKLLRHAPCPV 136 (140)
T ss_dssp --HHHHHHHHHHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTT----STTTSSSHHHHHHHHHHTSSEE
T ss_pred --hhhhhHHHHHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCC----CccCCCcCCHHHHHHHcCCCCE
Confidence 0001111133444455555555556999999999999999999999999998 8888999999999999 99999
Q ss_pred EEEe
Q 003576 173 YGVE 176 (810)
Q Consensus 173 ~vV~ 176 (810)
+||+
T Consensus 137 lvv~ 140 (140)
T PF00582_consen 137 LVVP 140 (140)
T ss_dssp EEEE
T ss_pred EEeC
Confidence 9986
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=162.42 Aligned_cols=144 Identities=14% Similarity=0.075 Sum_probs=111.9
Q ss_pred CceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHH
Q 003576 14 ALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKW 93 (810)
Q Consensus 14 ~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 93 (810)
+++||||+|+|+.+..|++||+..+...+. .++++||.++... +.+ .. ..........+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a-~l~ll~v~~~~~~-~~~----------~~-----~~~~~~~~~~~~~~~ 65 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGG-KITAFLPIYDFSY-EMT----------TL-----LSPDEREAMRQGVIS 65 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCC-CEEEEEeccCchh-hhh----------cc-----cchhHHHHHHHHHHH
Confidence 689999999999999999999997665555 5999999865321 110 00 111111222233334
Q ss_pred HHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-CcceE
Q 003576 94 KTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTV 172 (810)
Q Consensus 94 ~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cpV 172 (810)
..++.|+.+...+...|++++..+...|++.++|+++|.++++|+||||++|.+ ++.+.++||++.++++ ++|||
T Consensus 66 ~~~~~l~~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~----~~~~~~~gs~~~~l~~~~~~pv 141 (305)
T PRK11175 66 QRTAWIREQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHD----KLESVIFTPTDWHLLRKCPCPV 141 (305)
T ss_pred HHHHHHHHHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCc----HHHhhccChhHHHHHhcCCCCE
Confidence 456677777777777899999888765999999999999999999999999998 8888999999999999 99999
Q ss_pred EEEecC
Q 003576 173 YGVEKG 178 (810)
Q Consensus 173 ~vV~~~ 178 (810)
+||+.+
T Consensus 142 lvv~~~ 147 (305)
T PRK11175 142 LMVKDQ 147 (305)
T ss_pred EEeccc
Confidence 999874
|
|
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.2e-16 Score=130.87 Aligned_cols=68 Identities=43% Similarity=0.885 Sum_probs=59.8
Q ss_pred CCCCccCccccccccCCcccCCCcccchHHHHHHHhh-CCCCCCCCCCCCCCCCCccHHHHHHHHHHhh
Q 003576 742 PPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 809 (810)
Q Consensus 742 ~p~~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~-~~~sP~T~~~l~~~~l~pn~~l~~~~~~~~~ 809 (810)
.|..|.|||+.++|.||+++.+|+|||+.+|+.||.. +.+||+|+.++.+..|+||++||++|++|+.
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~ 69 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCA 69 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHH
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHH
Confidence 4789999999999999999999999999999999998 8999999999999999999999999999986
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=138.12 Aligned_cols=133 Identities=23% Similarity=0.223 Sum_probs=111.5
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCC--CceeeeeceecC--CCeEEEEeccCCC
Q 003576 460 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPD--HGCLVYEYMENGS 535 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~--~~~lV~Ey~~~gs 535 (810)
+...||.|+++.||++...+..+++|....... ...+.+|+.++..++| ++++++++++.. ..+++|||+.++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 346799999999999999888999999866543 5678999999999976 588888887765 4589999999887
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 536 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 536 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
+..+ +......++.+++.+|.+||.....+++|+||+|.|||++..+.++++|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7653 3456678899999999999986434599999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=145.90 Aligned_cols=136 Identities=18% Similarity=0.181 Sum_probs=97.7
Q ss_pred ceeeccCCcEEEEEEEEC-CeEEEEEEEcccCccc--hHH----------------------HHHHHHHHHhcCCCc--e
Q 003576 461 NLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQ--NKQ----------------------FLQELEVLSKIRHPH--L 513 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~--~~~----------------------~~~Ei~iL~~l~Hpn--I 513 (810)
.+.||+|+||.||+|.+. +..||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 356999999999999987 7799999987542211 111 135666666665433 3
Q ss_pred eeeeceecCCCeEEEEeccCCCHHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCceEecCC
Q 003576 514 LLLLGACPDHGCLVYEYMENGSLEDR-LYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHN 591 (810)
Q Consensus 514 v~l~g~~~~~~~lV~Ey~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLkp~NILld~~ 591 (810)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++ +
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 444443 345899999998544321 11111 11 4677899999999999999 88 99999999999999 8
Q ss_pred CceEEeeeccccccCC
Q 003576 592 LVSKIGDVGLSTMLNS 607 (810)
Q Consensus 592 ~~~kL~DFGla~~~~~ 607 (810)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.2e-14 Score=148.27 Aligned_cols=132 Identities=18% Similarity=0.200 Sum_probs=104.4
Q ss_pred eeec-cCCcEEEEEEEECCeEEEEEEEcccC-------------ccchHHHHHHHHHHHhcCCCce--eeeeceecCC--
Q 003576 462 LRIG-MGGYGTVYKGTFHHTFAAVKVLQSKG-------------NIQNKQFLQELEVLSKIRHPHL--LLLLGACPDH-- 523 (810)
Q Consensus 462 ~~LG-~G~~g~Vy~~~~~~~~vavK~l~~~~-------------~~~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~~~-- 523 (810)
..|| .||.|+||.+...+..++||.+.... ......+.+|+.++.+|+|++| +..++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4688 89999999999988899999875321 1223567889999999998775 6666654221
Q ss_pred ----CeEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEee
Q 003576 524 ----GCLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598 (810)
Q Consensus 524 ----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~D 598 (810)
.++||||++| .+|.+++... +++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++|+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 2599999997 6898887532 24443 3678999999999999 99999999999999999999999
Q ss_pred eccccc
Q 003576 599 VGLSTM 604 (810)
Q Consensus 599 FGla~~ 604 (810)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.3e-14 Score=153.34 Aligned_cols=144 Identities=12% Similarity=0.111 Sum_probs=100.7
Q ss_pred CCCceEEEEecCCcch-------HHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHH
Q 003576 12 SPALSVAVAVKGNRKS-------RYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVA 84 (810)
Q Consensus 12 ~~~~~VlVaVDgs~~S-------~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 84 (810)
..+++|+||+|+|+.+ ..|+++|+..+....+..|+||||++...... ... ++. .. .
T Consensus 150 ~~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~----------~~~-~~~--~~---~ 213 (305)
T PRK11175 150 PEGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINI----------AIE-LPE--FD---P 213 (305)
T ss_pred CCCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhc----------ccc-ccc--cc---h
Confidence 3578999999999753 68999999877655134599999987532110 000 010 01 1
Q ss_pred HHHHHHHHHHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCcccccc
Q 003576 85 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISI 164 (810)
Q Consensus 85 ~~~~~~~~~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~ 164 (810)
..+.+..++...+.+..+.. ..|+.....++..|+|+++|+++|++.++|+||||++|++ ++.++++||++.+
T Consensus 214 ~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~----~~~~~llGS~a~~ 286 (305)
T PRK11175 214 SVYNDAIRGQHLLAMKALRQ---KFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRT----GLSAAFLGNTAEH 286 (305)
T ss_pred hhHHHHHHHHHHHHHHHHHH---HhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccC----CCcceeecchHHH
Confidence 12233333333444444433 3456654344444999999999999999999999999999 8888999999999
Q ss_pred ccC-CcceEEEEecC
Q 003576 165 CVP-SFCTVYGVEKG 178 (810)
Q Consensus 165 v~~-~~cpV~vV~~~ 178 (810)
++. ++|||+||+..
T Consensus 287 v~~~~~~pVLvv~~~ 301 (305)
T PRK11175 287 VIDHLNCDLLAIKPD 301 (305)
T ss_pred HHhcCCCCEEEEcCC
Confidence 999 99999999754
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=126.62 Aligned_cols=129 Identities=26% Similarity=0.309 Sum_probs=107.7
Q ss_pred eEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHHHH
Q 003576 16 SVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKT 95 (810)
Q Consensus 16 ~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 95 (810)
+|+||+|+++.+..+++||.+.+...+. .|+++||.++.... +. ...+....+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~-~i~~l~v~~~~~~~----------------~~---------~~~~~~~~~~ 54 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGA-ELVLLHVVDPPPSS----------------AA---------ELAELLEEEA 54 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCC-EEEEEEEecCCCCc----------------ch---------hHHHHHHHHH
Confidence 5899999999999999999998877655 69999998663210 00 1233444566
Q ss_pred hhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-CcceEEE
Q 003576 96 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTVYG 174 (810)
Q Consensus 96 ~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~~cpV~v 174 (810)
++.|..+...|...|+.+...+.. |+++++|++++++.++|+||||+++++ .+.+.+.|+.+.+++. +.|||++
T Consensus 55 ~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~dlvvig~~~~~----~~~~~~~~~~~~~ll~~~~~pvli 129 (130)
T cd00293 55 RALLEALREALAEAGVKVETVVLE-GDPAEAILEAAEELGADLIVMGSRGRS----GLRRLLLGSVAERVLRHAPCPVLV 129 (130)
T ss_pred HHHHHHHHHHHhcCCCceEEEEec-CCCHHHHHHHHHHcCCCEEEEcCCCCC----ccceeeeccHHHHHHhCCCCCEEe
Confidence 788999998888889998888887 888999999999999999999999999 7777889999999999 9999998
Q ss_pred E
Q 003576 175 V 175 (810)
Q Consensus 175 V 175 (810)
|
T Consensus 130 v 130 (130)
T cd00293 130 V 130 (130)
T ss_pred C
Confidence 5
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.5e-15 Score=172.15 Aligned_cols=248 Identities=19% Similarity=0.236 Sum_probs=182.8
Q ss_pred hcCcccceeeccCCcEEEEEEEEC---CeEEEEEEEcccC--ccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--eE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~vavK~l~~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~l 526 (810)
...|.....||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.. ++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 345777778999999999887653 2356666554432 222344556888877787 999999999876544 78
Q ss_pred EEEeccCCCHHHHHh-hcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCEEecCCCCCceEecCCC-ceEEeeecccc
Q 003576 527 VYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLH-NTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLST 603 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivHrDLkp~NILld~~~-~~kL~DFGla~ 603 (810)
+++|..|+++.+.+. ... ...+....-.++.|+..+|.|+| ..+ +.|+||||+|.+++.++ .++++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999988773 222 13455567789999999999999 877 99999999999999999 99999999998
Q ss_pred ccCC-CCCcccccccccCCcc-CccccCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHh
Q 003576 604 MLNS-DPSFVSTTYKNTGPVG-TLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 604 ~~~~-~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
.+.. .... ......+| ++.|+|||...+ ....+..|+||.|+++.-+++|..||......... .....
T Consensus 174 ~~~~~~g~~----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----~~~~~ 244 (601)
T KOG0590|consen 174 AYRNKNGAE----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----YSSWK 244 (601)
T ss_pred cccccCCcc----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----ceeec
Confidence 8776 2221 12234477 999999998877 45678899999999999999999999754432211 11111
Q ss_pred hhh---CCCCChhHHHHHHHHHHHHhhhcCCCCCccccc
Q 003576 681 DAQ---AGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 716 (810)
Q Consensus 681 d~~---~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~ 716 (810)
... .............+++.+++..+|..|.+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 245 SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ccccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 111 011123456778899999999999999998853
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.3e-13 Score=126.99 Aligned_cols=146 Identities=18% Similarity=0.167 Sum_probs=112.6
Q ss_pred CCceEEEEec-CCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHH
Q 003576 13 PALSVAVAVK-GNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEE 91 (810)
Q Consensus 13 ~~~~VlVaVD-gs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 91 (810)
.+++|++++| +++.+..|+.+|+..+...+.. +.++||.+........ .. ... ... ........
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~-~~~~~v~~~~~~~~~~--------~~--~~~---~~~-~~~~~~~~ 68 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAP-LILLVVIDPLEPTALV--------SV--ALA---DAP-IPLSEEEL 68 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCe-EEEEEEeccccccccc--------cc--ccc---cch-hhhhHHHH
Confidence 4689999999 9999999999999977766554 8899998764432211 00 000 000 11223344
Q ss_pred HHHHhhhhHHHHHHhhccceee-EEEEEecccH-HHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC-C
Q 003576 92 KWKTDRLLLPFRNMCAQRRVEV-EVKVIESDDV-AKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-S 168 (810)
Q Consensus 92 ~~~~~~~l~~~~~~c~~~~v~~-~~~v~e~g~~-~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~-~ 168 (810)
.....+.+....+...+.|+.. +..+.+ |+| ...|++++.++++|+||||++|++ +++++++||++.+++. +
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~----~l~~~llGsvs~~v~~~~ 143 (154)
T COG0589 69 EEEAEELLAEAKALAEAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRS----GLSRLLLGSVAEKVLRHA 143 (154)
T ss_pred HHHHHHHHHHHHHHHHHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCc----cccceeeehhHHHHHhcC
Confidence 5566778888888888888885 677777 888 799999999999999999999999 7778999999999999 9
Q ss_pred cceEEEEecC
Q 003576 169 FCTVYGVEKG 178 (810)
Q Consensus 169 ~cpV~vV~~~ 178 (810)
+|||+||+..
T Consensus 144 ~~pVlvv~~~ 153 (154)
T COG0589 144 PCPVLVVRSE 153 (154)
T ss_pred CCCEEEEccC
Confidence 9999999853
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=139.65 Aligned_cols=206 Identities=24% Similarity=0.329 Sum_probs=142.0
Q ss_pred HHHHHHhcCCCceeeeeceecCCC-------eEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003576 501 ELEVLSKIRHPHLLLLLGACPDHG-------CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTK 572 (810)
Q Consensus 501 Ei~iL~~l~HpnIv~l~g~~~~~~-------~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 572 (810)
-..-|-++-|.|||++..++.+.. .++.|||..|+|..+|.+. .....+......+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 344566678999999999986544 5899999999999999863 33345777788899999999999999998
Q ss_pred CCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHH
Q 003576 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 652 (810)
Q Consensus 573 ~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~ 652 (810)
++|+|+++..+-|++..+|-+||+----... ..... ...........+-++|.+||+-.....+..+|||+||+..+
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~-~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVN-STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCcccc-chhhh-hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 5899999999999999999988852211110 00000 00011112235678899999888778888999999999999
Q ss_pred HHHhCCCC-ccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccchhh
Q 003576 653 QLLTAKPA-IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 653 eLltg~~P-f~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v~~ 719 (810)
+|..|..- -.....+. .+......+-... ...-+.++.+|++..|..||+++.++..
T Consensus 274 emailEiq~tnseS~~~---~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVE---VEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcceee---hhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 99887632 11111111 1112222111111 1122457889999999999999965533
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.9e-12 Score=145.02 Aligned_cols=137 Identities=19% Similarity=0.188 Sum_probs=98.7
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEcccCccch----------------------------------------HHHHH
Q 003576 462 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN----------------------------------------KQFLQ 500 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 500 (810)
..||.|++|.||+|++. ++.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999984 78999999876421100 12455
Q ss_pred HHHHHHhcC-----CCce--eeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 003576 501 ELEVLSKIR-----HPHL--LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS-ALAFLHNTK 572 (810)
Q Consensus 501 Ei~iL~~l~-----HpnI--v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 572 (810)
|...+.+++ ++++ .+++..+....+|||||++|++|.++....... + ....++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666652 3332 233333344569999999999999876532211 2 23456666665 478899988
Q ss_pred CCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 573 ~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
++|+|+||.||+++.++.++|+|||++..++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997665
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.6e-12 Score=124.70 Aligned_cols=130 Identities=20% Similarity=0.137 Sum_probs=100.8
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCc-eeeeeceecCCCeEEEEeccCCCHHHHH
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYEYMENGSLEDRL 540 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l 540 (810)
..|+.|.++.||++...+..+++|+...... ....+..|+.++..+.+.+ +.+++++..+..++||||++|.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~- 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE- 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc-
Confidence 4689999999999999989999999765432 2334678999999986544 345666666667999999999887643
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 541 YRKNNTPPIPWFERYRIAWEVASALAFLHNTK--PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 541 ~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
. . ....++.+++.+|..||..+ +..++|||++|.||+++ ++.++++|||.+..
T Consensus 82 ---~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 ---D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ---c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 1 11345679999999999987 23469999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-11 Score=131.10 Aligned_cols=108 Identities=18% Similarity=0.207 Sum_probs=78.9
Q ss_pred CCCceEEEEecCCcchHHHHHHHHhhcCCCC-CceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHH
Q 003576 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEG-INLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQE 90 (810)
Q Consensus 12 ~~~~~VlVaVDgs~~S~~Al~wA~~~~~~~~-~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 90 (810)
..+++||||||||+.|++|+++|++.+...+ +++|++|||.+..... .. . ..
T Consensus 3 ~~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~----------------~~----~-------~~ 55 (357)
T PRK12652 3 MAANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVD----------------PE----G-------QD 55 (357)
T ss_pred cccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccc----------------cc----h-------hH
Confidence 4689999999999999999999999776543 4579999998753210 00 0 01
Q ss_pred HHHHHhhhhHHHHHHhhc------cceeeEEEEEec-------ccHHHHHHHHHHhcCCcEEEEeccCC
Q 003576 91 EKWKTDRLLLPFRNMCAQ------RRVEVEVKVIES-------DDVAKAIADEVASCNINKLVIGAQSQ 146 (810)
Q Consensus 91 ~~~~~~~~l~~~~~~c~~------~~v~~~~~v~e~-------g~~~~~I~~~a~~~~~d~iVmGs~g~ 146 (810)
..+.++++++.+.+.+.. .||++++.++++ |+|++.|++||+++++|+||||-.-.
T Consensus 56 ~~~~~eelle~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 56 ELAAAEELLERVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCCC
Confidence 112233444444444433 589999888763 89999999999999999999997643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6e-12 Score=140.52 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=173.8
Q ss_pred Ccccceeecc--CCcEEEEEEEE--C--CeEEEEEEEccc--CccchHHHHHHHHHHHhcC-CCceeeeeceecCCC--e
Q 003576 457 SFSENLRIGM--GGYGTVYKGTF--H--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 525 (810)
Q Consensus 457 ~f~~~~~LG~--G~~g~Vy~~~~--~--~~~vavK~l~~~--~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~ 525 (810)
.|.....+|. |.+|.||.+.. . ...+|+|.-+.. .......=.+|+....+++ |+|.++.+..+.+.. +
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556677999 99999999877 2 347888873332 2233334456777777775 999999888887666 6
Q ss_pred EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeec
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS----ALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 600 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFG 600 (810)
+-+|++ +.+|..+...... .++....+.++.+... ||.++|..+ |+|-|+||.||++..+ ..++++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 677777 5788877765443 2667788888888888 999999999 9999999999999998 889999999
Q ss_pred cccccCCCCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc-chhhhhhccchhHHH
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT-HKVETAIDEDNLAEI 679 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~-~~~~~~~~~~~l~~~ 679 (810)
+...+....-. ..........|...|++||... +.++..+|||+||.++.+..+|..++... ...+..++...+.
T Consensus 269 ~v~~i~~~~~~-~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip-- 344 (524)
T KOG0601|consen 269 LVSKISDGNFS-SVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP-- 344 (524)
T ss_pred eeEEccCCccc-cceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc--
Confidence 99888765421 1112223447888999999766 56789999999999999999987655321 1111111111110
Q ss_pred hhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 680 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 680 ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
.++-...+..+...+..+++.+|..|++..
T Consensus 345 -----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 345 -----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred -----hhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 111112345566688999999999999886
|
|
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-11 Score=99.05 Aligned_cols=63 Identities=46% Similarity=0.962 Sum_probs=60.8
Q ss_pred CccCccccccccCCcccCCCcccchHHHHHHHhhCCCCCCCCCCCCCCCCCccHHHHHHHHHH
Q 003576 745 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDW 807 (810)
Q Consensus 745 ~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~~~~sP~T~~~l~~~~l~pn~~l~~~~~~~ 807 (810)
.+.|||..++|.||++...|++|++..|..|+.++.++|+|+.++...+|+||++||++|++|
T Consensus 1 ~~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 1 EFLCPISLEVMKDPVILPSGQTYERRAIEKWLLSHGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred CcCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHHCCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 378999999999999999999999999999999888999999999999999999999999999
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.6e-11 Score=134.21 Aligned_cols=141 Identities=18% Similarity=0.137 Sum_probs=92.7
Q ss_pred cCcccceeeccCCcEEEEEEEEC--CeEEEEEEEcccCccc----------------------------------h----
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ----------------------------------N---- 495 (810)
Q Consensus 456 ~~f~~~~~LG~G~~g~Vy~~~~~--~~~vavK~l~~~~~~~----------------------------------~---- 495 (810)
..|+. ..||.|++|.||+|+++ ++.||||+.++..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 67999999999999985 6799999998642100 0
Q ss_pred --HHHHHHHHHHHhcC----CCceee---eeceecCCCeEEEEeccCCCHHHHH--hhcCC-CCCCCHHHHHHHHHHHHH
Q 003576 496 --KQFLQELEVLSKIR----HPHLLL---LLGACPDHGCLVYEYMENGSLEDRL--YRKNN-TPPIPWFERYRIAWEVAS 563 (810)
Q Consensus 496 --~~~~~Ei~iL~~l~----HpnIv~---l~g~~~~~~~lV~Ey~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~qia~ 563 (810)
-+|.+|+..+.+++ +.+.+. +|.-+....+|||||++|+.|.++- ...+. ...+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 12445655555553 333333 3333344558999999999998742 22211 001222222223333
Q ss_pred HHHHHhhcCCCCEEecCCCCCceEecCCC----ceEEeeeccccccCC
Q 003576 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVGLSTMLNS 607 (810)
Q Consensus 564 aL~~LH~~~~~~ivHrDLkp~NILld~~~----~~kL~DFGla~~~~~ 607 (810)
++..| ++|+|+||.||+++.++ .++++|||++..++.
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34566 99999999999999887 999999999987764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-10 Score=113.47 Aligned_cols=135 Identities=19% Similarity=0.147 Sum_probs=98.0
Q ss_pred eeeccCCcEEEEEEEEC--------CeEEEEEEEcccCc----------------------cchHHH----HHHHHHHHh
Q 003576 462 LRIGMGGYGTVYKGTFH--------HTFAAVKVLQSKGN----------------------IQNKQF----LQELEVLSK 507 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~--------~~~vavK~l~~~~~----------------------~~~~~~----~~Ei~iL~~ 507 (810)
..||.|.-+.||.|... +..+|||+.+.... .....+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 36899999999999764 26899998753210 001123 379999999
Q ss_pred cC--CCceeeeeceecCCCeEEEEeccCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCEEecCCCC
Q 003576 508 IR--HPHLLLLLGACPDHGCLVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFL-HNTKPKPIIHRDMKP 583 (810)
Q Consensus 508 l~--HpnIv~l~g~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivHrDLkp 583 (810)
+. .-++...+++ ...+|||||+.++.+.. .+.. ..++......+..+++.+|..| |..+ ||||||+|
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 85 3455566654 56799999997654422 2211 1244456677889999999999 8888 99999999
Q ss_pred CceEecCCCceEEeeeccccccC
Q 003576 584 GNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 584 ~NILld~~~~~kL~DFGla~~~~ 606 (810)
.|||++ ++.+.|+|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.2e-10 Score=126.13 Aligned_cols=161 Identities=19% Similarity=0.230 Sum_probs=121.9
Q ss_pred CeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCCC--eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHH
Q 003576 479 HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 556 (810)
Q Consensus 479 ~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~ 556 (810)
+.+|.|.+.............+-+..|+.++||||++++..+.... |||.|-+. .|..++...+ ......
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHHHH
Confidence 4577777776554433455778899999999999999999997766 99999984 6777776543 456777
Q ss_pred HHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCccccCccccccC
Q 003576 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636 (810)
Q Consensus 557 i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 636 (810)
.+.||+.||.|||..+ .++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+...
T Consensus 109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCcc
Confidence 8999999999998655 299999999999999999999999999876553321 01111223346667644322
Q ss_pred CCCCcchhhhHHHHHHHHHhC
Q 003576 637 LISPKSDVYAYGMVILQLLTA 657 (810)
Q Consensus 637 ~~~~~sDVwSlGvil~eLltg 657 (810)
. -..|.|-|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 356999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.8e-10 Score=108.29 Aligned_cols=128 Identities=28% Similarity=0.378 Sum_probs=102.3
Q ss_pred eeccCCcEEEEEEEECCeEEEEEEEcccC-c-------cchHHHHHHHHHHHhcC--CCceeeeeceecCCCeEEEEecc
Q 003576 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKG-N-------IQNKQFLQELEVLSKIR--HPHLLLLLGACPDHGCLVYEYME 532 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~~~vavK~l~~~~-~-------~~~~~~~~Ei~iL~~l~--HpnIv~l~g~~~~~~~lV~Ey~~ 532 (810)
.+++|+-+.+|.+.+.+..+.+|.=.++. . ....+-.+|..+|.+++ --+...++.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 47899999999998888777777643321 1 12245678999999986 44556777788888899999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccc
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~ 604 (810)
|-.|.+.+... ...++..+-.-+.-||..| |+|+||.++||++..+. +.++|||++..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888654 2457778888889999999 99999999999997765 89999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-09 Score=115.73 Aligned_cols=258 Identities=19% Similarity=0.216 Sum_probs=169.1
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhc-CCCceee--------eeceecCC-CeEEEE
Q 003576 460 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLL--------LLGACPDH-GCLVYE 529 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~--------l~g~~~~~-~~lV~E 529 (810)
..+.||+||-+.+|-.---... +.|+.+........+. +..|... .||-+-. |+|--... ..+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4567999999999964322223 3466665443322222 2233333 4554432 22222222 256777
Q ss_pred eccCCC-HHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeecccccc
Q 003576 530 YMENGS-LEDRLY---RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 530 y~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~ 605 (810)
.+.|.- +.+++. +....+...|.-.++.++.++.+..-||..| .+-||+.++|||+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 776642 222222 2344566889999999999999999999999 899999999999999999999875443332
Q ss_pred CCCCCcccccccccCCccCccccCccccc-----cCCCCCcchhhhHHHHHHHHHhC-CCCcccc-------chhhhhhc
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTA-KPAIAIT-------HKVETAID 672 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~sDVwSlGvil~eLltg-~~Pf~~~-------~~~~~~~~ 672 (810)
..+. .....+|...|.+||... +-.-+...|.|.||+++++||.| ++||... ...+..+.
T Consensus 168 ~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 168 ANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 2211 123458999999999765 23346789999999999999987 9999732 23333444
Q ss_pred cchhHHHhhhhC------CCCChh-HHHHHHHHHHHHhhh--cCCCCCccccchhhHHHHHHHhhhccc
Q 003576 673 EDNLAEILDAQA------GDWPIK-ETKELAALGLSCAEL--RRKDRPDLKNQVLPVLERLKEVADRAR 732 (810)
Q Consensus 673 ~~~l~~~ld~~~------~~~p~~-~~~~l~~Li~~cl~~--dP~~RPs~~~~v~~~L~~l~~~~~~~~ 732 (810)
.+.+...-+... ..||.. .++.+..|..+|+.. ++.-||+.. ..+..|..++.....|.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~-aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK-AWVAALDALRQQLKKCT 308 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHHHHhhhhhh
Confidence 444443333332 234443 467889999999975 467899998 67888888877665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.8e-11 Score=140.28 Aligned_cols=248 Identities=19% Similarity=0.239 Sum_probs=172.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEECCe--EEEEEEEcccCcc---chHHHHHHHHHHHhcCCCceeeeece--ecCCCeE
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCL 526 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~~~---~~~~~~~Ei~iL~~l~HpnIv~l~g~--~~~~~~l 526 (810)
..+.|.+..-+-+|.++.++.+.-.++ ..++|+....... ..+....+-.++-..++|.++...-. |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 445677777788999999987654322 3344443322211 12223333333333456777766655 4556699
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
+++|+.+++|...|+.-+ +.+..-....+..+..+++|||... ++|+|++|.|+|...++..+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999887644 3444455667788999999999988 9999999999999999999999998544322
Q ss_pred CCCC---c--------------------cc--ccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCc
Q 003576 607 SDPS---F--------------------VS--TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 661 (810)
Q Consensus 607 ~~~~---~--------------------~~--~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf 661 (810)
.-.. . .. .........||+.|.+||...+......+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 1100 0 00 001234568999999999999999999999999999999999999999
Q ss_pred cccchhhhhhccchhHHHhhhhCCCC---ChhHHHHHHHHHHHHhhhcCCCCCccc
Q 003576 662 AITHKVETAIDEDNLAEILDAQAGDW---PIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 662 ~~~~~~~~~~~~~~l~~~ld~~~~~~---p~~~~~~l~~Li~~cl~~dP~~RPs~~ 714 (810)
....... .+..++. ....| +...+....+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~------~f~ni~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ------IFENILN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhh------hhhcccc-CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6443221 1122222 12233 346678899999999999999998876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.9e-11 Score=131.26 Aligned_cols=236 Identities=21% Similarity=0.228 Sum_probs=167.0
Q ss_pred hcCcccceeeccCCcEEEEEEEEC---CeEEEEEEEcccCccchHHH--HHHHHHHHhcC-CCceeeeeceec--CCCeE
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQF--LQELEVLSKIR-HPHLLLLLGACP--DHGCL 526 (810)
Q Consensus 455 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~vavK~l~~~~~~~~~~~--~~Ei~iL~~l~-HpnIv~l~g~~~--~~~~l 526 (810)
...|..+..||.|.|+.||....+ +..|++|.+.........++ ..|+.+...+. |.|++.++..+. ++.|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888999999999999987653 45888887766544333332 45777766664 888888766553 34488
Q ss_pred EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC-CceEEeeecccccc
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTML 605 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~-~~~kL~DFGla~~~ 605 (810)
-.|||.++++...+.... -+....++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||+...+
T Consensus 344 p~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 889999999887663222 2566788999999999999999988 9999999999999876 78899999998653
Q ss_pred CCCCCcccccccccCCccCccc-cCccccccCCCCCcchhhhHHHHHHHHHhCCCCcc-ccchhhhhhccchhHHHhhhh
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCY-IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA-ITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~-~~~~~~~~~~~~~l~~~ld~~ 683 (810)
.-.. .....++..| .+|.......+..+.|+||||..+.+.++|.+--. ..++ ..+....
T Consensus 418 ~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------~~i~~~~ 479 (524)
T KOG0601|consen 418 AFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------LTIRSGD 479 (524)
T ss_pred ceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------eeeeccc
Confidence 2111 1111233344 36666677778899999999999999999874321 1111 1111111
Q ss_pred CCCCChhHHHHHHHHHHHHhhhcCCCCCcccc
Q 003576 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 684 ~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~ 715 (810)
.... ......+..+...+...++..||.+.+
T Consensus 480 ~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~ 510 (524)
T KOG0601|consen 480 TPNL-PGLKLQLQVLLKVMINPDRKRRPSAVE 510 (524)
T ss_pred ccCC-CchHHhhhhhhhhhcCCccccchhhhh
Confidence 1112 223377888889999999999999873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1e-09 Score=112.69 Aligned_cols=139 Identities=24% Similarity=0.287 Sum_probs=107.5
Q ss_pred eeeccCCcEEEEEEEECC-eEEEEEEEcccCc-cchHHHHHHHHHHHhcCC--CceeeeeceecC-----CCeEEEEecc
Q 003576 462 LRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRH--PHLLLLLGACPD-----HGCLVYEYME 532 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~-~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~H--pnIv~l~g~~~~-----~~~lV~Ey~~ 532 (810)
..||.|.++.||++...+ ..+++|+...... .....+..|+.++..+.+ .++.+++.++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998876 7899998765432 134568899999999975 345667777755 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK---------------------------------------- 572 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 572 (810)
|.+|.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775531 23666677788888888888888531
Q ss_pred -------------CCCEEecCCCCCceEecC--CCceEEeeeccccc
Q 003576 573 -------------PKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTM 604 (810)
Q Consensus 573 -------------~~~ivHrDLkp~NILld~--~~~~kL~DFGla~~ 604 (810)
+..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.5e-09 Score=102.73 Aligned_cols=141 Identities=24% Similarity=0.284 Sum_probs=104.6
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEccc--------CccchHHHHHHHHHHHhcCCCc--eeeeeceecCCCeEEEE
Q 003576 460 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--------GNIQNKQFLQELEVLSKIRHPH--LLLLLGACPDHGCLVYE 529 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~--------~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~lV~E 529 (810)
....|-+|+-+.|+++.+.+..+.||.-..+ ......+..+|+.+|.+++--. ...++-+-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567889999999999999998888853322 1223456788999999986333 33444444556699999
Q ss_pred eccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCC---CceEEeeeccccc
Q 003576 530 YMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTM 604 (810)
Q Consensus 530 y~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~---~~~kL~DFGla~~ 604 (810)
|++| .++.+++.........+ .....++..|-..+.-||.++ ||||||..+||+|..+ ..+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9986 47888887655433222 233678889999999999999 9999999999999544 3458999999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=9.9e-08 Score=104.69 Aligned_cols=203 Identities=18% Similarity=0.224 Sum_probs=140.6
Q ss_pred cEEEEEEEE--CCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCceeeeeceecCC------CeEEEEeccC-CCHHHH
Q 003576 469 YGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------GCLVYEYMEN-GSLEDR 539 (810)
Q Consensus 469 ~g~Vy~~~~--~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~g~~~~~------~~lV~Ey~~~-gsL~~~ 539 (810)
-.+.|++.. +|..|++|.++............-+++++++.|+|+|+|..+|... .+|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788875 4778999999655443333345568899999999999998887522 2799999986 577776
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 540 LYRKN------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 540 l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
..... .....++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1234778899999999999999999999 88899999999999999999988888766554
Q ss_pred CCCcccccccccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCC
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
+.. +-+. --.+-|.=.||.+++.|.||..--... .......+ ...
T Consensus 446 d~~--------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~----d~~~~s~~--------~~I 490 (655)
T KOG3741|consen 446 DPT--------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRT----DSTQSSHL--------TRI 490 (655)
T ss_pred CCC--------------------cchh---HHhhhhHHHHHHHHHHHhhcccccccc----cchHHHHH--------HHh
Confidence 320 1111 123678999999999999996321100 00000001 111
Q ss_pred ChhHHHHHHHHHHHHhhhcCCC
Q 003576 688 PIKETKELAALGLSCAELRRKD 709 (810)
Q Consensus 688 p~~~~~~l~~Li~~cl~~dP~~ 709 (810)
-..++.++.+++.-....++++
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc
Confidence 2345666777777777777765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.6e-08 Score=96.89 Aligned_cols=125 Identities=20% Similarity=0.188 Sum_probs=81.2
Q ss_pred EEEEEEE-CCeEEEEEEEcccCcc--------------------------chHHHHHHHHHHHhcCCC--ceeeeeceec
Q 003576 471 TVYKGTF-HHTFAAVKVLQSKGNI--------------------------QNKQFLQELEVLSKIRHP--HLLLLLGACP 521 (810)
Q Consensus 471 ~Vy~~~~-~~~~vavK~l~~~~~~--------------------------~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~ 521 (810)
.||.|.. .+..+|||+.+..... ......+|...|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899887 4779999997642100 012357899999999755 45666644
Q ss_pred CCCeEEEEecc--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCEEecCCCCCceEecCCCceEEee
Q 003576 522 DHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF-LHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598 (810)
Q Consensus 522 ~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~ivHrDLkp~NILld~~~~~kL~D 598 (810)
...+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+||||.+.|||++++ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 65554433221 1122456677788885555 57888 9999999999999887 899999
Q ss_pred eccccccC
Q 003576 599 VGLSTMLN 606 (810)
Q Consensus 599 FGla~~~~ 606 (810)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.3e-08 Score=101.78 Aligned_cols=137 Identities=15% Similarity=0.029 Sum_probs=97.3
Q ss_pred eccCCcEEEEEEEECCeEEEEEEEcccCcc-----------chHHHHHHHHHHHhcCCCce--eeeeceec-------CC
Q 003576 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNI-----------QNKQFLQELEVLSKIRHPHL--LLLLGACP-------DH 523 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~-----------~~~~~~~Ei~iL~~l~HpnI--v~l~g~~~-------~~ 523 (810)
+-......|+++.+.+..+.||........ ....+.+|...+.+|..-+| +..+++.. ..
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 333334447788888889999976433211 11247789999988843222 23333331 12
Q ss_pred CeEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecC-------CCceE
Q 003576 524 GCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------NLVSK 595 (810)
Q Consensus 524 ~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~-------~~~~k 595 (810)
.+||+|++++. +|.+++..... .+.+......++.+++..+.-||..| |+|+||++.|||++. ++.+.
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence 48999999876 89998754221 23455677789999999999999999 999999999999975 47899
Q ss_pred Eeeeccccc
Q 003576 596 IGDVGLSTM 604 (810)
Q Consensus 596 L~DFGla~~ 604 (810)
|+||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998853
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.4e-07 Score=113.03 Aligned_cols=126 Identities=14% Similarity=0.072 Sum_probs=96.4
Q ss_pred CCCceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHH
Q 003576 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEE 91 (810)
Q Consensus 12 ~~~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 91 (810)
....+|||+|++++.+.+++++|...+.+.++. +++|||..+... . .. .
T Consensus 248 ~~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~-~~~l~V~~~~~~---------------~-----~~--------~-- 296 (895)
T PRK10490 248 HTRDAILLCIGHNTGSEKLVRTAARLAARLGSV-WHAVYVETPRLH---------------R-----LP--------E-- 296 (895)
T ss_pred CcCCeEEEEECCCcchHHHHHHHHHHHHhcCCC-EEEEEEecCCcC---------------c-----CC--------H--
Confidence 346889999999999999999999988887665 999999865211 0 00 0
Q ss_pred HHHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC--Cc
Q 003576 92 KWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP--SF 169 (810)
Q Consensus 92 ~~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~--~~ 169 (810)
+. .+-+..+..+|++.|.+ .+.+.++|++++|++||++++|+.||||.++++ ++ +.-||++.+++. ..
T Consensus 297 -~~-~~~l~~~~~lA~~lGa~--~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~----~~--~~~~s~~~~l~r~~~~ 366 (895)
T PRK10490 297 -KK-RRAILSALRLAQELGAE--TATLSDPAEEKAVLRYAREHNLGKIIIGRRASR----RW--WRRESFADRLARLGPD 366 (895)
T ss_pred -HH-HHHHHHHHHHHHHcCCE--EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCC----CC--ccCCCHHHHHHHhCCC
Confidence 01 22233444678887765 556677899999999999999999999999998 44 446799999998 66
Q ss_pred ceEEEEecC
Q 003576 170 CTVYGVEKG 178 (810)
Q Consensus 170 cpV~vV~~~ 178 (810)
..|+||...
T Consensus 367 idi~iv~~~ 375 (895)
T PRK10490 367 LDLVIVALD 375 (895)
T ss_pred CCEEEEeCC
Confidence 999999643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=87.44 Aligned_cols=136 Identities=16% Similarity=0.053 Sum_probs=102.8
Q ss_pred eccCCcEEEEEEEECCeEEEEEEEccc------CccchHHHHHHHHHHHhcCCC--ceeeeeceec---CC----CeEEE
Q 003576 464 IGMGGYGTVYKGTFHHTFAAVKVLQSK------GNIQNKQFLQELEVLSKIRHP--HLLLLLGACP---DH----GCLVY 528 (810)
Q Consensus 464 LG~G~~g~Vy~~~~~~~~vavK~l~~~------~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~---~~----~~lV~ 528 (810)
-|+||.+.|++..+.+..+-+|.-... .......|.+|+..|.+|..- .+.+.+ ++. .. .+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 478999999999888877888865421 133567899999999999632 244444 321 11 27999
Q ss_pred EeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCc--eEEeeeccccc
Q 003576 529 EYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--SKIGDVGLSTM 604 (810)
Q Consensus 529 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~--~kL~DFGla~~ 604 (810)
|-+.| -+|.+++..... .+.+......++.+++..|.-||..| +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 488888755332 24566777899999999999999999 999999999999986666 89999987654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.3e-08 Score=111.34 Aligned_cols=152 Identities=23% Similarity=0.294 Sum_probs=105.5
Q ss_pred HHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCccccccc---ccCCccCccccCccccc
Q 003576 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK---NTGPVGTLCYIDPEYQR 634 (810)
Q Consensus 558 ~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~ 634 (810)
+.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+++........+....|. .........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999875 3999999999999999999999999998766543222111111 11123466799999999
Q ss_pred cCCCCCcchhhhHHHHHHHHH-hCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCcc
Q 003576 635 TGLISPKSDVYAYGMVILQLL-TAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDL 713 (810)
Q Consensus 635 ~~~~~~~sDVwSlGvil~eLl-tg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~ 713 (810)
....++++|+|||||++|.+. .|+.-+......... ..-....+.....+....+.++.+=+.+++..++.-||++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~---~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY---SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh---hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 888899999999999999999 455444322111110 0001111112223445677889999999999999999965
Q ss_pred c
Q 003576 714 K 714 (810)
Q Consensus 714 ~ 714 (810)
.
T Consensus 260 ~ 260 (700)
T KOG2137|consen 260 D 260 (700)
T ss_pred h
Confidence 5
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.1e-07 Score=91.48 Aligned_cols=106 Identities=21% Similarity=0.231 Sum_probs=80.8
Q ss_pred chHHHHHHHHHHHhcCCCc--eeeeeceecC------CCeEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHH
Q 003576 494 QNKQFLQELEVLSKIRHPH--LLLLLGACPD------HGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASA 564 (810)
Q Consensus 494 ~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~------~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~a 564 (810)
......+|...+..|..-. +...+++... ..+||+|++++. +|.+++..... ++......++.+++..
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence 3456788999888885322 3344444322 227999999874 79998865332 4455678899999999
Q ss_pred HHHHhhcCCCCEEecCCCCCceEecCCC---ceEEeeecccccc
Q 003576 565 LAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIGDVGLSTML 605 (810)
Q Consensus 565 L~~LH~~~~~~ivHrDLkp~NILld~~~---~~kL~DFGla~~~ 605 (810)
+.-||..| |+|+|++|.|||++.++ .+.|+||+.++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 99999999999998876 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.6e-07 Score=91.78 Aligned_cols=135 Identities=18% Similarity=0.110 Sum_probs=95.7
Q ss_pred cccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCcc----------------------chHHHHHHHHHHHhcCCC--c
Q 003576 458 FSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI----------------------QNKQFLQELEVLSKIRHP--H 512 (810)
Q Consensus 458 f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~----------------------~~~~~~~Ei~iL~~l~Hp--n 512 (810)
.....+||-|.-+.||.|... +..+|||.-+..... .+...++|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 455678999999999999986 779999975432110 112357899999998644 4
Q ss_pred eeeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCC
Q 003576 513 LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 592 (810)
Q Consensus 513 Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~ 592 (810)
+..-+++ +..++||||++|-.|...- +.....-.|+..|+.-+.-+-..| |||||+.+-|||++.+|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 5555443 3348999999986665421 112233445555666655555777 99999999999999999
Q ss_pred ceEEeeecccccc
Q 003576 593 VSKIGDVGLSTML 605 (810)
Q Consensus 593 ~~kL~DFGla~~~ 605 (810)
.+.++||--+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999766543
|
|
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.4e-06 Score=100.68 Aligned_cols=131 Identities=18% Similarity=0.089 Sum_probs=103.8
Q ss_pred CCCceEEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHH
Q 003576 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEE 91 (810)
Q Consensus 12 ~~~~~VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 91 (810)
....+|+|+|++++.|.+.+++|...+.+.++. +++|||-.+.... .
T Consensus 246 ~~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~-~~av~v~~~~~~~--------------------------------~ 292 (890)
T COG2205 246 AARERILVCISGSPGSEKLIRRAARLASRLHAK-WTAVYVETPELHR--------------------------------L 292 (890)
T ss_pred cccceEEEEECCCCchHHHHHHHHHHHHHhCCC-eEEEEEecccccc--------------------------------c
Confidence 345899999999999999999999988777664 9999998663210 0
Q ss_pred HHHHhhhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCccccccccC--Cc
Q 003576 92 KWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP--SF 169 (810)
Q Consensus 92 ~~~~~~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lgSv~~~v~~--~~ 169 (810)
.+...+.+.....+|.+.| .+.+++.++|++++|++||+.+++..||||.+.++ ++++++-|+.+.+.+. ..
T Consensus 293 ~~~~~~~l~~~~~Lae~lG--ae~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~----rw~~~~~~~l~~~L~~~~~~ 366 (890)
T COG2205 293 SEKEARRLHENLRLAEELG--AEIVTLYGGDVAKAIARYAREHNATKIVIGRSRRS----RWRRLFKGSLADRLAREAPG 366 (890)
T ss_pred cHHHHHHHHHHHHHHHHhC--CeEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcch----HHHHHhcccHHHHHHhcCCC
Confidence 0112344556667777744 57778888999999999999999999999999999 7777777999999888 77
Q ss_pred ceEEEEecCccc
Q 003576 170 CTVYGVEKGKLS 181 (810)
Q Consensus 170 cpV~vV~~~~~~ 181 (810)
..|.+|..+...
T Consensus 367 idv~ii~~~~~~ 378 (890)
T COG2205 367 IDVHIVALDAPP 378 (890)
T ss_pred ceEEEeeCCCCc
Confidence 899998876643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.1e-06 Score=98.18 Aligned_cols=138 Identities=20% Similarity=0.199 Sum_probs=93.0
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEcccCccch----------------------------------------HHHHH
Q 003576 462 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN----------------------------------------KQFLQ 500 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 500 (810)
..|+.++-|.||+|+++ |..||||+.++.-.... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999998 78999999876532110 12345
Q ss_pred HHHHHHhcC-----CCce--eeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHHhhcC
Q 003576 501 ELEVLSKIR-----HPHL--LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA-LAFLHNTK 572 (810)
Q Consensus 501 Ei~iL~~l~-----HpnI--v~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~~LH~~~ 572 (810)
|...+.+++ .|++ .+++--+.....|+|||++|..+.+....... .++.. .|+..++.+ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHH---HHHHHHHHHHHHHHHhcC
Confidence 555565552 3332 23333234556899999999999887533322 24433 333333333 22333355
Q ss_pred CCCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 573 ~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+.|+|.+|.||+++.+|.+.+.|||+...++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.31 E-value=4e-06 Score=84.55 Aligned_cols=136 Identities=21% Similarity=0.145 Sum_probs=94.2
Q ss_pred hhcCcccceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHH---------HHHHHHHHhcCC---Cceeeeecee-
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF---------LQELEVLSKIRH---PHLLLLLGAC- 520 (810)
Q Consensus 454 ~~~~f~~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~---------~~Ei~iL~~l~H---pnIv~l~g~~- 520 (810)
..++|...+.+-......|.+-..++..+.+|..........+.| .+.+..+.+++. -....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 356777778888888888999999999999999877654333322 334444444432 2222222221
Q ss_pred ------cCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCce
Q 003576 521 ------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 521 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~ 594 (810)
....+|+|||++|..|.+... ++. .+...+..++.-||..| ++|||..|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 222368999999988876531 222 24566778899999999 99999999999998665 8
Q ss_pred EEeeeccccc
Q 003576 595 KIGDVGLSTM 604 (810)
Q Consensus 595 kL~DFGla~~ 604 (810)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.4e-06 Score=84.28 Aligned_cols=137 Identities=16% Similarity=0.175 Sum_probs=79.8
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCc--eeeeeceecCC--CeEEEEeccCCC-H
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLLLLGACPDH--GCLVYEYMENGS-L 536 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~g~~~~~--~~lV~Ey~~~gs-L 536 (810)
..||+|..+.||+.. +..+++|+..... ......+|.+++..+..-. +.+.++++.+. ..+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 468999999999842 4457788876533 3455788999999886333 34556655432 378999999863 2
Q ss_pred HHHH--------------hh-----cC-CCCCCCHHHHHH-HHH----------HHHH-HHHHHhhc-CCCCEEecCCCC
Q 003576 537 EDRL--------------YR-----KN-NTPPIPWFERYR-IAW----------EVAS-ALAFLHNT-KPKPIIHRDMKP 583 (810)
Q Consensus 537 ~~~l--------------~~-----~~-~~~~l~~~~~~~-i~~----------qia~-aL~~LH~~-~~~~ivHrDLkp 583 (810)
...+ .. +. .....+...... +.. .+.. ...+|... .+..++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 00 00 000111111100 000 0011 11222211 123579999999
Q ss_pred CceEecCCCceEEeeecccc
Q 003576 584 GNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 584 ~NILld~~~~~kL~DFGla~ 603 (810)
.||++++++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.1e-05 Score=78.74 Aligned_cols=106 Identities=23% Similarity=0.236 Sum_probs=84.5
Q ss_pred HHHHHHHHhcCC-CceeeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEE
Q 003576 499 LQELEVLSKIRH-PHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577 (810)
Q Consensus 499 ~~Ei~iL~~l~H-pnIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iv 577 (810)
..|.-+|+.+.+ +++++++|+|. .++|.||...+++......-......+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 458888999975 69999999994 478999998776643210001112368999999999999999999987656699
Q ss_pred ecCCCCCceEecCCCceEEeeeccccccC
Q 003576 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 578 HrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
-.|++|+|+-++++|.+|++|...+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 99999999999999999999998876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.4e-06 Score=85.04 Aligned_cols=140 Identities=22% Similarity=0.235 Sum_probs=83.9
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC--ceeeeeceecC---C--CeEEEEeccCC
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGACPD---H--GCLVYEYMENG 534 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~~---~--~~lV~Ey~~~g 534 (810)
..|+.|..+.||+....+..+++|+.... .....+.+|..++..+... .+..++.++.. . .+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56899999999999998889999997654 4556788899999888532 34566653321 1 27899999998
Q ss_pred CHHH----------------HHh---hc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh--
Q 003576 535 SLED----------------RLY---RK-NNTPPIPWFER---------YRI------------AWEVAS-ALAFLHN-- 570 (810)
Q Consensus 535 sL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~~LH~-- 570 (810)
.+.. .+. .. ....++..... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 111 11 01111111110 000 111222 3333332
Q ss_pred --cCCCCEEecCCCCCceEec-CCCceEEeeecccc
Q 003576 571 --TKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLST 603 (810)
Q Consensus 571 --~~~~~ivHrDLkp~NILld-~~~~~kL~DFGla~ 603 (810)
..+..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66666899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1e-06 Score=87.74 Aligned_cols=71 Identities=35% Similarity=0.559 Sum_probs=66.6
Q ss_pred CCCCCCCccCccccccccCCcccCCCcccchHHHHHHHhh-CCCCCCCCCCCCCCCCCccHHHHHHHHHHhh
Q 003576 739 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 809 (810)
Q Consensus 739 ~~~~p~~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~-~~~sP~T~~~l~~~~l~pn~~l~~~~~~~~~ 809 (810)
....|+...|-|+.++|++|++..-|.||++..|...|+. ++..|+|+.+|..-.++||++|+.+|..|+.
T Consensus 205 ~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~ 276 (284)
T KOG4642|consen 205 KREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLK 276 (284)
T ss_pred cccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHH
Confidence 3577888889999999999999999999999999999998 9999999999999999999999999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.8e-05 Score=90.20 Aligned_cols=139 Identities=18% Similarity=0.151 Sum_probs=92.9
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEcccCccch-------------------------------------HHHHHHHH
Q 003576 462 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN-------------------------------------KQFLQELE 503 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~~~-------------------------------------~~~~~Ei~ 503 (810)
..||.-+.|.||+|+.+ +..||||+-++.-.... -+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 45899999999999986 56899999776422110 12445555
Q ss_pred HHHhc----CCCc------eeeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003576 504 VLSKI----RHPH------LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573 (810)
Q Consensus 504 iL~~l----~Hpn------Iv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 573 (810)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|+-.-... .++...+..-+.++..-. |-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 44443 3555 555666666677999999999988775432222 144444443333333222 22334
Q ss_pred CCEEecCCCCCceEec----CCCceEEeeeccccccCC
Q 003576 574 KPIIHRDMKPGNILLD----HNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 574 ~~ivHrDLkp~NILld----~~~~~kL~DFGla~~~~~ 607 (810)
++|+|-+|.||+++ .++.+.+.|||+...+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998 367899999999887654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.5e-05 Score=77.19 Aligned_cols=150 Identities=19% Similarity=0.192 Sum_probs=95.7
Q ss_pred CHHHHHHhhcCcccce---eeccCCcEEEEEEEE-CCeEEEEEEEcccCccch-------------------H-----HH
Q 003576 447 TWEEIESATLSFSENL---RIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQN-------------------K-----QF 498 (810)
Q Consensus 447 ~~~ei~~~~~~f~~~~---~LG~G~~g~Vy~~~~-~~~~vavK~l~~~~~~~~-------------------~-----~~ 498 (810)
+++.+........+.. .|..|.-+.||+|.. .+..+|+|+.+....... . ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4444444444433333 466777888999876 477999999864321111 1 12
Q ss_pred HHHHHHHHhcC--CCceeeeeceecCCCeEEEEeccCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCC
Q 003576 499 LQELEVLSKIR--HPHLLLLLGACPDHGCLVYEYMENGSL-EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPK 574 (810)
Q Consensus 499 ~~Ei~iL~~l~--HpnIv~l~g~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~ 574 (810)
.+|+.-|.++. +-.+.+-+++. ...|||||+....+ .-.|. ..++...+...+..+++..+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~--~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR--NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec--CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 45777777774 22333333332 34799999954311 11111 1112233567788888999888887 66
Q ss_pred CEEecCCCCCceEecCCCceEEeeeccccccC
Q 003576 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 575 ~ivHrDLkp~NILld~~~~~kL~DFGla~~~~ 606 (810)
+||+||+.-|||+. ++.+.|+|||-|....
T Consensus 188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999987655
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.3e-05 Score=80.03 Aligned_cols=137 Identities=18% Similarity=0.075 Sum_probs=82.9
Q ss_pred eccCCc-EEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-CCceeeeeceecC--CCeEEEEeccCCCHHHH
Q 003576 464 IGMGGY-GTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCLVYEYMENGSLEDR 539 (810)
Q Consensus 464 LG~G~~-g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~lV~Ey~~~gsL~~~ 539 (810)
|-.|.+ ..||+....+..+.+|+..... ...+.+|+.++..+. +--+.++++++.. ..++||++++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 7899998777778888876543 345678999988884 3445567776654 35899999998877643
Q ss_pred H-------------------hhcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----cCC
Q 003576 540 L-------------------YRKNN-TPPIPW--FERYRIAW--------------------EVASALAFLHN----TKP 573 (810)
Q Consensus 540 l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qia~aL~~LH~----~~~ 573 (810)
. +.... ..++.. ........ .+...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11000 001110 00000000 01111222211 112
Q ss_pred CCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 574 ~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 459999999999999998888999998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.9e-05 Score=78.57 Aligned_cols=71 Identities=15% Similarity=0.155 Sum_probs=45.3
Q ss_pred eeeccCCcE-EEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC---ceeeeeceecC-----CCeEEEEecc
Q 003576 462 LRIGMGGYG-TVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---HLLLLLGACPD-----HGCLVYEYME 532 (810)
Q Consensus 462 ~~LG~G~~g-~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~g~~~~-----~~~lV~Ey~~ 532 (810)
..|+.||.. .||+. +..+.+|+.... .....+.+|..+|..+... .+...++.... ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457877776 49975 235677765442 2345788999999887531 23444444322 2378999999
Q ss_pred CCCHH
Q 003576 533 NGSLE 537 (810)
Q Consensus 533 ~gsL~ 537 (810)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.7e-05 Score=72.98 Aligned_cols=128 Identities=16% Similarity=0.152 Sum_probs=92.4
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCcee-eeeceecCCCeEEEEeccCCCHHH
Q 003576 460 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL-LLLGACPDHGCLVYEYMENGSLED 538 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~g~~~~~~~lV~Ey~~~gsL~~ 538 (810)
....||+|.+|.||+|.+.+..+|+|+-..++ .+..+..|+++|..+.--++- ++|.+ +..++.|||+.|-.|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y--g~~~i~me~i~G~~L~~ 101 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY--GEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe--chhhhhhhhhcCcchhh
Confidence 34569999999999999999999999877654 456789999999998765553 33333 23356799999888877
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCC-CCceEecCCCceEEeeeccccc
Q 003576 539 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK-PGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 539 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLk-p~NILld~~~~~kL~DFGla~~ 604 (810)
.-... . .+-+..++..-.-|-..| |-|+.|. |..++|-.++.+.|+||..|+.
T Consensus 102 ~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54221 1 223345555555566667 9999984 6666666666999999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00011 Score=90.62 Aligned_cols=146 Identities=19% Similarity=0.215 Sum_probs=91.2
Q ss_pred ceeeccCCcEEEEEEEECC----eEEEEEEEcccCc-cchHHHHHHHHHHHhcC-CCce--eeeeceecCC-----CeEE
Q 003576 461 NLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHL--LLLLGACPDH-----GCLV 527 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~~----~~vavK~l~~~~~-~~~~~~~~Ei~iL~~l~-HpnI--v~l~g~~~~~-----~~lV 527 (810)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|+.+. |+++ .+++++|.+. .|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568999999999987754 3567776544321 23356889999999995 6665 7888888653 4899
Q ss_pred EEeccCCCHHH--------------------H---HhhcCC--------CCCCCH--HHHHHHH---------------H
Q 003576 528 YEYMENGSLED--------------------R---LYRKNN--------TPPIPW--FERYRIA---------------W 559 (810)
Q Consensus 528 ~Ey~~~gsL~~--------------------~---l~~~~~--------~~~l~~--~~~~~i~---------------~ 559 (810)
|||++|..+.+ . |+.... ..+..+ ..+..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 111000 001111 1111111 1
Q ss_pred HHHHHHHHHhhcCCC--------CEEecCCCCCceEecCC--CceEEeeeccccccC
Q 003576 560 EVASALAFLHNTKPK--------PIIHRDMKPGNILLDHN--LVSKIGDVGLSTMLN 606 (810)
Q Consensus 560 qia~aL~~LH~~~~~--------~ivHrDLkp~NILld~~--~~~kL~DFGla~~~~ 606 (810)
.+...+.+|..+-|. .+||+|++|.|||++.+ ..+-|.||+++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 133345677554432 49999999999999752 345799999987644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0001 Score=77.77 Aligned_cols=139 Identities=12% Similarity=0.049 Sum_probs=81.1
Q ss_pred eeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCCce-eeeeceecCCCeEEEEeccCCCHHHH--
Q 003576 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENGSLEDR-- 539 (810)
Q Consensus 463 ~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~g~~~~~~~lV~Ey~~~gsL~~~-- 539 (810)
.+..|-.+.+|+....+..+++|+.........-...+|..+|+.+..-.+ .++++.+ ..++||||++|..+...
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQF 80 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCcccccccc
Confidence 356688889999987777888887654322211235789999998863322 3444443 35799999998665321
Q ss_pred ---------------HhhcC-CCCCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCCEEecCCCCCceEe
Q 003576 540 ---------------LYRKN-NTPPIPWFER-YRIAWEV---------ASALAFLHNT-----KPKPIIHRDMKPGNILL 588 (810)
Q Consensus 540 ---------------l~~~~-~~~~l~~~~~-~~i~~qi---------a~aL~~LH~~-----~~~~ivHrDLkp~NILl 588 (810)
|+... ...+++.... ..+..++ ...+..+-.. .+..++|+|+.|.|||+
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 11111 0111222211 1111111 1112222211 12358999999999999
Q ss_pred cCCCceEEeeeccccc
Q 003576 589 DHNLVSKIGDVGLSTM 604 (810)
Q Consensus 589 d~~~~~kL~DFGla~~ 604 (810)
++++ +.|+||+.+..
T Consensus 161 ~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 161 TPQG-LKLIDWEYASD 175 (256)
T ss_pred eCCC-CEEEeccccCc
Confidence 9877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00031 Score=78.27 Aligned_cols=74 Identities=15% Similarity=0.029 Sum_probs=55.8
Q ss_pred eeeccCCcEEEEEEEECCe--EEEEEEEcccC-------ccchHHHHHHHHHHHhcC---CCceeeeeceecCCCeEEEE
Q 003576 462 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG-------NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYE 529 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~--~vavK~l~~~~-------~~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lV~E 529 (810)
..||.|.+..||++...+. .+.||.-.+.. ....+++..|.+.|..+. ..++++++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 4689999999999998753 79999743211 224566778888888873 35678888887877899999
Q ss_pred eccCCC
Q 003576 530 YMENGS 535 (810)
Q Consensus 530 y~~~gs 535 (810)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0003 Score=73.09 Aligned_cols=140 Identities=20% Similarity=0.213 Sum_probs=81.4
Q ss_pred eeeccCCcEEEEEEEEC---CeEEEEEEEcccCccchHHHHHHHHHHHhcCCC-ceeeeeceecCCCeEEEEeccCCCHH
Q 003576 462 LRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP-HLLLLLGACPDHGCLVYEYMENGSLE 537 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~g~~~~~~~lV~Ey~~~gsL~ 537 (810)
..|..|-...+|+.... +..|.+|+....... .-...+|+.++..+... -.+++++.+. ..++|||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 45777888899998876 467888876543221 12235788899888532 3345555443 35899999987653
Q ss_pred HH--------------H---hhcCCC--------CCCC-HHHHHHHHH----------------------HHH---HHHH
Q 003576 538 DR--------------L---YRKNNT--------PPIP-WFERYRIAW----------------------EVA---SALA 566 (810)
Q Consensus 538 ~~--------------l---~~~~~~--------~~l~-~~~~~~i~~----------------------qia---~aL~ 566 (810)
.. | +..... .... +..+..+.. .+. ..|.
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 1 111110 0111 222212211 111 1111
Q ss_pred -HHhhc-CCCCEEecCCCCCceEecC-CCceEEeeeccccc
Q 003576 567 -FLHNT-KPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTM 604 (810)
Q Consensus 567 -~LH~~-~~~~ivHrDLkp~NILld~-~~~~kL~DFGla~~ 604 (810)
.+-.. .+..++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11211 2345999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00038 Score=75.19 Aligned_cols=73 Identities=15% Similarity=0.032 Sum_probs=54.3
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCC---CceeeeeceecC-----CCeEEEEeccC
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH---PHLLLLLGACPD-----HGCLVYEYMEN 533 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~g~~~~-----~~~lV~Ey~~~ 533 (810)
..||.|..+.||+....+..+.+|..+. ......|..|...|+.|.- -.+.+++++|.+ ..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 4599999999999877555677777543 1133578899999998853 367788887743 24999999998
Q ss_pred CCH
Q 003576 534 GSL 536 (810)
Q Consensus 534 gsL 536 (810)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=5.7e-06 Score=93.27 Aligned_cols=180 Identities=17% Similarity=0.151 Sum_probs=125.3
Q ss_pred eeeccCCcEEEEEEEECCe-EEEEEEEcccCccchHHHHHHHHHHHhcCCCc-eeeeeceecCCC--eEEEEeccCC-CH
Q 003576 462 LRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHG--CLVYEYMENG-SL 536 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~--~lV~Ey~~~g-sL 536 (810)
+-+++|+++.+||.+...+ ....+++.. .....-++++|.+++||| .+..++-+..+. .++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 3478999999999865433 222333322 244556899999999999 666666654443 6789998776 22
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccc
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~ 616 (810)
....... .-.+.......+.+.-..+|++||+.. =+|+| |||... +..|.+||+....+....
T Consensus 323 ~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~------- 385 (829)
T KOG0576|consen 323 ALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM------- 385 (829)
T ss_pred cccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-------
Confidence 2111000 001222344456677788999999864 48998 887765 678999999987766432
Q ss_pred cccCCccCccccCccccccCCCCCcchhhhHHHHHHHHHhCCCCccc
Q 003576 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 663 (810)
Q Consensus 617 ~~~~~~gt~~Y~aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~~ 663 (810)
......+|+.+++||....+.+....|+|++|+--.+|--|-+|-..
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 33456899999999999999999999999999987788888777653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0013 Score=66.32 Aligned_cols=127 Identities=22% Similarity=0.286 Sum_probs=87.2
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEcccC----------------ccchHHHHHHHHHHHhcC------CCceeeee
Q 003576 460 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG----------------NIQNKQFLQELEVLSKIR------HPHLLLLL 517 (810)
Q Consensus 460 ~~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~----------------~~~~~~~~~Ei~iL~~l~------HpnIv~l~ 517 (810)
....||+|+.-.||.--. +....||+..... .....++.+|+.....+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 345799999999997433 3356788887665 122455677777766665 88999999
Q ss_pred ceecCCC--eEEEEeccC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCceEec
Q 003576 518 GACPDHG--CLVYEYMEN------GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 589 (810)
Q Consensus 518 g~~~~~~--~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLkp~NILld 589 (810)
|+..... .+|+|.+.+ -+|.+++.... ++. . +...+-.-..||-.++ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 9987655 688887643 36777774432 443 3 3333444456777777 99999999999995
Q ss_pred CC---C-ceEEee
Q 003576 590 HN---L-VSKIGD 598 (810)
Q Consensus 590 ~~---~-~~kL~D 598 (810)
.+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 33 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00092 Score=66.91 Aligned_cols=123 Identities=21% Similarity=0.261 Sum_probs=89.4
Q ss_pred cCcccceeeccCCc-EEEEEEEECCeEEEEEEEcc---cCc------------------cchHHHHHHHHHHHhcC---C
Q 003576 456 LSFSENLRIGMGGY-GTVYKGTFHHTFAAVKVLQS---KGN------------------IQNKQFLQELEVLSKIR---H 510 (810)
Q Consensus 456 ~~f~~~~~LG~G~~-g~Vy~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~Ei~iL~~l~---H 510 (810)
.+++..+.||.|.- |.||++...+..+|+|++.. ... ....-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888899999999 99999999999999999332 110 11124778888887774 5
Q ss_pred Cce--eeeeceec-C-------------C-C-----eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003576 511 PHL--LLLLGACP-D-------------H-G-----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 568 (810)
Q Consensus 511 pnI--v~l~g~~~-~-------------~-~-----~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L 568 (810)
.++ |+.+|+.. + . . .||.||++... .+. ..-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence 566 89988861 0 0 0 46778776533 111 23356778888999
Q ss_pred hhcCCCCEEecCCCCCceEecCCCceEEeeeccc
Q 003576 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 569 H~~~~~~ivHrDLkp~NILld~~~~~kL~DFGla 602 (810)
|..| |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999976 3489999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0016 Score=71.15 Aligned_cols=158 Identities=16% Similarity=0.232 Sum_probs=85.2
Q ss_pred cccCCHHHHHHhhcCccc-----ceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcC-----CCc
Q 003576 443 YRNLTWEEIESATLSFSE-----NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HPH 512 (810)
Q Consensus 443 ~~~~~~~ei~~~~~~f~~-----~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~-----Hpn 512 (810)
|..++.+++...-..|.. ...|+.|....+|+....+..+++|+.. . .....+..|+.++..|. -|.
T Consensus 4 yt~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~ 80 (319)
T PRK05231 4 YTDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPA 80 (319)
T ss_pred cccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCc
Confidence 344455555444344433 2346677778999988776688999876 2 12334445666666653 233
Q ss_pred eeee-----eceecCCCeEEEEeccCCCHH-----------HHH---hhcCCC--------CCCCH-HHHHH--------
Q 003576 513 LLLL-----LGACPDHGCLVYEYMENGSLE-----------DRL---YRKNNT--------PPIPW-FERYR-------- 556 (810)
Q Consensus 513 Iv~l-----~g~~~~~~~lV~Ey~~~gsL~-----------~~l---~~~~~~--------~~l~~-~~~~~-------- 556 (810)
++.- +....+..+++++|++|..+. ..| +..... ..+.| .....
T Consensus 81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (319)
T PRK05231 81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD 160 (319)
T ss_pred ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence 3321 111223347899999986431 111 111100 01112 11111
Q ss_pred ----HHHH-HHHHHHHHhhc----CCCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 557 ----IAWE-VASALAFLHNT----KPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 557 ----i~~q-ia~aL~~LH~~----~~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.+.+ +...+..+... -|.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 34569999999999999977667899999875
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0003 Score=60.80 Aligned_cols=83 Identities=12% Similarity=0.067 Sum_probs=64.3
Q ss_pred EEEEecCCcchHHHHHHHHhhcCCCCCceEEEEEeecCCCCCCCCCccccCCCCCCccccccccHHHHHHHHHHHHHHHh
Q 003576 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTD 96 (810)
Q Consensus 17 VlVaVDgs~~S~~Al~wA~~~~~~~~~~~l~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (810)
|+|+++|+..|..++.||.+.. .. ..+++++|+.
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~-~~~~~~~~~~-------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SG-GPEVVALVVV-------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hc-CCCEEEEEeH--------------------------------------------
Confidence 6899999999999999998854 22 3346666652
Q ss_pred hhhHHHHHHhhccceeeEEEEEecccHHHHHHHHHHhcCCcEEEEeccCCCcceeecccCCCc-cccccccC-CcceEEE
Q 003576 97 RLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLS-SRISICVP-SFCTVYG 174 (810)
Q Consensus 97 ~~l~~~~~~c~~~~v~~~~~v~e~g~~~~~I~~~a~~~~~d~iVmGs~g~~~~~~~~~~~~lg-Sv~~~v~~-~~cpV~v 174 (810)
...+.+.++++++++|+||+|+++.. .....+.| +++.+++. +.|||+.
T Consensus 35 -------------------------~~~~~~~~~a~~~~~~~Iv~G~~~~d----~~~~~~~~~~~~~~~~~~~~~~vl~ 85 (86)
T cd01984 35 -------------------------AFVRILKRLAAEEGADVIILGHNADD----VAGRRLGASANVLVVIKGAGIPVLT 85 (86)
T ss_pred -------------------------HHHHHHHHHHHHcCCCEEEEcCCchh----hhhhccCchhhhhhcccccCCceeC
Confidence 34455667788899999999999988 55666667 88888888 9999874
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.34 E-value=6.4e-05 Score=91.94 Aligned_cols=176 Identities=13% Similarity=0.059 Sum_probs=123.1
Q ss_pred EEEEEEEcccCccch-----HHHHHHHHHHHhcCCCceeeeeceecCC----CeEEEEeccCCCHHHHHhhcCC-CCCCC
Q 003576 481 FAAVKVLQSKGNIQN-----KQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYMENGSLEDRLYRKNN-TPPIP 550 (810)
Q Consensus 481 ~vavK~l~~~~~~~~-----~~~~~Ei~iL~~l~HpnIv~l~g~~~~~----~~lV~Ey~~~gsL~~~l~~~~~-~~~l~ 550 (810)
.+.+++.+...-... +....|.+-++...|+++...+.-.++. .+.+++|+.+|.+.+.|.+... .+++.
T Consensus 1254 ~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld 1333 (2724)
T KOG1826|consen 1254 WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLD 1333 (2724)
T ss_pred eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcch
Confidence 455666554332222 2233455555667899988766554332 2889999999999998876433 33344
Q ss_pred HHHHHHHHHHHHHHHHHHhhcC--CCCEEecCCCCCceEecCCCceEEeeeccccccCCCCCcccccccccCCccCcccc
Q 003576 551 WFERYRIAWEVASALAFLHNTK--PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628 (810)
Q Consensus 551 ~~~~~~i~~qia~aL~~LH~~~--~~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~ 628 (810)
..-+.....+...+..-+|+.. ..--+|++||+-|.+|..+..+|++++|+.+........ .....+++.|+
T Consensus 1334 ~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf------~Gl~l~sp~~v 1407 (2724)
T KOG1826|consen 1334 RSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF------FGLELCSPIYV 1407 (2724)
T ss_pred hchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhh------hhhhhCCHHHH
Confidence 4444444444366666655432 244799999999999999999999999999954433222 12347888999
Q ss_pred CccccccCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 003576 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 662 (810)
Q Consensus 629 aPE~~~~~~~~~~sDVwSlGvil~eLltg~~Pf~ 662 (810)
.|++...-.++.++|+|..|+.+|.+.-|.++|-
T Consensus 1408 ~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1408 LQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999888888989999999999999999988873
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0043 Score=67.34 Aligned_cols=140 Identities=15% Similarity=0.189 Sum_probs=81.3
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC--ceeeeeceec--------CCCeEEEEec
Q 003576 462 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGACP--------DHGCLVYEYM 531 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~~--------~~~~lV~Ey~ 531 (810)
..++.|....+|+....+..+.+|+..... ....+..|+.++..|... .+.+.+.... +..+++++|+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 346677678999987766678888875532 234456677777777422 2344443321 2237899999
Q ss_pred cCCCHH-----------HH---HhhcCCC--CC-------CCHHHHH------------HHHHHHHHHHHHHhh----cC
Q 003576 532 ENGSLE-----------DR---LYRKNNT--PP-------IPWFERY------------RIAWEVASALAFLHN----TK 572 (810)
Q Consensus 532 ~~gsL~-----------~~---l~~~~~~--~~-------l~~~~~~------------~i~~qia~aL~~LH~----~~ 572 (810)
+|..+. .. ++..... .+ -.|.... .....+...+.+|.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 885432 11 1111110 00 1111110 001123344555543 23
Q ss_pred CCCEEecCCCCCceEecCCCceEEeeecccc
Q 003576 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 573 ~~~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4569999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0023 Score=69.00 Aligned_cols=140 Identities=16% Similarity=0.183 Sum_probs=85.1
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEcccCccchHHHHHHHHHHHhcCCC--ceeeeecee--------cCCCeEEEEe
Q 003576 461 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGAC--------PDHGCLVYEY 530 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~g~~--------~~~~~lV~Ey 530 (810)
...|..|....+|+....+..+++|+... .....+..|+.++..+.+- .+.+.+... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 34577787889999887777899998764 2345577788888888532 244444322 2233789999
Q ss_pred ccCCCHHH----H----------HhhcCC--C------CCCCHHHHH----------HHHHHHHHHHHHHhh----cCCC
Q 003576 531 MENGSLED----R----------LYRKNN--T------PPIPWFERY----------RIAWEVASALAFLHN----TKPK 574 (810)
Q Consensus 531 ~~~gsL~~----~----------l~~~~~--~------~~l~~~~~~----------~i~~qia~aL~~LH~----~~~~ 574 (810)
++|..+.. . |+.... . ....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99866531 0 111000 0 011221110 011123334455543 2234
Q ss_pred CEEecCCCCCceEecCCCceEEeeecccc
Q 003576 575 PIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 575 ~ivHrDLkp~NILld~~~~~kL~DFGla~ 603 (810)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 59999999999999998888999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0007 Score=81.86 Aligned_cols=190 Identities=20% Similarity=0.161 Sum_probs=131.5
Q ss_pred HHHHHHHHhcCCCceeeeeceecCCC------eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003576 499 LQELEVLSKIRHPHLLLLLGACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572 (810)
Q Consensus 499 ~~Ei~iL~~l~HpnIv~l~g~~~~~~------~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 572 (810)
..|+..+.++.|+|++.++++..+.. .+..+|+..-++...+...+ .++....+.+..++..||.|+|...
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 45677788889999999998864433 23457888888888776544 3777888899999999999999986
Q ss_pred CCCEEecCCCCC---ceEecCCCceEEe--eeccccccCCCCCcccccccccCCccCccccCccccccCCCCC--cchhh
Q 003576 573 PKPIIHRDMKPG---NILLDHNLVSKIG--DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP--KSDVY 645 (810)
Q Consensus 573 ~~~ivHrDLkp~---NILld~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~--~sDVw 645 (810)
..|.-|..+ +...+..+.+.++ ||+.+..+...... .....+..|.+||......+.. ..|+|
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------FSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc-------hhhcCccccccccccccccchhhhhhHHH
Confidence 566555444 4455666777777 99988876654321 1224455678888766555444 47999
Q ss_pred hHHHHHHHHHhCCCCccccchhhhhhccchhHHHhhhhCCCCChhHHHHHHHHHHHHhhhcCCCCCccccch
Q 003576 646 AYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 717 (810)
Q Consensus 646 SlGvil~eLltg~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~cl~~dP~~RPs~~~~v 717 (810)
++|..+..+..|..+-...... ..+++. .....+.+...+|+.-++++|++..+++
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~---------~~~l~~-------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVP---------VSLLDV-------LSTSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHHHhhhhhcCcccccccch---------hhhhcc-------ccchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999999987654211111 111111 1111577788899999999999988544
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0028 Score=70.38 Aligned_cols=73 Identities=14% Similarity=0.052 Sum_probs=54.3
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEcccCc-------cchHHHHHHHHHHHhcC---CCceeeeeceecCCCeEEEEe
Q 003576 461 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN-------IQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYEY 530 (810)
Q Consensus 461 ~~~LG~G~~g~Vy~~~~~~~~vavK~l~~~~~-------~~~~~~~~Ei~iL~~l~---HpnIv~l~g~~~~~~~lV~Ey 530 (810)
.+.||.|....||+....+..+.||.-..... ....+-..|...|..+. ..++.+++.++.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 45689999999999988777788987542111 13344455677777664 357889999999999999999
Q ss_pred ccC
Q 003576 531 MEN 533 (810)
Q Consensus 531 ~~~ 533 (810)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 976
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0019 Score=69.97 Aligned_cols=139 Identities=22% Similarity=0.223 Sum_probs=82.9
Q ss_pred eeeccCCcEEEEEEEECC--------eEEEEEEEcccCccchHHHHHHHHHHHhcCCCc-eeeeeceecCCCeEEEEecc
Q 003576 462 LRIGMGGYGTVYKGTFHH--------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYEYME 532 (810)
Q Consensus 462 ~~LG~G~~g~Vy~~~~~~--------~~vavK~l~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~lV~Ey~~ 532 (810)
..|..|-...+|+....+ ..+++|+...... ......+|..++..+...+ ..++++++. ..+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeC
Confidence 346667777999988653 5788898665432 2234578888888885322 345565554 346899998
Q ss_pred CCCHHHH-----------------HhhcCCCC------CCC--HHHHHH--------------------------HHHHH
Q 003576 533 NGSLEDR-----------------LYRKNNTP------PIP--WFERYR--------------------------IAWEV 561 (810)
Q Consensus 533 ~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~qi 561 (810)
|..+... |+...... ..+ +..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766431 11111110 011 111111 11122
Q ss_pred HHHHHHHhh------cCCCCEEecCCCCCceEecCC----CceEEeeecccc
Q 003576 562 ASALAFLHN------TKPKPIIHRDMKPGNILLDHN----LVSKIGDVGLST 603 (810)
Q Consensus 562 a~aL~~LH~------~~~~~ivHrDLkp~NILld~~----~~~kL~DFGla~ 603 (810)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 223334432 234569999999999999874 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00073 Score=71.24 Aligned_cols=152 Identities=13% Similarity=0.111 Sum_probs=102.3
Q ss_pred ccccCCHHHHHHhhc---CcccceeeccCCcEEEEEEEEC-CeEEEEEEEcccCcc----------------------ch
Q 003576 442 RYRNLTWEEIESATL---SFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI----------------------QN 495 (810)
Q Consensus 442 ~~~~~~~~ei~~~~~---~f~~~~~LG~G~~g~Vy~~~~~-~~~vavK~l~~~~~~----------------------~~ 495 (810)
.|..+.+--|....+ -++..+.||-|.-+.||.+-+. +++.++|+-+..... .+
T Consensus 75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 345566655655544 3677889999999999999886 788888864321100 01
Q ss_pred HHHHHHHHHHHhcC-CC-ceeeeeceecCCCeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003576 496 KQFLQELEVLSKIR-HP-HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573 (810)
Q Consensus 496 ~~~~~Ei~iL~~l~-Hp-nIv~l~g~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 573 (810)
-...+|+..|+.|. |- -+.+.++++ ..|+|||++.|..|...-+- . ..-.+...+..-+.-|-.+|
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~~--RH~Vvmelv~g~Pl~~v~~v------~---d~~~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDHN--RHCVVMELVDGYPLRQVRHV------E---DPPTLYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccccc--ceeeHHHhhcccceeeeeec------C---ChHHHHHHHHHHHHHHHHcC-
Confidence 12357888888885 22 233334332 33899999998887653211 1 12234455555566777888
Q ss_pred CCEEecCCCCCceEecCCCceEEeeeccccccCC
Q 003576 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 574 ~~ivHrDLkp~NILld~~~~~kL~DFGla~~~~~ 607 (810)
+||||..--||++++++.++++||--+.....
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhhccCC
Confidence 99999999999999999999999987655443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 810 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-82
Identities = 102/294 (34%), Positives = 149/294 (50%), Gaps = 24/294 (8%)
Query: 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQEL 502
+ ++E AT +F IG G +G VYKG A+K + + ++F E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 503 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAW 559
E LS RHPHL+ L+G C + L+Y+YMENG+L+ LY + T + W +R I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKN 618
A L +LH + IIHRD+K NILLD N V KI D G+S D + +ST K
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK- 202
Query: 619 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE---------T 669
GTL YIDPEY G ++ KSDVY++G+V+ ++L A+ AI + E
Sbjct: 203 ----GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 670 AIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722
+ + L +I+D A + ++ + C L +DRP + VL LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 4e-80
Identities = 101/312 (32%), Positives = 167/312 (53%), Gaps = 29/312 (9%)
Query: 433 ERALNGTFQRYRNLTWEEIESATLSFSENL------RIGMGGYGTVYKGTFHHTFAAVKV 486
++L + R+ + ++ E+++ T +F E ++G GG+G VYKG ++T AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK 61
Query: 487 LQSKGNIQ----NKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL 540
L + +I +QF QE++V++K +H +L+ LLG D CLVY YM NGSL DRL
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 541 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600
+ TPP+ W R +IA A+ + FLH IHRD+K NILLD +KI D G
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 660
L+ + T + VGT Y+ PE G I+PKSD+Y++G+V+L+++T PA
Sbjct: 179 LARASEKF----AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 661 IAITHK----VETA----IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 712
+ + ++ +E + + +D + D + + ++ C ++ RPD
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 713 LKNQVLPVLERL 724
+K +V +L+ +
Sbjct: 294 IK-KVQQLLQEM 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-74
Identities = 100/296 (33%), Positives = 158/296 (53%), Gaps = 23/296 (7%)
Query: 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNK-QFLQE 501
+ + E++ A+ +FS +G GG+G VYKG T AVK L+ + + QF E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 502 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIA 558
+E++S H +LL L G C P LVY YM NGS+ L R + PP+ W +R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618
A LA+LH+ IIHRD+K NILLD + +GD GL+ +++ + V+T +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 196
Query: 619 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI-----------AITHKV 667
GT+ +I PEY TG S K+DV+ YG+++L+L+T + A + V
Sbjct: 197 ----GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 668 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722
+ + E L ++D G++ +E ++L + L C + +RP + +V+ +LE
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 9e-62
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 447 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLS 506
+ I+ + E +G G +G V K + A+K ++S+ K F+ EL LS
Sbjct: 1 SLHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLS 56
Query: 507 KIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
++ HP+++ L GAC + CLV EY E GSL + L+ P + + +A
Sbjct: 57 RVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 567 FLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
+LH+ +PK +IHRD+KP N+LL V KI D G + + + T G+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---------HMTNNKGSA 167
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
++ PE S K DV+++G+++ +++T +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-61
Identities = 69/302 (22%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 449 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
E + ++ G +G V+K + + AVK+ + Q+ Q E+ L +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNEYEVYSLPGM 75
Query: 509 RHPHLLLLLGAC--PDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 562
+H ++L +GA L+ + E GSL D L + W E IA +A
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMA 131
Query: 563 SALAFLHNTKPK-------PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615
LA+LH P I HRD+K N+LL +NL + I D GL+ + S T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 616 YKNTGPVGTLCYIDPEYQRTGLI-----SPKSDVYAYGMVILQLLTAKPAIAITHKVETA 670
+ VGT Y+ PE + + D+YA G+V+ +L + A
Sbjct: 192 GQ----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV----- 242
Query: 671 IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP--VLERLKEVA 728
++ + + +++ +E+ + +K RP L++ + L E
Sbjct: 243 --DEYMLPFEEEIGQHPSLEDMQEVV--------VHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 729 DR 730
+
Sbjct: 293 EE 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-60
Identities = 71/240 (29%), Positives = 123/240 (51%), Gaps = 13/240 (5%)
Query: 423 KHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA 482
H + N FQ + +I L+ E +IG G +GTV++ +H +
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDV 63
Query: 483 AVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLED 538
AVK+L + +FL+E+ ++ ++RHP+++L +GA P + +V EY+ GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 539 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598
L++ + R +A++VA + +LHN P PI+HR++K N+L+D K+ D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 599 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
GLS + ST + GT ++ PE R + KSDVY++G+++ +L T +
Sbjct: 183 FGLSRLKA------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-55
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 41/296 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSK 507
+I L E IG G +G VY G +H A++++ + + ++ K F +E+ +
Sbjct: 29 DIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQ 85
Query: 508 IRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
RH +++L +GAC P H ++ + +L + + + +IA E+ +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGM 143
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
+LH K I+H+D+K N+ D+ V I D GL ++ + K G L
Sbjct: 144 GYLHA---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRRED-KLRIQNGWL 198
Query: 626 CYIDPEYQRTGLI---------SPKSDVYAYGMVILQLLTAK------PAIAITHKVETA 670
C++ PE R S SDV+A G + +L + PA AI ++
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-- 256
Query: 671 IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
+ G KE++ + L C +++RP +++ +LE+L +
Sbjct: 257 --TGMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFT-KLMDMLEKLPK 302
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-54
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 35/290 (12%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL--QSKGNIQNKQFLQELEVL 505
WE I ++ + RIG G +GTVYKG +H AVK+L + Q + F E+ VL
Sbjct: 19 WE-IPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 506 SKIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
K RH ++LL +G +V ++ E SL L + + IA + A
Sbjct: 75 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARG 132
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+ +LH K IIHRD+K NI L + KIGD GL+T + S +++ G+
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW----SGSHQFEQLSGS 185
Query: 625 LCYIDPE---YQRTGLISPKSDVYAYGMVILQLLTAK-------PAIAITHKVETAIDED 674
+ ++ PE Q + S +SDVYA+G+V+ +L+T + I V
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG----RG 241
Query: 675 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
+L+ L + P K + L C + +R +RP ++L +E L
Sbjct: 242 SLSPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFP-RILAEIEEL 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVL 505
EI+ A L+ E IG+GG+G VY+ + AVK + + + QE ++
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 506 SKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 563
+ ++HP+++ L G C + CLV E+ G L L K IP A ++A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIAR 116
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLD--------HNLVSKIGDVGLSTMLNSDPSFVSTT 615
+ +LH+ PIIHRD+K NIL+ N + KI D GL+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----- 171
Query: 616 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 658
G ++ PE R + S SDV++YG+++ +LLT +
Sbjct: 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-53
Identities = 44/218 (20%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSK 507
I+ L+F ++ G ++KG + VKVL+ + + F +E L
Sbjct: 6 GIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 508 IRHPHLLLLLGAC----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 563
HP++L +LGAC H L+ +M GSL + L + + + + A ++A
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMAR 122
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623
+AFLH +P I + ++++D ++ ++I + S G +
Sbjct: 123 GMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----------PGRMY 170
Query: 624 TLCYIDPE---YQRTGLISPKSDVYAYGMVILQLLTAK 658
++ PE + +D++++ +++ +L+T +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVL-------QSKGNIQNKQF 498
+ + + + +IG GG+G V+KG + A+K L +++ + ++F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 499 LQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 558
+E+ ++S + HP+++ L G + +V E++ G L RL K + PI W + R+
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLD-----HNLVSKIGDVGLSTMLNSDPSFVS 613
++A + ++ N P PI+HRD++ NI L + +K+ D GLS
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------- 178
Query: 614 TTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQLLTAK 658
+ + +G +G ++ PE + K+D Y++ M++ +LT +
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-51
Identities = 66/320 (20%), Positives = 122/320 (38%), Gaps = 46/320 (14%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSK 507
+ L E +G G +G K T T +K L + FL+E++V+
Sbjct: 6 IFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 508 IRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+ HP++L +G + EY++ G+L + K+ PW +R A ++AS +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGM 121
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP---- 621
A+LH+ IIHRD+ N L+ N + D GL+ ++ + + P
Sbjct: 122 AYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 622 ----VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--- 674
VG ++ PE K DV+++G+V+ +++ A D D
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----------DPDYLP 227
Query: 675 -NLAEILDAQAG-------DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
+ L+ + + P + + C +L + RP ++ LE L+
Sbjct: 228 RTMDFGLNVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFV-KLEHWLETLRM 282
Query: 727 VADRARDTVPSVHPAPPNHF 746
P + +
Sbjct: 283 HLAGHLPLGPQLEQLDRGFW 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-51
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 33/243 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LSK 507
++ L E IG G YG VYKG+ AVKV + F+ E + +
Sbjct: 9 SLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPL 63
Query: 508 IRHPHLLLLLGAC-------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 560
+ H ++ + LV EY NGSL L W R+A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHS 119
Query: 561 VASALAFLHNTKPK------PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV-- 612
V LA+LH P+ I HRD+ N+L+ ++ I D GLS L +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 613 STTYKNTGPVGTLCYIDPEY-------QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 665
VGT+ Y+ PE + + D+YA G++ ++ +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 666 KVE 668
V
Sbjct: 240 SVP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LSKIRHPHLLLLLGAC 520
+G G YG V++G++ AVK+ S+ K + +E E+ +RH ++L + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 521 ------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN---- 570
L+ Y E GSL D L + RI +AS LA LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 571 TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
T+ KP I HRD+K NIL+ N I D+GL+ M S N VGT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMA 185
Query: 630 PE------YQRTGLISPKSDVYAYGMVILQLLT 656
PE + D++A+G+V+ ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-49
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 449 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LS 506
+ + + + +IG G YG V+ G + AVKV + + + +E E+
Sbjct: 32 QRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTV 86
Query: 507 KIRHPHLLLLLGAC------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 560
+RH ++L + A L+ +Y ENGSL D L + ++A+
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYS 142
Query: 561 VASALAFLHN----TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615
S L LH T+ KP I HRD+K NIL+ N I D+GL+ SD +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN--EVD 200
Query: 616 YKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLT 656
VGT Y+ PE + +D+Y++G+++ ++
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-48
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 445 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV 504
L I + T+ E IG G +G V++G + AVK+ S+ + + + +E E+
Sbjct: 34 LLVQRTI-ARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEI 87
Query: 505 --LSKIRHPHLLLLLGACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 556
+RH ++L + A LV +Y E+GSL D L R + +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIK 143
Query: 557 IAWEVASALAFLH----NTKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611
+A AS LA LH T+ KP I HRD+K NIL+ N I D+GL+ +S
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD- 202
Query: 612 VSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLT 656
+ VGT Y+ PE + ++D+YA G+V ++
Sbjct: 203 -TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 37/288 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G GG+G V++ +A ++ + ++ ++E++ L+K+ HP ++ A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 520 CPDHG--------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+ + + +L+D + + I ++A A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN------T 619
FLH+ ++HRD+KP NI + V K+GD GL T ++ D + T
Sbjct: 132 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 620 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679
G VGT Y+ PE S K D+++ G+++ +LL P +V T L ++
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRT------LTDV 240
Query: 680 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL--PVLERLK 725
+ + ++ + +RP+ ++ V E L
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-INIIENAVFEDLD 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 48/291 (16%)
Query: 414 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 473
Q + + + E E + + + +G F ++ IG G + TVY
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIE-----------------IGRGSFKTVY 43
Query: 474 KGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGACPDHG----- 524
KG T A LQ + ++ ++F +E E+L ++HP+++ +
Sbjct: 44 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103
Query: 525 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKP 583
LV E M +G+L+ ++ I + ++ L FLH P PIIHRD+K
Sbjct: 104 IVLVTELMTSGTLKT-YLKRFKVMKIKVLRSW--CRQILKGLQFLHTRTP-PIIHRDLKC 159
Query: 584 GNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 642
NI + KIGD+GL+T+ + +GT ++ PE
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRAS--------FAKAVIGTPEFMAPEMYEEKY-DESV 210
Query: 643 DVYAYGMVILQLLTAKP-------AIAITHKVETAIDEDNLAEILDAQAGD 686
DVYA+GM +L++ T++ A I +V + + + ++ + +
Sbjct: 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 50/291 (17%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
IG GG+G V+K +K + N++ +E++ L+K+ H +++ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 521 PDHG------------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 562
+ E+ + G+LE + ++ + + ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622
+ ++H+ K +I+RD+KP NI L KIGD GL T L +D +
Sbjct: 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-------K 182
Query: 623 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 682
GTL Y+ PE + + D+YA G+++ +LL TA + D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---------TAFETSKF--FTDL 231
Query: 683 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL---PVLERLKEVADR 730
+ G K+ L + +DRP+ +++L V ++ E +R
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT-SEILRTLTVWKKSPEKNER 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 68/275 (24%), Positives = 111/275 (40%), Gaps = 40/275 (14%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLL 517
IG G YG K K L G++ + E+ +L +++HP+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 518 GACPDHG----CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTK 572
D +V EY E G L + + + R+ ++ AL H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 573 PKP--IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
++HRD+KP N+ LD K+GD GL+ +LN D SF T VGT Y+ P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF------VGTPYYMSP 185
Query: 631 E------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-ILDAQ 683
E Y + KSD+++ G ++ +L P TA + LA I + +
Sbjct: 186 EQMNRMSY------NEKSDIWSLGCLLYELCALMPPF-------TAFSQKELAGKIREGK 232
Query: 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 718
P + + EL + L+ RP + ++L
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSV-EEIL 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G V K + A+K + + L E+ +L+ + H +++ A
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 521 PDHG---------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+ + EY ENG+L D ++ +N E +R+ ++ AL
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD--EYWRLFRQILEAL 129
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN------- 618
+++H+ IIHRD+KP NI +D + KIGD GL+ ++ + +N
Sbjct: 130 SYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 619 -TGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVIL 652
T +GT Y+ E TG + K D+Y+ G +I
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG-IIF 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 39/269 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 518
IG G +G +K + + + +K + +E+ VL+ ++HP+++
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+ ++G L V +Y E G L R+ + + ++ AL +H+ K I
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRK---I 146
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 631
+HRD+K NI L + ++GD G++ +LNS +GT Y+ PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENK 200
Query: 632 -YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-ILDAQAGDWPI 689
Y + KSD++A G V+ +L T K A A NL I+ +
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKHAF-------EAGSMKNLVLKIISGSFPPVSL 247
Query: 690 KETKELAALGLSCAELRRKDRPDLKNQVL 718
+ +L +L + +DRP + N +L
Sbjct: 248 HYSYDLRSLVSQLFKRNPRDRPSV-NSIL 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVL 505
WE +E ++ ++G G YG VY+G + + AVK L+ ++ ++FL+E V+
Sbjct: 215 WE-MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVM 270
Query: 506 SKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 563
+I+HP+L+ LLG C ++ E+M G+L D L R+ N + +A +++S
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 329
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623
A+ +L IHR++ N L+ N + K+ D GLS ++ D TY G
Sbjct: 330 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA--G 378
Query: 624 TLCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
I PE S KSDV+A+G+++ ++ T
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL-- 517
+G G V++G T A+KV + ++ ++E EVL K+ H +++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 518 --GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
H L+ E+ GSL L +N +P E + +V + L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 576 IIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I+HR++KPGNI+ D V K+ D G + L D + Y GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY------GTEEYLHPD 185
Query: 632 -YQRTGLI-------SPKSDVYAYGMVILQLLTAKP 659
Y+R L D+++ G+ T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 38/319 (11%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 503
E L + ++G G +G+V + AVK LQ G Q + F +E++
Sbjct: 19 IFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 504 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559
+L + ++ G G LV EY+ +G L D L + + + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSS 134
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
++ + +L + + +HRD+ NIL++ KI D GL+ +L D Y
Sbjct: 135 QICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----YYVVR 187
Query: 620 G----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-----AKPAIAITHKVETA 670
P+ + PE + S +SDV+++G+V+ +L T P+ +
Sbjct: 188 EPGQSPI---FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 671 IDEDNLAEILDA-QAG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
D L+ +L+ + G P E+ L C +DRP + P L+ L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS-ALGPQLDMLWS 303
Query: 727 VADRARDTVPSVHPAPPNH 745
+ + HP +H
Sbjct: 304 GSRGCETHAFTAHPEGKHH 322
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
EI +L ++G G +G V+ GT+ T A+K L+ G + + FLQE +V+ K+
Sbjct: 180 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 236
Query: 509 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
RH L+ L + +V EYM GSL D L + + + +A ++AS +A+
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+ +HRD++ NIL+ NLV K+ D GL+ ++ + K P+ +
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIK---W 347
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PE G + KSDV+++G+++ +L T
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 59/300 (19%), Positives = 104/300 (34%), Gaps = 40/300 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
++G GG+ V H F A+K + ++ +E ++ HP++L L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 521 PDHG------CLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L+ + + G+L + + K+ + + + + L +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK---NTGPVGTLCYIDP 630
K HRD+KP NILL + D+G T+ Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 631 E---YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687
E Q +I ++DV++ G V+ ++ + D++A + Q
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQNQL-SI 266
Query: 688 PIKET--KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNH 745
P L L S + RP + +L LE L+ PAP H
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEALQ-------------PPAPGQH 312
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVL-QSKGNIQNKQFLQELEV 504
W + L E +IG G +G V+ G +T AVK ++ +FLQE +
Sbjct: 109 WV-LNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 505 LSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 562
L + HP+++ L+G C +V E ++ G L + + ++ + A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAA 223
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622
+ + +L + K IHRD+ N L+ V KI D G+S Y +G +
Sbjct: 224 AGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG------VYAASGGL 274
Query: 623 GTLCY--IDPEYQRTGLISPKSDVYAYGMVI 651
+ PE G S +SDV+++G+++
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 70/340 (20%), Positives = 137/340 (40%), Gaps = 41/340 (12%)
Query: 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNK 496
+ L + L + +G G +GTV+KG + +KV+ G +
Sbjct: 4 KVLARI-FKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 497 QFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERY 555
+ + + H H++ LLG CP LV +Y+ GSL D + + + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLL 118
Query: 556 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 615
++A + +L ++HR++ N+LL ++ D G++ +L D
Sbjct: 119 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQ 171
Query: 616 YKNTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVET 669
+ P+ ++ E G + +SDV++YG+ + +L+T A+P + +V
Sbjct: 172 LLYSEAKTPIK---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
Query: 670 AIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP---DLKNQVLPVLERLKE 726
+++ E L P T ++ + + C + RP +L N+ +
Sbjct: 229 LLEKG---ERLAQ-----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280
Query: 727 VADRARDTVPSVHPAP-PNHFICPILKEVMNEPCVAADGY 765
R++ P + P P P+ L+EV EP + D
Sbjct: 281 YLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLD 320
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-31
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
EI +L ++G G +G V+ GT+ T A+K L+ G + + FLQE +V+ K+
Sbjct: 263 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 319
Query: 509 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
RH L+ L + +V EYM GSL D L + + + +A ++AS +A+
Sbjct: 320 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+ +HRD++ NIL+ NLV K+ D GL+ ++ + K P+
Sbjct: 379 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTA- 432
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PE G + KSDV+++G+++ +L T
Sbjct: 433 --PEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 518
IG G + VY+ A+K +Q + K ++E+++L ++ HP+++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 519 ACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 573
+ + L V E + G L + + K IP ER + ++ SAL +H+ +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP--ERTVWKYFVQLCSALEHMHSRR- 156
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 631
++HRD+KP N+ + V K+GD+GL +S + + VGT Y+ PE
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYYMSPERI 208
Query: 632 ----YQRTGLISPKSDVYAYGMVILQLLTAKPA 660
Y + KSD+++ G ++ ++ +
Sbjct: 209 HENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLL--- 517
+G G V++G T A+KV + ++ +E EVL K+ H +++ L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 518 -GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
H L+ E+ GSL L +N +P E + +V + L I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 577 IHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 631
+HR++KPGNI+ D V K+ D G + L D + Y GT Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY------GTEEYLHPDM 186
Query: 632 YQRTGLI-------SPKSDVYAYGMVILQLLTAKP 659
Y+R L D+++ G+ T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-30
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 509
+ L + IG G +G V G + AVK + K + + FL E V++++R
Sbjct: 189 ALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLR 244
Query: 510 HPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
H +L+ LLG + +Y EYM GSL D L R + + + +V A+
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
+L +HRD+ N+L+ + V+K+ D GL+ +S K T
Sbjct: 304 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA------ 354
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PE R S KSDV+++G+++ ++ +
Sbjct: 355 ---PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 1/73 (1%)
Query: 739 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPN 797
P P +F CPI E+M +P + + G TY+R +I++WL + P + L + L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 798 YTLLSAILDWKSK 810
Y L S I W
Sbjct: 62 YVLKSLIALWCES 74
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 517
+G GG+ ++ + T A K++ K + ++ E+ + + H H++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 518 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G D +V E SL + R+ + E ++ +LH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+K GN+ L+ +L KIGD GL+T + D GT YI PE
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL------CGTPNYIAPEVLSK 189
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
S + DV++ G ++ LL KP
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQ-SKGNIQNKQFLQ 500
++ + +G G +GTVYKG + A+K L+ + NK+ L
Sbjct: 9 LRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 501 ELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559
E V++ + +PH+ LLG C L+ + M G L D + + + I
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCV 124
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
++A + +L + + ++HRD+ N+L+ KI D GL+ +L ++ Y
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAE 177
Query: 620 G---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
G P+ ++ E + + +SDV++YG+ + +L+T
Sbjct: 178 GGKVPIK---WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 503
+ E L F + ++G G +G+V + AVK LQ + F +E+E
Sbjct: 6 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 504 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559
+L ++H +++ G C G L+ EY+ GSL D L + + I + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
++ + +L K IHRD+ NIL+++ KIGD GL+ +L D F
Sbjct: 122 QICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 620 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
P+ + PE S SDV+++G+V+ +L T
Sbjct: 179 SPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVL 505
WE +E ++ ++G G YG VY+G + + AVK L+ + ++ ++FL+E V+
Sbjct: 8 WE-MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 63
Query: 506 SKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 563
+I+HP+L+ LLG C ++ E+M G+L D L R+ N + +A +++S
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--- 620
A+ +L IHRD+ N L+ N + K+ D GLS ++ D TY
Sbjct: 123 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAK 173
Query: 621 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
P+ + PE S KSDV+A+G+++ ++ T
Sbjct: 174 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK 507
W + L + IG G +G V G + AVK + K + + FL E V+++
Sbjct: 16 WA-LNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQ 70
Query: 508 IRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
+RH +L+ LLG + +Y EYM GSL D L R + + + +V A
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEA 129
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG---P 621
+ +L +HRD+ N+L+ + V+K+ D GL+ + P
Sbjct: 130 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLP 177
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
V + PE R S KSDV+++G+++ ++ +
Sbjct: 178 V---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP--HLLLL 516
IG GG V++ + A+K + + N+ + E+ L+K++ ++ L
Sbjct: 36 IGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 517 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+V E N L L +K I +ER + A+ +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 631
I+H D+KP N L+ ++ K+ D G++ + D +T+ VGT+ Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGTVNYMPPEAIK 201
Query: 632 --------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ ISPKSDV++ G ++ + K
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 501
S + F+E IG G +G VY GT AVK L +I FL E
Sbjct: 19 VIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 502 LEVLSKIRHPHLLLLLGACPDHG---CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 558
++ HP++L LLG C +V YM++G L + + +N T +
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFG 134
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYK 617
+VA + +L + K +HRD+ N +LD K+ D GL+ M + + Y
Sbjct: 135 LQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY------YS 185
Query: 618 NTGPVGTLCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
G + E +T + KSDV+++G+++ +L+T
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 517
+G GG+ ++ + T A K++ K + ++ E+ + + H H++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 518 G--ACPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
G D +V E SL + RK T P E ++ +LH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQIVLGCQYLHR---N 160
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
+IHRD+K GN+ L+ +L KIGD GL+T + D GT YI PE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL------CGTPNYIAPEVLS 214
Query: 635 TGLISPKSDVYAYGMVILQLLTAKP 659
S + DV++ G ++ LL KP
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQS-KGNIQNKQFLQEL 502
E L +G G +G V + AVK L+ G +E+
Sbjct: 17 HFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 503 EVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 558
E+L + H +++ G C + G L+ E++ +GSL++ L N I ++ + A
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYA 132
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618
++ + +L + + +HRD+ N+L++ KIGD GL+ + +D + +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 619 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV + PE SDV+++G+ + +LLT
Sbjct: 190 DSPV---FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 517
+G G + VY+ HT A+K++ K + ++ E+++ +++HP +L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMI-DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 518 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
D LV E NG + L + P E ++ + + +LH+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHS---HG 132
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
I+HRD+ N+LL N+ KI D GL+T L T GT YI PE
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL------CGTPNYISPEIATR 186
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+SDV++ G + LL +P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRP 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 503
+ E L F + ++G G +G+V + AVK LQ + F +E+E
Sbjct: 37 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 504 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559
+L ++H +++ G C G L+ EY+ GSL D L + + I + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
++ + +L K IHRD+ NIL+++ KIGD GL+ +L D + YK
Sbjct: 153 QICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVK 205
Query: 620 G----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
P+ + PE S SDV+++G+V+ +L T
Sbjct: 206 EPGESPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 51/204 (25%), Positives = 77/204 (37%), Gaps = 21/204 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKI-RHPHLLLLL 517
R+G G YG V+K AVK S G + L E+ K+ +HP + L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 518 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
A L E SL+ +P + + + ALA LH+
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG--- 177
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
++H D+KP NI L K+GD GL L + G Y+ PE +
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQ------EGDPRYMAPELLQG 230
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+DV++ G+ IL++
Sbjct: 231 SY-GTAADVFSLGLTILEVACNME 253
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHP--HLLLLL 517
IG GG V++ + A+K L+ N + E+ L+K++ ++ L
Sbjct: 17 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 518 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+V E N L L +K I +ER + A+ +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 631
I+H D+KP N L+ ++ K+ D G++ + D +T+ VGT+ Y+ PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGTVNYMPPEAIKD 183
Query: 632 -------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ ISPKSDV++ G ++ + K
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-AVKVLQSKGNIQNKQFLQELEVLS 506
W I+ + L+F + IG G +G V+ G + + A+K ++ +G + + F++E EV+
Sbjct: 3 WV-IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMM 58
Query: 507 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
K+ HP L+ L G C + CLV E+ME+G L D Y + + +V
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG 116
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+A+L +IHRD+ N L+ N V K+ D G++ + D Y ++ GT
Sbjct: 117 MAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD------QYTSST--GT 165
Query: 625 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
+ PE S KSDV+++G+++ ++ +
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLS 506
WE + TL E R+G G +G V+ G + HT AVK L+ G++ FL E ++
Sbjct: 8 WE-VPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMK 63
Query: 507 KIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+++H L+ L ++ EYMENGSL D L + + + + +A ++A +
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
AF+ IHRD++ NIL+ L KI D GL+ ++ + Y T G
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EY--TAREGAK 171
Query: 626 CYID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
I PE G + KSDV+++G+++ +++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 70/336 (20%), Positives = 139/336 (41%), Gaps = 41/336 (12%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSK-GNIQNKQFLQ 500
++ + +G G +GTVYKG + A+K L+ NK+ L
Sbjct: 9 LRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 501 ELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559
E V++ + +PH+ LLG C L+ + M G L D + + + I
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCV 124
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
++A + +L + + ++HRD+ N+L+ KI D GL+ +L ++ Y
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAE 177
Query: 620 G---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDE 673
G P+ ++ E + + +SDV++YG+ + +L+T +KP I ++ + +++
Sbjct: 178 GGKVPIK---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 733
E L P T ++ + + C + RP + +++ ++ R
Sbjct: 235 G---ERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLV 285
Query: 734 TVPSVHPAPPN----HFICPILKEVMNEPCVAADGY 765
P+ +F ++ E + V AD Y
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 501
S + F+E IG G +G VY GT AVK L +I FL E
Sbjct: 83 VIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 502 LEVLSKIRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIA 558
++ HP++L LLG C YM++G L + + +N T +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFG 198
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYK 617
+VA + FL + K +HRD+ N +LD K+ D GL+ M + + + +
Sbjct: 199 LQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHN 252
Query: 618 NTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
TG PV ++ E +T + KSDV+++G+++ +L+T
Sbjct: 253 KTGAKLPV---KWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGA 519
+G G G V+K + + A K++ + Q ++EL+VL + P+++ GA
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 520 CPDHGCLVY--EYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 575
G + E+M+ GSL+ + +K IP E+ +++ V L +L
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAG--RIP--EQILGKVSIAVIKGLTYLREKHK-- 152
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
I+HRD+KP NIL++ K+ D G+S L ++ ++ VGT Y+ PE +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF-----VGTRSYMSPERLQG 204
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
S +SD+++ G+ ++++ + I E + E A+ P + L
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 696 AALG 699
G
Sbjct: 265 NKFG 268
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-29
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
EI +L + ++G G +G V+ T++ HT AVK ++ G++ + FL E V+ +
Sbjct: 184 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 240
Query: 509 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
+H L+ L ++ E+M GSL D L + + P + + ++A +AF
Sbjct: 241 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+ + IHRD++ NIL+ +LV KI D GL+ ++ + Y T G
Sbjct: 300 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EY--TAREGAKFP 348
Query: 628 ID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
I PE G + KSDV+++G+++++++T
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 18/217 (8%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGNIQNKQ-FLQELE 503
I + + IG G +G VY G + + A+K L +Q + FL+E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 504 VLSKIRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 560
++ + HP++L L+G L + YM +G L + ++ + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQ 132
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKNT 619
VA + +L K +HRD+ N +LD + K+ D GL+ +L+ + V
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 620 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV + E +T + KSDV+++G+++ +LLT
Sbjct: 190 LPVK---WTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 506
E ++ ++ + +G G +G V G + AVK+++ +G++ +F QE + +
Sbjct: 3 ME-LKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMM 58
Query: 507 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
K+ HP L+ G C +V EY+ NG L + Y +++ + + + ++V
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+AFL + IHRD+ N L+D +L K+ D G++ + D Y ++ GT
Sbjct: 117 MAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSV--GT 165
Query: 625 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
+ PE S KSDV+A+G+++ ++ +
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 11/162 (6%)
Query: 653 QLLTAKPAI---AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKD 709
L AK ++ + L + + + + + + ++ +
Sbjct: 18 ALRIAKKKRWNSIEEKRISQENELHAYLSKLILAEKERELDDRVKQSDDSQNGGDISKMK 77
Query: 710 RPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDR 769
++ L ++ L D R P++ I E+M EPC+ G TYDR
Sbjct: 78 --SKHDKYLMDMDELFSQVDEKRKKRE-----IPDYLCGKISFELMREPCITPSGITYDR 130
Query: 770 KAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
K IEE LQ P+T PL L+PN + I + +
Sbjct: 131 KDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQE 172
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 506
WE I+ L+F + +G G +G V G + A+K+++ +G++ +F++E +V+
Sbjct: 19 WE-IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMM 74
Query: 507 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
+ H L+ L G C ++ EYM NG L + Y + + + +V A
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEA 132
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+ +L + + +HRD+ N L++ V K+ D GLS + D Y T VG+
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EY--TSSVGS 181
Query: 625 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 656
+ PE S KSD++A+G+++ ++ +
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHP--HLLLLL 517
IG GG V++ + A+K L+ N + E+ L+K++ ++ L
Sbjct: 64 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 518 GACPDHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ Y ME N L L +K I +ER + A+ +H
Sbjct: 123 DYEITDQYI-YMVMECGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 631
I+H D+KP N L+ ++ K+ D G++ + D +T+ VG + Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGAVNYMPPEAIKD 230
Query: 632 -------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ ISPKSDV++ G ++ + K
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 71/299 (23%), Positives = 118/299 (39%), Gaps = 31/299 (10%)
Query: 446 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQS---KGNIQNKQ 497
LT I L E ++G G +G V +G + AVK L+
Sbjct: 11 LTCL-IGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 498 FLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 556
F++E+ + + H +L+ L G +V E GSL DRL + + R
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSR 125
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616
A +VA + +L + K IHRD+ N+LL + KIGD GL L +
Sbjct: 126 YAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDE 673
P + PE +T S SD + +G+ + ++ T +P I + ++ ID+
Sbjct: 183 HRKVPFA---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 732
+ E L P +++ + + C + +DRP + L + RA
Sbjct: 240 EG--ERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEAQPTDMRAE 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGAC 520
+ GG+ VY+ + A+K L S +N+ +QE+ + K+ HP+++ A
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 521 ---------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
L+ + G L + L + + P+ +I ++ A+ +H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP------VGTL 625
KP PIIHRD+K N+LL + K+ D G +T ++ P + + + T
Sbjct: 156 KP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 626 CYIDPE----YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
Y PE Y I K D++A G ++ L + ++ I++
Sbjct: 215 MYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ----------HPFEDGAKLRIVN 263
Query: 682 AQAGDWPIKET--KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727
+ P +T +L + ++ ++R + +V+ L+ +
Sbjct: 264 GK-YSIPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAA 309
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQN--KQFLQEL 502
I + +G G +G+V + AVK+L++ + ++FL+E
Sbjct: 19 LIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 503 EVLSKIRHPHLLLLLGACPDHG--------CLVYEYMENGSLED--RLYRKNNTPPIPWF 552
+ + HPH+ L+G ++ +M++G L R P
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 553 ER-YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPS 610
+ R ++A + +L + IHRD+ N +L ++ + D GLS + + D
Sbjct: 137 QTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-- 191
Query: 611 FVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
Y+ PV ++ E L + SDV+A+G+ + +++T
Sbjct: 192 ----YYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 441 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA------AVKVL-QSKGNI 493
Q T E I + ++ + IG G +G VYKG + A+K L
Sbjct: 32 QAVLKFTTE-IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK 88
Query: 494 QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPW 551
Q FL E ++ + H +++ L G + ++ EYMENG+L+ + +
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV 146
Query: 552 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611
+ + +A+ + +L N +HRD+ NIL++ NLV K+ D GLS +L DP
Sbjct: 147 LQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-- 201
Query: 612 VSTTYKNTG---PVG-TLCYIDPEYQRTGLISPKSDVYAYGMVI 651
TY +G P+ T PE + SDV+++G+V+
Sbjct: 202 -EATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVM 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 501
+ I + + +G G +G VY+G + + AVK + + NK+ F+ E
Sbjct: 7 YG-IAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 502 LEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 560
++ + HPH++ L+G + ++ E G L L + N + + +
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQ 121
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 620
+ A+A+L + +HRD+ NIL+ K+GD GLS + + YK +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASV 173
Query: 621 ---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
P+ ++ PE + SDV+ + + + ++L+
Sbjct: 174 TRLPIK---WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA------AVKVLQSKGNIQNKQ-FLQEL 502
L +G G +G V + T AVK L++ Q++ + QE+
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 503 EVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 558
++L + H H++ G C D G LV EY+ GSL D L +++ I + A
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS---IGLAQLLLFA 140
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618
++ +A+LH IHRD+ N+LLD++ + KIGD GL+ + + Y+
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRV 193
Query: 619 TG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV + PE + SDV+++G+ + +LLT
Sbjct: 194 REDGDSPV---FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 50/217 (23%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQ-FLQELE 503
EI+ + IG G +G V++G + A+K ++ + ++ FLQE
Sbjct: 11 EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 504 VLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 562
+ + HPH++ L+G ++ ++ E G L + + + A++++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLS 126
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-- 620
+ALA+L + + +HRD+ N+L+ N K+GD GLS + T YK +
Sbjct: 127 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGK 178
Query: 621 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
P+ ++ PE + SDV+ +G+ + ++L
Sbjct: 179 LPIK---WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 48/252 (19%)
Query: 431 MLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQ 488
M+ + +N RY +I ++G GG TVY + A+K +
Sbjct: 4 MIGKIINE---RY------KIVD---------KLGGGGMSTVYLAEDTILNIKVAIKAIF 45
Query: 489 SKGNIQNKQFL----QELEVLSKIRHPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYR 542
+ ++ L +E+ S++ H +++ ++ + C LV EY+E +L + +
Sbjct: 46 IPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES 104
Query: 543 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
P+ ++ + H+ + I+HRD+KP NIL+D N KI D G++
Sbjct: 105 HG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA 158
Query: 603 TMLNSDPSFVSTTYKNTGPV-GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP-- 659
L+ T+ T V GT+ Y PE + +D+Y+ G+V+ ++L +P
Sbjct: 159 KALS------ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 660 ------AIAITH 665
+IAI H
Sbjct: 213 NGETAVSIAIKH 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 441 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVL-QSKGNIQ 494
+ R+ T E IE++ + + IG G G V G A+K L Q
Sbjct: 37 RAGRSFTRE-IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 495 NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF 552
+ FL E ++ + HP+++ L G +V EYMENGSL+ + + +
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIM 151
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612
+ + V + + +L + +HRD+ N+L+D NLV K+ D GLS +L DP
Sbjct: 152 QLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--- 205
Query: 613 STTYKNTG---PVG-TLCYIDPEYQRTGLISPKSDVYAYGMVI 651
Y TG P+ T PE S SDV+++G+V+
Sbjct: 206 DAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVM 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 22/247 (8%)
Query: 488 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNN 545
++ + + + L L + +L+D + R+ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 546 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605
I ++A A+ FLH+ ++HRD+KP NI + V K+GD GL T +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 606 NSDPSFVST------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ D + +TG VGT Y+ PE S K D+++ G+++ +LL +
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 660 AIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL- 718
++ T + + ++ + + +RP+ ++
Sbjct: 275 TQMERVRIITDVRNLKFPLL--------FTQKYPQEHMMVQDMLSPSPTERPEA-TDIIE 325
Query: 719 -PVLERL 724
+ E L
Sbjct: 326 NAIFENL 332
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQ-FLQELEV 504
++ L ++ + +G G +G+V +G + A+KVL+ + + ++E ++
Sbjct: 5 FLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 505 LSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 563
+ ++ +P+++ L+G C LV E G L L IP + +V+
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSM 121
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623
+ +L K +HRD+ N+LL + +KI D GLS L +D S+ + P+
Sbjct: 122 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 624 TLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+ PE S +SDV++YG+ +
Sbjct: 179 ---WYAPECINFRKFSSRSDVWSYGVTM 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 501
E+ ++ S +G G +G VY+G T A+K + +++ + FL E
Sbjct: 21 EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED-------RLYRKNNTPPIPWF 552
V+ + H++ LLG ++ E M G L+ + P
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612
+ ++A E+A +A+L+ +HRD+ N ++ + KIGD G++ +
Sbjct: 139 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---- 191
Query: 613 STTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
Y+ G PV ++ PE + G+ + SDV+++G+V+
Sbjct: 192 -DYYRKGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLL-- 517
R+G GG+G V + T A+K + + + +N++ E++++ K+ HP+++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 518 ------GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
A D L EY E G L L + N + + +++SAL +LH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 572 KPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
+ IIHRD+KP NI+L L+ KI D+G + L+ + VGTL Y+
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEF------VGTLQYL 190
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE + D +++G + + +T
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQN--KQFLQEL 502
I+ L + +G G +G+V +G AVK ++ + Q ++FL E
Sbjct: 30 VIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 503 EVLSKIRHPHLLLLLGACPDHGC-------LVYEYMENGSLED--RLYR-KNNTPPIPWF 552
+ HP+++ LLG C + ++ +M+ G L R + IP
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSF 611
+ ++A + +L N +HRD+ N +L ++ + D GLS + + D
Sbjct: 148 TLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD--- 201
Query: 612 VSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
Y+ PV +I E + + KSDV+A+G+ + ++ T
Sbjct: 202 ---YYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 441 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVL-QSKGNIQ 494
Q E +++ +S + +G G +G V G A+K L Q
Sbjct: 33 QTVHEFAKE-LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 495 NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF 552
+ FL E ++ + HP+++ L G +V EYMENGSL+ + + +
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVI 147
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612
+ + +AS + +L + +HRD+ NIL++ NLV K+ D GL +L DP
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
TT P+ + PE + SDV++YG+V+
Sbjct: 205 YTTRGGKIPIR---WTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEV-LSKIRHPHLLLLLG 518
+G G YG V K + AVK +++ N Q K+ L +L++ + + P + G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 574
A G + E M + SL D+ Y++ E +IA + AL LH+ K
Sbjct: 74 ALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 629
+IHRD+KP N+L++ K+ D G+S L V K+ G Y I+
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDID-AGCKPYMAPERIN 182
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE + G S KSD+++ G+ +++L +
Sbjct: 183 PELNQKGY-SVKSDIWSLGITMIELAILRF 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQEL 502
I+ + +G G +G V+ + AVK L+ K F +E
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 68
Query: 503 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERYR-- 556
E+L+ ++H H++ G C D +V+EYM++G L R + + + R
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 557 ---------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607
IA ++AS + +L + +HRD+ N L+ NL+ KIGD G+S + S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 608 DPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
Y+ G P+ ++ PE + +SDV+++G++
Sbjct: 186 TD-----YYRVGGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVI 224
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 499
WE LSF + +G G +G V + T + AVK+L+ ++ ++ +
Sbjct: 18 WE-FPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 500 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER 554
EL+VLS + H +++ LLGAC G ++ EY G L + R R +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 555 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
+++VA +AFL + IHRD+ NILL H ++KI D GL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 602 STMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
+ + +D Y G PV ++ PE + + +SDV++YG+
Sbjct: 192 ARDIKNDS-----NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIF 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 55/297 (18%), Positives = 104/297 (35%), Gaps = 50/297 (16%)
Query: 463 RIGMGGYGTVYKGTFHHTFA---AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL- 517
I GG G +Y + +K L G+ + + + E + L+++ HP ++ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 518 -GACPDHGC-----LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
D +V EY+ SL+ + +P E E+ AL++LH+
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS- 200
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDP 630
+++ D+KP NI+L + K+ D+G + +NS G + GT + P
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS-----------FGYLYGTPGFQAP 246
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 690
E + +D+Y G + L P + D+ +K
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP-------------VLK 292
Query: 691 ETKELAALGLSCAELRRKDRP----DLKNQVLPVLERLKEVADRARDTVPSVHPAPP 743
L + + R ++ Q+ VL + S +P
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPS 349
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 444 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQ-- 497
R ++ L+ E+ +G G +GTV KG + AVK+L+++ N +
Sbjct: 7 RPKEVY-LDRKLLTL-EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 498 FLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 556
L E V+ ++ +P+++ ++G C LV E E G L L ++N
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI--IE 121
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616
+ +V+ + +L +HRD+ N+LL +KI D GLS L +D ++
Sbjct: 122 LVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
PV + PE S KSDV+++G+++ + +
Sbjct: 179 HGKWPVK---WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 51/229 (22%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 438 GTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN 492
T+ +E I+ + IG G +G V++G + A+K ++ +
Sbjct: 375 DTYTMPSTRDYE-IQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431
Query: 493 IQNKQ-FLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIP 550
++ FLQE + + HPH++ L+G ++ ++ E G L + + +
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKFSLD 489
Query: 551 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
A+++++ALA+L + + +HRD+ N+L+ N K+GD GLS +
Sbjct: 490 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 544
Query: 611 FVSTTYKNTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 656
T YK + P+ ++ PE + SDV+ +G+ + ++L
Sbjct: 545 ---TYYKASKGKLPIK---WMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 517
+G G +G VY + A+KVL K ++ Q +E+E+ S +RHP++L L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 518 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G D L+ EY G++ L + + E+A+AL++ H+ K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHS---KR 129
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+KP N+LL KI D G S S S + GTL Y+ PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDL------CGTLDYLPPEMIEG 181
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+ K D+++ G++ + L KP
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/269 (19%), Positives = 96/269 (35%), Gaps = 30/269 (11%)
Query: 406 ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-- 463
S + Q AK + L+R T L E+++ + E +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 464 -----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G +G V++ T AVK ++ + +EL + + P ++ L
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPL 115
Query: 517 LGACPDHGCL--VYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
GA + + E +E GSL + ++ + L +LH +
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-----QALEGLEYLHTRR 170
Query: 573 PKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I+H D+K N+LL + + D G + L D S + GT ++ PE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPE 226
Query: 632 -YQRTGLISPKSDVYAYGMVILQLLTAKP 659
K D+++ ++L +L
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCH 254
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSK-IRHPHLLLLLG 518
+G G G V+K F T AVK ++ GN + NK+ L +L+V+ K P+++ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 574
+ + E M E R PIP ER ++ + AL +L
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQG--PIP--ERILGKMTVAIVKALYYLKEKHG- 145
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 629
+IHRD+KP NILLD K+ D G+S L V K+ G Y ID
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDKAKDRS-AGCAAYMAPERID 197
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
P ++DV++ G+ +++L T +
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQEL 502
I+ + +G G +G V+ H+ AVK L+ + F +E
Sbjct: 37 HIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 503 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRL------------YRKNNTPP 548
E+L+ ++H H++ G C + +V+EYM +G L L P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 549 IPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNS 607
+ + +A +VA+ + +L +HRD+ N L+ LV KIGD G+S + ++
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 608 DPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
D Y+ G P+ ++ PE + +SDV+++G+V
Sbjct: 212 D------YYRVGGRTMLPI---RWMPPESILYRKFTTESDVWSFGVV 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 499
WE L + +G G +G V + AVK+L+ + +
Sbjct: 22 WE-FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 500 QELEVLSKI-RHPHLLLLLGACPDHG---CLVYEYMENGSLED--RLYRKNNTPPIPWFE 553
EL++L I H +++ LLGAC G ++ E+ + G+L R R P E
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 554 RYR-----------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
+++VA + FL + K IHRD+ NILL V KI D GL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 603 TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+ DP Y G P+ ++ PE + + +SDV+++G+++
Sbjct: 196 RDIYKDP-----DYVRKGDARLPL---KWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
+G G YG VY G A+K + + + ++ +E+ + ++H +++ LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 522 DHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 577
++G + E + GSL L ++ P+ E+ ++ L +LH+ + I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 578 HRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQR 634
HRD+K N+L++ ++ V KI D G S L T GTL Y+ PE +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF------TGTLQYMAPEIIDKG 198
Query: 635 TGLISPKSDVYAYGMVILQLLTAKP 659
+D+++ G I+++ T KP
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQ-FLQEL 502
+ ++ + F + IG G +G V K AA+K ++ + + + F EL
Sbjct: 19 YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 76
Query: 503 EVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY---- 555
EVL K+ HP+++ LLGAC G L EY +G+L D L + P F
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 556 ---------RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606
A +VA + +L + IHRD+ NIL+ N V+KI D GLS
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--G 191
Query: 607 SDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
+ Y PV ++ E + + SDV++YG++
Sbjct: 192 QE------VYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVL 230
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
IG G V A+K + K + L+E++ +S+ HP+++ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 520 --CPDHGCLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTK 572
D LV + + GS+ D + + IA EV L +LH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 631
IHRD+K GNILL + +I D G+S L + + T VGT C++ PE
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWMAPEV 197
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKP 659
++ K+D++++G+ ++L T
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 51/241 (21%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELE 503
+ E+E +IG G +G+V+K A+K G++ + L+E+
Sbjct: 13 FHELE----------KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 504 VLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAW 559
+ + +H H++ A + + EY GSL D + E +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHN-------------------LVSKIGDVG 600
+V L ++H+ ++H D+KP NI + ++ KIGD+G
Sbjct: 123 QVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVILQLLTAKP 659
T ++S G ++ E Q PK+D++A + ++ A+P
Sbjct: 180 HVTRISSPQVE----------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 660 A 660
Sbjct: 230 L 230
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 499
WE L + +G G +G V K T H T AVK+L+ + + L
Sbjct: 18 WE-FPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 500 QELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERY 555
E VL ++ HPH++ L GAC G L+ EY + GSL R RK +
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 556 -------------------RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596
AW+++ + +L K ++HRD+ NIL+ KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKI 191
Query: 597 GDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
D GLS + + +Y PV ++ E + + +SDV+++G++
Sbjct: 192 SDFGLSRDVYEED-----SYVKRSQGRIPV---KWMAIESLFDHIYTTQSDVWSFGVL 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQ- 497
WE L+ + +G G +G V AVK+L+ ++
Sbjct: 30 WE-FPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 86
Query: 498 FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 554
+ E+E++ I +H +++ LLGAC G ++ EY G+L + L + ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 555 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
R +++A + +L + K IHRD+ N+L+ N V KI D GL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 203
Query: 602 S-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+ + N D YK T PV ++ PE + + +SDV+++G+++
Sbjct: 204 ARDINNID------YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 464 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN------------------KQFLQELEVL 505
+ G + + + F A+K K ++ F EL+++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKY-EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 506 SKIRHPHLLLLLG--ACPDHGCLVYEYMENGSLEDRL-----YRKNNTPPIPWFERYRIA 558
+ I++ + L G D ++YEYMEN S+ KN T IP I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618
V ++ +++HN K I HRD+KP NIL+D N K+ D G S + + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGS--- 210
Query: 619 TGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQLLTAKP 659
GT ++ PE + K D+++ G+ + +
Sbjct: 211 ---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 439 TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG 491
+ E + ++ +G G +G VY+G AVK L
Sbjct: 16 GKTSSISDLKE-VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 492 NIQNKQ-FLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNT 546
+ Q++ FL E ++SK H +++ +G ++ E M G L+ R R +
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 547 --PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGL 601
+ + +A ++A +L IHRD+ N LL V+KIGD G+
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 602 STMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+ + + Y+ G PV ++ PE G+ + K+D +++G+++
Sbjct: 190 ARDIYRA-----SYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 456 LSFSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHL 513
+SF +G G GT VY+G F + AVK + + +E+++L + HP++
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNV 80
Query: 514 LLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
+ D + E +L++ + +K+ E + + S LA LH+
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTSGLAHLHSL 137
Query: 572 KPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
I+HRD+KP NIL+ + + I D GL L + + +G GT
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR---HSFSRRSGVPGTEG 191
Query: 627 YIDPEY---QRTGLISPKSDVYAYGMVILQLLT 656
+I PE + D+++ G V +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 446 LTWEEIESATLSFSENLRIGMGGYGTVYKGTF---------HHTFAAVKVLQSKGNIQNK 496
+ + I + L F+E +G G + ++KG H T +KVL ++
Sbjct: 1 VFHK-IRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE 57
Query: 497 QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 554
F + ++SK+ H HL+L G C LV E+++ GSL+ L + N I W
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-- 115
Query: 555 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--------HNLVSKIGDVGLSTMLN 606
+A ++A+A+ FL +IH ++ NILL + K+ D G+S +
Sbjct: 116 LEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 607 SDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVI 651
+ + ++ PE + ++ +D +++G +
Sbjct: 173 PK-----DILQ--ERIP---WVPPECIENPKN--LNLATDKWSFGTTL 208
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 40/230 (17%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQ-FL 499
WE L F + L G G +G V + T AVK+L+S + K+ +
Sbjct: 41 WE-FPRNNLQFGKTL--GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 500 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT---------- 546
EL+++S + +H +++ LLGAC G ++ EY G L + L RK+
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 547 -PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605
+ + +VA +AFL + IHRD+ N+LL + V+KIGD GL+ +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 606 NSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+D Y G PV ++ PE + + +SDV++YG+++
Sbjct: 215 MNDS-----NYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 38/233 (16%), Positives = 73/233 (31%), Gaps = 29/233 (12%)
Query: 449 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQFLQE 501
E + + + +G G + VY+ T +KV + + Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 502 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRI 557
+E L + A + LV E G+L + + Y+ +P
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS-----------KIGDVGLSTMLN 606
A + + +H+ + IIH D+KP N +L + + + D+G S +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
P T T + E + + D + + +L
Sbjct: 235 LFPKGTIF----TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEV-LSKIRHPHLLLLLG 518
IG G YG+V K + AVK ++S + + KQ L +L+V + P+++ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 574
A G E M + S + + E +I AL L
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 629
IIHRD+KP NILLD + K+ D G+S L + T G Y ID
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQL-------VDSIAKTRDAGCRPYMAPERID 198
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
P R G +SDV++ G+ + +L T +
Sbjct: 199 PSASRQGY-DVRSDVWSLGITLYELATGRF 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQ-FLQE 501
EI + + F E +G +G VYKG A+K L+ K ++ F E
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR--- 556
+ ++++HP+++ LLG +++ Y +G L + L ++ + + R
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 557 ----------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606
+ ++A+ + +L + ++H+D+ N+L+ L KI D+GL +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 607 SDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
+ + YK G P+ ++ PE G S SD+++YG+V
Sbjct: 180 A-----ADYYKLLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVV 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 49/239 (20%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 499
WE L F + +G G +G V T + AVK+L+ K + ++ +
Sbjct: 40 WE-FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 500 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER 554
EL++++++ H +++ LLGAC G L++EY G L + R R+ + +E
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 555 YR------------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 596
+ A++VA + FL +HRD+ N+L+ H V KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKI 213
Query: 597 GDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
D GL+ + SD Y G PV ++ PE G+ + KSDV++YG+++
Sbjct: 214 CDFGLARDIMSDS-----NYVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 463 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 515
+G GG V+ H AVKVL + ++ F +E + + + HP ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 516 LLGACPDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
+ +V EY++ +L D ++ + P+ + + AL F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH 133
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYI 628
IIHRD+KP NI++ K+ D G++ + + T V GT Y+
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS----GNSVTQTAAVIGTAQYL 186
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP--------AIAITH 665
PE R + +SDVY+ G V+ ++LT +P ++A H
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 50/237 (21%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 501
E + + IG G +G V++ T AVK+L+ + + + F +E
Sbjct: 43 EYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRL------------------- 540
++++ +P+++ LLG C CL++EYM G L + L
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 541 --YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598
PP+ E+ IA +VA+ +A+L K +HRD+ N L+ N+V KI D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIAD 217
Query: 599 VGLS-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 650
GLS + ++D YK G P+ ++ PE + +SDV+AYG+V
Sbjct: 218 FGLSRNIYSAD------YYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVV 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 44/243 (18%)
Query: 439 TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQS 489
++ + WE + L + +G G +G V T AVK+L+S
Sbjct: 55 EYELPEDPRWE-LPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111
Query: 490 KGNIQNKQ-FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN 545
++ + E+E++ I +H +++ LLGAC G ++ EY G+L + L +
Sbjct: 112 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 546 TPPIPWFERYR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 592
+ A++VA + +L + K IHRD+ N+L+ +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN 228
Query: 593 VSKIGDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYG 648
V KI D GL+ ++ YK T PV ++ PE + + +SDV+++G
Sbjct: 229 VMKIADFGLARDIHHID-----YYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFG 280
Query: 649 MVI 651
+++
Sbjct: 281 VLL 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 501
E+ ++ +G G +G VY+G AVK L + Q++ FL E
Sbjct: 67 EVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 502 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER--Y 555
++SK H +++ +G ++ E M G L+ R R + P
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 556 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFV 612
+A ++A +L IHRD+ N LL V+KIGD G++ +
Sbjct: 185 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---- 237
Query: 613 STTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
Y+ G PV ++ PE G+ + K+D +++G+++
Sbjct: 238 -GYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-25
Identities = 48/202 (23%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 461 NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 515
++ +G G +G+V +G + A+KVL+ + + ++E +++ ++ +P+++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 516 LLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
L+G C LV E G L + IP + +V+ + +L K
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
+HR++ N+LL + +KI D GLS L +D S+ + P+ + PE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---WYAPECIN 512
Query: 635 TGLISPKSDVYAYGMVILQLLT 656
S +SDV++YG+ + + L+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQ- 497
WE L+ + +G G +G V AVK+L+ ++
Sbjct: 76 WE-FPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 498 FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 554
+ E+E++ I +H +++ LLGAC G ++ EY G+L + L + ++
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 555 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
R +++A + +L + K IHRD+ N+L+ N V KI D GL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 602 S-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 651
+ + N D YK T PV ++ PE + + +SDV+++G+++
Sbjct: 250 ARDINNID------YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 30/296 (10%), Positives = 76/296 (25%), Gaps = 61/296 (20%)
Query: 409 EKEAAQRQEAEMKAKHEAKEK--EMLERALNGTFQRYRNLTWEEIESATLSFSENLR--- 463
+ +E + EA ++ M+E + + T ++S L+
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETT---VDSLLSQGERKLKLVE 68
Query: 464 -IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 517
+ +G V+ A+KV ++ + +++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 518 GACP----------------------------DHGCLVYEYMENGSLEDRL----YRKNN 545
+ L+ LE +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 546 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605
+ + ++ A L + K ++H P N+ + + +GDV +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 606 NSDPSFVSTTYKNTGPVGTLCYIDPEY--QRTGLISPKSDVYAYGMVILQLLTAKP 659
+ + + Y E+ T + + + G+ I ++
Sbjct: 245 GT---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 35/222 (15%)
Query: 463 RIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN-----KQFLQELEVLSKIRHPHL 513
+G GG G VY+ T A+K++ + + + +E +++ PH+
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 514 LLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
+ + G + + L L R+ P+ I ++ SAL H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA 153
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDP 630
HRD+KP NIL+ + + + D G+++ G GTL Y+ P
Sbjct: 154 G---ATHRDVKPENILVSADDFAYLVDFGIASATT------DEKLTQLGNTVGTLYYMAP 204
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP-------AIAITH 665
E + ++D+YA V+ + LT P ++ H
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 517
+G G +G VY A+KVL K ++ Q +E+E+ S +RHP++L +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 518 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
D L+ E+ G L L + E+A AL + H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ---RSATFMEELADALHYCHE---RK 134
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+KP N+L+ + KI D G S + T GTL Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM------CGTLDYLPPEMIEG 186
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
K D++ G++ + L P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 33/314 (10%), Positives = 79/314 (25%), Gaps = 53/314 (16%)
Query: 390 EKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWE 449
+ Y R + E+ + +A ++ E + + + E
Sbjct: 11 RENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE 70
Query: 450 -EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ--------- 497
E+ + +G + T T V V +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 498 -------------------FLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENG 534
F+ +++ + ++ + D +Y M+
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-S 189
Query: 535 SLEDRL----YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 590
+L+ + + R ++ +V LA LH+ ++H ++P +I+LD
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQ 246
Query: 591 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-----YQRTGLISPKSDVY 645
+ + L++ D +
Sbjct: 247 RGGVFLTGFEHLVRDGASAVSPIGR-----GFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 646 AYGMVILQLLTAKP 659
G+ I + A
Sbjct: 302 TLGLAIYWIWCADL 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 464 IGMGGYGTV-YKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC- 520
+G G GTV ++G+F AVK + L E+++L++ HP+++ +
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 521 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV----ASALAFLHNTKPKP 575
+ E +L+D + KN + ++ + AS +A LH+ K
Sbjct: 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 576 IIHRDMKPGNILLDH-------------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 622
IIHRD+KP NIL+ NL I D GL L+S S T P
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN--NPS 193
Query: 623 GTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLT 656
GT + PE Q ++ D+++ G V +L+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 19/207 (9%)
Query: 465 GMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA- 519
G TV + T + V+ L++ N EL V HP+++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 520 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 575
+ +V +M GS +D L + + E IA+ V AL ++H+
Sbjct: 96 IADNELWVVTSFMAYGSAKD-LICTHFMDGMN--ELA-IAYILQGVLKALDYIHHMG--- 148
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCYIDPE--Y 632
+HR +K +IL+ + + + + + S + V L ++ PE
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
Q KSD+Y+ G+ +L
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHV 235
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-23
Identities = 20/90 (22%), Positives = 29/90 (32%), Gaps = 4/90 (4%)
Query: 721 LERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEND 780
+E + RA P+ F P++ +M +P G DR I L +
Sbjct: 9 VEEIVAKNARAEIDYSDA----PDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP 64
Query: 781 KSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
P L L P L I W +
Sbjct: 65 TDPFNRQTLTESMLEPVPELKEQIQAWMRE 94
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLLL 517
+G G +G V T AVKV+ SK ++ K L+E+++L ++ HP+++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 518 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKP 573
D G LV E G L D + + E RI +V S + ++H K
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-----EVDAARIIRQVLSGITYMHKNK- 146
Query: 574 KPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
I+HRD+KP N+LL + +I D GLST + +GT YI P
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------KDKIGTAYYIAP 197
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP 659
E G K DV++ G+++ LL+ P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCP 225
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G YG V T A+K+++ N + L+E+ VL + HP+++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 520 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 575
D LV E + G L D + + E I +V S + +LH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN-----EVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 576 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
I+HRD+KP N+LL + + + KI D GLS + + +GT YI PE
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-------KERLGTAYYIAPEV 209
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
R K DV++ G+++ LL P
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+IG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P++
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYY 86
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTK 572
G+ L + EY+ GS D L P E IA E+ L +LH+ K
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALD-LLEPG-----PLDETQ-IATILREILKGLDYLHSEK 139
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
IHRD+K N+LL + K+ D G++ L T K VGT ++ PE
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAPEV 190
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKP 659
+ K+D+++ G+ ++L +P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 464 IGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLL 516
IG G + V H A+K++ K + ++ +E+ ++ + HP+++ L
Sbjct: 23 IGKGNFAKVKLAR--HILTGREVAIKII-DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 517 LG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
L+ EY G + D L + E ++ SA+ + H K
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---K 133
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 633
I+HRD+K N+LLD ++ KI D G S + + G Y PE +Q
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAF------CGAPPYAAPELFQ 186
Query: 634 RTGLISPKSDVYAYGMVIL 652
P+ DV++ G VIL
Sbjct: 187 GKKYDGPEVDVWSLG-VIL 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
+G G + TV T A+K+L+ + I+ + +E +V+S++ HP + L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 519 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKP 575
D L Y +NG L + + + R E+ SAL +LH K
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE----TCTRFYTAEIVSALEYLHG---KG 150
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
IIHRD+KP NILL+ ++ +I D G + +L+ + N+ VGT Y+ PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---NSF-VGTAQYVSPE---- 202
Query: 636 GLISPK-----SDVYAYGMVILQLLTAKP 659
L++ K SD++A G +I QL+ P
Sbjct: 203 -LLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-22
Identities = 17/68 (25%), Positives = 24/68 (35%)
Query: 743 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLS 802
P+ F P++ +M +P G DR I L + P L L P L
Sbjct: 12 PDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSPTDPFNRQMLTESMLEPVPELKE 71
Query: 803 AILDWKSK 810
I W +
Sbjct: 72 QIQAWMRE 79
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 518
+G G +G V K T AVKV+ +K + +NK L+E+E+L K+ HP+++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 574
D +V E G L D + ++ E RI +V S + ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFS-----EHDAARIIKQVFSGITYMHKHN-- 141
Query: 575 PIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I+HRD+KP NILL + + KI D GLST + +GT YI PE
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE 193
Query: 632 YQRTGLISPKSDVYAYGMVIL-QLLTAKP 659
R G K DV++ G VIL LL+ P
Sbjct: 194 VLR-GTYDEKCDVWSAG-VILYILLSGTP 220
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG- 518
+G G YG V T AVK++ + + +E+ + + H +++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 519 -ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
+ L EY G L DR+ +P + R ++ + + +LH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 634
HRD+KP N+LLD KI D GL+T+ N+ ++ GTL Y+ PE +R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------CGTLPYVAPELLKR 181
Query: 635 TGLISPKSDVYAYGMVIL 652
+ DV++ G ++L
Sbjct: 182 REFHAEPVDVWSCG-IVL 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 5e-22
Identities = 37/306 (12%), Positives = 82/306 (26%), Gaps = 66/306 (21%)
Query: 405 RASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEI---ESATLSFSEN 461
E+ + +A ++ E + + + E TL
Sbjct: 21 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT- 79
Query: 462 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ------------------------- 494
+G + T T V V
Sbjct: 80 -VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 495 ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYME--NGSLEDRLY-RKN 544
+ +F+ +++ + ++ + D +Y M+ + + L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 545 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604
+ R ++ +V LA LH+ ++H ++P +I+LD +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEY-----------QRTGLISPKSDVYAYGMVILQ 653
+ + + PE R L++ D +A G+VI
Sbjct: 256 DGARVVS----------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 654 LLTAKP 659
+ A
Sbjct: 306 IWCADL 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G VYK T AA KV+++K + + ++ E+E+L+ HP+++ LLGA
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 521 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 575
G L + E+ G+++ + + + +I ++ AL FLH+ +
Sbjct: 86 YHDGKLWIMIEFCPGGAVDA-IMLELDRG----LTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 631
IIHRD+K GN+L+ ++ D G+S T K +GT ++ PE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL------KTLQKRDSFIGTPYWMAPEVVMC 191
Query: 632 -YQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ K+D+++ G+ ++++ +P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 517
+G+G +G V G T AVK+L ++ I++ + E++ L RHPH++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 518 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ P +V EY+ G L D + + + E R+ ++ SA+ + H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HM 131
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 634
++HRD+KP N+LLD ++ +KI D GLS M++ F+ T+ G+ Y PE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS------CGSPNYAAPEVISG 184
Query: 635 TGLISPKSDVYAYGMVIL 652
P+ D+++ G VIL
Sbjct: 185 RLYAGPEVDIWSCG-VIL 201
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 31/203 (15%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G V+ + +K + + + +Q E+EVL + HP+++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 521 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY------RIAWEVASALAFLHNTK 572
D+ +V E E G L +R+ + + ++ +ALA+ H+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARG-----KALSEGYVAELMKQMMNALAYFHSQH 144
Query: 573 PKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
++H+D+KP NIL + KI D GL+ + SD T GT Y+
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------TNAAGTALYMA 194
Query: 630 PEYQRTGLISPKSDVYAYGMVIL 652
PE + ++ K D+++ G V++
Sbjct: 195 PEVFK-RDVTFKCDIWSAG-VVM 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 53/226 (23%)
Query: 464 IGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFL--------------------- 499
IG G YG V + +T+ A+KVL SK + +
Sbjct: 21 IGKGSYGVVKLAY-NENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 500 ------QELEVLSKIRHPHLLLLL----GACPDHGCLVYEYMENGSLEDRLYRKNNTPPI 549
QE+ +L K+ HP+++ L+ DH +V+E + G + + K P+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PL 134
Query: 550 PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609
+ ++ + +LH K IIHRD+KP N+L+ + KI D G+S
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 610 SFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVIL 652
+ +S T VGT ++ PE R DV+A G V L
Sbjct: 192 ALLSNT------VGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKV-----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
IG G + V + T AVK+ S + + +E + ++HPH++ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 517 LGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTK 572
L G +V+E+M+ L + ++ + + E ++ AL + H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALRYCHDNN 150
Query: 573 PKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
IIHRD+KP +LL +++ K+G G++ L VGT ++
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR------VGTPHFMA 201
Query: 630 PEYQRTGLISPKSDVYAYGMVIL 652
PE + DV+ G VIL
Sbjct: 202 PEVVKREPYGKPVDVWGCG-VIL 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
++ +IG G GTVY T A++ + + + + + E+ V+ + ++P+++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 516 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 571
L + L V EY+ GSL D + + E + E AL FLH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTD-VVTET-----CMDEGQIAAVCRECLQALEFLHSN 135
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
+ +IHRD+K NILL + K+ D G + K + VGT ++ PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 186
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PK D+++ G++ ++++ +P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
F ++G G YG+VYK T A+K + + ++Q +E+ ++ + PH++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPHVVK 88
Query: 516 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHN 570
G+ + L V EY GS+ D + R N IA L +LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKT----LTEDEIATILQSTLKGLEYLHF 143
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+ IHRD+K GNILL+ +K+ D G++ L T K +GT ++ P
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT------DTMAKRNTVIGTPFWMAP 194
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP 659
E + + +D+++ G+ +++ KP
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 40/206 (19%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 518
+G G +G V K T AVKV+ +K + +NK L+E+E+L K+ HP+++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 574
D +V E G L D + ++ + E RI +V S + ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 575 PIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I+HRD+KP NILL + + KI D GLST + +GT YI PE
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE 193
Query: 632 -----YQRTGLISPKSDVYAYGMVIL 652
Y K DV++ G VIL
Sbjct: 194 VLRGTY------DEKCDVWSAG-VIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 520
IG G +G V T A K + K +++ F QE+E++ + HP+++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 521 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 576
D+ LV E G L +R+ K + E RI +V SA+A+ H +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLN---V 127
Query: 577 IHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 631
HRD+KP N L + K+ D GL+ VGT Y+ P+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------RTKVGTPYYVSPQVL 180
Query: 632 ---YQRTGLISPKSDVYAYGMVIL 652
Y P+ D ++ G V++
Sbjct: 181 EGLY------GPECDEWSAG-VMM 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG- 518
+G G YG V T AVK++ + + +E+ + + H +++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 519 -ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
+ L EY G L DR+ +P + R ++ + + +LH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 634
HRD+KP N+LLD KI D GL+T+ N+ ++ GTL Y+ PE +R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------CGTLPYVAPELLKR 181
Query: 635 TGLISPKSDVYAYGMVIL 652
+ DV++ G ++L
Sbjct: 182 REFHAEPVDVWSCG-IVL 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 28/212 (13%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 516
IG G + V K T A+K++ ++ + F +E +VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
A ++ LV EY G L L + P R+ +A E+ A+ +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVHR---L 181
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 633
+HRD+KP NILLD ++ D G L +D + S VGT Y+ PE Q
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-----AVGTPDYLSPEILQ 236
Query: 634 RTGLISPKS------DVYAYGMVILQLLTAKP 659
G D +A G+ ++ +
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 49/252 (19%), Positives = 105/252 (41%), Gaps = 31/252 (12%)
Query: 424 HEAKEKEMLERALNGTFQRYRNLTWEEIESA----------TLSFSENLRIGMGGYGTVY 473
H ++ + + +T E+ ++A L ++IG G G V
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 474 KGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYE 529
H+ AVK++ + + + E+ ++ +H +++ + + L + E
Sbjct: 63 LAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122
Query: 530 YMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587
+++ G+L D + + E + V ALA+LH +IHRD+K +IL
Sbjct: 123 FLQGGALTD-IVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173
Query: 588 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 647
L + K+ D G ++ K VGT ++ PE L + + D+++
Sbjct: 174 LTLDGRVKLSDFGFCAQIS------KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227
Query: 648 GMVILQLLTAKP 659
G+++++++ +P
Sbjct: 228 GIMVIEMVDGEP 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 378 LLEEKAIELAKQEKKKYETARREAECARASAEKEAAQR--------QEAEMKAKHEAKEK 429
+ + A+ + Y + + C+ AE A R Q +
Sbjct: 98 ADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQA 157
Query: 430 EMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKGTFHHT--FAAVKV 486
E + F R+ W E + + + R +G GG+G V+ T A K
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK 217
Query: 487 LQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLY 541
L K + K + + E ++L+K+ ++ L A CLV M G + +Y
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 542 RKNNTPPIPWFERYRI---AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 598
+ P F+ R ++ S L LH II+RD+KP N+LLD + +I D
Sbjct: 278 NVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 599 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKS-DVYAYGMVILQL 654
+GL+ L + + GT ++ PE + S D +A G+ + ++
Sbjct: 333 LGLAVELKAGQTKTKGY------AGTPGFMAPELLLGEEYD----FSVDYFALGVTLYEM 382
Query: 655 LTAKP 659
+ A+
Sbjct: 383 IAARG 387
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVL-------------QSKGNIQNKQFLQELEVLSKI 508
+G G YG V + + A+KV+ +++ E+ +L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 509 RHPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASA 564
HP+++ L D LV E+ E G L +++ ++ E I ++ S
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-----ECDAANIMKQILSG 158
Query: 565 LAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
+ +LH I+HRD+KP NILL + L KI D GLS+ + D
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-------RDR 208
Query: 622 VGTLCYIDPEYQRTGLISPKSDVYAYGMVIL-QLLTAKP 659
+GT YI PE + + K DV++ G VI+ LL P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCG-VIMYILLCGYP 245
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA 519
+G G YG VYKG T AA+KV+ G+ + ++ QE+ +L K H ++ GA
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 89
Query: 520 --------CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFL 568
D LV E+ GS+ D L + + E + IA+ E+ L+ L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK--EEW-IAYICREILRGLSHL 145
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H K +IHRD+K N+LL N K+ D G+S L+ T + +GT ++
Sbjct: 146 HQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRRNTFIGTPYWM 196
Query: 629 DPE-----YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE KSD+++ G+ +++ P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-21
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 742 PPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 800
+ F+ PI+ +M +P V T DR I L + P PL + PN L
Sbjct: 19 ACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTEL 78
Query: 801 LSAILDWKSK 810
I W ++
Sbjct: 79 KEKIQRWLAE 88
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 454 ATLSFSENLR---------IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQEL 502
+T SFS +G G + V T AVK+++ + + +E+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 503 EVLSKIR-HPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--R 556
E+L + + H ++L L+ + LV+E M GS+ ++++ + F E
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASV 115
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVS 613
+ +VASAL FLHN K I HRD+KP NIL + KI D L + + +
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 614 TTYKN-TGPVGTLCYIDPEYQRTGLISPKS-----DVYAYGMVIL 652
+ P G+ Y+ PE D+++ G VIL
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VIL 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 22/196 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL--LGA 519
IG G +G T AVK + +G ++ +E+ +RHP+++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 520 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
P H ++ EY G L +R+ E ++ S +++ H+ + I HR
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLSGVSYCHSMQ---ICHR 140
Query: 580 DMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 636
D+K N LLD + KI D G S S +T VGT YI PE R
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST------VGTPAYIAPEVLLRQE 193
Query: 637 LISPKSDVYAYGMVIL 652
+DV++ G V L
Sbjct: 194 YDGKIADVWSCG-VTL 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 41/235 (17%)
Query: 442 RYRNLTWEEIESATLSFSENLRI----GMGGYGTVYKGTFHHTFA--AVKVL-------- 487
+ +LT ++ + + + G G G V T A++++
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 488 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNN 545
++ E+E+L K+ HP ++ + D+ +V E ME G L D++
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR 235
Query: 546 TPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVG 600
E +++ A+ +LH IIHRD+KP N+LL + + + KI D G
Sbjct: 236 LK-----EATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVIL 652
S +L + S + T GT Y+ PE T + D ++ G VIL
Sbjct: 288 HSKILG-ETSLMRTL------CGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 516
IG G +G V K A+K+L ++ + F +E +VL + L
Sbjct: 82 IGRGAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
A ++ LV +Y G L L + + P R+ +A E+ A+ +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVHQ---L 194
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
+HRD+KP NIL+D N ++ D G L D + S+ VGT YI PE
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-----AVGTPDYISPE 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-- 519
+G G + V+ T A+K ++ ++ E+ VL KI+H +++ L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 520 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 577
H LV + + G L DR+ + + E+ + +V SA+ +LH I+
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 578 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
HRD+KP N+L + N I D GLS M +ST GT Y+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA------CGTPGYVAPEVLA 180
Query: 635 TGLISPKSDVYAYGMVIL 652
S D ++ G VI
Sbjct: 181 QKPYSKAVDCWSIG-VIT 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 24/198 (12%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 517
+G+G +G V G T AVK+L ++ I++ + E++ L RHPH++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL-NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 518 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+ P +V EY+ G L D + + E R+ ++ S + + H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---ESRRLFQQILSGVDYCHRHM--- 136
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 634
++HRD+KP N+LLD ++ +KI D GLS M++ F+ T+ G+ Y PE
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS------CGSPNYAAPEVISG 189
Query: 635 TGLISPKSDVYAYGMVIL 652
P+ D+++ G VIL
Sbjct: 190 RLYAGPEVDIWSSG-VIL 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-20
Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 27/258 (10%)
Query: 407 SAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRI-- 464
E++ + + + + K + + N F ++ + +E ++ I
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 465 --GMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
G G +G V++ T T A K + + + +E++ +S +RHP L+ L A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 576
+ ++YE+M G L +++ ++N E +V L +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE---NNY 276
Query: 577 IHRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
+H D+KP NI+ + K+ D GL+ L+ S GT + PE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-------KVTTGTAEFAAPEVAE 329
Query: 635 TGLISPKSDVYAYGMVIL 652
+ +D+++ G V+
Sbjct: 330 GKPVGYYTDMWSVG-VLS 346
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 34/206 (16%)
Query: 464 IGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQFL---------QELEVLSKIRH 510
+G G +G V+ VK + K + ++ E+ +LS++ H
Sbjct: 32 LGSGAFGFVWTAV--DKEKNKEVVVKFI-KKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 511 PHLLLLLG--ACPDHGCLVYEYMENGS-LEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
+++ +L LV E +G L + R I ++ SA+ +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE---PLASYIFRQLVSAVGY 145
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
L K IIHRD+K NI++ + K+ D G + L T GT+ Y
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF------CGTIEY 195
Query: 628 IDPE-YQRTGLISPKSDVYAYGMVIL 652
PE P+ ++++ G V L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLG-VTL 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 55/247 (22%), Positives = 82/247 (33%), Gaps = 57/247 (23%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKV-----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
IG G YG V + T A+K+ ++ ++ E+ ++ K+ HP++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 517 LGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE-------------- 560
D LV E G L D+L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 561 -----------------------VASALAFLHNTKPKPIIHRDMKPGNILL--DHNLVSK 595
+ SAL +LHN + I HRD+KP N L + + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 596 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVIL- 652
+ D GLS Y T GT ++ PE PK D ++ G V+L
Sbjct: 211 LVDFGLSKEF--YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLH 267
Query: 653 QLLTAKP 659
LL
Sbjct: 268 LLLMGAV 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 23/197 (11%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
+G G +G V++ T K + + + E+ +++++ HP L+ L A
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 522 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 577
D L+ E++ G L DR+ ++ E + L +H I+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMHE---HSIV 171
Query: 578 HRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
H D+KP NI+ + S KI D GL+T LN D T + PE
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-------KVTTATAEFAAPEIVDR 224
Query: 636 GLISPKSDVYAYGMVIL 652
+ +D++A G V+
Sbjct: 225 EPVGFYTDMWAIG-VLG 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKV-------LQSKGNIQNKQ--FLQELEVLSKI-RHP 511
+G G V + T AVK+ S +Q + L+E+++L K+ HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 512 HLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAF 567
+++ L + LV++ M+ G L D L K E+ +I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICA 139
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH I+HRD+KP NILLD ++ K+ D G S L+ GT Y
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-------REVCGTPSY 189
Query: 628 IDPE------YQRTGLISPKSDVYAYGMVIL 652
+ PE + D+++ G VI+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTG-VIM 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-20
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLLGA 519
+G G + V + +AA+ + K + ++ Q L +E + ++HP+++ L +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 520 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 575
+ G L+++ + G L + + + + E ++ A+ H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMG--- 130
Query: 576 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
++HR++KP N+LL K+ D GL+ + + GT Y+ PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF------AGTPGYLSPEV 184
Query: 633 QRTGLISPKSDVYAYGMVIL 652
R D++A G VIL
Sbjct: 185 LRKDPYGKPVDLWACG-VIL 203
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-----ELEVLSKIRHPHLLLL 516
+G G YG V + T AVK+L K ++ + E+++L ++RH +++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKIL-KKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 517 ----LGACPDHGCLVYEYMENGSLE--DRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+V EY G E D + K P + + ++ L +LH+
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHS 127
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN--SDPSFVSTTYKNTGPVGTLCYI 628
+ I+H+D+KPGN+LL KI +G++ L+ + T+ G+ +
Sbjct: 128 ---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------QGSPAFQ 178
Query: 629 DPEYQRTGLIS-------PKSDVYAYGMVILQLLTA 657
PE + + K D+++ G V L +T
Sbjct: 179 PPE-----IANGLDTFSGFKVDIWSAG-VTLYNITT 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 35/286 (12%)
Query: 375 EIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLER 434
Q ++ + ++ + + A+ K A A +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVT 79
Query: 435 ALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN 492
A G + ++ EI +G G +G V+K T A K+++++G
Sbjct: 80 AKQGAVNSFYTVSKTEI------------LGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 493 IQNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIP 550
++ E+ V++++ H +L+ L A + LV EY++ G L DR+ ++
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-- 185
Query: 551 WFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLN 606
E ++ + +H I+H D+KP NIL + KI D GL+
Sbjct: 186 --ELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 652
GT ++ PE +S +D+++ G VI
Sbjct: 241 PREKL-------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-VIA 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
IG G +G VY A+K + + N + + ++E+ L K+RHP+ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIA---WEVASALAFLHNTK 572
G V EY GS D L + P + IA LA+LH+
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASD-LLEVHKKP----LQEVEIAAVTHGALQGLAYLHSHN 174
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616
+IHRD+K GNILL + K+GD G ++++ SFV T Y
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 32/205 (15%)
Query: 464 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
+G G + V K T +AA ++ S+ + ++ +E+ +L +IRHP+++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 516 LLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 571
L L+ E + G L D L K + E + ++ + +LH+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT-----EDEATQFLKQILDGVHYLHSK 127
Query: 572 KPKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+ I H D+KP NI+L V K+ D G++ + + F GT +
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------KNIFGTPEF 177
Query: 628 IDPEYQRTGLISPKSDVYAYGMVIL 652
+ PE + ++D+++ G VI
Sbjct: 178 VAPEIVNYEPLGLEADMWSIG-VIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 464 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
+G G + V K T +AA + S+ + ++ +E+ +L ++ H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 571
L L+ E + G L D L +K + E ++ + +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLHTK 134
Query: 572 KPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
K I H D+KP NI+L K+ D GL+ + F GT +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-------KNIFGTPEF 184
Query: 628 IDPEYQRTGLISPKSDVYAYGMVIL 652
+ PE + ++D+++ G VI
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VIT 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 37/239 (15%)
Query: 438 GTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ 494
F R+ W E + T + R +G GG+G V T A K L+ K +
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 495 NKQF---LQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPI 549
K L E ++L K+ ++ L A D CLV M G L+ +Y
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---- 280
Query: 550 PWFERYRI---AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606
F R A E+ L LH + I++RD+KP NILLD + +I D+GL+ +
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 607 SDPSFVSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
T G VGT+ Y+ PE Y + D +A G ++ +++ +
Sbjct: 338 EG----QTI---KGRVGTVGYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQS 383
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 42/300 (14%), Positives = 89/300 (29%), Gaps = 73/300 (24%)
Query: 463 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLL 517
G ++ T A+ + +G + ++ L LS+I P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 518 --GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G +V E++ GSL++ +T P P R +A+A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV-GAIRAMQSLAAAADAAHRA---G 149
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+ P + + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPDA---- 179
Query: 636 GLISPKSDVYAYGMVILQLLTAKP-----------AIAITHKVETAIDEDNLAEILDAQA 684
+P+ D+ G + LL + A A I+ ++ +
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF-- 234
Query: 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPN 744
+++A+ + R + +L ++++ VADR P + AP +
Sbjct: 235 ---------QISAVAARSVQGDGGIRSA--STLLNLMQQATAVADRTEVLGP-IDEAPVS 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G + V + T A K++ +K ++ +E + K++HP+++ L +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 520 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 575
+ LV++ + G L + + + + E ++ ++A+ H+
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNG--- 125
Query: 576 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
I+HR++KP N+LL K+ D GL+ +N ++ G GT Y+ PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------HGFAGTPGYLSPEV 178
Query: 633 QRTGLISPKSDVYAYGMVIL 652
+ S D++A G VIL
Sbjct: 179 LKKDPYSKPVDIWACG-VIL 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 30/200 (15%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGAC 520
+G G + K + AVK++ + +E+ L HP+++ L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 521 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNTKPKP 575
D LV E + G L +R+ +K + F E I ++ SA++ +H+
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD---VG 126
Query: 576 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
++HRD+KP N+L + NL KI D G + + D + T P TL Y PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT------PCFTLHYAAPEL 180
Query: 633 QRTGLISPKSDVYAYGMVIL 652
D+++ G VIL
Sbjct: 181 LNQNGYDESCDLWSLG-VIL 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 464 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
+G G + V K T +AA + S+ + ++ +E+ +L ++ HP+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 571
L L+ E + G L D L +K + E ++ + +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLHT- 133
Query: 572 KPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
K I H D+KP NI+L K+ D GL+ + F GT +
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-------KNIFGTPEF 184
Query: 628 IDPEYQRTGLISPKSDVYAYGMVIL 652
+ PE + ++D+++ G VI
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 38/199 (19%), Positives = 78/199 (39%), Gaps = 28/199 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 520
+G G +G V++ + K + +E+ +L+ RH ++L L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 521 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFER--YRIAWEVASALAFLHNTKPKPII 577
+ +++E++ + +R+ ER +V AL FLH+ I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHS---HNIG 124
Query: 578 HRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
H D++P NI+ + KI + G + L +F Y PE
Sbjct: 125 HFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF-------RLLFTAPEYYAPEVH 175
Query: 634 RTGLISPKSDVYAYGMVIL 652
+ ++S +D+++ G ++
Sbjct: 176 QHDVVSTATDMWSLG-TLV 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G + V + T A K++ +K ++ +E + K++HP+++ L +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 520 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 575
+ LV++ + G L + + + + E ++ ++A+ H+
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNG--- 148
Query: 576 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
I+HR++KP N+LL K+ D GL+ +N ++ G GT Y+ PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------HGFAGTPGYLSPEV 201
Query: 633 QRTGLISPKSDVYAYGMVIL 652
+ S D++A G VIL
Sbjct: 202 LKKDPYSKPVDIWACG-VIL 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-19
Identities = 66/318 (20%), Positives = 122/318 (38%), Gaps = 32/318 (10%)
Query: 358 KVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQE 417
++ K + EEE + ++ + ++ + + E ++ +
Sbjct: 88 EIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQ 147
Query: 418 AEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIES---ATLSFSENLR-IGMGGYGTVY 473
++ + ++ ++ + R W+ +E T++ R IG GG+G VY
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFT-RFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 474 KGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKI---RHPHLLLLLGA--CPDH 523
T A+K L K + L E +LS + P ++ + A PD
Sbjct: 207 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266
Query: 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMK 582
+ + M G L L + R A E+ L +HN +++RD+K
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMHNRF---VVYRDLK 319
Query: 583 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 642
P NILLD + +I D+GL+ + K VGT Y+ PE + G+ S
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 643 -DVYAYGMVILQLLTAKP 659
D ++ G ++ +LL
Sbjct: 372 ADWFSLGCMLFKLLRGHS 389
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 28/194 (14%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 516
IG G +G V K T A+K+L I+ F +E ++++ P ++ L
Sbjct: 77 IGRGAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
A + +V EYM G L + + + F Y EV AL +H+
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--Y--TAEVVLALDAIHS---M 187
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
IHRD+KP N+LLD + K+ D G +N + T VGT YI PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPE--- 239
Query: 635 TGLISPKSDVYAYG 648
++ + YG
Sbjct: 240 --VLKSQGGDGYYG 251
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVL--------QSKGNIQNKQFLQELEVLSKIRHPHL 513
+G G G V T A+K++ ++ E+E+L K+ HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 514 LLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLH 569
+ + D+ +V E ME G L D++ E +++ A+ +LH
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK-----EATCKLYFYQMLLAVQYLH 131
Query: 570 NTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
IIHRD+KP N+LL + + + KI D G S +L + S + T GT
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL------CGTPT 181
Query: 627 YIDPE---YQRTGLISPKSDVYAYGMVIL 652
Y+ PE T + D ++ G VIL
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 36/207 (17%)
Query: 464 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
+G G + V K T +AA + S+ + + +E+ +L +I+HP+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 571
L L+ E + G L D L K + E ++ + + +LH+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT-----EEEATEFLKQILNGVYYLHSL 133
Query: 572 KPKPIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
+ I H D+KP NI+L + KI D GL+ ++ F GT
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNEF-------KNIFGTP 181
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVIL 652
++ PE + ++D+++ G VI
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIG-VIT 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 29/200 (14%)
Query: 464 IGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLL 515
+G G +G V T H A+K + S+ ++ + +E+ L +RHPH++
Sbjct: 17 LGEGSFGKVKLAT--HYKTQQKVALKFI-SRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 516 LLG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L P +V EY G L D + K E R ++ A+ + H K
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED---EGRRFFQQIICAIEYCHRHK- 128
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-Y 632
I+HRD+KP N+LLD NL KI D GLS ++ +F+ T+ G+ Y PE
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS------CGSPNYAAPEVI 179
Query: 633 QRTGLISPKSDVYAYGMVIL 652
P+ DV++ G ++L
Sbjct: 180 NGKLYAGPEVDVWSCG-IVL 198
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 67/298 (22%), Positives = 109/298 (36%), Gaps = 46/298 (15%)
Query: 385 ELAKQEKKKYETARREAECAR-ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRY 443
+ K+ ++ R R + R + A A+ K++ + GT Y
Sbjct: 14 KFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLY 73
Query: 444 RNLTWEEIESATLSFSENLR--------IGMGGYGTVYKGTFHHT--FAAVKVL------ 487
E E + ++ IG G V + T AVK++
Sbjct: 74 FQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER 133
Query: 488 --QSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYR 542
+ + +E +L ++ HPH++ L+ + LV++ M G L D L
Sbjct: 134 LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE 193
Query: 543 KNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600
K E+ I + A++FLH I+HRD+KP NILLD N+ ++ D G
Sbjct: 194 KVA-----LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245
Query: 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVIL 652
S L GT Y+ PE + + D++A G VIL
Sbjct: 246 FSCHLEPGEKL-------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VIL 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSK-IRHPHLLLLLGAC 520
IG+G Y + T AVK++ K + E+E+L + +HP+++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTE---EIEILLRYGQHPNIITLKDVY 85
Query: 521 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNTKPKP 575
D +V E M+ G L D++ R+ F ER + + + + +LH +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QG 136
Query: 576 IIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
++HRD+KP NIL + +I D G + L ++ + T P T ++ PE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT------PCYTANFVAPE 190
Query: 632 -YQRTGLISPKSDVYAYGMVIL 652
+R G D+++ G V+L
Sbjct: 191 VLERQGY-DAACDIWSLG-VLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 27/198 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 520
+G G VY+ T A+KVL+ + + E+ VL ++ HP+++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 521 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 577
P LV E + G L DR+ K + ER ++ A+A+LH I+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 578 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
HRD+KP N+L + KI D GLS ++ GT Y PE R
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-------KTVCGTPGYCAPEILR 223
Query: 635 TGLISPKSDVYAYGMVIL 652
P+ D+++ G +I
Sbjct: 224 GCAYGPEVDMWSVG-IIT 240
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 46/261 (17%)
Query: 417 EAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKG 475
A K + KE L +A +++ +A L + ++ +G G +G V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWET---PSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 476 TFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHGCL--VY 528
+ A+K+L + ++ KQ L E +L + P L+ L + D+ L V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 529 EYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPGNIL 587
EY+ G + L R R A ++ +LH+ +I+RD+KP N+L
Sbjct: 121 EYVAGGEMFSHLRRIGRFSE----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLL 173
Query: 588 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YIDPEYQRTGLISPKS- 642
+D ++ D G + + T+ TLC + PE +I K
Sbjct: 174 IDQQGYIQVTDFGFAKRVK------GRTW-------TLCGTPEALAPE-----IILSKGY 215
Query: 643 ----DVYAYGMVILQLLTAKP 659
D +A G++I ++ P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYP 236
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 36/204 (17%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 520
+G+G G V + T A+K+L + QE++ + PH++ +L
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 521 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 571
+ ++ E ME G L R+ + + F ER I ++ +A+ FLH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRDIGTAIQFLHS- 146
Query: 572 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
I HRD+KP N+L + + V K+ D G + + + T P T Y+
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT------PCYTPYYV 196
Query: 629 DPEYQRTGLISPKSDVYAYGMVIL 652
PE D+++ G VI+
Sbjct: 197 APEVLGPEKYDKSCDMWSLG-VIM 219
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 1e-17
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 721 LERLKEVADRARDTVPSVHP------APPNHFICPILKEVMNEPCV-AADGYTYDRKAIE 773
+E+L A++A + + P+ F+ P++ +M +P + A DR I+
Sbjct: 861 IEKLLNFANKAEEQRKADEEEDLEYGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIK 920
Query: 774 EWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810
L + P +PL +++ PN L IL +K +
Sbjct: 921 AHLLSDSTDPFNRMPLKLEDVTPNEELRQKILCFKKQ 957
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-------ELEVLSKIRH--PH 512
+G GG+G+VY G A+K + K I + L E+ +L K+
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 513 LLLLLG--ACPDHGCLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
++ LL PD L+ E E L D + + W+V A+ H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE---LARSFFWQVLEAVRHCH 166
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
N ++HRD+K NIL+D N K+ D G +L + + GT Y
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF------DGTRVYS 215
Query: 629 DPEY-QRTGLISPKSDVYAYGMVIL 652
PE+ + + V++ G ++L
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLG-ILL 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-------ELEVLSKIR----H 510
+G GG+GTV+ G A+KV+ + + L E+ +L K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 511 PHLLLLLG--ACPDHGCLVYEYMENGS-LEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
P ++ LL + LV E L D + K + +V +A+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQH 154
Query: 568 LHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
H+ + ++HRD+K NIL+D +K+ D G +L+ +P Y + GT
Sbjct: 155 CHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP------YTDF--DGTRV 203
Query: 627 YIDPEY-QRTGLISPKSDVYAYGMVIL 652
Y PE+ R + + V++ G ++L
Sbjct: 204 YSPPEWISRHQYHALPATVWSLG-ILL 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 56/182 (30%), Positives = 83/182 (45%), Gaps = 36/182 (19%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V+ + + A+KVL+ + ++ KQ E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 517 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 573
G D + + +Y+E G L L + P + A EV AL +LH+
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN----PVAKFYAAEVCLALEYLHS--- 124
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 629
K II+RD+KP NILLD N KI D G + + TY TLC YI
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTY-------TLCGTPDYIA 171
Query: 630 PE 631
PE
Sbjct: 172 PE 173
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 464 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 520
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 124
Query: 521 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 571
+ +V E ++ G L R+ + + F ER I + A+ +LH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS- 179
Query: 572 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
I HRD+KP N+L N + K+ D G + S S T P T Y+
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-------TTPCYTPYYV 230
Query: 629 DPEYQRTGLISPKSDVYAYGMVIL 652
PE D+++ G VI+
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIM 253
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 518
IG G +G V + T A+K + + ++ + +EL+++ + HP L+ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 519 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHNTKP 573
+ + +V + + G L L + + F E ++ E+ AL +L N
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVH------FKEETVKLFICELVMALDYLQN--- 133
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
+ IIHRDMKP NILLD + I D ++ ML + TT GT Y+ PE
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTM-----AGTKPYMAPE 184
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 49/218 (22%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V K T + A+K+L+ + I + + E VL RHP L L
Sbjct: 13 LGKGTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 573
A D C V EY G L L R+ ER R E+ SAL +LH+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHS--- 123
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC----Y 627
+ +++RD+K N++LD + KI D GL + + T T C Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-----TMK-------TFCGTPEY 171
Query: 628 IDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
+ PE Y R D + G+V+ +++ +
Sbjct: 172 LAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRL 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 38/207 (18%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRH-PHLLLLLG 518
+G G + V + T A K L + +G + L E+ VL + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 519 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY------RIAWEVASALAFLHN 570
L+ EY G + + E R+ ++ + +LH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPEL-------AEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 571 TKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
I+H D+KP NILL ++ KI D G+S + +GT
Sbjct: 150 NN---IVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGHACEL-------REIMGTP 197
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVIL 652
Y+ PE I+ +D++ G +I
Sbjct: 198 EYLAPEILNYDPITTATDMWNIG-IIA 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V K T + A+K+L+ + + + L E VL RHP L L
Sbjct: 156 LGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 573
+ D C V EY G L L R+ +R R E+ SAL +LH+
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHS--E 267
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 631
K +++RD+K N++LD + KI D GL D + + T GT Y+ PE
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGTPEYLAPEVL 321
Query: 632 ----YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y R D + G+V+ +++ +
Sbjct: 322 EDNDYGRA------VDWWGLGVVMYEMMCGRL 347
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 53/221 (23%)
Query: 464 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLL 515
+G G +G V+ K + A+KVL K ++ + E ++L ++ HP ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 570
L A L+ +++ G L RL ++ F E + E+A AL LH+
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHS 144
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 626
II+RD+KP NILLD K+ D GLS ++ + Y + C
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-----KAY-------SFCGT 189
Query: 627 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y+ PE + ++ +D +++G+++ ++LT
Sbjct: 190 VEYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGTL 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 464 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 516
G G +GTV G T +V KV+Q + +F LQ ++ L+ + HP+++ L
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 517 LGACPDHG---------CLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVA 562
G +V EY+ + R Y + P P + + +++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFL-FQLI 139
Query: 563 SALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
++ LH + HRD+KP N+L++ + K+ D G + L+ V+ Y
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--Y----- 191
Query: 622 VGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 659
+ + Y PE LI + D+++ G + +++ +P
Sbjct: 192 ICSRYYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 455 TLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQFLQELEVLSKIRHP 511
+S+++ IG G +G VY+ + V KVLQ K + +EL+++ K+ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107
Query: 512 HLLLLLGACPDHG--------CLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIA 558
+++ L G LV +Y+ E R Y + + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM- 162
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYK 617
+++ +LA++H+ I HRD+KP N+LLD + K+ D G + L VS Y
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--Y- 216
Query: 618 NTGPVGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 659
+ + Y PE LI + DV++ G V+ +LL +P
Sbjct: 217 ----ICSRYYRAPE-----LIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 55/223 (24%)
Query: 464 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQF-----LQELEVLSKIRHPHL 513
+G GGYG V+ K T +T A+KVL+ K I E +L +++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK-KAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 514 LLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFL 568
+ L+ A L+ EY+ G L +L R+ F + E++ AL L
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHL 137
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC 626
H II+RD+KP NI+L+H K+ D GL ++ + T+ T C
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTH-------TFC 182
Query: 627 ----YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y+ PE + R D ++ G ++ +LT P
Sbjct: 183 GTIEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGAP 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 4e-16
Identities = 40/254 (15%), Positives = 78/254 (30%), Gaps = 58/254 (22%)
Query: 446 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL--------QSKGNIQNKQ 497
+ + T +IG G +G V++ HT A+K++ ++
Sbjct: 11 VPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 498 FLQELEVLSKI---------RHPHLLLLL------GACPDHGCLVYEYM--ENGSLEDRL 540
L E+ + ++ R + L G+ P +++ GS DR
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 541 -YRKNNTPPIP-------------------WFERYRIAWEVASALAFLHNTKPKPIIHRD 580
+ K++ I I ++ ++LA HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 581 MKPGNILLDHNLVSKIGDVGLSTMLNSDPS---------FVSTTYKNTGPVGTLCYIDPE 631
+ GN+LL + K+ +S ++ V +D +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 632 YQRTGLISPKSDVY 645
TG + D+Y
Sbjct: 248 L-FTGDGDYQFDIY 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 36/266 (13%)
Query: 414 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTV 472
+ + A A + E+ L + E + E L+ +G G YG V
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70
Query: 473 Y---KGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGAC--- 520
+ K + H T A+KVL+ +Q + E +VL IR L+ L
Sbjct: 71 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130
Query: 521 PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHNTKPKPII 577
L+ +Y+ G L L ++ F +I E+ AL LH II
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHK---LGII 181
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQR 634
+RD+K NILLD N + D GLS +D + + + GT+ Y+ P+
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-----CGTIEYMAPDIVRGGD 236
Query: 635 TGLISPKS-DVYAYGMVILQLLTAKP 659
+G K+ D ++ G+++ +LLT
Sbjct: 237 SG--HDKAVDWWSLGVLMYELLTGAS 260
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 47/234 (20%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVL 505
+ E ++++ IG G +G V++ + A KVLQ K + +EL+++
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIM 86
Query: 506 SKIRHPHLLLLLGACPDHGC--------LVYEYMENGSLED-----RLYRKNNTPPIPWF 552
++HP+++ L +G LV EY+ E R Y K
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLL 142
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSF 611
+ + +++ +LA++H+ I HRD+KP N+LLD + V K+ D G + +L +
Sbjct: 143 IKLYM-YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 612 VSTTYKNTGPVGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 659
VS Y + + Y PE LI + D+++ G V+ +L+ +P
Sbjct: 199 VS--Y-----ICSRYYRAPE-----LIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG V+K T A+K + + K L+E+ +L +++HP+L+ LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
LV+EY ++ ++ +P I W+ A+ F H
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLH--ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 631
IHRD+KP NIL+ + V K+ D G + +L PS V T Y PE
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDE-----VATRWYRSPELLVGD 177
Query: 632 --YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y P DV+A G V +LL+ P
Sbjct: 178 TQY------GPPVDVWAIGCVFAELLSGVP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+G G YG V K T A+K + + K ++E+++L ++RH +L+ LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
C LV+E++++ ++ D + + + + +++ + + F H+ I
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILD--DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 631
IHRD+KP NIL+ + V K+ D G + L + P V V T Y PE
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDE-----VATRWYRAPELLVGD 199
Query: 632 --YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y DV+A G ++ ++ +P
Sbjct: 200 VKY------GKAVDVWAIGCLVTEMFMGEP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 50/219 (22%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSK-IRHPHLLL 515
+G G +G V +K T + F A+K L+ + + + E VLS HP L
Sbjct: 25 LGKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 572
+ ++ V EY+ G L + + R A E+ L FLH+
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEIILGLQFLHSKG 138
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 626
I++RD+K NILLD + KI D G+ ML T T C
Sbjct: 139 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-----KTN-------TFCGTPD 183
Query: 627 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
YI PE Y + D +++G+++ ++L +
Sbjct: 184 YIAPEILLGQKYNHSV------DWWSFGVLLYEMLIGQS 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 460 ENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 515
E ++G G YG VYK A+K ++ G + +E+ +L +++HP+++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVIS 82
Query: 516 LLGACPDHG----CLVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRI---AWEVASAL 565
L H L+++Y E+ ++ K N P+ R + +++ +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGI 141
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGP 621
+LH ++HRD+KP NIL+ KI D+G + + NS +
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPV 195
Query: 622 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
V T Y PE Y + D++A G + +LLT++P
Sbjct: 196 VVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEP 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
IG G Y V K T A+KV++ + ++ E V + + L+
Sbjct: 17 IGRGSYAKVLLVRLKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 570
L +C V EY+ G L + R+ E R + E++ AL +LH
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE 128
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 626
+ II+RD+K N+LLD K+ D G+ + D TT T C
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTS-------TFCGT 173
Query: 627 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 674
YI PE Y + D +A G+++ +++ + I +
Sbjct: 174 PNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V KGT AVK+L+ IQ+ + E VL+ P L
Sbjct: 28 LGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 572
L +C D V EY+ G L + + A E+A L FL +
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQS-- 139
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 626
K II+RD+K N++LD KI D G+ + + TT T C
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTK-------TFCGTPD 186
Query: 627 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
YI PE Y ++ D +A+G+++ ++L +
Sbjct: 187 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQA 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 69/221 (31%), Positives = 96/221 (43%), Gaps = 54/221 (24%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSK-IRHPHLLL 515
IG G +G V K F AVKVLQ K ++ K+ + E VL K ++HP L+
Sbjct: 46 IGKGSFGKVLLARHKAE--EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 570
L + D V +Y+ G L L R+ F R R A E+ASAL +LH+
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHS 157
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 626
I++RD+KP NILLD + D GL + ++ TT T C
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-----TTS-------TFCGT 202
Query: 627 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y+ PE Y RT D + G V+ ++L P
Sbjct: 203 PEYLAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGLP 237
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
IG G Y V K T A++V++ + ++ E V + + L+
Sbjct: 60 IGRGSYAKVLLVRLKKT--DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 570
L +C V EY+ G L + R+ E R + E++ AL +LH
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE 171
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 626
+ II+RD+K N+LLD K+ D G+ + D TT T C
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTS-------TFCGT 216
Query: 627 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 674
YI PE Y + D +A G+++ +++ + I +
Sbjct: 217 PNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 4e-15
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 464 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V KGT AVK+L+ IQ+ + E VL+ P L
Sbjct: 349 LGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 572
L +C D V EY+ G L + + A E+A L FL +
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQS-- 460
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 626
K II+RD+K N++LD KI D G+ + + TT T C
Sbjct: 461 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTK-------TFCGTPD 507
Query: 627 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
YI PE Y ++ D +A+G+++ ++L +
Sbjct: 508 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQA 540
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 63/219 (28%), Positives = 89/219 (40%), Gaps = 50/219 (22%)
Query: 464 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 516
+G G +G V K T AVKVL+ +Q+ + E +LS R+ L
Sbjct: 31 LGKGSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 517 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 572
L C PD V E++ G L + + R R A E+ SAL FLH+
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISALMFLHD-- 142
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 626
K II+RD+K N+LLDH K+ D G+ + N TT T C
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-----TTA-------TFCGTPD 189
Query: 627 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
YI PE Y D +A G+++ ++L
Sbjct: 190 YIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHA 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 51/249 (20%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------H 510
+G G + TV+ A+K+++ + E+++L ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 511 PHLLLLL------GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
H+L LL G H +V+E + +L L +K IP +I+ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVS------KIGDVGLSTMLNSDPSFVSTTYKN 618
L ++H + IIH D+KP N+L++ KI D+G + + T
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNS-- 195
Query: 619 TGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 672
+ T Y PE + +D+++ +I +L+T D
Sbjct: 196 ---IQTREYRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 673 EDNLAEILD 681
+D++A+I++
Sbjct: 247 DDHIAQIIE 255
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 5/182 (2%)
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
QR ++ + + + L AK + + E L L +E
Sbjct: 95 LQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLTRLIAAERERE 154
Query: 692 TKEL--AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICP 749
+E G R + ++ + + + E+ + + P++
Sbjct: 155 LEECQRNHEGHEDDGHIRAQQACIEAKHDKYMADMDELFSQVDEKR--KKRDIPDYLCGK 212
Query: 750 ILKEVMNEPCVAADGYTYDRKAIEEWLQENDK-SPITDLPLPNKNLLPNYTLLSAILDWK 808
I E+M EPC+ G TYDRK IEE LQ +P+T PL + L+PN + I +
Sbjct: 213 ISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFI 272
Query: 809 SK 810
S+
Sbjct: 273 SE 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 515
++G G Y TVYKG T + A+K + + +++ ++E+ ++ +++H +++
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 516 LLGACPDHGC--LVYEYMEN--GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
L LV+E+M+N D N + W++ LAF H
Sbjct: 68 LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602
K I+HRD+KP N+L++ K+GD GL+
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYK T A+K L ++ ++E+ +L ++ HP+++ LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
LV+E++ L+ + + IP +++ LAF H+ + +
Sbjct: 70 VIHTENKLYLVFEFLHQ-DLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 124
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLS 602
+HRD+KP N+L++ K+ D GL+
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 14/147 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YGTV+K T A+K L L+E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 519 ACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
LV+E+ + D + Y + + +++ L F H+
Sbjct: 69 VLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLS 602
++HRD+KP N+L++ N K+ + GL+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-13
Identities = 11/57 (19%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 744 NHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYT 799
+H +C I +V P ++ +++ +E+++++ PIT+ PL + ++
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVP 58
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 40/214 (18%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 515
++G G Y TVYKG T A+K + +++++ ++E+ +L ++H +++
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 516 LLGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
L LV+EY++ D + Y + I +++ LA+ H K
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 631
++HRD+KP N+L++ K+ D GL+ S P + TY V TL Y P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAK-SIP---TKTY--DNEVVTLWYRPPDI 171
Query: 632 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y S + D++ G + ++ T +P
Sbjct: 172 LLGSTDY------STQIDMWGVGCIFYEMATGRP 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 45/222 (20%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQE---LEVLSKIRHPH 512
IG+G YGTVYK H+ V V G ++E L L HP+
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 513 LLLLLGACPDHGC-------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVAS 563
++ L+ C LV+E+++ D K P +P + +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 564 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 623
L FLH I+HRD+KP NIL+ K+ D GL+ + + + T V
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-------TPVVV 181
Query: 624 TLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
TL Y PE Y + D+++ G + ++ KP
Sbjct: 182 TLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRKP 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ--F----LQELEVLSKIRHPHLL 514
+IG G +G V+K T A+K K ++N++ F L+E+++L ++H +++
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 515 LLLGACPDHGC----------LVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRIAWEV 561
L+ C LV+++ E+ G L N E R+ +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQML 133
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
+ L ++H K I+HRDMK N+L+ + V K+ D GL+ + + Y T
Sbjct: 134 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNR 188
Query: 622 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
V TL Y PE Y P D++ G ++ ++ T P
Sbjct: 189 VVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRSP 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 17/149 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 515
+G G + TVYK +T A+K ++ + K L+E+++L ++ HP+++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 516 LLGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
LL A LV+++ME D + K+N+ + L +LH
Sbjct: 77 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGL 601
I+HRD+KP N+LLD N V K+ D GL
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 56/275 (20%), Positives = 94/275 (34%), Gaps = 63/275 (22%)
Query: 464 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HP---HL 513
+G G + TV+ F A+KV++S + + L E+ +L +R P +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 514 LLLL------GACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
+ LL G H C+V+E + G L K+N +P +I +V L
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 567 FLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTY------- 616
+LH IIH D+KP NILL + + + + P S
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 617 ------------------------------KNTGPVGTLCYIDPEYQRTGLISPKSDVYA 646
T + T Y E + +D+++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278
Query: 647 YGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
+ +L T E DED++A I++
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
++G G YG VYK A+K L ++ ++E+ +L ++ HP+++ L+
Sbjct: 28 KVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 519 ACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
C LV+E+ME D + N + + +++ +A H +
Sbjct: 87 VIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--- 139
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLS 602
I+HRD+KP N+L++ + K+ D GL+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 33/147 (22%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYK ++ A+K L+ + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 519 ACPDHG--CLVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
LV+E+++ D + + ++ + +A+ H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLS 602
++HRD+KP N+L++ KI D GL+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 520
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 521 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 571
+ +V E ++ G L R+ + + F ER I + A+ +LH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS- 135
Query: 572 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGL 601
I HRD+KP N+L N + K+ D G
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 37/203 (18%), Positives = 64/203 (31%), Gaps = 25/203 (12%)
Query: 443 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQ- 494
Y WE L + +G G +G V + AVK+L+
Sbjct: 12 YDASKWE-FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 68
Query: 495 NKQFLQELEVLSKI-RHPHLLLLLGACPDHG---CLVYEYMENGSLEDRLYRKNNTPPIP 550
++ + EL++L I H +++ LLGAC G ++ E+ + G+L L K N
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 551 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610
+ R I D+K + + S L+
Sbjct: 129 KTKGARFR----------QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
Query: 611 FVSTTYKNTGPVGTLCYIDPEYQ 633
+ + I +Q
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQ 201
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 6e-12
Identities = 77/556 (13%), Positives = 158/556 (28%), Gaps = 175/556 (31%)
Query: 214 SSQTDLGSAVASYTHSSSPSLP---TQRLQALSAVNKTLLHLKPSSTEINH--------- 261
S T + ++ + RLQ + + LL L+P+ +
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165
Query: 262 ---SRCQSFDVEEQKD-----ASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTD 313
C S+ V+ + D + + PE + + Y+ +W+ ++ +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTSRSDHSS 221
Query: 314 VLPYDSSSESQVDVNFELEK-----LRIELRHVRGMYAIAQNEANDASRKVNDLN-KCKL 367
+ S K L + L +V+ +A + N N CK+
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLV-LLNVQ-----------NA-KAWNAFNLSCKI 268
Query: 368 EEETRLSEI--QLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAK-- 423
TR ++ L ++ T E ++ + + + +
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLT----------PDEVKSLLLKYLDCRPQDL 318
Query: 424 -HEAKE---------KEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 473
E E + L T+ ++++ +++ + S L Y
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLA-TWDNWKHVNCDKLTTIIESSLNVL------EPAEY 371
Query: 474 KGTFHHTFAAVKVLQSKGNIQNK---------------QFLQELEVLSKI-RHP------ 511
+ F + V +I + +L S + + P
Sbjct: 372 RKMF-DRLS---VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
Query: 512 -HLLLLLGACPD------HGCLVYEYMENGSLEDRLYRK--NNTPPIPWFERYRIAWEVA 562
+ L H +V Y + + ++ P+ ++Y
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHY--------NIPKTFDSDDLIPPYLDQY-FYS--- 475
Query: 563 SALAFL--HNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVST----- 614
+ H + + + LD L KI + N+ S ++T
Sbjct: 476 ----HIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHDSTA--WNASGSILNTLQQLK 528
Query: 615 TYKNTGPVGTLCYI---DPEYQR-------------TGLI-SPKSDVYAYGMVILQLLTA 657
YK YI DP+Y+R LI S +D +L+
Sbjct: 529 FYKP--------YICDNDPKYERLVNAILDFLPKIEENLICSKYTD-------LLR---- 569
Query: 658 KPAIAITHKVETAIDE 673
IA+ + E +E
Sbjct: 570 ---IALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 3e-11
Identities = 89/691 (12%), Positives = 180/691 (26%), Gaps = 277/691 (40%)
Query: 2 EVKDIVELPNSPALSVAVAVKGNRKSR-YAVLWAL--------EKFIPEGIN-----LFK 47
E+ I+ + S + W L +KF+ E + L
Sbjct: 50 EIDHIIMSK-------------DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 48 LLHVRPRITSVPTPTSLAIGHPVGN----FIP--------IEQVRD-------------- 81
+ R S+ T + + N F ++R
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 82 ------------DVAAAYKQEEK------W-------KTDRLLLPFRNMCAQRRVEVEVK 116
DV +YK + K W + +L + + Q ++
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ----IDPN 212
Query: 117 VIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNL-------SSRISICVPSF 169
D + I + S I A+ + + K +N L +++ +F
Sbjct: 213 WTSRSDHSSNIKLRIHS-------IQAELRRLLKSKPYENCLLVLLNVQNAKA---WNAF 262
Query: 170 ---CTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLG------ 220
C + L + R T ++++++H S +
Sbjct: 263 NLSCKI-------LLTTR------------FKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 221 -SAVASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTEINHSRCQSF---DVEEQKDAS 276
S + Y LP + L N L + S + ++ + ++
Sbjct: 304 KSLLLKYLDCRPQDLPREVLT----TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 277 SSC---LSGPEVRQTVSRSSSYRSMETENQDWSDQASTTDVLPYDSSSESQVDVNFELEK 333
S L E R+ + + V P + + + L
Sbjct: 360 ESSLNVLEPAEYRK------MFDRLS--------------VFPPSAHIPTIL-----LSL 394
Query: 334 LRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL------EEETRLSEIQLLEEKAIELA 387
+ ++ +D VN L+K L E + I L
Sbjct: 395 IWFDV------------IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL------- 435
Query: 388 KQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLT 447
+ + A H + +++ + +
Sbjct: 436 --------------------------KVKLENEYALH----RSIVDH-----YNIPKTFD 460
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ----------NKQ 497
+++ L Y + G HH L++ + + + +
Sbjct: 461 SDDLIPPYLD----------QYFYSHIG--HH-------LKNIEHPERMTLFRMVFLDFR 501
Query: 498 FLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLED-RLYRKNNTPPIPWFERYR 556
FL+ KIRH A G + +L+ + Y+ P +ER
Sbjct: 502 FLE-----QKIRHDST-----AWNASGSI------LNTLQQLKFYKPYICDNDPKYERL- 544
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587
V + L FL + I + ++L
Sbjct: 545 ----VNAILDFLPKIEENLICSKYT---DLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 75/509 (14%), Positives = 157/509 (30%), Gaps = 157/509 (30%)
Query: 359 VNDLNKCK-LEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQE 417
V++ + CK +++ + +L ++ I+ K R +
Sbjct: 30 VDNFD-CKDVQDMPK----SILSKEEIDHIIMSKDAVSGTLRLFWTLLS----------- 73
Query: 418 AEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF 477
K++EM+++ + + I++ S R+ Y
Sbjct: 74 ---------KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQR 116
Query: 478 HHTFAAVKVLQSKGNIQNKQFLQEL-EVLSKIRHPHLLLLLGACPDHG-------CLVYE 529
+ +V +K N+ Q +L + L ++R P +L+ G + +
Sbjct: 117 DRLYNDNQVF-AKYNVSRLQPYLKLRQALLELR-PAKNVLI-----DGVLGSGKTWVALD 169
Query: 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII-------HRDMK 582
+ ++ ++ ++I W L + P+ ++ ++
Sbjct: 170 VCLSYKVQCKMD-------------FKIFW-----LNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 583 PGNILLDH--NLVSKIGDV--GLSTMLNSDPSFVSTTYKNTGPVGTLCYI------DPEY 632
DH N+ +I + L +L S P Y+N C + + +
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP------YEN-------CLLVLLNVQNAK- 257
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKPAIA--ITHKVETAIDEDNLAEILDAQAGDWPIK 690
+ + IL L T + ++ T I D+ + L
Sbjct: 258 ----AW----NAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTP-------D 301
Query: 691 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPN---HFI 747
E K L + R +D P P L +A+ RD A + H
Sbjct: 302 EVKSLLL---KYLDCRPQDLPREVLTTNPRR--LSIIAESIRD-----GLATWDNWKHVN 351
Query: 748 CPILKEVMNEPCVAA---DGY--TYDRKAI-EE------------WLQ--ENDKSPITDL 787
C L ++ E + Y +DR ++ W ++D + +
Sbjct: 352 CDKLTTII-ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 788 PLPNKNLL---PN---YTLLSAILDWKSK 810
L +L+ P ++ S L+ K K
Sbjct: 411 -LHKYSLVEKQPKESTISIPSIYLELKVK 438
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 96/642 (14%), Positives = 189/642 (29%), Gaps = 185/642 (28%)
Query: 251 HLKPSSTEINHSR-----------CQSFDVEEQKDASSSCLSGPEVRQTVSRSS----SY 295
H+ + E + +FD ++ +D S LS E+ + +
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 296 RSMET--ENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRH---VRGMYAIAQN 350
R T Q+ Q +VL +++ F + ++ E R + MY ++
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVL--------RINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 351 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKK----------KYETARRE 400
+ ++ N +RL L + +EL + K K A
Sbjct: 118 RLYNDNQVFAKYNV------SRLQPYLKLRQALLEL-RPAKNVLIDGVLGSGKTWVA--- 167
Query: 401 AECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSE 460
+ + + + + K+ + +LE +Q N T + S
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT------SRSDHSS 221
Query: 461 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
N+++ H A ++ L +++K + L VL +++
Sbjct: 222 NIKL-----------RIHSIQAELRRL-----LKSKPYENCLLVLLNVQNAKAWNAF--- 262
Query: 521 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH---NTKPK- 574
+ C L+ + D L T + + + + L + +P+
Sbjct: 263 -NLSCKILLTT--RFKQVTDFL--SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 575 ---------P----IIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNS-DPSFVSTTYK 617
P II ++ G D H K+ + + + LN +P+ +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI-IESSLNVLEPAEYRKMFD 376
Query: 618 NTG--------PVGTLC-------YIDPE-----YQRTGLI--SPKSDVYAYGMVILQLL 655
P L D + L+ PK + + L+L
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 656 TAKPAIAITHKVETAIDEDNLAEILD-----AQAGD--W------------PIKETKELA 696
H+ + +D N+ + D D + +
Sbjct: 437 VKLENEYALHR--SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 697 ALGLSCAELRRKDRPD-----LKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPIL 751
+ L L +K R D +L L++LK +IC
Sbjct: 495 MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP----------------YICD-- 536
Query: 752 KEVMNEPCVAADGYTYDR--KAIEEWLQEND----KSPITDL 787
N+P Y+R AI ++L + + S TDL
Sbjct: 537 ----NDP-------KYERLVNAILDFLPKIEENLICSKYTDL 567
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
++G G YG VYK T A+K L+ + ++E+ +L +++H +++ L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 519 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+ L++EY EN L+ + + P + +++ + + F H+ +
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR---C 153
Query: 577 IHRDMKPGNILLDHNLVS-----KIGDVGL 601
+HRD+KP N+LL + S KIGD GL
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH------PHLLL 515
IG G +G V K H A+K+++++ +Q +E+ +L +R +++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
+L +H C+ +E + +L + L +KN + A + L LH +
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR- 220
Query: 574 KPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
IIH D+KP NILL S K+ D G S + TY + + Y PE
Sbjct: 221 --IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY----TY-----IQSRFYRAPE 269
Query: 632 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y D+++ G ++ +LLT P
Sbjct: 270 VILGARY------GMPIDMWSLGCILAELLTGYP 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 27/177 (15%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA 519
++G G Y V++ VK+L+ ++ K+ +E+++L +R P+++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 99
Query: 520 CPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
D LV+E++ N + +LY+ I R+ + +E+ AL + H+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDI----RFYM-YEILKALDYCHS---MG 150
Query: 576 IIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I+HRD+KP N+++DH + ++ D GL+ F + V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLA-------EFYHPGQEYNVRVASRYFKGPE 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 36/273 (13%)
Query: 403 CARASAEKEAAQRQ--EAEMKAKHEAKEKEMLERALNGTFQRY--RNLTWEEIESATLSF 458
C+ + + + A Q + ++ + AK M + ++ F + T+ +
Sbjct: 9 CSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFT----VLKRY 64
Query: 459 SENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLL 514
IG G G V V K+ + N + K+ +EL ++ + H +++
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 515 LLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
LL P LV E M+ L + Y + +++ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLL-YQMLCGIK 178
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
LH+ IIHRD+KP NI++ + KI D GL+ SF+ T Y V T
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-----VVTRY 228
Query: 627 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
Y PE D+++ G ++ +++ K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 2e-11
Identities = 20/76 (26%), Positives = 30/76 (39%), Gaps = 10/76 (13%)
Query: 745 HFICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQENDKS------PIT---DLPLPNKNL 794
F CPI KE M +P G+TY+ AI ++ K P + +L
Sbjct: 7 GFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDL 66
Query: 795 LPNYTLLSAILDWKSK 810
+ + L AI + K
Sbjct: 67 IQDEALRRAIENHNKK 82
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLG 518
IG G G V V K+ + N + K+ +EL ++ + H +++ LL
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91
Query: 519 A-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLH 569
P +V E M+ +L ++ + ER + +++ + LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQMELDH-----ERMSYLLYQMLCGIKHLH 144
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ IIHRD+KP NI++ + KI D GL+ SF+ T Y V T Y
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-----VVTRYYRA 194
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE D+++ G ++ +++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 45/264 (17%), Positives = 98/264 (37%), Gaps = 82/264 (31%)
Query: 452 ESATLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF-LQELEVLSK 507
E+++ +S +G G +G V + + KVLQ + ++ +EL+++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKV 56
Query: 508 IRHPHLLLLL----------------------------------GACPDHGC------LV 527
+ H +++ L+ + + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 528 YEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 582
EY+ + + + ++ I +++ A+ F+H+ I HRD+K
Sbjct: 117 MEYVP----DTLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG---ICHRDIK 168
Query: 583 PGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI--- 638
P N+L++ + K+ D G + L V+ Y + + Y PE L+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA--Y-----ICSRFYRAPE-----LMLGA 216
Query: 639 ---SPKSDVYAYGMVILQLLTAKP 659
+P D+++ G V +L+ KP
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKP 240
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 16/155 (10%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHP------HLLL 515
IG G +G V K + A+K++++K Q E+ +L + +++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 516 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L +H CLV+E + +L D L R N + + A ++ +AL FL +
Sbjct: 121 LKRHFMFRNHLCLVFEMLSY-NLYD-LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 574 KPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLN 606
IIH D+KP NILL + S KI D G S L
Sbjct: 179 S-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 57/227 (25%)
Query: 463 RIGMGGYGTVYKGT-FHHT--FAAVKVLQSKGNIQNKQ------------FLQELEVLSK 507
IG G YG V+K + F A+K + +Q + L+ L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIREVAVLRHL---ET 70
Query: 508 IRHPHLLLLLGACPDHGC-------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIA 558
HP+++ L C LV+E+++ D K P +P +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMM 126
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 618
+++ L FLH+ + ++HRD+KP NIL+ + K+ D GL+ + + +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------- 176
Query: 619 TGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
T V TL Y PE Y + D+++ G + ++ KP
Sbjct: 177 TSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRKP 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 51/225 (22%)
Query: 464 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN----------KQFLQELEVLSKIRH 510
I G YG V G V +V + + + K+ L+E+ +L+ H
Sbjct: 30 ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 511 PHLLLLLGA-CPDHGC------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEV 561
P++L L LV E M D ++ P +Y + +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQY-FMYHI 143
Query: 562 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
L LH ++HRD+ PGNILL N I D L+ +D + T Y
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHY----- 193
Query: 622 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
V Y PE + + D+++ G V+ ++ K
Sbjct: 194 VTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRKA 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 464 IGMGGYGTVYKGTFHHTFAAV------KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+G G YG+V + V + QS+ I K+ +EL +L ++H +++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLL 89
Query: 518 GA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
P LV +M+ D L + +Y + +++ L ++H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQY-LVYQMLKGLKYIH 143
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ ++HRD+KPGN+ ++ + KI D GL+ +++ T Y V T Y
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGY-----VVTRWYRA 191
Query: 630 PE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE Y + D+++ G ++ ++LT K
Sbjct: 192 PEVILSWMHY------NQTVDIWSVGCIMAEMLTGKT 222
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 15/137 (10%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH-----PHLLLL 516
+G G +G V + AVKV+++ + E ++L KI++ +++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIVKY 101
Query: 517 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
G DH CL++E + SL + + +NN + E+ AL +L
Sbjct: 102 HGKFMYYDHMCLIFEPLGP-SLYE-IITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-- 157
Query: 575 PIIHRDMKPGNILLDHN 591
+ H D+KP NILLD
Sbjct: 158 -LTHTDLKPENILLDDP 173
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 21/141 (14%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQN--KQFLQELEVLSKIR-----HPHL 513
+G G +G V + H AVK+++ N+ + E++VL +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 514 LLLLGACPD---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+ + + H C+V+E + S D ++N P ++A+++ ++ FLH+
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGL-STYD-FIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 571 TKPKPIIHRDMKPGNILLDHN 591
K + H D+KP NIL +
Sbjct: 137 NK---LTHTDLKPENILFVQS 154
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 40/268 (14%), Positives = 88/268 (32%), Gaps = 69/268 (25%)
Query: 396 TARREAECARASA---EKEAAQRQEAEMKAKHEAKEKEMLERALNGTF---QRYRNLTWE 449
++ A + ++ + +QE + + +H + + + + RY
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-- 59
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--------KQFL 499
IG G YG V + A+K I K+ L
Sbjct: 60 -------------LIGTGSYGHVCEAYDKLEKRVVAIK------KILRVFEDLIDCKRIL 100
Query: 500 QELEVLSKIRHPHLLLLLGACPDHGC-------LVYEYME---------NGSLEDRLYRK 543
+E+ +L+++ H H++ +L +V E + L + +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK- 159
Query: 544 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603
+ + + + ++H+ I+HRD+KP N L++ + K+ D GL+
Sbjct: 160 ------------TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204
Query: 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
++ + S + P
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 464 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHP-----HLLL 515
+G G +G V + H A+K++++ + E+ VL KI+ L +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 516 LLGACPD---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
L+ + H C+ +E + + + ++NN P P +A+++ AL FLH +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGK-NTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS-------FVSTTYKN 618
+ H D+KP NIL ++ + + S S + F S T+ +
Sbjct: 144 ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 19/175 (10%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 518
+IG G +G +Y GT V + ++ Q E ++ ++ P + G
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT-IRWCG 74
Query: 519 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
A D+ +V E + G SLED + + +A ++ S + ++H+ K I
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS---KNFI 127
Query: 578 HRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 627
HRD+KP N L+ NLV I D GL+ + Y+ N GT Y
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 38/180 (21%), Positives = 65/180 (36%), Gaps = 27/180 (15%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 518
RIG G +G +++GT V + Q E + P++ G
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF-G 75
Query: 519 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERY---RIAWEVASALAFLHNTKPK 574
H LV + + G SLED L F A ++ + + +H K
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---K 125
Query: 575 PIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 627
+++RD+KP N L+ + N++ + D G+ + Y+ GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 49/229 (21%), Positives = 95/229 (41%), Gaps = 55/229 (24%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 516
+G GG G V+ + A+K K + + Q L+E++++ ++ H +++ +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK----KIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 517 LGA-CPDHGC---------------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIA 558
P +V EYME D + + R
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEE--HARL-FM 126
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVS--TT 615
+++ L ++H+ ++HRD+KP N+ ++ +LV KIGD GL+ +++ S +
Sbjct: 127 YQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 616 YKNTGPVGTLCYIDPEYQRTGLISPKS-----DVYAYGMVILQLLTAKP 659
+ T Y P L+SP + D++A G + ++LT K
Sbjct: 184 G-----LVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 42/189 (22%), Positives = 74/189 (39%), Gaps = 26/189 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
IG G YG VY +T A+K + + I K+ L+E+ +L++++ +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRL 90
Query: 517 LGACPDHGC-------LVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAF 567
+V E + D L + K + I + + F
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHIKT-ILYNLLLGENF 144
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+H + IIHRD+KP N LL+ + K+ D GL+ +NS+
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 628 IDPEYQRTG 636
+ + Q T
Sbjct: 202 KNLKKQLTS 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 47/231 (20%), Positives = 83/231 (35%), Gaps = 61/231 (26%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI-QNKQFLQ----ELEVLSKIRHPHLLL 515
+G G YG V T T A+K K F E+++L +H +++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 516 LLGACPDHGC-------LVYEYME--------NGSLEDRLYRKNNTPPIPWFERYR-IAW 559
+ ++ E M+ L D + + +
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD--------------DHIQYFIY 119
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN- 618
+ A+ LH + +IHRD+KP N+L++ N K+ D GL+ +++ + S
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 619 ---TGPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
V T Y PE Y S DV++ G ++ +L +P
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 44/217 (20%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLG 518
+G G YG+V T V V + Q+ +EL +L ++H +++ LL
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 519 A-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLH 569
P LV M L + + + T + + + +++ L ++H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTD-----DHVQFLIYQILRGLKYIH 149
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ IIHRD+KP N+ ++ + KI D GL+ + T Y V T Y
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGY-----VATRWYRA 197
Query: 630 PE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE Y + D+++ G ++ +LLT +
Sbjct: 198 PEIMLNWMHY------NQTVDIWSVGCIMAELLTGRT 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 33/184 (17%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 517
IG G YG V + A+K + +++ + Q E+++L + RH +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 518 GACPDHGC-------LVYEYMENGSLEDRLYRKNNTPPI-PWFERYRIAWEVASALAFLH 569
+V + ME D LY+ T + Y +++ L ++H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGTLCY 627
+ ++HRD+KP N+LL+ KI D GL + D + T Y V T Y
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----VATRWY 197
Query: 628 IDPE 631
PE
Sbjct: 198 RAPE 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 48/219 (21%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G YG V T A+K QS+ + K+ +EL +L +RH +++ L
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGL 89
Query: 517 LGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAF 567
L PD LV +M L + + +R + + +++ L +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGE-----DRIQFLVYQMLKGLRY 143
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+H IIHRD+KPGN+ ++ + KI D GL+ +S+ T Y V T Y
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGY-----VVTRWY 191
Query: 628 IDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 659
PE Y + D+++ G ++ +++T K
Sbjct: 192 RAPEVILNWMRY------TQTVDIWSVGCIMAEMITGKT 224
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 25/178 (14%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 518
+IG G +G +Y GT T V + ++ Q L E ++ ++ P+ + G
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPN-VRWFG 72
Query: 519 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERY---RIAWEVASALAFLHNTKPK 574
D+ LV + + G SLED L+ + +A ++ + + F+H+ K
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFNFCSRK----LSLKTVLMLADQMINRVEFVHS---K 122
Query: 575 PIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 627
+HRD+KP N L+ N V I D GL+ + Y+ N GT Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIR-HPHLLLLL 517
++G G YG V+K T V K+ + N + ++ +E+ +L+++ H +++ LL
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 518 GAC-PDHGC---LVYEYME--------NGSLEDRLYRKNNTPPIPWFERYR-IAWEVASA 564
D+ LV++YME LE + + +++
Sbjct: 76 NVLRADNDRDVYLVFDYMETDLHAVIRANILEP--------------VHKQYVVYQLIKV 121
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 621
+ +LH+ ++HRDMKP NILL+ K+ D GLS + + +
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 39/186 (20%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLL 516
+IG G +G + G +T + A+K+ + Q E ++ P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLE--PMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 517 LGACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFER-------YRIAWEVASALAFL 568
G C + +V E + G SLED L+ + R IA ++ S + ++
Sbjct: 74 -GPCGKYNAMVLELL--GPSLED-LFDLCD--------RTFSLKTVLMIAIQLISRMEYV 121
Query: 569 HNTKPKPIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGP 621
H+ K +I+RD+KP N L+ ++ I D L+ + Y+ +
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHII-DFALAKEYIDPETKKHIPYREHKSL 177
Query: 622 VGTLCY 627
GT Y
Sbjct: 178 TGTARY 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 32/166 (19%)
Query: 463 RIGMGGYGTVYKGTFHHTFA----------AVKVLQSKGNIQNKQ-FLQELEVLSKIRHP 511
G +Y+ T ++K+ G + N+Q F Q ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 512 HLLLLLGA------------CPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIA 558
L + LV + G SL+ + + ++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 602
+ AL FLH +H ++ NI +D S++ G +
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 31/166 (18%), Positives = 58/166 (34%), Gaps = 35/166 (21%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHP---------H 512
+IG GG+G +Y + K +N EL+ ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 513 LLLLLGACPDHGCLVYEYMENG-----------SLEDRLYRKNNTPPIPWFER---YRIA 558
L LG +G + E+ L+ + +N T F++ ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGT-----FKKSTVLQLG 157
Query: 559 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 602
+ L ++H +H D+K N+LL + ++ D GLS
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 Length = 175 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 28/119 (23%), Positives = 40/119 (33%), Gaps = 15/119 (12%)
Query: 27 SRYAVLWALEKFIPEGINLFKL--LHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVA 84
+ A W LEK + + FK+ LHV+ P +
Sbjct: 27 CKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASP------------EDF 74
Query: 85 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 143
+Q K K LL F N C + V E + D I EV + LV+G+
Sbjct: 75 RDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGS 132
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 34/172 (19%), Positives = 58/172 (33%), Gaps = 44/172 (25%)
Query: 463 RIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---- 511
IG GG+G +Y + VKV S N EL+ + P
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQIQ 97
Query: 512 -----HLLLLLGACPDHGCLVYEYMENG-----------SLEDRLYRKNNTPPIPWFER- 554
L LG G +++ L+ +Y N F R
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKR----FSRK 152
Query: 555 --YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 602
+++ + L ++H +H D+K N+LL++ ++ D GL+
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 12/70 (17%), Positives = 25/70 (35%), Gaps = 5/70 (7%)
Query: 746 FICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQENDKS--PIT--DLPLPNKNLLPNYTL 800
CPI + P ++ + +DR I+ +LQ P + ++ + + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 801 LSAILDWKSK 810
K K
Sbjct: 242 ELRCKIAKMK 251
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 8e-05
Identities = 27/144 (18%), Positives = 49/144 (34%), Gaps = 9/144 (6%)
Query: 321 SESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND---LNKCKLEEETRLSEIQ 377
+++ F L + V+ + + Q + R V + E + +
Sbjct: 620 PKARDQAVFPQNGLVVSSVDVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQR 679
Query: 378 LLEEKAIELAKQ---EKKKYETARR---EAECARASAEKEAAQRQEAEMKAKHEAKEKEM 431
L +E L +Q ++ + E AR+ E E + E + EAE +A+ E E
Sbjct: 680 LEQEARGRLERQKILDQSEAEKARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEG 739
Query: 432 LERALNGTFQRYRNLTWEEIESAT 455
Q T E+E
Sbjct: 740 SVLQAKLKAQALAIETEAELERVK 763
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 30/147 (20%), Positives = 47/147 (31%), Gaps = 6/147 (4%)
Query: 313 DVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL----E 368
DV + + D +L IE+ A L + K+ E
Sbjct: 639 DVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKILDQSE 698
Query: 369 EETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQ-RQEAEMKAKHEAK 427
E E+ LE ++ + K E A AE AR E Q + +A+ A
Sbjct: 699 AEKARKELLELEAMSMAVESTGNAKAE-AESRAEAARIEGEGSVLQAKLKAQALAIETEA 757
Query: 428 EKEMLERALNGTFQRYRNLTWEEIESA 454
E E +++ R E+ A
Sbjct: 758 ELERVKKVREMELIYARAQLELEVSKA 784
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 8/58 (13%), Positives = 22/58 (37%), Gaps = 6/58 (10%)
Query: 380 EEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEA----KEKEMLE 433
EE+ L + + + +A + E ++++E K++ +K +
Sbjct: 92 EEQRKRLQELDAA--SKVMEQEWREKAKKDLEEWNQRQSEQVEKNKINNRIADKAFYQ 147
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 7e-04
Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 20/96 (20%)
Query: 323 SQVD-VNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE 381
+Q D + E E +R + R + + + DA+ K +E+E R E+
Sbjct: 75 AQADRLTQEPESIR-KWREEQR----KRLQELDAASK-------VMEQEWR-------EK 115
Query: 382 KAIELAKQEKKKYETARREAECARASAEKEAAQRQE 417
+L + +++ E + R + + Q
Sbjct: 116 AKKDLEEWNQRQSEQVEKNKINNRIADKAFYQQPDA 151
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} Length = 138 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 3e-04
Identities = 19/127 (14%), Positives = 43/127 (33%), Gaps = 21/127 (16%)
Query: 17 VAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPI 76
+ A+ A + L+ F + L+HV+P A
Sbjct: 4 LLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAY---------- 53
Query: 77 EQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNI 136
D++ +++ K T + ++ + V + E + + + +E N+
Sbjct: 54 ----DEIEMKEEEKAKLLTQKF----STFFTEKGINPFVVIKE-GEPVEMVLEEAKDYNL 104
Query: 137 NKLVIGA 143
L+IG+
Sbjct: 105 --LIIGS 109
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 28/114 (24%), Positives = 50/114 (43%), Gaps = 8/114 (7%)
Query: 322 ESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE 381
+ + E L+ +L+ +YA A+ + K +L + E E R+ E EE
Sbjct: 885 QKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEE----EE 940
Query: 382 KAIELAKQEKKKYETARREAECARASAEKEAAQRQEAE-MKAKHEAKEKEMLER 434
+ + + EKKK + + E E+E A RQ+ + K + K K+M +
Sbjct: 941 ERSQQLQAEKKKMQQQMLDLE---EQLEEEEAARQKLQLEKVTADGKIKKMEDD 991
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 24/104 (23%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 330 ELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQ 389
+ KL E + + + + K +L K K + E+ +SE+ E ++ ++
Sbjct: 998 QNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISEL----EVRLKKEEK 1053
Query: 390 EKKKYETARR--EAECARASAEKEAAQRQEAEMKAKHEAKEKEM 431
+++ E +R E E + + Q Q AE+KA+ KE+E+
Sbjct: 1054 SRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEEL 1097
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 810 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 4e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 8e-10 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 9e-10 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 2e-06 | |
| d2baya1 | 56 | g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 { | 3e-06 | |
| d2gm3a1 | 171 | c.26.2.4 (A:5-175) Putative ethylene-responsive pr | 7e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-61
Identities = 83/285 (29%), Positives = 130/285 (45%), Gaps = 21/285 (7%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVL 505
WE I ++ + RIG G +GTVYKG +H A VK+L + F E+ VL
Sbjct: 3 WE-IPDGQITVGQ--RIGSGSFGTVYKGKWHGDVA-VKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 506 SKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 564
K RH ++LL +G +V ++ E SL L+ + IA + A
Sbjct: 59 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQG 116
Query: 565 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
+ +LH K IIHRD+K NI L +L KIGD GL+T+ + S +++ G+
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW----SGSHQFEQLSGS 169
Query: 625 LCYIDPEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681
+ ++ PE Q S +SDVYA+G+V+ +L+T + + + + I L
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-RGYLS 228
Query: 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
K + L C + +R +RP Q+L +E L
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-55
Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 20/275 (7%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 508
E+ TL E R+G G +G V+ G ++ HT AVK L +G++ FL E ++ ++
Sbjct: 9 EVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 509 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
+H L+ L ++ EYMENGSL D L + + + +A ++A +AF
Sbjct: 66 QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAF 124
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
+ + IHRD++ NIL+ L KI D GL+ ++ + G + +
Sbjct: 125 IEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-----EYTAREGAKFPIKW 176
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687
PE G + KSDV+++G+++ +++T + + + +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLERGYRMVR 231
Query: 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722
P +EL L C + R +DRP + VLE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFD-YLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 1e-54
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 37/301 (12%)
Query: 447 TWEEIESATLSFSENL---------RIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGN 492
T+E+ A F++ + IG G +G V G F A+K L+S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 493 IQN-KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPI 549
+ + FL E ++ + HP+++ L G ++ E+MENGSL+ + + N
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQF 125
Query: 550 PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609
+ + +A+ + +L + +HRD+ NIL++ NLV K+ D GLS L D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 669
S + T G + + PE + + SDV++YG+V+ ++++ E
Sbjct: 183 SDPTYT-SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---------ER 232
Query: 670 AIDEDNLAEILDAQAGDW----PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725
+ ++++A D+ P+ L L L C + R RP Q++ L+++
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMI 291
Query: 726 E 726
Sbjct: 292 R 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 20/267 (7%)
Query: 463 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 521
IG G +G V+ G + + A+K + +G + + F++E EV+ K+ HP L+ L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 522 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
+ CLV+E+ME+G L D Y + + +V +A+L +IHR
Sbjct: 71 EQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 639
D+ N L+ N V K+ D G++ + D +TG + + PE S
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 640 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 699
KSDV+++G+++ ++ + ++ +I P + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----DISTGFRLYKPRLASTHVYQIM 235
Query: 700 LSCAELRRKDRPDLKNQVLPVLERLKE 726
C + R +DRP ++L L + E
Sbjct: 236 NHCWKERPEDRPAFS-RLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 58/268 (21%), Positives = 114/268 (42%), Gaps = 23/268 (8%)
Query: 463 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 520
+G G +G V G + A+K++ +G++ +F++E +V+ + H L+ L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 521 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
++ EYM NG L + L + + + +V A+ +L + K +HR
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 639
D+ N L++ V K+ D GLS + D + G + + PE S
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 640 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 699
KSD++A+G+++ ++ + E + + I P ++++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP-----YERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234
Query: 700 LSCAELRRKDRPDLKNQVLPVLERLKEV 727
SC + +RP K +L + +V
Sbjct: 235 YSCWHEKADERPTFKI----LLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-53
Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 24/266 (9%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-- 520
IG G +G V G + AVK +++ Q FL E V++++RH +L+ LLG
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 521 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
+V EYM GSL D L + + + + +V A+ +L +HR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 639
D+ N+L+ + V+K+ D GL+ +S + + PE R S
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFS 178
Query: 640 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 699
KSDV+++G+++ ++ + +D + + D P + +
Sbjct: 179 TKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 700 LSCAELRRKDRPDLKNQVLPVLERLK 725
+C L RP Q+ LE +K
Sbjct: 234 KNCWHLDAAMRPSFL-QLREQLEHIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 23/286 (8%)
Query: 460 ENLRIGMGGYGTVYKGTFHHT----FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLL 514
++ +G G +G+V +G + A+KVL Q ++ ++E +++ ++ +P+++
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 515 LLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L+G C LV E G L L K IP + +V+ + +L
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
K +HRD+ N+LL + +KI D GLS L +D S+ + + L + PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECI 184
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693
S +SDV++YG+ + + L+ + + +A I + + P +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 694 ELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 739
EL AL C + +DRPD V +R++ V H
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLT----VEQRMRACYYSLASKVEGHH 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 448 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLS 506
WE I +L ++G G +G V+ GT++ T A+K L G + + FLQE +V+
Sbjct: 12 WE-IPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMK 67
Query: 507 KIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
K+RH L+ L + +V EYM GSL + + + +A ++AS +
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
A++ +HRD++ NIL+ NLV K+ D GL+ ++ + G +
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPI 178
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685
+ PE G + KSDV+++G+++ +L T ++ + L ++
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRM 233
Query: 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
P + + L L C ++RP + + LE
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-51
Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 460 ENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHL 513
E+ +G G +GTV KG + AVK+L+++ N + L E V+ ++ +P++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 514 LLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ ++G C + LV E E G L L + + + +V+ + +L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
+HRD+ N+LL +KI D GLS L +D ++ T + + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWYAPEC 181
Query: 633 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692
S KSDV+++G+++ + + + A + + P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 693 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
+E+ L C ++RP V RL+
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAA----VELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-51
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 23/282 (8%)
Query: 457 SFSENLRIGMGGYGTVYKGTFHHT------FAAVKVL-QSKGNIQNKQFLQELEVLSKIR 509
+ IG G +G VYKG + A+K L Q FL E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 510 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
H +++ L G + ++ EYMENG+L+ + + + + +A+ + +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
L N +HRD+ NIL++ NLV K+ D GLS +L DP TT +G + +
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT---SGGKIPIRW 179
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687
PE + SDV+++G+V+ +++T + + + I D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAINDGFRLPT 234
Query: 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 729
P+ + L + C + R RP ++ +L++L D
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPD 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 64/332 (19%), Positives = 128/332 (38%), Gaps = 45/332 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G G V+K + + A K++ + Q ++EL+VL + P+++ GA
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 520 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
+ E+M+ GSL+ L + IP +++ V L +L I+
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637
HRD+KP NIL++ K+ D G+S L + VGT Y+ PE +
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSYMSPERLQGTH 179
Query: 638 ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 697
S +SD+++ G+ ++++ + I D L + Q +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPI-------PPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 698 LGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 757
G + RP + + + V P P+ ++ +N+
Sbjct: 233 PGRPLSSYGMDSRPPMA------------IFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
Query: 758 PCVAADGYTYDRKAIEE-----WLQENDKSPI 784
C+ + +R +++ +++ +D +
Sbjct: 281 -CLIKN--PAERADLKQLMVHAFIKRSDAEEV 309
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 2e-50
Identities = 73/285 (25%), Positives = 132/285 (46%), Gaps = 24/285 (8%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSK 507
E+E ++ ++G G YG VY+G + AVK L + ++ ++FL+E V+ +
Sbjct: 13 EMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 69
Query: 508 IRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
I+HP+L+ LLG C + E+M G+L D L N + +A +++SA+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 128
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 625
+L K IHRD+ N L+ N + K+ D GLS ++ D T + G +
Sbjct: 129 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPI 180
Query: 626 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QA 684
+ PE S KSDV+A+G+++ ++ T + ID + E+L+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKDYR 234
Query: 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 729
+ P +++ L +C + DRP ++ E + + +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMFQESS 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-50
Identities = 60/267 (22%), Positives = 106/267 (39%), Gaps = 24/267 (8%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
IG G YG K K L + + + E+ +L +++HP+++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 519 ACPDHG----CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLH--NT 571
D +V EY E G L + + + R+ ++ AL H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
++HRD+KP N+ LD K+GD GL+ +LN D SF T Y+ PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG------TPYYMSPE 184
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
+ KSD+++ G ++ +L P + E +I + + P +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGKFRRIPYRY 238
Query: 692 TKELAALGLSCAELRRKDRPDLKNQVL 718
+ EL + L+ RP ++ ++L
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVE-EIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 1e-49
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 40/296 (13%)
Query: 463 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 522
IG G +G V++G + AVK+ S ++ E+ +RH ++L + A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 523 HG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-----T 571
LV +Y E+GSL D L R + ++A AS LA LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I HRD+K NIL+ N I D+GL+ +S + VGT Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD--TIDIAPNHRVGTKRYMAPE 182
Query: 632 Y------QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET-------------AID 672
+ ++D+YA G+V ++ I + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 673 EDNLAEILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
+ + L + + + +A + C R ++ L +L +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-49
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 24/286 (8%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN-KQFLQELE 503
S + F+E IG G +G VY GT AVK L +I QFL E
Sbjct: 23 GPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 504 VLSKIRHPHLLLLLGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 560
++ HP++L LLG C +V YM++G L + + +N T + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQ 138
Query: 561 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 620
VA + FL + K +HRD+ N +LD K+ D GL+ + + + TG
Sbjct: 139 VAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--DSVHNKTG 193
Query: 621 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680
+ ++ E +T + KSDV+++G+++ +L+T D +L
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLL 248
Query: 681 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
+ P L + L C + + RP +++ + +
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 4e-49
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 44/295 (14%)
Query: 463 RIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLL 514
IG G +G V++ T AVK+L+ + + F +E ++++ +P+++
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 515 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKN---------------------NTPPIPW 551
LLG C CL++EYM G L + L + PP+
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 552 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611
E+ IA +VA+ +A+L K +HRD+ N L+ N+V KI D GLS + S
Sbjct: 140 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA--- 193
Query: 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 671
+ + ++ PE + +SDV+AYG+V+ ++ +
Sbjct: 194 -DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-----LQPYYGMA 247
Query: 672 DEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
E+ + + D P EL L C DRP + +L+R+ E
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMCE 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-48
Identities = 71/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 501
E LSF + +G G +G V + T + AVK+L+ ++ ++ + E
Sbjct: 19 EFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 502 LEVLSKI-RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRK--------------- 543
L+VLS + H +++ LLGAC ++ EY G L + L RK
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 544 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603
++ + + +++VA +AFL + K IHRD+ NILL H ++KI D GL+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 663
+ +D ++V + ++ PE + + +SDV++YG+ + +L + +
Sbjct: 194 DIKNDSNYVVKGN----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 664 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 723
V++ + I + P E+ + +C + RP K Q++ ++E+
Sbjct: 250 GMPVDSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEK 304
Query: 724 L 724
Sbjct: 305 Q 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 57/267 (21%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G VYK T AA KV+ +K + + ++ E+++L+ HP+++ LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 521 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
++ E+ G+++ + P+ + + + AL +LH+ IIH
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-----Q 633
RD+K GNIL + K+ D G+S + +GT ++ PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------RRDSFIGTPYWMAPEVVMCETS 187
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--DWPIKE 691
+ K+DV++ G+ ++++ +P + + L +I ++ P +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPPTLAQPSRW 241
Query: 692 TKELAALGLSCAELRRKDRPDLKNQVL 718
+ C E R Q+L
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTS-QLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 33/269 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
IG G + TVYKG T A LQ + ++ ++F +E E+L ++HP+++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 519 ACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ LV E M +G+L+ L R + ++ L FLH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 573 PKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
P PIIHRD+K NI + KIGD+GL+T+ + + +GT ++ PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--------KAVIGTPEFMAPE 183
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL--DAQAGDWPI 689
DVYA+GM +L++ T++ + + + + +
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDK 236
Query: 690 KETKELAALGLSCAELRRKDRPDLKNQVL 718
E+ + C + +R +K +L
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIK-DLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 29/276 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLL 514
++G G +G V +G + AVK L+ Q F++E+ + + H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 515 LLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 573
L G +V E GSL DRL + R A +VA + +L +
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 574 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 633
K IHRD+ N+LL + KIGD GL L + + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFAWCAPESL 186
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET- 692
+T S SD + +G+ + ++ T + ++ + +D + P E
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYG------QEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 693 -KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727
+++ + + C + +DRP + + L E
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 442 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN-K 496
Y L W +I+ F + IG G +G V K AA+K ++ + + +
Sbjct: 3 IYPVLDWNDIK-----FQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 497 QFLQELEVLSKI-RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTP------ 547
F ELEVL K+ HP+++ LLGAC + L EY +G+L D L +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 548 -------PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600
+ + A +VA + +L K IHRD+ NIL+ N V+KI D G
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 660
LS K T + ++ E + + SDV++YG+++ ++++
Sbjct: 173 LS-------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 661 IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 720
+ ++ + P+ E+ L C + +RP Q+L
Sbjct: 226 PYCGMTCAELYE-----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVS 279
Query: 721 LERLKE 726
L R+ E
Sbjct: 280 LNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 72/313 (23%), Positives = 130/313 (41%), Gaps = 51/313 (16%)
Query: 445 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSKGNIQN-K 496
+L WE L F + +G G +G V T + AVK+L+ K + +
Sbjct: 29 DLKWE-FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85
Query: 497 QFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN--------- 544
+ EL++++++ H +++ LLGAC G L++EY G L + L K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 545 -----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 593
+ + + + A++VA + FL K +HRD+ N+L+ H V
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV 202
Query: 594 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 653
KI D GL+ + SD S + ++ PE G+ + KSDV++YG+++ +
Sbjct: 203 VKICDFGLARDIMSD----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 654 LLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPD 712
+ + + + N +++ D P T+E+ + SC + RP
Sbjct: 259 IFSLG-----VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 713 LKNQVLPVLERLK 725
N + L
Sbjct: 314 FPN----LTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 65/309 (21%), Positives = 129/309 (41%), Gaps = 25/309 (8%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRH 510
F + +G G +GTVYKG + A+K L+ + + NK+ L E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 511 PHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 569
PH+ LLG C L+ + M G L D + + I ++A + +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE 128
Query: 570 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
+ + ++HRD+ N+L+ KI D GL+ +L ++ Y G + ++
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAEGGKVPIKWMA 181
Query: 630 PEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWP 688
E + + +SDV++YG+ + +L+T K I ++ IL+ + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISSILEKGERLPQP 235
Query: 689 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFIC 748
T ++ + + C + RP + +++ ++ R P+
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
Query: 749 PILKEVMNE 757
+ +M+E
Sbjct: 295 NFYRALMDE 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 26/262 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+IG G GTVY T A++ + + + + + E+ V+ + ++P+++ L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
D +V EY+ GSL D + + + + E AL FLH+ +IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 579 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 638
RD+K NILL + K+ D G + + S ST VGT ++ PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTRKAY 193
Query: 639 SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE--TKELA 696
PK D+++ G++ ++++ +P + + L I + E +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFR 247
Query: 697 ALGLSCAELRRKDRPDLKNQVL 718
C ++ + R K ++L
Sbjct: 248 DFLNRCLDMDVEKRGSAK-ELL 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 33/277 (11%)
Query: 456 LSFSENLR----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKI 508
+ F E+ +G G YG V T AVK++ K + + +E+ + +
Sbjct: 1 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 509 RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 566
H +++ G + L EY G L DR+ +P + R ++ + +
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVV 117
Query: 567 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 626
+LH I HRD+KP N+LLD KI D GL+T+ + + GTL
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKMCGTLP 170
Query: 627 YIDPEY-QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 685
Y+ PE +R + DV++ G+V+ +L + D+ E D +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--------DQPSDSCQEYSDWKEK 222
Query: 686 DWPIKE----TKELAALGLSCAELRRKDRPDLKNQVL 718
+ AL R + +
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIP-DIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 7e-45
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 458 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPH 512
FS+ IG G +G VY A+K + G N + ++E+ L K+RHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 513 LLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
+ G LV EY + + K P+ E + LA+LH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
+IHRD+K GNILL + K+GD G ++++ SF VGT ++ P
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----------VGTPYWMAP 180
Query: 631 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687
E G K DV++ G+ ++L KP + + + ++ + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---------NMNAMSALYHIAQNES 231
Query: 688 PIKE----TKELAALGLSCAELRRKDRPDLKNQVL 718
P + ++ SC + +DRP + +L
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSE-VLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-44
Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 29/263 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+G G +G VY + A+KVL Q + Q +E+E+ S +RHP++L L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 518 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G D L+ EY G++ L + + E+A+AL++ H+ K
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KR 126
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+IHRD+KP N+LL KI D G S S + T GTL Y+ PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTTLCGTLDYLPPEMIEG 178
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
+ K D+++ G++ + L KP A + + +P T+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFVTEGA 231
Query: 696 AALGLSCAELRRKDRPDLKNQVL 718
L + RP L+ +VL
Sbjct: 232 RDLISRLLKHNPSQRPMLR-EVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-44
Identities = 59/294 (20%), Positives = 118/294 (40%), Gaps = 32/294 (10%)
Query: 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVL-QSKGNIQNKQFLQE 501
E+ ++ S +G G +G VY+G A+K + ++ + +FL E
Sbjct: 16 EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 502 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKN-------NTPPIPWF 552
V+ + H++ LLG ++ E M G L+ L P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 553 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612
+ ++A E+A +A+L+ +HRD+ N ++ + KIGD G++ +
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---- 186
Query: 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 672
K + + ++ PE + G+ + SDV+++G+V+ ++ T + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSN 241
Query: 673 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
E L +++ D P L L C + K RP +++ ++ E
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 24/277 (8%)
Query: 463 RIGMGGYGTVYKGTFHHT-----FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
IG G +G V++G + A+K + ++FLQE + + HPH++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 517 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
+G ++ ++ E G L + + + A+++++ALA+L + K
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+HRD+ N+L+ N K+GD GLS + T YK + + ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESINF 183
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
+ SDV+ +G+ + ++L + + D + I + + P L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHG-----VKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 696 AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 732
+L C RP ++ L + E ++A+
Sbjct: 239 YSLMTKCWAYDPSRRPRFT-ELKAQLSTILE-EEKAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (394), Expect = 2e-42
Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 34/268 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G V++ T T A K + + + +E++ +S +RHP L+ L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 521 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
D ++YE+M G L +++ ++N + E +V L +H +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 579 RDMKPGNILL--DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
D+KP NI+ + K+ D GL+ L+ S TT GT + PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAEFAAPEVAEGK 200
Query: 637 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE----- 691
+ +D+++ G++ LL+ E++ + + ++ DW + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFG---------GENDDETLRNVKSCDWNMDDSAFSG 251
Query: 692 -TKELAALGLSCAELRRKDRPDLKNQVL 718
+++ R + Q L
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIH-QAL 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (377), Expect = 5e-41
Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 23/273 (8%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQ---SKGNIQNKQFLQELEVLSKIRHPHLLLLL 517
+G GG V+ AVKVL+ ++ +F +E + + + HP ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 518 GACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
+V EY++ +L D ++ + P+ + + AL F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
IIHRD+KP NI++ K+ D G++ + + V+ T +GT Y+ PE
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGTAQYLSPE 184
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
R + +SDVY+ G V+ ++LT +P V A ++ E +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVREDPIPPSARHE-GL 241
Query: 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
+ +L A+ L ++R ++ L R+
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (383), Expect = 6e-41
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G V++ T K + + + E+ +++++ HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 521 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
D L+ E++ G L DR+ ++ + E + L +H I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 579 RDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
D+KP NI+ + S KI D GL+T LN D T T + PE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-------TATAEFAAPEIVDRE 203
Query: 637 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE----- 691
+ +D++A G++ LL+ A ED+L + + + DW E
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFA---------GEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 692 -TKELAALGLSCAELRRKDRPDLKNQVL 718
+ E + + + R + L
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVH-DAL 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 8e-41
Identities = 65/288 (22%), Positives = 121/288 (42%), Gaps = 39/288 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT---------FAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHP 511
+G G +G V AVK+L+S ++ + E+E++ I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 512 HLLLLLGACPDHG--CLVYEYMENGSLEDRLYRK-------------NNTPPIPWFERYR 556
+++ LLGAC G ++ EY G+L + L + N + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 557 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 616
A++VA + +L + K IHRD+ N+L+ + V KI D GL+ ++ + TT
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 617 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 676
+ ++ PE + + +SDV+++G+++ ++ T + VE
Sbjct: 197 GR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK---- 248
Query: 677 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724
+ + D P T EL + C RP K Q++ L+R+
Sbjct: 249 -LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 3e-40
Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 24/259 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 517
+G G + TV T A+K+L+ + I+ +E +V+S++ HP + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 518 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
D Y +NG L + + E+ SAL +LH K
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
IIHRD+KP NILL+ ++ +I D G + +L+ + S + VGT Y+ PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFVGTAQYVSPELLTE 184
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
SD++A G +I QL+ P ++ +I+ + D+P K +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLE-YDFPEKFFPKA 237
Query: 696 AALGLSCAELRRKDRPDLK 714
L L R +
Sbjct: 238 RDLVEKLLVLDATKRLGCE 256
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 37/289 (12%)
Query: 463 RIGMGGYGTVYKGTFHHT-------FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLL 514
+G G +G V + AVK+L + + +++ + EL++L I H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 515 LLL-GACPDHG---CLVYEYMENGSLEDRLYRKNNTP-------------PIPWFERYRI 557
+ L GAC G ++ E+ + G+L L K N +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 558 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 617
+++VA + FL + + IHRD+ NILL V KI D GL+ + DP +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK--- 193
Query: 618 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 677
L ++ PE + + +SDV+++G+++ ++ + + IDE+
Sbjct: 194 -GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEEFCR 248
Query: 678 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726
+ + P T E+ L C RP +++ L L +
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 2e-38
Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 25/264 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
+G G + V T A+K + + + E+ VL KI+HP+++ L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 520 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
G L+ + + G L DR+ K + R+ ++V A+ +LH+ I+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIV 129
Query: 578 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
HRD+KP N+L D + I D GLS M + + GT Y+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLA 182
Query: 635 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694
S D ++ G++ LL P + + E L + + W +
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF--EQILKAEYEFDSPYWD-DISDS 239
Query: 695 LAALGLSCAELRRKDRPDLKNQVL 718
E + R + Q L
Sbjct: 240 AKDFIRHLMEKDPEKRFTCE-QAL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-38
Identities = 60/264 (22%), Positives = 98/264 (37%), Gaps = 27/264 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLL 516
+G G +G V+ F T F A+K L+ + + + E VLS HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 517 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
V EY+ G L + + A E+ L FLH+ K
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---K 122
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 634
I++RD+K NILLD + KI D G+ + K GT YI PE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 635 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 694
+ D +++G+++ ++L + DE+ L + +P KE
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 695 LAALGLSCAELRRKDRPDLKNQVL 718
L + + R ++ +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 9e-38
Identities = 41/203 (20%), Positives = 85/203 (41%), Gaps = 19/203 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+G G +G V++ + K ++ KG +E+ +L+ RH ++L L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70
Query: 521 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 578
+ +++E++ + +R+ + + E +V AL FLH+ I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 579 RDMKPGNILLDH--NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 636
D++P NI+ + KI + G + L +F Y PE +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-------TAPEYYAPEVHQHD 178
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
++S +D+++ G ++ LL+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (353), Expect = 1e-37
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 41/285 (14%)
Query: 458 FSENLR----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---------KQFLQEL 502
F EN +G G V + T AVK++ G + L+E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 503 EVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 559
++L K+ HP+++ L + LV++ M+ G L D L K + E +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMR 117
Query: 560 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 619
+ + LH I+HRD+KP NILLD ++ K+ D G S L+ K
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-------KLR 167
Query: 620 GPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 673
GT Y+ PE + + D+++ G+++ LL P ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--R 225
Query: 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 718
++ + +W + + L ++ + R + + L
Sbjct: 226 MIMSGNYQFGSPEWD-DYSDTVKDLVSRFLVVQPQKRYTAE-EAL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 2e-37
Identities = 52/264 (19%), Positives = 93/264 (35%), Gaps = 26/264 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
+IG G +G +Y GT A+K+ K ++ Q E ++ ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 521 ---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
D+ +V E + + + +A ++ S + ++H+ K I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 578 HRDMKPGNIL---LDHNLVSKIGDVGLSTMLNSDPSFVSTTY-KNTGPVGTLCYIDPEYQ 633
HRD+KP N L + I D GL+ + Y +N GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----IDEDNLAEILDAQAGDWP 688
S + D+ + G V++ I E ++ ++ +P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 689 IKETKELAALGLSCAELRRKDRPD 712
E A C LR D+PD
Sbjct: 246 ----SEFATYLNFCRSLRFDDKPD 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (351), Expect = 3e-37
Identities = 50/284 (17%), Positives = 90/284 (31%), Gaps = 27/284 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLGA 519
RIG G +G +++GT A+K + + + + ++L+ + G
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 520 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579
H LV + + + A ++ + + +H K +++R
Sbjct: 72 EGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 580 DMKPGNILLD-----HNLVSKIGDVGLSTMLNSDPSFVSTTY-KNTGPVGTLCYIDPEYQ 633
D+KP N L+ + + + D G+ + Y + GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----IDEDNLAEILDAQAGDWP 688
S + D+ A G V + L I E + L +P
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 689 IKETKELAALGLSCAELRRKDRPD---LKNQVLPVLERLKEVAD 729
+E L PD L+ VLERL D
Sbjct: 246 ----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-36
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 39/299 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQN--KQFLQELEVLSKI---RHPHLL 514
IG G YG V+K F A+K ++ + + ++E+ VL + HP+++
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 515 LLLGACPD-------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 567
L C LV+E+++ K P +P + +++ L F
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 568 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 627
LH+ ++HRD+KP NIL+ + K+ D GL+ + + + S V TL Y
Sbjct: 132 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-------VVTLWY 181
Query: 628 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ---- 683
PE + D+++ G + ++ KP + D D L +ILD
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDVIGLPG 235
Query: 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSV--HP 740
DWP A A+ K D+ +L + R + S HP
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (338), Expect = 3e-35
Identities = 66/256 (25%), Positives = 110/256 (42%), Gaps = 29/256 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLL 517
+G G +G V+ H + A+KVL+ + ++ KQ E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 518 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
G D + + +Y+E G L L + P A EV AL +LH+ K
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KD 124
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
II+RD+KP NILLD N KI D G + + GT YI PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
+ D +++G++I ++L ++ ++T +IL+A+ +P +++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAEL-RFPPFFNEDV 228
Query: 696 AALGLSCAELRRKDRP 711
L R
Sbjct: 229 KDLLSRLITRDLSQRL 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (339), Expect = 5e-35
Identities = 60/260 (23%), Positives = 100/260 (38%), Gaps = 29/260 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK------GNIQNKQFLQELEVLSKIRHPHLL 514
IG GG+G VY T A+K L K G L ++S P ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 515 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
+ A PD + + M G L L + + A E+ L +HN
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN-- 125
Query: 573 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 632
+ +++RD+KP NILLD + +I D+GL+ + K VGT Y+ PE
Sbjct: 126 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPEV 176
Query: 633 QRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
+ G+ +D ++ G ++ +LL + D+ + + A + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 692 TKELAALGLSCAELRRKDRP 711
+ EL +L + R
Sbjct: 233 SPELRSLLEGLLQRDVNRRL 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 53/267 (19%), Positives = 104/267 (38%), Gaps = 35/267 (13%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 520
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 521 PDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
+ +V E ++ G L R+ + + E I + A+ +LH+
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 575 PIIHRDMKPGNILLDH---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 631
I HRD+KP N+L N + K+ D G + S S + Y T Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 632 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691
D+++ G+++ LL P H + + + + ++P E
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYEFPNPE 240
Query: 692 ----TKELAALGLSCAELRRKDRPDLK 714
++E+ L + + R +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 519
IG G YG V + A+K + + ++ L+E+++L + RH +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 520 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
P + Y+ + LY+ T + +++ L ++H+ ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 637
HRD+KP N+LL+ KI D GL+ + + D T T V T Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 638 I-SPKSDVYAYGMVILQLLTAKP 659
+ D+++ G ++ ++L+ +P
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRP 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
+IG G YG VYK T A+K ++ + ++E+ +L ++ HP+++ LL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 519 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
+ LV+E++ + + IP +++ LAF H+ +
Sbjct: 69 VIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRV 123
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 635
+HRD+KP N+L++ K+ D GL+ + V TL Y PE
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE------VVTLWYRAPEILLGC 177
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
S D+++ G + +++T +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-34
Identities = 59/299 (19%), Positives = 109/299 (36%), Gaps = 28/299 (9%)
Query: 456 LSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL 513
+S+++ IG G +G VY+ + A+K + + +EL+++ K+ H ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNI 75
Query: 514 LLLLGACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
+ L G LV +Y+ + +P +++ +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
A++H+ I HRD+KP N+LLD + V K+ D G + L VS
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR------ 186
Query: 625 LCYIDP-EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683
Y P + DV++ G V+ +LL +P V+ ++ + +
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSV--HP 740
E + + RP + + + RL E AR T H
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 464 IGMGGYGTVYKGTFHHT--FAAVKVL-----QSKGNIQNKQFLQELEVLSKIRHPHLLLL 516
+G G + TVYK +T A+K + + N+ L+E+++L ++ HP+++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 517 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 574
L A + LV+++ME + K+N+ + L +LH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 575 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 633
I+HRD+KP N+LLD N V K+ D GL+ S T V T Y PE
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------RAYTHQVVTRWYRAPELLF 173
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKP 659
+ D++A G ++ +LL P
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
+IG G +G V+K T A+K + + + L+E+++L ++H +++ L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 519 ACPDHG----------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 568
C LV+++ E+ E R+ + + L ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 569 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
H K I+HRDMK N+L+ + V K+ D GL+ + + S + T V TL Y
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--SQPNRYTNRVVTLWYR 188
Query: 629 DPEYQRTG-LISPKSDVYAYGMVILQLLTAKP 659
PE P D++ G ++ ++ T P
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-33
Identities = 54/270 (20%), Positives = 102/270 (37%), Gaps = 31/270 (11%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL------QSKGNIQNKQFLQELEVLSKIRHPHLL 514
+G G + V K T A K + S+ + + +E+ +L +I+HP+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 515 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 572
L + L+ E + G L D L K + E ++ + + +LH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 131
Query: 573 PKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 628
I H D+KP NI+L V KI D GL+ ++ F GT ++
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------KNIFGTPEFV 183
Query: 629 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688
PE + ++D+++ G++ LL+ K ET N++ + ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVNYEFEDEYF 240
Query: 689 IKETKELAALGLSCAELRRKDRPDLKNQVL 718
+ K R ++ L
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQ-DSL 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 3e-32
Identities = 57/270 (21%), Positives = 98/270 (36%), Gaps = 41/270 (15%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN------KQFLQELEVLSKIRHPH-- 512
+G GG+G+VY G A+K ++ + E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 513 LLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
++ LL PD L+ E E + + W+V A+ HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 571 TKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 629
++HRD+K NIL+D N K+ D G +L T GT Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--------YTDFDGTRVYSP 177
Query: 630 PEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688
PE+ R + V++ G+++ ++ ++ EI+ Q +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------------EHDEEIIRGQV-FFR 224
Query: 689 IKETKELAALGLSCAELRRKDRPDLKNQVL 718
+ + E L C LR DRP + ++
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFE-EIQ 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (312), Expect = 4e-32
Identities = 41/203 (20%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 463 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 519
+IG G YG VYK ++ A+K ++ + + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 520 CPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 577
LV+E+++ + + + ++ + +A+ H+ + ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 578 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 636
HRD+KP N+L++ KI D GL+ K T + TL Y P+ +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIP------VRKYTHEIVTLWYRAPDVLMGSK 176
Query: 637 LISPKSDVYAYGMVILQLLTAKP 659
S D+++ G + +++ P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTP 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 62/256 (24%), Positives = 99/256 (38%), Gaps = 26/256 (10%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 517
+G G +G V T + A+K+L+ + I + E VL RHP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 518 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
A H C V EY G L L R+ E+ SAL +LH+ +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RD 125
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
+++RD+K N++LD + KI D GL SD + GT Y+ PE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLAPEVLED 179
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
D + G+V+ +++ + D + L E++ + +P + E
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 696 AALGLSCAELRRKDRP 711
+L + K R
Sbjct: 233 KSLLAGLLKKDPKQRL 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 5e-31
Identities = 59/303 (19%), Positives = 115/303 (37%), Gaps = 33/303 (10%)
Query: 417 EAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKG 475
A K + KE L +A +++ + +A L + ++ +G G +G V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQN---TAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 476 TFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLGACPDHGCL--VY 528
+ A+K+L + ++ KQ L E +L + P L+ L + D+ L V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588
EY+ G + L R A ++ +LH+ +I+RD+KP N+L+
Sbjct: 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 648
D ++ D G + + + GT + PE + + D +A G
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWTL---------CGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 649 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRK 708
++I ++ P A + E + + +P + +L L + ++
Sbjct: 226 VLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 709 DRP 711
R
Sbjct: 279 KRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-30
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
+G G YG V T A+K L + K+ +EL +L +RH +++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 519 ACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
LV +M G+ +L + + + +++ L ++H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA 139
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
IIHRD+KPGN+ ++ + KI D GL+ +S + TG V T Y P
Sbjct: 140 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVTRWYRAP 187
Query: 631 E-YQRTGLISPKSDVYAYGMVILQLLTAKP 659
E + D+++ G ++ +++T K
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 51/275 (18%), Positives = 105/275 (38%), Gaps = 25/275 (9%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
+IG G YGTV+K T A+K ++ + + L+E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 519 ACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 576
LV+E+ + + + + +++ L F H+ + +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 577 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 635
+HRD+KP N+L++ N K+ + GL+ + V TL Y P+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIP------VRCYSAEVVTLWYRPPDVLFGA 176
Query: 636 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 695
L S D+++ G + +L A + D D+ + + G ++ +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPL------FPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 696 AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADR 730
L L N V + +++
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 6e-28
Identities = 40/206 (19%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA 519
++G G Y V++ VK+L+ ++ K+ +E+++L +R P+++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 520 CPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
D LV+E++ N + + ++ +E+ AL + H+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS---MG 149
Query: 576 IIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 633
I+HRD+KP N+++DH + ++ D GL+ + + V + + PE
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-------EYNVRVASRYFKGPELLV 202
Query: 634 RTGLISPKSDVYAYGMVILQLLTAKP 659
+ D+++ G ++ ++ K
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-27
Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 28/209 (13%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 518
IG G G V A+K L Q K+ +EL ++ + H +++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 519 ACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
LV E M+ + + + +++ + LH+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHS 137
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
IIHRD+KP NI++ + KI D GL+ T++ T V T Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTRYYRAP 187
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKP 659
E D+++ G ++ +++ K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 5e-26
Identities = 55/368 (14%), Positives = 124/368 (33%), Gaps = 70/368 (19%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 520
++G G + TV+ A+K++ + + E+++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 521 ---------------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 565
P+ +V + G L +K IP +I+ ++ L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 566 AFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 624
++H IIH D+KP N+L++ + + ++ + N+ T + T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQT 192
Query: 625 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-- 682
Y PE +D+++ +I +L+T D+D++A+I++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 683 ---QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 739
K T+ + + L++ + + K+ A D
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD------ 306
Query: 740 PAPPNHFICPIL----------KEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPL 789
F+ P+L ++N P WL++ + ++ +
Sbjct: 307 ------FLSPMLQLDPRKRADAGGLVNHP----------------WLKDT--LGMEEIRV 342
Query: 790 PNKNLLPN 797
P++ L +
Sbjct: 343 PDRELYGS 350
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-25
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 18/204 (8%)
Query: 463 RIGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 518
+G G YG+V T AVK L + I K+ +EL +L ++H +++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 519 ACPDHGCLVYE---YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 575
L Y+ + L + + +++ L ++H+
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 576 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 635
IIHRD+KP N+ ++ + KI D GL+ + +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--------TGYVATRWYRAPEIMLNW 193
Query: 636 GLISPKSDVYAYGMVILQLLTAKP 659
+ D+++ G ++ +LLT +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-25
Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 30/264 (11%)
Query: 463 RIGMGGYGTVYKG---TFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRH-PH 512
+G G YG V+ + H T A+KVL+ +Q + E +VL IR P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 513 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 570
L+ L A L+ +Y+ G L L ++ E E+ AL LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK 147
Query: 571 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 630
II+RD+K NILLD N + D GLS +D + Y G + +
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIV 202
Query: 631 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG---DW 687
+G D ++ G+++ +LLT + ++++ AEI +
Sbjct: 203 RGGDSG-HDKAVDWWSLGVLMYELLTGASPFTVDG------EKNSQAEISRRILKSEPPY 255
Query: 688 PIKETKELAALGLSCAELRRKDRP 711
P + + L K R
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 71.3 bits (174), Expect = 4e-16
Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 739 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPN 797
P P +F CPI E+M +P + + G TY+R +I++WL K+ P + L + L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 798 YTLLSAILDWKSK 810
Y L S I W
Sbjct: 62 YVLKSLIALWCES 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 5e-15
Identities = 24/155 (15%), Positives = 46/155 (29%), Gaps = 19/155 (12%)
Query: 463 RIGMGGYGTVYKGTFH-HTFAAVKVL----------QSKGNIQNKQFLQELEVLSKIRHP 511
+G G V+ VK + K + + F ++
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 512 HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 571
L L G VY + N L + + K + + +A ++
Sbjct: 67 ALQKLQGLAVPK---VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYH- 121
Query: 572 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606
+ I+H D+ N+L+ + I D S +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.4 bits (130), Expect = 8e-10
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 742 PPNHFICPILKEVMNEPCVAADGY-TYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 800
+ F+ PI+ +M +P V T DR I L + P PL + PN L
Sbjct: 19 ACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTEL 78
Query: 801 LSAILDWKSK 810
I W ++
Sbjct: 79 KEKIQRWLAE 88
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.7 bits (128), Expect = 9e-10
Identities = 27/69 (39%), Positives = 37/69 (53%), Gaps = 1/69 (1%)
Query: 743 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPNYTLL 801
P++ I E+M EPC+ G TYDRK IEE LQ P+T PL + L+PN +
Sbjct: 5 PDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMK 64
Query: 802 SAILDWKSK 810
I + S+
Sbjct: 65 EVIDAFISE 73
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (106), Expect = 2e-06
Identities = 9/64 (14%), Positives = 23/64 (35%), Gaps = 3/64 (4%)
Query: 744 NHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS---PITDLPLPNKNLLPNYTL 800
CPI E++ EP + + + + + L + P+ + ++L +
Sbjct: 20 KILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRF 79
Query: 801 LSAI 804
+
Sbjct: 80 SQLV 83
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.8 bits (100), Expect = 3e-06
Identities = 10/54 (18%), Positives = 27/54 (50%), Gaps = 1/54 (1%)
Query: 747 ICPILKEVMNEPCVAA-DGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYT 799
+C I +V P ++ +++ +E+++++ PIT+ PL + ++
Sbjct: 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVP 55
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 171 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 39.1 bits (90), Expect = 7e-04
Identities = 33/127 (25%), Positives = 47/127 (37%), Gaps = 11/127 (8%)
Query: 27 SRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAA 86
+ A W LEK + + FK+L + V + E RD
Sbjct: 23 CKRAFEWTLEKIVRSNTSDFKILLL-----HVQVVDEDGFDDVDSIYASPEDFRD----- 72
Query: 87 YKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQ 146
+Q K K LL F N C + V E I++ D I EV + LV+G++
Sbjct: 73 MRQSNKAKGLHLLEFFVNKCHEIGVGCEA-WIKTGDPKDVICQEVKRVRPDFLVVGSRGL 131
Query: 147 GIFTWKF 153
G F F
Sbjct: 132 GRFQKVF 138
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 810 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.91 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.8 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.77 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.72 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.66 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 99.41 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 99.21 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 99.2 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 97.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.6 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.39 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 96.95 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 95.94 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 94.17 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 91.88 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 89.45 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 81.41 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=378.91 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=209.4
Q ss_pred CCCCCEEECCCCCEEEEEEEECCE-----EEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 764440223677089999998993-----89999970568-400598999999998158995665603005987--2799
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 457 ~f~~~~~iG~G~~g~Vyk~~~~~~-----~vAvK~l~~~~-~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
+|.....||+|+||.||+|.+..+ .||||.+.... ....+.|.+|+.+|++++|||||+++|+|.+.. ++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 42785698027882999999957997889999999784459899999999999998579988861899996288779999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 95248997788741299999998999999999999999976159988881579997568548971389220241004899
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~ 608 (810)
|||++|+|.+++.... ..++|..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 107 Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 7227985300210456--79999999999999999889885279---835761504489889991998884431575677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 986444433567756755568632236988973223559999999983-7997433200244310003678743207999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
.... .........||+.|+|||++.++.++.++|||||||++|||+| |++||......+ .+..+........
T Consensus 182 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 182 TSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQDYRLPP 254 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCC
T ss_pred CCCC-EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCCC
T ss_conf 7765-36502566688300387888369978612144535789999867999999999999------9999973788999
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9467899999999975002899996110013589878974
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 688 p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~~ 727 (810)
|..++..+.+|+.+||+.+|.+||++. +++..|+++...
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~-ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMIRN 293 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHS
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHCC
T ss_conf 742269999999997587976892999-999999998418
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.13 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=207.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEECCEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEEEEEC
Q ss_conf 2176444022367708999999899389999970568--400598999999998158995665603005987-2799952
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYM 531 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~~~~vAvK~l~~~~--~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~ 531 (810)
..+|....+||+|+||.||+|++++ .||||+++... ....+.|.+|+.+|.+++|||||+++|++.+.. ++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEEECC
T ss_conf 4518998898307885899999999-899999973469989999999999999847998786456797155899999658
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 48997788741299999998999999999999999976159988881579997568548971389220241004899986
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~ 611 (810)
++|+|.+++..... .+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 86 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~- 159 (276)
T d1uwha_ 86 EGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG- 159 (276)
T ss_dssp CEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC-
T ss_conf 99888999852357--8999999999999999988875099---95161478997981899788750022133355677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHH-----H
Q ss_conf 444433567756755568632236---98897322355999999998379974332002443100036787432-----0
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-----Q 683 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-----~ 683 (810)
........||+.|+|||++.+ +.++.++|||||||++|||+||+.||........ +...+.. .
T Consensus 160 ---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 160 ---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCCC
T ss_pred ---CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCC
T ss_conf ---6312566557431799999505689999531516359999999978899899896999------9999965888986
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 7999946789999999997500289999611001358987897
Q 003576 684 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 684 ~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
....+..++..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 0003655549999999997588976892999-99999999997
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.40 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=208.0
Q ss_pred CCCCCCE-EECCCCCEEEEEEEEC----CEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEEE
Q ss_conf 1764440-2236770899999989----93899999705684-00598999999998158995665603005987-2799
Q 003576 456 LSFSENL-RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 528 (810)
Q Consensus 456 ~~f~~~~-~iG~G~~g~Vyk~~~~----~~~vAvK~l~~~~~-~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV~ 528 (810)
.+|.... +||+|+||.||+|.+. +..||||++..... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCEEEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368079999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 95248997788741299999998999999999999999976159988881579997568548971389220241004899
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~ 608 (810)
||+++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 8078996899752125--69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 986444433567756755568632236988973223559999999983-7997433200244310003678743207999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... ........||+.|+|||++.++.++.++|||||||++|||+| |++||......+ .+..+........
T Consensus 163 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 163 DSY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC 233 (285)
T ss_dssp SCE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCC
T ss_pred CCC---CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCCC
T ss_conf 432---1135621137433586887279999541232201789999938999999979999------9999981899999
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 94678999999999750028999961100135898789
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 688 p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~ 725 (810)
|...+.++.+|+.+||..+|.+||++. ++.+.|+...
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~ 270 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACY 270 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 976789999999997577976890999-9999999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.98 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=202.6
Q ss_pred CCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEECC
Q ss_conf 7644402236770899999989--9389999970568400598999999998158995665603005987--27999524
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 457 ~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 532 (810)
.|....+||+|+||.||+|.+. +..||+|++........+.+.+|+.+|++++|||||++++++.+.. ++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
T ss_conf 53887898128582999999989998999999843017279999999999986799988058577988999899997037
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 89977887412999999989999999999999999761599888815799975685489713892202410048999864
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 612 (810)
||+|.+++... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-- 171 (293)
T d1yhwa1 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (293)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC--
T ss_conf 98089886415----9999999999999999999999879---72267768886887899686425156413213666--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC--CCCCHH
Q ss_conf 444335677567555686322369889732235599999999837997433200244310003678743207--999946
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIK 690 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~ 690 (810)
.....+||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..+..... ...|..
T Consensus 172 ----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEK 241 (293)
T ss_dssp ----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSCCCSSGGG
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCCCCCC
T ss_conf ----44444447773682664479988012031372999998048899899799999------99998579998888553
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 7899999999975002899996110
Q 003576 691 ETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 691 ~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.+..+.+|+.+||..+|.+||++.+
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 7999999999986699668909999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.48 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=208.5
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEEEEECC
Q ss_conf 217644402236770899999989-9389999970568400598999999998158995665603005987-27999524
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 532 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~~ 532 (810)
..+|....+||+|+||.||+|.++ ++.||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. ++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 89938867981079828999999999999999986476-88899999999998679998857873104597699999578
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 89977887412999999989999999999999999761599888815799975685489713892202410048999864
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++..... .++++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-- 164 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC--
T ss_conf 9828888751478-98878899999999999999997489---54675642251562024404234101477358864--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHH
Q ss_conf 4443356775675556863223698897322355999999998379-974332002443100036787432079999467
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~-~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
.......||+.|+|||++.++.++.++|||||||++|||+||. +|+...... ..+..+........|...
T Consensus 165 ---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCCCCTTC
T ss_pred ---CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHHCCCCCCCCCC
T ss_conf ---42035677444458289837999824564525799999996898888888999------999999706888896557
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8999999999750028999961100135898789
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 692 ~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~ 725 (810)
+..+.+|+.+||+.+|.+||++. +++..|+.+-
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~-ei~~~L~~~f 268 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFD-YLRSVLEDFF 268 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 19999999997588976893999-9999861132
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.60 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=209.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCC--CEEEEEECC
Q ss_conf 17644402236770899999989-938999997056840059899999999815899566560300598--727999524
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~--~~lV~Ey~~ 532 (810)
.+|....+||+|+||.||+|.+. +..||||++.... ...++|.+|+.++.+++|||||+++|+|.+. .++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 89977887412999999989999999999999999761599888815799975685489713892202410048999864
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 612 (810)
+|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf 991899752013--47889999999999999877653164---310443153266668877686553210023688733-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHH
Q ss_conf 444335677567555686322369889732235599999999837-9974332002443100036787432079999467
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG-~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++||......+ .+..+........|..+
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYKPRLA 227 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH------HHHHHHHTCCCCCCTTS
T ss_pred ----EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHHCCCCCCCCCC
T ss_conf ----50430017666785786079998403321059999999878988877899999------99999806888995436
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 899999999975002899996110013589878974
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 692 ~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~~ 727 (810)
+.++.+|+.+||+.+|.+||++. +++..|+++.+.
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~-~il~~L~~i~es 262 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFS-RLLRQLAEIAES 262 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHC
T ss_conf 79999999997657976891999-999999999857
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.84 Aligned_cols=254 Identities=25% Similarity=0.426 Sum_probs=207.6
Q ss_pred HCCCCCCEEECCCCCEEEEEEEECC-------EEEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCEEEEECEECCCC-
Q ss_conf 2176444022367708999999899-------38999997056-840059899999999815-8995665603005987-
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSK-GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 524 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~~-------~~vAvK~l~~~-~~~~~~~f~~Ev~iL~~l-~Hpniv~l~g~~~~~~- 524 (810)
.++|.....||+|+||.||+|++.+ ..||+|.+... .......|.+|+.+|.++ +|||||+++|+|.+..
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred -EEEEEECCCCCHHHHHHHCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf -279995248997788741299--------------------99999899999999999999997615998888157999
Q 003576 525 -CLVYEYMENGSLEDRLYRKNN--------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKP 583 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp 583 (810)
++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCC
Q ss_conf 7568548971389220241004899986444433567756755568632236988973223559999999983-799743
Q 003576 584 GNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIA 662 (810)
Q Consensus 584 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~ 662 (810)
+|||++.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+| |++||.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCE----EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf 2144345982898514222204577861----562343578765783887279999633030003999999838999999
Q ss_pred CCCHHHHHHCCCHHHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32002443100036787432-0799994678999999999750028999961100135898
Q 003576 663 ITHKVETAIDEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 663 ~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~ 722 (810)
...... .+..++.. ...+.|...+..+.+|+.+||+.+|.+||++. +++..|.
T Consensus 269 ~~~~~~------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDA------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322 (325)
T ss_dssp TCCCSH------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHH
T ss_pred CCCHHH------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 989899------99999856998998876789999999997588966893999-9999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=366.14 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=208.9
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEE
Q ss_conf 6217644402236770899999989--9389999970568400598999999998158995665603005987--27999
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 454 ~~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~E 529 (810)
...+|....+||+|+||.||+|.+. +..||||++.... ...++|.+|+.+|++++|||||+++|+|.+.. ++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 5799398659820888089999999999699999977761-039999999999986799988267752745785478763
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 52489977887412999999989999999999999999761599888815799975685489713892202410048999
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred CCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 146760677753035-541579999999999999788898789---3057604576899899928983244546537887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHH-HCCCCC
Q ss_conf 8644443356775675556863223698897322355999999998379974332002443100036787432-079999
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWP 688 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p 688 (810)
.. ..+...|++.|+|||++.++.++.++|||||||++|||+||..|+...... ..+...+.. .....|
T Consensus 170 ~~-----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 170 YT-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRMERP 238 (287)
T ss_dssp SE-----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCCCCC
T ss_pred CE-----EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHCCCCCCCC
T ss_conf 22-----103556654666927872799981043021789999998679988774259------9999998558888887
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 467899999999975002899996110013589878
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 689 ~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l 724 (810)
...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~-ei~~~L~~~ 273 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETM 273 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHT
T ss_pred CCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 43309999999997577976893999-999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.97 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=203.0
Q ss_pred EEECCCCCEEEEEEEECC----EEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEEEEECCCC
Q ss_conf 022367708999999899----389999970568--400598999999998158995665603005987-2799952489
Q 003576 462 LRIGMGGYGTVYKGTFHH----TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 534 (810)
Q Consensus 462 ~~iG~G~~g~Vyk~~~~~----~~vAvK~l~~~~--~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~~~g 534 (810)
++||+|+||.||+|.+.. ..||||+++... ....+.|.+|+.+|++++|||||+++|+|.+.. +|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEECCCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059779999747889
Q ss_pred CHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCC
Q ss_conf 97788741299999998999999999999999976159988881579997568548971389220241004899986444
Q 003576 535 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 614 (810)
Q Consensus 535 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~~~ 614 (810)
+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred CHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC--
T ss_conf 6899975225---7899999999999999976687479---5567776113102356751234134533134323443--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHHHH
Q ss_conf 433567756755568632236988973223559999999983-7997433200244310003678743207999946789
Q 003576 615 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 693 (810)
Q Consensus 615 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 693 (810)
.......||+.|+|||++.++.++.++|||||||++|||+| |++||......+ ....+........|..++.
T Consensus 165 -~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~~~ 237 (277)
T d1xbba_ 165 -KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPAGCPR 237 (277)
T ss_dssp -EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTTCCH
T ss_pred -CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCCCCCCCCH
T ss_conf -224456778420391665379998434430340313289658999999989999------9999982899999865679
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 9999999975002899996110013589878
Q 003576 694 ELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 694 ~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l 724 (810)
++.+|+.+||+.+|.+||++. ++...|+..
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~-~i~~~L~~~ 267 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFA-AVELRLRNY 267 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHH-HHHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHH-HHHHHHHCH
T ss_conf 999999997588976890989-999985288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.95 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=209.9
Q ss_pred CCCCCCEEECCCCCEEEEEEEECC------EEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EE
Q ss_conf 176444022367708999999899------3899999705684-00598999999998158995665603005987--27
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 526 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~~------~~vAvK~l~~~~~-~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~l 526 (810)
..|...+.||+|+||.||+|.+.. ..||||++..... .....|.+|+.+|.+++|||||+++|+|.+.. ++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99952489977887412999999989999999999999999761599888815799975685489713892202410048
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~ 606 (810)
||||+.+|++.+.+.... ..+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 997213574022210234--54208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCC
Q ss_conf 99986444433567756755568632236988973223559999999983799743320024431000367874320799
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
..... ........||+.|+|||++.++.++.++|||||||++|||+||..|+....... ..+..+.+.....
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 162 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFRLP 233 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTCCCC
T ss_pred CCCCC---CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHCCCCCC
T ss_conf 78765---267426777734348888704999973556344898999996798865568999-----9999986357899
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 994678999999999750028999961100135898789742
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 728 (810)
Q Consensus 687 ~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~~~ 728 (810)
.|...+..+.+|+.+||..+|.+||++. +++..|+.+....
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~L~~l~~~p 274 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAP 274 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHSG
T ss_pred CCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHCC
T ss_conf 8504579999999997767976893999-9999999986695
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.70 Aligned_cols=255 Identities=23% Similarity=0.390 Sum_probs=210.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEECCE------EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEE
Q ss_conf 1764440223677089999998993------8999997056-8400598999999998158995665603005987-279
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~~~------~vAvK~l~~~-~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV 527 (810)
.+|.....||+|+||.||+|.+..+ .||+|.+... .....+.|.+|+.+|++++|||||+++|+|.+.. +++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961983699
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99524899778874129999999899999999999999997615998888157999756854897138922024100489
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~ 607 (810)
+||+.+|+|.+.+.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 98426874010111334--57999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHH-HHCC
Q ss_conf 9986444433567756755568632236988973223559999999983-7997433200244310003678743-2079
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAG 685 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~ 685 (810)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...... .+...+. ....
T Consensus 164 ~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~ 232 (317)
T d1xkka_ 164 EEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERL 232 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------GHHHHHHHTCCC
T ss_pred CCCC----CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHCCCCC
T ss_conf 4453----22365105864467088746999835654407999999997799999999989-------999999759989
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999467899999999975002899996110013589878974
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 686 ~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~~ 727 (810)
..|..++..+.+|+.+||..+|.+||++. +++..|+.+...
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARD 273 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHC
T ss_conf 99855689999999984789934691999-999999998758
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.97 Aligned_cols=241 Identities=29% Similarity=0.382 Sum_probs=203.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCC---CCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 17644402236770899999989--938999997056---8400598999999998158995665603005987--2799
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
.+|.....||+|+||.||+|.+. +..||+|++... .......+.+|+.+|++++|||||++++++.+.. ++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 95248997788741299999998999999999999999976159988881579997568548971389220241004899
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~ 608 (810)
||+++|+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875048---9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 98644443356775675556863223698897322355999999998379974332002443100036787432079999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
. .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+. ...+.......|
T Consensus 160 ~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~p 224 (263)
T d2j4za1 160 R--------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVEFTFP 224 (263)
T ss_dssp C--------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCCCCC
T ss_pred C--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHCCCCCCC
T ss_conf 5--------2355788763499997589989314404675999998329999888999999-------999971899998
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 467899999999975002899996110013
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 689 ~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~ 718 (810)
...+.++.+|+.+||+.+|.+||++.+ ++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~e-il 253 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLRE-VL 253 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHH-HH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHH-HH
T ss_conf 668999999999976479768909999-97
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.01 Aligned_cols=243 Identities=23% Similarity=0.371 Sum_probs=201.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEEC
Q ss_conf 17644402236770899999989--9389999970568400598999999998158995665603005987--2799952
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 531 (810)
+.|....+||+|+||.||+|.+. +..||+|++........+.|.+|+.+|++++|||||++++++.+.. ++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 48997788741299999998999999999999999976159988881579997568548971389220241004899986
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~ 611 (810)
++|+|.+++..... ++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--- 163 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 163 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH---
T ss_pred CCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCC---
T ss_conf 99818899986289--9999999999999999999999889---887140700314878999899716123035778---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC--
Q ss_conf 44443356775675556863223-----69889732235599999999837997433200244310003678743207--
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 684 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-- 684 (810)
........||+.|+|||++. ...|+.++|||||||++|+|+||++||......+. +..+.....
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~~~~ 234 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPPT 234 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSCCCC
T ss_pred ---CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHCCCCCC
T ss_conf ---641001025626479999832025788888066578789999998208899999899999------99997079987
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9999467899999999975002899996110
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 685 ~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
...|...+.++.+|+.+||+.+|.+||++.+
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 7765669999999999976699668919999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.75 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=205.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEECEECCC----CEEE
Q ss_conf 17644402236770899999989--9389999970568--40059899999999815899566560300598----7279
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLV 527 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~----~~lV 527 (810)
.+|.....||+|+||.||+|... +..||+|++.... ....+.|.+|+.+|++++|||||++++++.+. .++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHHCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99524899778874129-99999989999999999999999761599--8888157999756854897138922024100
Q 003576 528 YEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKP--KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 604 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~--~~iiHrDLKp~NILl~~~~~~kI~DFGla~~ 604 (810)
|||+++|+|.+++.... ....+++..+..|+.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC
Q ss_conf 48999864444335677567555686322369889732235599999999837997433200244310003678743207
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
+..... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..+.....
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~~~~~ 231 (269)
T d2java1 164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKF 231 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC
T ss_pred CCCCCC------CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH------HHHHHHCCCC
T ss_conf 245777------5566778823279999839999938988752789999801889989989999------9999971899
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9999467899999999975002899996110
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 685 ~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
...|...+.++.+|+.+||+.+|.+||++.+
T Consensus 232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 8897435999999999976799557918999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.17 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=215.0
Q ss_pred HHHHHCCCCCCEEECCCCCEEEEEEEECC-------EEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCEEEEECEECC
Q ss_conf 99862176444022367708999999899-------38999997056840-05989999999981589956656030059
Q 003576 451 IESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD 522 (810)
Q Consensus 451 i~~~~~~f~~~~~iG~G~~g~Vyk~~~~~-------~~vAvK~l~~~~~~-~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~ 522 (810)
++...++|....+||+|+||.||+|++.+ +.||||++...... ....|.+|+.+|++++||||+.++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
T ss_conf 13898893886798207883999999888765778829999998821085799999999999996689976552466605
Q ss_pred CC--EEEEEECCCCCHHHHHHHCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEEC
Q ss_conf 87--27999524899778874129---------------------99999989999999999999999761599888815
Q 003576 523 HG--CLVYEYMENGSLEDRLYRKN---------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 579 (810)
Q Consensus 523 ~~--~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHr 579 (810)
.. ++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEE
T ss_conf 9803899981589929999985275542100001110012103467889899999999999999855413578---6854
Q ss_pred CCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-
Q ss_conf 7999756854897138922024100489998644443356775675556863223698897322355999999998379-
Q 003576 580 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK- 658 (810)
Q Consensus 580 DLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~- 658 (810)
||||+|||++.++.+||+|||+|+.+...... ...+...||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EECCCCEEECCCCCEEECCCHHHEECCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCC
T ss_conf 88401168989992898331442113677641----11577776767679899726889805630252362999980689
Q ss_pred CCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 9743320024431000367874320799994678999999999750028999961100135898789
Q 003576 659 PAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 659 ~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~ 725 (810)
+||......+ .+..+.+......|...+.++.+|+.+||+.+|.+||++. +|++.|+++.
T Consensus 241 ~p~~~~~~~e------~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~-ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAHEE------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 300 (301)
T ss_dssp CTTTTSCHHH------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCCCCHHH------HHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHC
T ss_conf 9999989999------9999973997888732529999999997488965793999-9999999842
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.56 Aligned_cols=241 Identities=25% Similarity=0.283 Sum_probs=203.9
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEE
Q ss_conf 217644402236770899999989--9389999970568---400598999999998158995665603005987--279
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV 527 (810)
-++|.....||+|+||.||+|+.. +..||+|++.... ......+.+|+.+|++++||||+++++++.+.. ++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99524899778874129999999899999999999999997615998888157999756854897138922024100489
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~ 607 (810)
||||+||+|.+++...+. +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 003579860555532567---759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 99864444335677567555686322369889732235599999999837997433200244310003678743207999
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... .....+||+.|+|||++.+..|+.++|||||||++|+|+||++||......+ +...+......+
T Consensus 158 ~~~------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~~~ 224 (337)
T d1o6la_ 158 DGA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRF 224 (337)
T ss_dssp TTC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred CCC------CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCCC
T ss_conf 786------2055100889966665048988833310223067889987899999969999-------999985289989
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 946789999999997500289999611
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 688 p~~~~~~l~~li~~Cl~~~p~~RPs~~ 714 (810)
|...++++.+|+.+||+.+|.+||+..
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~ 251 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred CCCCCHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 866899999999866638934422565
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=357.91 Aligned_cols=243 Identities=20% Similarity=0.281 Sum_probs=201.6
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEE
Q ss_conf 217644402236770899999989--9389999970568400598999999998158995665603005987--279995
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 530 (810)
-++|.....||+|+||.||+|.+. +..||||++........+.+.+|+.+|.+++|||||++++++.+.. ++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCC
Q ss_conf 24899778874129999999899999999999999997615998888157999756854--8971389220241004899
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~~kI~DFGla~~~~~~ 608 (810)
|+||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 79988999997623--78999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCC---
Q ss_conf 98644443356775675556863223698897322355999999998379974332002443100036787432079---
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--- 685 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~--- 685 (810)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+. +..+......
T Consensus 180 ~~-------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~~~ 246 (350)
T d1koaa2 180 QS-------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNMDD 246 (350)
T ss_dssp SC-------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCSCC
T ss_pred CC-------CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCC
T ss_conf 43-------2000686242188997589987267655465999999859899899799999------9999847889894
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 999467899999999975002899996110
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 686 ~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
......+..+.+|+.+||..||.+||++.+
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 223589999999999975689667908999
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.61 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=200.8
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 6217644402236770899999989--9389999970568-400598999999998158995665603005987--2799
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 454 ~~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
..++|....+||+|+||.||+|.+. +..||+|+++... ......+.+|+.+|++++|||||+++++|.+.. ++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 952489977887412999999989999999999999999761-5998888157999756854897138922024100489
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~ 607 (810)
||++||+|.+++.+.+ .+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 7679986899874249---99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCC--------------
Q ss_conf 998644443356775675556863223698897322355999999998379974332002443100--------------
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------------- 673 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~-------------- 673 (810)
. ..+..+||+.|+|||++.+..|+.++|||||||++|||+||+.||............
T Consensus 158 ~--------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 S--------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp H--------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred C--------CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 8--------62111377141194687589989488899899999999988899899887899999988751775457742
Q ss_pred ------------------CHHHHHHHHHC----CCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf ------------------03678743207----9999-4678999999999750028999961100135
Q 003576 674 ------------------DNLAEILDAQA----GDWP-IKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 674 ------------------~~l~~~ld~~~----~~~p-~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~ 719 (810)
....+.++... ...+ ...+.++.+|+.+||..||.+||++.+ ++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e-~L~ 297 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ-LMV 297 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHH-HHT
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHH
T ss_conf 12333221111222354134778876650268766764448999999999986899467908999-960
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.35 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=199.1
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEE
Q ss_conf 217644402236770899999989--9389999970568-400598999999998158995665603005987--27999
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~E 529 (810)
.++|.....||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+|++++|||||++++++.+.. ++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 52489977887412999999989999999999999999761599888815799975685489713892202410048999
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~ 609 (810)
|+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 458980899975379---9999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC-CCC
Q ss_conf 86444433567756755568632236988-9732235599999999837997433200244310003678743207-999
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GDW 687 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~~ 687 (810)
. ....+..+||+.|+|||++.+..+ +.++|||||||++|+|+||++||......... +........ ...
T Consensus 158 ~----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 158 R----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEKKTYLNP 228 (271)
T ss_dssp E----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHHTTCTTSTT
T ss_pred C----CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHHCCCCCCCC
T ss_conf 6----531113255747428728618999997101617379999998299788889859999-----9998638887886
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9467899999999975002899996110
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 688 p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
....+.++.+|+.+||+.+|.+||++.+
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 4469999999999976799668909999
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=356.77 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=202.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEE
Q ss_conf 217644402236770899999989--9389999970568400598999999998158995665603005987--279995
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 530 (810)
.+.|.....||+|+||.||+|... +..||||++..........+.+|+.+|.+++|||||++++++.+.. ++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCC
Q ss_conf 24899778874129999999899999999999999997615998888157999756854--8971389220241004899
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~--~~~~~kI~DFGla~~~~~~ 608 (810)
|+||+|.+.+...+ .++++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 89980888898638--99899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC---C
Q ss_conf 9864444335677567555686322369889732235599999999837997433200244310003678743207---9
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---G 685 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~---~ 685 (810)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..+..... .
T Consensus 183 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~~~ 249 (352)
T d1koba_ 183 EI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWEFDE 249 (352)
T ss_dssp SC-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCCCCS
T ss_pred CC-------EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCC
T ss_conf 72-------0100476453489997479989763338989999999968899899799999------9999847889893
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 999467899999999975002899996110
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 686 ~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
..+...+.++.+|+.+||+.+|.+||++.+
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 002479999999999975699668918999
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.75 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=205.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 17644402236770899999989--9389999970568---400598999999998158995665603005987--2799
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
.+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|++++||||+++++++.+.. ++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 95248997788741299999998999999999999999976159988881579997568548971389220241004899
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~ 608 (810)
||++||+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653159---9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 98644443356775675556863223698897322355999999998379974332002443100036787432079999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
... ......+||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..++ .....+|
T Consensus 162 ~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~-~~~~~~p 230 (288)
T d1uu3a_ 162 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKII-KLEYDFP 230 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH-TTCCCCC
T ss_pred CCC----CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-CCCCCCC
T ss_conf 764----333555677552584400268989666230456999998038899899599999------99997-1899998
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 4678999999999750028999961100135
Q 003576 689 IKETKELAALGLSCAELRRKDRPDLKNQVLP 719 (810)
Q Consensus 689 ~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~ 719 (810)
...++.+.+|+.+||+.+|.+||++.+ ++.
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e-~~~ 260 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEE-MEG 260 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGG-GTC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHH-HCC
T ss_conf 547999999999985579768919789-737
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.49 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=208.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEECC
Q ss_conf 17644402236770899999989-9389999970568400598999999998158995665603005987--27999524
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~~ 532 (810)
++|....+||+|+||.||+|+++ +..||||+++.... ..+.|.+|+.++.+++||||++++|+|.+.. ++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 89977887412999999989999999999999999761599888815799975685489713892202410048999864
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 612 (810)
+|+|..++..... .+++..+.+|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf 9938886410246--7768999999999999999875468---434665413588769984798861442023578722-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHH
Q ss_conf 44433567756755568632236988973223559999999983-79974332002443100036787432079999467
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
......||+.|+|||++....++.++|||||||++|||+| |+.||......+ ....+........|...
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCCCCCTTC
T ss_pred ----EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH------HHHHHHHCCCCCCCCCC
T ss_conf ----52465788775780786379988521033643246739755999988999999------99999807978996546
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 8999999999750028999961100135898
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLE 722 (810)
Q Consensus 692 ~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~ 722 (810)
+..+.+|+.+||+.+|.+||++. +++..|.
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~-eil~~L~ 256 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFK-ILLSNIL 256 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHH-HHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 59999999997668976893999-9998741
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=355.28 Aligned_cols=239 Identities=27% Similarity=0.404 Sum_probs=195.6
Q ss_pred CCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC---CHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEE
Q ss_conf 7644402236770899999989--938999997056840---0598999999998158995665603005987--27999
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 457 ~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~E 529 (810)
.|+..++||+|+||.||+|.+. +..||||++...... ..+.|.+|+.+|++++|||||+++++|.+.. ++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 52489977887412999999989999999999999999761599888815799975685489713892202410048999
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~ 609 (810)
||++|+|..++.... ++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 069994578997379---9999999999999999999998689---766678842179879997898443653346778-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCC-
Q ss_conf 86444433567756755568632236---98897322355999999998379974332002443100036787432079-
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG- 685 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~- 685 (810)
....||+.|+|||++.+ +.|+.++|||||||++|+|++|++||........ +..+......
T Consensus 169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~~~~~ 233 (309)
T d1u5ra_ 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPA 233 (309)
T ss_dssp ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCCC
T ss_pred ---------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCC
T ss_conf ---------731347663688998346788867214545589999999878899999799999------99998289998
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 999467899999999975002899996110013
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 686 ~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~ 718 (810)
..+...+..+.+|+.+||..+|.+||++.+ ++
T Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e-ll 265 (309)
T d1u5ra_ 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV-LL 265 (309)
T ss_dssp CSCTTSCHHHHHHHHHHTCSSGGGSCCHHH-HT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HH
T ss_conf 887888999999999977379657918999-97
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.26 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=207.9
Q ss_pred HCCCCCCEEECCCCCEEEEEEEECC-EEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEEEEECC
Q ss_conf 2176444022367708999999899-389999970568400598999999998158995665603005987-27999524
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 532 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV~Ey~~ 532 (810)
..+|....+||+|+||.||+|.+.+ ..||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. ++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEECC
T ss_conf 79979846993079809999999999999999988044-88899999999998666678868999982397599999447
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 89977887412999999989999999999999999761599888815799975685489713892202410048999864
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 612 (810)
+|+|..++..... ..++|..++.|+.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-- 168 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 168 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC--
T ss_conf 9943542000035-53059999999999999999875411---43353123079998999299844255542568873--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHHH
Q ss_conf 44433567756755568632236988973223559999999983799743320024431000367874320799994678
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 692 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 692 (810)
.......||+.|+|||++..+.++.++|||||||++|||+||..|+........ .+..+........+...+
T Consensus 169 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-----~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 169 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGYRMPCPPECP 240 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHTTCCCCCCTTSC
T ss_pred ---EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHHCCCCCCCCCCC
T ss_conf ---352454556654580898379989177413235899999868999998888999-----999998268999983237
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 99999999975002899996110013589878
Q 003576 693 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 693 ~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l 724 (810)
.++.+|+.+||+.+|.+||++. +|+..|+..
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~-~i~~~L~~~ 271 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 271 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTT
T ss_pred HHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 9999999997566975891999-999987666
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.05 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=200.2
Q ss_pred HHCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 6217644402236770899999989--9389999970568-400598999999998158995665603005987--2799
Q 003576 454 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 454 ~~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
..+.|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|.+++|||||++++++.+.. ++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCCC
Q ss_conf 9524899778874129999999899999999999999997615998888157999756854---8971389220241004
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTML 605 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~kI~DFGla~~~ 605 (810)
||++||+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||+. .++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 5268984888653036---7887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC-
Q ss_conf 8999864444335677567555686322369889732235599999999837997433200244310003678743207-
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 684 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~- 684 (810)
..... ....+||+.|+|||++.+..++.++|||||||++|+|+||++||........ ...++....
T Consensus 161 ~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~~ 227 (307)
T d1a06a_ 161 DPGSV-------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAEYE 227 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHTTCCC
T ss_pred CCCCE-------EEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHCCCCC
T ss_conf 58970-------4400328422591887379998078734515999999859799999899999------9998616877
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --9999467899999999975002899996110
Q 003576 685 --GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 685 --~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
...+...++.+.+|+.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 787666678999999999976089757918999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.21 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=204.6
Q ss_pred CEEECCCCCEEEEEEEECCE-----EEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEECEECC-C--CEEEEEEC
Q ss_conf 40223677089999998993-----8999997056-84005989999999981589956656030059-8--72799952
Q 003576 461 NLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-H--GCLVYEYM 531 (810)
Q Consensus 461 ~~~iG~G~~g~Vyk~~~~~~-----~vAvK~l~~~-~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~-~--~~lV~Ey~ 531 (810)
..+||+|+||+||+|.+..+ .||||.+... .......|.+|+.+|++++|||||+++|+|.+ . .++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 48997788741299999998999999999999999976159988881579997568548971389220241004899986
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~ 611 (810)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 0674144210134--54048999999999887652003367---625776687576779998899106523225566555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHH
Q ss_conf 44443356775675556863223698897322355999999998379974332002443100036787432079999467
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
.........||+.|+|||++..+.++.++||||||+++|||+||..||....... .....+........|...
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~~~~p~~~ 259 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQPEYC 259 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCCCCCTTC
T ss_pred --CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHCCCCCCCCCCC
T ss_conf --3100256555645567688743799974574661999999997899998889999-----999999808988996447
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89999999997500289999611001358987897
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 692 ~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
+..+.+|+.+||..+|.+||++. +|+..|+.+..
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~-ei~~~L~~i~~ 293 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 59999999997688976893999-99999999997
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.61 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=209.7
Q ss_pred HCCCCCCEEECCCCCEEEEEEEECC-----EEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EEE
Q ss_conf 2176444022367708999999899-----389999970568-400598999999998158995665603005987-279
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 527 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~lV 527 (810)
..+|.....||+|+||.||+|.+.. ..||||.+.... ......|.+|+.+|++++|||||+++|+|.+.. ++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953747999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99524899778874129999999899999999999999997615998888157999756854897138922024100489
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~ 607 (810)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 98406980776542247--89999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHHHCCC
Q ss_conf 9986444433567756755568632236988973223559999999983-799743320024431000367874320799
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 686 (810)
... ...+...||+.|+|||++..+.++.++|||||||++|||+| |.+||......+ .+..+.......
T Consensus 161 ~~~-----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 161 STY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLP 229 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCC
T ss_pred CCC-----EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH------HHHHHHCCCCCC
T ss_conf 762-----330540058310326675169988745244424789999826999988899999------999998189998
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9946789999999997500289999611001358987897
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 687 ~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
.|...+..+.+|+.+||..+|.+||++. +++..|+.+.+
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~ 268 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTILE 268 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 9877799999999997687976892999-99999999977
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=349.57 Aligned_cols=234 Identities=21% Similarity=0.289 Sum_probs=198.8
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 17644402236770899999989--9389999970568---400598999999998158995665603005987--2799
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
++|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++|||||++++++.+.. ++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 95248997788741299999998999999999999999976159988881579997568548971389220241004899
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~ 608 (810)
||+.+|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 98644443356775675556863223698897322355999999998379974332002443100036787432079999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..+ .......|
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i-~~~~~~~p 258 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKI-VSGKVRFP 258 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HHCCCCCC
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HCCCCCCC
T ss_conf ---------6433676356788997179988533114500789999758899899599999------9998-61798897
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 46789999999997500289999
Q 003576 689 IKETKELAALGLSCAELRRKDRP 711 (810)
Q Consensus 689 ~~~~~~l~~li~~Cl~~~p~~RP 711 (810)
...++.+.+|+.+||..+|.+|+
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred CCCCHHHHHHHHHHHHHCHHHCC
T ss_conf 66899999999998340998606
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.77 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=190.7
Q ss_pred CCCEEECCCCCEEEEEEEECC--EEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEECEECC----C--CEEEE
Q ss_conf 444022367708999999899--389999970568--4005989999999981589956656030059----8--72799
Q 003576 459 SENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD----H--GCLVY 528 (810)
Q Consensus 459 ~~~~~iG~G~~g~Vyk~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~----~--~~lV~ 528 (810)
....+||+|+||.||+|.+.. ..||+|++.... ....+.|.+|+++|++++|||||+++++|.+ . .++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEEECCCCCCCC
Q ss_conf 9524899778874129999999899999999999999997615998888157999756854-897138922024100489
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~-~~~~~kI~DFGla~~~~~ 607 (810)
||+++|+|.+++.+.. .+++..+..|+.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 5789894899975135---5469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC-CC
Q ss_conf 99864444335677567555686322369889732235599999999837997433200244310003678743207-99
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GD 686 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~ 686 (810)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|+||++||......... ...+..... ..
T Consensus 168 ~~--------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~-----~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 168 SF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPAS 233 (270)
T ss_dssp TS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCCGG
T ss_pred CC--------CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHCCCCCCC
T ss_conf 76--------677553813008988478-9998671100799999998788999876559999-----999973899865
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99467899999999975002899996110
Q 003576 687 WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 687 ~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
++...++++.+|+.+||..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~e 262 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKD 262 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 67557899999999976379758929999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=348.56 Aligned_cols=235 Identities=27% Similarity=0.339 Sum_probs=198.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEE
Q ss_conf 17644402236770899999989--9389999970568---400598999999998158995665603005987--2799
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 528 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~ 528 (810)
.+|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|++++|||||++++++.+.. ++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 95248997788741299999998999999999999999976159988881579997568548971389220241004899
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~ 608 (810)
||++||+|..++..... +++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 50378632234322221---110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 98644443356775675556863223698897322355999999998379974332002443100036787432079999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
....+||+.|+|||++.+..++.++|||||||++|+|+||++||......+. +..++. ....+|
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~-~~~~~p 221 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILN-AELRFP 221 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-CCCCCC
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH------HHHHHC-CCCCCC
T ss_conf ---------6434576343599998389998043046533368999759899999699999------999970-898899
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 467899999999975002899996
Q 003576 689 IKETKELAALGLSCAELRRKDRPD 712 (810)
Q Consensus 689 ~~~~~~l~~li~~Cl~~~p~~RPs 712 (810)
...++++.+++.+||..+|.+||+
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCHHHHHHHHHHHHHCHHHCCC
T ss_conf 778999999999995449976664
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=350.31 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=194.1
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHH---HHHHHHCCCCCEEEEECEECCCC--E
Q ss_conf 17644402236770899999989--9389999970568---4005989999---99998158995665603005987--2
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQE---LEVLSKIRHPHLLLLLGACPDHG--C 525 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~E---v~iL~~l~Hpniv~l~g~~~~~~--~ 525 (810)
++|.....||+|+||.||+|.+. +..||+|++.... ......+.+| +.+++.++|||||++++++.+.. +
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 79995248997788741299999998999999999999999976159988881579997568548971389220241004
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~ 605 (810)
+||||++||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 9999148983899987325---5327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHC
Q ss_conf 899986444433567756755568632236-9889732235599999999837997433200244310003678743207
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 684 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 684 (810)
.... ....+||+.|+|||++.. ..++.++|||||||++|+|+||++||........ ..+........
T Consensus 158 ~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~~~~~ 225 (364)
T d1omwa3 158 SKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTMA 225 (364)
T ss_dssp SSSC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHHSSSCC
T ss_pred CCCC--------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHCCCCC
T ss_conf 7886--------43311345542168760389998441046778999999859998888998999----99998604688
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 999946789999999997500289999611
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 685 ~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~ 714 (810)
...|...++++.+|+.+||..+|.+||+..
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCL 255 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHHCCCC
T ss_conf 878877899999999998566988808874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.80 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=207.8
Q ss_pred HHHCCCCCCEEECCCCCEEEEEEEECC-------EEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEECEECCC
Q ss_conf 862176444022367708999999899-------3899999705684-0059899999999815-899566560300598
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 453 ~~~~~f~~~~~iG~G~~g~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~iL~~l-~Hpniv~l~g~~~~~ 523 (810)
...++|....+||+|+||.||+|.+.+ +.||||++..... .....+.+|..++.++ +||||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 16799798449841678399999986777555783999999860017178999999999988614998499741154047
Q ss_pred ---CEEEEEECCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf ---7279995248997788741299-------------999998999999999999999976159988881579997568
Q 003576 524 ---GCLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 587 (810)
Q Consensus 524 ---~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NIL 587 (810)
.++|||||++|+|.+++..... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEE
T ss_conf 97579999845899299999853666665322202332146899999999999999999887379---717867731065
Q ss_pred ECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCH
Q ss_conf 5489713892202410048999864444335677567555686322369889732235599999999837-997433200
Q 003576 588 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHK 666 (810)
Q Consensus 588 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG-~~Pf~~~~~ 666 (810)
++.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+|| .+||.....
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ECCCCCEEECCCCCHHHCCCCCCC----CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf 779982898457520011356652----2247516672102036864688996632213678999998688999989998
Q ss_pred HHHHHCCCHHHHH-HHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 2443100036787-43207999946789999999997500289999611001358987897
Q 003576 667 VETAIDEDNLAEI-LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 667 ~~~~~~~~~l~~~-ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
.. .+... ........|...++.+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 243 ~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~~L~~ilq 296 (299)
T d1ywna1 243 DE------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 296 (299)
T ss_dssp SH------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HH------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 99------99999963898888865789999999997677966791999-99999979986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.01 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=209.8
Q ss_pred CCCCCCEEECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCC---CEEEEEECC
Q ss_conf 17644402236770899999989938999997056840059899999999815899566560300598---727999524
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYME 532 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~---~~lV~Ey~~ 532 (810)
++|....+||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||++++|+|.+. .++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 994885798207980899999999099999988577--799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 89977887412999999989999999999999999761599888815799975685489713892202410048999864
Q 003576 533 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 612 (810)
Q Consensus 533 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~~ 612 (810)
+|+|.++|..... ..++|..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9989999874578-88899999999999985232113376---5536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCCHHH
Q ss_conf 44433567756755568632236988973223559999999983-79974332002443100036787432079999467
Q 003576 613 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 691 (810)
Q Consensus 613 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 691 (810)
....+|+.|+|||++.++.+++++|||||||++|||+| |++||...... .....+......+.|...
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------~~~~~i~~~~~~~~~~~~ 225 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDGC 225 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTTTCCCCCCTTC
T ss_pred ------CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHCCCCCCCCCCC
T ss_conf ------65566646778178727988858877757999999997899999999999------999999808999997657
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89999999997500289999611001358987897
Q 003576 692 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 692 ~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
++.+.+|+.+||..+|.+||++. +++..|++++.
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~-~l~~~L~~i~~ 259 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIKT 259 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 99999999997566976893999-99999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.75 Aligned_cols=241 Identities=21% Similarity=0.282 Sum_probs=199.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC------CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--
Q ss_conf 217644402236770899999989--9389999970568------400598999999998158995665603005987--
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG------NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 524 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~------~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-- 524 (810)
.+.|.....||+|+||.||+|.+. +..||||++.... ....+.|.+|+.+|++++|||||+++++|.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEEC
Q ss_conf 27999524899778874129999999899999999999999997615998888157999756854897----13892202
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVG 600 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~----~~kI~DFG 600 (810)
++|||||++|+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99998677864310010356---4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHH
Q ss_conf 41004899986444433567756755568632236988973223559999999983799743320024431000367874
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 680 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 680 (810)
++..+..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||......+. +..+.
T Consensus 163 ~a~~~~~~~~-------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~ 229 (293)
T d1jksa_ 163 LAHKIDFGNE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVS 229 (293)
T ss_dssp TCEECTTSCB-------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred HHHHCCCCCC-------CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH------HHHHH
T ss_conf 4210577763-------1224777743099998189999766522140999999708899889999999------99998
Q ss_pred HHHCCCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 32079999----467899999999975002899996110
Q 003576 681 DAQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 681 d~~~~~~p----~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
. ....++ ...+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 230 A-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp T-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred H-CCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 1-6888870104788999999999986389668919999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.39 Aligned_cols=244 Identities=24% Similarity=0.307 Sum_probs=202.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHH-HCCCCCEEEEECEECCCC--EEE
Q ss_conf 17644402236770899999989--9389999970568---400598999999998-158995665603005987--279
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLS-KIRHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~iL~-~l~Hpniv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||+||+|.+. +..||||++.... ......+..|..++. .++|||||++++++.+.. ++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 99524899778874129999999899999999999999997615998888157999756854897138922024100489
Q 003576 528 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~ 607 (810)
|||+++|+|.+++..... +++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 750379808998640478---999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCC
Q ss_conf 99864444335677567555686322369889732235599999999837997433200244310003678743207999
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 687 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 687 (810)
... ..+...||+.|+|||++.+..++.++|||||||++|+|+||++||....... +...+......+
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~ 222 (320)
T d1xjda_ 156 GDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFY 222 (320)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred CCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHCCCCCC
T ss_conf 653------3454578777689999827998832320112278989873889999989999-------999997189989
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 9467899999999975002899996110013
Q 003576 688 PIKETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 688 p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~ 718 (810)
|...+..+.+|+.+||..+|.+||++..+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 7567999999999965448987838899998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.82 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=207.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEECC--E--EEEEEEECCC-CCCCHHHHHHHHHHHHHC-CCCCEEEEECEECCCC--EEE
Q ss_conf 176444022367708999999899--3--8999997056-840059899999999815-8995665603005987--279
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH--T--FAAVKVLQSK-GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 527 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~~--~--~vAvK~l~~~-~~~~~~~f~~Ev~iL~~l-~Hpniv~l~g~~~~~~--~lV 527 (810)
++|.....||+|+||.||+|.+.+ . .||||.+... .....+.|.+|+.+|+++ +|||||+++|+|.+.. ++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 9952489977887412-------------999999989999999999999999761599888815799975685489713
Q 003576 528 YEYMENGSLEDRLYRK-------------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 594 (810)
Q Consensus 528 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~ 594 (810)
|||+++|+|.++|... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHCC
Q ss_conf 8922024100489998644443356775675556863223698897322355999999998379-974332002443100
Q 003576 595 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDE 673 (810)
Q Consensus 595 kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~-~Pf~~~~~~~~~~~~ 673 (810)
||+|||+++...... ......||..|+|||.+..+.++.++|||||||++|||++|. +||......+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----- 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 234 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred EECCCCCCCCCCCCC-------CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHH-----
T ss_conf 874344322444223-------45530137755553875269999622153138899999836899999999999-----
Q ss_pred CHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 03678743207999946789999999997500289999611001358987897
Q 003576 674 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 674 ~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
.+..+........|...++++.+|+.+||+.+|++||++. +++..|+++.+
T Consensus 235 -~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~i~~ 285 (309)
T d1fvra_ 235 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 285 (309)
T ss_dssp -HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred -HHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf -9999982688888766789999999997678966894999-99999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.79 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=213.0
Q ss_pred HCCCCCCEEECCCCCEEEEEEEECC---------EEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEECEECCC
Q ss_conf 2176444022367708999999899---------3899999705684-0059899999999815-899566560300598
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 523 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~~---------~~vAvK~l~~~~~-~~~~~f~~Ev~iL~~l-~Hpniv~l~g~~~~~ 523 (810)
.++|...+.||+|+||.||+|+..+ +.||||+++.... .....+.+|+..+.++ +|||||+++|+|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred C--EEEEEECCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 7--279995248997788741299-------------9999989999999999999999761599888815799975685
Q 003576 524 G--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl 588 (810)
. ++||||+++|+|.++|..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 48971389220241004899986444433567756755568632236988973223559999999983-79974332002
Q 003576 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 667 (810)
Q Consensus 589 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~ 667 (810)
+.++.+||+|||+++......... ......||+.|+|||++.++.|+.++|||||||++|||+| |.+||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTC----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCC----CCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH
T ss_conf 478976762211101135555543----1466788846632667517988825554775888887401798989999999
Q ss_pred HHHHCCCHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 443100036787432079999467899999999975002899996110013589878974
Q 003576 668 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 668 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~~ 727 (810)
. .+..+........|...+..+.+|+.+||+.+|.+||++. +++..|+++..+
T Consensus 245 ~------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 E------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVAL 297 (299)
T ss_dssp H------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred H------HHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHC
T ss_conf 9------9999972888898743529999999997667976793999-999999888604
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.97 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=210.1
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC-------CEEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCEEEEECEECCCC-
Q ss_conf 217644402236770899999989-------93899999705684-0059899999999815-8995665603005987-
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 524 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~iL~~l-~Hpniv~l~g~~~~~~- 524 (810)
.++|....+||+|+||.||+|++. ++.||||+++.... .....|.+|+.++.++ +|||||+++|+|.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred -EEEEEECCCCCHHHHHHHCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf -27999524899778874129---------------99999989999999999999999761599888815799975685
Q 003576 525 -CLVYEYMENGSLEDRLYRKN---------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 588 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl 588 (810)
++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHH
Q ss_conf 48971389220241004899986444433567756755568632236988973223559999999983-79974332002
Q 003576 589 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 667 (810)
Q Consensus 589 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~ 667 (810)
+.++.+||+|||+++........ .......||+.|+|||++..+.++.++|||||||++|||+| |.+||......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCCCCCCCCCHHEECCCCCCC----EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 02575210234010233678861----58620135968767788617999974001025899999985899887789989
Q ss_pred HHHHCCCHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 4431000367874320-7999946789999999997500289999611001358987897
Q 003576 668 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 668 ~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
..+..++... ....|...+..+.+|+.+||+.+|.+||++. +++.+|+++..
T Consensus 255 ------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-~il~~L~~~i~ 307 (311)
T d1t46a_ 255 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQIS 307 (311)
T ss_dssp ------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred ------HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHC
T ss_conf ------999999866898898543659999999997577965792999-99999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.03 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=206.8
Q ss_pred CCCCCCEEECCCCCEEEEEEEECC-----EEEEEEEECCCC---CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC-EE
Q ss_conf 176444022367708999999899-----389999970568---400598999999998158995665603005987-27
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CL 526 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~~-----~~vAvK~l~~~~---~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~-~l 526 (810)
.+|.....||+|+||.||+|.+.. ..||||++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. ++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCHHE
T ss_conf 89199789803888399999998899907999999998355579899999999999998689999878987774010011
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 99952489977887412999999989999999999999999761599888815799975685489713892202410048
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 606 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~ 606 (810)
||||+++|+|.+++..... ++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 4654238612544421268--9999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHCCCHHHHHHHH-HC
Q ss_conf 99986444433567756755568632236988973223559999999983-79974332002443100036787432-07
Q 003576 607 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QA 684 (810)
Q Consensus 607 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~-~~ 684 (810)
...... .......|+..|+|||++.+..++.++|||||||++|||+| |++||......+. +..+... ..
T Consensus 163 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~ 233 (273)
T d1u46a_ 163 QNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER 233 (273)
T ss_dssp C-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC
T ss_pred CCCCCC---EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------HHHHHHCCCC
T ss_conf 588752---6547632573107999983799994215661489999999689999999699999------9999847999
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 9999467899999999975002899996110013589878
Q 003576 685 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 685 ~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l 724 (810)
.+.+...+..+.+|+.+||..+|.+||++. ++...|+.+
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHC
T ss_conf 998544539999999997688966792999-999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.30 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=209.6
Q ss_pred HHHCCCCCCEEECCCCCEEEEEEEEC-------CEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCEEEEECEECCC-
Q ss_conf 86217644402236770899999989-------93899999705684-0059899999999815899566560300598-
Q 003576 453 SATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH- 523 (810)
Q Consensus 453 ~~~~~f~~~~~iG~G~~g~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~- 523 (810)
...++|....+||+|+||.||+|.+. ++.||||+++.... .....|.+|+.++++++|||||+++|+|...
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 26899188359820788189999987864477896899999870128689999999999999769998841254784288
Q ss_pred -CEEEEEECCCCCHHHHHHHC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf -72799952489977887412-------9999999899999999999999997615998888157999756854897138
Q 003576 524 -GCLVYEYMENGSLEDRLYRK-------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 595 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~k 595 (810)
.++||||+++|+|.+++... .....+++..+..|+.+++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEE
T ss_conf 106777604899889998750332113444688799999999999999999876479---65432867754035996499
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHCCC
Q ss_conf 922024100489998644443356775675556863223698897322355999999998379-9743320024431000
Q 003576 596 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDED 674 (810)
Q Consensus 596 I~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~-~Pf~~~~~~~~~~~~~ 674 (810)
|+|||+++.+..... ........||+.|+|||.+.++.++.++||||||+++|||+||. +||...... .
T Consensus 174 l~DFGla~~~~~~~~----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~ 243 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q 243 (308)
T ss_dssp ECCTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H
T ss_pred EEECCCCEECCCCCC----EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH------H
T ss_conf 942454202357763----031340231632378888736998833344437899999996899999998999------9
Q ss_pred HHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 36787432079999467899999999975002899996110013589878
Q 003576 675 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 724 (810)
Q Consensus 675 ~l~~~ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l 724 (810)
.+..+.+......|...+..+.+|+.+||+.+|.+||++. +++..|+..
T Consensus 244 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-~il~~L~~~ 292 (308)
T d1p4oa_ 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEE 292 (308)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHGGG
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 9999980888888633539999999997577965893999-999997876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.42 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=197.1
Q ss_pred CCCCCEEECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHH--HHHHCCCCCEEEEECEECCC------CEEEE
Q ss_conf 76444022367708999999899389999970568400598999999--99815899566560300598------72799
Q 003576 457 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELE--VLSKIRHPHLLLLLGACPDH------GCLVY 528 (810)
Q Consensus 457 ~f~~~~~iG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~--iL~~l~Hpniv~l~g~~~~~------~~lV~ 528 (810)
.|....+||+|+||.||+|++++..||||++.... ...+.+|.+ .+.+++|||||+++|+|.+. .++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 89998898207881999999999899999987200---467999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 95248997788741299999998999999999999999976159-----9888815799975685489713892202410
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-----PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
|||++|+|.++|.+. .++|..++.++.+++.||.|||+.. .++|+||||||+|||++.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 646698989998658----9998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCC----
Q ss_conf 0489998644443356775675556863223698------897322355999999998379974332002443100----
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---- 673 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~---- 673 (810)
........ .........||+.|+|||++.... ++.++|||||||+||||+||.+|+............
T Consensus 157 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 157 RHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EEETTTTE--ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CCCCCCCC--EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCC
T ss_conf 34677762--0013552503547678221056545467776750122015999999962899887663112410122556
Q ss_pred ----CHHHH-HHHHHC-CCCC-----HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf ----03678-743207-9999-----467899999999975002899996110013589878974
Q 003576 674 ----DNLAE-ILDAQA-GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 727 (810)
Q Consensus 674 ----~~l~~-~ld~~~-~~~p-----~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~~ 727 (810)
..+.. ..+... +..| ......+.+|+.+||..+|.+||++. +++..|+++..-
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHH
T ss_conf 4309999998750246888776557768999999999997606985895999-999999988886
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=343.45 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=206.3
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCEEEEECEECCC------
Q ss_conf 217644402236770899999989--93899999705684---0059899999999815899566560300598------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 523 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~------ 523 (810)
.+.|.....||+|+||.||+|.+. +..||||++..... .....|.+|+.+|+.++|||||++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 72799952489977887412999999989999999999999999761599888815799975685489713892202410
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
.|+||||++||+|.+++...+ ++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120358---9999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHH
Q ss_conf 04899986444433567756755568632236988973223559999999983799743320024431000367874320
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
........ .......+||+.|+|||++.+..+++++|||||||++|+|+||++||......+. +...+...
T Consensus 160 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~ 230 (277)
T d1o6ya_ 160 AIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRED 230 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCC
T ss_pred HHCCCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCC
T ss_conf 21235443---3334642576243699998399999663202652899999769799899699999------99998469
Q ss_pred CC---CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 79---9994678999999999750028999961100135898789
Q 003576 684 AG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 684 ~~---~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~ 725 (810)
.. ..+...+..+.+|+.+||+.+|.+||+..++++..|.++.
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 999710034789999999999866797677739999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.48 Aligned_cols=242 Identities=21% Similarity=0.322 Sum_probs=192.6
Q ss_pred HCCCCCCE-EECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEECC------CC
Q ss_conf 21764440-2236770899999989--938999997056840059899999999815-89956656030059------87
Q 003576 455 TLSFSENL-RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------HG 524 (810)
Q Consensus 455 ~~~f~~~~-~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l-~Hpniv~l~g~~~~------~~ 524 (810)
.++|.... .||+|+||.||+|.+. +..||||++.. ...+.+|+.++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECC
Q ss_conf 279995248997788741299999998999999999999999976159988881579997568548---97138922024
Q 003576 525 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGL 601 (810)
Q Consensus 525 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~---~~~~kI~DFGl 601 (810)
|+|||||+||+|.+++...+. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 999977899849999986278-77579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHH
Q ss_conf 10048999864444335677567555686322369889732235599999999837997433200244310003678743
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 681 (810)
|+....... ....+||+.|+|||++.+..|+.++|||||||++|+|+||++||.......... .+...+.
T Consensus 161 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~ 230 (335)
T d2ozaa1 161 AKETTSHNS-------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIR 230 (335)
T ss_dssp CEECCCCCC-------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred EEECCCCCC-------CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HHHHHHH
T ss_conf 233368886-------432267756379277748988888888764516778865889988988778899---9999985
Q ss_pred HHCCCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 2079999----467899999999975002899996110
Q 003576 682 AQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 682 ~~~~~~p----~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.....+| ...++++.+|+.+||+.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 38888898543469999999999975699657909999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.30 Aligned_cols=243 Identities=19% Similarity=0.262 Sum_probs=198.5
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEE
Q ss_conf 217644402236770899999989--9389999970568400598999999998158995665603005987--279995
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 530 (810)
.+.|.....||+|+||.||+|.+. +..||+|++..... ....+.+|+.+|.+++|||||++++++.+.. ++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 0105887898317783999999989996999999757866-599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEEEECCCCCCCCC
Q ss_conf 2489977887412999999989999999999999999761599888815799975685489--71389220241004899
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--LVSKIGDVGLSTMLNSD 608 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~--~~~kI~DFGla~~~~~~ 608 (810)
|+||+|.+++...+ ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 89980889987538--99999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHHCCCCC
Q ss_conf 98644443356775675556863223698897322355999999998379974332002443100036787432079999
Q 003576 609 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 688 (810)
Q Consensus 609 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 688 (810)
.. .....||+.|++||...+..++.++|||||||++|+|+||++||......+ .+..++.. ...++
T Consensus 158 ~~-------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~-~~~~~ 223 (321)
T d1tkia_ 158 DN-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNA-EYTFD 223 (321)
T ss_dssp CE-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT-CCCCC
T ss_pred CC-------CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHC-CCCCC
T ss_conf 75-------321223322234021048777840113027999999982899999989999------99999838-99988
Q ss_pred H----HHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 4----67899999999975002899996110013
Q 003576 689 I----KETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 689 ~----~~~~~l~~li~~Cl~~~p~~RPs~~~~v~ 718 (810)
. ..+.++.+|+.+||..+|.+||++.+ ++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e-il 256 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASE-AL 256 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH-HH
T ss_pred HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HH
T ss_conf 0223678999999999986699668909999-96
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=332.19 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=198.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC---------CHHHHHHHHHHHHHCC-CCCEEEEECEECCC
Q ss_conf 17644402236770899999989--938999997056840---------0598999999998158-99566560300598
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---------QNKQFLQELEVLSKIR-HPHLLLLLGACPDH 523 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~---------~~~~f~~Ev~iL~~l~-Hpniv~l~g~~~~~ 523 (810)
.+|.....||+|+||+||+|+.. +..||||++...... ..+.+.+|+.+|++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred C--EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf 7--27999524899778874129999999899999999999999997615998888157999756854897138922024
Q 003576 524 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 601 (810)
Q Consensus 524 ~--~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGl 601 (810)
. +|||||+++|+|.++|...+ ++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 60599997689866899998659---9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCH
Q ss_conf 100489998644443356775675556863223------69889732235599999999837997433200244310003
Q 003576 602 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 675 (810)
Q Consensus 602 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~ 675 (810)
++.+..... .+...||+.|++||++. ...++.++||||+||++|+|+||++||........
T Consensus 157 a~~~~~~~~-------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------ 223 (277)
T d1phka_ 157 SCQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------ 223 (277)
T ss_dssp CEECCTTCC-------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred EEECCCCCC-------EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH------
T ss_conf 167268872-------1345246788898886053445678899233185656023103228889889999999------
Q ss_pred HHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 678743207---9999467899999999975002899996110
Q 003576 676 LAEILDAQA---GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 676 l~~~ld~~~---~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
+..++.... .......++++.+|+.+||+.+|.+||++.+
T Consensus 224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 9999818988898543468999999999976589668919999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.15 Aligned_cols=240 Identities=25% Similarity=0.296 Sum_probs=187.3
Q ss_pred CEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC-----CHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEEC
Q ss_conf 402236770899999989--938999997056840-----0598999999998158995665603005987--2799952
Q 003576 461 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 531 (810)
Q Consensus 461 ~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey~ 531 (810)
..+||+|+||+||+|.+. +..||||++...... ....+.+|+.+|++++|||||++++++.+.. ++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 48997788741299999998999999999999999976159988881579997568548971389220241004899986
Q 003576 532 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 611 (810)
Q Consensus 532 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~~ 611 (810)
.++++..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 45077655412---667789999999999999998863163---55035776258853778411465761000578755-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHH--------
Q ss_conf 444433567756755568632236-98897322355999999998379974332002443100036787432--------
Q 003576 612 VSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-------- 682 (810)
Q Consensus 612 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-------- 682 (810)
.....+||+.|+|||++.. ..++.++|||||||++|+|+||++||......+..... ...+..
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPD 227 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSS
T ss_pred -----CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHH---HHHCCCCCHHHCCC
T ss_conf -----4330204733363999726778880564363042899998596999999999999999---98518997254521
Q ss_pred -----------HCCCCC-----HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -----------079999-----467899999999975002899996110
Q 003576 683 -----------QAGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 683 -----------~~~~~p-----~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.....+ ...+..+.+|+.+||..||.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred HHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 0002134430347898867856568999999999976389456908999
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.12 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=192.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEE
Q ss_conf 17644402236770899999989--93899999705684--00598999999998158995665603005987--27999
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~E 529 (810)
++|....+||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+|++++|||||++++++.+.. ++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 52489977887412999999989999999999999999761599888815799975685489713892202410048999
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~ 609 (810)
|+.++ +.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCC-HHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 23774-455544202-568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCC---------HHHHH
Q ss_conf 8644443356775675556863223698-8973223559999999983799743320024431000---------36787
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLAEI 679 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~---------~l~~~ 679 (810)
. ......||+.|+|||.+.... ++.++|||||||++|+|++|++||...+......... .....
T Consensus 157 ~------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 R------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp B------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred C------CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 4------1001036521541122136657774221033331342796687998988999999999983289833314442
Q ss_pred --HHHHCCCCC-----------HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --432079999-----------467899999999975002899996110
Q 003576 680 --LDAQAGDWP-----------IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 680 --ld~~~~~~p-----------~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.......++ ...+.++.+|+.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e 279 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 2242124345432222044416678999999999976399557918999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.55 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=190.5
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC---CEEEEEEEECCCCC--CCHHHHHHHHHHHHHC---CCCCEEEEECEECC----
Q ss_conf 217644402236770899999989---93899999705684--0059899999999815---89956656030059----
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACPD---- 522 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~---~~~vAvK~l~~~~~--~~~~~f~~Ev~iL~~l---~Hpniv~l~g~~~~---- 522 (810)
.++|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred ---CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEE
Q ss_conf ---87279995248997788741299999998999999999999999976159988881579997568548971389220
Q 003576 523 ---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 523 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DF 599 (810)
..+++|||+.+|.+...... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 67469999974058714444430--3789998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHH---
Q ss_conf 24100489998644443356775675556863223698897322355999999998379974332002443100036---
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--- 676 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l--- 676 (810)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||++||......+.....-..
T Consensus 161 g~~~~~~~~~-------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred HHHHHHCCCC-------CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 0101100234-------577765485114831001798881110003289999998787998998989999999984079
Q ss_pred -------------HHHHHH----HCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -------------787432----079999467899999999975002899996110
Q 003576 677 -------------AEILDA----QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 677 -------------~~~ld~----~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
...... ....++...+..+.+|+.+||..||.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 96110532111103330223456454404458999999999987489667918999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.28 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=188.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEECC------C--CE
Q ss_conf 17644402236770899999989--93899999705684005989999999981589956656030059------8--72
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------H--GC 525 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~------~--~~ 525 (810)
..|...++||+|+||+||+|++. +..||||++..... .+.+|+.+|++++||||++++++|.. . .+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf 776751698217683999999999997999999881606----8999999998668989873878997447657731899
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCCC
Q ss_conf 7999524899778874129999999899999999999999997615998888157999756854897-138922024100
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTM 604 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~-~~kI~DFGla~~ 604 (810)
|||||+++|.+............+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 99841688607888863103689999999999999999999998668---764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCC---------C
Q ss_conf 489998644443356775675556863223-698897322355999999998379974332002443100---------0
Q 003576 605 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------D 674 (810)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~---------~ 674 (810)
+..... .....||+.|+|||.+. ...++.++|||||||++|||++|++||......+..... .
T Consensus 173 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 173 LVRGEP-------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CCTTSC-------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCC-------CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHH
T ss_conf 047765-------3200255555682776404688821000246527785502879989879999999999974898177
Q ss_pred HHHHHHHH----HCC---------CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 36787432----079---------999467899999999975002899996110013
Q 003576 675 NLAEILDA----QAG---------DWPIKETKELAALGLSCAELRRKDRPDLKNQVL 718 (810)
Q Consensus 675 ~l~~~ld~----~~~---------~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~ 718 (810)
.+...... ... ......++++.+|+.+||..||.+||++.+ ++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e-~L 301 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE-AC 301 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH-HH
T ss_pred HHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HH
T ss_conf 654306210110355445674444315689999999999976589557929999-96
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=321.21 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=196.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEE-CCC--CEEEEEE
Q ss_conf 17644402236770899999989--938999997056840059899999999815899566560300-598--7279995
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-PDH--GCLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~-~~~--~~lV~Ey 530 (810)
+.|.....||+|+||.||+|.+. +..||||++..... ...+.+|+++++.++|+|++.+++.| .+. .++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 889996898507880999999988998999999721005--888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCCCCC
Q ss_conf 24899778874129999999899999999999999997615998888157999756854---897138922024100489
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNS 607 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~---~~~~~kI~DFGla~~~~~ 607 (810)
+ +|+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-871333244306--88768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHH-HHCC
Q ss_conf 9986444-4335677567555686322369889732235599999999837997433200244310003678743-2079
Q 003576 608 DPSFVST-TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAG 685 (810)
Q Consensus 608 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~ 685 (810)
....... ........||+.|+|||++.+..++.++|||||||++|||+||++||.................... ....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 9994678999999999750028999961100135898789
Q 003576 686 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 725 (810)
Q Consensus 686 ~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~ 725 (810)
..+...+.++.+|+.+||..+|.+||++. .+...|+.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~~ 277 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLF 277 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHHH
T ss_pred HHCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 75347889999999998439955791999-9999999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.94 Aligned_cols=251 Identities=19% Similarity=0.261 Sum_probs=193.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCEEEEECEECCCC------E
Q ss_conf 217644402236770899999989--9389999970568-400598999999998158995665603005987------2
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG------C 525 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~------~ 525 (810)
+..|....+||+|+||+||+|... ++.||||++.... ....+.+++|+.+|.+++|||++++++++.... +
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 79995248997788741299999998999999999999999976159988881579997568548971389220241004
Q 003576 526 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 605 (810)
Q Consensus 526 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~ 605 (810)
++++|+.+|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999962598656644058----9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCH---------
Q ss_conf 8999864444335677567555686322-369889732235599999999837997433200244310003---------
Q 003576 606 NSDPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN--------- 675 (810)
Q Consensus 606 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~--------- 675 (810)
...... .......+||+.|+|||++ ....++.++||||+||++|+|+||++||..............
T Consensus 160 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCCCC---CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 477764---10101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred --------HHHHHHHH--CCCCC-----HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --------67874320--79999-----467899999999975002899996110
Q 003576 676 --------LAEILDAQ--AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 676 --------l~~~ld~~--~~~~p-----~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
........ ....+ ...+.++.+|+.+||..||..||++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 4234332222024467755778777837899999999999976489567908999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.27 Aligned_cols=234 Identities=23% Similarity=0.330 Sum_probs=191.3
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCC------CHHHHHHHHHHHHHCC--CCCEEEEECEECCCC
Q ss_conf 217644402236770899999989--938999997056840------0598999999998158--995665603005987
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI------QNKQFLQELEVLSKIR--HPHLLLLLGACPDHG 524 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ev~iL~~l~--Hpniv~l~g~~~~~~ 524 (810)
.+.|.....||+|+||.||+|.+. +..||||++...... ....+.+|+.+|++++ |||||++++++.+..
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred --EEEEEECCC-CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEEEC
Q ss_conf --279995248-9977887412999999989999999999999999761599888815799975685489-713892202
Q 003576 525 --CLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 600 (810)
Q Consensus 525 --~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~kI~DFG 600 (810)
++||||+.+ +++.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 68999983368622899986158---9999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHH
Q ss_conf 41004899986444433567756755568632236988-97322355999999998379974332002443100036787
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 679 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 679 (810)
+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|+|+||++||......
T Consensus 157 ~a~~~~~~~--------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------ 216 (273)
T d1xwsa_ 157 SGALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------ 216 (273)
T ss_dssp TCEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred CCEECCCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHH------------
T ss_conf 535324445--------566565877479999848997886533255403453675688998873677------------
Q ss_pred HHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 432079999467899999999975002899996110
Q 003576 680 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 680 ld~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
+. ....++...+.++.+|+.+||..+|.+||++.+
T Consensus 217 ~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 217 IR-GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp HH-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HH-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 61-544778779999999999976089758939999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.52 Aligned_cols=244 Identities=21% Similarity=0.285 Sum_probs=191.8
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEEECEECCC-------
Q ss_conf 217644402236770899999989--93899999705684--0059899999999815899566560300598-------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~------- 523 (810)
...|....+||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+|++++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred -CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf -7279995248997788741299999998999999999999999976159988881579997568548971389220241
Q 003576 524 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 602 (810)
Q Consensus 524 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla 602 (810)
.|+||||+ +++|...+.. . .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-E---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHH-C---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-5218999874-0---2269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCC--------
Q ss_conf 004899986444433567756755568632236-98897322355999999998379974332002443100--------
Q 003576 603 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 673 (810)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~-------- 673 (810)
+..... .+...||+.|+|||++.+ ..++.++||||+||++|+|++|++||............
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 206876---------31024553335889981787899650103003899999978699888976899999985037884
Q ss_pred ---------CHHHHHHHHH----CC---CCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf ---------0367874320----79---999467899999999975002899996110
Q 003576 674 ---------DNLAEILDAQ----AG---DWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 674 ---------~~l~~~ld~~----~~---~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.......... .. ......++.+.+|+.+||..+|.+||++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 8888653000344331157866655667755689999999999977299557929999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=314.61 Aligned_cols=263 Identities=16% Similarity=0.180 Sum_probs=200.2
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCEEEEECEECCCC--EEEEE
Q ss_conf 217644402236770899999989--93899999705684005989999999981589-95665603005987--27999
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~H-pniv~l~g~~~~~~--~lV~E 529 (810)
.++|....+||+|+||.||+|++. +..||||++..... ...+.+|+.++..+.| +|++.+++++.+.. ++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEEECCCCC
Q ss_conf 5248997788741299999998999999999999999976159988881579997568548-----97138922024100
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTM 604 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~-----~~~~kI~DFGla~~ 604 (810)
|+ +|+|.+.+...+. .+++..+..|+.+++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-8887999975203--1106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHHHH
Q ss_conf 4899986444-433567756755568632236988973223559999999983799743320024431000367874320
Q 003576 605 LNSDPSFVST-TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 683 (810)
Q Consensus 605 ~~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 683 (810)
+......... .......+||+.|+|||++.+..++.++|||||||++|+|+||+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf -7999946789999999997500289999611001358987897
Q 003576 684 -AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 726 (810)
Q Consensus 684 -~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~~v~~~L~~l~~ 726 (810)
....+...++++.+++..|+..+|.+||++. .+...|+.+..
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~-~l~~~l~~~~~ 278 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVLE 278 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHHH
T ss_pred CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHH
T ss_conf 95896579989999999998439930085999-99999999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=321.41 Aligned_cols=248 Identities=19% Similarity=0.270 Sum_probs=192.6
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC-CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEEE
Q ss_conf 17644402236770899999989-93899999705684--00598999999998158995665603005987--279995
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 530 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~--~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~Ey 530 (810)
++|....+||+|+||+||+|.+. +..||||++..... .....+.+|+.+|++++|||||+++++|.+.. ++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 24899778874129999999899999999999999997615998888157999756854897138922024100489998
Q 003576 531 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 610 (810)
Q Consensus 531 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~~ 610 (810)
+.++.+..+.... ..++...+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998604---77514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCH------------HH
Q ss_conf 6444433567756755568632236-9889732235599999999837997433200244310003------------67
Q 003576 611 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN------------LA 677 (810)
Q Consensus 611 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~------------l~ 677 (810)
......|++.|++||.+.. ..++.++|||||||++|+|++|++||......+....... ..
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf ------41010243110137887178888841002111758999977979989889899999999863899711042123
Q ss_pred HHHH--HHC--------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8743--207--------9999467899999999975002899996110
Q 003576 678 EILD--AQA--------GDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 678 ~~ld--~~~--------~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.... ... ...+...++.+.+|+.+||..||++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e 277 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 332214333335676466651258999999999986689668909999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=316.06 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=191.4
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCEEEEECEECC--------
Q ss_conf 217644402236770899999989--938999997056--84005989999999981589956656030059--------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 522 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~-------- 522 (810)
.++|....+||+|+||+||+|.+. +..||||++... .......+.+|+.+|++++|||++.+++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred --CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEEC
Q ss_conf --872799952489977887412999999989999999999999999761599888815799975685489713892202
Q 003576 523 --HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 600 (810)
Q Consensus 523 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFG 600 (810)
..++||||+.++.+...... ...++...+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 7638999853578741012220---344330899999999999998852299---8856767222036689968763135
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCH----
Q ss_conf 410048999864444335677567555686322369-889732235599999999837997433200244310003----
Q 003576 601 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---- 675 (810)
Q Consensus 601 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~---- 675 (810)
+++.+...... ........+||+.|+|||++.+. .++.++|||||||++|+|+||++||...+..........
T Consensus 163 ~~~~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEECCCCCCC--CCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf 00223554443--2113566024978742899707999891787006786466174487998998999999999984189
Q ss_pred -------------HHHHHHHHC-CCCC-------HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -------------678743207-9999-------467899999999975002899996110
Q 003576 676 -------------LAEILDAQA-GDWP-------IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 676 -------------l~~~ld~~~-~~~p-------~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
....+.... ...+ ....+.+.+|+.+||+.||++||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 9825534432034443320133445550334044459989999999987389658909999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.96 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCCCCEEECCCCCEEEEEEEE-----CCEEEEEEEECCCC----CCCHHHHHHHHHHHHHCCC-CCEEEEECEECCCC-
Q ss_conf 1764440223677089999998-----99389999970568----4005989999999981589-95665603005987-
Q 003576 456 LSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG- 524 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~iL~~l~H-pniv~l~g~~~~~~- 524 (810)
++|....+||+|+||.||+|.. .+..||||++.... ....+.+.+|+.+|.+++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred -EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf -2799952489977887412999999989999999999999999761599888815799975685489713892202410
Q 003576 525 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 525 -~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
++||||+.+|+|.+++...+. ++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 0012312341179999873045---437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCCHHHHHHH
Q ss_conf 048999864444335677567555686322369--889732235599999999837997433200244310003678743
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 681 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 681 (810)
.+..... .......|++.|++||.+... .++.++|||||||+||+|+||++||......... ..+....-
T Consensus 178 ~~~~~~~-----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~ 249 (322)
T d1vzoa_ 178 EFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRIL 249 (322)
T ss_dssp ECCGGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHH
T ss_pred HHCCCCC-----CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHCC
T ss_conf 2034444-----322122233333106876057768871325177779999997689998888777799---99998335
Q ss_pred HHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 207999946789999999997500289999611
Q 003576 682 AQAGDWPIKETKELAALGLSCAELRRKDRPDLK 714 (810)
Q Consensus 682 ~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~ 714 (810)
......|...+.++.+|+.+||..+|.+||++.
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCC
T ss_conf 689988654799999999997445898819997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.4e-45 Score=309.66 Aligned_cols=241 Identities=19% Similarity=0.312 Sum_probs=188.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEECEECCC----CEEEE
Q ss_conf 17644402236770899999989--9389999970568400598999999998158-99566560300598----72799
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH----GCLVY 528 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~-Hpniv~l~g~~~~~----~~lV~ 528 (810)
++|....+||+|+||+||+|++. +..||||++... ....+.+|+.+|..+. ||||+++++++... .++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEEECCCCCCCC
Q ss_conf 952489977887412999999989999999999999999761599888815799975685489-7138922024100489
Q 003576 529 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNS 607 (810)
Q Consensus 529 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~-~~~kI~DFGla~~~~~ 607 (810)
||+.+|+|.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHC-------CCHHHHH
Q ss_conf 99864444335677567555686322369-889732235599999999837997433200244310-------0036787
Q 003576 608 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-------EDNLAEI 679 (810)
Q Consensus 608 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~-------~~~l~~~ 679 (810)
... ....+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||........... .......
T Consensus 183 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TCC-------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHH
T ss_conf 874-------4432248642476102688888845232335455587604889998876018999999998788415555
Q ss_pred HHHH------------------------CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 4320------------------------79999467899999999975002899996110
Q 003576 680 LDAQ------------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 680 ld~~------------------------~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.... ........++++.+|+.+||..+|.+||++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 542254447430000033343311211552112448999999999986699568908999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=312.59 Aligned_cols=244 Identities=19% Similarity=0.219 Sum_probs=191.5
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCEEEEECEECCC--------
Q ss_conf 17644402236770899999989--9389999970568--40059899999999815899566560300598--------
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------- 523 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~-------- 523 (810)
+.|....+||+|+||+||+|.+. +..||||++.... ......+.+|+.+|++++|||||+++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 72799952489977887412999999989999999999999999761599888815799975685489713892202410
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
.|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHH-HHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 6999841446778-7650-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHC-----------
Q ss_conf 048999864444335677567555686322369889732235599999999837997433200244310-----------
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------- 672 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~----------- 672 (810)
...... ..+..+||+.|+|||++.+..+++++||||+||++|+|++|++||...+.......
T Consensus 168 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 146665-------5332214655558133147777877433356625789865989988897788999999720589879
Q ss_pred -----CCHHHHHHHHHC----------------C-C--CCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -----003678743207----------------9-9--99467899999999975002899996110
Q 003576 673 -----EDNLAEILDAQA----------------G-D--WPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 673 -----~~~l~~~ld~~~----------------~-~--~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
............ . . .+...+..+.+|+.+|+..+|.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 9987656677776417543566642126433354321013337999999999987699457908999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=304.96 Aligned_cols=248 Identities=19% Similarity=0.263 Sum_probs=193.2
Q ss_pred CCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEEECEECCCC--EEEEE
Q ss_conf 17644402236770899999989--93899999705684--00598999999998158995665603005987--27999
Q 003576 456 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 529 (810)
Q Consensus 456 ~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~~--~lV~E 529 (810)
+.|....+||+|+||+||+|++. +..||||+++.... .....+.+|+.+|+.++||||++++++|.+.. ++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 52489977887412999999989999999999999999761599888815799975685489713892202410048999
Q 003576 530 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 609 (810)
Q Consensus 530 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~~~~~~~ 609 (810)
++.+++|..++...+ .+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCCCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212356---5403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCCC-------------H
Q ss_conf 8644443356775675556863223698-8973223559999999983799743320024431000-------------3
Q 003576 610 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-------------N 675 (810)
Q Consensus 610 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~~-------------~ 675 (810)
.. .....+++.|++||++.... ++.++|||||||++|+|++|+.||.........+..- .
T Consensus 156 ~~------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 RC------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SC------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred CC------CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 51------001034431014667506988880444026541889985189999889999999999986118997355134
Q ss_pred HHHHHH----------HHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 678743----------2079999467899999999975002899996110
Q 003576 676 LAEILD----------AQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 676 l~~~ld----------~~~~~~p~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.....+ ......+...+..+.+|+.+|++.||++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 43222113344454431043306568999999999986499668909999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=307.25 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=191.1
Q ss_pred HCCCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCEEEEECEECCC-------
Q ss_conf 217644402236770899999989--93899999705684--0059899999999815899566560300598-------
Q 003576 455 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 523 (810)
Q Consensus 455 ~~~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~iL~~l~Hpniv~l~g~~~~~------- 523 (810)
...|....+||+|+||+||+|.+. +..||||++..... .....+.+|+.+|++++|||+|++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 72799952489977887412999999989999999999999999761599888815799975685489713892202410
Q 003576 524 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 524 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
.+++++|+.+|+|.+++... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 49999962588623200224----5309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHCC---------
Q ss_conf 048999864444335677567555686322369-8897322355999999998379974332002443100---------
Q 003576 604 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------- 673 (810)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~~--------- 673 (810)
.... ......||+.|+|||...+. .++.++|||||||++|+|++|++||...+........
T Consensus 170 ~~~~---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTG---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCC---------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 2575---------4444345435558355337756785512432058999997688997889889999999973079975
Q ss_pred --------CHHHHHHHHH--CCCCC-----HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --------0367874320--79999-----467899999999975002899996110
Q 003576 674 --------DNLAEILDAQ--AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 715 (810)
Q Consensus 674 --------~~l~~~ld~~--~~~~p-----~~~~~~l~~li~~Cl~~~p~~RPs~~~ 715 (810)
.......... ....+ ...+..+.+|+.+||..||.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 773200102445444303557875556626789999999999977588345938999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-40 Score=281.81 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=185.6
Q ss_pred CCCCCEEECCCCCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCEEEEECEECCC
Q ss_conf 7644402236770899999989--9389999970568400598999999998158-----------99566560300598
Q 003576 457 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------HPHLLLLLGACPDH 523 (810)
Q Consensus 457 ~f~~~~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~-----------Hpniv~l~g~~~~~ 523 (810)
.|....+||+|+||+||+|++. +..||||++..... ..+.+.+|+.+|..++ ||||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 57998997507781899999999997999999834313-36899999999998401455555422767647899876312
Q ss_pred ----CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC------
Q ss_conf ----72799952489977887412999999989999999999999999761-5998888157999756854897------
Q 003576 524 ----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL------ 592 (810)
Q Consensus 524 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~iiHrDLKp~NILl~~~~------ 592 (810)
.+++++++..+..............+++..+..++.+++.||.|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCCC
T ss_conf 565202343200035420000012234678689999999999999888764058---64656770570563057656443
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHC
Q ss_conf 13892202410048999864444335677567555686322369889732235599999999837997433200244310
Q 003576 593 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 672 (810)
Q Consensus 593 ~~kI~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDi~SlGvil~elltG~~Pf~~~~~~~~~~~ 672 (810)
.++++|||.+...... ....+||+.|+|||++....++.++||||+||++++|++|++||...........
T Consensus 170 ~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred EEEEEECCCCCCCCCC---------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 0567531442123445---------4223665210571321466777643201237899999878899898755432102
Q ss_pred CCHHHHHH-----------------------------------------HHHCCCCCHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 00367874-----------------------------------------3207999946789999999997500289999
Q 003576 673 EDNLAEIL-----------------------------------------DAQAGDWPIKETKELAALGLSCAELRRKDRP 711 (810)
Q Consensus 673 ~~~l~~~l-----------------------------------------d~~~~~~p~~~~~~l~~li~~Cl~~~p~~RP 711 (810)
...+...+ .......+...+..+.+|+.+|+..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 68999999983799878862453220001320122024323577644421000156743589999999998779945790
Q ss_pred CCCC
Q ss_conf 6110
Q 003576 712 DLKN 715 (810)
Q Consensus 712 s~~~ 715 (810)
|+.+
T Consensus 321 ta~e 324 (362)
T d1q8ya_ 321 DAGG 324 (362)
T ss_dssp CHHH
T ss_pred CHHH
T ss_conf 8999
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.91 E-value=1e-23 Score=170.52 Aligned_cols=149 Identities=25% Similarity=0.320 Sum_probs=124.1
Q ss_pred CCEEEEEECCCC---------CHHHHHHHHHHHCCCCCCC--EEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 856999853996---------6077799997513979995--49999840699977789755568999874356665478
Q 003576 14 ALSVAVAVKGNR---------KSRYAVLWALEKFIPEGIN--LFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDD 82 (810)
Q Consensus 14 ~~~I~VaVDgs~---------~S~~Al~wA~~~~~~~~~~--~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 82 (810)
+.||+||||||. +|++|++||++++.+.++. .|+++||.++....... .+......+
T Consensus 1 p~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~------------~~~~~~~~~ 68 (171)
T d2gm3a1 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDD------------VDSIYASPE 68 (171)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------------------CCCCSHH
T ss_pred CCEEEEEECCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCCCCCCC------------CCCCCCCHH
T ss_conf 98899997698566778999999999999999998779997289999954565434344------------444456777
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEECCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEECCCCCCCCCC
Q ss_conf 99999999999896653889997211542357999721538899999988539767897026889510000358986402
Q 003576 83 VAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRI 162 (810)
Q Consensus 83 ~~~~~~~~~~~~~~~~l~~~~~~c~~~~V~~e~~v~e~gd~~~~I~~~a~~~~i~~iVlGs~g~~~~~~~~~~~~lgs~~ 162 (810)
......++.+++++++|..+...|...++.++..+.+ |+|+++|+++|++.++|+||||++|++ ++++.++||++
T Consensus 69 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~----~~~~~~lGSv~ 143 (171)
T d2gm3a1 69 DFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLG----RFQKVFVGTVS 143 (171)
T ss_dssp HHHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC------------CHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHCCCCEEEEEEE-CCHHHHHHHHHHHCCCCEEEECCCCCC----CCCCCCCCCHH
T ss_conf 8999999999999999999999988639944799982-786999999876447757974367753----54557448699
Q ss_pred CCCCC-CCCEEEEEECCC
Q ss_conf 12258-862499984595
Q 003576 163 SICVP-SFCTVYGVEKGK 179 (810)
Q Consensus 163 ~~~~~-~~c~V~vV~~~~ 179 (810)
.+++. +.|||+||+++.
T Consensus 144 ~~vi~~~~cpVlvV~~~~ 161 (171)
T d2gm3a1 144 AFCVKHAECPVMTIKRNA 161 (171)
T ss_dssp HHHHHHCSSCEEEEECCG
T ss_pred HHHHHCCCCCEEEEECCC
T ss_conf 999838998989996898
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.89 E-value=9.4e-23 Score=164.19 Aligned_cols=157 Identities=10% Similarity=0.027 Sum_probs=126.4
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 98569998539966077799997513979995499998406999777897555689998743566654789999999999
Q 003576 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEK 92 (810)
Q Consensus 13 ~~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 92 (810)
.+++|+||||+|+.|.+|++||++.+...+. +|+++||.++......+. ... ...........++......+...
T Consensus 2 m~~~ILvavD~s~~s~~al~~a~~la~~~~a-~l~llhV~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~ 76 (160)
T d1mjha_ 2 MYKKILYPTDFSETAEIALKHVKAFKTLKAE-EVILLHVIDEREIKKRDI---FSL-LLGVAGLNKSVEEFENELKNKLT 76 (160)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHTCCSSCC-EEEEEEEEEGGGTC---------------------CHHHHHHHHHHHH
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHHHCCC-EEEEEEECCCCCCCCCCC---CCC-CCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 8682999987998999999999999875399-799998305665443333---222-24533222007889999999999
Q ss_pred HHHHHHHHHHHHHHHCCCEEEEEEEEECCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEECCCCCCCCCCCCCCC-CCCE
Q ss_conf 989665388999721154235799972153889999998853976789702688951000035898640212258-8624
Q 003576 93 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCT 171 (810)
Q Consensus 93 ~~~~~~l~~~~~~c~~~~V~~e~~v~e~gd~~~~I~~~a~~~~i~~iVlGs~g~~~~~~~~~~~~lgs~~~~~~~-~~c~ 171 (810)
+++++.+..+...|...|++++..+.. |+|+++|++++++.++|+||||++|++ ++++.++||++.++++ ++||
T Consensus 77 ~~~~~~l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~----~~~~~~~GS~a~~vl~~s~~p 151 (160)
T d1mjha_ 77 EEAKNKMENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKT----NLKEILLGSVTENVIKKSNKP 151 (160)
T ss_dssp HHHHHHHHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSS----CCTTCSSCHHHHHHHHHCCSC
T ss_pred HHHHHHHHHHHHHHHHCCCEEEEEEEE-CCHHHHHHHHHHCCCCCEEEECCCCCC----CCCCCCCCCHHHHHHHCCCCC
T ss_conf 999999999999987659769999994-558987766520242214776168998----642141070999999629998
Q ss_pred EEEEECCC
Q ss_conf 99984595
Q 003576 172 VYGVEKGK 179 (810)
Q Consensus 172 V~vV~~~~ 179 (810)
|+||++..
T Consensus 152 VlvV~~~~ 159 (160)
T d1mjha_ 152 VLVVKRKN 159 (160)
T ss_dssp EEEECCCC
T ss_pred EEEECCCC
T ss_conf 99982899
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=5.1e-23 Score=165.95 Aligned_cols=163 Identities=14% Similarity=0.077 Sum_probs=118.4
Q ss_pred CCCEEECCCCCEEEEEEEE-CCEEEEEEEECCCCCC------------------CHHHHHHHHHHHHHCCCCCEEEEECE
Q ss_conf 4440223677089999998-9938999997056840------------------05989999999981589956656030
Q 003576 459 SENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNI------------------QNKQFLQELEVLSKIRHPHLLLLLGA 519 (810)
Q Consensus 459 ~~~~~iG~G~~g~Vyk~~~-~~~~vAvK~l~~~~~~------------------~~~~f~~Ev~iL~~l~Hpniv~l~g~ 519 (810)
....+||+|+||.||+|.+ ++..||||+++..... ....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred ECCCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEE
Q ss_conf 05987279995248997788741299999998999999999999999976159988881579997568548971389220
Q 003576 520 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 599 (810)
Q Consensus 520 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iiHrDLKp~NILl~~~~~~kI~DF 599 (810)
. ..+++|||++++.+.. ++......++.+++.+|.|||..+ |+||||||+|||++.++ ++|+||
T Consensus 83 ~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 E--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp E--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCC
T ss_pred C--CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECCC-EEEEEC
T ss_conf 2--8889999504565420----------015789999999999999982688---89836890361142898-999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 241004899986444433567756755568------63223698897322355999999
Q 003576 600 GLSTMLNSDPSFVSTTYKNTGPVGTLCYID------PEYQRTGLISPKSDVYAYGMVIL 652 (810)
Q Consensus 600 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~a------PE~~~~~~~s~~sDi~SlGvil~ 652 (810)
|+|......... .|.. .+++ .+.|+.++|+||+.--++
T Consensus 147 G~a~~~~~~~~~--------------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR--------------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH--------------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCH--------------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 884308998709--------------99987799999997-578998446899999874
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.80 E-value=9.4e-20 Score=144.39 Aligned_cols=134 Identities=17% Similarity=0.171 Sum_probs=104.5
Q ss_pred CCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 85699985399660777999975139799954999984069997778975556899987435666547899999999999
Q 003576 14 ALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEKW 93 (810)
Q Consensus 14 ~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 93 (810)
|++|+||+|+|+.|.+|++||++.+...+. .|+|+||+++.... . .........++..+
T Consensus 1 yk~Ilv~~D~s~~s~~a~~~a~~~a~~~~~-~l~ll~V~~~~~~~-----------~---------~~~~~~~~~~~~~~ 59 (135)
T d2z3va1 1 FKTILLAYDGSEHARRAAEVAKAEAEAHGA-RLIVVHAYEPVPDY-----------L---------GEPFFEEALRRRLE 59 (135)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTC-EEEEEEEECCCCTT-----------C---------CTTHHHHHHHHHHH
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHHCCC-EEEEEEEECCCCCC-----------C---------CCCHHHHHHHHHHH
T ss_conf 998999978998999999999999998399-99999974577543-----------4---------65026899999999
Q ss_pred HHHHHHHHHHHHHHCCCEEEEEEEEECCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEECCCCCCCCCCCCCCC-CCCEE
Q ss_conf 89665388999721154235799972153889999998853976789702688951000035898640212258-86249
Q 003576 94 KTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCTV 172 (810)
Q Consensus 94 ~~~~~l~~~~~~c~~~~V~~e~~v~e~gd~~~~I~~~a~~~~i~~iVlGs~g~~~~~~~~~~~~lgs~~~~~~~-~~c~V 172 (810)
++++.+..+... .++.....++..|+|.++|++++.++++|+||||+++++ ++.+.++||++.++++ +.|||
T Consensus 60 ~~~~~l~~~~~~---~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~----~~~~~~~Gs~~~~ll~~~~~pV 132 (135)
T d2z3va1 60 RAEGVLEEARAL---TGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLG----ALGSLFLGSQSQRVVAEAPCPV 132 (135)
T ss_dssp HHHHHHHHHHHH---HCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSS----SCBCSSCBHHHHHHHHHCSSCE
T ss_pred HHHHHHHHHHHH---CCCCEEEEEEECCCHHHHHHHHHHHHHEEEEEECCCCCC----CCCCCCCCCHHHHHHHHCCCCE
T ss_conf 999999999986---699728999982776899998752000115775367998----5210413709999997099999
Q ss_pred EEE
Q ss_conf 998
Q 003576 173 YGV 175 (810)
Q Consensus 173 ~vV 175 (810)
+||
T Consensus 133 lvV 135 (135)
T d2z3va1 133 LLV 135 (135)
T ss_dssp EEE
T ss_pred EEC
T ss_conf 959
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.77 E-value=4.6e-19 Score=139.83 Aligned_cols=142 Identities=13% Similarity=-0.004 Sum_probs=108.3
Q ss_pred CCCCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9985699985399660777999975139799954999984069-997778975556899987435666547899999999
Q 003576 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPR-ITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQE 90 (810)
Q Consensus 12 ~~~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~-~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 90 (810)
..|++|+||||+|+.|.+|++||++.+.. .+. .+++|++.+ ....+.. ...........
T Consensus 3 ~~yk~ILv~vD~s~~s~~al~~A~~la~~-~~~-~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~ 62 (147)
T d1tq8a_ 3 SAYKTVVVGTDGSDSSMRAVDRAAQIAGA-DAK-LIIASAYLPQHEDARAA------------------DILKDESYKVT 62 (147)
T ss_dssp CCCCEEEEECCSSHHHHHHHHHHHHHHTT-TSE-EEEEEECCC-------------------------------------
T ss_pred CCCCEEEEEECCCHHHHHHHHHHHHHHHC-CCC-EEEEEEEECCCCCCCCC------------------CCCHHHHHHHH
T ss_conf 67897999988998999999999999861-898-79999994366654321------------------10002468999
Q ss_pred HHHHHHHHHHHHHHHHHCCCEEEEEEEEECCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEECCCCCCCCCCCCCCC-CC
Q ss_conf 99989665388999721154235799972153889999998853976789702688951000035898640212258-86
Q 003576 91 EKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SF 169 (810)
Q Consensus 91 ~~~~~~~~l~~~~~~c~~~~V~~e~~v~e~gd~~~~I~~~a~~~~i~~iVlGs~g~~~~~~~~~~~~lgs~~~~~~~-~~ 169 (810)
.++.+++.+..++..+.+.++......+..|++++.|+++++++++|+||||+++++ ++.+.++||++.+++. ++
T Consensus 63 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~----~~~~~l~Gs~~~~ll~~~~ 138 (147)
T d1tq8a_ 63 GTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLS----TIAGRLLGSVPANVSRRAK 138 (147)
T ss_dssp -CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCC----SHHHHHTBBHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCHHHHHHHHHHCCCEEEEEECCCCCC----CCCCCCCCCHHHHHHHHCC
T ss_conf 999999999999999987599738999984276999987642351369985578998----6332502649999997089
Q ss_pred CEEEEEEC
Q ss_conf 24999845
Q 003576 170 CTVYGVEK 177 (810)
Q Consensus 170 c~V~vV~~ 177 (810)
|||+||+.
T Consensus 139 ~pVlvV~~ 146 (147)
T d1tq8a_ 139 VDVLIVHT 146 (147)
T ss_dssp CEEEEECC
T ss_pred CCEEEEEC
T ss_conf 98899946
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.72 E-value=3.4e-18 Score=134.08 Aligned_cols=137 Identities=16% Similarity=0.126 Sum_probs=100.0
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 98569998539966077799997513979995499998406999777897555689998743566654789999999999
Q 003576 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEK 92 (810)
Q Consensus 13 ~~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 92 (810)
.|++|+||+|+|+.|+.|+.||+..+...++ .|+++||+++....... ..+...........
T Consensus 1 myk~ILv~vD~s~~s~~al~~A~~~a~~~~~-~v~~lhv~~~~~~~~~~-----------------~~~~~~~~~~~~~~ 62 (140)
T d1jmva_ 1 MYKHILVAVDLSEESPILLKKAVGIAKRHDA-KLSIIHVDVNFSDLYTG-----------------LIDVNMSSMQDRIS 62 (140)
T ss_dssp CCSEEEEEECCSTTHHHHHHHHHHHHHHHTC-EEEEEEEEECCGGGCCC-----------------CEEHHHHHHTTCCC
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHHHHHCCC-EEEEEEEEEECCCCCCC-----------------CCCCCHHHHHHHHH
T ss_conf 9870999987998999999999999987499-09999996404422123-----------------33223589999999
Q ss_pred HHHHHHHHHHHHHHHCCCEEEEEEEEECCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEECCCCCCCCCCCCCCC-CCCE
Q ss_conf 989665388999721154235799972153889999998853976789702688951000035898640212258-8624
Q 003576 93 WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP-SFCT 171 (810)
Q Consensus 93 ~~~~~~l~~~~~~c~~~~V~~e~~v~e~gd~~~~I~~~a~~~~i~~iVlGs~g~~~~~~~~~~~~lgs~~~~~~~-~~c~ 171 (810)
+...+.+.. .+...+......++..|+++++|+++++++++|+||||+++++ +. .+||++.++++ +.||
T Consensus 63 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~----~~---~lgs~~~~li~~~~~p 132 (140)
T d1jmva_ 63 TETQKALLD---LAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDF----WS---KLMSSTRQVMNTIKID 132 (140)
T ss_dssp CHHHHHHHH---HHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCC----HH---HHHHHHHHHHTTCCSE
T ss_pred HHHHHHHHH---HHHHCCCCEEEEEEEECCHHHHHHHHHHHCHHHEEEECCCCCC----CC---CCCCHHHHHHHCCCCC
T ss_conf 999999999---9985588617999981688999998640031428884058999----77---7353999998616998
Q ss_pred EEEEEC
Q ss_conf 999845
Q 003576 172 VYGVEK 177 (810)
Q Consensus 172 V~vV~~ 177 (810)
|+||+-
T Consensus 133 VliVp~ 138 (140)
T d1jmva_ 133 MLVVPL 138 (140)
T ss_dssp EEEEEC
T ss_pred EEEEEC
T ss_conf 999946
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.66 E-value=1.8e-17 Score=129.39 Aligned_cols=137 Identities=13% Similarity=0.059 Sum_probs=100.2
Q ss_pred CCCCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99856999853996607779999751397999549999840699977789755568999874356665478999999999
Q 003576 12 SPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEE 91 (810)
Q Consensus 12 ~~~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 91 (810)
..-++|+||+|+|+.|+.|+.||++.+...++ .++++||.++....... ... .+. + .. ....++.
T Consensus 2 ~~mk~ILv~~D~S~~s~~al~~A~~~a~~~~a-~l~llhv~~~~~~~~~~-~~~----~~~--~---~~----~~~~e~~ 66 (138)
T d1q77a_ 2 NAMKVLLVLTDAYSDCEKAITYAVNFSEKLGA-ELDILAVLEDVYNLERA-NVT----FGL--P---FP----PEIKEES 66 (138)
T ss_dssp CCCEEEEEEESTTCCCHHHHHHHHHHHTTTCC-EEEEEEECHHHHHHHHH-HHH----HCC--C---CC----THHHHHH
T ss_pred CCCCEEEEEEECCHHHHHHHHHHHHHHHHCCC-EEEEEEECCCCCCCCCC-CCC----CCC--C---HH----HHHHHHH
T ss_conf 87899999995999999999999996544054-38999973674333210-233----222--1---01----3456565
Q ss_pred HHHHHHHHHHHHHHHHCCCEEEEEEEEECCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEECCCCCCCCCCCCCCCCCCE
Q ss_conf 99896653889997211542357999721538899999988539767897026889510000358986402122588624
Q 003576 92 KWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCT 171 (810)
Q Consensus 92 ~~~~~~~l~~~~~~c~~~~V~~e~~v~e~gd~~~~I~~~a~~~~i~~iVlGs~g~~~~~~~~~~~~lgs~~~~~~~~~c~ 171 (810)
++.+++.+..+...+...++.++..+.. |+|++.|+++|++.++|+||||++|++ .+++..+| +.||
T Consensus 67 ~~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~----~l~r~l~g--------~~~~ 133 (138)
T d1q77a_ 67 KKRIERRLREVWEKLTGSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSA----YLCKVIDG--------LNLA 133 (138)
T ss_dssp HHHHHHHHHHHHHHHHSCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGG----GTHHHHHH--------SSSE
T ss_pred HHHCCCCCHHHCCCCCCCCEEEEEEEEC-CHHHHHHHHHHHHCCCCEEEEECCCCC----HHHHHHCC--------CCCC
T ss_conf 4311120022201122232147986402-304788887666426999999569976----78998559--------9988
Q ss_pred EEEEE
Q ss_conf 99984
Q 003576 172 VYGVE 176 (810)
Q Consensus 172 V~vV~ 176 (810)
++||+
T Consensus 134 ~livk 138 (138)
T d1q77a_ 134 SLIVK 138 (138)
T ss_dssp EEECC
T ss_pred EEEEC
T ss_conf 79869
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=8.7e-14 Score=105.03 Aligned_cols=70 Identities=27% Similarity=0.494 Sum_probs=65.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999976674100002597315998-201348799998628999998999999999860999999999850
Q 003576 740 PAPPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 809 (810)
Q Consensus 740 ~~~P~~f~cPi~~evM~dp~iaadg-~tye~~ai~~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~i~~~~~ 809 (810)
...|+.|+|||.+++|.||++...| +||++.+|+.||..+.++|+|+.+|...+|+||++||.+|++|+.
T Consensus 17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~ 87 (98)
T d1wgma_ 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTELKEKIQRWLA 87 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTTSCBCTTTCSBCCTTTSEECHHHHHHHHHHHH
T ss_pred CCCCHHHCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHCCHHHHHHHHHHHHH
T ss_conf 59907748867346887777623553201499999998706876655566640112013999999999999
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.21 E-value=8.6e-12 Score=91.88 Aligned_cols=71 Identities=38% Similarity=0.619 Sum_probs=66.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 999997667410000259731599820134879999862-89999989999999998609999999998509
Q 003576 740 PAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810 (810)
Q Consensus 740 ~~~P~~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~i~~~~~~ 810 (810)
...|++|.|||.+++|.||++...|+||++..|..|+.. +.++|.++.++...+|+||++||++|++|+.+
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~ 73 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISE 73 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCEECHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 989700118583732340330588685638899999863776578756665423555199999999999998
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.20 E-value=3.9e-12 Score=94.11 Aligned_cols=72 Identities=36% Similarity=0.711 Sum_probs=66.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 9999997667410000259731599820134879999862-89999989999999998609999999998509
Q 003576 739 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 810 (810)
Q Consensus 739 ~~~~P~~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~i~~~~~~ 810 (810)
.|.+|+.|.|||.+++|.||++...|++|++..|+.|+.. +.++|.++.++...+|+||++||++|++|+.+
T Consensus 2 ~peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~ 74 (78)
T d1t1ha_ 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCES 74 (78)
T ss_dssp CCCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCHHHCCEECCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 7989962799171812108337267774339999999998888788655637756562469999999999999
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=2e-08 Score=69.67 Aligned_cols=146 Identities=14% Similarity=0.059 Sum_probs=94.5
Q ss_pred HHHHHHCCCCCCEEECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEECEECC--CCEE
Q ss_conf 999862176444022367708999999899389999970568400598999999998158-9956656030059--8727
Q 003576 450 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCL 526 (810)
Q Consensus 450 ei~~~~~~f~~~~~iG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~-Hpniv~l~g~~~~--~~~l 526 (810)
++...-.+|......+.++.+.||+....+..+.+|+...........+.+|...+..+. +-.+..++..+.+ ..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEE
T ss_conf 99975135279976789987718999908986999984887653255699999999987606998728999750896499
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC---------------------------------
Q ss_conf 99952489977887412999999989999999999999999761599---------------------------------
Q 003576 527 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP--------------------------------- 573 (810)
Q Consensus 527 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~--------------------------------- 573 (810)
||++++|.++.+..... . ....++.+++..|..||+...
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEECCCCCCCCCCCCC-----C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 99860433435433440-----2---699999989999999855684214357644656555778998776555543033
Q ss_pred -----------------------CCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf -----------------------888815799975685489713892202410
Q 003576 574 -----------------------KPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 574 -----------------------~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 23200579999999984498678178986004764236499659996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=5.4e-06 Score=53.65 Aligned_cols=75 Identities=12% Similarity=0.024 Sum_probs=51.3
Q ss_pred EEECCCCCEEEEEEEEC--CEEEEEEEECCCC-------CCCHHHHHHHHHHHHHCC---CCCEEEEECEECCCCEEEEE
Q ss_conf 02236770899999989--9389999970568-------400598999999998158---99566560300598727999
Q 003576 462 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-------NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYE 529 (810)
Q Consensus 462 ~~iG~G~~g~Vyk~~~~--~~~vAvK~l~~~~-------~~~~~~f~~Ev~iL~~l~---Hpniv~l~g~~~~~~~lV~E 529 (810)
..||.|....||+.... +..+.+|.-.+.. .....+...|.+.|..+. ...++.++++..+...+|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCCCEEEEE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985988779871
Q ss_pred ECCCCCH
Q ss_conf 5248997
Q 003576 530 YMENGSL 536 (810)
Q Consensus 530 y~~~gsL 536 (810)
++++..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred CCCCCCC
T ss_conf 3577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=3.1e-05 Score=48.58 Aligned_cols=127 Identities=18% Similarity=0.142 Sum_probs=76.7
Q ss_pred EECCCCC-EEEEEEEECCE-EEEEEEECCCCCCCHHHHHHHHHHHHHCCC--CCEEEEECEECCCC--EEEEEECCCCCH
Q ss_conf 2236770-89999998993-899999705684005989999999981589--95665603005987--279995248997
Q 003576 463 RIGMGGY-GTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPDHG--CLVYEYMENGSL 536 (810)
Q Consensus 463 ~iG~G~~-g~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~H--pniv~l~g~~~~~~--~lV~Ey~~~gsL 536 (810)
.+..|.. +.||+....+. .+.+|...... ...+..|...|..+.. -.+..+++++.+.. ++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q ss_conf 7887412999999989999999999999999761----------------------------------------------
Q 003576 537 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN---------------------------------------------- 570 (810)
Q Consensus 537 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~---------------------------------------------- 570 (810)
.+.. .. ...++.++...|.-||.
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------26---899999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----C----CCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf -----5----99888815799975685489713892202410
Q 003576 571 -----T----KPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 571 -----~----~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
. .+..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 999871876579567867888763577379658999853326
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.95 E-value=1.3e-06 Score=57.79 Aligned_cols=52 Identities=19% Similarity=0.530 Sum_probs=48.4
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 6674100002597315-998201348799998628999998999999999860
Q 003576 746 FICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPN 797 (810)
Q Consensus 746 f~cPi~~evM~dp~ia-adg~tye~~ai~~wl~~~~~sP~t~~~l~~~~l~pn 797 (810)
.+|||.+++|.+|++. ..|++|++..|..||..+.++|+|+++|...+|+|.
T Consensus 1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHHHSBCTTTCCBCCGGGCEEC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHCEEC
T ss_conf 99936785688657457899845599999987603679854781887753647
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.60 E-value=0.0014 Score=37.80 Aligned_cols=158 Identities=15% Similarity=0.137 Sum_probs=81.4
Q ss_pred CCCCCCHHHHHHHHCCCC--CC---EEECCCCCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC--E
Q ss_conf 665679889998621764--44---02236770899999989-9389999970568400598999999998158995--6
Q 003576 442 RYRNLTWEEIESATLSFS--EN---LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--L 513 (810)
Q Consensus 442 ~~~~~~~~ei~~~~~~f~--~~---~~iG~G~~g~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpn--i 513 (810)
.|..++.+.|..+...+. .. ..|+ +---.||++... +..+++|+.++.. ....++..|...|..|.... +
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv 81 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 81 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCC-CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCC
T ss_conf 71666979999999975999775723256-61202699983899979999847877-88999999999999998559987
Q ss_pred EEEECE-------ECCCCEEEEEECCCCCHH--------------HHHHHC----C--CCCCCCHH--------------
Q ss_conf 656030-------059872799952489977--------------887412----9--99999989--------------
Q 003576 514 LLLLGA-------CPDHGCLVYEYMENGSLE--------------DRLYRK----N--NTPPIPWF-------------- 552 (810)
Q Consensus 514 v~l~g~-------~~~~~~lV~Ey~~~gsL~--------------~~l~~~----~--~~~~l~~~-------------- 552 (810)
+..+.. ..+..+.++++++|..+. -.++.. . .....++.
T Consensus 82 ~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~ 161 (325)
T d1zyla1 82 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 161 (325)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred CCCEECCCCEEEEEEEEEEEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 87520689805665347999986527768899999999998999999886303578655677897887665689998747
Q ss_pred --------HHHHHHHHHHHHHHHH-HHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf --------9999999999999997-61599888815799975685489713892202410
Q 003576 553 --------ERYRIAWEVASALAFL-HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 553 --------~~~~i~~~ia~aL~~L-H~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
....++..+...+.-+ ....+..+||+|+.|.|||++.+ ..++||+-|.
T Consensus 162 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 162 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEEECCCCCCCCEEEECC--CEEEECHHCC
T ss_conf 699889899999999999999984545687120247888042878389--3588652014
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.54 E-value=0.00049 Score=40.69 Aligned_cols=71 Identities=14% Similarity=0.156 Sum_probs=47.8
Q ss_pred EEECCCCCEEEEEEEECC---------EEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEECEECCCCEEEEEEC
Q ss_conf 022367708999999899---------389999970568400598999999998158-9956656030059872799952
Q 003576 462 LRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYM 531 (810)
Q Consensus 462 ~~iG~G~~g~Vyk~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~-Hpniv~l~g~~~~~~~lV~Ey~ 531 (810)
..|+.|-.-.+|++.... ..+.+++... .. ..-...+|..+++.+. +.-..+++++|.+ .+|+||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CC-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC--CEEEEEE
T ss_conf 9917853343489996887754457898179996599-61-165899999999999757999808998189--5699973
Q ss_pred CCCCH
Q ss_conf 48997
Q 003576 532 ENGSL 536 (810)
Q Consensus 532 ~~gsL 536 (810)
+|.+|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred CCCCC
T ss_conf 45548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.39 E-value=0.0033 Score=35.24 Aligned_cols=157 Identities=11% Similarity=0.047 Sum_probs=81.7
Q ss_pred CCCHHHHHHHHCCCCCCE-----EECCCCCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC--EEEEE
Q ss_conf 679889998621764440-----22367708999999899389999970568400598999999998158995--66560
Q 003576 445 NLTWEEIESATLSFSENL-----RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLLLL 517 (810)
Q Consensus 445 ~~~~~ei~~~~~~f~~~~-----~iG~G~~g~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~iL~~l~Hpn--iv~l~ 517 (810)
.++.++++....+|.... .|..|---+.|+....+..+++|+..... ....+..|+.+|..+...+ +...+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8899999999986799985685237888526738999789728999807899--98899999999875430255545564
Q ss_pred CEE--------CCCCEEEEEECCCCCHH--------------HHHHHCCC----CC---CCCH-----------------
Q ss_conf 300--------59872799952489977--------------88741299----99---9998-----------------
Q 003576 518 GAC--------PDHGCLVYEYMENGSLE--------------DRLYRKNN----TP---PIPW----------------- 551 (810)
Q Consensus 518 g~~--------~~~~~lV~Ey~~~gsL~--------------~~l~~~~~----~~---~l~~----------------- 551 (810)
-.. ......++.++.+.... ..++.... .. ...+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHH-HCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 999999999999999976-1599888815799975685489713892202410
Q 003576 552 FERYRIAWEVASALAFLH-NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 603 (810)
Q Consensus 552 ~~~~~i~~~ia~aL~~LH-~~~~~~iiHrDLKp~NILl~~~~~~kI~DFGla~ 603 (810)
......+..+...+.-.. ..-|.++||+|+.++||+++.+...-|+||+.|.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 12799999998764204855454503337863656402045412674222123
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.95 E-value=0.00084 Score=39.18 Aligned_cols=62 Identities=16% Similarity=0.185 Sum_probs=55.2
Q ss_pred CCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 76674100002597315-99820134879999862899999899999999986099999999985
Q 003576 745 HFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWK 808 (810)
Q Consensus 745 ~f~cPi~~evM~dp~ia-adg~tye~~ai~~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~i~~~~ 808 (810)
.+.|||-.++|.+|+.. .=|++|-+..|..|+. ..||..+.++...+|.||++|...|+.+.
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~--~~CP~Cr~~~~~~~l~~n~~l~~lv~~~~ 84 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG--TGCPVCYTPAWIQDLKINRQLDSMIQLCS 84 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT--TBCSSSCCBCSCSSCCCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHCCCEECCCCCCHHHHHHHHHHH--CCCCCCCCCCCHHHCCCCHHHHHHHHHHH
T ss_conf 2899258722112746588999302999999985--36662278676551860589999999999
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.94 E-value=0.0036 Score=34.97 Aligned_cols=64 Identities=14% Similarity=0.287 Sum_probs=57.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 76674100002597315998201348799998628---99999899999999986099999999985
Q 003576 745 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN---DKSPITDLPLPNKNLLPNYTLLSAILDWK 808 (810)
Q Consensus 745 ~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~~---~~sP~t~~~l~~~~l~pn~~l~~~i~~~~ 808 (810)
.+.|||-.++|.+|+...=|++|-+.-|..|+... ..+|+-+.++...+|.||+.|++.++.++
T Consensus 21 ~l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~ 87 (103)
T d1jm7a_ 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELL 87 (103)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHH
T ss_pred CCCCCCCCCHHCCEEECCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHCCCCHHHHHHHHHHH
T ss_conf 8499721823189188379986416789999997799980969888387552875789999999999
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.17 E-value=0.032 Score=28.74 Aligned_cols=60 Identities=18% Similarity=0.301 Sum_probs=53.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCC-CCHHHHHHH
Q ss_conf 7667410000259731599820134879999862-89999989999999998-609999999
Q 003576 745 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLL-PNYTLLSAI 804 (810)
Q Consensus 745 ~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~-~~~sP~t~~~l~~~~l~-pn~~l~~~i 804 (810)
.+.|||=.+.|.+|.+..=|++|=+.-|+.|+.. +.++|+-+.++...+|. |..++++.+
T Consensus 23 ~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l 84 (86)
T d1rmda2 23 SISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNIL 84 (86)
T ss_dssp HTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHH
T ss_pred CCCCCCCCCCHHCCEECCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHCCCHHHHHHHHH
T ss_conf 75995678444155526788763199999999648790703699799666359899999986
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=91.88 E-value=0.25 Score=22.83 Aligned_cols=102 Identities=13% Similarity=0.005 Sum_probs=61.4
Q ss_pred CCCCCCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 99998569998539966077799997513979995499998406999777897555689998743566654789999999
Q 003576 10 PNSPALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQ 89 (810)
Q Consensus 10 ~~~~~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 89 (810)
.-.+..+|+||+-|...|...|..+.......+...+.++||..... . ..
T Consensus 20 l~~~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r-------------------~----------~s- 69 (216)
T d1wy5a1 20 IFSGERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR-------------------E----------SA- 69 (216)
T ss_dssp SCSSCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS-------------------T----------HH-
T ss_pred CCCCCCEEEEEECCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC-------------------C----------CH-
T ss_conf 56899869999678599999999999998766877088887511234-------------------1----------03-
Q ss_pred HHHHHHHHHHHHHHHHHHCCCEEEEEEEEECC--------C--------HHHHHHHHHHHCCCCEEEEECCCCC
Q ss_conf 99998966538899972115423579997215--------3--------8899999988539767897026889
Q 003576 90 EEKWKTDRLLLPFRNMCAQRRVEVEVKVIESD--------D--------VAKAIADEVASCNINKLVIGAQSQG 147 (810)
Q Consensus 90 ~~~~~~~~~l~~~~~~c~~~~V~~e~~v~e~g--------d--------~~~~I~~~a~~~~i~~iVlGs~g~~ 147 (810)
.+-....+.+|...||.+...-+... . --..+.+++.+.+++.|++|-+..-
T Consensus 70 ------~~~~~~~~~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~dD 137 (216)
T d1wy5a1 70 ------ERDEEFCKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLND 137 (216)
T ss_dssp ------HHHHHHHHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHHH
T ss_pred ------HHHHHHHHHHHHHHHHHHHHHCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECCC
T ss_conf ------32134789999862000102102101111377644578799999887641111223121576520241
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.45 E-value=0.41 Score=21.41 Aligned_cols=51 Identities=12% Similarity=0.252 Sum_probs=45.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCCCCCC
Q ss_conf 7667410000259731599820134879999862-89999989999999998
Q 003576 745 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLL 795 (810)
Q Consensus 745 ~f~cPi~~evM~dp~iaadg~tye~~ai~~wl~~-~~~sP~t~~~l~~~~l~ 795 (810)
...|||-.+.+.+|.+..=|++|-+.-|..||.+ +.++|+.+..+.....+
T Consensus 23 ~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~~i 74 (79)
T d1fbva4 23 FQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEPI 74 (79)
T ss_dssp TTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCCCS
T ss_pred CCCCCCCCCCCCCEEEECCCCEEEHHHHHHHHHHCCCCCCCCCCCCCCCCEE
T ss_conf 8999358976899699589993529999999997858189979586477666
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=81.41 E-value=1 Score=18.84 Aligned_cols=97 Identities=16% Similarity=0.121 Sum_probs=54.4
Q ss_pred CCCEEEEEECCCCCHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 98569998539966077799997513979995499998406999777897555689998743566654789999999999
Q 003576 13 PALSVAVAVKGNRKSRYAVLWALEKFIPEGINLFKLLHVRPRITSVPTPTSLAIGHPVGNFIPIEQVRDDVAAAYKQEEK 92 (810)
Q Consensus 13 ~~~~I~VaVDgs~~S~~Al~wA~~~~~~~~~~~i~lvHV~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 92 (810)
+.++|+|||=|...|..++....+......+..++++||-.... +.
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r------------------~~---------------- 57 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS------------------AN---------------- 57 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC------------------SS----------------
T ss_pred CCCCEEEEECCCHHHHHHHHHHHHHHHHCCCCEEEEEEECCCCC------------------CC----------------
T ss_conf 89968999638499999999999998758895699998678987------------------52----------------
Q ss_pred HHHHHHHHHHHHHHHCCCEEEEEEEEECCC----------HHHHHHHHHHHCCCCEEEEECCC
Q ss_conf 989665388999721154235799972153----------88999999885397678970268
Q 003576 93 WKTDRLLLPFRNMCAQRRVEVEVKVIESDD----------VAKAIADEVASCNINKLVIGAQS 145 (810)
Q Consensus 93 ~~~~~~l~~~~~~c~~~~V~~e~~v~e~gd----------~~~~I~~~a~~~~i~~iVlGs~g 145 (810)
..........+|...++........... ............+.+.|++|-+.
T Consensus 58 --s~~~~~~~~~~~~~~~i~~~i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 58 --ADAWVTHCENVCQQWQVPLVVERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp --HHHHHHHHHHHHHHTTCCEEEECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred --HHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_conf --1445899999975415763266313333443036689999999888775203899999888
|